Citrus Sinensis ID: 048419
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 653 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M2S4 | 684 | L-type lectin-domain cont | yes | no | 0.970 | 0.926 | 0.439 | 1e-158 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.955 | 0.921 | 0.457 | 1e-157 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.963 | 0.933 | 0.442 | 1e-150 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.914 | 0.892 | 0.431 | 1e-148 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.952 | 0.929 | 0.445 | 1e-147 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.924 | 0.894 | 0.449 | 1e-147 | |
| O04534 | 666 | Putative L-type lectin-do | no | no | 0.898 | 0.881 | 0.431 | 1e-141 | |
| Q9FIF1 | 674 | Probable L-type lectin-do | no | no | 0.897 | 0.869 | 0.431 | 1e-133 | |
| Q9FIF0 | 694 | Putative L-type lectin-do | no | no | 0.917 | 0.863 | 0.411 | 1e-133 | |
| Q9LSR9 | 657 | L-type lectin-domain cont | no | no | 0.901 | 0.896 | 0.435 | 1e-132 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 558 bits (1437), Expect = e-158, Method: Compositional matrix adjust.
Identities = 288/656 (43%), Positives = 424/656 (64%), Gaps = 22/656 (3%)
Query: 11 FLYNGFLHA--NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFR 68
F + GF A NL+L G A I+ +G + +T +++ +IGHA Y P+RFK + A+ F
Sbjct: 26 FSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIGVNRALSFS 85
Query: 69 TNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEF 128
T+F +++P++ LGG GLAF I T L +Q+LGL N SS FS+ AVEF
Sbjct: 86 TSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLN---SSRVNFSSHFFAVEF 142
Query: 129 DIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQ 188
D +++ E DINDNHVGIDI+S+ SS S PA Y+ N+ + + L G IQAW+DY S
Sbjct: 143 DTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWIDYDSN 202
Query: 189 EMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248
+ ++V + P KP L+S +DLSSV+ + MY GFSASTGL+ +SH + GW+ ++
Sbjct: 203 KKRLDVKLSPFS-EKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMS 261
Query: 249 GKAQDLNPMKVPTLEKR-SHEVVQRRGFSVGITL-AGMAFLILIIAGAIHVLQRIKYADK 306
G+A L+ +P + +R+ +G++L + +++A ++ V++++K D+
Sbjct: 262 GEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVRKVKDEDR 321
Query: 307 MLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN 366
+E+WE+ G RF Y EL T GFG++ L+GSGGFG+VY+G +P VA+KRI H
Sbjct: 322 -VEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHE 380
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
S+QG++EF++E+ S+G LRHRNLVQL GWCR++D+LLLVYD++PNGSLD LFD++ ++
Sbjct: 381 SRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEV- 439
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
+LTW QR+KI+ G+A LLYLHE Q V+HRD+K +N+LLD+ +N ++GDFGLAK+YE
Sbjct: 440 -ILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYE 498
Query: 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
HG++P T +VGT GYLAPELT++GK TTSTDVY++G ++LEVACGRR IE EL+
Sbjct: 499 HGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELV 558
Query: 547 LVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605
+VDWV G+I +D+ L+ +D E +V+ LGL CS +P RP MR+VV +L
Sbjct: 559 MVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLE 618
Query: 606 GDSSLPPLPPDIHLKDTRNIMG----------FSDFPNDSDFFNSKLMSSQSNSFT 651
P + P D + M F DF + + F++ ++ S+ F+
Sbjct: 619 KQFPSPEVVPAPDFLDANDSMCLDERSGSAGEFEDFVDSARFYSGPNETTTSSIFS 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 555 bits (1429), Expect = e-157, Method: Compositional matrix adjust.
Identities = 292/638 (45%), Positives = 412/638 (64%), Gaps = 14/638 (2%)
Query: 1 MVVVHADTTSFLYNGFLH---ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFK 57
+++ + +F YNGF H ++SL+G A ++ +G+L +TN S GHA +RFK
Sbjct: 17 IMISSSQNLNFTYNGF-HPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFK 75
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S F T FVF+I + P L G G+AF++ T L +Q++GL NI S++
Sbjct: 76 DSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNI--SNNG 133
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
+ + AVEFD IQ++E D NDNHVGID++ L S+ A Y ++ + L S
Sbjct: 134 NDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHDKFQNLSLISRK 193
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS 237
IQ W+DY ++ I+V++ P KP +PL+S DLSS++ E MY GFS++TG + +
Sbjct: 194 RIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLSE 253
Query: 238 HNVHGWSISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHV 297
H + GWS + G+A L+ K+P L + + + +G+ L ++ + II A ++
Sbjct: 254 HFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEF-YKIGMPLISLSLIFSIIFLAFYI 312
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
++R K ++ L+DWE + G RF++ EL TKGF E++L+GSGGFGRVYRG++P+ LE
Sbjct: 313 VRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLE 372
Query: 358 VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKL 417
VA+KR+ H+S+QGMKEFVAEI+S+GR+ HRNLV L G+CR++ ELLLVYDY+PNGSLDK
Sbjct: 373 VAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKY 432
Query: 418 LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
L++ L W QR I+ G+A L YLHEE Q V+HRDVK SN+LLD N +LG
Sbjct: 433 LYNNPE---TTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLG 489
Query: 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
DFGLA++Y+HG++PQTTH+VGTLGYLAPE +RTG+ATT+TDVY++G +LEV GRR IE
Sbjct: 490 DFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIE 549
Query: 538 PQKAAAE-LLLVDWVKELHLEGEITQAIDQTLDY--YDLAEAELVLNLGLFCSAPNPVYR 594
A+ + LLV+WV L L G I +A D L YDL E E+VL LGL CS +P R
Sbjct: 550 FHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRAR 609
Query: 595 PDMRRVVEFLLGDSSLPPLPP-DIHLKDTRNIMGFSDF 631
P MR+V+++L GD +LP L P D+ N+ G F
Sbjct: 610 PSMRQVLQYLRGDMALPELTPLDLSAGSVMNLGGRDGF 647
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1367), Expect = e-150, Method: Compositional matrix adjust.
Identities = 285/644 (44%), Positives = 406/644 (63%), Gaps = 15/644 (2%)
Query: 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSV 63
+ + +F YN F N+S++G A ++++GIL +T+K+ GHA Y P+RFK S
Sbjct: 24 SQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSPNDT 83
Query: 64 AIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRM 123
F T FV I P + G G+AF I + +A+Q+LGL + +++ + +
Sbjct: 84 VSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGL--FSSTNNGNDTNHI 141
Query: 124 LAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWV 183
LAVEFD I N E D NDNHVGI+I+SL S S Y+ N + L S +Q WV
Sbjct: 142 LAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWV 201
Query: 184 DYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243
DY + I+V++ P G KP + L+S+ DLSSV + MY GFSA+TG + + H V GW
Sbjct: 202 DYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGW 261
Query: 244 SISIGGK-AQDLNPMKVPTLEKRSHEVVQR----RGFSVGITLAGMAFLILIIAGAIHVL 298
S + GK A L KVP + +QR R + L + F++ +I ++
Sbjct: 262 SFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFIV 321
Query: 299 QRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEV 358
+R + + EDWE + G R ++ +L TKGF +++L+GSGGFGRVYRG+MP+ E+
Sbjct: 322 RRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEI 381
Query: 359 AIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL 418
A+KR+ + S+QG+KEFVAEI+S+GR+ HRNLV L G+CR++DELLLVYDY+PNGSLDK L
Sbjct: 382 AVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYL 441
Query: 419 FDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478
+D L W QR+ ++IG+A L YLHEE Q V+HRD+K SN+LLD N +LGD
Sbjct: 442 YDCPE---VTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGD 498
Query: 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEP 538
FGLA++ +HG++PQTT +VGT GYLAP+ RTG+ATT+TDV+++G+L+LEVACGRR IE
Sbjct: 499 FGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEI 558
Query: 539 QKAAAE-LLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPD 596
+ + E +LLVD V +EG I A D L YD E E VL LGL CS +P RP
Sbjct: 559 EIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPT 618
Query: 597 MRRVVEFLLGDSSLPPLPPDIHLKDTRNIMGFSDFPNDSDFFNS 640
MR+V+++L GD++LP L P + + + ++G + ++S F+S
Sbjct: 619 MRQVLQYLRGDATLPDLSP-LDFRGSGKMLGMNHRFSESCTFSS 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1355), Expect = e-148, Method: Compositional matrix adjust.
Identities = 264/612 (43%), Positives = 396/612 (64%), Gaps = 15/612 (2%)
Query: 5 HADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVA 64
++ F +NG+L+ N G A ++ G++ +TN SE GH Y +P+RFK S
Sbjct: 22 QSEEGEFGFNGYLYDN---SGIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGTV 78
Query: 65 IDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRML 124
F T FVF+I+ L G GLAF+I T ++Q+LGL N+T + S ++
Sbjct: 79 SSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDP--SNHIV 136
Query: 125 AVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIP-ILLRSGDPIQAWV 183
AVEFD QN E D+++NHVGIDI+SL S + A YY ++ I L + PIQAW+
Sbjct: 137 AVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWI 196
Query: 184 DYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243
+Y S +NV+I P+ +PKP PL+SL DLS + + MY GF+++TG + +SH + GW
Sbjct: 197 EYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGW 256
Query: 244 SISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKY 303
+ + G A +++ ++P L + S ++ ++ ++L +A L+ + + L+R K
Sbjct: 257 TFKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKKL 316
Query: 304 ADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI 363
+ +LEDWE+Q G RF Y +L TKGF L+G GGFG+VY+G + + +++A+K++
Sbjct: 317 ME-VLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKV 375
Query: 364 GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDH 423
H+S+QGM+EFVAEI ++GRLRH NLV+L G+CR++ EL LVYD +P GSLDK L+ H
Sbjct: 376 SHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLY---H 432
Query: 424 KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483
+ + L W QR+KI+ +A L YLH + Q ++HRD+KP+N+LLD +N KLGDFGLAK
Sbjct: 433 QPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAK 492
Query: 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA- 542
+ EHG +PQT+++ GT GY++PEL+RTGKA+TS+DV+++GILMLE+ CGRR + P+ ++
Sbjct: 493 LCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSP 552
Query: 543 AELLLVDWVKELHLEGEITQAIDQTL---DYYDLAEAELVLNLGLFCSAPNPVYRPDMRR 599
+E++L DWV + E +I Q +D+ + D Y + LVL LGLFCS P RP M
Sbjct: 553 SEMVLTDWVLDC-WEDDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSS 611
Query: 600 VVEFLLGDSSLP 611
V++FL G + LP
Sbjct: 612 VIQFLDGVAQLP 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1347), Expect = e-147, Method: Compositional matrix adjust.
Identities = 284/637 (44%), Positives = 404/637 (63%), Gaps = 15/637 (2%)
Query: 11 FLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFR 68
F YNGF ++S+ G A I+ +G+L +TN + GHA Y P+RFK S F
Sbjct: 28 FTYNGFRPPPTDISILGIATITPNGLLKLTNTTMQSTGHAFYTKPIRFKDSPNGTVSSFS 87
Query: 69 TNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEF 128
T FVF+I + P G+AF+I R Q+LGL N+T + + + + AVE
Sbjct: 88 TTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPLQYLGLFNVTNNGNVR--NHVFAVEL 143
Query: 129 DIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQ 188
D I N E D N+NHVGIDI+SL S S PA Y+ N+ + L S +Q WVD+
Sbjct: 144 DTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQFHNLTLISSKRMQVWVDFDGP 203
Query: 189 EMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248
LI+V++ P G KP +PL+S+ DLSSV+ + M+ GFS++TG I + V GWS +
Sbjct: 204 THLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVSEIFVLGWSFGVN 263
Query: 249 GKAQDLNPMKVPTL---EKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKYAD 305
G+AQ L K+P L + + V + V + + +LII +++R +
Sbjct: 264 GEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIPFLLIIFLVRFIMKRRRKFA 323
Query: 306 KMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH 365
+ +EDWE + G R ++ +L TKGF ++N++GSGGFG VY+G+MP E+A+KR+ +
Sbjct: 324 EEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKRVSN 383
Query: 366 NSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL 425
S+QG+KEFVAEI+S+G++ HRNLV L G+CR++DELLLVYDY+PNGSLDK L++
Sbjct: 384 ESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEVT 443
Query: 426 RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485
L W QR+K++ G+A +L YLHEE Q V+HRDVK SN+LLD LN +LGDFGLA++
Sbjct: 444 ---LDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLC 500
Query: 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE- 544
+HG++PQTT +VGT GYLAP+ RTG+ATT+TDV+++G+L+LEVACGRR IE + E
Sbjct: 501 DHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGER 560
Query: 545 LLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603
++LVDWV +E I A D L YD E E+VL LGL CS +P+ RP MR+V+++
Sbjct: 561 VVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQY 620
Query: 604 LLGDSSLPPLPPDIHLKDTRNIMGFSDFPNDSDFFNS 640
L GD+ LP L P + L+ + ++G + N+S F S
Sbjct: 621 LRGDAMLPDLSP-LDLRGSGIMLGTHNGSNESGMFTS 656
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1342), Expect = e-147, Method: Compositional matrix adjust.
Identities = 276/614 (44%), Positives = 391/614 (63%), Gaps = 10/614 (1%)
Query: 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSV 63
+ + +F YN + +LS++G ++ +G+L +TN + GHA Y P+RFK S
Sbjct: 22 SQSLNFAYNNGFNPPTDLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKDSPNGT 81
Query: 64 AIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRM 123
F T+FVF+I + L G G+AF++ +Q++GL N+ + + + +
Sbjct: 82 VSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNE--TNHV 139
Query: 124 LAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWV 183
AVE D I +TE D NDNHVGIDI+SL S S PA Y+ + L S P+Q WV
Sbjct: 140 FAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRKPMQVWV 199
Query: 184 DYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243
DY + I+V++ P KP RPL++ DLSSV+ + MY GFS++TG + + H + GW
Sbjct: 200 DYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYILGW 259
Query: 244 SISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKY 303
S + KA L ++P L + + + + +G+ L + + I ++++R +
Sbjct: 260 SFGLNEKAPPLALSRLPKLPRFEPKRISEF-YKIGMPLISLFLIFSFIFLVCYIVRRRRK 318
Query: 304 ADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI 363
+ LE+WE + G RF++ +L TKGF E+ L+G+GGFG VY+G+MP LE+A+KR+
Sbjct: 319 FAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRV 378
Query: 364 GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDH 423
H S+QGMKEFVAEI+S+GR+ HRNLV L G+CR++ ELLLVYDY+PNGSLDK L++
Sbjct: 379 SHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPE 438
Query: 424 KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483
L W QR K+++G+A L YLHEE Q V+HRDVK SN+LLD LN +LGDFGLA+
Sbjct: 439 VT---LNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 495
Query: 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA 543
+Y+HG++PQTTH+VGTLGYLAPE TRTG+AT +TDV+++G +LEVACGRR IE Q+
Sbjct: 496 LYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETD 555
Query: 544 E-LLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601
E LLVDWV L +G+I A D + D E E+VL LGL CS +P RP MR+V+
Sbjct: 556 ETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVL 615
Query: 602 EFLLGDSSLPPLPP 615
+L GD+ LP L P
Sbjct: 616 HYLRGDAKLPELSP 629
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1296), Expect = e-141, Method: Compositional matrix adjust.
Identities = 257/596 (43%), Positives = 377/596 (63%), Gaps = 9/596 (1%)
Query: 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78
N+ G+AYI+ +G++ +TN + G Y + LRFK S F T FVFSI
Sbjct: 32 GNMYTSGSAYINNNGLIRLTNSTPQTTGQVFYNDQLRFKNSVNGTVSSFSTTFVFSIEFH 91
Query: 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELID 138
GG G+AF+I T +LGL N + K ++AVE D + + D
Sbjct: 92 NGIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDPK--NHIVAVELDTKVDQQFED 149
Query: 139 INDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICP 198
+ NHVGIDI++L+S A YY N +LL SG P+Q W++Y S++ INV++ P
Sbjct: 150 KDANHVGIDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHP 209
Query: 199 LGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIGGKAQDLNPMK 258
L VPKP PL+SL DLS + E MY GF+++TG +TASH + GW+ + G D++P +
Sbjct: 210 LYVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPDIDPSR 269
Query: 259 VPTLEKRSHEVVQRRG--FSVGITLAGMAFLILIIAGAIHVLQRIKYADKMLEDWEIQCG 316
+P + + + +Q ++ +T++G+ LI++ L+R K + +LEDWE+Q G
Sbjct: 270 LPKIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLFLKRKKLLE-VLEDWEVQFG 328
Query: 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA 376
RF + +L TKGF + ++G GGFG+VY+G +P +E+A+K + H+S+QGM+EF+A
Sbjct: 329 PHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIA 388
Query: 377 EIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK 436
EI ++GRLRH NLV+L G+CR + EL LVYD + GSLDK L+ H+ L W QR+K
Sbjct: 389 EIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLY---HQQTGNLDWSQRFK 445
Query: 437 ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI 496
I+ +A L YLH++ Q ++HRD+KP+NILLD +NAKLGDFGLAK+ +HG +PQT+H+
Sbjct: 446 IIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHV 505
Query: 497 VGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556
GTLGY++PEL+RTGKA+T +DV+++GI+MLE+ACGR+ I P+ + E++L DWV E
Sbjct: 506 AGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWE 565
Query: 557 EGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLP 611
+I Q +D + Y +A LVL LGLFCS P RP+M V++ L + LP
Sbjct: 566 NEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQLP 621
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 475 bits (1223), Expect = e-133, Method: Compositional matrix adjust.
Identities = 268/621 (43%), Positives = 384/621 (61%), Gaps = 35/621 (5%)
Query: 11 FLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTN 70
F+Y F +A+L L+G A + G L +TN + GHA Y P++F S+ S
Sbjct: 30 FVYYDFRNADLELDGMAN-TNHGPLHLTNNTNTGTGHAFYNIPIKFTASSLSSFSFSTEF 88
Query: 71 FVFSILPKYPDLGGQGLAFIIIST-NRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFD 129
+I P G G+AF++ T + N AN LG+ N ++ K +T + AVE D
Sbjct: 89 VF-AIFPLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFN--RANDNKTATHIFAVELD 145
Query: 130 IIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHR-IPILLRSGDPIQAWVDYSSQ 188
QN+E D N VGIDI+S++S S ASY++ + I + L SG I W+DY
Sbjct: 146 TNQNSESFDKGGNDVGIDINSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGI 205
Query: 189 EMLINVSICPLGVPKPYRP-----------LISLPIDLSSVIDEYMYTGFSASTGLITAS 237
E ++NV++ P+ PKP P L+S I+LS + E MY GFS STG I ++
Sbjct: 206 EKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTGSIKSN 265
Query: 238 HNVHGWSISIGGKAQDLNPMKV---PTLEKRS--HEVVQRRGFSVGITLAGMAFLILIIA 292
+ GWS GGKA+ L+ ++ P KR EV+ G T++ +AFL L
Sbjct: 266 QYILGWSFKQGGKAESLDISRLSNPPPSPKRFPLKEVL-------GATISTIAFLTL--G 316
Query: 293 GAIHVLQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMP 352
G +++ ++ KYA+ +LE WE + +R+ + L TKGF E L+G+GGFG+VY+G++P
Sbjct: 317 GIVYLYKKKKYAE-VLEQWEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILP 375
Query: 353 SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412
S G ++A+KR+ H+++QGMK++VAEI SMGRLRH+NLV L G+CR++ ELLLVYDY+PNG
Sbjct: 376 S-GTQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNG 434
Query: 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472
SLD LF K+ KL+ L TW QR I+ G+A +LLYLHEE Q V+HRD+K SNILLD L
Sbjct: 435 SLDDYLFHKN-KLKDL-TWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADL 492
Query: 473 NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532
N KLGDFGLA+ ++ G N + T +VGT+GY+APELT G TT TDVY++G +LEV CG
Sbjct: 493 NGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCG 552
Query: 533 RRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPV 592
RR ++P +++LV WV +T +D L + + EA+L+L LG+ CS NP
Sbjct: 553 RRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLIDFKVEEAKLLLKLGMLCSQINPE 612
Query: 593 YRPDMRRVVEFLLGDSSLPPL 613
RP MR+++++L G+ S+P +
Sbjct: 613 NRPSMRQILQYLEGNVSVPAI 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF0|LRK22_ARATH Putative L-type lectin-domain containing receptor kinase II.2 OS=Arabidopsis thaliana GN=LECRK22 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 268/652 (41%), Positives = 392/652 (60%), Gaps = 53/652 (8%)
Query: 2 VVVHADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNK 61
+V+ D F+Y+ F A+L L+G A I G L +TN + GHA + P+ F TS
Sbjct: 21 LVLAQDRDEFVYHDFSQADLHLDGMASID-DGRLHLTNNTTKSTGHAFWKIPMNFTTSPS 79
Query: 62 SVAIDFRTNFVFSILPKYPDLGGQGLAFIIIS-TNRPENCLANQFLGLPNITMSSSTKFS 120
S T FVF+I P D GQG+AF++ + + A +LGL N + K
Sbjct: 80 SSLSF-STEFVFAIFPLLGD--GQGMAFVVAPFMDIRYSGDAASYLGLFN--RKNDNKTE 134
Query: 121 TRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHR-IPILLRSGDPI 179
+LAVE D + E I+ +DNHVGIDI+S+IS S ASY+SG + I L S I
Sbjct: 135 NHILAVELDTNSSPEAIEDSDNHVGIDINSIISEDSANASYFSGTEGKNISFRLASEKSI 194
Query: 180 QAWVDYSSQEMLINVSICPLGVPKP-----------YRPLISLPIDLSSVIDEYMYTGFS 228
W+DY+ E L+NV++ P+ PKP +PL+S I++S + + M+ GFS
Sbjct: 195 LVWIDYNGTEKLLNVTVAPVPTPKPALPYLSSSIKPRKPLLSRFINISEIFNGTMFVGFS 254
Query: 229 ASTGLITASHNVHGWSISIGGKAQDLNPMKV------------------------PTLEK 264
STG + + + GWS GG+A+ L+ K+ + K
Sbjct: 255 GSTGTVKSDQYILGWSFKKGGQAESLDLSKILDPPNRPPPPSSPPPPPPPPPTPPTSRSK 314
Query: 265 RSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKYADKMLEDWEIQCGARRFKYAE 324
S ++ + +T+ +AFL L++ G +++ ++ KYA+ +LE WE + +R+ +
Sbjct: 315 DSKNII-----IICVTVTSIAFL-LMLGGFLYLYKKKKYAE-VLEHWENEYSPQRYSFRN 367
Query: 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL 384
L +GF E L+G+GGFG+VY+G +PS G ++A+KR+ HN++QGMK++ AEI SMGRL
Sbjct: 368 LYKAIRGFRENRLLGAGGFGKVYKGELPS-GTQIAVKRVYHNAEQGMKQYAAEIASMGRL 426
Query: 385 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS 444
RH+NLVQL G+CR++ ELLLVYDY+PNGSLD LF+K+ KL+ L TW QR I+ G+A +
Sbjct: 427 RHKNLVQLLGYCRRKGELLLVYDYMPNGSLDDYLFNKN-KLKDL-TWSQRVNIIKGVASA 484
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
LLYLHEE Q V+HRD+K SNILLD LN +LGDFGLA+ ++ G N Q T +VGT+GY+A
Sbjct: 485 LLYLHEEWEQVVLHRDIKASNILLDADLNGRLGDFGLARFHDRGENLQATRVVGTIGYMA 544
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564
PELT G ATT TD+Y++G +LEV CGRR +EP + ++ L+ WV + +
Sbjct: 545 PELTAMGVATTKTDIYAFGSFILEVVCGRRPVEPDRPPEQMHLLKWVATCGKRDTLMDVV 604
Query: 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLPPLPPD 616
D L + EA+L+L LG+ CS NP RP MR ++++L G++++P + D
Sbjct: 605 DSKLGDFKAKEAKLLLKLGMLCSQSNPESRPSMRHIIQYLEGNATIPSISFD 656
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LSR9|LRK18_ARATH L-type lectin-domain containing receptor kinase I.8 OS=Arabidopsis thaliana GN=LECRK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1212), Expect = e-132, Method: Compositional matrix adjust.
Identities = 266/611 (43%), Positives = 373/611 (61%), Gaps = 22/611 (3%)
Query: 9 TSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFR 68
T F +NGF +L ++G A I G+L +T+ SE GHA + PL F N S + F
Sbjct: 26 TGFSFNGFRQGDLHVDGVAQILPGGLLRLTDTSEQKKGHAFFRQPLVF---NSSEPLSFS 82
Query: 69 TNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEF 128
T+FV +++ K GG G+AF + + N A Q+LGL N T + S S+ + A+E
Sbjct: 83 THFVCAMVRKPGVTGGNGIAFFLSPSMDLTNADATQYLGLFNTTTNRSP--SSHIFAIEL 140
Query: 129 DIIQNTELIDINDNHVGIDISSLISSASEPASYYS---GNNHRIPILLRSGDPIQAWVDY 185
D +Q+ E DI++NHVGID++SL S S PASY+S G N I +L SGD IQ WVD+
Sbjct: 141 DTVQSAEFDDIDNNHVGIDVNSLTSVESAPASYFSDKKGLNKSISLL--SGDSIQVWVDF 198
Query: 186 SSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSI 245
++NVS+ PLG+ KP + LIS ++LS VI + M+ GFSA+TG + +H + GWS
Sbjct: 199 DG--TVLNVSLAPLGIRKPSQSLISRSMNLSEVIQDRMFVGFSAATGQLANNHYILGWSF 256
Query: 246 SIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKYAD 305
S L + + L + H ++ + + + L++++ GA ++ +R KYA+
Sbjct: 257 S--RSKASLQSLDISKLPQVPHPKMKTSLLLILLLIVLGIILLVLLVGA-YLYRRNKYAE 313
Query: 306 KMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH 365
+ E+WE + G R+ Y L TKGF + +G GGFG VY+G +P ++A+KR H
Sbjct: 314 -VREEWEKEYGPHRYSYKSLYKATKGFHKDGFLGKGGFGEVYKGTLPQE--DIAVKRFSH 370
Query: 366 NSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL 425
+ ++GMK+FVAEI SMG L HRNLV L G+CR++ E LLV Y+PNGSLD+ LF H
Sbjct: 371 HGERGMKQFVAEIASMGCLDHRNLVPLFGYCRRKGEFLLVSKYMPNGSLDQFLF---HNR 427
Query: 426 RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485
LTW +R IL GIA +L YLH E Q V+HRD+K SN++LDT KLGDFG+A+ +
Sbjct: 428 EPSLTWSKRLGILKGIASALKYLHTEATQVVLHRDIKASNVMLDTDFTGKLGDFGMARFH 487
Query: 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL 545
+HGANP TT VGT+GY+ PELT G A+T TDVY++G L+LEV CGRR +EP +
Sbjct: 488 DHGANPTTTGAVGTVGYMGPELTSMG-ASTKTDVYAFGALILEVTCGRRPVEPNLPIEKQ 546
Query: 546 LLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605
LLV WV + ++ A D L + + E+VL LGL C+ P RPDM +VV++L
Sbjct: 547 LLVKWVCDCWKRKDLISARDPKLSGELIPQIEMVLKLGLLCTNLVPESRPDMVKVVQYLD 606
Query: 606 GDSSLPPLPPD 616
SLP PD
Sbjct: 607 RQVSLPDFSPD 617
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 653 | ||||||
| 147860501 | 625 | hypothetical protein VITISV_016437 [Viti | 0.917 | 0.958 | 0.637 | 0.0 | |
| 356528060 | 666 | PREDICTED: L-type lectin-domain containi | 0.940 | 0.921 | 0.621 | 0.0 | |
| 359481749 | 1258 | PREDICTED: L-type lectin-domain containi | 0.947 | 0.492 | 0.492 | 1e-167 | |
| 449439978 | 683 | PREDICTED: L-type lectin-domain containi | 0.958 | 0.916 | 0.472 | 1e-167 | |
| 225449434 | 679 | PREDICTED: L-type lectin-domain containi | 0.901 | 0.867 | 0.495 | 1e-166 | |
| 255559006 | 667 | kinase, putative [Ricinus communis] gi|2 | 0.911 | 0.892 | 0.489 | 1e-166 | |
| 356567976 | 674 | PREDICTED: L-type lectin-domain containi | 0.957 | 0.927 | 0.474 | 1e-165 | |
| 255584540 | 683 | kinase, putative [Ricinus communis] gi|2 | 0.918 | 0.878 | 0.479 | 1e-164 | |
| 225439478 | 680 | PREDICTED: L-type lectin-domain containi | 0.918 | 0.882 | 0.478 | 1e-164 | |
| 255558978 | 662 | kinase, putative [Ricinus communis] gi|2 | 0.917 | 0.904 | 0.488 | 1e-164 |
| >gi|147860501|emb|CAN83975.1| hypothetical protein VITISV_016437 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 830 bits (2143), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/624 (63%), Positives = 507/624 (81%), Gaps = 25/624 (4%)
Query: 9 TSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTS--NKSVAID 66
TSF+YNGFL A+LSL+GA+ + ++GIL++TN S LIGHA YP+P+ FK S ++S +
Sbjct: 20 TSFVYNGFLKADLSLDGASQLRSNGILSLTNDSVRLIGHAFYPSPIHFKRSKDHRSWVVT 79
Query: 67 FRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAV 126
F TNFVFS+ PKYP LGG GLAF+++ST P CL NQ+LGLPN+T S+ FSTR+LAV
Sbjct: 80 FSTNFVFSMAPKYPGLGGHGLAFVLLSTKAPMGCLPNQYLGLPNVT--SNADFSTRVLAV 137
Query: 127 EFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYS 186
EFD +QN EL+DINDNHVGIDISSLIS+ S+PA+YY NN I +SGDPIQAW++Y+
Sbjct: 138 EFDAVQNLELMDINDNHVGIDISSLISNVSKPAAYYFTNNSNNSIAFKSGDPIQAWIEYN 197
Query: 187 SQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSIS 246
SQE L+NV+I PLG+PK +RPLIS PIDLS V++EYM+ GFSASTGL+TA+HNVHGWS
Sbjct: 198 SQEQLMNVTISPLGIPKSFRPLISFPIDLSMVLNEYMHIGFSASTGLLTAAHNVHGWSFR 257
Query: 247 IGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKYADK 306
IGG+A DL+P+++P+ RS +V+ +RG ++GI LA +IL+I+G HV+ RI+ ++
Sbjct: 258 IGGRAADLDPLRLPSPVTRSRKVLHQRGLTLGIILASATLVILVISGTAHVVHRIRNKEE 317
Query: 307 MLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN 366
+LE+WE++ GA RFKY++L S T+GF E+NL+GSGGFGRVY+G++P GLEVAIKR+ H+
Sbjct: 318 ILEEWEVEYGAHRFKYSDLFSATRGFREKNLIGSGGFGRVYKGIIPRTGLEVAIKRVAHD 377
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
S+QGMKEFVAEI+SMGRLRHRNLVQLHGWCR+QDEL+LVYDYVPNGSLDK+LFD D + +
Sbjct: 378 SRQGMKEFVAEIISMGRLRHRNLVQLHGWCRRQDELILVYDYVPNGSLDKILFD-DQQKK 436
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
K+LTW+QRYKILIG++Q+LLYLHEEC+QRVVHRDVKPSN+L+D LNA+LGDFGLA++Y+
Sbjct: 437 KILTWEQRYKILIGVSQALLYLHEECDQRVVHRDVKPSNVLIDAELNARLGDFGLARMYK 496
Query: 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
HG NP+TTHIVGTLGYLAPELTR GKATTS DVY+YG+LMLEVA GRR IEPQ+ A EL+
Sbjct: 497 HGNNPETTHIVGTLGYLAPELTRIGKATTSIDVYAYGVLMLEVATGRRPIEPQRNAQELV 556
Query: 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606
L+DW Y+ EA+LVL+LGL CS P+P YRPD+RRV+++LL
Sbjct: 557 LMDW--------------------YNPDEAKLVLSLGLLCSHPHPDYRPDIRRVIQYLLK 596
Query: 607 DSSLPPLPPDIHLKDTRNIMGFSD 630
D LP LPPD+HL+ ++ FSD
Sbjct: 597 DVCLPELPPDVHLEVPGTMIEFSD 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528060|ref|XP_003532623.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2124), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/621 (62%), Positives = 491/621 (79%), Gaps = 7/621 (1%)
Query: 10 SFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTS-NKSVAIDFR 68
+F+ GF A L ++GA+Y+ +GILT+ N S ++GHA YP+PL FK+S NKS+ F
Sbjct: 25 NFVKYGFKQAGLKMDGASYVRPNGILTLINDSPKILGHAFYPSPLPFKSSKNKSIVATFS 84
Query: 69 TNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEF 128
T FVFSI+PKYP+LG QG AF++ISTN+P+ CL NQ+LGLPN+T SS +FSTR LA+EF
Sbjct: 85 TTFVFSIVPKYPELGAQGFAFVLISTNKPKGCLMNQYLGLPNVT--SSLEFSTRFLAIEF 142
Query: 129 DIIQNTELIDINDNHVGIDISSLISSASEPASYY-SGNNHRIPILLRSGDPIQAWVDYSS 187
D IQN +L D+NDNHVGIDISSLIS+ S P +YY S ++ I L+SG PIQAWVDY+
Sbjct: 143 DGIQNLDLHDMNDNHVGIDISSLISNISRPVAYYLSDHSKNISFSLKSGKPIQAWVDYNE 202
Query: 188 QEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISI 247
EML+NV++ P G+PKPY PLIS PIDLS V+++YMY GFSAS GL+ A HN+HGW I
Sbjct: 203 GEMLMNVTVSPFGMPKPYFPLISFPIDLSLVLNDYMYAGFSASNGLLVAEHNIHGWGFKI 262
Query: 248 GGKAQDLNPMKVPTL---EKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKYA 304
G Q+L+ VP + S +VV ++ F+VGITL IL + GA HVL+R++
Sbjct: 263 GEAGQELDKSAVPLIGSSTSTSSKVVHKKDFAVGITLTSATLFILTVIGAFHVLRRLRNG 322
Query: 305 DKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG 364
D++LEDWE++ + +FKY+EL S T FG+ NL+G GGFG+VYRG++ S GLEVA+KR+
Sbjct: 323 DEILEDWELEFASHKFKYSELHSATGKFGDSNLIGYGGFGKVYRGVIASTGLEVAVKRVA 382
Query: 365 HNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHK 424
+S+QG++EFV+EI SM +L+HRNLVQLHGWCRK+DELL+VY+YVPNGSLDKLLF+ +H+
Sbjct: 383 PDSRQGIREFVSEITSMAQLKHRNLVQLHGWCRKKDELLIVYNYVPNGSLDKLLFENEHQ 442
Query: 425 LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484
+KLLTWDQRY I+ G+AQ LLYLHEEC +VVHRDVKPSN+L+D L KLGDFGLA+
Sbjct: 443 KKKLLTWDQRYTIITGVAQGLLYLHEECELQVVHRDVKPSNVLIDEDLQPKLGDFGLART 502
Query: 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE 544
YEHG NPQTT++VGTLGY+APELT+TGKA TSTDVY YGIL+LEVACGR+ IEPQK E
Sbjct: 503 YEHGINPQTTNVVGTLGYMAPELTKTGKARTSTDVYGYGILILEVACGRKPIEPQKNPEE 562
Query: 545 LLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
L+LVDWV+ELH +G+I++AID +LD YD EA LVL+LGLFC+ PNP YRP MRR+V+FL
Sbjct: 563 LVLVDWVRELHHQGKISRAIDPSLDEYDKDEARLVLSLGLFCAHPNPDYRPSMRRIVQFL 622
Query: 605 LGDSSLPPLPPDIHLKDTRNI 625
LG++SLPPLPPDIH +D I
Sbjct: 623 LGETSLPPLPPDIHCEDPTAI 643
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481749|ref|XP_003632669.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-167, Method: Compositional matrix adjust.
Identities = 313/636 (49%), Positives = 425/636 (66%), Gaps = 17/636 (2%)
Query: 6 ADTTSFLYNGF-LHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVA 64
+ SF YNGF ANLSL+G A + +G+L +TN+++ GHA Y +P+RFK S+ + A
Sbjct: 609 GEDVSFTYNGFQTAANLSLDGLAQFTPNGLLILTNRTKQETGHAFYSHPMRFKNSSNAPA 668
Query: 65 IDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRML 124
F T FVF+I P+YP L G G+AF+I T L +Q LGL + +++ + ++
Sbjct: 669 FSFSTTFVFAIHPQYPTLSGHGIAFVIAPTRGLPGALPSQHLGL--FSDANNGNSTNHIV 726
Query: 125 AVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPIL-LRSGDPIQAWV 183
AVE D IQN EL DINDNHVGIDI+ L S + PA Y++ N L L SG P+Q WV
Sbjct: 727 AVELDTIQNEELGDINDNHVGIDINGLKSDKAAPAGYFASKNGDFKNLSLISGRPMQVWV 786
Query: 184 DYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243
DY++ E I+V + P+ V KP PL+SLP DLS +++ MY GFS+STG + SH + GW
Sbjct: 787 DYNALEKQIDVRLAPVSVDKPDIPLLSLPRDLSLILNNTMYVGFSSSTGSVLTSHYLLGW 846
Query: 244 SISIGGKAQDLNPMKVPTLEKRSHEVVQRRGF-SVGITLAGMAFLILIIAGAIHVLQRIK 302
S + G+AQ L ++P L + + ++ F + G+ + + ++ +++GA+++++R K
Sbjct: 847 SFKMNGQAQPLAISQLPKLPRIGGQ--KKSAFLTSGLPVICVVSILAVMSGAVYLIRRKK 904
Query: 303 YADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKR 362
+ LEDWE+ G RFKY +L TKGF ++ L+GSGGFGRVYRG++P+ LE+A+K+
Sbjct: 905 KFAEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRGVLPTSKLEIAVKK 964
Query: 363 IGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKD 422
I H S+QGMKEFVAEI+S+GRLRHRN+V L G+CR++ ELLLVYDY+PNGSLDK L+D+
Sbjct: 965 ISHESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP 1024
Query: 423 HKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482
+ L W+QR+++L G+A L YLH E Q VVHRDVK SN+LLD LN +LGDFGLA
Sbjct: 1025 ---KVTLNWNQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDGELNGRLGDFGLA 1081
Query: 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542
++Y+HG +PQTTH+VGTLGYLAPE TRTGKATT TDVY++G +LEVACGRR I P +
Sbjct: 1082 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVACGRRPIAPME-- 1139
Query: 543 AELLLVDWVKELHLEGEITQAIDQTLDY-YDLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601
+L+LVDWV GEI QA D L Y+ E ELVL LGL CS P RP M +VV
Sbjct: 1140 -DLILVDWVFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHSEPNARPSMPQVV 1198
Query: 602 EFLLGDSSLPPLPPDIHLKDTRNIMGFSDFPNDSDF 637
++L PLP L + N + F+ DF
Sbjct: 1199 QYL---ERTVPLPEFTSLGLSANGLSFAHREGFDDF 1231
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439978|ref|XP_004137762.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus] gi|449524894|ref|XP_004169456.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1534), Expect = e-167, Method: Compositional matrix adjust.
Identities = 311/658 (47%), Positives = 439/658 (66%), Gaps = 32/658 (4%)
Query: 6 ADTTSFLYNGF-----LHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSN 60
A + ++GF + ANL+L A I +GIL +TN + L GHA Y +P+RFK S+
Sbjct: 19 AASQQLYFSGFQDDAAVAANLTLTDIAKIEQNGILKLTNDTSRLQGHAFYSSPVRFKNSS 78
Query: 61 KSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFS 120
F T FV +++P+YP LGG GLAF I + ++ L +Q+LGL N F+
Sbjct: 79 DGKVFSFSTAFVIAVVPEYPTLGGHGLAFTI-APSKNLRGLPSQYLGLLN--AKDVGNFT 135
Query: 121 TRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNN-HRIPILLRSGDPI 179
+ AVEFD +Q+ E DINDNHVGI+++ +IS+ S ASY+ + + + L+SG PI
Sbjct: 136 NHLFAVEFDTVQDFEFADINDNHVGINLNHMISNVSTTASYFVDDGPTKQNLTLKSGRPI 195
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHN 239
QAWVDY S + V++ P KP +P++S +DLS ++DE+MY GFSASTGL+ +SH
Sbjct: 196 QAWVDYDSSVNSLTVALSPSST-KPKKPILSFNVDLSPILDEFMYVGFSASTGLLASSHY 254
Query: 240 VHGWSISIGGKAQDLNPMKVPTLE--KRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHV 297
V GWS S+ G+A+ L+ +P++ K+ H F++GI++A + +I+ I A+ +
Sbjct: 255 VLGWSFSMNGQARSLDLSSLPSVPGPKKKHTA-----FTIGISVAAVLIVIIAICVAVLI 309
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
+ +IK AD ++E WE + G R+ Y EL TK F ++ L+G GGFG+VY+G +P+ ++
Sbjct: 310 IWKIKNAD-IIEAWEHEIGPHRYSYKELKKATKRFRDKELLGRGGFGKVYKGTLPNSKIQ 368
Query: 358 VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKL 417
VA+KRI H S+QG++EFV+EI S+GRLRHRNLVQL GWCR++ +LLLVYD++ NGSLD
Sbjct: 369 VAVKRISHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDFMANGSLDNY 428
Query: 418 LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
+FD D + L+W QR+ I+ G+A LLYLHE Q V+HRDVK SN+LLD+ +N KLG
Sbjct: 429 IFD-DPDVN--LSWQQRFGIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEMNGKLG 485
Query: 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
DFGLA++YEHGANP TT +VGTLGYLAPEL RTGKATTS+DVY++G L+LEVACGRR I+
Sbjct: 486 DFGLARLYEHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVYAFGALLLEVACGRRPID 545
Query: 538 PQKAAAELLLVDWVKELHLEGEITQAIDQTLDY-YDLAEAELVLNLGLFCSAPNPVYRPD 596
P+ ++ EL+LVDWV E + EG++ +D L +++ EA ++L LGLFCS + RP
Sbjct: 546 PKSSSEELVLVDWVWENYREGKLLDVMDPKLKGDFNVVEAMMILKLGLFCSNDSAAARPS 605
Query: 597 MRRVVEFLLGDSSLPP--LPPDIHLKDTRNIMGFSDFPNDSDFFNSKLMSSQSNSFTS 652
MR+VV FL G+ +P P + ++ RN GF DF N SS N F+S
Sbjct: 606 MRQVVRFLEGEMGVPEEISAPKV-MEGGRNGEGFDDFVN-------SFASSSFNKFSS 655
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449434|ref|XP_002278015.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 300/606 (49%), Positives = 409/606 (67%), Gaps = 17/606 (2%)
Query: 11 FLYNGFLHA--NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFR 68
F Y+ F A NLSL G A I +G+L +TN G YP+P+RFK S+ A F
Sbjct: 26 FFYDSFHGAGNNLSLNGVAKIEKNGMLRLTNDVARWFGRGFYPSPIRFKNSSGGKAFSFS 85
Query: 69 TNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEF 128
T F F+I+P+YP LGG GLAF I ST L Q+LGL N T + ++ + + AVEF
Sbjct: 86 TAFAFAIVPQYPTLGGHGLAFAITSTKELPGALPRQYLGLLNATDNGNS--TNHVFAVEF 143
Query: 129 DIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQ 188
D +Q+ E DI+DNHVGID++S+ S AS ASY+S N+ + + L+ G IQAW+DY Q
Sbjct: 144 DTVQDFEFNDISDNHVGIDLNSMTSYASANASYFSDNSTKEYLNLKGGKTIQAWIDYDGQ 203
Query: 189 EMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248
+NV + P KP P++S ++LSS++ E+MY GFSASTGL+ +SH V GW +
Sbjct: 204 RDQLNVFLSPHST-KPTSPILSCGVNLSSILKEFMYVGFSASTGLLASSHYVLGWRFKMN 262
Query: 249 GKAQDLNPMKVPTLE--KRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKYADK 306
G A+ L+ +P L KR++ + +G+++A + ++ +A A +++++IK AD
Sbjct: 263 GVAESLDLSSLPKLPGPKRNNTPLI-----IGVSVAATSMIVFAVALAFYLIRKIKNAD- 316
Query: 307 MLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN 366
++E WE+ G RF Y EL T+GF ++ L+G GGFG+VY+G + + +VA+KRI H
Sbjct: 317 VIEAWELDIGPHRFSYQELKKATRGFRDKELIGFGGFGKVYKGTLRNSNTQVAVKRISHE 376
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
S+QGM+EFV+EI S+GRLRHRNLVQL GWCR++ +LLLVYDY+PNGSLDK LFD +
Sbjct: 377 SKQGMREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDYMPNGSLDKYLFDTS---K 433
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
L+W+QR+KI+ G+A LLYLHEE Q V+HRD+K NILLD+ LN +LGDFGLAK+YE
Sbjct: 434 STLSWEQRFKIIKGVASGLLYLHEEWEQTVIHRDIKAGNILLDSELNGRLGDFGLAKLYE 493
Query: 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
HG+NP TT +VGTLGYLAPELTRTGK T S+DV+++G L+LEV CGRR +E + EL+
Sbjct: 494 HGSNPSTTRVVGTLGYLAPELTRTGKPTRSSDVFAFGALLLEVVCGRRPVEAKALPEELI 553
Query: 547 LVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605
LVDWV E EG I +D L YD E +VL LGL CS +P RP MR+V+ +L
Sbjct: 554 LVDWVWERWREGAILDVVDPRLKGEYDEVEVVVVLKLGLMCSNNSPAVRPSMRQVLRYLE 613
Query: 606 GDSSLP 611
G+ +LP
Sbjct: 614 GEVALP 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559006|ref|XP_002520526.1| kinase, putative [Ricinus communis] gi|223540368|gb|EEF41939.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-166, Method: Compositional matrix adjust.
Identities = 300/613 (48%), Positives = 421/613 (68%), Gaps = 18/613 (2%)
Query: 7 DTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTS----NKS 62
+ F+YNGF ANLSL GAA I +G+L +TN S IGHA +P PL F +S +++
Sbjct: 26 EADQFIYNGFNGANLSLNGAANIHPNGLLELTNTSHQQIGHAFFPFPLHFNSSLSNNSRT 85
Query: 63 VAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTR 122
+ F TNFVF+++P+ P L G GLAF I + + +A Q+LGL N T + S
Sbjct: 86 SLVSFSTNFVFAMVPESPGLDGHGLAFAISPSLEFKGAIATQYLGLFNSTTIGLS--SNH 143
Query: 123 MLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPIL-LRSGDPIQA 181
+LA+E D ++N E DI+ NHVG+D+++L S S ASY+S + L L SG P+Q
Sbjct: 144 LLAIELDTVKNPEFGDIDGNHVGVDVNNLTSIQSVSASYFSETEEKNKSLELTSGRPMQM 203
Query: 182 WVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVH 241
W+DY E L+NV++ P+ KP +PL+S IDLS+++ E MY GFSASTG ++++H +
Sbjct: 204 WIDYDEMEKLLNVTLAPIERMKPEKPLLSTNIDLSALLLESMYVGFSASTGSVSSNHYIL 263
Query: 242 GWSISIGGKAQDLNPMKVPTL--EKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQ 299
GWS + G+AQ L+P K+P+L E++S + + + L + L++ I+ I++++
Sbjct: 264 GWSFNRSGQAQSLDPSKLPSLPQERKSR---GKLAMKIMLPLVIVIVLLMTISATIYIMR 320
Query: 300 RIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVA 359
K +++ EDWE Q G +RF Y +L TKGF ++ L+G GGFG+VYRG +PS +EVA
Sbjct: 321 --KRYEEIREDWEQQYGPQRFSYKDLYKATKGFKDKELLGCGGFGKVYRGTLPSSNVEVA 378
Query: 360 IKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLF 419
+K++ H+S+QGMKEFVAEI SMGRLRHRNLVQL G+CR++ EL LVYD++PNGSLDK LF
Sbjct: 379 VKKVSHDSRQGMKEFVAEIASMGRLRHRNLVQLLGYCRRKGELFLVYDHMPNGSLDKFLF 438
Query: 420 DKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479
+ + + W +RY+I+ G+A +L YLHEE Q V+HRDVK SN+LLD LN +LGDF
Sbjct: 439 SNE---KPNIDWVRRYQIIKGVASALYYLHEEWEQVVLHRDVKASNVLLDADLNGRLGDF 495
Query: 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQ 539
GLAK+Y+HG+ PQTTH+VGTLGYLAPELT TGKATTS+DV+++GI MLEVACGR+ ++ +
Sbjct: 496 GLAKLYDHGSTPQTTHVVGTLGYLAPELTTTGKATTSSDVFAFGIFMLEVACGRKPVKSE 555
Query: 540 KAAAELLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMR 598
+ E++LVDWV E G I ID L D Y E ELVL LGL + P RP +R
Sbjct: 556 RPPEEVILVDWVLECWERGNILGTIDPRLEDSYVAEETELVLKLGLLSTQRIPTARPTIR 615
Query: 599 RVVEFLLGDSSLP 611
+V+++L G+++LP
Sbjct: 616 QVMQYLDGNATLP 628
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567976|ref|XP_003552190.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1513), Expect = e-165, Method: Compositional matrix adjust.
Identities = 311/655 (47%), Positives = 429/655 (65%), Gaps = 30/655 (4%)
Query: 1 MVVVHADTTSFLYNGFLH---ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFK 57
++ V LY GF +NL++ G A I +GIL +TN S L+GHA YP+P + K
Sbjct: 15 LIPVSCQVDQLLYAGFKDVGASNLTMNGVAKIEHNGILKLTNDSSRLMGHAFYPSPFQLK 74
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S + F ++F +I+P+YP LGG GLAF I +T++ L +Q+LGL N S +
Sbjct: 75 NSTSGKVLSFSSSFALAIVPEYPKLGGHGLAFTI-ATSKDLKALPSQYLGLLN--SSDNG 131
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
S + AVEFD +Q+ E DINDNHVGIDI+S+ S+AS N + + L+SG
Sbjct: 132 NISNHIFAVEFDTVQDFEFGDINDNHVGIDINSMQSNAS-------ANVSLVGLTLKSGK 184
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS 237
PI AWVDY SQ LI+V++ P KP PL++ +DLS V + MY GFSASTGL+ +S
Sbjct: 185 PILAWVDYDSQLNLISVALSP-NSSKPKTPLLTFNVDLSPVFHDIMYVGFSASTGLLASS 243
Query: 238 HNVHGWSISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHV 297
H + GWS I G A L+ +P L + ++ +G++++ ++L I+ I+
Sbjct: 244 HYILGWSFKINGPAPPLDLSSLPQLPQPKK---KQTSLIIGVSVSVFVIVLLAISIGIYF 300
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
++IK AD ++E WE++ G R+ Y EL T+GF ++ L+G GGFGRVY+G +P+ ++
Sbjct: 301 YRKIKNAD-VIEAWELEIGPHRYSYQELKKATRGFKDKELLGQGGFGRVYKGTLPNSKIQ 359
Query: 358 VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKL 417
VA+KR+ H S+QG++EFV+EI S+GRLRHRNLVQL GWCR++ +LLLVYD++ NGSLDK
Sbjct: 360 VAVKRVSHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDFMANGSLDKY 419
Query: 418 LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
LFD+ + +L W+ R+KI+ G+A +LLYLHE Q V+HRDVK SN+LLD LN +LG
Sbjct: 420 LFDEP---KIILNWEHRFKIIKGVASALLYLHEGYEQVVIHRDVKASNVLLDFELNGRLG 476
Query: 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
DFGLA++YEHGANP TT +VGTLGYLAPEL RTGKATTS+DV+++G L+LEVACGRR IE
Sbjct: 477 DFGLARLYEHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVFAFGALLLEVACGRRPIE 536
Query: 538 PQKAAAELLLVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPD 596
P+ EL+LVDWV E + +G I +D L+ Y+D E +VL LGL CS PV RP
Sbjct: 537 PKALPEELVLVDWVWEKYKQGRILDLVDPKLNVYFDEKEVIVVLKLGLMCSNDVPVTRPS 596
Query: 597 MRRVVEFLLGDSSLP---PLPPDIHLKDTRNIMGFSDFPNDSDFFNSKLMSSQSN 648
MR+VV +L G+ +P P DI + GF +F + + MSS SN
Sbjct: 597 MRQVVRYLDGEVEVPEDLKKPGDISHHE-----GFDEFLHSLASSSFDKMSSGSN 646
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584540|ref|XP_002532997.1| kinase, putative [Ricinus communis] gi|223527226|gb|EEF29389.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-164, Method: Compositional matrix adjust.
Identities = 295/615 (47%), Positives = 418/615 (67%), Gaps = 15/615 (2%)
Query: 2 VVVHADTTSFLYNGFLHA---NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKT 58
+ V Y GF H N+SL G A I +GI+ +TN++ L+G A Y +P +FK
Sbjct: 16 IPVSCQLNELYYPGFKHVDTVNISLTGVAEIQKNGIIRLTNETSRLMGQAFYASPFQFKN 75
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
S+ A F T+F +I P+Y LGG GLAF I S ++ L +Q+LGL N S
Sbjct: 76 SSNGKAFSFSTSFALAIFPEYKKLGGHGLAFTI-SASKDLKGLPSQYLGLLN--ASDLGN 132
Query: 119 FSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDP 178
F+ +LAVEFD +Q+ E DINDNHVGIDI++L S+AS A+YY + + + L++G P
Sbjct: 133 FTNHLLAVEFDTVQDFEFGDINDNHVGIDINNLKSNASAAAAYYINDTSKQDLNLKTGKP 192
Query: 179 IQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASH 238
IQ W+DY S + L+NV+I P KP P++S PIDLS + +EYMY GFSASTGL+ +SH
Sbjct: 193 IQVWIDYDSIQNLLNVTISPTS-EKPRLPILSFPIDLSQIFEEYMYVGFSASTGLLASSH 251
Query: 239 NVHGWSISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAI-HV 297
+ GWS + G+A+ L+ +P+L + + G ++ + + + I+ ++ AI +V
Sbjct: 252 YILGWSFKMDGQARALDLSSLPSLPRGPK--TKHTGLTIAVIVPSVFLAIIALSLAIFYV 309
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
+++I+ AD ++EDWE++ G R+ Y EL TKGF + L+G GGFG+VY+G++P ++
Sbjct: 310 IRKIRNAD-VIEDWELEIGPHRYSYQELKKATKGFSGKELLGQGGFGQVYKGILPDSKVQ 368
Query: 358 VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKL 417
VA+KRI + S QG++EFV+EI S+GRLRHRNLVQL GWCR++D+ LLVYDY+ NGSLD
Sbjct: 369 VAVKRISNESNQGLREFVSEIASVGRLRHRNLVQLLGWCRRRDDFLLVYDYMANGSLDNF 428
Query: 418 LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
LFD+ + +L W+QR+KI+ +A LLYLHE Q V+HRDVK SN+LLD+ L +LG
Sbjct: 429 LFDEP---KIILNWEQRFKIIKDVASGLLYLHEGYEQVVIHRDVKASNVLLDSELTGRLG 485
Query: 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
DFGLA++YEHG+NP TT +VGTLGYLAPE+ RTGKAT +DVY++G L+LEVACGRR IE
Sbjct: 486 DFGLARLYEHGSNPGTTRVVGTLGYLAPEMPRTGKATACSDVYAFGALLLEVACGRRPIE 545
Query: 538 PQKAAAELLLVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPD 596
P+ + E++LVDWV E+ +G + +D L+ Y+ E +VL LGL CS P+ RP
Sbjct: 546 PKASPEEMVLVDWVWEMFKQGRVLDVVDSRLNGEYNEGEMMMVLTLGLMCSNNAPMARPS 605
Query: 597 MRRVVEFLLGDSSLP 611
MR+VV++L G+ +P
Sbjct: 606 MRQVVKYLDGEVGMP 620
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439478|ref|XP_002267692.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1509), Expect = e-164, Method: Compositional matrix adjust.
Identities = 294/615 (47%), Positives = 417/615 (67%), Gaps = 15/615 (2%)
Query: 6 ADTTSFLYNGFLH---ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKS 62
+D F++ GF NLSL GA+ I+++G + +TN S+ LIG A Y +PL ++
Sbjct: 23 SDNIQFIFQGFKGNSIENLSLNGASVITSTGAIRLTNYSKNLIGRAFYSSPLHMFKTHSQ 82
Query: 63 VAIDFRTNFVFSILPKYPDLGG-QGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFST 121
A F T FVF I+P P +GG GLAF + T + +LGL + ++ FS
Sbjct: 83 NASSFSTTFVFVIVPLDPQIGGGHGLAFTLAPTQQLPGARFENYLGL--LGPENNGNFSN 140
Query: 122 RMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRI-PILLRSGDPIQ 180
+ AVEFD + DI+ NHVGIDI+S+ S+ S+ ASYY+ H I P+ L SG PIQ
Sbjct: 141 HVFAVEFDTATGLWVNDIDGNHVGIDINSMNSTVSKAASYYANQTHPIEPLKLESGMPIQ 200
Query: 181 AWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNV 240
AW++Y + ++NV+I PL VPKP RPL+S P+DLS ++ E M+ GFS++TG + SH +
Sbjct: 201 AWIEYDGTQKIVNVTISPLFVPKPSRPLLSAPVDLSHILKETMFAGFSSATGKLAGSHYI 260
Query: 241 HGWSISIGGKAQDLNPMKVPTLEK-RSHEVVQRRGFSVGITLAG--MAFLILIIAGAIHV 297
GWS + G A LNP ++P+L + + E +++ G +G + + L++++ +++
Sbjct: 261 LGWSFRMNGVAPPLNPSQLPSLPRPKISEKIRKEGIGIGAVCSATTLVLLVIVVFISLYY 320
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
LQR+KY D +LE+WE+QC + RF Y +L TKGF + ++GSGGFG VY+G++P+ E
Sbjct: 321 LQRLKYKD-VLEEWELQC-SHRFPYRDLFKATKGFKDSEILGSGGFGCVYKGVLPATQEE 378
Query: 358 VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKL 417
VA+K+I HNS+QG++EF+ EI S+GR+RH++LV LHGWC+ +DELLLVYD++PNGSL +
Sbjct: 379 VAVKKISHNSRQGIREFIMEIASLGRMRHKHLVHLHGWCKHKDELLLVYDFMPNGSLGDI 438
Query: 418 LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
LF+ HK +L+W+QR+ IL G+A +LLYLHEE Q VVHRDVK +N+LLD +NA+LG
Sbjct: 439 LFN--HKKSGILSWEQRFSILKGVASALLYLHEEWEQVVVHRDVKANNVLLDADMNARLG 496
Query: 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
DFGLA++Y+HG TTHIVGTLGY+APEL+RTGKATT D++SYG L+LEVACGR I+
Sbjct: 497 DFGLARLYDHGEEACTTHIVGTLGYIAPELSRTGKATTHCDMFSYGALLLEVACGRPPID 556
Query: 538 PQKAAAELLLVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPD 596
P ++ +LL+DWV+E G I +A D LD Y + E ELV+ LGL C P RP
Sbjct: 557 PNASSKWVLLLDWVRECWAAGCIVEAADPKLDNEYAVEEMELVMKLGLICCQKMPEARPT 616
Query: 597 MRRVVEFLLGDSSLP 611
MR V+ +L G +LP
Sbjct: 617 MREVICYLDGSDNLP 631
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558978|ref|XP_002520512.1| kinase, putative [Ricinus communis] gi|223540354|gb|EEF41925.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1508), Expect = e-164, Method: Compositional matrix adjust.
Identities = 300/614 (48%), Positives = 409/614 (66%), Gaps = 15/614 (2%)
Query: 7 DTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTS---NKSV 63
+ F+YNGF ANLSL G A I +G+L +TN S +IG A +P P RF TS N
Sbjct: 22 EINQFIYNGFQGANLSLSGIATIHPNGLLELTNTSYQMIGRAFFPLPFRFNTSSSNNFQS 81
Query: 64 AIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRM 123
A+ F TNFVF+++P+ P GG G+AF I + +A Q+LGL N T + S +
Sbjct: 82 ALSFSTNFVFAMVPELPTHGGHGIAFAISPSKLCVGSMATQYLGLLNSTTDGLS--SNHL 139
Query: 124 LAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPIL-LRSGDPIQAW 182
AVE D ++ +L D+N NHVGIDI+SL S+ S P +YY R L L SGDP+Q W
Sbjct: 140 FAVELDSAKSPDLEDMNANHVGIDINSLKSNESAPVTYYLDKEGRNQTLELNSGDPMQVW 199
Query: 183 VDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHG 242
+DY +E L+NV++ P+GV KP RPL+S ++LS V+ E MY GFSA+TG +++ H + G
Sbjct: 200 IDYKEEEKLLNVTVAPIGVSKPSRPLLSKSLNLSQVLLESMYVGFSAATGSVSSRHYILG 259
Query: 243 WSISIGGKAQDLNPMKVPTLEK--RSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQR 300
WS + G++Q L+P K+P+L +S ++ R + +TL + ++ + G + + R
Sbjct: 260 WSFNKSGESQTLDPSKLPSLPSLAKSRKLNLRLIILLAVTLT-VTIIVTAVLGTMFI--R 316
Query: 301 IKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAI 360
K +++ EDWE G +RF Y L T+ F +++L+G+GGFG+VYRG++ S +VA+
Sbjct: 317 RKRYEEIREDWEKAYGPQRFSYEVLYKATRDFRDKDLLGAGGFGKVYRGILSSCNTQVAV 376
Query: 361 KRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD 420
K+I HNS QGMKEF+AEI SMGRLRHRNLVQL G+CR++ ELLLVY+Y+PNGSLDK LF
Sbjct: 377 KKISHNSAQGMKEFIAEIASMGRLRHRNLVQLLGYCRRKGELLLVYEYMPNGSLDKFLFS 436
Query: 421 KDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480
K L WDQR++I+ G+A LLYLH + Q V+HRDVK SN+LLD NA+LGDFG
Sbjct: 437 KK---EAKLNWDQRHRIIRGVASGLLYLHHDWEQVVLHRDVKASNVLLDANFNARLGDFG 493
Query: 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQK 540
LAK Y+HG NPQTT +VGT+GYLAPEL +TGK TTS+DV+++G MLE+ACGR+ EP+
Sbjct: 494 LAKFYDHGTNPQTTCVVGTVGYLAPELIKTGKPTTSSDVFAFGNFMLEIACGRKPFEPKC 553
Query: 541 AAAELLLVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPDMRR 599
E +L DWV E G+I + D L+ Y + E ELVL LGL C+ P RPDMR+
Sbjct: 554 LPEETILADWVLECWKRGDILSSSDPRLEGNYVVQEMELVLKLGLLCAHSTPAARPDMRQ 613
Query: 600 VVEFLLGDSSLPPL 613
VV +L + SLP +
Sbjct: 614 VVNYLDHNVSLPEI 627
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 653 | ||||||
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.894 | 0.853 | 0.443 | 7.4e-137 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.912 | 0.880 | 0.448 | 2e-134 | |
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.905 | 0.875 | 0.432 | 5.9e-128 | |
| TAIR|locus:2133229 | 674 | LPK1 "lectin-like protein kina | 0.906 | 0.878 | 0.440 | 9.6e-128 | |
| TAIR|locus:2119936 | 669 | AT4G29050 [Arabidopsis thalian | 0.892 | 0.871 | 0.416 | 1.6e-127 | |
| TAIR|locus:2133239 | 669 | AT4G02420 [Arabidopsis thalian | 0.895 | 0.874 | 0.435 | 2.9e-126 | |
| TAIR|locus:2020608 | 666 | AT1G70110 [Arabidopsis thalian | 0.883 | 0.866 | 0.418 | 4.9e-124 | |
| TAIR|locus:2168509 | 674 | AT5G59260 [Arabidopsis thalian | 0.886 | 0.859 | 0.414 | 1.8e-119 | |
| TAIR|locus:2144025 | 657 | AT5G60280 [Arabidopsis thalian | 0.892 | 0.887 | 0.413 | 6.4e-115 | |
| TAIR|locus:2196608 | 656 | AT1G15530 [Arabidopsis thalian | 0.900 | 0.896 | 0.390 | 5.8e-114 |
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1340 (476.8 bits), Expect = 7.4e-137, P = 7.4e-137
Identities = 266/600 (44%), Positives = 388/600 (64%)
Query: 11 FLYNGFLHA--NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFR 68
F + GF A NL+L G A I+ +G + +T +++ +IGHA Y P+RFK + A+ F
Sbjct: 26 FSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIGVNRALSFS 85
Query: 69 TNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEF 128
T+F +++P++ LGG GLAF I T L +Q+LGL N SS FS+ AVEF
Sbjct: 86 TSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLN---SSRVNFSSHFFAVEF 142
Query: 129 DIIQNTELIDINDNHVGIDXXXXXXXXXXXXXYYSGNNHRIPILLRSGDPIQAWVDYSSQ 188
D +++ E DINDNHVGID Y+ N+ + + L G IQAW+DY S
Sbjct: 143 DTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWIDYDSN 202
Query: 189 EMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248
+ ++V + P KP L+S +DLSSV+ + MY GFSASTGL+ +SH + GW+ ++
Sbjct: 203 KKRLDVKLSPFS-EKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMS 261
Query: 249 GKAQDLN-PM--KVPTLEKRSHEVVQRRGFSVGITL-AGMAFLILIIAGAIHVLQRIKYA 304
G+A L+ P ++P+ K+ + +R+ +G++L + +++A ++ V++++K
Sbjct: 262 GEAFSLSLPSLPRIPSSIKKRKK--KRQSLILGVSLLCSLLIFAVLVAASLFVVRKVKDE 319
Query: 305 DKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG 364
D++ E+WE+ G RF Y EL T GFG++ L+GSGGFG+VY+G +P VA+KRI
Sbjct: 320 DRV-EEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRIS 378
Query: 365 HNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXXXXXXXXXXX 424
H S+QG++EF++E+ S+G LRHRNLVQL GWCR++D+LLLVYD++PNGS
Sbjct: 379 HESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPE 438
Query: 425 XXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484
TW QR+KI+ G+A LLYLHE Q V+HRD+K +N+LLD+ +N ++GDFGLAK+
Sbjct: 439 VIL--TWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKL 496
Query: 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE 544
YEHG++P T +VGT GYLAPELT++GK TTSTDVY++G ++LEVACGRR IE E
Sbjct: 497 YEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEE 556
Query: 545 LLLVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603
L++VDWV G+I +D+ L+ +D E +V+ LGL CS +P RP MR+VV +
Sbjct: 557 LVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMY 616
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1317 (468.7 bits), Expect = 2.0e-134, P = 2.0e-134
Identities = 273/609 (44%), Positives = 385/609 (63%)
Query: 1 MVVVHADTTSFLYNGFLH---ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFK 57
+++ + +F YNGF H ++SL+G A ++ +G+L +TN S GHA +RFK
Sbjct: 17 IMISSSQNLNFTYNGF-HPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFK 75
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S F T FVF+I + P L G G+AF++ T L +Q++GL NI S++
Sbjct: 76 DSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNI--SNNG 133
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDXXXXXXXXXXXXXYYSGNNHRIPILLRSGD 177
+ + AVEFD IQ++E D NDNHVGID Y ++ + L S
Sbjct: 134 NDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHDKFQNLSLISRK 193
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS 237
IQ W+DY ++ I+V++ P KP +PL+S DLSS++ E MY GFS++TG + +
Sbjct: 194 RIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLSE 253
Query: 238 HNVHGWSISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHV 297
H + GWS + G+A L+ K+P L + + + +G+ L ++ + II A ++
Sbjct: 254 HFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEF-YKIGMPLISLSLIFSIIFLAFYI 312
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
++R K ++ L+DWE + G RF++ EL TKGF E++L+GSGGFGRVYRG++P+ LE
Sbjct: 313 VRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLE 372
Query: 358 VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXXXX 417
VA+KR+ H+S+QGMKEFVAEI+S+GR+ HRNLV L G+CR++ ELLLVYDY+PNGS
Sbjct: 373 VAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKY 432
Query: 418 XXXXXXXXXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
W QR I+ G+A L YLHEE Q V+HRDVK SN+LLD N +LG
Sbjct: 433 LYNNPETTLD---WKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLG 489
Query: 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
DFGLA++Y+HG++PQTTH+VGTLGYLAPE +RTG+ATT+TDVY++G +LEV GRR IE
Sbjct: 490 DFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIE 549
Query: 538 PQKAAAE-LLLVDWVKELHLEGEITQAIDQTLDY--YDLAEAELVLNLGLFCSAPNPVYR 594
A+ + LLV+WV L L G I +A D L YDL E E+VL LGL CS +P R
Sbjct: 550 FHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRAR 609
Query: 595 PDMRRVVEF 603
P MR+V+++
Sbjct: 610 PSMRQVLQY 618
|
|
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 5.9e-128, P = 5.9e-128
Identities = 261/603 (43%), Positives = 372/603 (61%)
Query: 6 ADTTSFLYN-GFLH-ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSV 63
+ + +F YN GF +LS++G ++ +G+L +TN + GHA Y P+RFK S
Sbjct: 22 SQSLNFAYNNGFNPPTDLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKDSPNGT 81
Query: 64 AIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRM 123
F T+FVF+I + L G G+AF++ +Q++GL N+ + + + +
Sbjct: 82 VSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNE--TNHV 139
Query: 124 LAVEFDIIQNTELIDINDNHVGIDXXXXXXXXXXXXXYYSGNNHRIPILLRSGDPIQAWV 183
AVE D I +TE D NDNHVGID Y+ + L S P+Q WV
Sbjct: 140 FAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRKPMQVWV 199
Query: 184 DYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243
DY + I+V++ P KP RPL++ DLSSV+ + MY GFS++TG + + H + GW
Sbjct: 200 DYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYILGW 259
Query: 244 SISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRI-K 302
S + KA L ++P L + + + + +G+ L + + I ++++R K
Sbjct: 260 SFGLNEKAPPLALSRLPKLPRFEPKRISEF-YKIGMPLISLFLIFSFIFLVCYIVRRRRK 318
Query: 303 YADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKR 362
+A++ LE+WE + G RF++ +L TKGF E+ L+G+GGFG VY+G+MP LE+A+KR
Sbjct: 319 FAEE-LEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKR 377
Query: 363 IGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXXXXXXXXX 422
+ H S+QGMKEFVAEI+S+GR+ HRNLV L G+CR++ ELLLVYDY+PNGS
Sbjct: 378 VSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTP 437
Query: 423 XXXXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482
W QR K+++G+A L YLHEE Q V+HRDVK SN+LLD LN +LGDFGLA
Sbjct: 438 EVTL---NWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 494
Query: 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542
++Y+HG++PQTTH+VGTLGYLAPE TRTG+AT +TDV+++G +LEVACGRR IE Q+
Sbjct: 495 RLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQET 554
Query: 543 AE-LLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRV 600
E LLVDWV L +G+I A D + D E E+VL LGL CS +P RP MR+V
Sbjct: 555 DETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQV 614
Query: 601 VEF 603
+ +
Sbjct: 615 LHY 617
|
|
| TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1254 (446.5 bits), Expect = 9.6e-128, P = 9.6e-128
Identities = 268/608 (44%), Positives = 373/608 (61%)
Query: 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSV 63
+ + +F YN F N+S++G A ++++GIL +T+K+ GHA Y P+RFK S
Sbjct: 24 SQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSPNDT 83
Query: 64 AIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRM 123
F T FV I P + G G+AF I + +A+Q+LGL + T + + + +
Sbjct: 84 VSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGND--TNHI 141
Query: 124 LAVEFDIIQNTELIDINDNHVGIDXXXXXXXXXXXXXYYSGNNHRIPILLRSGDPIQAWV 183
LAVEFD I N E D NDNHVGI+ Y+ N + L S +Q WV
Sbjct: 142 LAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWV 201
Query: 184 DYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243
DY + I+V++ P G KP + L+S+ DLSSV + MY GFSA+TG + + H V GW
Sbjct: 202 DYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGW 261
Query: 244 SISIGGK-AQDLNPMKVPTLEKRSHEVVQR----RGFSVGITLAGMAFLI-LIIAGAIHV 297
S + GK A L KVP + +QR R + L + F++ LI V
Sbjct: 262 SFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFIV 321
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
+R K+A++ EDWE + G R ++ +L TKGF +++L+GSGGFGRVYRG+MP+ E
Sbjct: 322 RRRRKFAEEF-EDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKE 380
Query: 358 VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXXXX 417
+A+KR+ + S+QG+KEFVAEI+S+GR+ HRNLV L G+CR++DELLLVYDY+PNGS
Sbjct: 381 IAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKY 440
Query: 418 XXXXXXXXXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
W QR+ ++IG+A L YLHEE Q V+HRD+K SN+LLD N +LG
Sbjct: 441 LYDCPEVTLD---WKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLG 497
Query: 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
DFGLA++ +HG++PQTT +VGT GYLAP+ RTG+ATT+TDV+++G+L+LEVACGRR IE
Sbjct: 498 DFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIE 557
Query: 538 PQKAAAE-LLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRP 595
+ + E +LLVD V +EG I A D L YD E E VL LGL CS +P RP
Sbjct: 558 IEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRP 617
Query: 596 DMRRVVEF 603
MR+V+++
Sbjct: 618 TMRQVLQY 625
|
|
| TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1252 (445.8 bits), Expect = 1.6e-127, P = 1.6e-127
Identities = 249/598 (41%), Positives = 373/598 (62%)
Query: 11 FLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTN 70
F +NG+L+ N G A ++ G++ +TN SE GH Y +P+RFK S F T
Sbjct: 28 FGFNGYLYDN---SGIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGTVSSFSTT 84
Query: 71 FVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDI 130
FVF+I+ L G GLAF+I T ++Q+LGL N+T + S ++AVEFD
Sbjct: 85 FVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDP--SNHIVAVEFDT 142
Query: 131 IQNTELIDINDNHVGIDXXXXXXXXXXXXXYYSGNNHRIP-ILLRSGDPIQAWVDYSSQE 189
QN E D+++NHVGID YY ++ I L + PIQAW++Y S
Sbjct: 143 FQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWIEYDSSR 202
Query: 190 MLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIGG 249
+NV+I P+ +PKP PL+SL DLS + + MY GF+++TG + +SH + GW+ + G
Sbjct: 203 RQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNG 262
Query: 250 KAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQRIKYADKMLE 309
A +++ ++P L + S ++ ++ ++L +A L+ + + L+R K + +LE
Sbjct: 263 TASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKKLME-VLE 321
Query: 310 DWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ 369
DWE+Q G RF Y +L TKGF L+G GGFG+VY+G + + +++A+K++ H+S+Q
Sbjct: 322 DWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQ 381
Query: 370 GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXXXXXXXXXXXXXXXX 429
GM+EFVAEI ++GRLRH NLV+L G+CR++ EL LVYD +P GS
Sbjct: 382 GMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLD-- 439
Query: 430 TWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489
W QR+KI+ +A L YLH + Q ++HRD+KP+N+LLD +N KLGDFGLAK+ EHG
Sbjct: 440 -WSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGF 498
Query: 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA-AELLLV 548
+PQT+++ GT GY++PEL+RTGKA+TS+DV+++GILMLE+ CGRR + P+ ++ +E++L
Sbjct: 499 DPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLT 558
Query: 549 DWVKELHLEGEITQAIDQTL---DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603
DWV + E +I Q +D+ + D Y + LVL LGLFCS P RP M V++F
Sbjct: 559 DWVLDCW-EDDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQF 615
|
|
| TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 262/601 (43%), Positives = 374/601 (62%)
Query: 11 FLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFR 68
F YNGF ++S+ G A I+ +G+L +TN + GHA Y P+RFK S F
Sbjct: 28 FTYNGFRPPPTDISILGIATITPNGLLKLTNTTMQSTGHAFYTKPIRFKDSPNGTVSSFS 87
Query: 69 TNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEF 128
T FVF+I + P G+AF+I R Q+LGL N+T + + + + AVE
Sbjct: 88 TTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPLQYLGLFNVTNNGNVR--NHVFAVEL 143
Query: 129 DIIQNTELIDINDNHVGIDXXXXXXXXXXXXXYYSGNNHRIPILLRSGDPIQAWVDYSSQ 188
D I N E D N+NHVGID Y+ N+ + L S +Q WVD+
Sbjct: 144 DTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQFHNLTLISSKRMQVWVDFDGP 203
Query: 189 EMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248
LI+V++ P G KP +PL+S+ DLSSV+ + M+ GFS++TG I + V GWS +
Sbjct: 204 THLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVSEIFVLGWSFGVN 263
Query: 249 GKAQDLNPMKVPTL---EKRSHEVVQ-RRGFSVGITLAGMAFLILIIAGAIHVLQRIKYA 304
G+AQ L K+P L + + V + + + I+L + FL++I + +R K+A
Sbjct: 264 GEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIPFLLIIFLVRFIMKRRRKFA 323
Query: 305 DKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG 364
+++ EDWE + G R ++ +L TKGF ++N++GSGGFG VY+G+MP E+A+KR+
Sbjct: 324 EEV-EDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKRVS 382
Query: 365 HNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXXXXXXXXXXX 424
+ S+QG+KEFVAEI+S+G++ HRNLV L G+CR++DELLLVYDY+PNGS
Sbjct: 383 NESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEV 442
Query: 425 XXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484
W QR+K++ G+A +L YLHEE Q V+HRDVK SN+LLD LN +LGDFGLA++
Sbjct: 443 TLD---WKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQL 499
Query: 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE 544
+HG++PQTT +VGT GYLAP+ RTG+ATT+TDV+++G+L+LEVACGRR IE + E
Sbjct: 500 CDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGE 559
Query: 545 -LLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
++LVDWV +E I A D L YD E E+VL LGL CS +P+ RP MR+V++
Sbjct: 560 RVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQ 619
Query: 603 F 603
+
Sbjct: 620 Y 620
|
|
| TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1219 (434.2 bits), Expect = 4.9e-124, P = 4.9e-124
Identities = 245/586 (41%), Positives = 359/586 (61%)
Query: 20 NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79
N+ G+AYI+ +G++ +TN + G Y + LRFK S F T FVFSI
Sbjct: 33 NMYTSGSAYINNNGLIRLTNSTPQTTGQVFYNDQLRFKNSVNGTVSSFSTTFVFSIEFHN 92
Query: 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDI 139
GG G+AF+I T +LGL N + K ++AVE D + + D
Sbjct: 93 GIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDPK--NHIVAVELDTKVDQQFEDK 150
Query: 140 NDNHVGIDXXXXXXXXXXXXXYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPL 199
+ NHVGID YY N +LL SG P+Q W++Y S++ INV++ PL
Sbjct: 151 DANHVGIDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHPL 210
Query: 200 GVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIGGKAQDLNPMKV 259
VPKP PL+SL DLS + E MY GF+++TG +TASH + GW+ + G D++P ++
Sbjct: 211 YVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPDIDPSRL 270
Query: 260 PTLEKRSHEVVQR-RGF-SVGITLAGMAFLILIIAGAIHVLQRIKYADKMLEDWEIQCGA 317
P + + + +Q G ++ +T++G+ LI++ L+R K + +LEDWE+Q G
Sbjct: 271 PKIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLFLKRKKLLE-VLEDWEVQFGP 329
Query: 318 RRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAE 377
RF + +L TKGF + ++G GGFG+VY+G +P +E+A+K + H+S+QGM+EF+AE
Sbjct: 330 HRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIAE 389
Query: 378 IMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXXXXXXXXXXXXXXXXTWDQRYKI 437
I ++GRLRH NLV+L G+CR + EL LVYD + GS W QR+KI
Sbjct: 390 IATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLD---WSQRFKI 446
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIV 497
+ +A L YLH++ Q ++HRD+KP+NILLD +NAKLGDFGLAK+ +HG +PQT+H+
Sbjct: 447 IKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHVA 506
Query: 498 GTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557
GTLGY++PEL+RTGKA+T +DV+++GI+MLE+ACGR+ I P+ + E++L DWV E
Sbjct: 507 GTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWEN 566
Query: 558 GEITQAIDQTLDY-YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+I Q +D + Y +A LVL LGLFCS P RP+M V++
Sbjct: 567 EDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQ 612
|
|
| TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1176 (419.0 bits), Expect = 1.8e-119, P = 1.8e-119
Identities = 252/608 (41%), Positives = 364/608 (59%)
Query: 11 FLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTN 70
F+Y F +A+L L+G A + G L +TN + GHA Y P++F S+ S + F T
Sbjct: 30 FVYYDFRNADLELDGMAN-TNHGPLHLTNNTNTGTGHAFYNIPIKFTASSLS-SFSFSTE 87
Query: 71 FVFSILPKYPDLGGQGLAFIIIST-NRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFD 129
FVF+I P G G+AF++ T + N AN LG+ N ++ K +T + AVE D
Sbjct: 88 FVFAIFPLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFN--RANDNKTATHIFAVELD 145
Query: 130 IIQNTELIDINDNHVGIDXXXXXXXXXXXXXYYSGNNHR-IPILLRSGDPIQAWVDYSSQ 188
QN+E D N VGID Y++ + I + L SG I W+DY
Sbjct: 146 TNQNSESFDKGGNDVGIDINSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGI 205
Query: 189 EMLINVSICPLGVPKP---YR--------PLISLPIDLSSVIDEYMYTGFSASTGLITAS 237
E ++NV++ P+ PKP Y PL+S I+LS + E MY GFS STG I ++
Sbjct: 206 EKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTGSIKSN 265
Query: 238 HNVHGWSISIGGKAQ--DLNPMKVPTLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAI 295
+ GWS GGKA+ D++ + P + + + +G T++ +AFL L G +
Sbjct: 266 QYILGWSFKQGGKAESLDISRLSNPPPSPKRFPLKE----VLGATISTIAFLTL--GGIV 319
Query: 296 HVLQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLG 355
++ ++ KYA+ +LE WE + +R+ + L TKGF E L+G+GGFG+VY+G++PS G
Sbjct: 320 YLYKKKKYAE-VLEQWEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILPS-G 377
Query: 356 LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSXX 415
++A+KR+ H+++QGMK++VAEI SMGRLRH+NLV L G+CR++ ELLLVYDY+PNGS
Sbjct: 378 TQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLD 437
Query: 416 XXXXXXXXXXXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAK 475
TW QR I+ G+A +LLYLHEE Q V+HRD+K SNILLD LN K
Sbjct: 438 DYLFHKNKLKDL--TWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGK 495
Query: 476 LGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRS 535
LGDFGLA+ ++ G N + T +VGT+GY+APELT G TT TDVY++G +LEV CGRR
Sbjct: 496 LGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRP 555
Query: 536 IEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP 595
++P +++LV WV +T +D L + + EA+L+L LG+ CS NP RP
Sbjct: 556 VDPDAPREQVILVKWVASCGKRDALTDTVDSKLIDFKVEEAKLLLKLGMLCSQINPENRP 615
Query: 596 DMRRVVEF 603
MR+++++
Sbjct: 616 SMRQILQY 623
|
|
| TAIR|locus:2144025 AT5G60280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
Identities = 252/610 (41%), Positives = 361/610 (59%)
Query: 1 MVVVHADT---TSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFK 57
++++H + T F +NGF +L ++G A I G+L +T+ SE GHA + PL F
Sbjct: 15 LLLIHLSSQQETGFSFNGFRQGDLHVDGVAQILPGGLLRLTDTSEQKKGHAFFRQPLVF- 73
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
N S + F T+FV +++ K GG G+AF + + N A Q+LGL N T + S
Sbjct: 74 --NSSEPLSFSTHFVCAMVRKPGVTGGNGIAFFLSPSMDLTNADATQYLGLFNTTTNRSP 131
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDXXXXXXXXXXXXXYYS---GNNHRIPILLR 174
S+ + A+E D +Q+ E DI++NHVGID Y+S G N I +L
Sbjct: 132 --SSHIFAIELDTVQSAEFDDIDNNHVGIDVNSLTSVESAPASYFSDKKGLNKSISLL-- 187
Query: 175 SGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI 234
SGD IQ WVD+ ++NVS+ PLG+ KP + LIS ++LS VI + M+ GFSA+TG +
Sbjct: 188 SGDSIQVWVDFDGT--VLNVSLAPLGIRKPSQSLISRSMNLSEVIQDRMFVGFSAATGQL 245
Query: 235 TASHNVHGWSISIGGKAQDLNPMKVPTLEKRSHEVVQRRGFSVGITLA-GMAFLILIIAG 293
+H + GWS S KA L + + L + H ++ + + + G+ L+L++ G
Sbjct: 246 ANNHYILGWSFS-RSKAS-LQSLDISKLPQVPHPKMKTSLLLILLLIVLGIILLVLLV-G 302
Query: 294 AIHVLQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPS 353
A ++ +R KYA+ + E+WE + G R+ Y L TKGF + +G GGFG VY+G +P
Sbjct: 303 A-YLYRRNKYAE-VREEWEKEYGPHRYSYKSLYKATKGFHKDGFLGKGGFGEVYKGTLPQ 360
Query: 354 LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS 413
++A+KR H+ ++GMK+FVAEI SMG L HRNLV L G+CR++ E LLV Y+PNGS
Sbjct: 361 E--DIAVKRFSHHGERGMKQFVAEIASMGCLDHRNLVPLFGYCRRKGEFLLVSKYMPNGS 418
Query: 414 XXXXXXXXXXXXXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473
TW +R IL GIA +L YLH E Q V+HRD+K SN++LDT
Sbjct: 419 LDQFLFHNREPSL---TWSKRLGILKGIASALKYLHTEATQVVLHRDIKASNVMLDTDFT 475
Query: 474 AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
KLGDFG+A+ ++HGANP TT VGT+GY+ PELT G A+T TDVY++G L+LEV CGR
Sbjct: 476 GKLGDFGMARFHDHGANPTTTGAVGTVGYMGPELTSMG-ASTKTDVYAFGALILEVTCGR 534
Query: 534 RSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVY 593
R +EP + LLV WV + ++ A D L + + E+VL LGL C+ P
Sbjct: 535 RPVEPNLPIEKQLLVKWVCDCWKRKDLISARDPKLSGELIPQIEMVLKLGLLCTNLVPES 594
Query: 594 RPDMRRVVEF 603
RPDM +VV++
Sbjct: 595 RPDMVKVVQY 604
|
|
| TAIR|locus:2196608 AT1G15530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1124 (400.7 bits), Expect = 5.8e-114, P = 5.8e-114
Identities = 243/623 (39%), Positives = 374/623 (60%)
Query: 1 MVVVHADTTS----FLYNGFLHAN-----LSLEGAAYISTSGILTVTNKSEGL-IGHALY 50
++V+H ++S FLYN F + +E + ST ++++ N S+ L G Y
Sbjct: 18 LIVLHLVSSSSAIDFLYNSFSSVTNRTDVILIEDSRVEST--VISLINDSDPLSFGRVFY 75
Query: 51 PNPLRF---KTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLG 107
P L T N + F T+FVFSILP G GL F++ ++ P N +++Q+ G
Sbjct: 76 PQKLTIIPDPTRNPTRLSSFSTSFVFSILPDISTSPGFGLCFVLSNSTSPPNAISSQYFG 135
Query: 108 LPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDXXXXXXXXXXXXXYY-SGNN 166
L T +++ +F+ +LAVEFD +N+E+ DI+DNHVGID YY S N
Sbjct: 136 L--FT-NATVRFNAPLLAVEFDTGRNSEVNDIDDNHVGIDLNNIESTTSVTAGYYDSVNG 192
Query: 167 HRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISL--PIDLSSVIDEYMY 224
+ +R+G+ ++AW+D+ INVS+ P+GV +P RP ++ P+ +++ + MY
Sbjct: 193 SFVRFNMRNGNNVRAWIDFDGPNFQINVSVAPVGVLRPRRPTLTFRDPV-IANYVSADMY 251
Query: 225 TGFSASTGLITASHNVHGWSISIGGKAQDLNPMKVPT--LEKRSHEVVQRRGFSVGITLA 282
GFSAS + + WS+S G +++N +P LE S + G GI +
Sbjct: 252 AGFSASKTNWNEARRILAWSLSDTGALREINTTNLPVFFLENSSSSL--STGAIAGIVIG 309
Query: 283 GMAFLILIIAGAIHVLQRI--KYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGS 340
+ F+ LI G + +++ + ++ +E+WE++ RF Y ELA+ T+ F L+GS
Sbjct: 310 CVVFVALIGFGGYLIWKKLMREEEEEEIEEWELEFWPHRFSYEELAAATEVFSNDRLLGS 369
Query: 341 GGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD 400
GGFG+VYRG++ S E+A+K + H+S+QG++EF+AEI SMGRL+H+NLVQ+ GWCR+++
Sbjct: 370 GGFGKVYRGIL-SNNSEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRGWCRRKN 428
Query: 401 ELLLVYDYVPNGSXXXXXXXXXXXXXXXXTWDQRYKILIGIAQSLLYLHEECNQRVVHRD 460
EL+LVYDY+PNGS W +R +++ +A+ L YLH +Q V+HRD
Sbjct: 429 ELMLVYDYMPNGSLNQWIFDNPKEPM---PWRRRRQVINDVAEGLNYLHHGWDQVVIHRD 485
Query: 461 VKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVY 520
+K SNILLD+ + +LGDFGLAK+YEHG P TT +VGTLGYLAPEL T ++DVY
Sbjct: 486 IKSSNILLDSEMRGRLGDFGLAKLYEHGGAPNTTRVVGTLGYLAPELASASAPTEASDVY 545
Query: 521 SYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL--DYYDLAEAEL 578
S+G+++LEV GRR IE + +++LVDWV++L+ G + A D+ + + + E EL
Sbjct: 546 SFGVVVLEVVSGRRPIEYAEEE-DMVLVDWVRDLYGGGRVVDAADERVRSECETMEEVEL 604
Query: 579 VLNLGLFCSAPNPVYRPDMRRVV 601
+L LGL C P+P RP+MR +V
Sbjct: 605 LLKLGLACCHPDPAKRPNMREIV 627
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9M2S4 | LRKS4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4390 | 0.9709 | 0.9269 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00031525001 | SubName- Full=Chromosome chr12 scaffold_57, whole genome shotgun sequence; (647 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 653 | |||
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 2e-86 | |
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 6e-81 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 4e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 269 bits (691), Expect = 2e-86
Identities = 104/245 (42%), Positives = 145/245 (59%), Gaps = 13/245 (5%)
Query: 9 TSFLYNGF--LHANLSLEGAAYISTSGILTVTNKSEG--LIGHALYPNPLRFKTSNKSVA 64
SF +NGF +NL+L+G A IS++G L +TN + +G ALY P+R S
Sbjct: 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKV 60
Query: 65 IDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRML 124
F T+F FSI P P LGG GLAF + T+ + +LGL N + ++ S ++
Sbjct: 61 ASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSS--NNGNSSNHIV 118
Query: 125 AVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVD 184
AVEFD QN E D +DNHVGID++SL+S A Y+ + + L+SG P+QAW+D
Sbjct: 119 AVEFDTFQNPEFGDPDDNHVGIDVNSLVSV---KAGYWDDDGGK----LKSGKPMQAWID 171
Query: 185 YSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWS 244
Y S ++V++ GV KP +PL+S P+DLS V+ E +Y GFSASTGL+T H + WS
Sbjct: 172 YDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWS 231
Query: 245 ISIGG 249
S G
Sbjct: 232 FSSNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 6e-81
Identities = 102/242 (42%), Positives = 141/242 (58%), Gaps = 13/242 (5%)
Query: 7 DTTSFLYNGFLH-ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAI 65
T SF YNGF + +NL+L+G A + +G+L +TN + G ALY P+R S+
Sbjct: 1 STVSFNYNGFSNVSNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLWDSSTGKVA 60
Query: 66 DFRTNFVFSILPK-YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRML 124
F T+FVF+I GG GLAF + + + +LGL N S++ S ++
Sbjct: 61 SFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFN--SSNNGNSSNHIV 118
Query: 125 AVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVD 184
AVEFD N E DI+DNHVGID++S+IS ASE AS+ +P+ L SG PIQ W+D
Sbjct: 119 AVEFDTFLNPEFNDIDDNHVGIDVNSIISVASESASF-------VPLDLNSGKPIQVWID 171
Query: 185 YSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWS 244
Y ++V++ KP RPL+S +DLS+V+ E++Y GFSASTG T SH V WS
Sbjct: 172 YDGSSKRLSVTLAY--PNKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWS 229
Query: 245 IS 246
S
Sbjct: 230 FS 231
|
Length = 231 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 6e-51
Identities = 72/194 (37%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE-FVAEIMSMGRLRHRNLVQLHGWC 396
+G GGFG VY G +VAIK I + E + EI + +L H N+V+L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
++ L LV +Y GSL LL + + K L+ D+ +IL+ I + L YLH +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHS---NGI 113
Query: 457 VHRDVKPSNILLD-TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKAT 514
+HRD+KP NILLD KL DFGL+K+ IVGT Y+APE L G +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 515 TSTDVYSYGILMLE 528
+D++S G+++ E
Sbjct: 173 EKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 9e-49
Identities = 69/200 (34%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFV---AEIMSMGRLRHRNLVQLHG 394
+GSG FG VY+ G VA+K + + K+ EI + RL H N+V+L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKIL-KKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+D L LV +Y G L L L+ D+ KI + I + L YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK-A 513
++HRD+KP NILLD K+ DFGLAK ++ T VGT Y+APE+ G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 514 TTSTDVYSYGILMLEVACGR 533
DV+S G+++ E+ G+
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE-FVAEIMSMGRLRHRNLVQLHG 394
+G G FG+VY G VAIK I + +E + EI + +L+H N+V+L+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+D+L LV +Y G L LL K R L+ D+ L I +L YLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLHS---K 116
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
+VHRD+KP NILLD + KL DFGLA+ + + T VGT Y+APE+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 515 TSTDVYSYGILMLEVACGR 533
+ D++S G+++ E+ G+
Sbjct: 175 KAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-44
Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 339 GSGGFGRVYRGLM----PSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG VY+G + +EVA+K + S+Q ++EF+ E M +L H N+V+L
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G C +++ L +V +Y+ G L L K R L+ + IA+ + YL
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLG---YLAPELTR 509
+ +HRD+ N L+ L K+ DFGL++ +Y+ G ++APE +
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD----DYYRKRGGKLPIRWMAPESLK 176
Query: 510 TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ-TL 568
GK T+ +DV+S+G+L+ E+ P + E+L +++K G
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL--EYLK----NGYRLPQPPNCPP 230
Query: 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+ YDL C A +P RP +VE L
Sbjct: 231 ELYDLMLQ---------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 61/197 (30%), Positives = 108/197 (54%), Gaps = 13/197 (6%)
Query: 339 GSGGFGRVYRGLM----PSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG VY+G + +EVA+K + S+Q ++EF+ E M +L H N+V+L
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G C +++ L++V +Y+P G L L + ++ K L+ + IA+ + YL
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYL--RKNR-PKELSLSDLLSFALQIARGMEYLES--- 121
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTGK 512
+ +HRD+ N L+ L K+ DFGL++ +Y+ + + ++APE + GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEGK 180
Query: 513 ATTSTDVYSYGILMLEV 529
T+ +DV+S+G+L+ E+
Sbjct: 181 FTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 336 NLVGSGGFGRVYRGLM---PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G FG VY+G + EVA+K + + S++ K+F+ E M +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLL----FDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
L G C +++ L LV +Y+ G L L + L+ I IA+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLG-----Y 502
L ++ VHRD+ N L+ L K+ DFGL++ + T G +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEV 529
+APE + G T+ +DV+S+G+L+ E+
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 82/272 (30%), Positives = 127/272 (46%), Gaps = 27/272 (9%)
Query: 339 GSGGFGRVYRG----LMPSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG VY+G +VA+K + S++ +EF+ E M +L H N+V+L
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G C + + L +V +Y+P G L L K + LT ++ + IA+ + YL
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTGK 512
+ VHRD+ N L+ L K+ DFGL++ IYE + + ++APE + GK
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 513 ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572
T+ +DV+S+G+L+ E+ P + E V EL +G L +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE------VLELLEDGYR-------LPRPE 227
Query: 573 LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
EL L L C A +P RP +VE L
Sbjct: 228 NCPDELY-ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 17/206 (8%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
L+G G FG VY L G +A+K + +S++ ++ EI + L+H N+V+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 394 GWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYLH 449
G R +++ L + +YV GSL LL K KL + + ++Y +IL G+A YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVI--RKYTRQILEGLA----YLH 118
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELT 508
+VHRD+K +NIL+D+ KL DFG AK + + T + GT ++APE+
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 509 RTGKATTSTDVYSYGILMLEVACGRR 534
R + + D++S G ++E+A G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 12/207 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G GGFG VY+ G EVAIK I S++ ++ + EI + + +H N+V+ +G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
K+DEL +V ++ GSL LL + LT Q + + + L YLH + ++
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQT----LTESQIAYVCKELLKGLEYLH---SNGII 120
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTST 517
HRD+K +NILL + KL DFGL+ +VGT ++APE+
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDT--KARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 518 DVYSYGILMLEVACGR---RSIEPQKA 541
D++S GI +E+A G+ + P KA
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKA 205
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 67/196 (34%), Positives = 105/196 (53%), Gaps = 11/196 (5%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQL 392
+L+G G FG VY+GL G VAIK+I ++ +K + EI + L+H N+V+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
G D L ++ +Y NGSL +++ K + L Y++L G L YLHE
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQG----LAYLHE-- 117
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
Q V+HRD+K +NIL KL DFG+A + + +VGT ++APE+
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 513 ATTSTDVYSYGILMLE 528
A+T++D++S G ++E
Sbjct: 176 ASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 7/202 (3%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG+VY S G +K I + S++ ++ + E+ + +L H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ ++ +L +V +Y G L + + K K K +Q + + +L YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
++++HRD+KP NI L + KLGDFG++K+ + T +VGT YL+PEL +
Sbjct: 122 -RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKP 179
Query: 513 ATTSTDVYSYGILMLEVACGRR 534
+D++S G ++ E+ +
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 68/200 (34%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+G G FG V G G +VA+K + + + F+AE M LRH NLVQL G
Sbjct: 13 TIGKGEFGDVMLGDY--RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+ + L +V +Y+ GSL L + R ++T Q+ + + + + YL E +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL--GYLAPELTRTGKAT 514
VHRD+ N+L+ L AK+ DFGLAK G L + APE R K +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 515 TSTDVYSYGILMLEV-ACGR 533
T +DV+S+GIL+ E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 69/205 (33%), Positives = 117/205 (57%), Gaps = 19/205 (9%)
Query: 334 EQNLVGSGGFGRVYRGLMPSLG---LEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRN 388
+Q ++G+G FG V+RG++ G + VAIK + G+ +Q ++F++E MG+ H N
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHN 67
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+++L G K +++ +Y+ NG+LDK L D D + Q +L GIA + YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYL 123
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG----TLGYLA 504
+ VHRD+ NIL+++ L K+ DFGL+++ E +P+ T+ + + A
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTA 178
Query: 505 PELTRTGKATTSTDVYSYGILMLEV 529
PE K T+++DV+S+GI+M EV
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEV 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 70/201 (34%), Positives = 109/201 (54%), Gaps = 14/201 (6%)
Query: 335 QNLVGSGGFGRVYRGLMPSLG---LEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLV 390
+ ++G G FG V RG + G ++VAIK + S + +F+ E MG+ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+L G K ++++ +Y+ NGSLDK L + D K T Q +L GIA + YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSE 124
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG--TLGYLAPELT 508
VHRD+ NIL+++ L K+ DFGL++ E + T G + + APE
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED-SEATYTTKGGKIPIRWTAPEAI 180
Query: 509 RTGKATTSTDVYSYGILMLEV 529
K T+++DV+S+GI+M EV
Sbjct: 181 AYRKFTSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G G FG V + S G + K I G+ +++ ++ V+E+ + L+H N+V+ +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 396 C--RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH--EE 451
R L +V +Y G L +L+ K K RK + + ++IL + +L H +
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
V+HRD+KP+NI LD N KLGDFGLAKI H ++ T+ VGT Y++PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQLNHM 185
Query: 512 KATTSTDVYSYGILMLEVACGR 533
+D++S G L+ E+
Sbjct: 186 SYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 2e-28
Identities = 83/322 (25%), Positives = 131/322 (40%), Gaps = 27/322 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGH---NSQQGMKEFVAEIMSMGRLRH-RNLVQL 392
+G G FG VY VA+K + + + ++ F+ EI + L H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ + + + L LV +YV GSL+ LL K + L+ + IL I +L YLH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHS-- 119
Query: 453 NQRVVHRDVKPSNILLDTYLN-AKLGDFGLAKIYEHGANPQ-----TTHIVGTLGYLAPE 506
+ ++HRD+KP NILLD KL DFGLAK+ + + VGT GY+APE
Sbjct: 120 -KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 507 L---TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563
+ A++S+D++S GI + E+ G P + ++ LE
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLP---PFEGEKNSSATSQTLKIILELPTPSL 235
Query: 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLPPLPPDIHLKDTR 623
++ +L A +P R + L + L D
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA---HLKLKESDLSDLL 292
Query: 624 NIMGFSDFPNDSDFFNSKLMSS 645
+ L+SS
Sbjct: 293 KPDDSAPLRLSLPPSLEALISS 314
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 22/206 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI-----GHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
L+GSG FG VY GL G A+K + G Q+ +K+ EI + +L+H N+VQ
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLL--FDK-DHKLRKLLTWDQRYKILIGIAQSLLYL 448
G R++D L + + VP GSL KLL + + +L T +IL+G+ YL
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT----RQILLGLE----YL 118
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-L 507
H ++ VHRD+K +NIL+DT KL DFG+AK G+ ++APE +
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVI 173
Query: 508 TRTGKATTSTDVYSYGILMLEVACGR 533
+ G + D++S G +LE+A G+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 336 NLVGSGGFGRVYRG----LMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLV 390
+G G FG+V L + G +VA+K + H+ +Q +F EI + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 391 QLHGWCRKQ--DELLLVYDYVPNGSLDKLL-FDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
+ G C K L L+ +Y+P+GSL L +D K L I + + Y
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL-----LFSSQICKGMDY 124
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI------YEHGANPQTTHIVGTLG 501
L +QR +HRD+ NIL+++ K+ DFGLAK+ Y + P + I
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---- 177
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEV-ACGRRSIEP 538
+ APE RT K ++++DV+S+G+ + E+ G S P
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 69/204 (33%), Positives = 111/204 (54%), Gaps = 17/204 (8%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLE---VAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNL 389
+ ++G+G FG V RG + G VAIK + G+ +Q ++F++E MG+ H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+ L G K ++++ +++ NG+LD L D + T Q +L GIA + YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ----FTVIQLVGMLRGIAAGMKYLS 123
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA-NPQTTHIVG---TLGYLAP 505
E VHRD+ NIL+++ L K+ DFGL++ E +P T +G + + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E K T+++DV+SYGI+M EV
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEV 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
F + +GSG FG V+ GL + + VAIK + + ++F E+ ++ RLRH++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGI----AQSLLY 447
L C + + ++ + + GSL L + + LI + A+ + Y
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAY 119
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPE 506
L E Q +HRD+ NIL+ L K+ DFGLA+ I E I + APE
Sbjct: 120 LEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPE 174
Query: 507 LTRTGKATTSTDVYSYGILMLEV 529
G +T +DV+S+GIL+ E+
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 27/208 (12%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI-GHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
+G G +G+VY+ G VA+K+I N ++G EI + +LRH N+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 396 C--RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR----YKILIGIAQSLLYLH 449
+ + + +V++Y+ + L LL + K T Q ++L G+ YLH
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKF----TESQIKCYMKQLLEGLQ----YLH 117
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL-- 507
+ ++HRD+K SNIL++ KL DFGLA+ Y + T+ V TL Y PEL
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 508 --TRTGKATTSTDVYSYGILMLEVACGR 533
TR G D++S G ++ E+ G+
Sbjct: 175 GATRYG---PEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFV-AEIMSMGRLRHRNLVQLHG 394
+G G FG+V G A+K + ++ E E + R+ H +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 395 WCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLYLHEE 451
Q E L LV +Y P G L L K + ++R + I +L YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFS--EERARFYAAEIVLALEYLH-- 110
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+ +++RD+KP NILLD + KL DFGLAK +T GT YLAPE+
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFCGTPEYLAPEVLLGK 168
Query: 512 KATTSTDVYSYGILMLEVACGR 533
+ D +S G+L+ E+ G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 57/198 (28%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
G G G VY+ G A+K+I + + K+ + E+ ++ +V+ +G
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYLHEECNQR 455
K+ E+ +V +Y+ GSL LL +K+ + I I + L YLH +
Sbjct: 70 KEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT--KRH 120
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
++HRD+KPSN+L+++ K+ DFG++K+ E+ + T VGT+ Y++PE + +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESYSY 179
Query: 516 STDVYSYGILMLEVACGR 533
+ D++S G+ +LE A G+
Sbjct: 180 AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 68/209 (32%), Positives = 110/209 (52%), Gaps = 20/209 (9%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
N +G G FG+VY + G +A+K RI N + +KE E+ + L+H NLV+ +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYLHEE 451
G ++++ + +Y G+L++LL +H + Y ++L G+A YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLA----YLHS- 117
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP---QTTHIVGTLGYLAPELT 508
+VHRD+KP+NI LD KLGDFG A ++ + + GT Y+APE+
Sbjct: 118 --HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 509 RTGKAT---TSTDVYSYGILMLEVACGRR 534
GK + D++S G ++LE+A G+R
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+G G +G VY+ + G VAIK + ++ ++E + EI + + +V+ +G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLR-KLLTWDQRYKILIGIAQSLLYLHEECNQR 455
K +L +V +Y GS+ ++ K+ K LT ++ IL + L YLH + +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM-----KITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
+HRD+K NILL+ AKL DFG++ + ++GT ++APE+ +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 516 STDVYSYGILMLEVACGR 533
D++S GI +E+A G+
Sbjct: 179 KADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 91/337 (27%), Positives = 159/337 (47%), Gaps = 43/337 (12%)
Query: 275 FSVGITLAGMAFLILIIAGAIHVLQR------IKYADKMLEDWEIQCGARRF-KYAELAS 327
F + TL AFL+L + V R +K + WE+Q + K +
Sbjct: 630 FYITCTLG--AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND 687
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRH 386
+ E+N++ G G Y+G G++ +K I NS EI MG+L+H
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQH 742
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
N+V+L G CR + L+++Y+ +L ++L + L+W++R KI IGIA++L
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALR 794
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKL--GDFGLAKIYEHGANPQTTHIVGTLGYLA 504
+LH C+ VV ++ P I++D L GL T + + Y+A
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCT-------DTKCFISS-AYVA 846
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK----ELHLEGEI 560
PE T T +D+Y +G++++E+ G+ + + +V+W + + HL+ I
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWI 905
Query: 561 TQAI--DQTLDYYDLAEAELVLNLGLFCSAPNPVYRP 595
+I D +++ ++ E V+NL L C+A +P RP
Sbjct: 906 DPSIRGDVSVNQNEIVE---VMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 85/270 (31%), Positives = 127/270 (47%), Gaps = 30/270 (11%)
Query: 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
GE+ ++G G +G VY S + +AIK I + ++ EI L+HRN+VQ
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILI---GIAQSLLYLH 449
G + + + VP GSL LL K L+ D I+ I + L YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLK-----DNEQTIIFYTKQILEGLKYLH 125
Query: 450 EECNQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
+ ++VHRD+K N+L++TY K+ DFG +K G NP T GTL Y+APE+
Sbjct: 126 D---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVI 181
Query: 509 RTGKA--TTSTDVYSYGILMLEVACGRRS-IEPQKAAAELLLVDWVKELHLEGEITQAID 565
G D++S G ++E+A G+ IE + A + V K + EI +++
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK---IHPEIPESLS 238
Query: 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRP 595
AEA+ N L C P+P R
Sbjct: 239 --------AEAK---NFILRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 43/230 (18%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEF-VAEIM----SMGRL-R 385
FG+ ++G G F V E AIK + + +Q +KE V + + RL
Sbjct: 5 FGK--IIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY---KILIGIA 442
H +++L+ + ++ L V +Y PNG L + + K L R+ +IL+ +
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALE 116
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY----------------- 485
YLH ++ ++HRD+KP NILLD ++ K+ DFG AK+
Sbjct: 117 ----YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 486 --EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+ VGT Y++PEL A S+D+++ G ++ ++ G+
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 338 VGSGGFGRVYRG--LMPSLG-LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G FG V +G LM S +EVA+K + G KEF+ E M +L H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDH-KLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
G C K + L+LV + P G L K L + + L +A + YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN--PQTTHIVGTLGYLAPELTRT 510
+ VHRD+ N+LL AK+ DFG+++ G++ TT L + APE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 511 GKATTSTDVYSYGILMLEV 529
GK ++ +DV+SYG+ + E
Sbjct: 173 GKFSSKSDVWSYGVTLWEA 191
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 69/202 (34%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 335 QNLVGSGGFGRVYRGLMPSLG---LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNL 389
+ ++G+G FG V G + G + VAIK + G+ +Q ++F++E MG+ H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+ L G K +++V +Y+ NGSLD L D + T Q +L GIA + YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ----FTVIQLVGMLRGIASGMKYL- 122
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLG--YLAPEL 507
+ VHRD+ NIL+++ L K+ DFGL+++ E T G + + APE
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 508 TRTGKATTSTDVYSYGILMLEV 529
K T+++DV+SYGI+M EV
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G G +G VY+ G VAIK+I S+ K + EI + L H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
R + +L LV++++ + L KL+ D+ ++ L L + Q L + H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS---HG 118
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKAT 514
++HRD+KP N+L++T KL DFGLA+ + TH V T Y APE L +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 515 TSTDVYSYGILMLEVACGR 533
T D++S G + E+ R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 30/205 (14%)
Query: 339 GSGGFGRVYRGLMPSLG----LEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLH 393
GSG FG VY+G+ G + VAIK + + + KE + E M + H ++V+L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR----KLLTWDQRYKILIGIAQSLLYLH 449
G C ++ L+ +P G L + ++HK LL W + IA+ + YL
Sbjct: 76 GICLSS-QVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLG-----YLA 504
E +R+VHRD+ N+L+ T + K+ DFGLAK+ + G ++A
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD----VDEKEYHAEGGKVPIKWMA 179
Query: 505 PELTRTGKATTSTDVYSYGILMLEV 529
E T +DV+SYG+ + E+
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI-GHNSQQGM-KEFVAEIMSMGRLRHRNLVQLHGW 395
+G G +G VY+ G VA+K+I N ++G+ + EI + L+H N+V+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
+ +L LV++Y L K L K L+ + I+ + + L Y H R
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHS---HR 118
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKAT 514
++HRD+KP NIL++ KL DFGLA+ + TH V TL Y APE L + +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGI-PLRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 515 TSTDVYSYGILMLEVACGR 533
T+ D++S G + E+ G+
Sbjct: 178 TAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G G VY+ + G EVAIK++ +Q + + EI+ M +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
DEL +V +Y+ GSL ++ ++ Q + + Q L YLH +Q V+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRM----NEPQIAYVCREVLQGLEYLH---SQNVI 138
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTST 517
HRD+K NILL + KL DFG A + + + +VGT ++APE+ +
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKDYGPKV 197
Query: 518 DVYSYGILMLEVACG 532
D++S GI+ +E+A G
Sbjct: 198 DIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVA---EIMSMGRLRHRNLVQ 391
L+G G FGRVY G E+A+K++ +S + KE A EI + L+H +VQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 392 LHGWCRKQDELLLVY-DYVPNGSLDKLLFDKDH-KLRKLLTWDQRYKILIGIAQSLLYLH 449
+G C + DE L ++ +Y+P GS+ KD K LT K I + + YLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSV------KDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----IYEHGANPQTTHIVGTLGYLAP 505
+ +VHRD+K +NIL D+ N KLGDFG +K I G ++ GT +++P
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT--GTPYWMSP 176
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E+ DV+S G ++E+
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGLE-----VAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G FG+V+ G L E VA+K + S K+F E + +H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL---------LTWDQRYKILIGIA 442
+G C + D ++V++Y+ +G L+K L L LT Q +I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLG 501
++YL +Q VHRD+ N L+ L K+GDFG+++ +Y H + +
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEV 529
++ PE K TT +DV+S+G+++ E+
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 11/241 (4%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMK-EFVAEIMSMGRLRHRNL 389
F N +G G FG V++ + + A+K+I + + E + E + +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL-LTWDQRYKILIGIAQSLLYL 448
++ + + +L +V +Y NG L KLL R L DQ ++ I I L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL----KMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H +++++HRD+K N+ LD Y N K+GD G+AK+ N T IVGT YL+PEL
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELC 173
Query: 509 RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568
+DV++ G+++ E G+ + A +L + + +Q + Q +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLI 233
Query: 569 D 569
D
Sbjct: 234 D 234
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 37/219 (16%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIK------RIGHNSQQGMKEFV----AEIMSMGRLRH 386
L+G G +GRVY L + G +A+K I K+ V +EI ++ L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIGI 441
N+VQ G+ ++ L + +YVP GS+ L F++ L + T ++L G+
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ--LVRFFT----EQVLEGL 121
Query: 442 AQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----IYEHGANPQTTHIV 497
A YLH ++ ++HRD+K N+L+D K+ DFG++K IY N Q +
Sbjct: 122 A----YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY---DNDQNMSMQ 171
Query: 498 GTLGYLAPELTRTGKATTS--TDVYSYGILMLEVACGRR 534
G++ ++APE+ + S D++S G ++LE+ GRR
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+ +GSG +G VY+ + G VAIK I + EI + RH N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIA-------QS 444
G ++D+L +V +Y GSL + R L+ Q IA +
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIY----QVTRGPLSELQ-------IAYVCRETLKG 113
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
L YLHE +HRD+K +NILL + KL DFG++ + + I GT ++A
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMA 169
Query: 505 PELT---RTGKATTSTDVYSYGILMLEVA 530
PE+ R G D+++ GI +E+A
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELA 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 26/200 (13%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK--EFVAEIMSMGRLRHRNLVQLHGWC 396
G+G FG V+ G +VA+K + + M F+ E M +LRH LVQL+ C
Sbjct: 15 GAGQFGEVWMGTWNG-TTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG----IAQSLLYLHEEC 452
+++ + +V +Y+ GSL L F K + +KL R L+ IA+ + YL
Sbjct: 71 SEEEPIYIVTEYMSKGSL--LDFLKSGEGKKL-----RLPQLVDMAAQIAEGMAYLES-- 121
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT---LGYLAPELTR 509
+ +HRD+ NIL+ L K+ DFGLA++ E + T G + + APE
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAR-EGAKFPIKWTAPEAAN 177
Query: 510 TGKATTSTDVYSYGILMLEV 529
G+ T +DV+S+GIL+ E+
Sbjct: 178 YGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+VG G +G V + + G VAIK + + + K + E+ + +LRH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDK---DHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
R++ L LV++YV L+ L + W + Q++ Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS- 118
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL---- 507
++HRD+KP NIL+ KL DFG A+ T V T Y APEL
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 508 TRTGKATTSTDVYSYGILMLEVACGR 533
T GK DV++ G +M E+ G
Sbjct: 177 TNYGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 12/218 (5%)
Query: 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKR--IGHNSQQGMKEFVAEIMSMGRLRHRN 388
F +G G +G VY+ S A+K +G SQ+ ++ V EI + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
++ ++L +V +Y P G L K + K K RKL+ + ++I I + + L L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG-ANPQTTHIVGTLGYLAPEL 507
HE Q+++HRD+K +NILL K+GD G++K+ + A Q GT Y+APE+
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEV 172
Query: 508 TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL 545
+ + +D++S G L+ E+A E ++ +L
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI-GHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
+G G G V++ G VA+K++ + G+ EI ++ +H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYLHEECN 453
+LV +Y+P L ++L D++ L + + Y +L G+A Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQV--KSYMRMLLKGVA----YMHAN-- 118
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL---TRT 510
++HRD+KP+N+L+ K+ DFGLA+++ +H V T Y APEL R
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR- 176
Query: 511 GKATTSTDVYSYGILMLE 528
K D+++ G + E
Sbjct: 177 -KYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 68/202 (33%), Positives = 111/202 (54%), Gaps = 17/202 (8%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEF-VAEIMSMGRLRHRNLVQLHGWC 396
+G G + VY+G + G VA+K I ++++G + EI M L+H N+V+LH
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+++L+LV++Y+ + L K + + L Y++L GIA + HE
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHE---N 119
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL---TRTG 511
RV+HRD+KP N+L++ KL DFGLA+ + N + +V TL Y AP++ +RT
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRT- 177
Query: 512 KATTSTDVYSYGILMLEVACGR 533
+TS D++S G +M E+ GR
Sbjct: 178 -YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G+G FG V+ GL + VA+K + + K+F+AE M +LRH L+QL+ C
Sbjct: 14 LGAGQFGEVWEGLW-NNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ + +V + + GSL + L + KL Q + +A + YL Q +
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL---PQLIDMAAQVASGMAYLEA---QNYI 125
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTST 517
HRD+ N+L+ K+ DFGLA++ + + + APE + + +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 518 DVYSYGILMLE-VACGR 533
DV+S+GIL+ E V GR
Sbjct: 186 DVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+GSG FG V+ G ++VAIK I +F+ E M +L H NLVQL+G C
Sbjct: 12 LGSGQFGVVHLGKWRGK-IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
KQ + +V +Y+ NG L L ++ KL D + + +++ YL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD----MCSDVCEAMEYLESNG---FI 122
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT---LGYLAPELTRTGKAT 514
HRD+ N L+ K+ DFGLA+ + Q T GT + + PE+ + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 515 TSTDVYSYGILMLEV-ACGR 533
+ +DV+S+G+LM EV + G+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 338 VGSGGFGRVYRGLMPSLGLE-----VAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G FG+VY+G + VAIK + N + +EF E M L+H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLF-----------DKDHKLRKLLTWDQRYKILIG 440
L G C K+ ++++Y+ +G L + L D ++ L I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGT 499
IA + YL + VHRD+ N L+ L K+ DFGL++ IY + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ ++ PE GK TT +D++S+G+++ E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIG---HNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
++G G FG+V A+K + + ++ + E + L H LV
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLYLHE 450
L + ++ + LV D + G L + H +K+ +++ K I I +L YLH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDL------RYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ ++HRD+KP NILLD + + DF +A TT GT GY+APE+
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCR 173
Query: 511 GKATTSTDVYSYGILMLEVACGRR 534
+ + D +S G+ E G+R
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
++G G VY + +VAIKRI Q + E E+ +M + H N+V+ +
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
DEL LV Y+ GSL ++ K R L +L + + L YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTH--IVGTLGYLAPELTRT 510
+HRD+K NILL + K+ DFG+ A + + G + VGT ++APE+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 511 GKATTS-TDVYSYGILMLEVACGR 533
D++S+GI +E+A G
Sbjct: 181 VHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE---FVA--EIMSMGRLRHRNLV 390
+G G + VY+ G VAIK+I ++ K+ F A EI + L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
L + + LV++++ L+K++ DK +LT ++ + L YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLH- 119
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT--THIVGTLGYLAPELT 508
+ ++HRD+KP+N+L+ + KL DFGLA+ + +P TH V T Y APEL
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSF---GSPNRKMTHQVVTRWYRAPELL 174
Query: 509 RTGKA-TTSTDVYSYGILMLE 528
+ D++S G + E
Sbjct: 175 FGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 26/243 (10%)
Query: 9 TSFLYNGFL---HANLSLEGAAYIST-SGILTVTNKSEGLIGHALYPNPLRFKTSNKSVA 64
TS ++ F +N L G+A ++T SG+L +T + G A Y P+
Sbjct: 1 TSLNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLSK------ 54
Query: 65 IDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRML 124
DF T F F L G G+AF++ N P L G + +
Sbjct: 55 -DFTTTFKFY-LGTKGTNGADGIAFVL--QNDPAGALGGGG-GGGGLGYGGIGNS----V 105
Query: 125 AVEFDIIQNTELIDINDNHVGIDISSL-ISSASEPASYYSGNNHRIPILLRSGDPIQAWV 183
AVEFD +N + D N NH+ ID++ ++A + + + + G+ +
Sbjct: 106 AVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGL----GNEHTVRI 161
Query: 184 DYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243
Y + V + I++P+DL + Y GF+ASTG +T H++ W
Sbjct: 162 TYDPTTNTLTVYL--DNGSTLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNW 219
Query: 244 SIS 246
S +
Sbjct: 220 SFT 222
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLV 390
F +G G FG VY+ + VAIK I ++ +++ EI + + R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYL 448
+ +G K +L ++ +Y GS LL K KL D+ Y IL + L YL
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKL---DETYIAFILREVLLGLEYL 114
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
HE + +HRD+K +NILL + KL DFG++ + + T VGT ++APE+
Sbjct: 115 HE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVI 170
Query: 509 RTGKATTSTDVYSYGILMLEVACG---RRSIEPQKA 541
+ D++S GI +E+A G + P +
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 82/283 (28%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 337 LVGSGGFGRVYRGLMPSLG---LEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRNLVQL 392
+G G FG V RG + G + VA+K + + M +F+ E M L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 393 HGWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLT---WDQRYKILIGIAQSLLYL 448
+G L++V + P GSL D+L + L L D +I G+ YL
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMR----YL 113
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT--HIVGTLGYLAPE 506
+R +HRD+ NILL + K+GDFGL + + H+ + APE
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 507 LTRTGKATTSTDVYSYGILMLEV-ACGRRSIEPQKAAAELLLVDWVKELHLEG-EITQAI 564
RT + ++DV+ +G+ + E+ G EP W L G +I + I
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGE---EP-----------WA---GLSGSQILKKI 213
Query: 565 DQTLDYYDLAEA--ELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605
D+ + + EA + + N+ L C A NP RP + EFL
Sbjct: 214 DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 26/204 (12%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM-KEFVAEIMSMGRLRHRNLVQLHGWCR 397
G+G G V + L G +A+K I + + K+ + E+ + + +V +G
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY 69
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ + +Y+ GSLDK+L +++ + KI + + + L YLHE +++
Sbjct: 70 NNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHE--KHKII 123
Query: 458 HRDVKPSNILLDTYLNAKLGDFG--------LAKIYEHGANPQTTHIVGTLGYLAPELTR 509
HRDVKPSNIL+++ KL DFG LAK + VGT Y+APE +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----------VGTSSYMAPERIQ 172
Query: 510 TGKATTSTDVYSYGILMLEVACGR 533
+ +D++S G+ ++E+A GR
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 38/287 (13%)
Query: 336 NLVGSGGFGRVYRG-----LMPSLG-LEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRN 388
N +GSG FG VY G L P G + VA+K + + Q KEF+ E M H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRK----LLTWDQRYKILIGIAQS 444
+V+L G C + ++ + + G L L + +D ++ + LLT + I + +A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDL--LSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 445 LLYLHEECNQRVVHRDVKPSNILL-----DTYLNAKLGDFGLAK-IYEHGANPQTTHIVG 498
+YL + +HRD+ N L+ D K+GDFGLA+ IY+ + +
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEV-ACGRRSIEPQKAAAELLLVDWVKELHLE 557
+ ++APE GK TT +DV+S+G+LM E+ G+ +P A ++ V
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ---QPYPALNNQEVLQHVTA---G 229
Query: 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
G + + + Y L C A +P RP R+ E L
Sbjct: 230 GRLQKPENCPDKIYQLM---------TNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 70/220 (31%), Positives = 107/220 (48%), Gaps = 33/220 (15%)
Query: 323 AELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMK-EFVAEIMS 380
SVT+ F + N +G G +G VYR + G VA+K++ N + G+ + EI
Sbjct: 1 GRCRSVTE-FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITL 59
Query: 381 MGRLRHRNLVQLH----GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLL------- 429
+ LRH N+V+L G + D + LV +Y + L LL
Sbjct: 60 LLNLRHPNIVELKEVVVG--KHLDSIFLVMEYC------------EQDLASLLDNMPTPF 105
Query: 430 TWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489
+ Q +++ + + L YLHE ++HRD+K SN+LL K+ DFGLA+ Y A
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162
Query: 490 NPQTTHIVGTLGYLAPE-LTRTGKATTSTDVYSYGILMLE 528
P T +V TL Y APE L TT+ D+++ G ++ E
Sbjct: 163 KPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
GE +G G FG V +G G +VA+K I + F+ E M +L H+NLV+
Sbjct: 10 LGEI--IGEGEFGAVLQG--EYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L G L +V + + G+L L + R L++ Q + + +A+ + YL
Sbjct: 64 LLGVILHNG-LYIVMELMSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLE-- 117
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
++++VHRD+ NIL+ AK+ DFGLA++ G + + T APE +
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHK 172
Query: 512 KATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL 545
K ++ +DV+SYG+L+ EV R+ P+ + E+
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+GSG FG V+ G +VAIK I G S++ +F+ E M +L H LVQL+G
Sbjct: 12 IGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGV 67
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C ++ + LV++++ +G L L + R + + + + + + + YL
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT---LGYLAPELTRTGK 512
V+HRD+ N L+ K+ DFG+ + + Q T GT + + +PE+ K
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 513 ATTSTDVYSYGILMLEV 529
++ +DV+S+G+LM EV
Sbjct: 178 YSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFV-AEIMSMGRLRHRNLVQLHG 394
+G GGFGRV + S A+K + H + G +E + +E + H +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+ + + ++ +Y G L + + R+ + + + YLH N+
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLH---NR 112
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPELTRTGKA 513
+++RD+KP N+LLD+ KL DFG AK + G Q T GT Y+APE+
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPEYVAPEIILNKGY 169
Query: 514 TTSTDVYSYGILMLEVACGR 533
S D +S GIL+ E+ GR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 15/196 (7%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G G FG V G G +VA+K I +++ + F+AE M +LRH NLVQL G
Sbjct: 11 LQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 66
Query: 395 -WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
++ L +V +Y+ GSL L + R +L D K + + +++ YL E N
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYL--EAN 121
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
VHRD+ N+L+ AK+ DFGL K E + T + + + APE R K
Sbjct: 122 N-FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKF 176
Query: 514 TTSTDVYSYGILMLEV 529
+T +DV+S+GIL+ E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 34/212 (16%)
Query: 335 QNLVGSGGFGRV----YRGLMPSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNL 389
++G G FG+V Y G VA+K + QQ + EI + L H N+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 390 VQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
V+ G C +Q L L+ +YVP GSL L L +LL + Q+ I + + Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAY 122
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----------IYEHGANPQTTHIV 497
LH +Q +HRD+ N+LLD K+GDFGLAK + E G +P
Sbjct: 123 LH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------ 173
Query: 498 GTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + A E + K + ++DV+S+G+ + E+
Sbjct: 174 --VFWYAVECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 35/211 (16%)
Query: 337 LVGSGGFGRV----YRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG V Y L + G VA+K++ H++ + +++F EI + L+H N+V+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 393 HGWC--RKQDELLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYL 448
G C + L LV +Y+P GSL L +L RKLL + + I + + YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ------ICKGMEYL 124
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY----------EHGANPQTTHIVG 498
+R VHRD+ NIL+++ K+GDFGL K+ E G +P
Sbjct: 125 GS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP------- 174
Query: 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + APE K + ++DV+S+G+++ E+
Sbjct: 175 -IFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI--------GHNSQQGMKEFVA-EIMSMGRLRHR 387
L+GSG FG VY G+ S G +A+K++ + ++ M + +A EI + L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
N+VQ G D L + +YVP GS+ LL + + L + +IL G L Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVRNFVRQILKG----LNY 121
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH-----GANPQTTHIVGTLGY 502
LH N+ ++HRD+K +NIL+D K+ DFG++K E N + G++ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+APE+ + T D++S G L++E+ G+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHG 394
N +GSG G VY+ + G A+K I N + ++ + EI + + H N+V+ H
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
E+ ++ +++ GSL+ + L D +IL GIA YLH +
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIA----YLHR---R 187
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT---- 510
+VHRD+KPSN+L+++ N K+ DFG+++I +P + VGT+ Y++PE T
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERINTDLNH 246
Query: 511 ----GKATTSTDVYSYGILMLEVACGR 533
G A D++S G+ +LE GR
Sbjct: 247 GAYDGYA---GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHG 394
LVG G +G V + G VAIK+ + M + +A EI + +LRH NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
R++ L LV+++V + LD L + L + ++IL GI + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIE----FCH---SH 119
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT--THIVGTLGYLAPEL----T 508
++HRD+KP NIL+ KL DFG A+ A P T V T Y APEL T
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTL---AAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 509 RTGKATTSTDVYSYGILMLEVACG 532
+ G+A D+++ G L+ E+ G
Sbjct: 177 KYGRA---VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRN 388
+ E + +G G G V + + + G+ A+K I + K+ + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 389 LVQLHGWC--RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQS 444
+V+ +G + + +Y GSLD + +K+ R K+L IA+S
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-------KKVKKRGGRIGEKVLGKIAES 113
Query: 445 LL----YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL 500
+L YLH ++++HRD+KPSNILL KL DFG++ N GT
Sbjct: 114 VLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTS 167
Query: 501 GYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQK 540
Y+APE + + ++DV+S G+ +LEVA R P+
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398
G G FG+VY+ GL A K I S++ +++F+ EI + +H N+V L+
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVH 458
+++L ++ ++ G+LD ++ +L + LT Q + + ++L +LH + +V+H
Sbjct: 74 ENKLWILIEFCDGGALDSIML----ELERGLTEPQIRYVCRQMLEALNFLH---SHKVIH 126
Query: 459 RDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL--TRTGKAT-- 514
RD+K NILL + KL DFG++ + + T I GT ++APE+ T K
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 515 -TSTDVYSYGILMLEVACGR 533
D++S GI ++E+A
Sbjct: 186 DYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG---HNSQQGMKEFVAEIMSMGRLR 385
F + +G G F VY+ + G VA+K++ + ++ + EI + +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDKDHKLRKLLTWDQRYKILIGIAQ 443
H N+++ + +EL +V + G L +++ F K ++L+ +K + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ---KRLIPERTIWKYFVQLCS 117
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT---HIVGTL 500
+L ++H +R++HRD+KP+N+ + KLGD GL + + + +TT +VGT
Sbjct: 118 ALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTP 170
Query: 501 GYLAPELTRTGKATTSTDVYSYGILMLEVAC 531
Y++PE +D++S G L+ E+A
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 41/216 (18%)
Query: 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEF-VAEIMSMGRLR---HRN 388
E +G G +G VY+ + G VA+K++ S++G+ + EI + +L H N
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 389 LVQL----HGWCRKQD-ELLLVYDYV-----------PNGSLDKLLFDKDHKLRKLLTWD 432
+V+L HG ++ +L LV+++V P L ++ L+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPP------ETIKDLM--- 113
Query: 433 QRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492
++L G+ +LH + R+VHRD+KP NIL+ + K+ DFGLA+IY
Sbjct: 114 --RQLLRGVD----FLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMA 162
Query: 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLE 528
T +V TL Y APE+ T D++S G + E
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-------EFVA--EIMSMGRL-RHR 387
+G G FG VY G VAIK+ MK E + E+ S+ +L H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKK--------MKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
N+V+L R+ DEL V++Y+ G+L +L+ KD K K + I+ I Q L +
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLM--KDRK-GKPFSESVIRSIIYQILQGLAH 114
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE- 506
+H HRD+KP N+L+ K+ DFGLA+ E + P T V T Y APE
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEI 169
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
L R+ ++ D+++ G +M E+ R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 72/276 (26%), Positives = 135/276 (48%), Gaps = 31/276 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLE-VAIKRIG-HN---------SQQGMKEFVAEIMSMG-RL 384
+GSG FG VY+ + G +A+K I HN + + + V+E+ + +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 385 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS 444
RH N+V+ + + D L +V D + L + K ++ T ++ + I + + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLA 125
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
L YLH+E +R+VHRD+ P+NI+L + DFGLAK + + T +VGT+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564
PE+ + DV+++G ++ ++ +++P + + L L +I +A+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC----TLQPPFYSTNM--------LSLATKIVEAV 229
Query: 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRV 600
+ L + +E V ++ C P+ RPD+ +V
Sbjct: 230 YEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRH---RNLVQL 392
L+G G +G VYRG G VA+K I ++ + + E+ + +LR N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILI--GIAQSLLYLHE 450
+G K L ++ +Y GS+ L+ K + ++Y +I + +L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPI---AEKYISVIIREVLVALKYIHK 119
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
V+HRD+K +NIL+ N KL DFG+A + ++ ++T VGT ++APE+
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITE 175
Query: 511 GKA-TTSTDVYSYGILMLEVACG 532
GK T D++S GI + E+A G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 338 VGSGGFGRVYRGLM-----PSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQ 391
+G G FG VY GL VAIK + N+ + EF+ E M ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLF-----DKDHKLRKLLTWDQRYKILIGIAQSLL 446
L G L+V + + G L L +++ T + ++ IA +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAP 505
YL ++ VHRD+ N ++ L K+GDFG+ + IYE + + + ++AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 506 ELTRTGKATTSTDVYSYGILMLEVA 530
E + G TT +DV+S+G+++ E+A
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 24/202 (11%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEF-VAEIMSMGRLRHRNLVQLHGW 395
+G G +G VY+ +A+K+I +G+ + EI + ++H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 396 CRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+ L LV++Y+ + L K + F K+ +L K + +IL GIA Y H
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLY----QILRGIA----YCH- 119
Query: 451 ECNQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQT-THIVGTLGYLAPELT 508
+ RV+HRD+KP N+L+D NA KL DFGLA+ + G +T TH V TL Y APE+
Sbjct: 120 --SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEIL 175
Query: 509 RTGKA-TTSTDVYSYGILMLEV 529
+ +T D++S G + E+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 9e-19
Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 23/199 (11%)
Query: 338 VGSGGFGRV----YRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G+G FG V +RG +VAIK I S EF+ E M +L H LVQL+
Sbjct: 12 LGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLY 65
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G C KQ + +V +Y+ NG L L + ++H K Q ++ + + + YL +
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCL--LNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE---S 118
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT---LGYLAPELTRT 510
++ +HRD+ N L+D K+ DFGL++ + + + T VG+ + + PE+
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 511 GKATTSTDVYSYGILMLEV 529
K ++ +DV+++G+LM EV
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE-FVAEIMSMGRLRHRNLVQLHGW 395
+G G FG VY+G++ EVA+K +K F+ E + + H N+V+L G
Sbjct: 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C ++ + +V + VP GSL L K ++L + ++ + A + YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV----KKLLQMSLDAAAGMEYLESKN--- 113
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG---ANPQTTHIVGTLGYLAPELTRTGK 512
+HRD+ N L+ K+ DFG+++ E G + I + + APE G+
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGR 171
Query: 513 ATTSTDVYSYGILMLEV 529
T+ +DV+SYGIL+ E
Sbjct: 172 YTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+GSG +G V + G +VAIK+I + + K + EI + LRH N++ L
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 393 HGWCR-----KQDELLLVYDYVPNGSLDKLLFDKD-HKL---RKLLTWDQR----YKILI 439
R +++ +V + L + D HK+ + LT D Y+IL
Sbjct: 65 LDILRPPSPEDFNDVYIVTE----------LMETDLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT--THIV 497
G L YLH N V+HRD+KPSNIL+++ + K+ DFGLA+ + + + T V
Sbjct: 115 G----LKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 498 GTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
T Y APEL + T + D++S G + E+ +
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-----EIMSMGRLRHRNLVQL 392
+G G +G VY+ G VA+K+I ++ E V EI + L H N+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRL 63
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+++L LV++++ D L+K + D + YL++
Sbjct: 64 LDVVHSENKLYLVFEFL------------DLDLKKYM--DSSPLTGLDPPLIKSYLYQLL 109
Query: 453 N-------QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLA 504
RV+HRD+KP N+L+D KL DFGLA+ + G +T TH V TL Y A
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRA 167
Query: 505 PELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEP 538
PE+ + +T D++S G + E+ RR + P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEM-VNRRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 25/221 (11%)
Query: 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGL-MP---SLGLEVAIKRIGHNS-QQGM 371
AR K EL + L+GSG FG V++G+ +P S+ + VAIK I S +Q
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 372 KEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL--RKLL 429
+E +++MG L H +V+L G C L LV P GSL + L ++LL
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 430 TWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHG 488
W + IA+ + YL E R+VHR++ NILL + ++ DFG+A +Y
Sbjct: 113 NW------CVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
Query: 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + ++A E G+ T +DV+SYG+ + E+
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G+G FG V+ G +VAIK + S + F+AE M +L+H LV+L+
Sbjct: 14 LGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 398 KQDELLLVYDYVPNGSL-DKLLFDKDHKLR--KLLTWDQRYKILIGIAQSLLYLHEECNQ 454
++ + ++ +Y+ NGSL D L + KL KL+ + IA+ + ++ +
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAFIER---K 121
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
+HRD++ +NIL+ L K+ DFGLA++ E + + APE G T
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 515 TSTDVYSYGILMLE-VACGR 533
+DV+S+GIL+ E V GR
Sbjct: 182 IKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVA---EIMSMGRLRHRNLVQ 391
L+G G FG VY G E+A+K++ + SQ+ KE A EI + LRH +VQ
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 392 LHGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+G R +E L + +Y+P GS+ L K LT + + I Q + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----IYEHGANPQTTHIVGTLGYLAP 505
+ +VHRD+K +NIL D+ N KLGDFG +K I G ++ + GT +++P
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPYWMSP 178
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E+ DV+S ++E+
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 15/215 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE----FVAEIMSMGRLRHRNLVQL 392
+VG G FG V+ + V IK+I +Q K+ E + L H N+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQI--PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ + L++V +Y P G+L + + + LL D IL Q LL LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR---CNSLLDEDT---ILHFFVQILLALHHVH 118
Query: 453 NQRVVHRDVKPSNILLDTYLN-AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+ ++HRD+K NILLD + K+GDFG++KI + + +VGT Y++PEL
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGK 176
Query: 512 KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
+D+++ G ++ E+A +R+ E A +L
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 338 VGSGGFGRVYRGLMPSLGLE-----VAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG+V+ +L E VA+K + S K+F E + L+H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL----------LTWDQRYKILIGIA 442
+G C + D L++V++Y+ +G L+K L + H + LT Q I IA
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLG 501
++YL +Q VHRD+ N L+ L K+GDFG+++ +Y H + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEV 529
++ PE K TT +DV+S G+++ E+
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI----GHNSQQG--MKEFVAEIMSMGRLRHRNLV 390
+G+G F Y+ G +A+K++ +S+Q ++ EI M RL H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
++ G + L +++ GS+ LL ++ + + L YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHE 121
Query: 451 ECNQRVVHRDVKPSNILLD-TYLNAKLGDFGLA-----KIYEHGANPQTTHIVGTLGYLA 504
+++HRDVK +N+L+D T ++ DFG A K GA ++GT+ ++A
Sbjct: 122 ---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT--GAGEFQGQLLGTIAFMA 176
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGR 533
PE+ R + S DV+S G +++E+A +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G FG V+ G VAIK + + + F+ E M +LRH LVQL+
Sbjct: 14 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA-VV 70
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ + +V +Y+ GSL L + K +L Q + IA + Y+ E N V
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL---PQLVDMAAQIASGMAYV-ERMN--YV 124
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTST 517
HRD++ +NIL+ L K+ DFGLA++ E + + APE G+ T +
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 518 DVYSYGILMLEVACGRRSIEPQKAAAELL 546
DV+S+GIL+ E+ R P E+L
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGWC 396
+G G G VY + + G EVAIK++ + QQ KE + EI+ M +H N+V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
DEL +V +Y+ GSL ++ + + Q + Q+L +LH NQ V
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS--NQ-V 136
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
+HRD+K NILL + KL DFG + ++T +VGT ++APE+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPK 195
Query: 517 TDVYSYGILMLEVACG 532
D++S GI+ +E+ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G G FG VY VAIK++ G S + ++ + E+ + +LRH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
++ LV +Y + D L +K L + I G Q L YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDIL-----EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT---G 511
+HRD+K NILL KL DFG A + +P + VGT ++APE+ G
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS-FVGTPYWMAPEVILAMDEG 189
Query: 512 KATTSTDVYSYGILMLEVA 530
+ DV+S GI +E+A
Sbjct: 190 QYDGKVDVWSLGITCIELA 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 32/210 (15%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEF-VAEIMSMGRLRHRNLVQLHGW 395
+G G +G VY+G G VA+K+I + ++G+ + EI + L+H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 396 CRKQDELLLVYDYVPNGSLD-KLLFD---KDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
++ L L+++++ S+D K D K + L Y+IL GI L+ H
Sbjct: 68 LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFCHS- 119
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-------KIYEHGANPQTTHIVGTLGYLA 504
+RV+HRD+KP N+L+D KL DFGLA ++Y TH V TL Y A
Sbjct: 120 --RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY--------THEVVTLWYRA 169
Query: 505 PE-LTRTGKATTSTDVYSYGILMLEVACGR 533
PE L + + +T D++S G + E+A +
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGL--EVAIKRIG-HNSQQGMKEFVAEIMSMGRL-RHRNLV 390
Q+++G G FG+V + + GL + AIKR+ + S+ ++F E+ + +L H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKILI 439
L G C + L L +Y P+G+L L F + L+ Q
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT 499
+A+ + YL + ++ +HRD+ NIL+ AK+ DFGL++ Q ++ T
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 181
Query: 500 LG-----YLAPELTRTGKATTSTDVYSYGILMLEV 529
+G ++A E TT++DV+SYG+L+ E+
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHRNLVQLH 393
+G+G FGRV G A+K + +K+ V +++ + +RH LV L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIGIAQSLL-- 446
G + L LV +YVP G L L F + AQ +L
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-------------ARFYAAQVVLAL 114
Query: 447 -YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
YLH + +V+RD+KP N+LLD+ K+ DFG AK + T + GT YLAP
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAP 167
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACG 532
E+ + + D ++ GIL+ E+ G
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 51/198 (25%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
++ +G G +G VY G+ L VA+K + ++ + ++EF+ E M ++H NLVQL G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
C ++ ++ +++ G+L L + + R+ + + I+ ++ YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---K 123
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT--LGYLAPELTRTGK 512
+HRD+ N L+ K+ DFGL+++ + T H + + APE K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 513 ATTSTDVYSYGILMLEVA 530
+ +DV+++G+L+ E+A
Sbjct: 182 FSIKSDVWAFGVLLWEIA 199
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 9/209 (4%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G+G FG V+ G +VA+K + + + F+ E M +LRH LVQL+
Sbjct: 14 LGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYA-VV 70
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ + +V +Y+ GSL L D + + KL + +A + Y+ E N +
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKL---PNLVDMAAQVAAGMAYI-ERMN--YI 124
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTST 517
HRD++ +NIL+ L K+ DFGLA++ E + + APE G+ T +
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 518 DVYSYGILMLEVACGRRSIEPQKAAAELL 546
DV+S+GIL+ E+ R P E+L
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFV-AEIMSMGRLRHRNLVQLHG 394
+ G +GRV+ S G AIK I ++ + V E + + + +V+L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 395 WCRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIG-IAQSLLYL 448
+ + L LV +Y+P G L LL D+D +I I I +L YL
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-----------RIYIAEIVLALEYL 109
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-------IYEHGANPQTTHIVGTLG 501
H + ++HRD+KP NIL+D+ + KL DFGL+K I + + IVGT
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEVACG 532
Y+APE+ + + D +S G ++ E G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEV--AIKRIG-HNSQQGMKEFVAEIMSMGRL-RHRNLV 390
++++G G FG+V R ++ GL++ AIK + S+ ++F E+ + +L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKILI 439
L G C + L + +Y P G+L L F K+H LT Q +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT 499
+A + YL E ++ +HRD+ N+L+ L +K+ DFGL++ E ++ T
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKT 176
Query: 500 LG-----YLAPELTRTGKATTSTDVYSYGILMLEV 529
+G ++A E TT +DV+S+G+L+ E+
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 338 VGSGGFGRVYRGLMPSLG-----LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG+V+ +L + VA+K + + K+F E + L+H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD-------------QRYKILI 439
+G C D L++V++Y+ +G L+K L + H ++ D Q I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVG 498
IA ++YL +Q VHRD+ N L+ L K+GDFG+++ +Y H +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ ++ PE K TT +DV+S+G+++ E+
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVA---EIMSMGRLRHRNLVQ 391
L+G G FGRVY G E+A K++ + S + KE A EI + L+H +VQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 392 LHGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+G R + E L + +Y+P GS+ L K LT K I + + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----IYEHGANPQTTHIVGTLGYLAP 505
+ +VHRD+K +NIL D+ N KLGDFG +K I G ++ + GT +++P
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWMSP 178
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E+ DV+S G ++E+
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRH-RNLVQLHG 394
+G G FG V + L G +A+KRI ++ K + ++ + R +V+ +G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 395 --------W-CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
W C EL+ + SLDK L+ ++ + KI + ++L
Sbjct: 71 ALFREGDCWICM---ELMDI-------SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYLA 504
YL EE ++HRDVKPSNILLD N KL DFG++ ++ + A T G Y+A
Sbjct: 121 NYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMA 175
Query: 505 PEL----TRTGKATTSTDVYSYGILMLEVACGR 533
PE R G S DV+S GI + EVA G+
Sbjct: 176 PERIDPSARDGYDVRS-DVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKE-----FVAEIMSMG 382
TKG ++G G +G VY GL + G +A+K++ S E E+ +
Sbjct: 3 TKG----EVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 383 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIA 442
L+H N+VQ G C + + + ++VP GS+ +L ++ L + + +IL G+A
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVA 116
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIV---- 497
YLH C VVHRD+K +N++L KL DFG A ++ G + ++++
Sbjct: 117 ----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 498 GTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
GT ++APE+ +D++S G + E+A G+
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 338 VGSGGFGRVYRGL-MPSLGLEVAIKRIG-HNSQQGMK----EFVAEIMSMGRLRHRNLVQ 391
+G G +G+V++ + + G VA+KR+ ++GM VA + + H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 392 LHGWCR-----KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
L C ++ +L LV+++V L + + D +++L + L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL----RGLD 124
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
+LH + RVVHRD+KP NIL+ + KL DFGLA+IY T +V TL Y APE
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPE 179
Query: 507 LTRTGKATTSTDVYSYGILMLEV 529
+ T D++S G + E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRN 388
F + +G G F VYR G+ VA+K++ + + + EI + +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+++ + + +EL +V + G L +++ K ++L+ +K + + +L ++
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H ++RV+HRD+KP+N+ + KLGD GL + + + +VGT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 178
Query: 509 RTGKATTSTDVYSYGILMLEVA 530
+D++S G L+ E+A
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEV--AIKRIG-HNSQQGMKEFVAEIMSMGRL-RHRNLVQ 391
+++G G FG+V + + GL + AIKR+ + S+ ++F E+ + +L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKILIG 440
L G C + L L +Y P+G+L L F + L+ Q
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL 500
+A+ + YL + ++ +HRD+ NIL+ AK+ DFGL++ E ++ T+
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 501 G-----YLAPELTRTGKATTSTDVYSYGILMLEV 529
G ++A E TT++DV+SYG+L+ E+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEF-VAEIMSMGRLRHRNLVQLHGW 395
+G G +G VY+ G VA+K+I +++ +G+ + EI + L H N+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
+++L LV++++ + L K + D + L + Q L + H + R
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFCH---SHR 120
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLAPELTRTGK-A 513
V+HRD+KP N+L++T KL DFGLA+ + G +T TH V TL Y APE+ K
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 514 TTSTDVYSYGILMLEVACGRRSIEP 538
+T+ D++S G + E+ RR++ P
Sbjct: 179 STAVDIWSLGCIFAEMVT-RRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 26/212 (12%)
Query: 335 QNLVGSGGFGRVYRGLM--PS-LGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNL 389
+ ++G+G FG + RG + PS L VAI R G + +Q + F+AE +++G+ H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNI 68
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
V+L G + + +++V +Y+ NG+LD L K L Q +L G+A + YL
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLG------YL 503
E VH+ + +L+++ L K+ F ++ I T+ +
Sbjct: 125 E---MGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWA 175
Query: 504 APELTRTGKATTSTDVYSYGILMLEV-ACGRR 534
APE + ++++DV+S+GI+M EV + G R
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVA---EIMSMGRLRHRNLVQ 391
L+G G FGRVY G E+A+K++ + S + KE A EI + L H +VQ
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 392 LHGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+G R E L + +++P GS+ L K LT + K I + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----IYEHGANPQTTHIVGTLGYLAP 505
+ +VHRD+K +NIL D+ N KLGDFG +K I G ++ + GT +++P
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSP 178
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E+ D++S G ++E+
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 40/211 (18%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEF----VAEIMSMGRLRHRNLV 390
N + G +G VYR G VA+K++ ++G F + EI + +L+H N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 391 QLH----GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
+ G D++ +V +YV +H L+ L+ + L + L+
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYV------------EHDLKSLME-TMKQPFLQSEVKCLM 112
Query: 447 --------YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG 498
+LH+ ++HRD+K SN+LL+ K+ DFGLA+ Y P T +V
Sbjct: 113 LQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-YTQLVV 168
Query: 499 TLGYLAPE-LTRTGKATTSTDVYSYGILMLE 528
TL Y APE L + +T+ D++S G + E
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 57/195 (29%), Positives = 102/195 (52%), Gaps = 14/195 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G+G FG V+ G + +VA+K + + ++ F+ E M L+H LV+L+
Sbjct: 14 LGAGQFGEVWMGYYNN-STKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 398 KQDELLLVYDYVPNGSL-DKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
K++ + ++ +Y+ GSL D L D+ K L KL+ + + IA+ + Y+ +
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---K 122
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
+HRD++ +N+L+ L K+ DFGLA++ E + + APE G T
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 515 TSTDVYSYGILMLEV 529
+DV+S+GIL+ E+
Sbjct: 183 IKSDVWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G FG+VY+ G A K I S++ +++++ EI + H +V+L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
+L ++ ++ P G++D ++ + D L + Q I + ++L YLH + +++
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVICRQMLEALQYLH---SMKII 132
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH----IVGTLGYLAPE--LTRTG 511
HRD+K N+LL + KL DFG++ N +T +GT ++APE + T
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 512 KATT---STDVYSYGILMLEVACGRRSIEP 538
K T D++S GI ++E+A IEP
Sbjct: 188 KDTPYDYKADIWSLGITLIEMA----QIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI-GHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
G G FG VY+ G VA+K+I HN + G + EI + +L+H N+V L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPL---- 72
Query: 397 RKQDELLLVYDYVPN-----GSLDKLLFDKDHKLRKLLTWDQRYK--------ILIGIAQ 443
+ + + GS+ + DH L LL + K ++ + +
Sbjct: 73 -----IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLE 126
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT---------- 493
+ YLHE ++HRD+K +NIL+D K+ DFGLA+ Y G P
Sbjct: 127 GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPY-DGPPPNPKGGGGGGTRK 182
Query: 494 -THIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
T++V T Y PEL + TT+ D++ G + E+ R
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 334 EQNLVGSGGFGRVYRGLMPSLGLE-----VAIKRIGH-NSQQGMKEFVAEIMSMGRLRHR 387
E +G G FG V+ + E V +K + + EF E+ +L H+
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL----LTWDQRYKILIGIAQ 443
N+V+L G CR+ + ++ +Y G L + L K KL L+ Q+ + IA
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGY 502
+ +L N R VHRD+ N L+ + K+ L+K +Y ++ L +
Sbjct: 129 GMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRW 184
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEV 529
LAPE + +T +DV+S+G+LM EV
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL 389
K + +G G G V+ + + G EVAIK+I Q + + EI+ M L++ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
V DEL +V +Y+ GSL ++ + + Q + Q+L +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH 132
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELT 508
NQ V+HRD+K N+LL + KL DFG A+I + T +VGT ++APE+
Sbjct: 133 --ANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 187
Query: 509 RTGKATTSTDVYSYGILMLEVACG 532
D++S GI+ +E+ G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGW 395
++G G +G+VY+ G VAIK I + +E E + + H N+ +G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 396 CRK------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK------ILIGIAQ 443
K D+L LV + GS+ L+ + L +R K IL +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV-------KGLRKKGKRLKEEWIAYILRETLR 124
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL 503
L YLHE +V+HRD+K NILL KL DFG++ + + T I GT ++
Sbjct: 125 GLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWM 180
Query: 504 APELTRTGKATTST-----DVYSYGILMLEVACG 532
APE+ + ++ DV+S GI +E+A G
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 9/193 (4%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGW 395
L+G G FG V++G + VA+K + Q +K +F++E + + H N+V+L G
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C ++ + +V + VP G L K +L+ Q K + A + YL ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYLE---SKN 113
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
+HRD+ N L+ K+ DFG+++ + G + + + APE G+ ++
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 516 STDVYSYGILMLE 528
+DV+SYGIL+ E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 28/206 (13%)
Query: 337 LVGSGGFGRVYRGL-MP---SLGLEVAIKRIGHNSQQGMK---EFVAEIMSMGRLRHRNL 389
++GSG FG VY+G+ +P ++ + VAIK + N G K EF+ E + M + H +L
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPHL 71
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHK----LRKLLTWDQRYKILIGIAQSL 445
V+L G C + LV +P+G L L + +HK + LL W + IA+ +
Sbjct: 72 VRLLGVCLSP-TIQLVTQLMPHGCL--LDYVHEHKDNIGSQLLLNW------CVQIAKGM 122
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL--GYL 503
+YL E +R+VHRD+ N+L+ + + K+ DFGLA++ E G + G + ++
Sbjct: 123 MYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWM 178
Query: 504 APELTRTGKATTSTDVYSYGILMLEV 529
A E K T +DV+SYG+ + E+
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 338 VGSGGFGRVYRGL--MPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHG 394
+GSG FG V +G+ M ++VAIK + + +++ ++ E + E M +L + +V++ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
C + + L+LV + G L+K L K + +T +++ ++ + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEG---K 114
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT--LGYLAPELTRTGK 512
VHRD+ N+LL AK+ DFGL+K + G L + APE K
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 513 ATTSTDVYSYGILMLE 528
++ +DV+SYGI M E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 332 FGEQNLV-----GSGGFGRVYRGLMPSLG-----LEVAIKRIGHNSQQGMKE-FVAEIMS 380
F NL G+G FG+V L ++VA+K + + +E ++E+
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 381 MGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILI 439
M L H N+V L G C +L++ +Y G L L K L D L+
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLED-----LL 144
Query: 440 G----IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH 495
+A+ + +L ++ +HRD+ N+LL K+ DFGLA+ + +N +
Sbjct: 145 SFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN----Y 197
Query: 496 IVG-----TLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+V + ++APE T +DV+SYGIL+ E+
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G G V G +VA+K + QQ + E++ M +H+N+V+++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
+EL ++ +++ G+L ++ + R L +Q + + Q+L YLH +Q V+
Sbjct: 89 VGEELWVLMEFLQGGALTDIV----SQTR--LNEEQIATVCESVLQALCYLH---SQGVI 139
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
HRD+K +ILL KL DFG A+I + P+ +VGT ++APE+ T
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 517 TDVYSYGILMLEVACG 532
D++S GI+++E+ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 27/201 (13%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE--FVAEIMSMGRLRHRNLVQLHGW 395
+GSG FG V+ G + ++VAIK I ++ M E F+ E M +L H LVQL+G
Sbjct: 12 LGSGQFGVVHLGKWRA-QIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL----YLHEE 451
C +Q L +V +++ NG L L + KL K +L+ + Q + YL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK--------DMLLSMCQDVCEGMEYLER- 118
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT---LGYLAPELT 508
+HRD+ N L+ + K+ DFG+ + + + + T G + + PE+
Sbjct: 119 --NSFIHRDLAARNCLVSSTGVVKVSDFGMTR---YVLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 509 RTGKATTSTDVYSYGILMLEV 529
K ++ +DV+S+G+LM EV
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEF-VAEIMSMGRLRHRNLVQLHGW 395
+G G +G V++ VA+KR+ + +G+ + EI + L+H+N+V+L+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 396 CRKQDELLLVYDYVPNG---SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+L LV++Y D D D ++ K +++L G+A + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM----FQLLKGLA----FCHS-- 117
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGYLAPELTRT 510
V+HRD+KP N+L++ KL DFGLA+ + P + V TL Y P++
Sbjct: 118 -HNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 511 GKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
K +TS D++S G + E+A R + P + L
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G FG+VY+ G+ A K I S++ +++++ EI + H N+V+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ L ++ ++ G++D ++ + L + LT Q + ++L YLHE +++
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH----IVGTLGYLAPE--LTRTG 511
HRD+K NIL + KL DFG++ N +T +GT ++APE + T
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 512 KATT---STDVYSYGILMLEVACGRRSIEP 538
K DV+S GI ++E+A IEP
Sbjct: 181 KDRPYDYKADVWSLGITLIEMA----QIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 12/196 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G G V S G +VA+K++ QQ + E++ M +H N+V+++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
DEL +V +++ G+L D + +Q + + + ++L +LH Q V+
Sbjct: 87 VGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVI 137
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
HRD+K +ILL + KL DFG A++ + P+ +VGT ++APE+ T
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 517 TDVYSYGILMLEVACG 532
D++S GI+++E+ G
Sbjct: 196 VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 338 VGSGGFGRVY----RGLMP-SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG+V+ L+P + VA+K + S+ ++F E + L+H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL----------LTWDQRYKILIGIA 442
+G C + LL+V++Y+ +G L++ L + L LT Q I IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLG 501
++YL + VHRD+ N L+ L K+GDFG+++ IY + +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEV 529
++ PE K TT +D++S+G+++ E+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGW 395
+G G +G V++ G VAIK+ + + + +A EI + +L+H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKD-HKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
R++ +L LV++Y + L++L +K+ + + L KI+ Q++ + H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLI----KKIIWQTLQAVNFCHK---H 119
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL----TRT 510
+HRDVKP NIL+ KL DFG A+I G T V T Y APEL T+
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 511 GKATTSTDVYSYGILMLEVACG 532
G DV++ G + E+ G
Sbjct: 179 G---PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRH 386
K F + +G G FG VY VAIK++ G S + ++ + E+ + +LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
N +Q G ++ LV +Y + D L K K L + + G Q L
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLA 129
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
YLH + ++HRDVK NILL KLGDFG A I P VGT ++APE
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX-FVGTPYWMAPE 181
Query: 507 LTRT---GKATTSTDVYSYGILMLEVA 530
+ G+ DV+S GI +E+A
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 34/212 (16%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEI-MSMGRLRHRNLVQLHGW 395
G G +G V + G +A+KRI NSQ+ K + ++ +SM + V +G
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
++ ++ + + V + SLDK + K + + D KI + I ++L YLH + +
Sbjct: 69 LFREGDVWICME-VMDTSLDKF-YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-- 124
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFG--------LAKIYEHGANPQTTHIVGTLGYLAPEL 507
V+HRDVKPSN+L++ KL DFG +AK + G P Y+APE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----------YMAPE- 173
Query: 508 TRTGKATTS------TDVYSYGILMLEVACGR 533
R +DV+S GI M+E+A GR
Sbjct: 174 -RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G FG V+ G +VAIK + + + F+ E M +LRH LV L+
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYA-VV 70
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ + +V +++ GSL L + D K KL Q + IA + Y+ E N +
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKL---PQLVDMAAQIADGMAYI-ERMN--YI 124
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTST 517
HRD++ +NIL+ L K+ DFGLA++ E + + APE G+ T +
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 518 DVYSYGILMLEVACGRRSIEPQKAAAELL 546
DV+S+GIL+ E+ R P E+L
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G G V G +VA+K++ QQ + E++ M H N+V ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
DEL +V +++ G+L ++ + +Q + + + ++L YLH NQ V+
Sbjct: 90 VGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLSVLRALSYLH---NQGVI 140
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
HRD+K +ILL + KL DFG A++ + P+ +VGT ++APE+ T
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 517 TDVYSYGILMLEVACG 532
D++S GI+++E+ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 41/217 (18%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMK-EFVAEIMSMGRLRHRNLVQLH 393
+G G +G+VY+ G VA+K++ N ++G + EI + +L HRN+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 394 GWCR-KQDEL---------LLVYDYVPNGSLDKLLFDKDHKLRKLL-------TWDQRYK 436
KQD L LV++Y+ DH L LL + D
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYM------------DHDLMGLLESGLVHFSEDHIKS 120
Query: 437 ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI 496
+ + + L Y H + +HRD+K SNILL+ KL DFGLA++Y + T+
Sbjct: 121 FMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 497 VGTLGYLAPEL----TRTGKATTSTDVYSYGILMLEV 529
V TL Y PEL R G A DV+S G ++ E+
Sbjct: 178 VITLWYRPPELLLGEERYGPA---IDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLG---LEVAIKRIGHNSQQGMKE-FVAEIMSMGRLRHRNLVQL 392
+G G FG VY+G+ S + VA+K + + ++E F+ E M + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHK----LRKLLTWDQRYKILIGIAQSLLYL 448
G ++ + +V + P G L L + +K L L+ + + ++ +L YL
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQ------LSTALAYL 123
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
++R VHRD+ N+L+ + KLGDFGL++ E + + + + ++APE
Sbjct: 124 E---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180
Query: 509 RTGKATTSTDVYSYGILMLEV 529
+ T+++DV+ +G+ M E+
Sbjct: 181 NFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 26/203 (12%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA---EIMSMGRLRHRNLVQLHG 394
+G G FG++Y S IK I ++ +KE A E++ + +++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 395 WCRKQDELLLVYDYVPNGSLDK-------LLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
++ L +V +Y G L K +LF +D ++L+W + I+ L +
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED----QILSW------FVQISLGLKH 116
Query: 448 LHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
+H+ ++++HRD+K NI L + AKLGDFG+A+ T VGT YL+PE
Sbjct: 117 IHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPE 172
Query: 507 LTRTGKATTSTDVYSYGILMLEV 529
+ + TD++S G ++ E+
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 61/212 (28%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G+G FG V+ + +VA+K + S ++ F+AE M L+H LV+LH
Sbjct: 14 LGAGQFGEVWMATY-NKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 398 KQDELLLVYDYVPNGSL-DKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
K+ + ++ +++ GSL D L D+ K L KL+ + + IA+ + ++ + +
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ---R 121
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
+HRD++ +NIL+ L K+ DFGLA++ E + + APE G T
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 515 TSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
+DV+S+GIL++E+ R P + E++
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 336 NLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNL 389
+G G FG VY GL ++ L+VA+K + + S+Q +F+ E + M + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRK--LLTWDQRYKILIGIAQSLLY 447
V+L G ++ ++ + + G L L + + + LT +A+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 448 LHEECNQRVVHRDVKPSNILLDTY---LNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYL 503
L E +HRD+ N LL AK+ DFG+A+ IY + + + ++
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 504 APELTRTGKATTSTDVYSYGILMLEV 529
PE G T+ TDV+S+G+L+ E+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 324 ELASVTKGFGEQNLVGSGGFGRVYRGLM--PSLGLE---VAIKRIGHNSQQGMKE-FVAE 377
E+ T F E+ +G FG+VY+G + + G + VAIK + ++ ++E F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 378 IMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLF-----------DKDHKLR 426
M RL+H N+V L G K+ L +++ Y + L + L D D ++
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IY 485
L I+ IA + +L + VVH+D+ N+L+ LN K+ D GL + +Y
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + + +++PE GK + +D++SYG+++ EV
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM-KEFVAEIMSMGRLRHRNLVQLHGWC 396
+G+G G V + G +A K + ++ + K+ + E+ M R +V +G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL--LTWDQRYKILIGIAQSLLYLHEECNQ 454
++ + + +++ GSLD++ +K + + KI + + + L YL+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY-------KKGGPIPVEILGKIAVAVVEGLTYLYNV--H 123
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
R++HRD+KPSNIL+++ KL DFG++ N VGT Y++PE + GK T
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 515 TSTDVYSYGILMLEVACGR 533
+DV+S GI ++E+A G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
+G+G G V++ GL +A K I + ++ + + E+ + +V +G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
E+ + +++ GSLD++L ++L K+ I + + L YL E+ ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREK--HKI 125
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
+HRDVKPSNIL+++ KL DFG++ ++ + AN VGT Y++PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSV 181
Query: 516 STDVYSYGILMLEVACGRRSIEPQKA 541
+D++S G+ ++E+A GR I P A
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIG---HN--SQQGMKEFVAEIMSMGRLRHRNL 389
+ +G G +G V G++VAIK+I H Q+ ++E I + R +H N+
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLRE----IKILRRFKHENI 65
Query: 390 VQLHGWCRKQD-----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQ----RYKILIG 440
+ + R ++ +V + + L KL+ + L+ D Y+IL G
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH------LSNDHIQYFLYQILRG 118
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY--EHGANPQTTHIVG 498
L Y+H N V+HRD+KPSN+LL+T + K+ DFGLA+I EH T V
Sbjct: 119 ----LKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 499 TLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
T Y APE+ K T + D++S G ++ E+ R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 338 VGSGGFGR--VYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G FG +YR V K + S++ ++ + EI+ + L+H N++ +
Sbjct: 8 LGKGAFGEATLYR--RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 394 GWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ LL+ +Y G+L DK++ + +L + L I ++ Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIV----RQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH---IVGTLGYLAPELTR 509
++HRD+K NI L KLGDFG++KI + + +VGT Y++PEL +
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKIL----GSEYSMAETVVGTPYYMSPELCQ 174
Query: 510 TGKATTSTDVYSYGILMLEVACGRRSIE 537
K +D+++ G ++ E+ +R+ +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
+G+G G V + GL +A K I + ++ + + E+ + +V +G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
E+ + +++ GSLD++L + ++L K+ I + + L YL E+ ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK--HQI 125
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
+HRDVKPSNIL+++ KL DFG++ ++ + AN VGT Y++PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSV 181
Query: 516 STDVYSYGILMLEVACGRRSIEPQKA 541
+D++S G+ ++E+A GR I P A
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 27/208 (12%)
Query: 336 NLVGSGGFGRVYRG-LMPSLGLEV--AIK---RIGHNSQQGMKEFVAEIMSMGRLRHRNL 389
++G G FG VY G L+ S G ++ A+K RI + +++F+ E + M H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 390 VQLHGWCRKQDEL-LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG----IAQS 444
+ L G C + L+V Y+ +G L + + H + K LIG +A+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--------NPTVKDLIGFGLQVAKG 110
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IY--EHGANPQTTHIVGTLG 501
+ YL +++ VHRD+ N +LD K+ DFGLA+ IY E+ + T +
Sbjct: 111 MEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEV 529
++A E +T K TT +DV+S+G+L+ E+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 338 VGSGGFGRVYRGLMPSLGLE----VAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G FG++Y+G + G++ VAIK + N+ Q EF E M L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLF------------DKDHKLRKLLTWDQRYKILIG 440
G ++ + ++++Y+ G L + L D+D ++ L I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGT 499
IA + YL + VH+D+ NIL+ L+ K+ D GL++ IY +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ ++ PE GK ++ +D++S+G+++ E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 20/247 (8%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G GGFG V + + G A K++ ++G + + E + ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY---KILIGIAQSLLYLHEE 451
+D+L LV + G L +++ + +I+ G L +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYN--VGEPGFPEARAIFYAAQIICG----LEHLHQR 114
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
R+V+RD+KP N+LLD + N ++ D GLA E + GT GY+APE+ +
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 512 KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571
S D ++ G + E+ GR P + E + + +K LE + + +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR---SPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAK 226
Query: 572 DLAEAEL 578
DL EA L
Sbjct: 227 DLCEALL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 30/274 (10%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLV 390
F + +G G FG VY+G+ VAIK I ++ +++ EI + + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYL 448
+ +G K +L ++ +Y+ GS LL K ++ Y IL I + L YL
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--------KPGPLEETYIATILREILKGLDYL 117
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H E R +HRD+K +N+LL + KL DFG+A + T VGT ++APE+
Sbjct: 118 HSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 173
Query: 509 RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568
+ D++S GI +E+A G L L+ LEG+ ++
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP----- 228
Query: 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+ + EA C +P +RP + +++
Sbjct: 229 -FKEFVEA---------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFVAEIMSMGRLRHRNLVQL-HG 394
VG G +G V + G + IK++ + S++ K E + +L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
W + L +V + G L L K+ K KLL +Q + + IA +L YLHE+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKL--KEQK-GKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
++HRD+K N+ L K+GD G+A++ E+ + +T ++GT Y++PEL
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYN 180
Query: 515 TSTDVYSYGILMLEVA 530
+DV++ G + E+A
Sbjct: 181 YKSDVWALGCCVYEMA 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMK-EFVAEIMSMGRLR---HRNLVQL 392
+G G +G VY+ P G VA+K + ++ G+ V E+ + RL H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 393 HGWCR-----KQDELLLVYDYVPNGSLDKLLFDKDHK--LRKL----LTWDQRYKILIGI 441
C ++ ++ LV+++V D+D + L K+ L + ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV----------DQDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 442 AQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLG 501
+ L +LH C +VHRD+KP NIL+ + KL DFGLA+IY T +V TL
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLW 172
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEV 529
Y APE+ T D++S G + E+
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G G VY + + G EVAIK++ Q + + EI+ M ++ N+V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
DEL +V +Y+ GSL ++ + + Q + Q+L +LH + +V+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVI 137
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
HRD+K NILL + KL DFG A+I + T +VGT ++APE+
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 517 TDVYSYGILMLEVACG 532
D++S GI+ +E+ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ---GMKEFVAEIMSMGRLRHRNLVQLHG 394
+G G FG VY VA+K++ ++ +Q ++ + E+ + +L+H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
K+ LV +Y + D L + HK K L + I G Q L YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLL---EVHK--KPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT---G 511
++HRD+K NILL KL DFG A ++P + VGT ++APE+ G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS-FVGTPYWMAPEVILAMDEG 195
Query: 512 KATTSTDVYSYGILMLEVA 530
+ DV+S GI +E+A
Sbjct: 196 QYDGKVDVWSLGITCIELA 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-15
Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 21/196 (10%)
Query: 355 GLEVAIKRIGHNSQQGMKE---FVAEIMSMGRLRHRNLVQLHGWCRKQDELLL-VYDYVP 410
G EVAIK + ++ + + F E RL H N+V L LL V++YVP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL-- 468
+L ++L D L T ++L +A + H NQ +VHRD+KP NI++
Sbjct: 63 GRTLREVL-AADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIMVSQ 114
Query: 469 -DTYLNAKLGDFGLAKIYE--HGANPQ----TTHIVGTLGYLAPELTRTGKATTSTDVYS 521
+AK+ DFG+ + A+ TT ++GT Y APE R T ++D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 522 YGILMLEVACGRRSIE 537
+G++ LE G+R ++
Sbjct: 175 WGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 30/274 (10%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG---HNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G G F VYR VA+K++ + ++ V EI + +L H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 395 WCRKQDELLLVYDYVPNGSLDKLL--FDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ +EL +V + G L +++ F K ++L+ +K + + ++ ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQ---KRLIPERTVWKYFVQLCSAVEHMH--- 123
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
++RV+HRD+KP+N+ + KLGD GL + + + +VGT Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENG 182
Query: 513 ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572
+D++S G L+ E+A + K L + Q I+Q DY
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLF------------SLCQKIEQC-DYPP 227
Query: 573 LAE---AELVLNLGLFCSAPNPVYRPDMRRVVEF 603
L +E + L C P+P RPD+ V +
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLG----LEVAIKRIGH-NSQQGMKEFVAEIMSMGRLRH 386
F + ++GSG FG VY+GL G + VAIK + S + KE + E M + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR----KLLTWDQRYKILIGIA 442
++ +L G C + L+ +P G L L + ++HK LL W + IA
Sbjct: 69 PHVCRLLGICLTS-TVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNW------CVQIA 119
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG---T 499
+ + YL E +R+VHRD+ N+L+ T + K+ DFGLAK+ GA+ + H G
Sbjct: 120 KGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVP 174
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ ++A E T +DV+SYG+ + E+
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLV 390
F + +G G FG V++G+ VAIK I ++ +++ EI + + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLL----FDKDHKLRKLLTWDQRYKILIGIAQSLL 446
+ +G K +L ++ +Y+ GS LL FD+ Q +L I + L
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF----------QIATMLKEILKGLD 115
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
YLH E + +HRD+K +N+LL + KL DFG+A + T VGT ++APE
Sbjct: 116 YLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPE 171
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566
+ + + D++S GI +E+A G L L+ L GE ++ +
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKE 231
Query: 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+D C +P +RP + +++
Sbjct: 232 FIDA---------------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 31/197 (15%)
Query: 331 GFGEQNLVGSGGFGRVY--RGLMPSLGLEVAIKRIGHNSQQGM---KEFVAEIMSMGRLR 385
+ + +G G +GRVY + G E AIK+ + +Q + EI + L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 386 HRNLVQLHGWC--RKQDELLLVYDYVPNGSLDKLLFDKDHKLR-------KLLTWDQRYK 436
H N+V L + L++DY + + F + K K L W +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----Q 116
Query: 437 ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA----KLGDFGLAKIYEHGANPQ 492
IL G+ YLH V+HRD+KP+NIL+ K+GD GLA+++ P
Sbjct: 117 ILNGVH----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 493 TT--HIVGTLGYLAPEL 507
+V T+ Y APEL
Sbjct: 170 ADLDPVVVTIWYRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 45/226 (19%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHRNLVQL 392
++G G FG V+ G A+K + S + +A + + + +V+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 393 HGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+ QDE L LV +Y+P G L LL KD + + Y IA+ +L L
Sbjct: 67 Y--YSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPE--ETARFY-----IAELVLALDS 116
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY------------------------E 486
+HRD+KP NIL+D + KL DFGL K
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 487 HGANPQTTH----IVGTLGYLAPELTRTGKATTSTDVYSYGILMLE 528
+ Q VGT Y+APE+ R D +S G+++ E
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G G V + S G VA+K++ QQ + E++ M +H N+V+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
DEL +V +++ G+L ++ + +Q + + + ++L LH Q V+
Sbjct: 88 VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLKALSVLHA---QGVI 138
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
HRD+K +ILL KL DFG A++ + P+ +VGT ++APEL
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 517 TDVYSYGILMLEVACG 532
D++S GI+++E+ G
Sbjct: 197 VDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRH 386
K F + +G G FG VY VAIK++ G S + ++ + E+ + R++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
N ++ G ++ LV +Y + D L K K L + I G Q L
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAITHGALQGLA 139
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
YLH + ++HRD+K NILL KL DFG A I A+P + VGT ++APE
Sbjct: 140 YLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS-FVGTPYWMAPE 191
Query: 507 LTRT---GKATTSTDVYSYGILMLEVA 530
+ G+ DV+S GI +E+A
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELA 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI----GHNSQQGMKEFVA----------EIMSM 381
+G G +G+V + G VAIK++ N ++ V E+ M
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 382 GRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGI 441
++H N++ L + D + LV D + L K++ D K+R LT Q IL+ I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIR--LTESQVKCILLQI 128
Query: 442 AQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY------------EHGA 489
L LH +HRD+ P+NI +++ K+ DFGLA+ Y E
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 490 -NPQTTHIVGTLGYLAPELTR-TGKATTSTDVYSYGILMLEVACGR 533
+ T V TL Y APEL K + D++S G + E+ G+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLE--VAIKRIGH-NSQQGMK-EFVAEIMSMGRLRHRNLVQLH 393
+GSG FG V +G+ E VA+K + + N+ +K E + E M +L + +V++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G C + + +LV + G L+K L H K +T +++ ++ + YL EE N
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYL-EETN 115
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN--PQTTHIVGTLGYLAPELTRTG 511
VHRD+ N+LL T AK+ DFGL+K N TH + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 512 KATTSTDVYSYGILMLE 528
K ++ +DV+S+G+LM E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 28/210 (13%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG---HNSQQGMKEFVAEIMSMGRLR-HRNLVQLH 393
+G G +G V++ + VA+K+I N+ + F EIM + L H N+V+L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLL 73
Query: 394 GWCRKQD--ELLLVYDYVP---NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+ ++ ++ LV++Y+ + + + + HK RY I+ + ++L Y+
Sbjct: 74 NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK---------RY-IMYQLLKALKYI 123
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----IYEHGANPQTTHIVGTLGYLA 504
H + V+HRD+KPSNILL++ KL DFGLA+ + E+ NP T V T Y A
Sbjct: 124 H---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 505 PE-LTRTGKATTSTDVYSYGILMLEVACGR 533
PE L + + T D++S G ++ E+ G+
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G G VY + + G EVAI+++ Q + + EI+ M ++ N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
DEL +V +Y+ GSL ++ + + Q + Q+L +LH + +V+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
HRD+K NILL + KL DFG A+I + + + +VGT ++APE+
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 517 TDVYSYGILMLEVACG 532
D++S GI+ +E+ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 32/275 (11%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLV 390
F + +G G FG V++G+ VAIK I ++ +++ EI + + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+ +G K +L ++ +Y+ GS LL L Q IL I + L YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 119
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
E + +HRD+K +N+LL + KL DFG+A + VGT ++APE+ +
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQ 175
Query: 511 GKATTSTDVYSYGILMLEVACGR---RSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567
+ D++S GI +E+A G + P K L L+ LEG ++ + +
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLIPKNNPPTLEGNYSKPLKE- 231
Query: 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
EA C P +RP + +++
Sbjct: 232 -----FVEA---------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 338 VGSGGFGRVY----RGLMPSLGLE----------VAIKRIGHN-SQQGMKEFVAEIMSMG 382
+G G FG V+ GL LG VA+K + + ++ +F+ EI M
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 383 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL--------FDKDHKLRKLLTWDQR 434
RL++ N+++L G C D L ++ +Y+ NG L++ L F + + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 435 YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQT 493
Y + + IA + YL + VHRD+ N L+ + K+ DFG+++ +Y
Sbjct: 133 Y-MAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 494 THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
V + ++A E GK TT++DV+++G+ + E+
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRNLVQLHGWC 396
+G G +G VY+ L G+ +A+K I + + + E+ + + +V +G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+ + + +Y+ GSLDKL D +I + + L +L EE N +
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGI--PEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA--- 513
+HRDVKP+N+L++ KL DFG++ A+ T+I G Y+APE ++G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--ASLAKTNI-GCQSYMAPERIKSGGPNQN 181
Query: 514 ---TTSTDVYSYGILMLEVACGRRSIEPQ 539
T +DV+S G+ +LE+A GR P+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 338 VGSGGFGRVYRGLMPSL-----GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G FGRV++ P L VA+K + S +F E M H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKD--------HKLRKLLTWDQRY-------- 435
L G C + L+++Y+ G L++ L + H
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 436 -KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQT 493
I +A + YL E ++ VHRD+ N L+ + K+ DFGL+ IY +
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 494 THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + ++ PE + TT +DV++YG+++ E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMG------RLR 385
F + ++G GGFG V + + G A K++ ++ +K+ E M++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMALNEKQILEKVN 58
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG--IAQ 443
R +V L +D L LV + G L ++ +++ + I
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-----GFEEGRAVFYAAEICC 113
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGY 502
L LH+E R+V+RD+KP NILLD + + ++ D GLA H QT VGT+GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGY 167
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQK 540
+APE+ + + T S D ++ G L+ E+ G+ + +K
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 33/239 (13%)
Query: 341 GGFGRVYRGLMPSLGLEVAIK------RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
G FG VY S G AIK I N +K A +M G + +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLYY 64
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL-LTWDQRY--KILIGIAQSLLYLHEE 451
+ +D L LV +Y+ G L+ L L W ++Y ++++G+ LH+
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVE----DLHQ- 115
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+ ++HRD+KP N+L+D + KL DFGL++ N + VGT YLAPE
Sbjct: 116 --RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL--ENKK---FVGTPDYLAPETILGV 168
Query: 512 KATTSTDVYSYGILMLEVACGRRSIE---PQKAAAELL--LVDWVKELHLEGEITQAID 565
+D +S G ++ E G P +L ++W +E+ E +A+D
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK-EFCSPEAVD 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 71/291 (24%), Positives = 131/291 (45%), Gaps = 44/291 (15%)
Query: 337 LVGSGGFGRVYRGLMPSLGLE-------VAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHR 387
+G G FG+V + ++GL+ VA+K + + +++ + + V+E+ M + +H+
Sbjct: 19 PLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYK 436
N++ L G C ++ L +V +Y +G+L L D + LT
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 437 ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTH 495
+A+ + +L +++ +HRD+ N+L+ K+ DFGLA+ I+ +TT+
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 496 IVGTLGY--LAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553
G L +APE T +DV+S+G+L+ E+ S P E L +KE
Sbjct: 194 --GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLLKE 249
Query: 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+ + + + T + Y L C P RP +++VE L
Sbjct: 250 GY---RMEKPQNCTQELYHLM---------RDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 11/213 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
+G G + V++G VA+K I ++G + E+ + L+H N+V LH
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
L LV++Y LDK L +++ L I + L Y H ++V
Sbjct: 74 HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKATT 515
+HRD+KP N+L++ KL DFGLA+ + +V TL Y P+ L + + +T
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 516 STDVYSYGILMLEVACGRRSIEPQKAAAELLLV 548
D++ G + E+A GR EL L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 385 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR-YKILIGIAQ 443
+H L QLH + +D L V +YV G L +F + + R Y I +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHI-QRSGRFDEPRARFYAAEIVLG- 108
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGY 502
L +LHE + +++RD+K N+LLD+ + K+ DFG+ K E TT GT Y
Sbjct: 109 -LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDY 162
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+APE+ + D ++ G+L+ E+ G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS-----MGRLRHRNLVQL 392
+G G FG+V + G A+K + + KE IM+ + ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLYLHEE 451
H + D+L V DYV G +L F H R+ + R + IA +L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGG---ELFF---HLQRERSFPEPRARFYAAEIASALGYLHS- 114
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+++RD+KP NILLD+ + L DFGL K + T+ GT YLAPE+ R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 512 KATTSTDVYSYGILMLEVACG 532
+ D + G ++ E+ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+GSG +G VY+ + G AIK I + EI+ M +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++D+L + ++ GSL + + + L+ Q + Q L YLH ++ +
Sbjct: 77 RRDKLWICMEFCGGGSLQDI-----YHVTGPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELT---RTGKA 513
HRD+K +NILL + KL DFG+ A+I A ++ +GT ++APE+ R G
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKGGY 186
Query: 514 TTSTDVYSYGILMLEVA 530
D+++ GI +E+A
Sbjct: 187 NQLCDIWAVGITAIELA 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 48/144 (33%), Positives = 80/144 (55%), Gaps = 12/144 (8%)
Query: 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRD 460
E+ + +++ GSLD++L +L KI I + + L YL E+ +++HRD
Sbjct: 73 EISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREK--HKIMHRD 125
Query: 461 VKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDV 519
VKPSNIL+++ KL DFG++ ++ + AN VGT Y++PE + T +D+
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYTVQSDI 181
Query: 520 YSYGILMLEVACGRRSIEPQKAAA 543
+S G+ ++E+A GR I P A
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKE 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGR-LRHRNLVQLHG 394
+VG G +G V + VAIK+ + + + +KE + M R L+ N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
R++ +L LV++YV L+ L ++ K+ I Q + +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELL--------EEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
+VHRD+KP N+L+ KL DFG A+ G+N T V T Y +PEL
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 515 TSTDVYSYGILMLEVACGR 533
+ D++S G ++ E++ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
+G G + VY+G VA+K I ++G + E+ + L+H N+V LH
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+ L LV++Y LDK L + L + + L Y H ++V
Sbjct: 74 HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKV 125
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKATT 515
+HRD+KP N+L++ KL DFGLA+ + +V TL Y P+ L + +T
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 516 STDVYSYGILMLEVACGR 533
D++ G + E++ GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI-----GHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+VG G FGR + + A+K I + KE V + +++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL----LAKMKHPNIVA 62
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L +V +Y G L + + K + KL D + + + + ++HE
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKI--KLQR-GKLFPEDTILQWFVQMCLGVQHIHE- 118
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+RV+HRD+K NI L KLGDFG A++ T+ VGT Y+ PE+
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENM 175
Query: 512 KATTSTDVYSYGILMLEV 529
+D++S G ++ E+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVG 498
+ ++L YLH + ++HRDVK NI LD NA LGDFG A K+ H PQ G
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSI 536
TL +PEL TD++S G+++ E++ ++
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS-----MGRLRHRNLVQ 391
++G G FG+V S G A+K + + KE IM+ + L+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
LH + ++L V DYV G L F + R L R+ +A ++ YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARF-YAAEVASAIGYLH-- 113
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ--TTHIVGTLGYLAPELTR 509
+ +++RD+KP NILLD+ + L DFGL K G P+ T+ GT YLAPE+ R
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLR 169
Query: 510 TGKATTSTDVYSYGILMLEVACG 532
+ D + G ++ E+ G
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLH 393
Q ++G G G VY+ +A+K I + + + K+ ++E+ + + ++ +
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G ++ + + +++ GSLD +H L + I + + + L YL +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR---------IAVAVVKGLTYL---WS 113
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
+++HRDVKPSN+L++T KL DFG++ N VGT Y+APE +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 514 TTSTDVYSYGILMLEVACGR 533
+DV+S GI +E+A GR
Sbjct: 171 GIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA---------EI 378
+T + + VG G FG V G VAIK+I MK F E+
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYREL 60
Query: 379 MSMGRLRHRNLVQLHG-WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKI 437
+ LRH N++ L + +++ V + + L +LL L K Y+I
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQI 117
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIV 497
L G L Y+H + VVHRD+KPSNIL++ + K+ DFGLA+I + PQ T V
Sbjct: 118 LRG----LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYV 166
Query: 498 GTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGR 533
T Y APE+ T K D++S G + E+ G+
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 11/244 (4%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G GGFG V M + G A K++ ++G + + E + ++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+ + +L LV + G L +++ D + + AQ + L +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGF----PEPRACFYTAQIISGLEHLHQR 116
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
R+++RD+KP N+LLD N ++ D GLA + G + +T GT G++APEL + +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYD 175
Query: 515 TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574
S D ++ G+ + E+ R P +A E + +K+ L +T +
Sbjct: 176 FSVDYFALGVTLYEMIAAR---GPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFC 232
Query: 575 EAEL 578
EA L
Sbjct: 233 EALL 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 12/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
LV LH + +L L+ DYV G L L+ ++H + ++ I I +L +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH------FTESEVRVYIAEIVLALDH 120
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
LH+ +++RD+K NILLD+ + L DFGL+K + + GT+ Y+APE+
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 508 TRTGKA--TTSTDVYSYGILMLEVACG 532
R G + D +S G+L E+ G
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 35/231 (15%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G G +G V +VAIK+I + +++ K + EI + L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 396 ----CRKQ-DELLLVYDYVPNGSLDKLLFDKD-HKLRK---LLTWDQRYKILIGIAQSLL 446
R+ +++ +VY+ L D D H++ + L+ D L + + L
Sbjct: 73 MPPPHREAFNDVYIVYE----------LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
Y+H + V+HRD+KPSN+LL+ + K+ DFGLA+ + T ++V T Y APE
Sbjct: 123 YIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 507 -LTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556
L + TT+ DV+S G + E+ GR+ + P K D+V +L L
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGK--------DYVHQLKL 220
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN-------LV 390
+G G FG+VY+ A+K + KE VA + + R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE-VAHTIGERNILVRTLLDESPFIV 59
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLYLH 449
L + +L LV DY+ G L L K+ + + R K I + +L +LH
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFS-----EDRAKFYIAELVLALEHLH 113
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR 509
+ +V+RD+KP NILLD + L DFGL+K N T GT YLAPE+
Sbjct: 114 K---YDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 510 TGKA-TTSTDVYSYGILMLEVACG 532
K T D +S G+L+ E+ CG
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 337 LVGSGGFGRVY--RGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS---MGRLRHRNLVQ 391
++G G FG+V+ R + ++ ++ + +++ V M + + H +V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
LH + + +L L+ D++ G L F + K + T + L +A +L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDL----FTRLSK-EVMFTEEDVKFYLAELALALDHLH-- 115
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+ +++RD+KP NILLD + KL DFGL+K + GT+ Y+APE+
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRR 173
Query: 512 KATTSTDVYSYGILMLEVACG 532
T S D +S+G+LM E+ G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 13/216 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGW 395
+G G + VY+G+ G VA+K I +++G+ F A E + L+H N+V LH
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
++ L V++Y+ + L + + L +++L G+A Y+H Q
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA----YIH---GQH 123
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKAT 514
++HRD+KP N+L+ KL DFGLA+ + ++ +V TL Y P+ L +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYS 182
Query: 515 TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW 550
++ D++ G + +E+ G+ + E L W
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 35/227 (15%)
Query: 321 KYAELASVTKG-FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFVAE 377
KY ++ + +G FG+ LV S G+ Y IK I S + +E E
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQY-----------VIKEINISKMSPKEREESRKE 49
Query: 378 IMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDK-------LLFDKDHKLRKLLT 430
+ + ++H N+VQ + L +V DY G L K +LF +D ++L
Sbjct: 50 VAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED----QILD 105
Query: 431 WDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490
W + I +L ++H+ ++++HRD+K NI L KLGDFG+A++
Sbjct: 106 W------FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156
Query: 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
T I GT YL+PE+ +D+++ G ++ E+ + + E
Sbjct: 157 LARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHRNLVQLH 393
VG GG+G+V+ G VA+KR+ + + E V +++ + + LV+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
+ + L L +YVP G LL + +L+ D + + +++ LHE
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHE--- 119
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
+HRD+KP N L+D + KL DFGL+K AN +VG+ Y+APE+ R
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYMAPEVLRGKGY 175
Query: 514 TTSTDVYSYGILMLEVACG 532
+ D +S G ++ E CG
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 338 VGSGGFGRVYRGLMPSL-GL----EVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRNLVQ 391
+G G FG+V + L G VA+K + N+ +++ ++E + ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLL------------FDKDHKLRKLLTWDQR---YK 436
L+G C + LLL+ +Y GSL L D + L D+R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 437 ILIG----IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANP 491
LI I++ + YL E ++VHRD+ N+L+ K+ DFGL++ +YE +
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + + ++A E TT +DV+S+G+L+ E+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 41/103 (39%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTT 494
K+ + I ++L YL E V+HRDVKPSNILLD N KL DFG++ ++ + A T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172
Query: 495 HIVGTLGYLAPEL----TRTGKATTSTDVYSYGILMLEVACGR 533
G Y+APE K DV+S GI ++E+A G+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 39/211 (18%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGWC 396
G G + VY+G G VA+K I ++G F A E + L+H N+V LH
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDII 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR-----------YKILIGIAQSL 445
+ L LV++Y+ D D L++ + +++L G+A
Sbjct: 73 HTKKTLTLVFEYL----------DTD--LKQYMDDCGGGLSMHNVRLFLFQLLRGLA--- 117
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT--HIVGTLGYL 503
Y H+ +RV+HRD+KP N+L+ KL DFGLA+ + P T + V TL Y
Sbjct: 118 -YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARA---KSVPSKTYSNEVVTLWYR 170
Query: 504 APE-LTRTGKATTSTDVYSYGILMLEVACGR 533
P+ L + + +TS D++ G + E+A GR
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+GSG +G V + G +VAIK+I H K + E+ + +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 396 CRKQDELL----LVYDYVPNGSLDKLLFDK----DHKLRKLLTWDQRYKILIGIAQSLLY 447
R +V D + + L ++ + +R L Y++L G L Y
Sbjct: 73 LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFL-----YQLLRG----LKY 122
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI---VGTLGYLA 504
+H V+HRD+KPSN+L++ ++GDFG+A+ + V T Y A
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 505 PELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQK 540
PEL + + TT+ D++S G + E+ GRR + P K
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFPGK 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 13/150 (8%)
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
H LV LH + + L V +YV G L +F + RKL R+ I+ +L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQ-RKLPEEHARF-YSAEISLAL 109
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGYL 503
YLHE + +++RD+K N+LLD+ + KL D+G+ K G P T+ GT Y+
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYI 163
Query: 504 APELTRTGKATTSTDVYSYGILMLEVACGR 533
APE+ R S D ++ G+LM E+ GR
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA------EIMSMGR 383
K F ++LVG G FG V + G A+K + S +E V+ +I+S+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVM-KKSVLLAQETVSFFEEERDILSI-- 57
Query: 384 LRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG 440
N + QL + +D L LV +Y P G L LL + + + + Q Y
Sbjct: 58 ---SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA--QFY----- 107
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL 500
+A+ +L +H VHRD+KP N+L+D + KL DFG A + VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 501 GYLAPELTRT----GKAT--TSTDVYSYGILMLEVACGR 533
Y+APE+ T GK T D +S G++ E+ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 338 VGSGGFGRVYRGLMPSL--GLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G+G FG+V G V +K + ++ F+ E+ L H N++Q G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
C + LLV ++ P G L L + ++ D ++ +A LL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---A 119
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLA--KIYEHGANPQTTHIVGTLGYLAPELT---- 508
+H D+ N L L+ K+GD+GLA + E + H V L +LAPEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIRG 178
Query: 509 ---RTGKATTSTDVYSYGILMLEV 529
T ++++S G+ M E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 49/193 (25%), Positives = 92/193 (47%), Gaps = 9/193 (4%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
+G G FG V+ G + + VA+K +K +F+ E + + H N+V+L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
++ + +V + V G L + +L+ + +++ A + YL +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKV----KELIQMVENAAAGMEYLESKH---C 115
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT-LGYLAPELTRTGKATT 515
+HRD+ N L+ K+ DFG+++ E G T + + + APE G+ ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 516 STDVYSYGILMLE 528
+DV+S+GIL+ E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 337 LVGSGGFGRVYRGLMP---SLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
++G G FG V G + L+VA+K ++ ++ ++EF++E M H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 392 LHGWCRKQDEL------LLVYDYVPNGSLDK-LLFDKDHKLRKLLTWDQRYKILIGIAQS 444
L G C + L +++ ++ +G L LL+ + L + L K ++ IA
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT-LGYL 503
+ YL N+ +HRD+ N +L + + DFGL+K G + I + ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 504 APELTRTGKATTSTDVYSYGILMLEVA 530
A E T+ +DV+++G+ M E+A
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLG----LEVAIKRIGHNSQQGMKEFVAEI-MSMGRLRHRNLVQ 391
++G G FG+V G ++V K+I N ++ K +AE + + ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVG 60
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLYLHE 450
LH + ++L V D+V G +L F H R+ + R + IA +L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGG---ELFF---HLQRERSFPEPRARFYAAEIASALGYLH- 113
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ +V+RD+KP NILLD+ + L DFGL K ++ TT GT YLAPE+ R
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-FCGTPEYLAPEVIRK 170
Query: 511 GKATTSTDVYSYGILMLEVACG 532
+ D + G ++ E+ G
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 50/149 (33%), Positives = 77/149 (51%), Gaps = 17/149 (11%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
LV LH + + +L L+ DYV G + L+ +D+ + + G I +L +
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN------FSEDEVRFYSGEIILALEH 120
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
LH+ +V+RD+K NILLD+ + L DFGL+K + +T GT+ Y+APE+
Sbjct: 121 LHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 508 TRT----GKATTSTDVYSYGILMLEVACG 532
R GKA D +S GIL+ E+ G
Sbjct: 178 IRGKGGHGKA---VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 53/215 (24%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 338 VGSGGFGRVYRGLMPSLGLE---------VAIKRIGHN-SQQGMKEFVAEIMSMGRL-RH 386
+G G FG+V + +LG++ VA+K + + +++ + + V+E+ M + +H
Sbjct: 23 LGEGCFGQVV--MAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRY 435
+N++ L G C + L ++ +Y G+L + L +D + +T+
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTT 494
+A+ + YL +Q+ +HRD+ N+L+ K+ DFGLA+ + +TT
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + ++APE T +DV+S+G+LM E+
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
+G G + V++G VA+K I ++G + E+ + L+H N+V LH
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+ L LV++Y LD L L++ + + + L Y H+ +++
Sbjct: 73 HTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKATT 515
+HRD+KP N+L++ KL DFGLA+ + +V TL Y P+ L + + +T
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 516 STDVYSYGILMLEVACGRRSIEPQKAAAELLLV 548
D++ G ++ E+A GR EL L+
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 338 VGSGGFGRVYRGLMPSLG--LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G FG V G + L+VA+K +I ++ M++F++E + M H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 394 GWCRKQDEL------LLVYDYVPNGSLDK-LLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
G C + E +++ ++ +G L LL+ + + L K + IA +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYLAP 505
YL ++ +HRD+ N +L+ +N + DFGL+ KIY Q + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 506 ELTRTGKATTSTDVYSYGILMLEVA 530
E TT +DV+S+G+ M E+A
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIA 208
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 31/217 (14%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG---MKEFVAEIMSMGRLRHRNLVQLH 393
L+G GG G VY P VA+K+I + + K F+ E L H +V ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLL---FDKDHKLRKLLTWDQRYK----ILIGIAQSLL 446
C D + Y+ +L LL + K+ L K L I I ++
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKE-SLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT------------ 494
Y+H ++ V+HRD+KP NILL + + D+G A +
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 495 -----HIVGTLGYLAPELTRTGKATTSTDVYSYGILM 526
IVGT Y+APE A+ STD+Y+ G+++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGW 395
+VG+G +G+VY+G G AIK + ++ +E EI + + HRN+ +G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 396 CRKQ------DELLLVYDYVPNGSLDKLLFD-KDHKLRKLLTWDQRYKILIGIAQSLLYL 448
K+ D+L LV ++ GS+ L+ + K + L++ D I I + L +L
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE----DWIAYICREILRGLAHL 137
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H +V+HRD+K N+LL KL DFG++ + + T I GT ++APE+
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 193
Query: 509 RTGKATTST-----DVYSYGILMLEVACG 532
+ +T D++S GI +E+A G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 337 LVGSGGFGRVYRGLMPSLG----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQ 391
++GSG FG VY+G+ G + VAIK + N S + KE + E M + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR----KLLTWDQRYKILIGIAQSLLY 447
L G C + LV +P G L L + +++K R LL W + IA+ + Y
Sbjct: 74 LLGICLTS-TVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNW------CVQIAKGMSY 124
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG---TLGYLA 504
L E R+VHRD+ N+L+ + + K+ DFGLA++ + + H G + ++A
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWMA 179
Query: 505 PELTRTGKATTSTDVYSYGILMLEV 529
E + T +DV+SYG+ + E+
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 12/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
LV LH + +L L+ DY+ G L H ++ +Q +I G I +L +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGEL------FTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
LH+ +++RD+K NILLD+ + L DFGL+K + + GT+ Y+AP++
Sbjct: 121 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 508 TRTGKA--TTSTDVYSYGILMLEVACG 532
R G + D +S G+LM E+ G
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 378 IMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKI 437
I+++ +H L LH + +D L V +YV G L +F + + RK R+
Sbjct: 48 ILALAA-KHPFLTALHCCFQTKDRLFFVMEYVNGGDL---MF-QIQRSRKFDEPRSRF-Y 101
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTH 495
+ +L++LH V++RD+K NILLD + KL DFG+ K G TT
Sbjct: 102 AAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155
Query: 496 IVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
GT Y+APE+ + + S D ++ G+LM E+ G+ E
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMG------RLR 385
F ++G GGFG V + + G A K++ ++ +K+ E M++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQILEKVN 58
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
R +V L +D L LV + G L K H + + A+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDL------KFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYLA 504
L + +R+V+RD+KP NILLD Y + ++ D GLA +I E VGT+GY+A
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMA 169
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQK 540
PE+ + + T S D + G L+ E+ G+ +K
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 25/234 (10%)
Query: 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH 386
S K + N++G+G FG VY + +VAIK++ + Q + E++ M L H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNH 118
Query: 387 RNLVQLHGW----CRKQDE----LLLVYDYVPNG--SLDKLLFDKDHKLRKLLTWDQRYK 436
N++ L + C K++E L +V +++P K +H L L Y+
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 437 ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQTTH 495
+ ++L Y+H ++ + HRD+KP N+L+D + KL DFG AK G ++
Sbjct: 179 ----LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVS 229
Query: 496 IVGTLGYLAPELTR-TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLV 548
+ + Y APEL TT D++S G ++ E+ G Q + +L+ +
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283
|
Length = 440 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 332 FGEQNLV-----GSGGFGRVYRGLM-------PSLGLEVAIKRIGHN-SQQGMKEFVAEI 378
F LV G G FG+V R P + VA+K + N + + + + ++E+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 379 MSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLR 426
M + +H+N++ L G C ++ L ++ +Y G+L + L FD
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IY 485
+ L++ +A+ + YL ++R +HRD+ N+L+ K+ DFGLA+ ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ +T++ + ++APE T +DV+S+GILM E+
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 4e-12
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGW 395
LVG+G +G+VY+G G AIK + + +E EI + + HRN+ +G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 396 CRKQ------DELLLVYDYVPNGSLDKLLFD-KDHKLRKLLTWDQRYKILIGIAQSLLYL 448
K+ D+L LV ++ GS+ L+ + K + L++ W I I + L +L
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EWIAY--ICREILRGLSHL 127
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H+ +V+HRD+K N+LL KL DFG++ + + T I GT ++APE+
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 183
Query: 509 RTGKATTST-----DVYSYGILMLEVACG 532
+ +T D++S GI +E+A G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRL 384
+V K + + +GSG G V LG+ VA+K++ +Q K E++ + +
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 385 RHRNLVQLHGWCRKQ------DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKIL 438
H+N++ L Q ++ LV + + + + DH+ L Y++L
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL----YQML 133
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG 498
GI +LH + ++HRD+KPSNI++ + K+ DFGLA+ N T V
Sbjct: 134 CGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVV 184
Query: 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532
T Y APE+ + D++S G +M E+ G
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 54/148 (36%), Positives = 76/148 (51%), Gaps = 15/148 (10%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR-YKILIGIAQSLLY 447
LV LH + L LV +YV G L +F + RKL R Y I IA L +
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYAAEICIA--LNF 111
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGYLAP 505
LHE + +++RD+K N+LLD + KL D+G+ K G P T+ GT Y+AP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAP 165
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGR 533
E+ R + S D ++ G+LM E+ GR
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL----RHRNLVQL 392
L+G G FG+V + G A+K I K+ VA ++ R+ RH L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKIL-IGIAQSLLYLHEE 451
+ D L V +Y G +L F H R+ + + R + I +L YLH E
Sbjct: 61 KYSFQTHDRLCFVMEYANGG---ELFF---HLSRERVFSEDRARFYGAEIVSALDYLHSE 114
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI-YEHGANPQTTHIVGTLGYLAPELTRT 510
N VV+RD+K N++LD + K+ DFGL K + GA +T GT YLAPE+
Sbjct: 115 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLED 170
Query: 511 GKATTSTDVYSYGILMLEVACGR 533
+ D + G++M E+ CGR
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR-YKILIGIAQS 444
H LV LH + + L V ++V G L +F + RKL R Y I +A
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQ-RKLPEEHARFYSAEISLA-- 108
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGY 502
L +LHE + +++RD+K N+LLD + KL D+G+ K G P T+ GT Y
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNY 162
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+APE+ R S D ++ G+LM E+ GR
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 5/155 (3%)
Query: 376 AEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY 435
+E+ + H +V+ + D+LLL+ +Y G L+K + +L++ L + Q Y
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPF-QEY 169
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-T 494
++ + Q +L L E +++++HRD+K +NI L KLGDFG +K Y + +
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
GT YLAPEL + + D++S G+++ E+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264
|
Length = 478 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMG------RLR 385
F + ++G GGFG V + + G A KR+ ++ +K+ E M++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRL---EKKRIKKRKGESMALNEKQILEKVN 58
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
+ +V L +D L LV + G L +++ + + + L A+ L
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP------GFEEERALFYAAEIL 112
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHI---VGTLG 501
L + + V+RD+KP NILLD Y + ++ D GLA KI P+ I VGT+G
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI------PEGESIRGRVGTVG 166
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQK 540
Y+APE+ + T S D + G L+ E+ G+ +K
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS-----MGRLRHRNLVQ 391
++G G FG+V + A+K + + KE IMS + ++H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVG 60
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
LH + D+L V DY+ G L F + R L R+ IA +L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARF-YAAEIASALGYLH-- 113
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI-YEHGANPQTTHIVGTLGYLAPELTRT 510
+ +V+RD+KP NILLD+ + L DFGL K EH N T+ GT YLAPE+
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLHK 170
Query: 511 GKATTSTDVYSYGILMLEVACG 532
+ D + G ++ E+ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL----RHRNLVQL 392
L+G G FG+V + G A+K I K+ VA ++ R+ RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKIL-IGIAQSLLYLHEE 451
+ D L V +Y G +L F H R+ + ++R + I +L YLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGG---ELFF---HLSRERVFTEERARFYGAEIVSALEYLH-- 112
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI-YEHGANPQTTHIVGTLGYLAPELTRT 510
++ VV+RD+K N++LD + K+ DFGL K GA +T GT YLAPE+
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLED 169
Query: 511 GKATTSTDVYSYGILMLEVACGR 533
+ D + G++M E+ CGR
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 40/120 (33%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL 500
I +L+LH +V+RD+KP N+LLD N +L D GLA + G T GT
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTN 158
Query: 501 GYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560
GY+APE+ + + D ++ G + E+ GR P K E + + +K LE E+
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR---TPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 337 LVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL 389
++G GG+G+V++ + ++V K +Q+ AE + ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
V L + +L L+ +Y+ G L L + + D L I+ +L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALEHLH 117
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE-L 507
+ Q +++RD+KP NILLD + KL DFGL K E TH GT+ Y+APE L
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 508 TRTGKATTSTDVYSYGILMLEVACG 532
R+G + D +S G LM ++ G
Sbjct: 173 MRSGHG-KAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMG------RLR 385
F ++G GGFG V + + G A K++ ++ +K+ E M++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVN 58
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
R +V L +D L LV + G L +++ + +D++ I A+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-----GFDEQRAIFYA-AELC 112
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
L + +R+V+RD+KP NILLD + ++ D GLA G + VGT+GY+AP
Sbjct: 113 CGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--VGTVGYMAP 170
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQK 540
E+ K T S D + G L+ E+ G+ +K
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
VGSG +G VY+ G A+K I EI + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
+++L + +Y GSL + + + L+ Q + Q L YLH + +
Sbjct: 77 SREKLWICMEYCGGGSLQDI-----YHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 458 HRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELT---RTGKA 513
HRD+K +NILL + KL DFG+ AKI A ++ +GT ++APE+ + G
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNGGY 186
Query: 514 TTSTDVYSYGILMLEVA 530
D+++ GI +E+A
Sbjct: 187 NQLCDIWAVGITAIELA 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 35/190 (18%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGW 395
+G G FG V++ VA+K++ +++ A EI + L+H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 396 CRK--------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLL-------TWDQRYKILIG 440
CR + LV+++ +H L LL T + K++
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFC------------EHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY---EHGANPQTTHIV 497
+ L Y+H +++HRD+K +NIL+ KL DFGLA+ + ++ + T+ V
Sbjct: 128 LLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 498 GTLGYLAPEL 507
TL Y PEL
Sbjct: 185 VTLWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWC 396
+G G + VY+G G VA+K I ++G + E + L+H N+V LH
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
++ L LV++YV D + H L + L + + L Y+H+ + +
Sbjct: 73 HTKETLTLVFEYV---HTDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQ---RYI 124
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKATT 515
+HRD+KP N+L+ KL DFGLA+ ++ + +V TL Y P+ L + + +T
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 516 STDVYSYGILMLEVACG 532
D++ G + +E+ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 50/215 (23%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 338 VGSGGFGRVYRGLMPSLGLE---------VAIKRIGHN-SQQGMKEFVAEIMSMGRL-RH 386
+G G FG+V + ++GL+ VA+K + + +++ + + ++E+ M + +H
Sbjct: 26 LGEGCFGQVV--MAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRY 435
+N++ L G C + L ++ +Y G+L + L ++ + L++
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH-GANPQTT 494
+A+ + YL +++ +HRD+ N+L+ K+ DFGLA+ H +TT
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ + ++APE T +DV+S+G+L+ E+
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 338 VGSGGFGRV----YRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG+V Y + G +VA+K + + + + EI + L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 393 HGWCRKQ--DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
G C + + + L+ +++P+GSL + L +K+ Q+ K + I + + YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI----NLKQQLKYAVQICKGMDYLG- 126
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH--IVGTLGYLAPELT 508
+++ VHRD+ N+L+++ K+GDFGL K E T + + + APE
Sbjct: 127 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 509 RTGKATTSTDVYSYGILMLEV 529
K ++DV+S+G+ + E+
Sbjct: 185 IQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 64/278 (23%), Positives = 123/278 (44%), Gaps = 33/278 (11%)
Query: 338 VGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNSQQGMKE---FVAEIMSMGRLRHRNL 389
+G G FG VY G+ + VAIK + N M+E F+ E M ++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFD-----KDHKLRKLLTWDQRYKILIGIAQS 444
V+L G + L++ + + G L L +++ ++ + + ++ IA
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYL 503
+ YL+ + VHRD+ N ++ K+GDFG+ + IYE + + + ++
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 504 APELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563
+PE + G TT +DV+S+G+++ E+A + +P + + ++ +V +EG +
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQGMSNEQVLRFV----MEGGLLDK 242
Query: 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601
D D ++ L C NP RP ++
Sbjct: 243 PDNCPD--------MLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL----RHRNLVQL 392
L+G G FG+V + G A+K I K+ VA ++ R+ RH L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKIL-IGIAQSLLYLHEE 451
+ +D L V +YV G +L F H R+ + + R + I +L YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGG---ELFF---HLSRERVFSEDRTRFYGAEIVSALDYLH-- 112
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+ ++V+RD+K N++LD + K+ DFGL K A T GT YLAPE+
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDN 170
Query: 512 KATTSTDVYSYGILMLEVACGRRSIEPQ--KAAAELLLVDWVK 552
+ D + G++M E+ CGR Q + EL+L++ +K
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 68/286 (23%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 338 VGSGGFGRVYRGLM-------PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRN 388
+G G FG+V P+ + VA+K + + + + + + V+E+ M + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKI 437
++ L G C + L ++ +Y G+L + L FD + LT+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHI 496
+A+ + YL +Q+ +HRD+ N+L+ K+ DFGLA+ ++ +TT+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 497 VGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556
+ ++APE T +DV+S+G+L+ E+ S P EL + +KE H
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL--LKEGH- 253
Query: 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+ + + T + Y + C P RP +++VE
Sbjct: 254 --RMDKPANCTHELYMIMRE---------CWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWC 396
+G G +G+VY+ G A+K + S +E AE + L H N+V+ +G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 397 RKQD-----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK------ILIGIAQSL 445
K D +L LV + GS+ +L+ + LL QR IL G L
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELV-------KGLLICGQRLDEAMISYILYGALLGL 141
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
+LH N R++HRDVK +NILL T KL DFG++ + T VGT ++AP
Sbjct: 142 QHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAP 197
Query: 506 ELTRTGKATTST-----DVYSYGILMLEVACG 532
E+ + + DV+S GI +E+ G
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 46/206 (22%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 338 VGSGGFGRVYRGLMPSLG-------LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLV 390
+G G F ++++G+ +G EV +K + + + + F M +L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+G C DE ++V +YV GSLD L + + ++W + ++ +A +L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN--ISW--KLEVAKQLAWALHFLED 118
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH---IVGTLGYLAPEL 507
+ + H +V N+LL + K G+ K+ + G + ++ + ++ PE
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175
Query: 508 TRTGKA-TTSTDVYSYGILMLEVACG 532
+ + + D +S+G + E+ G
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL----RHRNLVQL 392
L+G G FG+V + G A+K I K+ VA ++ R+ RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ D L V +Y G +L F + ++ + D+ I +L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGG---ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS-- 113
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI-YEHGANPQTTHIVGTLGYLAPELTRTG 511
VV+RD+K N++LD + K+ DFGL K GA +T GT YLAPE+
Sbjct: 114 -CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDN 170
Query: 512 KATTSTDVYSYGILMLEVACGR 533
+ D + G++M E+ CGR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMK--EFV-AEIMSMGRLRHRNLVQLH 393
VG+G FGRV+ A+K + +K + V E + + H +++L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG--IAQSLLYLHEE 451
Q L ++ +YVP G L F LR + + I +L YLH
Sbjct: 68 WTEHDQRFLYMLMEYVPGGEL----FSY---LRNSGRFSNSTGLFYASEIVCALEYLH-- 118
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
++ +V+RD+KP NILLD + KL DFG AK +T + GT YLAPE+ ++
Sbjct: 119 -SKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVIQSK 173
Query: 512 KATTSTDVYSYGILMLEVACG 532
+ D ++ GIL+ E+ G
Sbjct: 174 GHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 53/212 (25%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+V+L+ + +D L V DY+P G + LL +L +++ IA+ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-------RLGIFEEDLARFY-IAELTCAI 114
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL---------AKIYEHGANPQ------- 492
+HRD+KP NIL+D + KL DFGL +K Y+ G + +
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 493 -------------------------TTH-IVGTLGYLAPE-LTRTGKATTSTDVYSYGIL 525
H +VGT Y+APE L RTG T D +S G++
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVI 233
Query: 526 MLEVACGRRS-IEPQKAAAELLLVDWVKELHL 556
+ E+ G+ + A +L +++W LH+
Sbjct: 234 LYEMLVGQPPFLADTPAETQLKVINWETTLHI 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 335 QNLVGSGGFGRVY--------RGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLR 385
Q +G G FG VY + E+ + + N + Q +E A+++S +L
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE--AQLLS--KLD 60
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
H +V+ H ++D ++ +Y LD L + H K L+ +Q + I + +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGV 119
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
Y+H+ +R++HRD+K NI L L K+GDFG++++ + TT GT Y++P
Sbjct: 120 HYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMSP 174
Query: 506 ELTRTGKATTSTDVYSYGILMLEVAC 531
E + + +D++S G ++ E+ C
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 389 LVQLHGWCRKQDE--LLLVYDYVPNGSLDKLL--FDKDHKLRKLLTWDQRYKILIGIAQS 444
+VQL +C QD+ L +V +Y+P G L L+ +D K K T A+
Sbjct: 105 VVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT-----------AEV 151
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
+L L + ++HRDVKP N+LLD + + KL DFG + + VGT Y++
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 505 PELTRT----GKATTSTDVYSYGILMLEVACG 532
PE+ ++ G D +S G+ + E+ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G FG V+ P G VA+K++ + Q ++S R+ R L L C
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ--------NLVSCKRV-FRELKML---CF 55
Query: 398 -KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD--------QR----------YKIL 438
K D +L D + +D F++ + + +L+ D Q Y+IL
Sbjct: 56 FKHDNVLSALDILQPPHID--PFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG 498
G L YLH + ++HRD+KP N+L+++ K+ DFGLA++ E + T V
Sbjct: 114 RG----LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 499 TLGYLAPE-LTRTGKATTSTDVYSYGILMLEVACGR 533
T Y APE L + T++ D++S G + E+ R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+ LH + ++ L LV DY G L LL + +L + + R+ I A+ +L +
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYI----AEMVLAI 115
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H VHRD+KP N+LLD + +L DFG Q++ VGT Y++PE+
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 509 RT-----GKATTSTDVYSYGILMLEVACG 532
+ GK D +S G+ M E+ G
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 48/220 (21%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 325 LASVTKGFGEQNLVGSGGFGRVYRGLM----PSLGLEVAIKRI-GHNSQQGMKEFVAEIM 379
+A +L+ G FGR++ G++ P EV +K + H S+ + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 380 SMGRLRHRNLVQLHGWC-RKQDELLLVYDYVPNGSLDKLLFD-KDHKLRKLLTWDQRYKI 437
+ L H+N++ + C + ++Y Y+ G+L L + + + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 438 LIG--IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH 495
+ IA + YLH + V+H+D+ N ++D L K+ D L++ P H
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR----DLFPMDYH 173
Query: 496 IVGT-----LGYLAPELTRTGKATTSTDVYSYGILMLEVA 530
+G + ++A E + ++++DV+S+G+L+ E+
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLRHRNLVQ 391
+ VGSG +G+V G +VAIK++ Q + K E+ + + H N++
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI- 77
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKL--------LFDKD-HKLRKL--LTWDQRYKILI- 439
LL V+ P SL+ L D + + K L+ D + L+
Sbjct: 78 ---------GLLDVF--TPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFLVY 125
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT 499
I + L Y+H + ++HRD+KPSNI ++ K+ DFGLA+ + + T V T
Sbjct: 126 QILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVAT 178
Query: 500 LGYLAPE-LTRTGKATTSTDVYSYGILMLEVACGR 533
Y APE + + D++S G +M E+ G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 338 VGSGGFGRVYRGLMPSLGLE-VAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G+G FGRV + VAIKR + Q+ + +E + + H V L+
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGI---AQSLLYLHE 450
G + + L LV ++V G + L ++R+ +G AQ +L
Sbjct: 98 GSFKDESYLYLVLEFVIGG-----------EFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ +V+RD+KP N+LLD K+ DFG AK+ + +T + GT Y+APE+
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLN 202
Query: 511 GKATTSTDVYSYGILMLEVACG 532
+ D ++ GI + E+ G
Sbjct: 203 VGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 335 QNL--VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLRHRNLV 390
QNL VGSG +G V GL VA+K++ Q + K E+ + ++H N++
Sbjct: 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79
Query: 391 QL---HGWCRKQDELLLVY--DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
L R +E VY ++ L+ ++ K +KL T D ++ I + L
Sbjct: 80 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKL-TDDHVQFLIYQILRGL 133
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
Y+H + ++HRD+KPSN+ ++ K+ DFGLA+ H + T + V T Y AP
Sbjct: 134 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGY-VATRWYRAP 186
Query: 506 ELTRTGKATTST-DVYSYGILMLEVACGR 533
E+ T D++S G +M E+ GR
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-------QQGMKEFVAEIMSMGRLRHRNL 389
++G G FG+V + G A+K + + + M E I+S+ R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPFL 58
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQ-RYKILIG-IAQSLLY 447
QL+ + D L V ++V G L +F ++K +D+ R + I +L++
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDL---MF----HIQKSRRFDEARARFYAAEITSALMF 111
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE 506
LH+ + +++RD+K N+LLD + KL DFG+ K E N +TT GT Y+APE
Sbjct: 112 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE 166
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGRRSIEPQ 539
+ + S D ++ G+L+ E+ CG E +
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 15/148 (10%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG--IAQSLL 446
L QLH + D L V +YV G L ++ ++++ + + + + IA L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL---MY----HIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAP 505
+LH ++ +++RD+K N++LD + K+ DFG+ K E+ +TT GT Y+AP
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAP 170
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGR 533
E+ S D +++G+L+ E+ G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 338 VGSGGFGRVYRGLMPSL-----GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G FG VY G + VA+K + + S + EF+ E M ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----KDHKLRKLLTWDQRYKILIGIAQSLL 446
L G K L+V + + +G L L +++ R T + ++ IA +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAP 505
YL+ ++ VHRD+ N ++ K+GDFG+ + IYE + + + ++AP
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565
E + G TTS+D++S+G+++ E+ S+ Q L E Q +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEIT----SLAEQPYQG------------LSNE--QVLK 232
Query: 566 QTLD--YYDLAE--AELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607
+D Y D + E V +L C NP RP +V L D
Sbjct: 233 FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLV------- 390
+G G G V+ + VA+K+I Q +K + EI + RL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 391 ----QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQ---------RYKI 437
L EL VY + + + D L +L Y++
Sbjct: 73 PSGSDLTEDVGSLTELNSVY-------IVQEYMETD--LANVLEQGPLSEEHARLFMYQL 123
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKI----YEHGANPQ 492
L G L Y+H + V+HRD+KP+N+ ++T L K+GDFGLA+I Y H
Sbjct: 124 LRG----LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG--Y 174
Query: 493 TTHIVGTLGYLAPELT-RTGKATTSTDVYSYGILMLEVACGR 533
+ + T Y +P L T + D+++ G + E+ G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 377 EIMSMGRLRHRNLVQLHGWCRKQDELLLV---YDYVPNGSLDKLLFDKDH--KLRKLLTW 431
EI+++GRL H N++++ R + ++ YD+ L ++D+ K R LL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLL-K 267
Query: 432 DQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491
R I+ + ++ Y+H +++++HRD+K NI L+ LGDFG A +E
Sbjct: 268 QTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
VGT+ +PE+ TD++S G+++L++
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--- 388
F ++G G FG+V AIK + + + ++ L ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 389 -LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG--IAQSL 445
L QLH + D L V +YV G L + ++++ + + + I+ L
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPQAVFYAAEISVGL 114
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLA 504
+LH + +++RD+K N++LD+ + K+ DFG+ K EH + TT GT Y+A
Sbjct: 115 FFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIA 169
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGR 533
PE+ S D ++YG+L+ E+ G+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE---FVAEIMSMGRLRHRNLVQL 392
+G+G FGRV G AIK + MK+ E + L H +V +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
+ ++ + + ++V G L L F D + K Y + +A Y
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND--VAKF------YHAELVLA--FEY 133
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
LH ++ +++RD+KP N+LLD + K+ DFG AK +T + GT YLAPE+
Sbjct: 134 LH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPEV 186
Query: 508 TRTGKATTSTDVYSYGILMLEVACG 532
++ + D ++ G+L+ E G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 389 LVQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
+VQLH QD+ L +V +Y+P G L L+ + D + W + Y A+ +L
Sbjct: 105 IVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFY-----TAEVVL 153
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
L + +HRDVKP N+LLD + KL DFG + + VGT Y++PE
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 507 LTRT----GKATTSTDVYSYGILMLEVACG 532
+ ++ G D +S G+ + E+ G
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 50/262 (19%)
Query: 339 GSGGFGRVYRGLM----------PSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN 388
G G F +Y+G++ P + V +K +G + + + F M +L H++
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHKH 62
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
LV+L+G C + DE ++V +YV G LD L H+ + ++ + + +A +L YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFL----HREKNNVSLHWKLDVAKQLASALHYL 117
Query: 449 HEECNQRVVHRDVKPSNILLDTY-------LNAKLGDFGLAKIYEHGANPQTTHIVGTLG 501
+ +++VH +V NIL+ Y KL D G+ V +
Sbjct: 118 ED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER-----VERIP 169
Query: 502 YLAPELTRTGKA--TTSTDVYSYGILMLEVACG----------RRSIEPQKAAAELLLVD 549
++APE R G+A T + D +S+G +LE+ + L + D
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD 229
Query: 550 WVKELHLEGEITQAIDQTLDYY 571
E+ I+Q Y
Sbjct: 230 C-------AELANLINQCWTYD 244
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-----RHRNLVQ 391
++G G FG+V+ + AIK + + M + V M R+ H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L+ + ++ L V +Y+ G L HK +I+ G L +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDLPRATFYAAEIICG----LQFLH-- 113
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
++ +V+RD+K NILLDT + K+ DFG+ K G + +T GT Y+APE+
Sbjct: 114 -SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEILLGQ 171
Query: 512 KATTSTDVYSYGILMLEVACGR 533
K TS D +S+G+L+ E+ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 338 VGSGGFGRVYRGLMPSLGL---EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G+G FG+V G + S G +V +K + + S Q +F+ E L+H NL+Q
Sbjct: 3 IGNGWFGKVILGEVNS-GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR--YKILIGIAQSLLYLHEE 451
G C + LLV ++ P G L L + + +L+T D ++ IA LL+LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQRMACEIALGLLHLHK- 118
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI-YEHGANPQTTHIVGTLGYLAPELTR- 509
+H D+ N LL L K+GD+GL+ Y+ + L ++APEL
Sbjct: 119 --NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 510 ------TGKATTSTDVYSYGILMLEV 529
T ++V+S G+ + E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 1/93 (1%)
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLG 501
Q LL +H ++ ++HRD+K +NILL + KLGDFG +K+Y + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 502 YLAPELTRTGKATTSTDVYSYGILMLEVACGRR 534
Y+APE+ R + D++S G+L+ E+ +R
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 50/192 (26%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 356 LEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414
L VA+K + ++ + + +F+ E+ + RL+ N+++L G C +D L ++ +Y+ NG L
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 415 DKLL------------FDKDHKLRKLLTWDQRYKILIG----IAQSLLYLHEECNQRVVH 458
++ L D L Y L+ IA + YL + VH
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPA--ISYSSLLHVALQIASGMKYL---SSLNFVH 161
Query: 459 RDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTGKATTST 517
RD+ N L+ L K+ DFG+++ +Y V + ++A E GK TT++
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 518 DVYSYGILMLEV 529
DV+++G+ + E+
Sbjct: 222 DVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 24/163 (14%)
Query: 374 FVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD---KDHKLRKLLT 430
V ++M + N ++L+ +L+ DY+ +G L FD K+ KL +
Sbjct: 60 MVHQLMK----DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEV 111
Query: 431 WDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN-AKLGDFGLAKIYEHGA 489
KI+ + ++L LH ++H D+K N+L D + L D+GL KI
Sbjct: 112 ----KKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IG-- 161
Query: 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532
+ GTL Y +PE + S D ++ G+L E+ G
Sbjct: 162 --TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
++G GGFG VY G A+K + ++ +K E +++ +LV G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVST-GDC 56
Query: 397 ----------RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY---KILIGIAQ 443
D+L + D + G L L K + R+ +I++G
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK----EMRFYATEIILG--- 109
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL 503
L ++H N+ VV+RD+KP+NILLD + + ++ D GLA + P + VGT GY+
Sbjct: 110 -LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYM 162
Query: 504 APELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQK 540
APE+ + G A +S D +S G ++ ++ G K
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE---FVAEIMSMGRLRHRNLVQ 391
Q ++G G +G V + G +VAIK+I ++ + + + + EI + LRH ++V+
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVE 63
Query: 392 -----LHGWCRKQDELLLVYDYVPNGSLDKLLFDKD-HKLRKL---LTWDQRYKILIGIA 442
L R+ ++ +V++ L + D H++ K LT + L +
Sbjct: 64 IKHIMLPPSRREFKDIYVVFE----------LMESDLHQVIKANDDLTPEHHQFFLYQLL 113
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT--THIVGTL 500
++L Y+H V HRD+KP NIL + K+ DFGLA++ + T V T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 501 GYLAPELTRT--GKATTSTDVYSYGILMLEVACGR 533
Y APEL + K T + D++S G + EV G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 43/152 (28%), Positives = 79/152 (51%), Gaps = 15/152 (9%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG--IAQSLL 446
L QLH + D L V +YV G L ++++++ + + + + IA L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLM-------YQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAP 505
+LH ++ +++RD+K N++LD+ + K+ DFG+ K E+ + TT GT Y+AP
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAP 170
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
E+ S D +++G+L+ E+ G+ E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR---LRHRN--LVQ 391
++G G FG+V + G A+K + + + + V M R L N L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTH 60
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYLH 449
L+ + ++ L V +++ G L +F K R L Y +I+ G L +LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCG----LQFLH 113
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR 509
++ +++RD+K N++LD + K+ DFG+ K G N +T GT Y+APE+ +
Sbjct: 114 ---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQ 169
Query: 510 TGKATTSTDVYSYGILMLEVACGR 533
K T S D +S+G+L+ E+ G+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLR-HRNLVQLHGW 395
G G F V + G AIK + + +++ EI ++ RL H N+++L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI-- 64
Query: 396 CRKQDELLLVYDYVPNGSL-------DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
E+L +D G L D L++ ++ L + + + +SL ++
Sbjct: 65 -----EVL--FD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPE- 506
H + HRD+KP NIL+ + KL DFG + IY P T +I T Y APE
Sbjct: 117 HR---NGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKP--PYTEYI-STRWYRAPEC 169
Query: 507 LTRTGKATTSTDVYSYGILMLEV 529
L G D+++ G + E+
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 335 QNL--VGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLRHRNLV 390
QNL +GSG G V L VAIK++ +Q K E++ M + H+N++
Sbjct: 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 391 QLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIGIAQS 444
L Q L D Y+ +D L + DH+ L Y++L GI
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL----YQMLCGIK-- 140
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
+LH + ++HRD+KPSNI++ + K+ DFGLA+ G + T V T Y A
Sbjct: 141 --HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGR 533
PE+ + D++S G +M E+ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
R + LH + ++ L LV DY G L LL + +L + + + Y +A+ +L
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA--RFY-----LAEMVL 113
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG-LAKIYEHGANPQTTHIVGTLGYLAP 505
+ VHRD+KP N+LLD + +L DFG ++ G Q+ VGT Y++P
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISP 172
Query: 506 ELTR-----TGKATTSTDVYSYGILMLEVACG 532
E+ + G+ D +S G+ M E+ G
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 338 VGSGGFGRVY----RGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G FG+V R L+ I++ S+ + +AE + ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK-TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
+ ++L LV ++ G L F H L++ +D + A+ L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL----F---HHLQREGRFDL-SRARFYTAELLCALENLHK 111
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
V++RD+KP NILLD + L DFGL K+ + +T GT YLAPEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 514 TTSTDVYSYGILMLEVACG 532
T + D ++ G+L+ E+ G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLRHRNLVQLHGW 395
VGSG +G V L G +VAIK++ Q + K E+ + ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL--- 79
Query: 396 CRKQDELLLVYDYVPNGSLDKLL------------FDKDHKLRKLLTWDQRYKILI-GIA 442
+ + P+ SLD+ K K KL + R + L+ +
Sbjct: 80 ---------LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL--SEDRIQFLVYQML 128
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY 502
+ L Y+H ++HRD+KP N+ ++ K+ DFGLA+ + + T V T Y
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWY 181
Query: 503 LAPELTRTGKATTST-DVYSYGILMLEVACGR 533
APE+ T T D++S G +M E+ G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 35/92 (38%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 442 AQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLG 501
A+ +L L N+ VV+RD+KP+NILLD + + ++ D GLA + P + VGT G
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHG 160
Query: 502 YLAPELTRTGKA-TTSTDVYSYGILMLEVACG 532
Y+APE+ + G A +S D +S G ++ ++ G
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFVAEIMSMGRLR-HRNLVQLHG 394
+G G +G+V++ L G + A+K + H+ + E AE + L H N+V+ +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSDHPNVVKFYG 82
Query: 395 WCRKQD-----ELLLVYDYVPNGSLDKL---LFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
K+D +L LV + GS+ L + ++ + + ++ L+G L
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG----LQ 138
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
+LH + +HRDVK +NILL T KL DFG++ + T VGT ++APE
Sbjct: 139 HLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPE 194
Query: 507 LTRTGKATTST-----DVYSYGILMLEVACG 532
+ + ST DV+S GI +E+ G
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 358 VAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDK 416
VA+K + ++ + + +F+ EI M RL+ N+++L C D L ++ +Y+ NG L++
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 417 LLFDKDHKLRKLLTWDQRYKILIG--------IAQSLLYLHEECNQRVVHRDVKPSNILL 468
L H+ ++ I IA + YL + VHRD+ N L+
Sbjct: 109 FL--SRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 469 DTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILML 527
K+ DFG+++ +Y V + +++ E GK TT++DV+++G+ +
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 528 EV 529
E+
Sbjct: 224 EI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 335 QNL--VGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLRHRNLV 390
QNL +GSG G V L VAIK++ +Q K E++ M + H+N++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 391 QLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS 444
L Q L LV + + + + DH+ L Y++L GI
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL----YQMLCGIK-- 133
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
+LH + ++HRD+KPSNI++ + K+ DFGLA+ G + T V T Y A
Sbjct: 134 --HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 186
Query: 505 PELTRTGKATTSTDVYSYGILMLEV 529
PE+ + D++S G +M E+
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 44/145 (30%), Positives = 73/145 (50%), Gaps = 15/145 (10%)
Query: 393 HGWCRKQ--DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYL 448
H +C Q + L V +Y+ G L +F R + Y +I+ G L +L
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICG----LQFL 112
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H + +++RD+K N+LLD + K+ DFG+ K +G +T GT Y+APE+
Sbjct: 113 H---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEIL 168
Query: 509 RTGKATTSTDVYSYGILMLEVACGR 533
+ K S D +S+G+L+ E+ G+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 382 GRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK--ILI 439
RH LV L + +D + V +Y G L + + Y +++
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA----VFYAACVVL 112
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT 499
G L YLHE ++V+RD+K N+LLDT K+ DFGL K G +T+ GT
Sbjct: 113 G----LQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGT 164
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532
+LAPE+ T + D + G+L+ E+ G
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 39/227 (17%)
Query: 332 FGEQNLVGSGGFGRV----------YRGLMPSLGLE------VAIKRIGHN-SQQGMKEF 374
F E+ G G FG V + + VA+K + + S ++F
Sbjct: 9 FVEKL--GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF 66
Query: 375 VAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKL- 428
+ E+ + RL N+ +L G C L ++ +Y+ NG L++ L
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 429 LTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK----- 483
L++ + IA + YL E N VHRD+ N L+ K+ DFG+++
Sbjct: 127 LSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 484 -IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
Y + ++A E GK TT +DV+++G+ + E+
Sbjct: 184 DYYRVQGRA-----PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 34/194 (17%)
Query: 358 VAIKRIGHNSQQGM--KEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGS- 413
VAIK+I + + + K + E+ + R H+N+ L+ ++ +V+ N
Sbjct: 30 VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLY-------DMDIVFPGNFNELY 82
Query: 414 LDKLLFDKDHKLRKLLTWDQR----------YKILIGIAQSLLYLHEECNQRVVHRDVKP 463
L + L + D L +++ Q Y+IL G L Y+H + V+HRD+KP
Sbjct: 83 LYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCG----LKYIH---SANVLHRDLKP 133
Query: 464 SNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI---VGTLGYLAPELTRTGKA-TTSTDV 519
N+L++ K+ DFGLA+ + + V T Y APE+ + ++ T + DV
Sbjct: 134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193
Query: 520 YSYGILMLEVACGR 533
+S G ++ E+ +
Sbjct: 194 WSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 49/150 (32%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+ LH + ++ L LV DY G L LL + +L + + +++I I S+ L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQL 121
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFG-LAKIYEHGANPQTTHIVGTLGYLAPEL 507
H VHRD+KP NIL+D + +L DFG K+ E G Q++ VGT Y++PE+
Sbjct: 122 H------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEI 174
Query: 508 TRT-----GKATTSTDVYSYGILMLEVACG 532
+ GK D +S G+ M E+ G
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 47/233 (20%)
Query: 337 LVGSGGFGRVY----RGLMPSLGLEVAIKR--IGHNSQQGMKEFVAEIMSMGRLRHRNLV 390
L+G G GRV+ +G L+V K+ I N + + EI++ L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRV-LTEQEILA--TLDHPFLP 64
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD--QRYKILIGIAQSLLYL 448
L+ + + L LV DY P G L +LL + K L+ + + Y + +A L YL
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAAEVLLA--LEYL 119
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK--------IYEHGANP--------- 491
H +V+RD+KP NILL + L DF L+K + +
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 492 -----------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
++ VGT Y+APE+ ++ D ++ GIL+ E+ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLRHRNLVQLHG 394
VGSG +G V + G +VAIK++ Q + K E+ + ++H N++ G
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVI---G 78
Query: 395 WCRKQ---------DELLLVYDYVPNGSLDKLLFDK--DHKLRKLLTWDQRYKILIGIAQ 443
+ LV Y+ L K++ + K++ L+ Y++L G
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLV-----YQMLCG--- 129
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL 503
L Y+H ++HRD+KP N+ ++ K+ DFGLA+ A+ + T V T Y
Sbjct: 130 -LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYR 181
Query: 504 APELTRTGKATTST-DVYSYGILMLEVACGR 533
APE+ T D++S G +M E+ G+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 429 LTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488
L DQ I I + L YLH QR++HRDVK NI ++ +GD G A+
Sbjct: 154 LPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PV 208
Query: 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
P + GT+ APE+ K + D++S GI++ E+
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 55/219 (25%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+V+L+ + +D L V DY+P G + LL ++ + + IA+ L +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-------RMEVFPEVLARFY-IAELTLAI 114
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL---------AKIYEHGAN--------- 490
+HRD+KP NIL+D + KL DFGL +K Y+ G++
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 491 ---------------------PQTTH-------IVGTLGYLAPELTRTGKATTSTDVYSY 522
H +VGT Y+APE+ T D +S
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 523 GILMLEVACGRRS-IEPQKAAAELLLVDWVKELHLEGEI 560
G+++ E+ G+ + P +L +++W LH+ ++
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV 273
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 335 QNL--VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLRHRNLV 390
QNL +GSG G V G VAIK++ Q K E++ M + H+N++
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNII 78
Query: 391 QLHGWCRKQ------DELLLVYDYVPNGSLDKLLFDKDHK-LRKLLTWDQRYKILIGIAQ 443
L Q ++ LV + + + D DH+ + LL Y++L GI
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL-----YQMLCGIK- 132
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL 503
+LH + ++HRD+KPSNI++ + K+ DFGLA+ G + T V T Y
Sbjct: 133 ---HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 184
Query: 504 APELTRTGKATTSTDVYSYGILMLEVACGR 533
APE+ + D++S G +M E+ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 4e-08
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 41/201 (20%)
Query: 367 SQQGMKE-----FVAEIMSMGRLRHRNLVQ-LHGWCRKQDE-LLLVYDYVPNGSLDKLLF 419
S +G+KE V E+ M L+H+N+V+ + + K ++ L ++ ++ G L + +
Sbjct: 47 SYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI- 105
Query: 420 DKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN--------QRVVHRDVKPSNILLDTY 471
K K+ + + I + I + LL+ C+ +RV+HRD+KP NI L T
Sbjct: 106 ---QKCYKMFGKIEEHAI-VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161
Query: 472 LN-----------------AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT--RTGK 512
+ AK+GDFGL+K G VGT Y +PEL T
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKS 219
Query: 513 ATTSTDVYSYGILMLEVACGR 533
+D+++ G ++ E+ G+
Sbjct: 220 YDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 15/140 (10%)
Query: 399 QDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
QD+ L +V +Y+P G L L+ + D + W + Y A+ +L L +
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT-----AEVVLALDAIHSMGF 163
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT----GK 512
+HRDVKP N+LLD + KL DFG + VGT Y++PE+ ++ G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 513 ATTSTDVYSYGILMLEVACG 532
D +S G+ + E+ G
Sbjct: 224 YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 337 LVGSGGFGRVYRGLMPS---LGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLRHRNLVQ 391
++G G FG V + S +VA+K + S ++EF+ E M H N+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 392 LHGWC---RKQDEL---LLVYDYVPNGSLDK-LLFDKDHKLRKLLTWDQRYKILIGIAQS 444
L G R + L +++ ++ +G L LL + + L + +I IA
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYL 503
+ YL ++ +HRD+ N +L+ + + DFGL+ KIY Q + +L
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 504 APELTRTGKATTSTDVYSYGILMLEVA 530
A E TT +DV+++G+ M E+
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 51/185 (27%), Positives = 73/185 (39%), Gaps = 55/185 (29%)
Query: 390 VQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD--QRYKILIGIAQSL 445
V+L + QDE L L+ +Y+P G + LL KD T + + Y IA+++
Sbjct: 64 VKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKD-----TFTEEETRFY-----IAETI 111
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK------------IYEH---GAN 490
L + +HRD+KP N+LLD + KL DFGL I H
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 491 PQTTH----------------------IVGTLGYLAPE-LTRTGKATTSTDVYSYGILML 527
VGT Y+APE +TG D +S G++M
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMY 230
Query: 528 EVACG 532
E+ G
Sbjct: 231 EMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI---------YEHGANPQT- 493
+L YLH N +VHRD+KP N+L+ + + KL DFGL+KI YE T
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 494 ----THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532
+ GT Y+APE+ D ++ GI++ E G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 67/243 (27%), Positives = 96/243 (39%), Gaps = 55/243 (22%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
F ++G G FG V G A+K I + KE VA I R LV+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKEQVAHI----RAERDILVE 57
Query: 392 LHG-WCRK-----QDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQ 443
G W K QD+ L L+ +++P G + LL KD L + T Q Y IA+
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEAT--QFY-----IAE 109
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL---------------------- 481
++L + +HRD+KP N+LLD + KL DFGL
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 482 ------------AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
A+ ++ VGT Y+APE+ D +S G++M E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 530 ACG 532
G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 77/226 (34%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL-- 446
+V+L+ + +D L V DY+P G + LL I +GI L
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL------------------IRMGIFPEDLAR 104
Query: 447 -YLHE-----ECNQRV--VHRDVKPSNILLDTYLNAKLGDFGL---------AKIYEHGA 489
Y+ E E ++ +HRD+KP NIL+D + KL DFGL +K Y+ G
Sbjct: 105 FYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD 164
Query: 490 NPQTT-------------------------------------HIVGTLGYLAPE-LTRTG 511
+ + +VGT Y+APE L RTG
Sbjct: 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224
Query: 512 KATTSTDVYSYGILMLEVACGRRSIEPQKA-AAELLLVDWVKELHL 556
T D +S G+++ E+ G+ Q ++ +++W LH+
Sbjct: 225 -YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 441 IAQSLL----YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH- 495
+A+ LL Y+H E ++HRD+K N+L++ + LGDFG A + G+ H
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHY 320
Query: 496 -IVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVA 530
I GT+ APE+ T S D++S G+++ E A
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 335 QNL--VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLRHRNLV 390
QNL VGSG +G V L +VA+K++ Q + + E+ + ++H N++
Sbjct: 18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77
Query: 391 QL------HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILI-GIAQ 443
L +E+ LV + + L+ ++ K +KL D+ + LI + +
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLM-GADLNNIV-----KCQKLS--DEHVQFLIYQLLR 129
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL 503
L Y+H + ++HRD+KPSN+ ++ ++ DFGLA+ A+ + T V T Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYR 182
Query: 504 APELTRTGKATTST-DVYSYGILMLEVACGR 533
APE+ T D++S G +M E+ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGT 499
+ +++ YLH R++HRD+K NI ++ + LGDFG A + N + GT
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGT 246
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSI 536
+ APEL + D++S GI++ E+A S+
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 71/274 (25%), Positives = 108/274 (39%), Gaps = 60/274 (21%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
F ++G G FG V G A+K I + KE V I R LV+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMK-ILRKADMLEKEQVGHI----RAERDILVE 57
Query: 392 LHG-WCRK-----QDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQ 443
W K QD+ L L+ +++P G + LL KD L + T Q Y IA+
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEET--QFY-----IAE 109
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL---------------------- 481
++L + +HRD+KP N+LLD+ + KL DFGL
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 482 ------------AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
A+ ++ VGT Y+APE+ D +S G++M E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 530 ACGRR---SIEPQKAAAELLLVDWVKELHLEGEI 560
G S PQ+ +++ +W + L E+
Sbjct: 230 LIGYPPFCSETPQETYKKVM--NWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 435 YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQT 493
Y++L G+A + H+ V+HRD+KP N+L+D K+ D GL + + T
Sbjct: 117 YQLLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 494 THIVGTLGYLAPE-LTRTGKATTSTDVYSYGILMLEVA 530
IV TL Y APE L + +T D++S G + E++
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 24/159 (15%)
Query: 381 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG 440
M ++ H +L +HG C + E ++V ++V +G LD L + K R + W KI +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAW----KITVA 123
Query: 441 --IAQSLLYLHEECNQRVVHRDVKPSNILL-------DTYLNAKLGDFGLAKIYEHGANP 491
+A +L YL ++ +VH +V NILL T KL D G++ A
Sbjct: 124 QQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS----FTALS 176
Query: 492 QTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEV 529
+ V + ++APE G + +T+ D +S+G +LE+
Sbjct: 177 REER-VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 12/94 (12%)
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG-- 498
+AQ + +L ++ +HRDV N+LL AK+ DFGLA+ + +N ++V
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YVVKGN 273
Query: 499 ---TLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+ ++APE T +DV+SYGIL+ E+
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 338 VGSGGFGRVYRG--LMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G+G FG+V + V +K + N S + EF+ + L+H N++Q G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
C + LLV++Y G L L + R ++ IA + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL-LLQRMACEIAAGVTHMHK---H 118
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH--IVGTLGYLAPELTR--- 509
+H D+ N L + L K+GD+G+ + + T L +LAPEL
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 510 ----TGKATTSTDVYSYGILMLEV 529
T + T ++V++ G+ + E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 27/155 (17%)
Query: 341 GGFGRVYRGLMPSLGLEVAIK------RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
G FG+VY G + A+K I N ++ AE ++ + +V L+
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQ---AERDALALSKSPFIVHLYY 71
Query: 395 WCRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+ + + LV +Y+ G + LL FD++ + K + +A +L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----------KYISEVALALDYLH 121
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484
++HRD+KP N+L+ + KL DFGL+K+
Sbjct: 122 R---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 377 EIMSMGR-LRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY 435
E SM R + H+++V L+G C + E ++V ++V G LD + H+ +LT ++
Sbjct: 53 ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM----HRKSDVLTTPWKF 108
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKIYEHGANPQTT 494
K+ +A +L YL + + +VH +V NILL ++ + G F K+ + G P T
Sbjct: 109 KVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGI-PITV 162
Query: 495 ----HIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEV 529
V + ++APE K + + D +S+G + E+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 338 VGSGGFGRVYRGLMP--SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG- 394
VG G +G VY+ + A+K+I + M EI + L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSA-CREIALLRELKHPNVISLQKV 66
Query: 395 -WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY-----L 448
++ L++DY + + F + K K + ++ G+ +SLLY +
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK-----KPVQLPRGMVKSLLYQILDGI 121
Query: 449 HEECNQRVVHRDVKPSNILL----DTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGY 502
H V+HRD+KP+NIL+ K+ D G A+++ P +V T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 503 LAPELTRTGKA-TTSTDVYSYGILMLEV 529
APEL + T + D+++ G + E+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTG 511
+++ +HRD+ NILL K+ DFGLA+ IY+ + L ++APE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 512 KATTSTDVYSYGILMLEV 529
TT +DV+S+G+L+ E+
Sbjct: 251 VYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 338 VGSGGFGRVYRGLMPSLG--LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG- 394
VG G +G VY+ E A+K+I + M EI + L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSA-CREIALLRELKHPNVIALQKV 66
Query: 395 -WCRKQDELLLVYDYVPNGSLDKLLFDKDHK-------LRKLLTWDQRYKILIGIAQSLL 446
++ L++DY + + F + K L + + Y+IL GI
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH---- 122
Query: 447 YLHEECNQRVVHRDVKPSNILL----DTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTL 500
YLH V+HRD+KP+NIL+ K+ D G A+++ P +V T
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 501 GYLAPELTRTGKA-TTSTDVYSYGILMLEV 529
Y APEL + T + D+++ G + E+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTG 511
+++ +HRD+ NILL K+ DFGLA+ IY+ + L ++APE
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 256
Query: 512 KATTSTDVYSYGILMLEV 529
T +DV+S+G+L+ E+
Sbjct: 257 VYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTG 511
+++ +HRD+ NILL K+ DFGLA+ IY+ + L ++APE
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251
Query: 512 KATTSTDVYSYGILMLEV 529
TT +DV+S+G+L+ E+
Sbjct: 252 VYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 32/193 (16%)
Query: 358 VAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLD 415
VA+K+I +S + +K EI++ +L+H N++ EL +V + GS +
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 416 KLLFDKDH---KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472
LL K H L +L + IL + +L Y+H ++ +HR VK S+ILL
Sbjct: 88 DLL--KTHFPEGLPELAI---AF-ILKDVLNALDYIH---SKGFIHRSVKASHILLSGDG 138
Query: 473 NAKL-----------GDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA--TTSTDV 519
L +++ V L +L+PE+ + +D+
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193
Query: 520 YSYGILMLEVACG 532
YS GI E+A G
Sbjct: 194 YSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 11/127 (8%)
Query: 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465
Y + + LL D + LT +A+ + +L ++ VHRD+ N
Sbjct: 214 YKGSNDSEVKNLLSDD---GSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARN 267
Query: 466 ILLDTYLNAKLGDFGLAKIYEHGAN---PQTTHIVGTLGYLAPELTRTGKATTSTDVYSY 522
+LL K+ DFGLA+ H +N +T + + ++APE TT +DV+SY
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSY 325
Query: 523 GILMLEV 529
GIL+ E+
Sbjct: 326 GILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 30/105 (28%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 428 LLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487
L++ +A + +L ++ VHRD+ N+L+ K+ DFGLA+
Sbjct: 235 ALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 488 GAN---PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529
+N +T + L ++APE TT +DV+S+GIL+ E+
Sbjct: 292 DSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 9/78 (11%)
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG-----TLGYLAPELTRTG 511
+HRD+ NILL K+ DFGLA+ + +N ++V + ++APE
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSN----YVVKGNARLPVKWMAPESIFNC 291
Query: 512 KATTSTDVYSYGILMLEV 529
T +DV+SYGIL+ E+
Sbjct: 292 VYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 16/170 (9%)
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
N+V LH + +D + LV + G L + + + + +R+ + +A L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECV---KRWAAEMVVA--LDA 100
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
LH E +V RD+ P+NILLD + +L F E + + + Y APE+
Sbjct: 101 LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEV 153
Query: 508 TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA----AELLLVDWVKE 553
+ T + D +S G ++ E+ G+ +E + L + +WV E
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE 203
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 33/220 (15%)
Query: 335 QNLVGSGGFGRVYRGLMPS--LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
L+G GGFG VY S A+ +I + + + V E + + + + L
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETI---VMETLVYNNIYDIDKIAL 73
Query: 393 HGWCR-KQDELLLVYDYVPNGS------------LDKLLFDKDHKLRKLLTWDQRY--KI 437
W + L + Y GS L+KL+ + +++ +++ I
Sbjct: 74 --WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-------KIYEHGAN 490
+ + +L Y+HE + H D+KP NI++D + D+G+A K E+
Sbjct: 132 MKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVA 530
+ H GTL Y + T D+ S G ML+ A
Sbjct: 189 QKDLH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227
|
Length = 294 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 29/122 (23%), Positives = 43/122 (35%), Gaps = 46/122 (37%)
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLA------------------KIYEHGANPQTTHI-- 496
+HRD+KP NIL+D + KL DFGL+ K ++ + + +
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 497 --------------------------VGTLGYLAPELTRTGKATTSTDVYSYGILMLEVA 530
VGT Y+APE+ D +S G +M E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
Query: 531 CG 532
G
Sbjct: 243 IG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 35/107 (32%), Positives = 50/107 (46%), Gaps = 15/107 (14%)
Query: 437 ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI 496
IL G + L YLH+ +HR++K S+IL+ L GL+ +Y N Q +
Sbjct: 106 ILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 497 V--------GTLGYLAPELTRTGKA--TTSTDVYSYGILMLEVACGR 533
V L +L+PEL R +D+YS GI E+A GR
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 653 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.5 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.79 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.95 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.91 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.88 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.47 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.28 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.25 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.19 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 | |
| PLN02236 | 344 | choline kinase | 96.6 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.45 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.28 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.14 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.07 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.95 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.86 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.61 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.6 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=472.98 Aligned_cols=288 Identities=46% Similarity=0.802 Sum_probs=254.8
Q ss_pred CCcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeee
Q 048419 316 GARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395 (653)
Q Consensus 316 ~~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 395 (653)
..+.|+|.|++.||++|+..++||+|+||.||+|...+ +..||||++.....+..++|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 46789999999999999999999999999999999975 58999998866544315669999999999999999999999
Q ss_pred ecccc-eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 396 CRKQD-ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 396 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
|.+.+ +.+||||||++|+|.++|+..... .|+|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+++++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999 599999999999999999886531 78999999999999999999999998899999999999999999999
Q ss_pred EEEeecCcccccC-CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 475 KLGDFGLAKIYEH-GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 475 kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
||+|||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....+++|++.
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999999976543 22111111 799999999999999999999999999999999999999886654455568999999
Q ss_pred hhcccchhHhhhhcc--CcCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 554 LHLEGEITQAIDQTL--DYYDL-AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l--~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
....+++.+++|+.+ ..+.. .++.++..++.+|++.+|.+||+|.||+++|+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999999998 35554 68899999999999999999999999999995543
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-55 Score=434.94 Aligned_cols=231 Identities=44% Similarity=0.699 Sum_probs=209.8
Q ss_pred eeEEeCCCCC--CCeEEecceEecCCCcEEecCCC--CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCC
Q 048419 9 TSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKS--EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGG 84 (653)
Q Consensus 9 ~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~--~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g 84 (653)
++|+|++|.. .+|+|+|+|.+.++|.|+||++. ..++|||+|++||+||+..+++++||+|+|+|.|.+.+...+|
T Consensus 1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~g 80 (236)
T cd06899 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLGG 80 (236)
T ss_pred CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCCC
Confidence 4899999975 79999999999778999999998 8999999999999999999999999999999999987667789
Q ss_pred CceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccC
Q 048419 85 QGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSG 164 (653)
Q Consensus 85 dGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~ 164 (653)
|||||+|+|....+.+..|++||+++..+. +...+++|||||||++|.+++||++||||||+|++.|..+..+..
T Consensus 81 dGlAF~i~~~~~~~~~~~G~~lG~~~~~~~--~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~--- 155 (236)
T cd06899 81 DGLAFFLAPTDSLPPASSGGYLGLFNSSNN--GNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDD--- 155 (236)
T ss_pred CeEEEEEecCCCCCCCCCcceeeeecCCCC--CCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccc---
Confidence 999999999876655788999999988755 456789999999999999888999999999999998887766542
Q ss_pred CCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeeccee
Q 048419 165 NNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWS 244 (653)
Q Consensus 165 ~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWs 244 (653)
..+.|.+|+.++|||+|++.+++|+|+|...+..+|..|++++++||+.+|+++||||||||||...|.|+|++|+
T Consensus 156 ----~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWs 231 (236)
T cd06899 156 ----DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWS 231 (236)
T ss_pred ----ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEE
Confidence 2345789999999999999999999999988877899999999999999999999999999999999999999999
Q ss_pred eeec
Q 048419 245 ISIG 248 (653)
Q Consensus 245 f~~~ 248 (653)
|++.
T Consensus 232 F~s~ 235 (236)
T cd06899 232 FSSN 235 (236)
T ss_pred EEcC
Confidence 9863
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-54 Score=426.48 Aligned_cols=232 Identities=36% Similarity=0.571 Sum_probs=205.1
Q ss_pred ceeEEeCCC-CCCCeEEecceEecCCCcEEecCCCC-CceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC--CCCCC
Q 048419 8 TTSFLYNGF-LHANLSLEGAAYISTSGILTVTNKSE-GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK--YPDLG 83 (653)
Q Consensus 8 ~~~f~~~~f-~~~~l~~~g~a~~~~~g~l~Lt~~~~-~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~--~~~~~ 83 (653)
+++|+|+.| +..+++|+|+|.+..+|+|+||+... +++|||+|++||+|||..+++++||+|+|+|.|... ....+
T Consensus 1 ~~~F~~~~F~~~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~~~ 80 (236)
T PF00139_consen 1 SVSFSFPSFSNSSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSNNG 80 (236)
T ss_dssp EEEEEESSBTTGTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSSS-
T ss_pred CceEEcCCCCCCCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCccC
Confidence 479999999 56899999999996689999999987 999999999999999999999999999999999643 45668
Q ss_pred CCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCcccc
Q 048419 84 GQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYS 163 (653)
Q Consensus 84 gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~ 163 (653)
||||||||+|....+.+..|++||+.+.... +...++.|||||||++|++++||+++|||||+|++.|..+.+++++
T Consensus 81 ~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~--~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~- 157 (236)
T PF00139_consen 81 GDGLAFVIQPDPNLPGGSSGGYLGLFNSSTD--GNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYY- 157 (236)
T ss_dssp BEEEEEEEEETTSSTTTSSGGGTTTSSSSST--TGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE-----
T ss_pred CCceEEEEecCcccccCCCCCccCccccccC--CCccCcEEEEEEeeeecccccccCCCEEEEECCCCccccccccccc-
Confidence 9999999999986677789999999987655 4457789999999999999999999999999999999988776544
Q ss_pred CCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecce
Q 048419 164 GNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243 (653)
Q Consensus 164 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sW 243 (653)
.....++.+|+.++|||+||+.+++|+|++.... .+|..|++++.+||+.+|+++||||||||||...|.|.|++|
T Consensus 158 ---~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW 233 (236)
T PF00139_consen 158 ---SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSW 233 (236)
T ss_dssp ---EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEE
T ss_pred ---ccccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEE
Confidence 2467789999999999999999999999999884 678889999999999999999999999999999999999999
Q ss_pred eee
Q 048419 244 SIS 246 (653)
Q Consensus 244 sf~ 246 (653)
+|+
T Consensus 234 ~F~ 236 (236)
T PF00139_consen 234 SFS 236 (236)
T ss_dssp EEE
T ss_pred EeC
Confidence 995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=370.86 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=216.3
Q ss_pred cccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeee
Q 048419 318 RRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396 (653)
Q Consensus 318 ~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 396 (653)
..++..||+. .+.||+|..|+|||++++.+++.+|+|.+... .....+++.+|++++++.+||+||+++|.|
T Consensus 74 ~~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF 146 (364)
T KOG0581|consen 74 NGISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF 146 (364)
T ss_pred cccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence 3466667655 57899999999999999999999999999544 455678899999999999999999999999
Q ss_pred cccc-eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEE
Q 048419 397 RKQD-ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAK 475 (653)
Q Consensus 397 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 475 (653)
.... .+.|+||||.+|||+.++... +.+++...-+|+.+|++||.|||+. ++||||||||+|||+++.|++|
T Consensus 147 ~~~~~~isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVK 219 (364)
T KOG0581|consen 147 YSNGEEISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVK 219 (364)
T ss_pred EeCCceEEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEE
Confidence 9998 599999999999999999764 3489999999999999999999963 8999999999999999999999
Q ss_pred EEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhh--hhHHHHHHHHHh
Q 048419 476 LGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKA--AAELLLVDWVKE 553 (653)
Q Consensus 476 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~ 553 (653)
|||||.++.+... .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+ .....+.
T Consensus 220 icDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll----- 291 (364)
T KOG0581|consen 220 ICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL----- 291 (364)
T ss_pred eccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH-----
Confidence 9999999977554 34557899999999999999999999999999999999999999986411 1111111
Q ss_pred hhcccchhHhhhhccCcCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 554 LHLEGEITQAIDQTLDYYDL-AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..+++..-...+. ...+++..++..||+.||.+||++.|++++-
T Consensus 292 -------~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 292 -------CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred -------HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1122211111222 3568899999999999999999999999865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=385.35 Aligned_cols=249 Identities=33% Similarity=0.520 Sum_probs=206.7
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcE-EEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-eeEEEEeccC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLE-VAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-ELLLVYDYVP 410 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~-vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~ 410 (653)
.+.||+|+||+||+|.+. |+. ||||++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. .++||||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 445999999999999997 455 9999997543 222679999999999999999999999999988 7999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcEEEcCCC-cEEEEeecCcccccCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR-VVHRDVKPSNILLDTYL-NAKLGDFGLAKIYEHG 488 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 488 (653)
+|+|.++|+... +..+++..+++++.|||+||.|||+ ++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999998851 4569999999999999999999999 67 99999999999999997 9999999999876543
Q ss_pred CCCcccccccCCcccCccccc--cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 489 ANPQTTHIVGTLGYLAPELTR--TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
. ...+...||+.|||||++. ...++.|+||||||++||||+||+.||...... + ....+......
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~--~~~~v~~~~~R--------- 264 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-Q--VASAVVVGGLR--------- 264 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-H--HHHHHHhcCCC---------
Confidence 2 2333468999999999999 568999999999999999999999999876542 1 11111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+..+...+..|+.+||+.||..||++.+++..|+.
T Consensus 265 --p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 265 --PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred --CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 11122256778899999999999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=383.24 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=214.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
..|...++||+|||++||+++...+|+.||+|++.+. .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999999889999999999763 3445678899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|+|++++|.+++.. ++.+++.+.+.+..||+.||.|||+ ++|+|||||..|+||++++++||+|||||..+.
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999974 4679999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
..... ....+||+.|+|||++.....+..+||||+||+||.|++|++||+...-.+... .+.. .+.
T Consensus 170 ~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~---~Ik~-------~~Y--- 235 (592)
T KOG0575|consen 170 YDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN---KIKL-------NEY--- 235 (592)
T ss_pred Ccccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH---HHHh-------cCc---
Confidence 54333 334699999999999998889999999999999999999999998654322111 1110 000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+........+|+.++|++||.+|||+.+|+.+--
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 111223466889999999999999999999997543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=364.96 Aligned_cols=203 Identities=29% Similarity=0.512 Sum_probs=185.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.+|...+.||+|.||+||+|+++.++..||||.+.+. .+...+.+..|+.+|+.|+|||||++++++...+.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5677788899999999999999999999999999776 66677788999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC------CcEEEEeecC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY------LNAKLGDFGL 481 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGl 481 (653)
||.||+|.+||+.+. .+++.....++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 90 yC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred eCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999998764 48999999999999999999999 999999999999999664 5689999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~ 542 (653)
|+.+..+ ......+|++.|||||++...+|+.|+|+||+|++|||+++|+.||+.....
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9988743 2345579999999999999999999999999999999999999999976654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=378.45 Aligned_cols=249 Identities=31% Similarity=0.448 Sum_probs=210.7
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
.+.||+|-||.||.|.++. ...||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+|
T Consensus 211 ~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 6789999999999999975 4589999996653 3457889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.++|.... +..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||||+....+......
T Consensus 289 l~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 289 LDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred HHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99998743 4568899999999999999999999 99999999999999999999999999999966555544444
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDL 573 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 573 (653)
...-+..|.|||.+..++++.|||||||||+||||+| |+.|+......+... .+.+-+ +| ..+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~---~le~Gy-----------Rl-p~P~ 427 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE---LLERGY-----------RL-PRPE 427 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH---HHhccC-----------cC-CCCC
Confidence 4455779999999999999999999999999999999 888888766543221 111111 11 1233
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 574 AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.++..+.+|+..||+.+|++|||++.+...|+.
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 467889999999999999999999999888864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=352.96 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=213.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeee-ecccce-eEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGW-CRKQDE-LLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 406 (653)
+|.+.++||+|.||+|||+....+|..+|.|.+.-. +.+..+.+..|+.+|++|+|||||+++++ +.+.++ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 366788999999999999999999999999998643 45567789999999999999999999994 444444 89999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||..|+|...+..... .++.++++.+|+++.|+++||..+|..+.+ -|+||||||.||+|+++|.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999876532 367899999999999999999999997654 4899999999999999999999999999988
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... ......+|||.||+||.+.+..|+.||||||+||++|||+..+.||.+..- ..+... ...++...+
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L~~K----I~qgd~~~~-- 248 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSLCKK----IEQGDYPPL-- 248 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHHHHH----HHcCCCCCC--
Confidence 6543 233457899999999999999999999999999999999999999987521 112111 112221111
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+...+..+..|+..|+..||+.||+.-.+++.+..
T Consensus 249 -----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 -----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 113456889999999999999999996666665544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=360.07 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=208.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-------hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-------QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 400 (653)
..+.|...+.||+|+||.|-+|+.+.+|+.||||++.+.. ........+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778899999999999999999999999999996531 112234579999999999999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEE
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY---LNAKLG 477 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 477 (653)
..|+||||++||+|.+.+-.+. .+.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999987653 46777777899999999999999 999999999999999655 779999
Q ss_pred eecCcccccCCCCCcccccccCCcccCccccccCCC---CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhh
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA---TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
|||+|+.... ...+...+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||....... .+. +.
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQ 393 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQ 393 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HH
Confidence 9999998763 345667899999999999976643 348899999999999999999998654321 011 11
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
...|+.... .....+..++..+|+.+||..||++|||+.|++++-+-.
T Consensus 394 I~~G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 394 ILKGRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred HhcCccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 111111100 011123467899999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=337.50 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=209.8
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.|+...++|+|+||.|||++++++|+.||||++... ++.-.+..++|+++|++|+|+|+|.++++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 466678899999999999999999999999999654 334456778999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
|+. ++.+-|.... ..++.+...+++.|+++|+.|+|+ +++|||||||+|||++.++.+||||||+|+.+..
T Consensus 83 ~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 83 CDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred cch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 977 4444454443 237888899999999999999999 8999999999999999999999999999998764
Q ss_pred CCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh--
Q 048419 489 ANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID-- 565 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-- 565 (653)
....-+.++.|.+|+|||.+.+ .+|....|||++||++.||++|.+.|-+..+.+.+.+....-.... .+..+++.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~-prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI-PRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC-HHHHHHhccC
Confidence 3344566789999999999987 6899999999999999999999999887766665544332211110 11111111
Q ss_pred --------hccC------cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 566 --------QTLD------YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 566 --------~~l~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
|... .........+++++..|++.||.+|++.+|++.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1110 1111223578999999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.79 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=208.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.+.|+..++||+|+||+||.++.+++++.+|+|++++. .....+...+|..+|.+++||.||++.-.|.+.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35789999999999999999999999999999999764 344567788999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
+||+.||.|..+|.+.. .+++....-.+..|+.||.|||+ ++||||||||+|||||++|+++|+||||++..
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999998754 48888888899999999999999 99999999999999999999999999999964
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... ...+...+||+.|||||++....++..+|.||+|+++|||++|.+||...+... +... +..
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~---------I~~ 239 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDK---------ILK 239 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHH---------Hhc
Confidence 332 234455799999999999999999999999999999999999999998765321 1111 111
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRP----DMRRVVE 602 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~ 602 (653)
..+...+.-......+++.+.++.||++|- .+.+|-+
T Consensus 240 ~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 240 GKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 111111222346678999999999999995 5555544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=374.58 Aligned_cols=265 Identities=30% Similarity=0.488 Sum_probs=222.8
Q ss_pred ccCHHHHHHhhcCc---------CcceeeeeeCcEEEEEEEeCCCC---cEEEEEEeccC-chhhHHHHHHHHHHHhhcC
Q 048419 319 RFKYAELASVTKGF---------GEQNLVGSGGFGRVYRGLMPSLG---LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLR 385 (653)
Q Consensus 319 ~f~~~el~~at~~f---------~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~ 385 (653)
.++|+|-..|-..| .+.++||.|.||.||+|.++..| ..||||.++.. ......+|+.|+.+|.+..
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 36676665555443 45689999999999999987554 57999999865 4556789999999999999
Q ss_pred CCceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 048419 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465 (653)
Q Consensus 386 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 465 (653)
||||++|.|+..+.+..+||.|||++|+|+.+|..+.+ .+++.|+..++++||.|+.||.+ .++|||||.++|
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARN 761 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARN 761 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhh
Confidence 99999999999999999999999999999999998863 38999999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEEeecCcccccCCCCCccccccc--CCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhh
Q 048419 466 ILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG--TLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAA 542 (653)
Q Consensus 466 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~ 542 (653)
||++++..+|++||||++.++.+.....+..-| ..+|.|||.+...++|.+|||||||++|||.++ |.+||-.+.+.
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 999999999999999999886655333333333 469999999999999999999999999999777 99999876653
Q ss_pred hHHHHHHHHHhhhcccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 543 AELLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 543 ~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+. ...+++.. ...+++++..|.+|++.||+.|-.+||.+.||+..|..
T Consensus 842 dV----------------IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 842 DV----------------IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred HH----------------HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 32 12222222 22345678889999999999999999999999998865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=378.01 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=215.7
Q ss_pred CcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
...+.||+|.||+||+|...+ ..+.||||.++..... ..++|.+|++++..|+|||||+|+|.|.+++.+++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 446779999999999998643 3467999999876544 7889999999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccc---------cchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEE
Q 048419 407 DYVPNGSLDKLLFDKDHKLRK---------LLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 477 (653)
|||..|+|.++|..+.+.... +|+..+.+.|+.|||.|++||-+ +.+|||||..+|+|+.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEec
Confidence 999999999999876554332 38899999999999999999999 999999999999999999999999
Q ss_pred eecCcccccCCCCCccc-ccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhh
Q 048419 478 DFGLAKIYEHGANPQTT-HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
||||++..-...+.... ...-.++||+||.+..+++|.+||||||||+|||+.+ |+-|+.+..+.+.. + ..
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI---e----~i 718 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI---E----CI 718 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH---H----HH
Confidence 99999965443333222 3344679999999999999999999999999999999 99999877654321 1 11
Q ss_pred cccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 556 LEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 556 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
..+.+ -..+..++.++..|+..||+.+|.+||+++||-..|..-
T Consensus 719 ~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 719 RAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 22222 234456788999999999999999999999999999753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.39 Aligned_cols=261 Identities=27% Similarity=0.393 Sum_probs=209.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc--eeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD--ELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~ 408 (653)
++...+.||+|.||.||++....+|...|||.+...+....+.+.+|+.+|++++|||||+++|.....+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3455789999999999999999889999999987654334677899999999999999999999755544 68999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEeecCcccccC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~ 487 (653)
+++|+|.+++.... . .|++..+.+..+||++||.|||+ ++|+||||||+||||+. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred cCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999998765 2 59999999999999999999999 99999999999999999 79999999999987663
Q ss_pred --CCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 488 --GANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 488 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
..........||+.|||||++..+ ....++||||+||++.||+||++||..... ..+++.........+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~~~~~~ig~~~~~P--- 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EAEALLLIGREDSLP--- 242 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hHHHHHHHhccCCCC---
Confidence 222334457899999999999854 334599999999999999999999986311 111111111111111
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLP 611 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 611 (653)
..+........+++.+|++.+|+.|||+.+++++..-....+
T Consensus 243 -----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 243 -----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 112223567889999999999999999999999876544333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.68 Aligned_cols=274 Identities=25% Similarity=0.331 Sum_probs=215.5
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEEEEe
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLLVYD 407 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 407 (653)
|+..++||+|.||.||||++..+|+.||+|+++... .....-..+||.+|++|+||||++|.+...+. ..+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 444678999999999999999999999999997654 33345567899999999999999999998777 68999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
||++ +|.-++.... -.+++.++..+++|++.||+|||. ++|+|||||.+|||||.+|.+||+|||||+++..
T Consensus 199 YMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred cccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9976 8888886643 348999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh-----hhcccchh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE-----LHLEGEIT 561 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~~~~~ 561 (653)
......+..+-|..|+|||++.+. .|+.+.|+||.||+|.||++|++.+.+..+.+++..+-.+-. .|...++.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 766667777889999999998765 699999999999999999999999998777655432211100 01101111
Q ss_pred --HhhhhccCcCC--H-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC-CCCCCCCC
Q 048419 562 --QAIDQTLDYYD--L-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG-DSSLPPLP 614 (653)
Q Consensus 562 --~~~d~~l~~~~--~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-~~~~p~~p 614 (653)
..+.+. ..+. . ......++|+..+|..||.+|.|+.++++.=.. ..++|..|
T Consensus 351 ~~~~~kp~-~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p 412 (560)
T KOG0600|consen 351 HATIFKPQ-QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDP 412 (560)
T ss_pred cccccCCC-CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCc
Confidence 000000 0111 1 113567899999999999999999999975443 44444433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=348.31 Aligned_cols=268 Identities=25% Similarity=0.336 Sum_probs=215.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHH--HHHHHHHHhhcC-CCceeeeeeeecccc-eeE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE--FVAEIMSMGRLR-HRNLVQLHGWCRKQD-ELL 403 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~ 403 (653)
.-++|...+.||.|.||.||+|+...+|..||||+++..-.. .++ -++|+..|++|+ ||||++|.+.+.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346777788999999999999999999999999999765333 333 358999999998 999999999999988 899
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|||||+ .+|++++..+ ++.+++..+..|+.||++||+|+|+ +|+.||||||+|||+..+..+||+|||+||
T Consensus 87 fVfE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccc
Confidence 9999995 5999999877 4679999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCcccCcccc-ccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc----
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELT-RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG---- 558 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---- 558 (653)
.+... +.-+.++.|.+|+|||++ ..+.|+.+.|||++||+++|+.+.++.|-+..+.++..-+-.+.......
T Consensus 159 ev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 159 EVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 76543 345667899999999986 46679999999999999999999999988766655433222221111111
Q ss_pred --chhHhhhhcc---CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 559 --EITQAIDQTL---DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 559 --~~~~~~d~~l---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+...+.-++ ...+ .....++.+++..|++.||.+|||+.|++++--.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 1222222222 1111 1245789999999999999999999999997643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.83 Aligned_cols=284 Identities=24% Similarity=0.345 Sum_probs=221.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-h-HHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-G-MKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|.||.||+|++..+|+.||||+++..... + .....+|++.|+.++|+||+.+++.+...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4566788999999999999999999999999999765322 2 3467899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
||+. +|+..+.... ..|+..++..++.++++||+|||+ +.|+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9965 9999997763 568888999999999999999999 8999999999999999999999999999998865
Q ss_pred CCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc------h
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE------I 560 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~ 560 (653)
..... +..+-|..|+|||.+.+. .|+...||||.||++.||+-|.+-|.+..+.++....-.+.....+.. +
T Consensus 154 p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 154 PNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 44333 334779999999988765 699999999999999999998877776655544332211111111111 1
Q ss_pred hHhhh------hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC-CCCCCCCCCccccccc
Q 048419 561 TQAID------QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG-DSSLPPLPPDIHLKDT 622 (653)
Q Consensus 561 ~~~~d------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-~~~~p~~p~~~~~~~~ 622 (653)
.+... +.+...-..+...+++|+..++..||.+|+++.|++++-.. ..|+|..|...+.+..
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 11111 11111222345667999999999999999999999987754 3555555555544444
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.20 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=207.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+.+.....||+|.||+||+|.+.+ .||||++... ..+..+.|++|+..+++-+|.||+-+.|||.+... .||+-
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 344557789999999999999975 4999999765 55678899999999999999999999999999887 99999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
+|+|-+|+.+|+... ..+...+.+.|++|||+|+.|||. ++|||||||..||||.+++.+||+||||+..-..
T Consensus 468 wCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred hccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 999999999998864 448899999999999999999999 9999999999999999999999999999986543
Q ss_pred CC-CCcccccccCCcccCccccccC---CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 488 GA-NPQTTHIVGTLGYLAPELTRTG---KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 488 ~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.. .......-|...|||||++... .|+..+||||||+|+|||+||..||... ..+... + ....|.+.
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIi-----f-mVGrG~l~-- 611 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQII-----F-MVGRGYLM-- 611 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheE-----E-EecccccC--
Confidence 31 1222334577899999998743 5889999999999999999999999833 222211 0 01111111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+.+......+.+.+.+|+..||..++++||.+.+|+..|+..
T Consensus 612 --pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 612 --PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred --ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 111112234567899999999999999999999999977654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.75 Aligned_cols=257 Identities=27% Similarity=0.362 Sum_probs=212.1
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC----ch-hhHHHHHHHHHHHhhcC-CCceeeeeeeecccc
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN----SQ-QGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQD 400 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 400 (653)
...++|...+.||+|.||+|+.|.+..++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4456888999999999999999999989999999977553 11 23455668999999999 999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEee
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDF 479 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 479 (653)
.+++||||+.+|+|.+++... ..+.+....+++.|+++|++|||+ ++|+||||||+||||+.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999873 348889999999999999999999 999999999999999999 99999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCC-CC-CccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK-AT-TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... +...
T Consensus 166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~~k------- 234 (370)
T KOG0583|consen 166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LYRK------- 234 (370)
T ss_pred ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HHHH-------
Confidence 9999874 2233455679999999999999877 75 79999999999999999999999743321 1100
Q ss_pred cchhHhhhhccCcCCHHH-HHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 558 GEITQAIDQTLDYYDLAE-AELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
+...--.++... ...+..|+.+|+..||..|+++.+++++-+...
T Consensus 235 ------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 235 ------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 111000111111 567899999999999999999999997665443
|
|
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.12 Aligned_cols=204 Identities=28% Similarity=0.397 Sum_probs=170.5
Q ss_pred CCeEEecceEecC-CCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCC
Q 048419 19 ANLSLEGAAYIST-SGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRP 97 (653)
Q Consensus 19 ~~l~~~g~a~~~~-~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~ 97 (653)
.++.++|+|.+.+ ++.|+||++..+++|++||++||++| ++|+|+|+|.|.... ..+||||||+|+|....
T Consensus 14 ~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~-------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~~ 85 (223)
T cd01951 14 SNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPAG 85 (223)
T ss_pred hhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc-------CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCCC
Confidence 5899999999976 78999999999999999999999998 679999999998764 56899999999998765
Q ss_pred CCCCCC--ccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCC--cccCccccCCCCcccccc
Q 048419 98 ENCLAN--QFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSA--SEPASYYSGNNHRIPILL 173 (653)
Q Consensus 98 ~~~~~g--~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~--~~~~~~~~~~~~~~~~~l 173 (653)
+.+.+| ++||+... ++.+||||||++|.+++||+.+|||||+|+..+.. ..+..+. ..+...
T Consensus 86 ~~~~~g~~~~lG~~~~---------~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~-----~~~~~~ 151 (223)
T cd01951 86 ALGGGGGGGGLGYGGI---------GNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSA-----SLPNGT 151 (223)
T ss_pred ccccCCCCCccCcccc---------CCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCccccccccee-----eCCCcc
Confidence 555555 78887533 34599999999999888999999999999987541 1111111 111122
Q ss_pred CCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecceeee
Q 048419 174 RSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSIS 246 (653)
Q Consensus 174 ~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~ 246 (653)
.+|+.++|||+|++.+++|+|++..... |..|.++.++||+..++++||||||||||...+.|.|++|+|+
T Consensus 152 ~~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~ 222 (223)
T cd01951 152 GLGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT 222 (223)
T ss_pred CCCCEEEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEec
Confidence 2399999999999999999999986654 6678999999999999999999999999999999999999996
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.88 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=213.8
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
|.....||+|..|.||.+....+++.||||++........+-+.+|+.+|+..+|+|||+++..+...+++|.|||||++
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 55567899999999999999999999999999877766777889999999999999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|.+.+.... +++.++..|++++++||+|||. ++|+|||||.+||||+.++.+||+|||++..+.....
T Consensus 355 gsLTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 355 GSLTDVVTKTR------MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred Cchhhhhhccc------ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999986543 8999999999999999999999 9999999999999999999999999999998765543
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
.....+||+.|||||+.....|.+|.||||||++++||+-|.+||-...+...+.+. ...+. +.+ ..
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng~------P~l-k~ 491 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PKL-KN 491 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcCC------CCc-CC
Confidence 334568999999999999999999999999999999999999999875543222111 01111 111 11
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.......+.+++.+||+.|+++||++.|+|++-
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 223457789999999999999999999999854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=333.13 Aligned_cols=262 Identities=26% Similarity=0.354 Sum_probs=212.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+.|+....||.|..++||+|+....++.||||++... .....+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5688899999999999999999989999999999754 334478899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
|.+||+.+++.... ...+++..+..|++++++||.|||. +|.||||||+.||||+++|.+||+|||....+...
T Consensus 106 Ma~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999998765 3458999999999999999999999 99999999999999999999999999987655332
Q ss_pred CCCcc---cccccCCcccCccccccC--CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 489 ANPQT---THIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 489 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
..+.. ....||++|||||++... .|+.|+||||||++.+||.+|..||....+...+. . ...+.....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-~------tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-L------TLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-H------HhcCCCCCc
Confidence 22211 446899999999995433 58999999999999999999999998765532211 1 111221111
Q ss_pred hhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 564 IDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 564 ~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.-..+ .+........+.+++..||+.||.+|||+++++++-
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 10011 111112345789999999999999999999999743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.36 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=210.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 404 (653)
.++|...+.||+|+|++|++|+...++++||||++.+. .....+-...|-..|.+| .||.|++|+.-|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 35677889999999999999999999999999999654 122234456788899999 89999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|+||+++|+|.++|...+ .+++...+..+.+|+.||+|||+ +|||||||||+|||||+++++||+|||.|+.
T Consensus 152 vLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999998764 48888899999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCC------------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 485 YEHGANP------------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 485 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
+...... ....++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||....+- .+-+.+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI- 299 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKI- 299 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHH-
Confidence 7543211 114478999999999999999999999999999999999999999865432 111111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+ + -.++....+.+.+|+.+.|..||.+|++..||.++.-
T Consensus 300 --------~~l-~---y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 300 --------QAL-D---YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred --------HHh-c---ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 110 0 1122223467889999999999999999999998774
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=348.94 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=203.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc-
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD- 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~- 400 (653)
.++|...+.||+|+||.||+|.+. ..+..||||++.... ....+.+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467888999999999999999752 335689999986543 33456789999999999 8999999999987654
Q ss_pred eeEEEEeccCCCCchhhhhccccc--------------------------------------------------------
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHK-------------------------------------------------------- 424 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 424 (653)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 589999999999999998753210
Q ss_pred -ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcc
Q 048419 425 -LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGY 502 (653)
Q Consensus 425 -~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y 502 (653)
....+++.++.+++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 02357888999999999999999999 99999999999999999999999999999865332211 11223456789
Q ss_pred cCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHH
Q 048419 503 LAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLN 581 (653)
Q Consensus 503 ~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 581 (653)
+|||.+.+..++.++|||||||++|||++ |..||........ +... ...+... ..+......+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~----~~~~~~~--------~~~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQR----LKDGTRM--------RAPENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHH----HhcCCCC--------CCCCCCCHHHHH
Confidence 99999998899999999999999999997 9999875432211 1111 1111100 011123456889
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 582 LGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 582 l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
|+.+||+.||.+|||+.||++.|+.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.04 Aligned_cols=247 Identities=22% Similarity=0.285 Sum_probs=204.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4688899999999999999999989999999998643 2234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999998754 347888899999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+. .+.
T Consensus 170 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~----~~~------- 231 (329)
T PTZ00263 170 DR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEKIL----AGR------- 231 (329)
T ss_pred CC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHHHh----cCC-------
Confidence 32 223578999999999999889999999999999999999999997544321 111111 111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 604 (653)
+ ..+......+.+++.+||+.||.+||+ +.+++.+-
T Consensus 232 -~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 232 -L-KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred -c-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 0 001112356789999999999999997 78888764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.15 Aligned_cols=254 Identities=25% Similarity=0.315 Sum_probs=204.9
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.|+..+.||+|+||.||+|.+..+++.||||.+.... ......+.+|+.++++++|+|++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999998889999999986432 2234567899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++|+|..++.... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999998886543 2358899999999999999999999 9999999999999999999999999999986533
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .+..... ..
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~---------~~ 220 (285)
T cd05631 155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVK---------ED 220 (285)
T ss_pred CC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhh---------cc
Confidence 22 2233468999999999999999999999999999999999999998643321100 0000000 00
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFL 604 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 604 (653)
...+.......+.+|+.+||+.||.+||+ +.+++++-
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 01112223467889999999999999997 88888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=388.24 Aligned_cols=261 Identities=28% Similarity=0.521 Sum_probs=215.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
...|...++||+|+||.||+|+...++..||||++...... ...|++.+++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677889999999999999999888999999998643321 13468899999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|+|.++++. ++|.++.+++.|+|+||+|||..+.++|+||||||+||+++.++.+++. +|.......
T Consensus 765 ~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 765 IEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence 999999999842 7899999999999999999997666899999999999999999998876 666543321
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.....++..|+|||++.+..++.++|||||||++|||+||+.|++.... ....+.+|++...........+|+.+
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence 1223678999999999999999999999999999999999999864322 22345667766555555556666666
Q ss_pred C---cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 569 D---YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 569 ~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
. ....++..++.+++.+||+.||++||+|+||++.|+...
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 2 234566778999999999999999999999999998653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.51 Aligned_cols=256 Identities=24% Similarity=0.322 Sum_probs=208.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+..|++++.+++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999999889999999996542 234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999653 348899999999999999999999 899999999999999999999999999998653
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+... ...+. .+
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~--~~~~~---~~ 220 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW--KETLQ---RP 220 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH---HHHhc--ccccc---CC
Confidence 3 2234578999999999998899999999999999999999999997654322111 01000 00000 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
............+.+++.+||+.+|.+||++.+++++..
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 000001123467889999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.77 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=206.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688899999999999999999988999999998654 23345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|++++.|..+... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998777655432 2348889999999999999999999 8999999999999999999999999999987644
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhh---------hccc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL---------HLEG 558 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~ 558 (653)
..........|++.|+|||++.+..++.++|||||||++|||++|+.||......+........... ....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 3332333457899999999998888999999999999999999999999765443322211111100 0000
Q ss_pred chhHhhhhccC-------cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 EITQAIDQTLD-------YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 ~~~~~~d~~l~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.......+... .........+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 0001124569999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=342.56 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=213.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|.||.||||+.+.+.+.||+|.+.+. ...+.+.+.+|++++++|+||||+.+++||+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677788999999999999999999999999999764 34457789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+.| +|..+|.... .+++++...|+.++..||.|||+ .+|+|||+||.||||+..+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9976 9999998754 49999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. ...+...||+-|||||...+..|+..+|+||+||++||+.+|++||...... +.++....++
T Consensus 153 ~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~------~Lv~~I~~d~--------- 216 (808)
T KOG0597|consen 153 NT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT------QLVKSILKDP--------- 216 (808)
T ss_pred Cc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH------HHHHHHhcCC---------
Confidence 33 3456678999999999999999999999999999999999999999754321 1111111111
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
-.++......+..++...|..||..|.+-.+++.+-
T Consensus 217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 112234557788999999999999999999999754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.85 Aligned_cols=248 Identities=25% Similarity=0.278 Sum_probs=205.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999999889999999986432 234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999998654 348889999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... +.+.+.. +.
T Consensus 153 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i~~----~~------- 214 (291)
T cd05612 153 DR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKILA----GK------- 214 (291)
T ss_pred CC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CC-------
Confidence 32 223468999999999998889999999999999999999999997654321 1111110 10
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~ 605 (653)
+ .++......+.+++.+||+.||.+||+ +.+++++-.
T Consensus 215 -~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 215 -L-EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred -c-CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 0 011112456889999999999999995 889887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=332.22 Aligned_cols=258 Identities=17% Similarity=0.280 Sum_probs=204.9
Q ss_pred CcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh---hHHHHHHHHHHHhhcCCCceeeee
Q 048419 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ---GMKEFVAEIMSMGRLRHRNLVQLH 393 (653)
Q Consensus 317 ~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~ 393 (653)
.+.+++.++. ......||+|++|.||+|.+. |+.||||++...... ..+.+.+|+.+|++++||||++++
T Consensus 12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred ceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 3455666662 223468999999999999984 789999999764332 257788999999999999999999
Q ss_pred eeecc----cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 394 GWCRK----QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 394 g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
|++.+ ....++||||+++|+|.+++... ..++|...++++.|++.||.|||+. .+++||||||+||+++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~ 157 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVT 157 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEEC
Confidence 99876 34689999999999999999764 3488999999999999999999972 3788999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCCcccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l 547 (653)
+++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ +
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~ 230 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I 230 (283)
T ss_pred CCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H
Confidence 99999999999998654321 22467889999999976 678999999999999999999999998654321 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.... .. . ..+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 231 ~~~i~~~~--~~--------~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 231 YDLIINKN--NS--------L-KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHhcC--CC--------C-CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11111000 00 0 0111245678999999999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.16 Aligned_cols=244 Identities=26% Similarity=0.320 Sum_probs=200.7
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
+.||+|+||.||++....+|+.||||++... .......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999989999999998653 2334567889999999999999999999999999999999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~ 151 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GAT 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCc
Confidence 999988653 348899999999999999999999 89999999999999999999999999998753221 122
Q ss_pred ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCC
Q 048419 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 572 (653)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +...+.. +. ..++
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~~----~~---------~~~p 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILM----EE---------IRFP 215 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHHc----CC---------CCCC
Confidence 334579999999999998899999999999999999999999997543321 1111110 00 0111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 573 LAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
......+.+++.+||+.||.+|| ++.+++++-
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 12345688999999999999999 899998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.91 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=204.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..+.||+|+||.||+|.+. ..+..||+|.++... ....+.+.+|+..+++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56788899999999999999864 346789999987653 33456789999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999987542 358999999999999999999999 89999999999999999999999999987654
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||....... +.+.+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~----~~~---- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVED----GFR---- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHC----CCC----
Confidence 3221111112335678999999998999999999999999999775 999997654322 1111111 100
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++..||+.+|.+||++.+|.+.|..
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 00112234678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=333.59 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=204.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC----------------CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS----------------LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQL 392 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 392 (653)
++|...+.||+|+||.||+|.+.. .+..||+|.+... .......|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999998532 3457999998754 33445679999999999999999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhccccc--------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHK--------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVH 458 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 458 (653)
++++.+.+..++||||+++|+|.+++...... ....++|.++++++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 99999999999999999999999998653210 12347889999999999999999999 89999
Q ss_pred cCCCCCcEEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh--CCCC
Q 048419 459 RDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC--GRRS 535 (653)
Q Consensus 459 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt--G~~p 535 (653)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865432211 1223345788999999988899999999999999999987 5567
Q ss_pred CChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 536 IEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 536 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+....... ....+......... ... ...+..+...+.+++.+||+.+|.+|||+.||.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGR-QVY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccc-ccc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543221 11111111111000 000 0011223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.02 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=212.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.++|+..++||+|+||.||+|+-+++|..+|+|++++. .....+..+.|-.+|...+++.||+|+..|.+.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46799999999999999999999999999999999876 345567788999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||.|||++..+|...+ .|++......+.+++.|+..||+ .|+|||||||+|+|||..|++||+||||+.-+
T Consensus 220 MEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999997754 59999999999999999999999 99999999999999999999999999999532
Q ss_pred cC---------------C-------CCC------------------------cccccccCCcccCccccccCCCCCccce
Q 048419 486 EH---------------G-------ANP------------------------QTTHIVGTLGYLAPELTRTGKATTSTDV 519 (653)
Q Consensus 486 ~~---------------~-------~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV 519 (653)
.. . ... .....+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0 000 0012469999999999999999999999
Q ss_pred eehHHHHHHHHhCCCCCChhhhhhH-HHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC--
Q 048419 520 YSYGILMLEVACGRRSIEPQKAAAE-LLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-- 596 (653)
Q Consensus 520 ~s~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-- 596 (653)
||+||++|||+.|.+||...++.+. ..+..|........+ .....+..+||.+|+. ||++|--
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-------------~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-------------VDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-------------CcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 9999999999999999998776543 234444433222111 1123678899999999 9999974
Q ss_pred -HHHHHHHHc
Q 048419 597 -MRRVVEFLL 605 (653)
Q Consensus 597 -~~evl~~L~ 605 (653)
+.||-++-.
T Consensus 438 G~~EIK~HPf 447 (550)
T KOG0605|consen 438 GAEEIKKHPF 447 (550)
T ss_pred cHHHHhcCCc
Confidence 777776653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=338.72 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=206.4
Q ss_pred ccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc
Q 048419 319 RFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 398 (653)
.+.+++|.. .+-||.|+.|.||+|++. ++.||||+++.- -..+|+.|++|+|+||+.+.|+|..
T Consensus 120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 120 EIPFEEISE-------LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred cCCHHHhhh-------hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC
Confidence 345666644 568999999999999996 789999998322 1368899999999999999999999
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
...+|||||||+.|-|.+.|.... .++......|.++||.|+.|||. +.|||||||.-||||..+..+||+|
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred CceeEEeeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEecc
Confidence 999999999999999999997643 47778889999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
||-++..... .....++||..|||||++.+...++|.||||||||||||+||..||...+... .+|.
T Consensus 256 FGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwG----- 322 (904)
T KOG4721|consen 256 FGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWG----- 322 (904)
T ss_pred ccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEe-----
Confidence 9999876432 22334789999999999999999999999999999999999999997644321 1111
Q ss_pred chhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 559 EITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 559 ~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+-...| ...+..+++-+.-|+..||+..|..||++++++.+|+-.
T Consensus 323 ----VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 323 ----VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ----ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 111112 123345677888999999999999999999999999754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=367.17 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=210.4
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCC-----cEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLG-----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
....+.||+|.||.||+|...+.. ..||||.+.+. +.+...+|++|..+|++++|||||+++|.|.+....+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 445678999999999999976533 34999999765 566788999999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhccccc--ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 406 YDYVPNGSLDKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|||++|+|..+|++.... ....|+..+.+.++.|||+|+.||++ +++|||||.++|+||++...+||+|||||+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999886321 13468999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 484 IYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 484 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
.+..... .......-...|||||.+..+.++.|+|||||||+|||++| |..||....+.+... .+. ..+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~~~----~gg--- 921 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--DVL----EGG--- 921 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--HHH----hCC---
Confidence 4433222 22222233568999999999999999999999999999999 778887665532211 111 112
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+| ..+..+.+.+.+|+..||+.+|++||++..|++.+..
T Consensus 922 -----RL-~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 922 -----RL-DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred -----cc-CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 12 2344567788999999999999999999999997754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=344.85 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=204.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
++|+..+.||+|+||.||+|.. .+++..||||+++... ....+.+.+|+.+++.+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4678889999999999999974 3456789999986442 33456788999999999 899999999999999999
Q ss_pred EEEEeccCCCCchhhhhccccc----------------------------------------------------------
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK---------------------------------------------------------- 424 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~---------------------------------------------------------- 424 (653)
++|||||++|+|.+++......
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999998653210
Q ss_pred ------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 425 ------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 425 ------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
....++|..+++++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01247889999999999999999999 899999999999999999999999999998654322111
Q ss_pred -ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCc
Q 048419 493 -TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570 (653)
Q Consensus 493 -~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 570 (653)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+..++...... .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~------------~ 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGYRM------------L 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCccC------------C
Confidence 112334668999999999999999999999999999998 888886543221 111222111100 0
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+......+.+|+.+||+.||++||++.||++.|+.
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001123568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.62 Aligned_cols=250 Identities=33% Similarity=0.566 Sum_probs=196.1
Q ss_pred cceeeeeeCcEEEEEEEeC----CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 334 EQNLVGSGGFGRVYRGLMP----SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
..+.||.|.||.||+|.+. ..+..|+||.+... ..+..+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 34678999999654 344578999999999999999999999999988889999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|+|.++|.... ...+++.++++|+.||++||.|||+ ++++|+||+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998862 3458999999999999999999999 89999999999999999999999999999876322
Q ss_pred CC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 489 AN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 489 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. ...........|+|||.+....++.++||||||+++|||++ |+.|+....... +...+.. +...
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~----~~~~----- 224 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQ----GQRL----- 224 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHT----TEET-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc----cccc-----
Confidence 11 11223356778999999999899999999999999999999 678886553321 1111111 1111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..+......+.+++..||+.+|.+||++.++++.|
T Consensus 225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112346688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=325.89 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=207.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
.+|...+.||+|++|.||+|.....++.||+|.+... ....+++.+|++.+++++|+||++++++|...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3477788999999999999999888999999998644 334567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++..++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999999986543 3458999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+.+..++.++|||||||++|||++ |..|+....... +........ .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~---------~--- 223 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKGY---------R--- 223 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCC---------C---
Confidence 222222234668999999988899999999999999999998 888886543221 111111100 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 01111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=309.07 Aligned_cols=236 Identities=25% Similarity=0.327 Sum_probs=200.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+|+..+.||.|+||.|.+++.+.+|..+|+|++++. .....+...+|..+|+.+.||.++++.+.|.+.+.+++|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 467789999999999999999999999999999764 23445677889999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|.+||.|..+|+... .++++..+-++.||+.||+|||+ .+|++|||||+|||||.+|.+||.|||.|+....
T Consensus 125 yv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred ccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999998754 48999999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.+...+||+.|+|||++.+..+..++|-|+|||++|||+.|..||....+.. +.+ .++...
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---iY~------------KI~~~~ 257 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---IYE------------KILEGK 257 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---HHH------------HHHhCc
Confidence 3566899999999999999999999999999999999999999998765421 111 011111
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYR 594 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~R 594 (653)
-.++......+.+|+...++.|-.+|
T Consensus 258 -v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 -VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11222334567778888888888888
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=334.44 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=212.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
.|.....||+|.||.||||.+..+++.||+|++... .....++..+|+.+|.+++++||.+++|.+.....++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 456678899999999999999999999999999765 4556788999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
.+|++.+.|.... .+.+..+.-|++++..||.|||. ++.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 94 ~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred cCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999997643 35777788899999999999999 899999999999999999999999999998776554
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
... ...+||+.|||||++....|+.|+||||||++.+||++|.+|+....+.... -.+.+-..|.|.
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------flIpk~~PP~L~ 232 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------FLIPKSAPPRLD 232 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------EeccCCCCCccc
Confidence 443 5679999999999999889999999999999999999999999865542111 112222223332
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....+.+.+++..||+.||+.||++.+++++
T Consensus 233 ---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 ---GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2345678999999999999999999999863
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.80 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=208.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCC-----cEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLG-----LEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
+|+..+.||+|+||.||+|.....+ ..||+|.+.... ......+.+|++.+++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 5677889999999999999876544 679999986543 3445678999999999999999999999999889999
Q ss_pred EEeccCCCCchhhhhcccccc-----------cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKL-----------RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
+|||+++++|.+++....... ...+++.+++.++.|++.||.|||+ ++++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 999999999999997643211 1458889999999999999999999 89999999999999999999
Q ss_pred EEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHH
Q 048419 474 AKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 551 (653)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ +...+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEMI 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999986533221 22233456788999999988899999999999999999998 999987644321 11111
Q ss_pred HhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 552 KELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 552 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. +. ........+..+.+|+.+||+.||.+||++.||+++|+.
T Consensus 240 ~~----~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RS----RQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred Hc----CC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11 111122345779999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.61 Aligned_cols=264 Identities=25% Similarity=0.360 Sum_probs=209.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|+..+.||+|+||.||++.+..++..+|+|.+... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36788999999999999999999999999999998754 33445679999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999998653 3478899999999999999999982 3699999999999999999999999999876533
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc---------
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG--------- 558 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 558 (653)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +...+......+
T Consensus 157 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred c---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccC
Confidence 2 2233468999999999998899999999999999999999999997544321 111111100000
Q ss_pred ---------------------chhHhhhhcc-----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 ---------------------EITQAIDQTL-----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ---------------------~~~~~~d~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+..+... ..........+.+++.+||+.||++|||+.|++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000111000 0001123467899999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.83 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=205.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
..++|+..+.||+|+||.||++....++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346788899999999999999999989999999998643 22334567889999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998643 36778888899999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccCccccccC----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTG----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
.............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ .. .+.. ..
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~-~i~~----~~- 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YS-KIMD----HK- 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH--HH-HHHc----CC-
Confidence 543322222345799999999988653 478899999999999999999999986543211 11 1100 00
Q ss_pred hHhhhhccC-cCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHc
Q 048419 561 TQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVY--RPDMRRVVEFLL 605 (653)
Q Consensus 561 ~~~~d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 605 (653)
..+. .........+.+++.+||+.+|.+ ||++.|++++-.
T Consensus 264 -----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 264 -----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred -----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 0000 001123467889999999999988 999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.11 Aligned_cols=241 Identities=24% Similarity=0.297 Sum_probs=197.0
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
||+|+||.||+|....+++.||+|++... .......+..|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999988999999998643 334456788999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 9998654 248899999999999999999999 999999999999999999999999999998543222 2233
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...... .+. + ..+..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~-~~~--------~-~~~~~ 215 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKIL-QEP--------L-RFPDG 215 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHH-cCC--------C-CCCCc
Confidence 4578999999999999899999999999999999999999997543221 111110 000 0 11112
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRPD---MRRVVEF 603 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 603 (653)
....+.+++.+||+.||.+||+ +.|++.+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 3456789999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.97 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=207.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|....+++.||||++... .......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4688899999999999999999988999999998653 2244567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999764 348899999999999999999999 999999999999999999999999999998654
Q ss_pred CCC----------------------------CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCCh
Q 048419 487 HGA----------------------------NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEP 538 (653)
Q Consensus 487 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~ 538 (653)
... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 1122345689999999999999999999999999999999999999986
Q ss_pred hhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHc
Q 048419 539 QKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-MRRVVEFLL 605 (653)
Q Consensus 539 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~ 605 (653)
........ .+... .... .+. ........+.+++..|++ +|.+||+ +.+++++..
T Consensus 233 ~~~~~~~~---~i~~~--~~~~------~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 233 DTLQETYN---KIINW--KESL------RFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCHHHHHH---HHhcc--CCcc------cCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 54321110 00000 0000 000 000134678899999997 9999999 999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.55 Aligned_cols=248 Identities=26% Similarity=0.327 Sum_probs=203.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC-cEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG-LEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||.||+|.+...+ ..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888999999999999999876544 68999998643 233456788999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999754 348899999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. .+..
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~i~----~~~~----- 245 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQKIL----EGII----- 245 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHHHh----cCCC-----
Confidence 432 234578999999999998889999999999999999999999998654321 111111 1100
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHc
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFLL 605 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 605 (653)
.++......+.+++.+|++.||.+|+ ++++++++-.
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 01111234578999999999999995 8999988743
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.81 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=203.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|...+.||+|+||.||+|....++..||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999999889999999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++ +|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LDS-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCc-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 975 8988886542 347888999999999999999999 99999999999999999999999999999764332
Q ss_pred CCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh------
Q 048419 489 ANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT------ 561 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 561 (653)
. .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..................
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 T-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred C-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 2 12233467899999998865 568899999999999999999999997655433222111110000000000
Q ss_pred ---HhhhhccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 562 ---QAIDQTLDYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 562 ---~~~d~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....+...... ......+.+++.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 0123567899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.10 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=203.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|....+++.||||++... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999999988999999999653 2334566788999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998754 348999999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCC-------------------------------------cccccccCCcccCccccccCCCCCccceeehHHHHHHH
Q 048419 487 HGANP-------------------------------------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV 529 (653)
Q Consensus 487 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~el 529 (653)
..... ......||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 00123689999999999988999999999999999999
Q ss_pred HhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Q 048419 530 ACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD---MRRVVEFL 604 (653)
Q Consensus 530 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L 604 (653)
++|+.||......... ..+... ...+. . .......+.+.+++.+|+. +|.+|++ +.|++++-
T Consensus 233 ~~G~~Pf~~~~~~~~~---~~i~~~--~~~~~------~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 233 LVGYPPFCSDNPQETY---RKIINW--KETLQ------F-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred hcCCCCCCCCCHHHHH---HHHHcC--CCccC------C-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999999865432211 111000 00000 0 0001123567788888986 9999998 99998864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=342.67 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=203.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
++|...+.||+|+||.||+|+... ++..||||++... .....+.+.+|+.+++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 468889999999999999998543 3357999999654 333456788999999999 899999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccc-----------------------------------------------------------
Q 048419 403 LLVYDYVPNGSLDKLLFDKDH----------------------------------------------------------- 423 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 423 (653)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864321
Q ss_pred ------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC-ccccc
Q 048419 424 ------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP-QTTHI 496 (653)
Q Consensus 424 ------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~ 496 (653)
.....+++.++++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 001347888999999999999999999 99999999999999999999999999999865432211 11122
Q ss_pred ccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHH
Q 048419 497 VGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAE 575 (653)
Q Consensus 497 ~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 575 (653)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........ ....+.... ... .....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~~~~---------~~~---~~~~~ 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVKRGY---------QMS---RPDFA 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHHccc---------Ccc---CCCCC
Confidence 35668999999988899999999999999999997 9999875432211 111111000 000 00112
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 576 AELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.+++.+||+.||.+||++.+|++.|+.
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 4678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.42 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=200.5
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
+.||+|+||.||++....+++.||||++... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999989999999999653 2344567889999999999999999999999999999999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
+|..++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 999888653 348899999999999999999999 899999999999999999999999999987532211 22
Q ss_pred ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCC
Q 048419 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 572 (653)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+. .... ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~~~~~----~~~~---------~~p 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELIL----MEDI---------KFP 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---HHHhc----cCCc---------cCC
Confidence 2345789999999999988999999999999999999999999975443211 11100 0000 011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 573 LAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
......+.+++.+||+.||.+|| ++.|++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 12245678999999999999997 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=337.64 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=211.0
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
|...+.||.|+-|.|-.|++..+|+.+|||++.+. .......+.+|+-+|+-|+|||++++++.+++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 34467899999999999999999999999999654 222345677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|-|.++|-.++ +|++.+..+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.+...+
T Consensus 94 v~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred cCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999998754 49999999999999999999999 89999999999999999999999999999875543
Q ss_pred CCCcccccccCCcccCccccccCCCC-CccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKAT-TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
. .....+|++.|.|||++.+..|. .++||||.||+||.|+||+.||++.... .+...|..-
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV~~G------------- 227 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKVQRG------------- 227 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHHHcC-------------
Confidence 3 34556999999999999998875 5999999999999999999999853321 122222211
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--cCCCCCC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL--LGDSSLP 611 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L--~~~~~~p 611 (653)
.-+.+.....++.+|+.+|+..||+.|.|++||+++. .+...+|
T Consensus 228 ~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 228 VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 0011222346788999999999999999999999975 4444333
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.51 Aligned_cols=244 Identities=26% Similarity=0.330 Sum_probs=199.7
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
+.||+|+||.||++....+|..||+|++... .......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999999988999999999653 2334567788999999999999999999999999999999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 151 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cc
Confidence 999888653 348899999999999999999999 899999999999999999999999999987532211 12
Q ss_pred ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCC
Q 048419 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 572 (653)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+. ... . ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~~~----~~~--------~-~~p 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELIL----MEE--------I-RFP 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHh----cCC--------C-CCC
Confidence 2335689999999999988999999999999999999999999976543211 11000 000 0 011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 573 LAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
......+.+++.+||+.||.+|| ++.+++++-
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 12245678999999999999998 899988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=337.24 Aligned_cols=255 Identities=25% Similarity=0.275 Sum_probs=205.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||++....+++.||+|++... ..+..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999999989999999999653 2234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999997652 358899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCccccc------cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 487 HGANPQTTHIVGTLGYLAPELTR------TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||........ +. ........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~----~i~~~~~~ 227 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--YN----NIMNFQRF 227 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--HH----HHHcCCCc
Confidence 43332333457899999999986 45678899999999999999999999976543211 10 00000000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
... .........+.+|+..|++ +|.+||++.+++++-
T Consensus 228 ~~~------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 228 LKF------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred cCC------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 000 0011234567889999998 999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.28 Aligned_cols=264 Identities=20% Similarity=0.198 Sum_probs=203.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||++.+..+++.||+|... .+.+.+|++++++|+||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56899999999999999999999999999999753 235678999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
. ++|..++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 166 ~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 166 K-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 5 6888887653 348899999999999999999999 899999999999999999999999999997543322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhh-----hHHHHHHHHHhhhc--------
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA-----AELLLVDWVKELHL-------- 556 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~-------- 556 (653)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....+...+.....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22233457999999999999889999999999999999999999886533210 01111111111000
Q ss_pred -ccchhHhh---hhcc----CcC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 557 -EGEITQAI---DQTL----DYY-----DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 557 -~~~~~~~~---d~~l----~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
...+.+.. .... ... .......+.+|+.+||+.||.+|||+.|++++-....
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00001100 0000 000 0123457889999999999999999999998766544
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.01 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=202.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||++.... +..+|+|.+.... ...+.+.+|+.++++++||||++++++|...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 357778899999999999998864 5689999886432 23467889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 82 ENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999999987543 248899999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+.... .. ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~~~---~~---~~--- 222 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRGF---RL---YR--- 222 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCC---CC---CC---
Confidence 222222345668999999988889999999999999999999 889987654321 111221110 00 00
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+......+.+++.+||+.+|.+||++.++++.|.
T Consensus 223 ---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 ---PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.51 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=206.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCC-CcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSL-GLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
.|...+.||+|+||.||+|....+ +..||+|.+..........+..|+.+++.++||||++++++|...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 388899999999999999998776 7889999876655555667888999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.++|...... ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988653211 3458888999999999999999999 899999999999999999999999999998764332
Q ss_pred C-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 N-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. .+..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~----~~~~-------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVL----YGKY-------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCC--------
Confidence 2 12234569999999999998899999999999999999999999997543321 111110 0110
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
...+......+.+++.+||+.+|++||++.++++
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111123456889999999999999999999874
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.57 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=205.2
Q ss_pred HHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc
Q 048419 324 ELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD 400 (653)
Q Consensus 324 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 400 (653)
++....++|+..+.||+|+||.||++....+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3344557899999999999999999999988999999998642 2233456889999999999999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
.+++||||+++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999999998543 37888899999999999999999 999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccC----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTG----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
++...............||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ....+.
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--~~~i~~---- 261 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--YSKIMD---- 261 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--HHHHHh----
Confidence 9987643322222345799999999998654 378899999999999999999999976543211 111100
Q ss_pred ccchhHhhhhccC-cCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHc
Q 048419 557 EGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVY--RPDMRRVVEFLL 605 (653)
Q Consensus 557 ~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 605 (653)
... .+. .........+.+++..|+..++.+ ||++.|++++-.
T Consensus 262 ~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 262 HKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred CCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 000 000 001123456778888899755543 899999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=303.22 Aligned_cols=262 Identities=26% Similarity=0.294 Sum_probs=213.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-----eeE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-----ELL 403 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 403 (653)
.++|.+.+.||+|||+-||.++.-.++..+|+|++.....++.+..++|++..++++|||++++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 467999999999999999999988889999999998888888999999999999999999999999985544 489
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
|+++|...|+|.+.+.....+ +..+++.+.++|+.+|++||++||+.. .++.||||||.|||+.+.+.++|.|||.++
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999876543 457999999999999999999999932 359999999999999999999999999998
Q ss_pred cccCCCC--------CcccccccCCcccCcccccc---CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 484 IYEHGAN--------PQTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 484 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
...-... +.......|..|+|||.+.- ...++++|||||||+||+|+.|..||+......
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 6532211 11123357899999998853 457899999999999999999999998543211
Q ss_pred hhhcccchhHhhhh-ccC-cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 553 ELHLEGEITQAIDQ-TLD-YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 553 ~~~~~~~~~~~~d~-~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.+.-++.. .+. .......+.+.+++.+|++.||.+||++.+++..+..
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111111111 111 0111256789999999999999999999999998754
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=323.26 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=205.5
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+|+..++||+|+||.||++....+++.||||++.... ......+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999998889999999986532 2233557789999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++|+|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999998886543 2458999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. ......|+..|+|||.+.+..++.++||||+||++|||++|+.||......... +.+ ...+...
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~---------~~~~~~~ 220 (285)
T cd05605 155 GE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEV---------ERRVKED 220 (285)
T ss_pred CC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHH---------HHHhhhc
Confidence 22 122346899999999998888999999999999999999999999864332110 000 0111111
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
...+.......+.+|+.+||+.||.+|| ++.+++++-
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 1112223456788999999999999999 888987753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=336.68 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=200.3
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.|...+.||+|+||+||+|+...+++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999999999999999999653 23445678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++|+|.+++... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999998754 347888889999999999999999 9999999999999999999999999999764311
Q ss_pred CCC----------------------------------------------CcccccccCCcccCccccccCCCCCccceee
Q 048419 488 GAN----------------------------------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVYS 521 (653)
Q Consensus 488 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s 521 (653)
... .......||+.|+|||.+.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0012346999999999999888999999999
Q ss_pred hHHHHHHHHhCCCCCChhhhhhHHH-HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHH--cCCCCCCCCCCHH
Q 048419 522 YGILMLEVACGRRSIEPQKAAAELL-LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLF--CSAPNPVYRPDMR 598 (653)
Q Consensus 522 ~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ 598 (653)
|||++|||++|+.||.......... +..| .... . + + ........+.+++.+ |+..+|..||++.
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~-~-~-~----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINW------ENTL-H-I-P----PQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcc------cccc-C-C-C----CCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 9999999999999997654322110 0000 0000 0 0 0 000123455666665 6677777899999
Q ss_pred HHHHHHc
Q 048419 599 RVVEFLL 605 (653)
Q Consensus 599 evl~~L~ 605 (653)
|++++-.
T Consensus 301 ~~l~hp~ 307 (381)
T cd05626 301 DIKAHPF 307 (381)
T ss_pred HHhcCcc
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.15 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=195.0
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||.||+|.+..+|+.||+|.+.... ....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999996532 23445667788887765 899999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 9999988653 347889999999999999999999 899999999999999999999999999987432211 2
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+.+.. . .+ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~~----~------~~---~~ 215 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRV----D------TP---HY 215 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----C------CC---CC
Confidence 2234578999999999999899999999999999999999999997554321 1111110 0 00 01
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMR-RVVEF 603 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~ 603 (653)
+......+.+++.+||+.||.+||++. +++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 111235678999999999999999985 66643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.29 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=200.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----ceeE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-----DELL 403 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 403 (653)
+|+..+.||+|+||.||+|....++..||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999999988999999998643 233455788999999999999999999987543 2579
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|||||. ++|.+++... ..+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 6898888653 348899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCC--CcccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh------
Q 048419 484 IYEHGAN--PQTTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE------ 553 (653)
Q Consensus 484 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~------ 553 (653)
....... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6432211 11234578999999999865 5789999999999999999999999976443221111100000
Q ss_pred --hhcccchhHhhhhccCc--CC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 554 --LHLEGEITQAIDQTLDY--YD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 554 --~~~~~~~~~~~d~~l~~--~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
........+.+...... .. ......+.+++.+||+.||.+||++.|++++-
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 00000001111100000 00 01235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.30 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=205.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|...+ +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 467888999999999999999754 6789999986533 24578899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999997643 3457889999999999999999999 899999999999999999999999999998764432
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||++....++.++|||||||++|||++ |+.||....... ....+..... .+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~--------~~~~ 226 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYR--------MPRM 226 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCC--------CCCC
Confidence 222223345678999999988889999999999999999998 999986543321 1111111110 0111
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=302.94 Aligned_cols=251 Identities=26% Similarity=0.391 Sum_probs=213.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|++.+.||+|-||.||.|+.+.++-.||+|++.+.. .+..+++.+|+++-+.|+||||+++++|+.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56888999999999999999999999999999986542 233567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||.++|.|...|.... .+.+++...+.+..|+|.||.|+|. ++|+||||||+|+|++..+..||+|||.+....
T Consensus 102 Eya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999998654 3558888889999999999999999 999999999999999999999999999987643
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.......+||..|.+||...+..++.+.|+|++|++.||++.|.+||+.....+ ....+... +.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~k~-------~~--- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIRKV-------DL--- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHHHc-------cc---
Confidence 233455789999999999999999999999999999999999999998765322 11111111 11
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.++......+.+++..|+..+|.+|.+..|++++-.
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 111223466889999999999999999999998753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=339.09 Aligned_cols=249 Identities=27% Similarity=0.354 Sum_probs=204.9
Q ss_pred ceeeeeeCcEEEEEEEeCCCCc---E-EEEEEecc---CchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGL---E-VAIKRIGH---NSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~---~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++||+|.||.||+|.+...+. . ||||.... ..+...++|++|+++|++++|||||+++|++.....++||||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 5899999999999999865422 3 89999874 346778899999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
+|+||+|.++|.... ..++..++++++.+.|.||+|||+ ++++||||.++|+|++.++.+||+||||++.-..
T Consensus 242 l~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred ecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999998764 358999999999999999999999 9999999999999999999999999999885431
Q ss_pred CCCCccc-ccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHH-HhhhcccchhHhh
Q 048419 488 GANPQTT-HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWV-KELHLEGEITQAI 564 (653)
Q Consensus 488 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~ 564 (653)
..... ...-...|+|||.+..+.++.++|||||||++||+.+ |..|+.+....+ +..++ ...+.
T Consensus 315 --~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~~~~~r-------- 381 (474)
T KOG0194|consen 315 --YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIVKNGYR-------- 381 (474)
T ss_pred --eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHHhcCcc--------
Confidence 11111 1124579999999999999999999999999999999 888998765432 22222 11111
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
...+...+..+..+...||..+|++||+|.++.+.|+..
T Consensus 382 ----~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 382 ----MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred ----CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 011113356677888899999999999999999998754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.01 Aligned_cols=255 Identities=30% Similarity=0.441 Sum_probs=206.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..+.||+|+||.||+|.+... ...||||.+... .......|.+|+..+++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5688899999999999999998643 457999998654 334456789999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++.... ..+++.++++++.|++.||.|||+ ++|+|+||||+||++++++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999997643 358899999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 486 EHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 486 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... +.+.+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~------ 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVEDGYRL------ 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCCC------
Confidence 522111 1122344678999999998899999999999999999998 999986543321 11111111000
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.........+.+++.+||+.+|++||++.||+++|+.
T Consensus 228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111234678899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.56 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=210.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
..+|...+.||+|+||.||+|.... +..+|+|.+..........+..|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4567788999999999999999987 889999999877665677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.+++.++.||+.||.|||+ ++++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 84 MEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred cccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999997653 3458999999999999999999999 89999999999999999999999999999866433
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
... .....++..|+|||.+....++.++||||||+++++|++ |+.||......+ ....+.....
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~----------- 222 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITAGYR----------- 222 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHhCCc-----------
Confidence 221 123345678999999988889999999999999999998 889987544221 1111111000
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 -MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.85 Aligned_cols=271 Identities=26% Similarity=0.346 Sum_probs=201.0
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhh--cCCCceeeeeeeecccc----eeEEE
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR--LRHRNLVQLHGWCRKQD----ELLLV 405 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV 405 (653)
....+++|+|+||.||||.+. ++.||||++.. +..+.|.+|-.+.+. ++|+||++++++-.... +++||
T Consensus 212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 344678999999999999996 58999999854 445677777776665 58999999999876655 79999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC------NQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
+||.+.|+|.+||..+- ++|....+|+.-+++||+|||++. ..+|+|||||++||||.+|+++.|+||
T Consensus 287 t~fh~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999998754 899999999999999999999864 457999999999999999999999999
Q ss_pred cCcccccCCCCC-cccccccCCcccCccccccCC-C-----CCccceeehHHHHHHHHhCCCCCCh-hhhhhHHHHHHHH
Q 048419 480 GLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGK-A-----TTSTDVYSYGILMLEVACGRRSIEP-QKAAAELLLVDWV 551 (653)
Q Consensus 480 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~-----~~ksDV~s~Gvvl~elltG~~p~~~-~~~~~~~~l~~~~ 551 (653)
|+|..+..+... .....+||.+|||||++.+.. + -.+.||||+|.|||||++...-.+. ..+.-+..+...+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988755433 233468999999999997642 2 2478999999999999997644421 1111011111111
Q ss_pred HhhhcccchhHhhh-----hcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCCCC
Q 048419 552 KELHLEGEITQAID-----QTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLPPL 613 (653)
Q Consensus 552 ~~~~~~~~~~~~~d-----~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~~ 613 (653)
.....-+++.+.+- |.+ .+..-..+..+.+.+..||+.||+.|-|+.=|.+++.....+++.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11111111111110 111 011113467799999999999999999999999888765555443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=320.31 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=213.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
-+|++.+.||+|.||.|-+++....|..||||.+++. +.++.-.+.+|+++|+.|+||||+.++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3566678899999999999999888999999999764 5556667889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||..+|.|++|+.+.. .|++.+.+.+++||.+|+.|+|. ++++|||||.+|||||.++++||+||||+-++.
T Consensus 133 EYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999998754 49999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCCcccccccCCcccCccccccCCCC-CccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKAT-TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... ....++|++-|.+||++.+..|. +..|-|||||+||.|+.|.-||++.+... ++..+ ..|..
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQI----s~GaY----- 270 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQI----SRGAY----- 270 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHHh----hcccc-----
Confidence 433 44567999999999999988774 69999999999999999999999865431 11111 11111
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.+....-|+.|||-.||++|-|+.+|..+.+-
T Consensus 271 -----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 271 -----REPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 112234557789999999999999999999998864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=324.93 Aligned_cols=263 Identities=26% Similarity=0.356 Sum_probs=197.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-CCcEEEEEEeccCc--hhhHHHHHHHHHHHhhc---CCCceeeeeeeec-----c
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-LGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRL---RHRNLVQLHGWCR-----K 398 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~ 398 (653)
++|+..+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368889999999999999999753 46889999986432 22234556677776665 6999999999885 2
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
...+++||||++ ++|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 446899999996 68999887643 3458899999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh--c
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH--L 556 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~ 556 (653)
||+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+... ..+.... .
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~--~i~~~~~~~~ 229 (290)
T cd07862 154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIGLPG 229 (290)
T ss_pred ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH--HHHHHhCCCC
Confidence 9999865433 22334568999999999988889999999999999999999999998654432211 1111100 0
Q ss_pred ccchhHh---hhhcc---CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 557 EGEITQA---IDQTL---DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 557 ~~~~~~~---~d~~l---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....... ....+ .... ......+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000 00000 0000 1123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=335.46 Aligned_cols=204 Identities=25% Similarity=0.362 Sum_probs=177.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||+||++....+++.||||++.... ......+..|+.++.+++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999999889999999996532 233457788999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999754 348899999999999999999999 999999999999999999999999999987543
Q ss_pred CCCC----------------------------------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhC
Q 048419 487 HGAN----------------------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532 (653)
Q Consensus 487 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG 532 (653)
.... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001234799999999999988999999999999999999999
Q ss_pred CCCCChhhh
Q 048419 533 RRSIEPQKA 541 (653)
Q Consensus 533 ~~p~~~~~~ 541 (653)
+.||.....
T Consensus 233 ~~Pf~~~~~ 241 (363)
T cd05628 233 YPPFCSETP 241 (363)
T ss_pred CCCCCCCCH
Confidence 999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=316.96 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=208.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|...+.||+|++|.||+|....+++.|++|.+... .....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467789999999999999999988999999998643 344567889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.+++.++.|++.||.|||+ ++++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999997643 3458899999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.. ......|+..|+|||+..+..++.++|||||||+++||++|+.||....... ....+. .+. .
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~--------~ 218 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKII----RGV--------F 218 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCC--------C
Confidence 22 1223467889999999998889999999999999999999999997654321 111111 111 1
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..........+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111334678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.20 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=195.1
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|.+..+++.||||++.... ....+.+..|..+++.+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999889999999986531 23345567788888764 899999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-A 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-C
Confidence 9999998653 347889999999999999999999 899999999999999999999999999987532211 2
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +...+... .+. +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~~~----------~~~---~ 215 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIRMD----------NPC---Y 215 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC----------CCC---C
Confidence 2234578999999999998899999999999999999999999997654321 11111100 000 1
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMR-RVVE 602 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 602 (653)
+......+.+++.+||+.||.+||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111235678999999999999999997 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=318.94 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=206.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|+..+.||+|++|.||+|.... +..||+|.+.... ...+++.+|++.+++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3568889999999999999999754 5789999986543 2356788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.++..++.|++.||.|||+ ++++|+||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 83 MKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999997653 3458999999999999999999999 89999999999999999999999999999876532
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
..........+..|+|||.+.+..++.++||||||++++||++ |+.||....... +...+.... .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~---~-------- 222 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQGY---R-------- 222 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC---C--------
Confidence 2221222223457999999998899999999999999999999 999987543321 111111100 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+ .........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 223 ~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 M-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred C-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 0111234678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=329.64 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=197.6
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHH---hhcCCCceeeeeeeecccceeEEE
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSM---GRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+..|+.++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566889999999999999999889999999996432 23345566666554 567899999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|..++.. ..+++.+++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999888754 248999999999999999999999 99999999999999999999999999998753
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+. .+.
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~i~----~~~------ 217 (324)
T cd05589 152 MGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDSIV----NDE------ 217 (324)
T ss_pred CCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCC------
Confidence 2211 222345789999999999988999999999999999999999999976543211 11000 000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
. .++......+.+++.+||+.||.+|| ++.+++++.
T Consensus 218 --~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 218 --V-RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred --C-CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 0 01112245678999999999999999 577777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=333.14 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=214.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce-eEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE-LLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 406 (653)
++|...+++|+|+||.++.++++.++..+++|.+... .....+...+|+.++++++|||||.+.+.+.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4677789999999999999999999999999998654 33344567899999999999999999999999988 99999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
+||+||+|.+.+.+.. +..++++++++++.|++.|+.|||+ +.|+|||||+.|||++.+..+||+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999998765 4678999999999999999999998 999999999999999999999999999999886
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......||+.|+.||.+.+..|..|+|||||||++|||++-+++|...+-.. ++ .++...
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li------------~ki~~~ 221 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI------------LKINRG 221 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH------------HHHhhc
Confidence 643 23445789999999999999999999999999999999999999998654321 11 111111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.....+......+..++..|++.+|..||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122334456788999999999999999999999975
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=328.17 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=197.2
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|+...+++.||||++... .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999998643 233456778888888877 699999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 9999988654 348899999999999999999999 999999999999999999999999999987542221 2
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +...+. .+.. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~----~~~~---------~~ 215 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAIL----NDEV---------VY 215 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHh----cCCC---------CC
Confidence 2234578999999999998889999999999999999999999997654321 111111 1100 01
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDM------RRVVEF 603 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 603 (653)
+......+.+++.+||+.||.+||++ .+++++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11124567899999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=331.06 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=207.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|+..+.||+|+||.||++.+..++..+|+|.+... .....+.+.+|++++++++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 36788999999999999999999988999999998654 33445678999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... ..+++.....++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999653 3478888999999999999999972 4799999999999999999999999999876532
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHH-HHhhhc----------
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW-VKELHL---------- 556 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~-~~~~~~---------- 556 (653)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.............. ......
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 2 12234688999999999988899999999999999999999999975433211100000 000000
Q ss_pred --------------ccchhHhhhhccCc----CC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 --------------EGEITQAIDQTLDY----YD-LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 --------------~~~~~~~~d~~l~~----~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
........+..... .. ......+.+++.+||+.||++||++.|++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 00000111111100 00 012356889999999999999999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.32 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=203.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc----EEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL----EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
.+|+..+.||+|+||.||+|.+..++. .||+|.+... .....+++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 458889999999999999999765554 4899998654 334567889999999999999999999999765 5789
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++||+++|+|.+++.... ..+++..+++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999997643 347889999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcc-cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANPQT-THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
......... ....++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... +...... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~--- 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK----GE--- 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhC----CC---
Confidence 654322211 12234678999999998899999999999999999998 999987543221 1111111 00
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.+ ..+..+...+.+++.+||+.+|.+||++.++++.|...
T Consensus 229 ----~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 229 ----RL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ----CC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00111235688999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.11 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=193.7
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||.||+|....+++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999998653 223344556677777654 899999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 9999988654 248888999999999999999999 999999999999999999999999999998543222 2
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +...+.. .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~-------------~~~~~ 215 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSILN-------------DRPHF 215 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHc-------------CCCCC
Confidence 2334578999999999998889999999999999999999999997654321 1111100 00011
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMR-RVVE 602 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 602 (653)
+......+.+++.+||+.||.+||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 112345678999999999999999975 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.21 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=210.1
Q ss_pred HHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc
Q 048419 323 AELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD 400 (653)
Q Consensus 323 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 400 (653)
.+.....++|...+.||+|+||.||+|....+++.||||++... .......+.+|+..+..++|+|+++++..+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 44455668999999999999999999999888999999998654 3445667889999999999999999988764432
Q ss_pred --------eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 401 --------ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 401 --------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
.+++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCC
Confidence 368999999999999999764321 3468899999999999999999999 8999999999999999999
Q ss_pred cEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 473 NAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~ 254 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VM 254 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HH
Confidence 999999999986543221 12234579999999999999899999999999999999999999997543321 11
Q ss_pred HhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 552 KELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 552 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.... .+.. ...+......+.+++.+||+.||.+||++.+++++
T Consensus 255 ~~~~-~~~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTL-AGRY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHh-cCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1100 1110 11112234678899999999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=322.37 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=199.6
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
||+|+||+||++.+..+++.||+|.+.... ....+.+..|+.++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999889999999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
..++..... ....+++.+++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 988754321 13468999999999999999999999 8999999999999999999999999999976543322 223
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .. +.... .... ...+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~-~~~~~--------~~~~-~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE-LKQRI--------LNDS-VTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HH-HHHhh--------cccC-CCCccc
Confidence 356899999999999999999999999999999999999999754321110 00 00000 0000 011222
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
....+.+++.+||+.||++|| ++.+++++-
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 356788999999999999999 778888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=334.97 Aligned_cols=265 Identities=22% Similarity=0.234 Sum_probs=208.4
Q ss_pred cCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeee
Q 048419 320 FKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396 (653)
Q Consensus 320 f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 396 (653)
-.+.++....++|...+.||+|+||.||++.+..+++.+|+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34556666678999999999999999999999999999999998642 223345678899999999999999999999
Q ss_pred cccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 397 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
.+.+.+++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999998643 37788888999999999999999 99999999999999999999999
Q ss_pred EeecCcccccCCCCCcccccccCCcccCccccccC----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 477 GDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 477 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
+|||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||........ . ..+.
T Consensus 184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~-~~i~ 260 (371)
T cd05622 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--Y-SKIM 260 (371)
T ss_pred EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH--H-HHHH
Confidence 99999987643322233345799999999998654 378899999999999999999999986443211 1 1110
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHc
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVY--RPDMRRVVEFLL 605 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 605 (653)
. ........ ........+.+++.+|+..++.+ ||++.|++++..
T Consensus 261 ~---~~~~~~~~------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 N---HKNSLTFP------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred c---CCCcccCC------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 0 00000000 00123456788999999844433 789999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=331.17 Aligned_cols=255 Identities=24% Similarity=0.302 Sum_probs=201.1
Q ss_pred CcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccC----chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHN----SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
+|+..+.||+|+||.||+++.. .++..||+|++... .....+.+..|+.+++++ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998863 46889999998643 223345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999998654 348899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
+..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+......
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~---- 225 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILK---- 225 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhc----
Confidence 86544333333445799999999998765 47889999999999999999999996432211100 00000000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHc
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFLL 605 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 605 (653)
.++. .+......+.+++.+||+.||.+|| ++.+++++-.
T Consensus 226 --~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 226 --CDPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred --CCCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 0011 1112245678999999999999999 7888887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.79 Aligned_cols=261 Identities=22% Similarity=0.371 Sum_probs=205.5
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
++++|+..+.||+|+||.||+|.+.+ .+..||||++... ......++.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 56789999999999999999998642 3567999998543 23345678999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhccccc-----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK-----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
.++||||+++++|.+++...... ....+++.+++.++.|++.||.|||+ ++++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653221 02346788999999999999999999 89999999999999999999999
Q ss_pred EeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhh
Q 048419 477 GDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 477 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH--
Confidence 999998755332211 1122345778999999998889999999999999999999 688886543321 111111
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.. ...+......+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 236 --~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 --EGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --cCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1110 01111234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=322.73 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=207.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|...+.||+|+||.||+|.... ++..||||.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998743 3578999999765443 5678999999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccc---------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 404 LVYDYVPNGSLDKLLFDKDH---------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
+||||+++++|.+++..... .....+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 99999999999999976532 113458899999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ..+.+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 9999999975432211 11223345788999999999999999999999999999998 999987544322 111111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+.. ..........+.+++.+||+.||.+||++.||++.|+
T Consensus 239 ----~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRL--------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 1111123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=336.31 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=199.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+|+..+.||+|+||.||+++...+++.||||++.... ....+.+.+|++++++++|+||+++++.+.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999999899999999986432 2334668899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++|+|.+++... ..+++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999654 347888888999999999999999 8999999999999999999999999999753210
Q ss_pred CC------------------------------------------CCcccccccCCcccCccccccCCCCCccceeehHHH
Q 048419 488 GA------------------------------------------NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGIL 525 (653)
Q Consensus 488 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvv 525 (653)
.. ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000113469999999999999899999999999999
Q ss_pred HHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHH
Q 048419 526 MLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP---DMRRVVE 602 (653)
Q Consensus 526 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~ 602 (653)
+|||++|+.||.......... .+... .... ..+. .......+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~---~i~~~--~~~~---~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL---KVINW--ETTL---HIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH---HHhcc--Cccc---cCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999998654322111 00000 0000 0000 0112345666777765 4999999 8999998
Q ss_pred HHc
Q 048419 603 FLL 605 (653)
Q Consensus 603 ~L~ 605 (653)
+-.
T Consensus 301 h~~ 303 (376)
T cd05598 301 HPF 303 (376)
T ss_pred CCC
Confidence 743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.11 Aligned_cols=245 Identities=25% Similarity=0.312 Sum_probs=199.3
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
+.||+|+||.||++....++..||+|.+... .......+..|+++++.++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999888999999999653 2334567788999999999999999999999999999999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
+|..++... ..+++.++..++.||+.||.|||+. ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 999888653 3489999999999999999999962 699999999999999999999999999987532221 12
Q ss_pred ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCC
Q 048419 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 572 (653)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... .. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~i~~~--~~-----------~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILME--EI-----------RFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHHHhcC--CC-----------CCC
Confidence 2335689999999999988999999999999999999999999976443211 1111000 00 011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 573 LAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
......+.+++.+||+.||.+|+ ++.+++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 11245678999999999999996 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=323.67 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=207.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|...+.||+|+||.||++.. ..++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999985 23456799999977666667789999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccc--------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 405 VYDYVPNGSLDKLLFDKDH--------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 9999999999999975431 112358999999999999999999999 89999999999999999999999
Q ss_pred EeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhh
Q 048419 477 GDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 477 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
+|||+++....... .......++..|+|||.+.+..++.++|||||||+++||++ |..||....... ..+.+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i~-- 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECIT-- 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH--
Confidence 99999986533221 11122345778999999988889999999999999999998 888886543321 111111
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.... . .......+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 237 --~~~~~~-----~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 237 --QGRVLQ-----R---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred --cCCcCC-----C---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 111100 0 11123568999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=324.43 Aligned_cols=261 Identities=24% Similarity=0.405 Sum_probs=209.7
Q ss_pred CcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
+|...+.||+|+||.||+|... .++..+++|.+........+.+.+|++.+++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4677889999999999999853 23567999998776666667899999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 406 YDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
|||+++++|.+++..... .....+++.+++.++.||+.||+|||+ ++++||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 999999999999976431 112348999999999999999999999 999999999999999999999
Q ss_pred EEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||+| |+.||....... ..+.+.
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~ 239 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIECIT 239 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh
Confidence 9999999976543221 11223456788999999998899999999999999999999 999986544322 111111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSS 609 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 609 (653)
.+... ......+..+.+++.+||+.+|.+||++.+|+++|+....
T Consensus 240 ----~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 ----QGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----CCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111 1111234678899999999999999999999999976533
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=332.89 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=196.5
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++|+||+++++++...+.+++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 344678999999999999998889999999986543 3345678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+++|.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 156 ~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 156 GGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 99986532 24566778899999999999999 8999999999999999999999999999987643221
Q ss_pred CcccccccCCcccCcccccc-----CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 491 PQTTHIVGTLGYLAPELTRT-----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+...+.. .
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~------- 291 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----S------- 291 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----c-------
Confidence 2233578999999998753 2345689999999999999999999974322111111100000 0
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
............+.+++.+||+.||++||++.|++++-.-.
T Consensus 292 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 292 -QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred -CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 00011122346788999999999999999999999875433
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.61 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=199.3
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
+.||+|+||.||+|.+..+++.+|+|.+... ..+....+.+|++++++++|+||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999999888999999988644 344557799999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcc-
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT- 493 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 493 (653)
.+++.... ..+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99986532 347899999999999999999999 8999999999999999999999999999875433211111
Q ss_pred cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCC
Q 048419 494 THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572 (653)
Q Consensus 494 ~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 572 (653)
.....+..|+|||.+.+..++.++|||||||++|||++ |..|+......... ..+... .. ....
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~---~~~~~~---~~---------~~~~ 218 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR---EAIEQG---VR---------LPCP 218 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH---HHHHcC---CC---------CCCc
Confidence 11123457999999998889999999999999999998 88888654332111 111100 00 0111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 573 LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
......+.+++.+||+.+|++||++.+|++.|.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=328.85 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=200.1
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCC-ceeeeeeeecccceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHR-NLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 406 (653)
+|+..+.||+|+||.||+|....+++.||||++... .....+.+..|.+++..++|+ +|+++++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999999988999999998653 234456788899999999765 5888999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999999886543 47889999999999999999999 899999999999999999999999999987432
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. ..
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~~----~~------- 217 (324)
T cd05587 153 FGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSIME----HN------- 217 (324)
T ss_pred CCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHc----CC-------
Confidence 211 122345689999999999998899999999999999999999999976543211 111111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDM-----RRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 603 (653)
..++......+.+++.+||+.||.+||+. .+++++
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 --VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01111224567899999999999999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=328.82 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=198.4
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||.||+|+...+++.||||++... .....+.+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999988999999998653 233456677888888876 799999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-V 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-c
Confidence 9999888653 348889999999999999999999 899999999999999999999999999987543221 2
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+.+. .+.. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i~----~~~~---------~~ 215 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESIL----HDDV---------LY 215 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCCC---------CC
Confidence 2234568999999999998899999999999999999999999998654322 111111 0000 01
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRP-------DMRRVVEFL 604 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~L 604 (653)
+......+.+++..||+.||.+|| ++.+++++-
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 111235678999999999999999 888888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.47 Aligned_cols=269 Identities=22% Similarity=0.270 Sum_probs=202.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|...+.||+|+||.||+|....+++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 3678899999999999999999988899999999865432 233467789999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 995 68888776542 347888999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH-HHHHHHHhhhcccch-----
Q 048419 488 GANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL-LLVDWVKELHLEGEI----- 560 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~----- 560 (653)
.. .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......... ...............
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 21 12233467899999998865 45788999999999999999999999764332111 000000000000000
Q ss_pred -hHhhhhccC---cCCH-------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 -TQAIDQTLD---YYDL-------AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 -~~~~d~~l~---~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
......... .... .....+.+++.+||+.||.+|||+.|++++-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 000000000 0000 012467899999999999999999999976544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=343.52 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=206.5
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeee-cc---c---cee
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWC-RK---Q---DEL 402 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~~---~---~~~ 402 (653)
+.++.+.|.+|||+.||.|.+...|..||+|++-..++...+...+|+++|++|+ |+|||.+++.. .. . -++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 3456889999999999999998877999999998778889999999999999997 99999999932 21 1 267
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
+|.||||++|.|-+++..+.. ..|++.++++|+.++++|+++||. +..+|||||||-+||||..+++.||||||.|
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 899999999999999987653 449999999999999999999998 4567999999999999999999999999999
Q ss_pred ccccCCCCCc--------ccccccCCcccCcccc---ccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 483 KIYEHGANPQ--------TTHIVGTLGYLAPELT---RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 483 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
...-...... .-...-|+.|+|||.+ .+...++|+|||+|||+||-||....||+......
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------- 265 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------- 265 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------
Confidence 8543322110 0112458999999976 46678999999999999999999999998653211
Q ss_pred HhhhcccchhHhhhhccCcC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 552 KELHLEGEITQAIDQTLDYY-DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 552 ~~~~~~~~~~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
++.-.-... ...+..++.+||..||++||.+||++.||+..+-.
T Consensus 266 -----------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 266 -----------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -----------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 011000000 13567889999999999999999999999987743
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=330.17 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=197.5
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||++....+++.||+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999753 334456678899888877 799999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~ 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CC
Confidence 9998888653 348899999999999999999999 89999999999999999999999999998753221 12
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhh--HHHHHHHHHhhhcccchhHhhhhccC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA--ELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... .....+++........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~ 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------I 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------C
Confidence 2234578999999999999999999999999999999999999996321110 0001111111111110 0
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPD------MRRVVEF 603 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 603 (653)
..+......+.+++.+||+.||.+||+ +.+++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111223456789999999999999998 5677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.73 Aligned_cols=243 Identities=24% Similarity=0.334 Sum_probs=198.4
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|.+..+++.||||++... .....+.+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999999653 233456677898998888 699999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++.++..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 151 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-V 151 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-C
Confidence 9999888654 248999999999999999999999 999999999999999999999999999987532211 1
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... +...+.. .. . ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i~~----~~--------~-~~ 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSILE----DE--------V-RY 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHHHc----CC--------C-CC
Confidence 2233568999999999999999999999999999999999999997544321 1111110 00 0 01
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDM-----RRVVEF 603 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 603 (653)
+......+.+++.+||+.||.+||++ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11234568899999999999999999 888875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=317.75 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=202.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|...+ +..+|||.+..... ..+.+.+|+..+++++||||++++++|...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 346778899999999999998764 55699999865432 3467899999999999999999999999988999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.... ..+++.++++++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 82 SNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999986543 258999999999999999999999 899999999999999999999999999988654332
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..+.+.. +..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~-------- 219 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQ----GLR-------- 219 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhc----CCC--------
Confidence 222222345678999999988889999999999999999999 999987543321 1111111 100
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..........+.+++.+||+.+|.+||++.++++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0001112467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.56 Aligned_cols=244 Identities=27% Similarity=0.351 Sum_probs=196.9
Q ss_pred eeeeeeCcEEEEEEEeC---CCCcEEEEEEeccC----chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 336 NLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHN----SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+.||+|+||.||+++.. ..++.||||++... .......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 46789999998643 223345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999998654 347788888999999999999999 99999999999999999999999999998754322
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+. .+. +
T Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~~~~----~~~--------~ 217 (323)
T cd05584 154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---IDKIL----KGK--------L 217 (323)
T ss_pred C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCC--------C
Confidence 1 122335689999999999988899999999999999999999999976543211 01000 110 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
..+......+.+++.+||+.+|.+|| ++.+++++-
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 01112245688999999999999999 899988754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.46 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=196.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+|...+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.++++++|+||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999999899999999986532 3345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
||++|+|.+++... ..+++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999998654 247888889999999999999999 8999999999999999999999999999753210
Q ss_pred CC----------------------------------------------CCcccccccCCcccCccccccCCCCCccceee
Q 048419 488 GA----------------------------------------------NPQTTHIVGTLGYLAPELTRTGKATTSTDVYS 521 (653)
Q Consensus 488 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s 521 (653)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00011246899999999999889999999999
Q ss_pred hHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC---HH
Q 048419 522 YGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD---MR 598 (653)
Q Consensus 522 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ 598 (653)
|||++|||++|+.||.......... ... .. ..... .+. .......+.+++.+|+ .+|.+|++ +.
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~--~i~-~~--~~~~~---~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQM--KVI-NW--QTSLH---IPP----QAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHH--HHH-cc--CCCcC---CCC----cccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999999998654322111 000 00 00000 000 0111244556666655 49999997 88
Q ss_pred HHHHH
Q 048419 599 RVVEF 603 (653)
Q Consensus 599 evl~~ 603 (653)
|++++
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 88865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.06 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=205.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCC-----CcEEEEEEeccCc-hhhHHHHHHHHHHHhhcC-CCceeeeeeeecccce
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDE 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 401 (653)
.++|...++||+|+||.||+|.+... +..||||++.... ....+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 35678889999999999999986432 3479999996543 334567899999999996 9999999999999999
Q ss_pred eEEEEeccCCCCchhhhhccccc---------------------------------------------------------
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK--------------------------------------------------------- 424 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 424 (653)
.+||||||++|+|.++|......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999998653210
Q ss_pred ----------------------------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 048419 425 ----------------------------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT 470 (653)
Q Consensus 425 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 470 (653)
....+++.+++.++.||++||.|||+ .+|+|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01247888899999999999999999 89999999999999999
Q ss_pred CCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHH
Q 048419 471 YLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLV 548 (653)
Q Consensus 471 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 548 (653)
++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||........ +.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999986543221 11222346778999999988889999999999999999997 8899875432211 11
Q ss_pred HHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 549 DWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 549 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
..+.. +. .+ .........+.+++.+||+.+|++||++.+|.++|+..
T Consensus 351 ~~~~~----~~-------~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 NKIKS----GY-------RM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHhc----CC-------CC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111 00 00 01122346788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.65 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=203.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEe----CCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLM----PSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 403 (653)
++|+..+.||+|+||.||++.. ..++..||+|++........+.+.+|++++++++|+||+++++++... ..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 346789999999777666778899999999999999999999987543 4689
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|+||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999996542 348999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc--ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc-c---
Q 048419 484 IYEHGANPQ--TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL-E--- 557 (653)
Q Consensus 484 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~--- 557 (653)
......... .....++..|+|||.+.+..++.++|||||||+++||++|..++...... ....+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 232 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIV 232 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccch
Confidence 764322211 11122345699999998888999999999999999999988765432211 0000000000 0
Q ss_pred cchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 GEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+.+.+.... ..........+.+++.+||+.+|++|||+.||++.|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 00111111110 01112234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.20 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=209.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|....+++.||||.+... .......+.+|++++++++|||++++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999999888999999987542 3344567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++...... ...+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988653221 3457889999999999999999999 999999999999999999999999999988654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..+...+.... .+
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------~~ 226 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQCD---------YP 226 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcCC---------CC
Confidence 3221 1223467889999999988889999999999999999999999986543211 11111111100 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+++.+||+.+|++||++.+|++.|++
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 00112234678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.53 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=203.1
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-----eeE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-----ELL 403 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 403 (653)
+|+..+.||+|+||.||++....+++.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999999888999999998643 2334567889999999999999999999998776 789
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 5787777543 348999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch--
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI-- 560 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 560 (653)
..............++..|+|||.+.+. .++.++|||||||++|||++|+.||............ .........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~ 228 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEA 228 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHH
Confidence 6544333333344678999999998764 4789999999999999999999999765543221111 110000000
Q ss_pred --------hHhhhhccC---------cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 561 --------TQAIDQTLD---------YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 561 --------~~~~d~~l~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
...+..... .......+.+.+++.+||+.||.+|||+.|++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000000000 00111246788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.59 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=207.6
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 403 (653)
.-++|...++||+|.||+|+++..+.+++.+|||.+++. ..++.+..+.|-+++.... ||.+++++..+...++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 346789999999999999999999999999999999875 4567788888988888874 999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+||||+.||++..+.+. ..+++..+.-++..|+.||+|||+ ++||+||||.+|||||.+|.+||+||||++
T Consensus 446 fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 99999999996555432 348888999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.--. ....+...+||+.|||||++.+..|+.+.|-|||||+||||+.|..||.+.++++ +
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~ 576 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------V 576 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------H
Confidence 6432 2335677899999999999999999999999999999999999999998765532 2
Q ss_pred hhhcc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048419 564 IDQTL---DYYDLAEAELVLNLGLFCSAPNPVYRPDM 597 (653)
Q Consensus 564 ~d~~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 597 (653)
.|..+ -.|+.....+...|+.+.+..+|++|--+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22222 12444556788999999999999999866
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.15 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=205.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-----hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-----QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|...+.||+|++|.||++....++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999998889999999986432 2234578899999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|+||+++++|.+++... ..+++..+.+++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999988654 347888999999999999999999 8999999999999999999999999999976
Q ss_pred ccCCCCCcc--cccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANPQT--THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~---~~~--- 224 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIAT---QPT--- 224 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhc---cCC---
Confidence 543221111 2345778999999999888999999999999999999999999754332111 00000 000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
....+......+.+++.+||+.+|.+||++.+++++.
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 225 -----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred -----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0111222345688999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.00 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=198.8
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||.||++.+..+++.||||+++.. .....+.+..|..++.++ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999753 233456688899999998 799999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++..++.++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GD 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CC
Confidence 9999888653 348999999999999999999999 99999999999999999999999999998743211 12
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhh--HHHHHHHHHhhhcccchhHhhhhccC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA--ELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... .....++......... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~- 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C-
Confidence 2234578999999999999899999999999999999999999996322111 0001111111111110 0
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPD------MRRVVEFL 604 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~L 604 (653)
..+......+.+++.+||+.||.+||+ +.+++++-
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP 263 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence 111122456889999999999999997 77887653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=315.74 Aligned_cols=264 Identities=25% Similarity=0.310 Sum_probs=203.1
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-----eeEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-----ELLLV 405 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 405 (653)
.|...+++|.|.||.||+|+...+++.||||+.-...+ --..|+++|++++|||||+++-++.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45668999999999999999999999999999854432 2247999999999999999998874432 34689
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEeecCccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKI 484 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~ 484 (653)
|||||. +|.+.+..... .+..++.-.+.-+..||.+||.|||+ .+|+||||||.|+|+|.+ +.+||||||.|+.
T Consensus 101 leymP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhchH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999987 99998875321 13446666777789999999999999 999999999999999877 8999999999998
Q ss_pred ccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
+..+... .....|..|+|||.+.+. .|+.+.||||.||++.||+-|+.-|.+....++..+.-.+-......++...
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 8765443 345778999999998765 6999999999999999999999999886655544333222222212122111
Q ss_pred -------hhhccC-----c-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 564 -------IDQTLD-----Y-YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 564 -------~d~~l~-----~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
-.+.+. . .......++++++.++++.+|.+|.++.|++.+--
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 111110 0 12233577899999999999999999999997653
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.55 Aligned_cols=255 Identities=21% Similarity=0.275 Sum_probs=200.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||++....+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999999999999999998543 2334567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999998653 347888899999999999999999 999999999999999999999999999996331
Q ss_pred CCCC------------C----------------------------------cccccccCCcccCccccccCCCCCcccee
Q 048419 487 HGAN------------P----------------------------------QTTHIVGTLGYLAPELTRTGKATTSTDVY 520 (653)
Q Consensus 487 ~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~ 520 (653)
.... . ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 0 00124689999999999988999999999
Q ss_pred ehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCC---CCH
Q 048419 521 SYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYR---PDM 597 (653)
Q Consensus 521 s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~ 597 (653)
||||++|||++|+.||......... .. +... ...+ .. + . .......+.+++.+|++ +|.+| |++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~--~~-i~~~--~~~~-~~--p--~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETY--RK-IINW--RETL-YF--P--D--DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHH--HH-HHcc--CCcc-CC--C--C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 9999999999999999765432111 00 0000 0000 00 0 0 00123567889999997 66664 699
Q ss_pred HHHHHHHc
Q 048419 598 RRVVEFLL 605 (653)
Q Consensus 598 ~evl~~L~ 605 (653)
.|++++..
T Consensus 300 ~~~l~hp~ 307 (377)
T cd05629 300 HEIKSHPF 307 (377)
T ss_pred HHHhcCCC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.12 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 406 (653)
+|...+.||+|+||.||+|....+++.||||++.... ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999999889999999986532 23345567788888877 5899999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999888654 348899999999999999999999 899999999999999999999999999997543
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+.. ..
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~~----~~------- 217 (323)
T cd05616 153 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIME----HN------- 217 (323)
T ss_pred CCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CC-------
Confidence 211 12234578999999999999999999999999999999999999998654321 1111111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDM-----RRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 603 (653)
..++......+.+++.+|++.+|.+|++. .++.++
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01111234568899999999999999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.54 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=213.0
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
...++||-|-||.||.|+++.....||||.++.. .-..++|+.|..+|+.++|||+|+|+|+|..+..+|||+|||..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 3478999999999999999998999999999554 446789999999999999999999999999999999999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
+|.+||.+.. +..++--..+.++.||+.|+.||.. +++|||||..+|+|+.++..+|++||||++++..+....
T Consensus 349 NLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 349 NLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999998876 4556777788999999999999999 999999999999999999999999999999987766554
Q ss_pred ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
.....-.+.|.|||-+....++.|+|||+|||+|||+.| |..||-+-+-.... .+...+- + -..
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-------~LLEkgy-------R-M~~ 487 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------GLLEKGY-------R-MDG 487 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-------HHHhccc-------c-ccC
Confidence 444455779999999999999999999999999999998 88888654432211 1111111 1 123
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+..|++.+.+|++.||+.+|.+||+++|+-+.++
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 4457788999999999999999999999987665
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=314.50 Aligned_cols=254 Identities=31% Similarity=0.483 Sum_probs=204.8
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhH--HHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
|+..+.||+|+||+||++....+++.+|+|.+........ .....|+..+++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4568899999999999999999999999999977644332 23456999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.. ...+++.+++.++.|+++||.+||+ .+++|+||||+||++++++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SEN 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEES-TST
T ss_pred ccccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 99999999973 3458999999999999999999999 89999999999999999999999999999764 122
Q ss_pred CCcccccccCCcccCccccc-cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTR-TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+. +...+.++||||+|+++++|++|+.|+.................. ... ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~---~~~~ 224 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR----PLP---SSSQ 224 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT----HHH---HHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc----ccc---cccc
Confidence 23444567899999999998 788999999999999999999999999875222211111111100 000 0000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. .......+.+++.+||+.||++||++.+++++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00112789999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.01 Aligned_cols=259 Identities=22% Similarity=0.379 Sum_probs=204.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC----CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP----SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|+..+.||+|+||.||+|... ..+..+++|.+... ..+....+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 35677899999999999999852 34678999999643 34455788999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccc------------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 405 VYDYVPNGSLDKLLFDKDH------------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
||||+++++|.+++..... .....+++.+.+.++.|++.||.|||+ ++++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999864321 012357889999999999999999999 8999999999999999999
Q ss_pred cEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHH
Q 048419 473 NAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDW 550 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 550 (653)
.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... +.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986533221 11222345678999999988889999999999999999998 888886543211 1111
Q ss_pred HHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 551 VKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 551 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.. .... ..+......+.+++.+||+.+|.+||++.+|+++|..
T Consensus 239 ~~~----~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK----RQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc----CCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 0000 0111234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=314.96 Aligned_cols=259 Identities=27% Similarity=0.368 Sum_probs=208.1
Q ss_pred HHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 324 ELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 324 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
|++.+++++.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34566788888899999999999999998889999999997776667788999999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccc--hhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEeec
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLL--TWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFG 480 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 480 (653)
+|+||+++++|.+++.... ..+ ++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 9999999999999997542 224 778888999999999999999 89999999999999976 6799999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCC--CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGK--ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
++....... .......++..|+|||++.... ++.++||||||+++|||++|+.|+.......... +.....
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~--- 227 (268)
T cd06624 155 TSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMF--- 227 (268)
T ss_pred hheecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhh---
Confidence 987654322 1222345788999999986643 7889999999999999999999986533211110 000000
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
......+......+.+++.+||+.+|.+||++.|++++
T Consensus 228 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00011122234668899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.11 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=201.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
+|+..+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|++++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46678899999999999998864 66899999864332 34578899999999999999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 83 NGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999997543 258899999999999999999999 8999999999999999999999999999986543221
Q ss_pred CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.... ..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~---------~~--- 220 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVSAGY---------RL--- 220 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHHcCC---------cC---
Confidence 11112234457999999998899999999999999999999 788887543321 111111100 00
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 011123567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=310.26 Aligned_cols=270 Identities=25% Similarity=0.331 Sum_probs=213.0
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEecc--CchhhHHHHHHHHHHHhhcCCCceeeeeeeecc-----
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK----- 398 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----- 398 (653)
..+...|...+.||+|++|.|+.+.++.+|+.||||++.. ...-..++-.+|+.+|+.++|+||+.+++.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3455566667899999999999999999999999999973 345556788899999999999999999998755
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
-+..|+|+|+| ..+|...++.. +.|+.....-+..|+++||.|+|+ .+|+||||||+|+|++++..+||+|
T Consensus 98 f~DvYiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecc
Confidence 34689999999 56899998764 348889999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCC-CCCcccccccCCcccCccccc-cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 479 FGLAKIYEHG-ANPQTTHIVGTLGYLAPELTR-TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 479 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
||+|+..... .....+..+.|..|.|||++. ...|+.+.||||.||++.||++|+..|-+.+...+..+.-.+-....
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 9999987542 123446678899999999875 45799999999999999999999999987765554443322221111
Q ss_pred cc--------chhHhhhhcc--CcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 557 EG--------EITQAIDQTL--DYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 557 ~~--------~~~~~~d~~l--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+. +....+.... ...+. ......++|+.+||..||.+|+|++|.+++-
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11 1111111111 11111 2236788999999999999999999999865
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.00 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=202.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc-ce
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ-DE 401 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 401 (653)
++|+..+.||+|+||.||+|...+ +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468889999999999999997543 34789999986542 33456788999999999 899999999988654 56
Q ss_pred eEEEEeccCCCCchhhhhccccc--------------------------------------------------------c
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK--------------------------------------------------------L 425 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------~ 425 (653)
+++++||+++++|.+++...... .
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998643210 0
Q ss_pred cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccC
Q 048419 426 RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLA 504 (653)
Q Consensus 426 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 504 (653)
...++|.++.+++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1368999999999999999999999 89999999999999999999999999999865432211 1223355678999
Q ss_pred ccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHH
Q 048419 505 PELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLG 583 (653)
Q Consensus 505 PE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~ 583 (653)
||++.+..++.++|||||||++|||++ |..||......+. +...+. .+.. ...+......+.+++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~----~~~~--------~~~~~~~~~~~~~l~ 309 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLK----EGTR--------MRAPEYATPEIYSIM 309 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHh----ccCC--------CCCCccCCHHHHHHH
Confidence 999999999999999999999999998 9999865322111 111110 1100 001112346788999
Q ss_pred HHcCCCCCCCCCCHHHHHHHHcC
Q 048419 584 LFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 584 ~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+||+.+|++||++.||+++|+.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.84 Aligned_cols=242 Identities=26% Similarity=0.315 Sum_probs=192.7
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHH-HHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIM-SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|.+..+|+.||||++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999899999999986432 223344555554 56789999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~ 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SK 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CC
Confidence 9999988653 347888999999999999999999 89999999999999999999999999998753221 12
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.+. .+ .+ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i~----~~--------~~-~~ 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM---YDNIL----NK--------PL-RL 215 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH---HHHHH----cC--------CC-CC
Confidence 23345789999999999998999999999999999999999999976433211 00000 00 00 01
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMR----RVVE 602 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~----evl~ 602 (653)
.......+.+++.+||+.||.+||+++ ++++
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 111245688999999999999999984 5554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.12 Aligned_cols=260 Identities=24% Similarity=0.377 Sum_probs=206.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
.+++|...+.||+|++|.||+|.+.. .+..||+|.+.... ......+..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678889999999999999999876 67889999986443 3345678999999999999999999999999989
Q ss_pred eEEEEeccCCCCchhhhhccccc--ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL---NAKL 476 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 476 (653)
.++||||+++++|.+++...... ....++|.++++++.||+.||+|||+ ++++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999765321 12358999999999999999999999 8999999999999998654 5999
Q ss_pred EeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhh
Q 048419 477 GDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 477 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||....... +.+.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~- 236 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFVTG- 236 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc-
Confidence 999999865322111 1112233568999999998899999999999999999997 999987544322 1111111
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
... ...+......+.+++.+||+.+|++||++.+|+++|+
T Consensus 237 --~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 --GGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --CCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 0111223467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.68 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=197.8
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
||+|+||.||++....+|+.||+|++.... ....+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999889999999986432 22234556799999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 98886543 3458899999999999999999999 999999999999999999999999999988654322 223
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...|+..|+|||++.+..++.++||||+||++|||++|+.||........ ..+..... .... .......
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~-~~~~--------~~~~~~~ 221 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRT-LEDE--------VKFEHQN 221 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHh-hccc--------ccccccc
Confidence 34689999999999888899999999999999999999999975332111 00111110 0000 1000012
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 575 EAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+.+++.+||+.||.+||+++|+++.+..
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 24568899999999999999999877654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.72 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=202.4
Q ss_pred cCcceeeeeeCcEEEEEEE----eCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEE
Q 048419 332 FGEQNLVGSGGFGRVYRGL----MPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLL 404 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 404 (653)
|...+.||+|+||.||++. ...++..||+|.+.... ....+.+.+|++.+++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3778999999999998765 33457889999987543 33467788999999999999999999988654 35899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++++|.+++... .+++.+++.++.|+++||.|||+ ++++|+||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999998643 38999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... ......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ..............+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIE 235 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhh
Confidence 6432211 11222456679999999888899999999999999999999999865332110 00111110011111122
Q ss_pred hhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.++... ...+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 222211 11122335689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.28 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=200.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc----EEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL----EVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|+..+.||+|+||.||+|.+..++. .+++|.+.... ....+++..|+..+++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 356678899999999999999866665 47788875432 3345678889999999999999999998864 45788
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++++|+||||+||++++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999997643 358999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
...... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... +.+.+. .+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~~ 231 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLE----KGERLA 231 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCcCC
Confidence 543221 12223456778999999998899999999999999999998 999987644321 111111 111000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.+ ..+...+.+++.+||..+|.+||++.|+++.|..-
T Consensus 232 --~~------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 232 --QP------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred --CC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00 01234567899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.51 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=202.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|...+ +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+ +..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 467778999999999999998764 67799999865433 34678999999999999999999998854 5688999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++.+++.++.|++.||.|||+ ++++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 83 SKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999997643 2347899999999999999999999 899999999999999999999999999998764432
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..+...... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~---~--------- 221 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVERGY---R--------- 221 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC---C---------
Confidence 222222345668999999988889999999999999999999 888886543221 111111100 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.15 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=204.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999998889999999997665555667889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++... ..+++.++..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998653 347899999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 490 NPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
. ......++..|+|||.+. ...++.++|||||||++|||++|+.|+.......... .+ ..... ..+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~-----~~~~~---~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LM-----SKSNF---QPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--ee-----ecCCC---CCC
Confidence 1 122346888999999874 3457889999999999999999999986443221110 00 00000 001
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
... ........+.+++.+||+.+|++||++.+++++|
T Consensus 230 ~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 0112346788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.77 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=202.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|.+.++ ..||+|++..... ..+.+.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 4688899999999999999988654 5699999865332 34678999999999999999999998754 5679999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 83 SKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999997543 2457899999999999999999999 899999999999999999999999999998665433
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||...+..++.++|||||||++|||++ |+.||........ .+... .+. .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~----~~~--------~ 221 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVE----RGY--------R 221 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHh----cCC--------C
Confidence 222223346678999999988889999999999999999999 7888865433211 11000 000 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 01112345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.36 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=207.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC-----CcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|...+.||+|+||.||+|..... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 5678889999999999999987643 3789999986543 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccc-----cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKL-----RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
+||||+++++|.+++....... ...++|.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999997643211 2347889999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 479 FGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 479 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||....... +.+++.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~---- 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI---- 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh----
Confidence 999986543221 12233456789999999988889999999999999999998 888886543322 111111
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+... ..+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11110 111122567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.43 Aligned_cols=261 Identities=24% Similarity=0.366 Sum_probs=206.8
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCC-----CcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
..++|+..+.||+|+||.||++..... ...+|+|.+... ..+....+.+|+++++++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 345678889999999999999987533 378999998754 334456788999999999 7999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
..+++|||+++|+|.+++..... .....+++..+++++.|++.||.|||+ ++|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999965321 113468999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 999999999999986543221 11222335678999999988889999999999999999998 8888865432211
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.... +. ....+......+.+|+.+||+.+|.+|||+.|+++.|+.
T Consensus 244 ~~~~~~----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 244 FKLLKE----GY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HHHHHc----CC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 111110 00 001122234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.12 Aligned_cols=275 Identities=24% Similarity=0.300 Sum_probs=211.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhH-HHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGM-KEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 406 (653)
+|+..+.|++|.||.||+|+++.+++.||+|+++... +++. -.-++|+.+|.+++|||||.+..+.... +.+|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4666889999999999999999999999999997653 2221 1357899999999999999998876443 4799999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||+. +|..++.... .++...+...+..|+++|++|||. +.|+|||||++|+|+...|.+||+|||+|+.+.
T Consensus 157 e~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99976 9999997764 457888899999999999999999 899999999999999999999999999999887
Q ss_pred CCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH---
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ--- 562 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 562 (653)
.... ..+..+-|..|+|||.+.+. .|+...|+||+||++.||+++++.|.+..+.++...+-.......+.....
T Consensus 229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 6533 34556779999999998765 589999999999999999999999987766554432211111111111110
Q ss_pred --hhh---------hcc-CcCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC-CCCCCCCC
Q 048419 563 --AID---------QTL-DYYDLA-EAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG-DSSLPPLP 614 (653)
Q Consensus 563 --~~d---------~~l-~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-~~~~p~~p 614 (653)
.+. ..+ ..+... ..+.-.+|....+..||.+|-|+.|.+++=.. +.|.|..|
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 000 000 111111 33667889999999999999999999987654 34444333
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.29 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=205.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCc---EEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGL---EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
.++|+..+.||+|+||.||+|....++. .+|+|.+... .....+.+.+|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999999865443 7999998655 34446778999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999986542 348999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCccc--ccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 485 YEHGANPQTT--HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 485 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
.......... ....+..|+|||++....++.++|||||||++|||++ |+.||....... +...+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~~---~~-- 228 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAINDG---FR-- 228 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhcC---CC--
Confidence 6433221111 1223457999999988889999999999999999998 999996543321 11111110 00
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 229 -------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 229 -------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00111234668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.26 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=206.8
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--------------hhHHHHHHHHHHHhhcCCCceeee
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--------------QGMKEFVAEIMSMGRLRHRNLVQL 392 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l 392 (653)
..-+.|...+.||+|.||.|-+|+...+++.||||++.+... ...+...+|+.+|++|+|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 344778889999999999999999999999999999965311 123578999999999999999999
Q ss_pred eeeeccc--ceeEEEEeccCCCCchhhhhccccccccc-chhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 393 HGWCRKQ--DELLLVYDYVPNGSLDKLLFDKDHKLRKL-LTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 393 ~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
+++..+. +.+|||+|||..|.+...=. .++ |++.+.++++.++..||+|||. ++||||||||+|+||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEc
Confidence 9998775 47999999999887754321 233 8999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeecCcccccCCC----CCcccccccCCcccCccccccCC----CCCccceeehHHHHHHHHhCCCCCChhhh
Q 048419 470 TYLNAKLGDFGLAKIYEHGA----NPQTTHIVGTLGYLAPELTRTGK----ATTSTDVYSYGILMLEVACGRRSIEPQKA 541 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~s~Gvvl~elltG~~p~~~~~~ 541 (653)
++|++||+|||.+.....+. .......+||+.|+|||...++. ...+.||||+||+||-|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999999998663321 12234468999999999987743 35689999999999999999999976443
Q ss_pred hhHHHHHHHHHhhhcccchhHhhhhccCcC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 542 AAELLLVDWVKELHLEGEITQAIDQTLDYY-DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 542 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.+ + ...++...|... ..+..+.+.+|++++|+.||+.|.+..+|..+....
T Consensus 325 ~~---l------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 325 LE---L------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HH---H------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 21 1 122233333111 124567899999999999999999999999998643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.07 Aligned_cols=241 Identities=26% Similarity=0.299 Sum_probs=192.0
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHH-HHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIM-SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|....+|+.+|+|++... .....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999989999999998643 2233445556654 56779999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~ 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SD 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CC
Confidence 9999888653 348899999999999999999999 89999999999999999999999999998753221 12
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... .+.+. .. .+ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~~~----~~--------~~-~~ 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---YDNIL----HK--------PL-VL 215 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---HHHHH----cC--------Cc-cC
Confidence 23345789999999999998999999999999999999999999976543211 11100 00 00 00
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (653)
.......+.+++.+|++.+|.+||++++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 111345678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.80 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=206.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
+++...+.||+|+||.||++... .++..+|+|.+........+.+.+|++.+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45667889999999999999742 3467899999877766677889999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhccccc----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 405 VYDYVPNGSLDKLLFDKDHK----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
++||+++++|.+++...... ....+++.+++.++.|++.||+|||+ ++++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 99999999999999764321 11358899999999999999999999 999999999999999999999
Q ss_pred EEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......... ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HHHH
Confidence 9999999976533221 11122345678999999998899999999999999999998 88888654332211 1111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
. +.. ...+......+.+++.+||+.||.+||++.||++.|+
T Consensus 239 ~----~~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 Q----GRE--------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred c----Ccc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 000 0011123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.88 Aligned_cols=239 Identities=26% Similarity=0.338 Sum_probs=193.4
Q ss_pred eeeeeeCcEEEEEEEe---CCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 336 NLVGSGGFGRVYRGLM---PSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
+.||+|+||.||++.. ..+|+.||+|++.... ......+..|++++++++||||+++++++...+.+++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3568999999996532 2234567789999999999999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 99999998653 348999999999999999999999 899999999999999999999999999988653321
Q ss_pred CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCc
Q 048419 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 570 (653)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+.. .. . .
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i~~----~~--------~-~ 216 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMILK----AK--------L-G 216 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHHHc----CC--------C-C
Confidence 223345789999999999888899999999999999999999999976543211 111110 00 0 0
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048419 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRR 599 (653)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 599 (653)
.+......+.+++.+||+.||.+||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122456789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.84 Aligned_cols=238 Identities=26% Similarity=0.324 Sum_probs=189.8
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHH-HHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIM-SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||.||+|.+..+++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999889999999986432 222344555554 67889999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|..++... ..+++.++..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~ 151 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EE 151 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CC
Confidence 9998888643 347888889999999999999999 89999999999999999999999999998753221 12
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... +.+.+.. . .+ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~----~--------~~-~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNILH----K--------PL-QL 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHHhc----C--------CC-CC
Confidence 2334578999999999998889999999999999999999999997654221 1111110 0 00 11
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMR 598 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 598 (653)
+......+.+++.+||+.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=313.62 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=202.7
Q ss_pred cCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce-----
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE----- 401 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 401 (653)
|...+.||+|+||.||+|.+..+ +..||||++... .....+.+.+|++.+++++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678999999999999987643 478999998653 33446789999999999999999999998866554
Q ss_pred -eEEEEeccCCCCchhhhhccccc-ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 402 -LLLVYDYVPNGSLDKLLFDKDHK-LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 402 -~~lV~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
.++++||+++|+|..++...... ....+++...+.++.|++.||.|||+ ++++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999998654211 13468999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 480 GLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 480 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... +.+++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~~--- 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRHG--- 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC---
Confidence 999865433211 1122234678999999988889999999999999999999 888886543321 11222111
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. ....+......+.+++.+||+.||.+||++.|+++.|+.
T Consensus 232 -~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 -N--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred -C--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 001112235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=314.00 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=208.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||++....++..+|||.+... ......++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999998888999999988643 2334568889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++..... ....+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999865322 13458999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ .....+. ....+
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~---------~~~~~ 226 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE---------QCDYP 226 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhhhhh---------cCCCC
Confidence 3321 12234688899999999888899999999999999999999999865332111 1111110 00001
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+ ........+.+++.+||+.+|.+||||.+|++.++.
T Consensus 227 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 00 111234678899999999999999999999988854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=318.25 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=203.5
Q ss_pred CcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
+|...+.||+|+||.||+|.... ....+++|.+.... ....+.+.+|+..+++++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 36678899999999999998642 23578999886543 3445678999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccc-------------------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 048419 405 VYDYVPNGSLDKLLFDKDH-------------------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 465 (653)
++||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999865311 012358899999999999999999999 999999999999
Q ss_pred EEEcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhh
Q 048419 466 ILLDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAA 543 (653)
Q Consensus 466 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~ 543 (653)
||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986533221 11122345678999999988889999999999999999998 999986543221
Q ss_pred HHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.+.+..... ...+......+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 238 ---~~~~~~~~~~------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 238 ---LFNLLKTGYR------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred ---HHHHHhCCCC------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1222111110 00111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=309.41 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=199.3
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
++||+|+||.||+|... ++..+|+|.+.... ......+.+|++.+++++|+||++++++|...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999875 57889999986553 33345788999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++.... ..+++.+++.++.|++.+|.|||+ ++++|+||||+||+++.++.+||+|||++............
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99986543 347899999999999999999999 89999999999999999999999999998764433222222
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDL 573 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 573 (653)
...++..|+|||++.+..++.++||||||+++|||++ |..||........ ...+.. +. .. ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~~----~~-------~~-~~~~ 217 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVEK----GY-------RM-SCPQ 217 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHHc----CC-------CC-CCCC
Confidence 2344668999999998899999999999999999998 9999875433211 111111 10 00 1111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 574 AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.....+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=315.71 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=202.3
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
|+..+.||+|+||+||++.+..+++.+|+|.+.... ......+.+|++++++++|+|++++.+.+...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999999889999999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998886543 2358999999999999999999999 89999999999999999999999999999765332
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
. ......|+..|+|||++.+..++.++|+|||||++|||++|+.||........... +........
T Consensus 156 ~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~--------- 221 (285)
T cd05632 156 E--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE--------- 221 (285)
T ss_pred C--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc---------
Confidence 1 12334689999999999888899999999999999999999999976443221110 111000000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEF 603 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 603 (653)
..+.......+.+|+..||+.||.+||+ +.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0111123456789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.62 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=198.7
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 406 (653)
+|+..+.||+|+||.||+|....+++.||+|++... .....+.+..|..++..+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999999989999999998653 2234556788888888886 577888999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999988654 348899999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+.. ..
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~----~~------- 217 (323)
T cd05615 153 VDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIME----HN------- 217 (323)
T ss_pred CCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CC-------
Confidence 221 12233568999999999998889999999999999999999999997654321 1111111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDM-----RRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 603 (653)
. .++......+.+++.+||+.+|.+|++. .++.++
T Consensus 218 -~-~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 218 -V-SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred -C-CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 0 1111224567899999999999999984 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.48 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=200.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||++....+++.||||++... .......+..|+.++.+++|+||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999999989999999998643 2334567888999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998754 348899999999999999999999 999999999999999999999999999987542
Q ss_pred CCCC----------------------------------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhC
Q 048419 487 HGAN----------------------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532 (653)
Q Consensus 487 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG 532 (653)
.... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2100 001134699999999999999999999999999999999999
Q ss_pred CCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Q 048419 533 RRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD---MRRVVEFL 604 (653)
Q Consensus 533 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L 604 (653)
+.||......... ..+... ...+ .+.+ . ......+.+++.+|+ .||.+|++ +.|++++-
T Consensus 233 ~~Pf~~~~~~~~~---~~i~~~--~~~~--~~p~---~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 233 YPPFCSETPQETY---RKVMNW--KETL--VFPP---E--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCCCCCCHHHHH---HHHHcC--CCce--ecCC---C--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC
Confidence 9999765432211 001000 0000 0000 0 012345667777766 49999985 67777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.54 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=207.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|++|.||+|+...++..|++|.+........+.+.+|+.++++++|+|++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999998889999999997765556678899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.+. .+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998543 37888999999999999999999 899999999999999999999999999988654322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||......... ..+.. .+. +.+
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~----~~~------~~~- 236 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIAT----NGT------PEL- 236 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhc----CCC------CCC-
Confidence 1 122346888999999998888999999999999999999999999765432211 11100 000 000
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.........+.+++.+||..+|.+||++.+++++-
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 01112345688999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.80 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=210.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|....+|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788899999999999999999888999999988642 2334668899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++..... ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999865321 13458899999999999999999999 899999999999999999999999999988654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+...... +.+..... ..+.
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~------- 224 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EKCD------- 224 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhh-hcCC-------
Confidence 3221 122346788999999998888999999999999999999999998643321 11111110 0010
Q ss_pred ccCcCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDL-AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+. .....+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 011111 234578899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=314.51 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=201.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..++||+|+||.||+|.+..++..||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577789999999999999999888999999998654 344456789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999996542 25777888999999999999999 99999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH-HHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~ 567 (653)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ........ ... ..+.
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~-----~~~~ 219 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDE-----DPPV 219 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-hcc-----CCCC
Confidence 1223478899999999998889999999999999999999999997533221110 00000000 000 0011
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+ ........+.+++.+||+.+|.+||++.|++++.
T Consensus 220 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 L--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred C--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1 0111235688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.04 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=202.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc--EEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL--EVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..+.||+|+||.||+|....++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568889999999999999999876654 4788888643 344567789999999999 799999999999999999999
Q ss_pred EeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 406 YDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
+||+++++|.+++...... ....+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 9999999999999754210 11358899999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHh
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 553 (653)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |+.||....... +.+.+.
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~~~- 232 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEKLP- 232 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh-
Confidence 999999986432211 1111223457999999988889999999999999999997 999997544321 111110
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+. . ...+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 233 ---~~~-----~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 233 ---QGY-----R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred ---cCC-----C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 0 00111234568899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=299.14 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=208.4
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--------hhhHHHHHHHHHHHhhc-CCCceeeeeeeecc
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--------QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRK 398 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 398 (653)
.-+.|...+.||+|..+.|-++.++.+|..+|+|++.... .+-.+.-.+|+.+|+++ -||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999999999999999999985431 11234556799999998 59999999999999
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
...+++|+|.|+.|.|.++|... -.++++..++|.+|+..|++|||. +.||||||||+|||+|++.++||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEec
Confidence 99999999999999999999764 358999999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCcccccc------CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRT------GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+++.+..+. .....+||++|+|||.+.. ..|+...|+|++||+||.|+.|.+||-.......+ ..+
T Consensus 167 FGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML---R~I- 240 (411)
T KOG0599|consen 167 FGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML---RMI- 240 (411)
T ss_pred cceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH---HHH-
Confidence 99999876543 4567899999999998864 35788999999999999999999999765442111 111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+|+.. .-.+ .=.+......+|+.+||+.||.+|.|++|++++-
T Consensus 241 ---meGkyq-F~sp----eWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 241 ---MEGKYQ-FRSP----EWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred ---Hhcccc-cCCc----chhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 111100 0000 0012346688999999999999999999999755
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.72 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=202.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc--EEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL--EVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..+.||+|+||.||+|.+..++. .+++|.+... .....+.+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888999999999999999876665 4578777543 344566888999999999 899999999999999999999
Q ss_pred EeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 406 YDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
+||+++++|.+++...... ....+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 9999999999999754311 12358899999999999999999999 999999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHh
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 553 (653)
||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||......+ ..+.+..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQ 238 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHHhc
Confidence 99999998643211 11112234568999999988889999999999999999998 999986543321 1111110
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+. .. .........+.+|+.+||+.+|.+||++.++++.|+.
T Consensus 239 ----~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 239 ----GY-------RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred ----CC-------cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 00 0111224568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=323.12 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=197.9
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||.||+|....+++.||+|++... .....+.+..|+.++.++ +|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999754 233456688999999888 699999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~ 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CC
Confidence 9999888653 348999999999999999999999 89999999999999999999999999998753221 12
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............+++........ ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------IRI 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------CCC
Confidence 22345789999999999999999999999999999999999999964322111111111111111100 011
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPD------MRRVVEFL 604 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~L 604 (653)
+......+.+++.+||+.||.+||+ +.+++++-
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 1122356789999999999999998 45776653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.22 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=203.0
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
|+..+.||+|+||.||++....+++.||||.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667889999999999999999999999999986532 22345677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999886543 2458899999999999999999999 99999999999999999999999999998765432
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH-HHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL-LLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ........ .. .
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------~~----~- 222 (285)
T cd05630 156 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------VQ----E- 222 (285)
T ss_pred c--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------hh----h-
Confidence 2 112346899999999999889999999999999999999999999754321100 00000000 00 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFL 604 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 604 (653)
.........+.+|+..||+.||.+||+ +.|++++-
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 011112356789999999999999999 88988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.53 Aligned_cols=268 Identities=22% Similarity=0.292 Sum_probs=204.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|...+.||+|+||.||+|....++..||+|++.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999998889999999986543 22344677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 975 8888876542 347888999999999999999999 99999999999999999999999999999764332
Q ss_pred CCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh----
Q 048419 489 ANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA---- 563 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---- 563 (653)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....................
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 21 1223467889999998865 46889999999999999999999999765543322211111100000000000
Q ss_pred --hhhccCc--------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 --IDQTLDY--------YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 --~d~~l~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+..... ........+.+++.+||+.||.+|||+.|++++-.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 0000000 001123567899999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.87 Aligned_cols=256 Identities=26% Similarity=0.373 Sum_probs=203.7
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc-----
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ----- 399 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----- 399 (653)
+.+++.|+..+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++++ +|+|++++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346778888999999999999999999889999999986543 3346788999999998 699999999998653
Q ss_pred -ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 400 -DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 400 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
..+++||||+++++|.+++.... ...+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.+||+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEcc
Confidence 46899999999999999987643 2458899999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
||++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+........... ..
T Consensus 155 fg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~---~~- 229 (272)
T cd06637 155 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---IP- 229 (272)
T ss_pred CCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---Hh-
Confidence 99998654322 1223356889999999986 33578899999999999999999999975433211110 00
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
... ...+ ........+.+++.+||+.+|.+||++.+++++
T Consensus 230 ---~~~-----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 ---RNP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---cCC-----CCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000 0001 011223568899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=317.98 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=202.9
Q ss_pred cCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
|...+.||+|+||.||+|.... .+..||||++..... ...+.+..|+.++++++|+||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 5557789999999999998753 257899999975533 3346788999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 406 YDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
+||+++++|.+++..... .....+++..+++++.|++.||.|||+ ++++||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence 999999999999853211 112357888999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..|+......+ ..+.+.
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~i~ 240 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEMIR 240 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH
Confidence 9999999886543221 11223345778999999988889999999999999999998 778886543321 111111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. +. ...........+.+++..||+.+|.+||++.+|++.|+.
T Consensus 241 ~----~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 N----RQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred c----CC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11 111122345668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=313.77 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=200.0
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCc--EEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc------cee
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGL--EVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ------DEL 402 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 402 (653)
...+.||+|+||.||+|.....+. .+|+|.++.. .....+.+..|+..+++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999876664 6999988653 345567889999999999999999999987532 246
Q ss_pred EEEEeccCCCCchhhhhccc-ccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 403 LLVYDYVPNGSLDKLLFDKD-HKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
++++||+++|+|.+++.... ......+++...+.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 1113458999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 482 AKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 482 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +.+.+.. +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~----~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQ----GN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc----CC
Confidence 9876432211 1122345678999999998899999999999999999999 788886543221 1111111 11
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. .........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 0111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.34 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=192.5
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHH-HHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEI-MSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999889999999986432 22233444444 456788999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|.+++... ..+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~ 151 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NG 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CC
Confidence 9999998653 236778888899999999999999 99999999999999999999999999999754221 12
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+.. ..+ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~------------~~~-~~ 215 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN------------KPL-QL 215 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHHh------------CCc-CC
Confidence 2334579999999999999899999999999999999999999997644321 1111110 000 01
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.......+.+++.+||+.+|.+||++.+.+..+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 112245688999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=310.67 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=203.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+.|+..++||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 56788899999999999999875 478899999865433 3467889999999999999999999874 45689999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 83 ENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999986543 3458899999999999999999999 899999999999999999999999999998665332
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+....++.++||||||+++|||++ |+.||....... +.+.+..... .
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~----~------- 222 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLERGYR----M------- 222 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHcCCC----C-------
Confidence 222223345678999999988889999999999999999999 999997544321 1111111000 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.........+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111123568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=310.29 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=205.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+|+..+.||+|+||.||++....++..+|+|.+... .....+.+.+|+.++++++|+|++++++.+...+.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467789999999999999999988999999998643 3445677889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++...+.++.|++.||.|||+ ++++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999999886533 3457889999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+. .+...
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~----~~~~~-------- 218 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKVC----QGSYK-------- 218 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHHh----cCCCC--------
Confidence 122335688899999999988899999999999999999999999976433211 11111 11100
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..+......+.+++.+||+.||.+||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=311.14 Aligned_cols=246 Identities=27% Similarity=0.379 Sum_probs=196.6
Q ss_pred eeeeeCcEEEEEEEe--CCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 337 LVGSGGFGRVYRGLM--PSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
.||+|+||.||+|.+ ..++..+|+|++.... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 4557899999986443 334678899999999999999999999885 45678999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
+|.+++... ..+++..+.+++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999998653 348899999999999999999999 899999999999999999999999999998764432211
Q ss_pred --ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 493 --TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 493 --~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.....++..|+|||.+....++.++|||||||++|||++ |+.||....... +.+.+.. +...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~~----~~~~-------- 217 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIES----GERM-------- 217 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC----CCCC--------
Confidence 112234578999999988889999999999999999998 999997543321 1222211 1100
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+......+.+++.+||+.||.+||++.+|.+.|++
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0111234668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=316.30 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=206.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC----------------cEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG----------------LEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQL 392 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 392 (653)
++|+..+.||+|+||.||++.....+ ..||+|.+.... ....+.+.+|++++++++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 56888999999999999999876433 568999987543 3456788999999999999999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhccccc------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHK------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNI 466 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 466 (653)
+++|...+..++++||+++++|.+++...... ....+++..++.++.|++.||.|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 99999999999999999999999999765421 12358999999999999999999999 8999999999999
Q ss_pred EEcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh--CCCCCChhhhhh
Q 048419 467 LLDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC--GRRSIEPQKAAA 543 (653)
Q Consensus 467 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt--G~~p~~~~~~~~ 543 (653)
+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999876533221 12233456778999999988889999999999999999998 667776433211
Q ss_pred HHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
....+............ ..........+.+++.+||+.||.+||++.||++.|+
T Consensus 242 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ---VIENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11122111111110000 0011123467999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=319.11 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=205.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
++|...+.||+|+||.||++.. ...+..||||.++... ....+.+.+|+.+++++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688899999999999999975 2345689999987543 33456789999999999 799999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+ ++++|+||||+|||++.++.+||+|||++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999997543 2348999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 483 KIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 483 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+........ +...+.. +..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~~----~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIKE----GYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHHc----CCc
Confidence 865432211 1122345678999999988889999999999999999998 9999865432211 1111111 100
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+++.+||+.+|++||++.|+++.|+.
T Consensus 263 --------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 --------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00011124578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.16 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=201.8
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc----
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD---- 400 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 400 (653)
...++|...+.||+|+||.||++.+..+|..||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3457899999999999999999999888999999998643 3344567889999999999999999999886543
Q ss_pred --eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 401 --ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 401 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
..++||||+++ +|...+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEec
Confidence 47999999965 56665532 37788889999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL-- 556 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 556 (653)
||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...+..... .........
T Consensus 167 fg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~ 242 (359)
T cd07876 167 FGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW--NKVIEQLGTPS 242 (359)
T ss_pred CCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCc
Confidence 9999754322 2223457899999999999989999999999999999999999999765432211 000000000
Q ss_pred -----------------c-----cchhHhhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 -----------------E-----GEITQAIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 -----------------~-----~~~~~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
. ....+...... ..........+.+++.+||+.||++|||+.|++++-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0 00000000000 0001112356889999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=315.98 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=205.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
.+++|+..+.||+|+||.||+|...+ .+..||+|.+.... ......+.+|+..+++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678889999999999999997642 35589999986443 2334568899999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhccccc-----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK-----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
.++||||+++|+|.+++...... ....+++..+++++.|++.||.|||+ ++++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 12345677889999999999999999 99999999999999999999999
Q ss_pred EeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhh
Q 048419 477 GDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 477 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......+ ..+.+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~-- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFVM-- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH--
Confidence 999999865332211 1122245678999999998889999999999999999999 788886543221 111111
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.+ ............+.+++.+||+.+|.+||++.++++.|...
T Consensus 236 --~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 --DG--------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --cC--------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 01 00011112346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.48 Aligned_cols=258 Identities=24% Similarity=0.270 Sum_probs=199.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+++...+++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999999988999999998642 2234556889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999996532 348889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCcccccccCCcccCcccccc-----CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRT-----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
...........||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ..+. ......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---~~i~---~~~~~~ 227 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKIM---NHKEHF 227 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH---HHHH---cCCCcc
Confidence 433222233468999999999863 45788999999999999999999999754332110 0010 000000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCC--CCCCCCCHHHHHHHHc
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAP--NPVYRPDMRRVVEFLL 605 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~ 605 (653)
. +..........+.+++.+|+.. ++..||++.+++++-.
T Consensus 228 ~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 228 Q-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred c-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0 0000011234566777776644 4445889999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.33 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=204.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc-cceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 407 (653)
+|+..+.||+|++|.||++....+++.||+|++... .....+.+.+|++++++++|+|++++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999999888999999998643 33455678899999999999999999988764 446799999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++.... ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999997643 3458999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
... ......+++.|+|||.+.+..++.++||||||++++||++|+.||...+.... .... ..+.+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~-~~~~~------- 219 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRI-IEGKL------- 219 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHH-HhcCC-------
Confidence 222 22334678899999999988899999999999999999999999875432211 1110 01111
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..........+.+++.+|++.+|.+||++.+++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=324.22 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=210.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
...+.++||+|-||.|.++.... +..||||.++... ....++|..|+++|.+|+||||++++|.|...+.+++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 35567889999999999999864 7999999998764 445689999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|..+|..+.. ..+.-..-.+|+.|||.|++||.+ .++|||||.++|+|++.++++||+|||+++.+-.+.
T Consensus 618 EnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred hcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999988742 224555667899999999999999 899999999999999999999999999999654433
Q ss_pred C-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHH--hCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 490 N-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVA--CGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 490 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
. ......+-.++|||||.+..++++.++|||+||+++||++ |...||.....+... +..-....... ...
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~-~~~--- 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQG-RQV--- 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCC-cce---
Confidence 3 2333445678999999999999999999999999999974 577898866543321 11111111110 000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
....+.-+...+.++++.||..+-++||+++++..+|..+
T Consensus 765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0122344567788999999999999999999999988654
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.84 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=201.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|.....||+|++|.||+|.+... ..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4577788999999999999988654 569999885433 23467889999999999999999999875 45688999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 83 GKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999997643 3457899999999999999999999 899999999999999999999999999998664332
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||...+..++.++||||||+++|||++ |+.||....... ...+...... .
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~---~-------- 222 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGYR---M-------- 222 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC---C--------
Confidence 222222345678999999988889999999999999999999 888987543321 1111111100 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.........+.+++.+||+.+|.+||++++|++.|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.08 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=208.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|+||.||.+....++..+++|.+... .....+.+.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999999888999999998654 345567889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.++..++.|++++|.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999997653 2458899999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.. ......++..|+|||.+.+..++.++||||||++++||++|+.||........ .... ..+..
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~-~~~~~-------- 218 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKI-VQGNY-------- 218 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH-HcCCC--------
Confidence 32 22334688999999999888889999999999999999999999975433211 1110 01111
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..........+.+++.+||+.+|.+||++.++++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111122346688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.96 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=196.2
Q ss_pred eeeeeCcEEEEEEEeC--CCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCC
Q 048419 337 LVGSGGFGRVYRGLMP--SLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.||+|+||.||+|.+. +.+..||+|++.... ....+.+.+|+.++++++|+||++++++|.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 445679999986553 3345678999999999999999999998854 56899999999999
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc-
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ- 492 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 492 (653)
|.+++.... ..+++.++++++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++..........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999986532 358999999999999999999999 899999999999999999999999999998654332211
Q ss_pred -ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCc
Q 048419 493 -TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570 (653)
Q Consensus 493 -~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 570 (653)
.....++..|+|||.+....++.++|||||||++|||++ |..||....... ....+. .+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~--------~~ 218 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIE----QGKR--------LD 218 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----CCCC--------CC
Confidence 111233568999999988889999999999999999996 999997654322 111111 1110 01
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+..+...+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 112335678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.51 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=199.0
Q ss_pred eeeeeeCcEEEEEEEeCCCC---cEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLG---LEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|+....+ ..+|+|.+..... ...+.+.+|+.+++++.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999875544 7899999875543 34567899999999999999999999876 4468999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|.+++.... .+++..++.++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999997643 48899999999999999999999 89999999999999999999999999999866443322
Q ss_pred cc--cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 492 QT--THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 492 ~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +..++..... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~~~---~-------- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESGER---L-------- 217 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcCCc---C--------
Confidence 11 11223567999999998899999999999999999998 999987654321 2222221110 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
..+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01112345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.26 Aligned_cols=249 Identities=31% Similarity=0.425 Sum_probs=205.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46778899999999999999875 78899999976544 5678999999999999999999999999988999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999997654 2358999999999999999999999 999999999999999999999999999998663221
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.....+..|+|||.+.+..++.++||||||++++||++ |+.||....... +...+.....
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~------------ 217 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYR------------ 217 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcCCC------------
Confidence 12334668999999988889999999999999999997 999987543321 1111111100
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+...+..+.+++.+||+.+|.+||++.+++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=336.39 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=196.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--------c
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--------D 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 400 (653)
.++|...+.||+|+||.||+|....+++.||||++.... ....+|+.++++++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457899999999999999999998889999999985432 2234799999999999999998876332 2
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEee
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDF 479 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df 479 (653)
.+++||||+++ +|.+++..... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 46799999975 77777654221 13458899999999999999999999 9999999999999998665 6999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh--c
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH--L 556 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~ 556 (653)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... ..+.... .
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--RIIQVLGTPT 291 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCC
Confidence 9998664322 22235689999999987654 68999999999999999999999998654432211 1111100 0
Q ss_pred ccchh-------Hhhhhcc------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 EGEIT-------QAIDQTL------DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 ~~~~~-------~~~d~~l------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+. +.--+.. ..++......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 00000 0000000 0011122467889999999999999999999997654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=330.06 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=203.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcC-CCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 402 (653)
++|...+.||+|+||.||+|.+.+ .+..||||++.... ....+.+.+|+.++.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 456678899999999999998642 35689999997543 333457889999999997 99999999999999999
Q ss_pred EEEEeccCCCCchhhhhccccc----------------------------------------------------------
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK---------------------------------------------------------- 424 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~---------------------------------------------------------- 424 (653)
++|+||+++|+|.++++.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999999999999754210
Q ss_pred -----------------------------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 425 -----------------------------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 425 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
....+++..++.++.||+.||.|||+ ++++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 11346788889999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
+++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. +
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--~ 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--F 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--H
Confidence 999999999999986533221 11223356788999999988889999999999999999998 8888865332111 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.. +. .+ ..+......+.+|+.+||+.+|.+||++++|++.|+.
T Consensus 352 ~~~~~~----~~-------~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 352 YNAIKR----GY-------RM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHHHHc----CC-------CC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111 10 00 0111234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=316.05 Aligned_cols=260 Identities=23% Similarity=0.385 Sum_probs=205.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeeccccee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 402 (653)
.++|+..+.||+|+||.||++.... ++..||+|.+.... ....+.+.+|+..+++++|+||++++++|...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4578889999999999999998743 56889999986543 34456789999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhhhccccc-----------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK-----------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~-----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 465 (653)
++|+||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 9999999999999999753210 11347889999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhh
Q 048419 466 ILLDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAA 543 (653)
Q Consensus 466 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~ 543 (653)
|+++.++.+||+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875433221 11122234667999999988899999999999999999998 888886443221
Q ss_pred HHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+ ..+... ..+......+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 241 ---~~~~~----~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ---VIYYV----RDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHH----hcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 111111 0111234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.80 Aligned_cols=263 Identities=27% Similarity=0.325 Sum_probs=196.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhc---CCCceeeeeeeecc-----cc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRL---RHRNLVQLHGWCRK-----QD 400 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 400 (653)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999999999999999986532 12223455677666655 79999999998754 24
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++||||+++ +|.+++.... ...+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 57999999974 8888886543 2348999999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH-HHHHHHhhhcccc
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDWVKELHLEGE 559 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~ 559 (653)
+++...... ......++..|+|||++.+..++.++||||+||++|||++|+.||.......... +...... .....
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~ 230 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDD 230 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhh
Confidence 998654321 2233467899999999988889999999999999999999999997554322111 1111000 00000
Q ss_pred hhH-------hhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 560 ITQ-------AIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 560 ~~~-------~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
... ...+.. ........+.+.+++.+||+.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000 00111234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.23 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=205.5
Q ss_pred eeeeeeCcEEEEEEEeCCC---CcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|..... +..|++|.+...... ..+.+.+|++.+++++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 889999999765433 367899999999999999999999999999999999999999
Q ss_pred CCchhhhhccccc----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 412 GSLDKLLFDKDHK----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 412 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
++|.+++...... ....+++.+++.++.|+++||.|||+ ++++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999775211 02458999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 488 GAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 488 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||....... +.+.+.. +.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK----GY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----CC------
Confidence 321 12233457889999999988889999999999999999999 689987653321 1111111 10
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...........+.+++.+||+.+|.+||++.|++++|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.65 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=203.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc----EEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL----EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|+..+.||+|+||.||+|.+..++. .||+|.+... .....+.+.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 467788999999999999999766555 4899998654 344467888999999999999999999999754 5789
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999987642 358899999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... ......++..|+|||...+..++.++|||||||++|||++ |..|+....... +..++......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~----- 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGERL----- 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCcC-----
Confidence 6432211 1112234678999999988889999999999999999998 889987543321 11222111000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.........+.+++.+||+.||++||++.++++.|+..
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 01112345688999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=315.24 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=202.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEe----CCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--cee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLM----PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 402 (653)
+.|...+.||+|+||.||++.. ..++..||+|.+... .....+.+.+|++++++++|+|++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999974 345788999998654 344456899999999999999999999998775 568
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 99999999999999986542 348999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc-
Q 048419 483 KIYEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE- 559 (653)
Q Consensus 483 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 559 (653)
+........ ......++..|+|||.+.+..++.++|||||||++|||++++.|....... ....+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~~~~~~~ 232 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPTHGQMTV 232 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhcccccccccH
Confidence 866432211 112345677899999998888999999999999999999987764322110 0000000000000
Q ss_pred --hhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 560 --ITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 560 --~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+.+.... .......+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 000000000 01112245679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.66 Aligned_cols=254 Identities=30% Similarity=0.462 Sum_probs=203.8
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCc---EEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGL---EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
.|+..+.||+|+||.||+|....++. .||||.+... .....+.|..|+..+++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678999999999999999876554 6999998754 3445678999999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999987643 348899999999999999999999 899999999999999999999999999987654
Q ss_pred CCCCCc--ccccc--cCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 487 HGANPQ--TTHIV--GTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 487 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
...... ..... .+..|+|||.+....++.++|||||||++|||++ |..||....... ..+++.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~---~-- 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDY---R-- 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCC---c--
Confidence 322111 11111 2457999999998899999999999999999886 999987544321 222221110 0
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+ ....+.+..+.+++..||+.+|.+||++.+|++.|+.
T Consensus 230 ------~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ------L-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ------C-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0011234568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.65 Aligned_cols=269 Identities=20% Similarity=0.244 Sum_probs=199.3
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC------Cceeeeeeeecc
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH------RNLVQLHGWCRK 398 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~ 398 (653)
+...+++|.+.++||+|+||+||+|.+...++.||||+++... ...+.+..|+.++++++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999998889999999996432 223455667777777654 458899998866
Q ss_pred c-ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-----
Q 048419 399 Q-DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL----- 472 (653)
Q Consensus 399 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----- 472 (653)
. +++++|||++ +++|.+++... ..+++.++..|+.||+.||.|||+. .+|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence 5 4789999988 77898888654 3489999999999999999999972 4999999999999998765
Q ss_pred -----------cEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhh
Q 048419 473 -----------NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKA 541 (653)
Q Consensus 473 -----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~ 541 (653)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998864322 22345789999999999999999999999999999999999999986554
Q ss_pred hhHHHHHHHHHhhhc--------ccchhHhhhh------c---------cC---cCCHHHHHHHHHHHHHcCCCCCCCCC
Q 048419 542 AAELLLVDWVKELHL--------EGEITQAIDQ------T---------LD---YYDLAEAELVLNLGLFCSAPNPVYRP 595 (653)
Q Consensus 542 ~~~~~l~~~~~~~~~--------~~~~~~~~d~------~---------l~---~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (653)
.+...+......... .....+..+. . .. .........+.+|+.+||+.||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 332222211100000 0000000000 0 00 00011235678999999999999999
Q ss_pred CHHHHHHHHcC
Q 048419 596 DMRRVVEFLLG 606 (653)
Q Consensus 596 s~~evl~~L~~ 606 (653)
|+.|++++-.-
T Consensus 431 ta~e~L~Hp~~ 441 (467)
T PTZ00284 431 NARQMTTHPYV 441 (467)
T ss_pred CHHHHhcCccc
Confidence 99999986543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.33 Aligned_cols=257 Identities=23% Similarity=0.263 Sum_probs=201.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||++....+++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999999988999999998642 2233456788999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999997632 347888999999999999999999 999999999999999999999999999998664
Q ss_pred CCCCCcccccccCCcccCcccccc-----CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRT-----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
...........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......... ..+ .......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~---~~i---~~~~~~~ 227 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKI---MNHEERF 227 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH---HHH---HcCCCcc
Confidence 433222233569999999999875 46788999999999999999999999754432110 000 0000000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVY--RPDMRRVVEFL 604 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 604 (653)
. +.+.. ....+.+.+++.+|++.++.+ |+++.+++++.
T Consensus 228 ~-~p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 228 Q-FPSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred c-CCCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 0 00101 112456788888888865544 56888888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.17 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=202.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC--------------CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL--------------GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHG 394 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 394 (653)
++|+..+.||+|+||.||++...+. ...||+|.+... .......+.+|++.+++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5688889999999999999987532 235899998654 3344567899999999999999999999
Q ss_pred eecccceeEEEEeccCCCCchhhhhccccc-------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 048419 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHK-------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNIL 467 (653)
Q Consensus 395 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 467 (653)
++...+..++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ ++++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 999999999999999999999998653210 01246889999999999999999999 89999999999999
Q ss_pred EcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh--CCCCCChhhhhhH
Q 048419 468 LDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC--GRRSIEPQKAAAE 544 (653)
Q Consensus 468 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt--G~~p~~~~~~~~~ 544 (653)
++.++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||+++||++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976533221 11222345678999999988899999999999999999998 5567765432211
Q ss_pred HHHHHHHHhhhcc-cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 545 LLLVDWVKELHLE-GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 545 ~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+...... +.... ..........+.+|+.+||+.+|.+||++.+|++.|.
T Consensus 242 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 ---IENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111110000 00000 0001112467999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.71 Aligned_cols=263 Identities=27% Similarity=0.369 Sum_probs=207.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||+|+||.||++.+..++..+|+|.+... .....+.+.+|++++++++||||+++++.|.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688899999999999999999988999999998654 333456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... ..+++..+..++.|+++||.|||+. .+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999654 3478899999999999999999972 48999999999999999999999999998755322
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc----------
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG---------- 558 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 558 (653)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+....... ...+........
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCccccc
Confidence 1233468899999999988889999999999999999999999986543221 111111100000
Q ss_pred ----------chhHhhhhccCc----C-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 ----------EITQAIDQTLDY----Y-DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ----------~~~~~~d~~l~~----~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+..+..... . .......+.+++.+||+.+|++||++.||+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000111111100 0 0012456889999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.54 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=208.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||.|++|.||+|....+++.|++|.+........+.+.+|+..++.++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888999999999999999998889999999997665555678899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999988542 38899999999999999999999 899999999999999999999999999988654332
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
. ......++..|+|||.+.+..++.++|||||||++|||++|+.||........... +.. .. . +.+
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~~---~~-~-----~~~- 235 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT---NG-T-----PEL- 235 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh---cC-C-----ccc-
Confidence 2 12234688899999999988899999999999999999999999976544322110 000 00 0 000
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.........+.+++.+||+.||.+||++.+++++=.-
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 0111223567889999999999999999999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.60 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=201.8
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch---------hhHHHHHHHHHHHhhcCCCceeeeeeeeccccee
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 402 (653)
|...+.||+|++|.||+|....++..+|+|.+..... +..+.+..|+.++++++|+||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5667899999999999999988899999998864322 1235688899999999999999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999654 347888999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-----cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 483 KIYEHGANP-----QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 483 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
+........ ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~--- 224 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF------KI--- 224 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH------HH---
Confidence 876532111 1112357889999999988889999999999999999999999997643321110 00
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..... ...+......+.+++.+||+.+|.+||++.|++++
T Consensus 225 ---~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 ---GENAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---hccCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00000 11112234678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.87 Aligned_cols=257 Identities=22% Similarity=0.248 Sum_probs=199.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||++....+++.+|+|++.+. .....+.+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4688899999999999999999988999999998542 2223445788999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999997632 348888999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||......... ..+........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~---~~i~~~~~~~~-- 228 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKIMNHKERFQ-- 228 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH---HHHhCCCcccc--
Confidence 33222223357999999999986 345788999999999999999999999765432211 11110000000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHHH
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPN--PVYRPDMRRVVEFL 604 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~L 604 (653)
...........+.+++.+|+..+ +..||++.|++++-
T Consensus 229 ------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 229 ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred ------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 00001122456777888877554 44478999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.15 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=206.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|+||.||+|...+ +..+|||.+.... ...+++.+|+..+++++|+|++++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3578889999999999999999764 5789999986543 2356789999999999999999999999988899999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.++..++.|++.||.|||+ ++++|+||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999997653 2458999999999999999999999 89999999999999999999999999999866432
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.........++..|+|||.+.+..++.++||||||++++||++ |+.||....... ..+.+.....
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~----------- 222 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVERGYR----------- 222 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC-----------
Confidence 2222222234568999999998889999999999999999999 999986543321 1111111000
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. ..+......+.+++.+|++.+|.+||++.++.+.|+.
T Consensus 223 ~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 M-PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 0011124578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.25 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=208.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|....+++.+++|.+.....+..+.+.+|++++++++|+||+++++++...+.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999998888999999998766667788999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ..+++.+++.++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999886642 348899999999999999999999 899999999999999999999999999998654321
Q ss_pred CCcccccccCCcccCccccccC---CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 490 NPQTTHIVGTLGYLAPELTRTG---KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+........... ...... ...
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~~~~--------~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISKSNF--------PPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccC--------CCc
Confidence 122334678899999998776 789999999999999999999999976443221110 000000 000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+ .........+.+++.+||+.+|.+||++.+|+.+
T Consensus 225 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KL-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cc-cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01 1112335678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.20 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=204.4
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
|+..+.||+|+||.||+|....++..+++|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45567899999999999999988999999999776666778899999999999999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|..++... ...+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||++....... .
T Consensus 87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 9999887653 2358999999999999999999999 899999999999999999999999999987643221 1
Q ss_pred cccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 492 QTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
......++..|+|||++. ...++.++|||||||++|||++|+.||........ ........ .+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~~----------~~ 226 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSE----------PP 226 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhhcC----------CC
Confidence 223346889999999874 34577899999999999999999999875433211 11111100 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+ ..+......+.+++.+||+.+|.+||++.+++++-.
T Consensus 227 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 227 TL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 00 011122356889999999999999999999987664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.70 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=203.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC----------------CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP----------------SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQL 392 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~----------------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 392 (653)
++|+..+.||+|+||.||++... .++..+|+|.+... .......+.+|+..+++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998543 23457999998754 34455789999999999999999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhcccccc------cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL------RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNI 466 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 466 (653)
++++...+..++||||+++++|.+++....... ...+++.+++.++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999997643211 2347888999999999999999999 8999999999999
Q ss_pred EEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh--CCCCCChhhhhh
Q 048419 467 LLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC--GRRSIEPQKAAA 543 (653)
Q Consensus 467 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt--G~~p~~~~~~~~ 543 (653)
|++.++.+||+|||+++.+...... ......++..|+|||....+.++.++|||||||++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865432211 1122334678999999888889999999999999999998 667886543321
Q ss_pred HHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. ............ ....+ .+..+...+.+++.+||+.||.+||++.+|++.|+
T Consensus 242 ~~---~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VI---ENTGEFFRDQGR-QVYLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHhhccc-cccCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 111110000000 00000 11123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.75 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=204.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.+|...+.||+|+||.||+|.+..+ +..+|+|.+.... ....+.+..|+..+++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4677889999999999999987533 3479999986543 33456889999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999997543 347899999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCcc--cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 486 EHGANPQT--THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 486 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
........ ....++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ ....+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~---~~-- 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEGY---RL-- 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCCC---cC--
Confidence 44322111 11223568999999998889999999999999999886 999987544321 111111110 00
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+ .....+..+.+++.+|++.+|.+||+|.++++.|..
T Consensus 229 ---~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ---P----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---C----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 011234567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.31 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=206.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+.|++.+.||+|+||.||+|....++..+++|.+........+.+.+|+..+++++|+|++++++.+...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56778899999999999999999889999999998777777888999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|..++.+.. ..+++..++.++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999988876542 348899999999999999999999 899999999999999999999999999987543221
Q ss_pred CCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 490 NPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.......++..|+|||.+. ...++.++|||||||++|||++|+.|+........ ..... ....
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~-----~~~~---- 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-----KSEP---- 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHh-----cCCC----
Confidence 1223346788999999884 34467899999999999999999999875432111 11110 0000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+.+ .........+.+++.+||+.+|++||++.+++++-.
T Consensus 233 -~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 233 -PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred -ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000 011123456889999999999999999999987543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.92 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=205.8
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|+||.+|++....+++.||+|++... .....+++.+|+..+++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999999888999999998643 334456889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.++++++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999886543 2347889999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.. ......|+..|+|||.+.+...+.++|||||||+++||++|+.|+......+. ..... .+..
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~~~~-----~~~~-------- 218 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--VLKII-----RGSY-------- 218 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--HHHHh-----cCCC--------
Confidence 21 12234578899999999988899999999999999999999999875433211 00111 1110
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..........+.+++.+||+.+|.+||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11112234668899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.12 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=206.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|....++..+++|.+..... .+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999988889999999865432 678999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 81 GAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999986542 458999999999999999999999 899999999999999999999999999998764432
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... +. . ...+.+
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---~~----~-----~~~~~~- 219 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---IP----N-----KPPPTL- 219 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---hc----c-----CCCCCC-
Confidence 1 22334578899999999988999999999999999999999999976443221110 00 0 000000
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..+......+.+++.+||+.+|.+||++.||+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0111234578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.59 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=194.2
Q ss_pred eeeeeeCcEEEEEEEeCC--CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 336 NLVGSGGFGRVYRGLMPS--LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
+.||+|+||.||+|...+ .+..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 34679999986543 334457889999999999999999999999999999999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC-
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP- 491 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~- 491 (653)
+|.+++..........+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432223346777888999999999999999 89999999999999999999999999999754332211
Q ss_pred cccccccCCcccCccccccC-------CCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 492 QTTHIVGTLGYLAPELTRTG-------KATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
......++..|+|||++... .++.++||||||+++|||++ |+.||.......... .... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~~----~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTVR----EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHhh----cccCCC
Confidence 11224567889999988642 35789999999999999996 999997544322111 1000 000111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.++.+ .....+.+.+++..|+ .+|++|||+.||++.|+
T Consensus 231 ~~~~~---~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL---KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc---CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1112345778899999 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.37 Aligned_cols=266 Identities=25% Similarity=0.338 Sum_probs=201.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|++|.||+|+...++..||||++.... ....+.+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677899999999999999998889999999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
++ ++|.+++..... ...+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 689888865432 3468999999999999999999999 89999999999999999999999999999765332
Q ss_pred CCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH-HHHHHh----hhcc-cchh
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL-VDWVKE----LHLE-GEIT 561 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~----~~~~-~~~~ 561 (653)
. .......+++.|+|||.+.+. .++.++|||||||+++||+||+.||..........- ...... .+.. ..+.
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 V-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 112233568899999987654 478899999999999999999999976543221110 000000 0000 0000
Q ss_pred H---hhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 562 Q---AIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 562 ~---~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. ..+... ..........+.+++.+||+.||.+|||+.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 000000 00001124567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.44 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=206.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||.|++|.||+|....+++.||+|.+.... ......+.+|+.++++++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777889999999999999999889999999986543 44556788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... .+++..++.++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998653 48899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
. .......++..|+|||++.+..++.++||||||+++|||++|+.||........ ...+. .. ..+.+
T Consensus 152 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~----~~-----~~~~~ 218 (274)
T cd06609 152 M-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIP----KN-----NPPSL 218 (274)
T ss_pred c-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhh----hc-----CCCCC
Confidence 2 222334678899999999988899999999999999999999999975442211 00000 00 01111
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. ......+.+++.+||+.+|++||++++++++-
T Consensus 219 ~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 219 EG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred cc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 00 00345688999999999999999999998853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.10 Aligned_cols=260 Identities=29% Similarity=0.431 Sum_probs=213.4
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCch
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLD 415 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 415 (653)
-+||+|.||+||.|++.++...+|||.+.....+..+.+..|+.+-++|+|+|||+++|.|.+++.+-|.||..|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999999999999999998877777888999999999999999999999999999999999999999999
Q ss_pred hhhhcccccccccc--hhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEEEEeecCcccccCCCCCc
Q 048419 416 KLLFDKDHKLRKLL--TWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD-TYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 416 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
++|...-+ +| .+...--..+||++||.|||+ +.|||||||-+|||++ -.|.+||+|||-++.+.. .++.
T Consensus 661 sLLrskWG----PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~ 732 (1226)
T KOG4279|consen 661 SLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPC 732 (1226)
T ss_pred HHHHhccC----CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCcc
Confidence 99987643 34 566677789999999999999 9999999999999995 578999999999987653 4566
Q ss_pred ccccccCCcccCccccccC--CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCc
Q 048419 493 TTHIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 570 (653)
+..+.||..|||||++..+ .|..++|||||||++.||.||++||..........+. +-..... ..
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--VGmyKvH-----------P~ 799 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--VGMYKVH-----------PP 799 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--hcceecC-----------CC
Confidence 7778899999999999876 4888999999999999999999999765443221110 0000000 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHcC--CCCCCCCCCc
Q 048419 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLG--DSSLPPLPPD 616 (653)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~--~~~~p~~p~~ 616 (653)
.+.+...+...++++|..+||.+||+++++++ +|.- .++-|++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls~~ 849 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLSLN 849 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCCcc
Confidence 33455678899999999999999999999997 4432 2334444433
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.01 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=203.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|....+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999998889999999997665555667889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++... ..+++.+.+.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998654 348899999999999999999999 899999999999999999999999999987654322
Q ss_pred CCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 490 NPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.|+....+...... ........ +
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~--~~~~~~~~--------~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MTKSNFQP--------P 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh--hhccCCCC--------C
Confidence 2223446899999999874 45588899999999999999999999865432211110 00000000 0
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.... .......+.+++.+||+.+|++||++.+|+++
T Consensus 230 ~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 00123467899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.40 Aligned_cols=263 Identities=22% Similarity=0.259 Sum_probs=201.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc------
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ------ 399 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 399 (653)
..++|...+.||+|+||.||++++...++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999888999999998653 334456788999999999999999999987543
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
...++||||+++ +|..++.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999965 67766632 37788899999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc---
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--- 556 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 556 (653)
|+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+...... ..+.....
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~ 246 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPCP 246 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCCH
Confidence 9998654321 2234568999999999999999999999999999999999999997654322111 11100000
Q ss_pred ------ccchhHhhh---------------hcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 ------EGEITQAID---------------QTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 ------~~~~~~~~d---------------~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+...+. ..+ ..........+.+++.+||+.||.+|||+.|++++-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000000000 000 0001112356889999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=313.39 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=203.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+..+++++|+||+++++++...+..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556778999999999999998889999999986543 345567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++... .+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLKPG------PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999988542 37889999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
. ......++..|+|||.+.+..++.++|||||||+++||++|+.|+......... .++. ... . .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~----~~~-----~---~ 219 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIP----KNS-----P---P 219 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhh----cCC-----C---C
Confidence 1 122345788999999999888999999999999999999999998754322110 0000 000 0 1
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.........+.+++.+||+.+|.+||++.+++++-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 11123346688999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.51 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=209.2
Q ss_pred ccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeec
Q 048419 319 RFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCR 397 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 397 (653)
.+.+..+..++++|+..+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3556777788999999999999999999999998889999999985432 2235678899999999 6999999999874
Q ss_pred -----ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 398 -----KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 398 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
..+..++||||+++++|.+++...... ...+++..++.++.|+++||.|||+ ++++||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCC
Confidence 345689999999999999988643211 3457889999999999999999999 8999999999999999999
Q ss_pred cEEEEeecCcccccCCCCCcccccccCCcccCcccccc-----CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH
Q 048419 473 NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL 547 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l 547 (653)
.+||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.........
T Consensus 162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-- 238 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-- 238 (286)
T ss_pred CEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--
Confidence 99999999998654322 12233468999999998753 44788999999999999999999998754432111
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
... .........++ ......+.+++.+||+.+|++||++.|+++++
T Consensus 239 ~~~-----~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKI-----PRNPPPTLHQP------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhc-----cccCCCcccCC------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 00000000001 11235688999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.45 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=201.4
Q ss_pred eeeeeeCcEEEEEEEeCC-CC--cEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPS-LG--LEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|++|.||+|.+.. .+ ..||||.+..... ...+.+.+|+..+++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999754 33 3699999977655 667789999999999999999999999988 889999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|.+++..... ..++|...+.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999977541 458999999999999999999999 89999999999999999999999999999876442211
Q ss_pred --cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 492 --QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 492 --~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
......++..|+|||++.+..++.++|||||||++|||++ |+.|+......+. ...+.. .. ..+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~-------~~~ 220 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EG-------ERL 220 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cC-------CcC
Confidence 1122456789999999998899999999999999999999 9999865433221 111111 00 000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
......+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.09 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=207.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|++|.||++....+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788899999999999999999888999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... .+++.++..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999998543 37888999999999999999999 89999999999999999999999999998765433
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... . . ...+ .+.+
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~--~---~~~~------~~~~ 235 (297)
T cd06656 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-L--I---ATNG------TPEL 235 (297)
T ss_pred cc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-e--e---ccCC------CCCC
Confidence 21 2233468889999999998889999999999999999999999997543321100 0 0 0000 0000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.........+.+++.+||+.+|.+||++.+++++-
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 01112345678999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.16 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=201.9
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ----- 399 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 399 (653)
...++|...+.||+|+||.||++.+...++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3557899999999999999999999888999999998653 333456788999999999999999999987543
Q ss_pred -ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 400 -DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 400 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 357999999965 66666532 37888899999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh---
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH--- 555 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--- 555 (653)
||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ..+....
T Consensus 163 fg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~ 238 (355)
T cd07874 163 FGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPC 238 (355)
T ss_pred CcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCC
Confidence 9999865332 12233578999999999998889999999999999999999999997654322110 0000000
Q ss_pred ------cccchhHhhh---------------hcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 556 ------LEGEITQAID---------------QTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 556 ------~~~~~~~~~d---------------~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
........++ ..+ ..........+.+++.+||+.||.+|||+.|++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 0000000000 000 0001112356889999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.21 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=205.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeC-------CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMP-------SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ 399 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 399 (653)
.++|...+.||+|+||.||+|+.. ..+..||+|.+... .....+.+.+|+..++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356778899999999999999752 23457999998644 344567889999999999 899999999999999
Q ss_pred ceeEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL 468 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 468 (653)
...++||||+++|+|.+++...... ....+++.+++.++.||+.||.|||+ ++++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 9999999999999999999764321 12357889999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHH
Q 048419 469 DTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELL 546 (653)
Q Consensus 469 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 546 (653)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 99999999999999866432221 1222345678999999988889999999999999999998 777876433211
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.+.+.. +.. . .........+.+++.+||+.+|.+||++.|+++.|..
T Consensus 248 ~~~~~~~----~~~-------~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 248 LFKLLKE----GHR-------M-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred HHHHHHc----CCc-------C-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 1111111 100 0 0112234678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.54 Aligned_cols=264 Identities=21% Similarity=0.288 Sum_probs=200.9
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc----
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ---- 399 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---- 399 (653)
..+.++|...+.||+|+||.||+|....++..||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678899999999999999999998889999999986532 23345678899999999999999999987543
Q ss_pred --ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEE
Q 048419 400 --DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477 (653)
Q Consensus 400 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 477 (653)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||+++++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEc
Confidence 3578999998 7799887753 238899999999999999999999 999999999999999999999999
Q ss_pred eecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+......
T Consensus 161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~ 234 (343)
T cd07878 161 DFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGT 234 (343)
T ss_pred CCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCC
Confidence 99999865432 233468999999999876 46889999999999999999999999754332211 111100000
Q ss_pred -ccchh--------HhhhhccCcCCH--------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 -EGEIT--------QAIDQTLDYYDL--------AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 -~~~~~--------~~~d~~l~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..... ......+..... .....+.+++.+||+.||.+|||+.|++++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00000 000000100000 11245789999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.88 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=191.1
Q ss_pred eeeeeeCcEEEEEEEeCCC------------CcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 336 NLVGSGGFGRVYRGLMPSL------------GLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
+.||+|+||.||+|+.... ...|++|.+..........+.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986422 3368999987665556678889999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-------EEE
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN-------AKL 476 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 476 (653)
+||||+++++|..++.... ..+++..+++++.||++||+|||+ ++|+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998886542 348899999999999999999999 99999999999999987664 899
Q ss_pred EeecCcccccCCCCCcccccccCCcccCccccc-cCCCCCccceeehHHHHHHHH-hCCCCCChhhhhhHHHHHHHHHhh
Q 048419 477 GDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR-TGKATTSTDVYSYGILMLEVA-CGRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 477 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~s~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+... ..
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~~-- 222 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----FY-- 222 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----HH--
Confidence 999998754321 2235788899999886 456889999999999999998 5778776433211100 00
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.... .. .......+.+|+.+||+.||.+||++.+|++.++
T Consensus 223 --~~~~------~~---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 --EGQC------ML---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --hcCc------cC---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 00 0112356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=344.37 Aligned_cols=260 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..++||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788899999999999999999988999999998653 2233567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccc------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 407 DYVPNGSLDKLLFDKDH------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
||+++|+|.+++..... .....+++..+++++.||++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999865311 112346678889999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCC-----------------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhh
Q 048419 481 LAKIYEHGAN-----------------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA 543 (653)
Q Consensus 481 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~ 543 (653)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 01122468999999999999999999999999999999999999997633211
Q ss_pred HHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHc
Q 048419 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-DMRRVVEFLL 605 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~ 605 (653)
. .. . ..+. ++.-.......+..+.+++.+|++.||.+|| ++.++++.|+
T Consensus 239 i-~~-----~----~~i~---~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 239 I-SY-----R----DVIL---SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred h-hh-----h----hhcc---ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 00 0 0000 0000000012345688999999999999996 5566666554
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.95 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=197.3
Q ss_pred eeeeeeCcEEEEEEEeCCCCc--EEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGL--EVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||.||+|.+.+++. .+++|.+... .....+.+.+|+++++++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999877665 4688888643 345567889999999999 799999999999999999999999999
Q ss_pred CCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 412 GSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 412 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
|+|.+++...... ....+++.+++.++.|++.||+|||+ ++++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 9999998754210 12347899999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
++...... ........+..|+|||++....++.++|||||||++|||++ |+.||....... ..+.+.. +.
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~~----~~ 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQ----GY 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHHhC----CC
Confidence 98632211 11111233567999999988889999999999999999997 999996543221 1111110 00
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+ .........+.+++.+||+.+|.+||++.++++.|+.
T Consensus 229 -------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 -------RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred -------CC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 00 0111223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=305.38 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=203.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||++.... +..+|+|.+... ....+.+.+|++++++++|+|++++.+.+.+ ...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 567889999999999999998754 567999988643 2345678899999999999999999999887 7789999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999997643 3457889999999999999999999 899999999999999999999999999998654332
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+....++.++|+|||||++||+++ |+.||....... +..+... +...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~~~~------- 222 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER----GYRM------- 222 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhC----CCCC-------
Confidence 222223345678999999988889999999999999999999 888987543221 1111111 1000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.31 Aligned_cols=267 Identities=21% Similarity=0.279 Sum_probs=203.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|...+.||+|+||.||+|....++..||+|.+.... ......+.+|+..+++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999998889999999986442 23345677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
++ ++|.+++.... ..+++..+..++.||++||.|||+ ++++|+||||+||++++++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 58988886542 347889999999999999999999 99999999999999999999999999999764332
Q ss_pred CCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh-
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ- 566 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~- 566 (653)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.......................+..
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 21 12233568899999988653 5788999999999999999999999765443221111100000000001111000
Q ss_pred -----ccCc--------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 -----TLDY--------YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 -----~l~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.... ........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 00112356789999999999999999999998553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.97 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=204.1
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+|+..+.||+|+||.||++....++..||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 567788999999999999999888999999998654 3344578899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|..++..... ...+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 82 DAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred CCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999998865321 23589999999999999999999972 58999999999999999999999999998765322
Q ss_pred CCcccccccCCcccCccccccCC------CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGK------ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||......... ..+ ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~---------~~~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQL---------SAI 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHH---------HHH
Confidence 122345788999999986543 478999999999999999999999754322111 000 011
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+......+......+.+++.+||+.+|.+||++.+++++-
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 11111112223456788999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.23 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=206.7
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-C-----CceeeeeeeecccceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-H-----RNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 404 (653)
+|.+.++||+|.||.|-||.+.++++.||||+++.. +.-..+-..|+.+|..|+ | -|+|++++++..++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999999999999999999544 444566778999999997 4 379999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC--CcEEEEeecCc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY--LNAKLGDFGLA 482 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla 482 (653)
|+|.+ .-+|+++|..+. -..++...++.++.||+.||.+||+ .+|||+||||+||||.+. ..+||+|||.+
T Consensus 266 VfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999 459999998875 3558999999999999999999999 999999999999999543 46999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh---------
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE--------- 553 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------- 553 (653)
+...... ....-+..|+|||++.+..|+.+.|||||||++.||++|.+.|.+..+.+.....--+..
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8754322 244567899999999999999999999999999999999887776665544322211100
Q ss_pred ------hhcc----------cch---------hHh----hhhcc--------C-cCCHHHHHHHHHHHHHcCCCCCCCCC
Q 048419 554 ------LHLE----------GEI---------TQA----IDQTL--------D-YYDLAEAELVLNLGLFCSAPNPVYRP 595 (653)
Q Consensus 554 ------~~~~----------~~~---------~~~----~d~~l--------~-~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (653)
.... ... ... .+... . .........+.+++.+|+..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0000 000 000 00000 0 01112346789999999999999999
Q ss_pred CHHHHHHHHc
Q 048419 596 DMRRVVEFLL 605 (653)
Q Consensus 596 s~~evl~~L~ 605 (653)
|..|.+++-.
T Consensus 495 tp~qal~Hpf 504 (586)
T KOG0667|consen 495 TPAQALNHPF 504 (586)
T ss_pred CHHHHhcCcc
Confidence 9999998664
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=304.58 Aligned_cols=267 Identities=25% Similarity=0.313 Sum_probs=206.7
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh--hHHHHHHHHHHHhhcCCCc-eeeeeeeecccc------ee
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ--GMKEFVAEIMSMGRLRHRN-LVQLHGWCRKQD------EL 402 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~ 402 (653)
|...+.||+|.||+||+|+...+|+.||+|+++....+ .-....+|+.++++|+|+| |+++++++...+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44566799999999999999999999999999765432 2345679999999999999 999999998877 78
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++|+||+. -+|..++....... ..++...+..+..||+.||+|||+ ++|+||||||.||||+++|.+||+|||+|
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 99999995 49999998765321 346668889999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
+....... ..+..++|..|+|||++.+. .|+...||||+||++.||++++..|.+..+.++....-.+.....+...+
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 96653322 23456789999999998876 68999999999999999999999888776644332221111111111111
Q ss_pred Hh---hhhcc---CcC---CH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 562 QA---IDQTL---DYY---DL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 562 ~~---~d~~l---~~~---~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. .+-.. ... +. .......+++.+|++.+|.+|.|++.++++-
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 11 11110 000 00 0114788999999999999999999999874
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.26 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=202.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||.||+|.+... ...|+||...... .+..+.+.+|+.++++++|+||++++++|.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577789999999999999987543 3469999986554 4556789999999999999999999999875 457899
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999996542 348999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
............++..|+|||.+....++.++||||||++++||++ |..||......+. ...+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~----~~~---- 226 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIEN----GER---- 226 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc----CCc----
Confidence 4432222222334568999999988889999999999999999986 9999976543221 111111 000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+ .........+.+++.+|+..+|.+||++.++++.|+.
T Consensus 227 ---~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 227 ---L-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ---C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 0111234578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.04 Aligned_cols=269 Identities=24% Similarity=0.353 Sum_probs=205.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC----CCcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecc--ccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS----LGLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 402 (653)
+.|...+.||+|+||.||++.+.. ++..+|||.+...... ..+.+.+|++.+++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 346667899999999999998643 3789999999765443 56789999999999999999999999877 5578
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
+++|||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999997653 248999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 483 KIYEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 483 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
......... ......++..|+|||.+.+..++.++||||||++++||++|+.|+............. .........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHH
Confidence 876532211 1112244567999999988889999999999999999999999876432211000000 0000000011
Q ss_pred hHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.+.... ..........+.+++.+||+.+|.+||++.||+++|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 11111111 01112234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.59 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=203.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-------CCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
++|...+.||+|+||.||++.... ....+|+|.+... ......++..|+.+++++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 568889999999999999998643 2357999999754 234456788999999999 7999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
..++||||+++|+|.+++...... ....+++.++++++.|++.||+|||+ ++++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 999999999999999999764321 12358899999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... +
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---H
Confidence 999999999999876533211 11112234568999999988889999999999999999998 888886433211 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.+.. +.. ...+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 252 ~~~~~~----~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 252 FKLLKE----GHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHHHc----CCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 111111 100 01111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=306.30 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=197.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-----hhhHHHHHHHHHHHhhcCCCceeeeeeeecc--ccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-----QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 402 (653)
.+|...+.||+|+||.||+|....++..|++|++.... .+..+.+.+|+.++++++|+||+++++++.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999998889999999985431 2345678899999999999999999998865 3568
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++++||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 8999999999999998653 237889999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 483 KIYEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 483 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
+....... .......++..|+|||++.+..++.++|||||||++|||++|+.||......... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~~- 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQPT- 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCCC-
Confidence 76532111 1122345788999999999888999999999999999999999999754322111 00000000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+ ..+....+.+..++ .||..+|++||+++||+++
T Consensus 227 ----~~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 ----NP---QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----CC---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01 11112234455555 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.82 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=200.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc-ce
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ-DE 401 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 401 (653)
++|+..+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 56888999999999999999842 357889999997543 33456788999999999 689999999988655 45
Q ss_pred eEEEEeccCCCCchhhhhccccc---------------------------------------------------------
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK--------------------------------------------------------- 424 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 424 (653)
.++||||+++|+|.+++......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999998653210
Q ss_pred -----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC-Cccccccc
Q 048419 425 -----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVG 498 (653)
Q Consensus 425 -----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~g 498 (653)
....+++.++.+++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01347888999999999999999999 9999999999999999999999999999986532211 11122345
Q ss_pred CCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHH
Q 048419 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAE 577 (653)
Q Consensus 499 t~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 577 (653)
+..|+|||.+.+..++.++||||||+++|||++ |..|+........ +...+ ..+.... . +.....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~----~~~~~~~-----~---~~~~~~ 309 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRL----KEGTRMR-----A---PDYTTP 309 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHH----hccCCCC-----C---CCCCCH
Confidence 678999999988889999999999999999997 8888865332111 11111 0110000 0 001234
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 578 LVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.+++..||+.+|.+||++.||+++|+.
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 68899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.91 Aligned_cols=248 Identities=30% Similarity=0.386 Sum_probs=199.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeec-ccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR-KQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~ 408 (653)
++|...+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.++++++|+|++++++++. +.+..++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46778899999999999999875 6789999985432 3467889999999999999999999764 45678999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++..+++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 82 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999987653 2458899999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.|+....... +...+..... .
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~~---------~- 218 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYK---------M- 218 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC---------C-
Confidence 1 22344568999999988889999999999999999998 898886543211 1111111100 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=304.56 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=204.8
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|++|.||++....+++.+|||.+... ..+..+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999999888999999998654 334567889999999999999999999999989999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEeecCcccccC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKIYEH 487 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~ 487 (653)
+++++|.+++.... ...+++..+.+++.|++++|.|||+ ++++|+||+|+||+++++ +.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999997643 3458899999999999999999999 899999999999999755 4689999999987644
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. ......++..|+|||.+....++.++||||||+++++|++|+.|+....... ....... +.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~----~~-------- 217 (256)
T cd08220 155 KS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIMS----GT-------- 217 (256)
T ss_pred Cc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHHh----cC--------
Confidence 32 1223467889999999998889999999999999999999999997654321 1111110 00
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...........+.+++..||+.+|.+|||+.|++++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=310.01 Aligned_cols=260 Identities=21% Similarity=0.330 Sum_probs=206.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCC----CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecc-ccee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPS----LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QDEL 402 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 402 (653)
.++|...++||+|+||.||+|.+.. .+..|++|++... .....+.+.+|+..+++++|+|++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999865 3578999988644 34446778899999999999999999998876 4678
Q ss_pred EEEEeccCCCCchhhhhccccc---ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK---LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
++++||+++++|.+++...... ....+++.+++.++.|++.||+|||+ ++++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764321 11458999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCc-ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 480 GLAKIYEHGANPQ-TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 480 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|+++.+....... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||....... +..++....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~-- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDGY-- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHcCC--
Confidence 9998653322111 112345678999999988889999999999999999999 999997543321 222222110
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. + .........+.+++.+||+.+|++||++.++++.|+.
T Consensus 237 -~--------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 237 -R--------L-AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred -C--------C-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0 0 0011224568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.19 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=189.5
Q ss_pred eeeeeCcEEEEEEEeCC------------------------CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeee
Q 048419 337 LVGSGGFGRVYRGLMPS------------------------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 392 (653)
.||+|+||.||+|.... ....|++|.+..........+.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998532 124689999876555556788899999999999999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
+++|.+....++||||+++|+|..++... ...+++..+..++.||++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccC
Confidence 99999999999999999999999988653 2357889999999999999999999 8999999999999997643
Q ss_pred -------cEEEEeecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHH-hCCCCCChhhhhh
Q 048419 473 -------NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVA-CGRRSIEPQKAAA 543 (653)
Q Consensus 473 -------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~ell-tG~~p~~~~~~~~ 543 (653)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999987643221 12356788999998865 56889999999999999995 6888887543322
Q ss_pred HHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. .+.... .. + +......+.+++.+||+.+|++||++.+|++.|.
T Consensus 230 ~~---~~~~~~---~~--------~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KE---RFYEKK---HR--------L---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---HHHHhc---cC--------C---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 111100 00 0 0011246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=304.11 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=203.6
Q ss_pred CcceeeeeeCcEEEEEEEeCCCC----cEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLG----LEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
...+.||+|+||.||++.....+ ..||+|.+...... ..+.+..|+..+++++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 45788999999999999998765 88999999665433 56789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 82 YMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred ccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999976432 228999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
..........++..|+|||.+.+..++.++||||+|++++||++ |+.|+....... +.+.+... ..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~----~~------ 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKKG----YR------ 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcC----CC------
Confidence 32222212346789999999988889999999999999999998 778876533211 11111111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..........+.+++.+|++.+|.+|||+.|+++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 001111356788999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.48 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=207.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|+..+.||+|++|.||++....++..+|+|.+........+.+..|++++++++|+|++++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35678888999999999999999888999999999777666778899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999986642 358999999999999999999999 89999999999999999999999999998764332
Q ss_pred CCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 489 ANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
. .......++..|+|||.+. ...++.++||||||+++|||++|+.||........ +..+. .+..
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~-----~~~~--- 225 (280)
T cd06611 157 L-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKIL-----KSEP--- 225 (280)
T ss_pred c-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHh-----cCCC---
Confidence 2 1223346889999999874 34467899999999999999999999976543211 11110 0000
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+.+ ..+......+.+++..||+.+|.+||++.+++++-
T Consensus 226 --~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 226 --PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred --CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 001 00112235688999999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.38 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=203.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC-------CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP-------SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
++|...+.||+|+||.||++... .....+|+|.+... .......+..|+.+++++ +|+||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999753 23457999998654 334466788999999999 6999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
..+++|||+++|+|.+++..... .....+++.++.+++.|++.||.|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999976421 012458899999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... +
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---L 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 9999999999999865432211 1112234467999999988889999999999999999999 888886543221 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.... +... .........+.+++.+||+.+|.+||++.|+++.|..
T Consensus 246 ~~~~~~----~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 246 FKLLRE----GHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred HHHHHc----CCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111111 1100 1111234567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=346.52 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=203.4
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc--cc
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QD 400 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~ 400 (653)
.....++|.+.+.||+|+||.||++.+..++..+|+|.+... .......+..|+.++++|+|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 344557899999999999999999999999999999998643 33445678999999999999999999998754 35
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCcEEEcC------
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC----NQRVVHRDVKPSNILLDT------ 470 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivH~Dlkp~NIll~~------ 470 (653)
.++|||||+++|+|.++|...... ...+++..++.|+.||+.||.|||+.. .++|+||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 689999999999999999754221 245899999999999999999999832 145999999999999964
Q ss_pred -----------CCcEEEEeecCcccccCCCCCcccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHhCCCCCC
Q 048419 471 -----------YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVACGRRSIE 537 (653)
Q Consensus 471 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~elltG~~p~~ 537 (653)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3348999999998654322 2234578999999999854 458899999999999999999999997
Q ss_pred hhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 538 PQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 538 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....... .+....... .+ ........+.+|+..||+.+|.+||++.|++++
T Consensus 245 ~~~~~~q-----li~~lk~~p--------~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 245 KANNFSQ-----LISELKRGP--------DL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cCCcHHH-----HHHHHhcCC--------CC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 5433211 111111000 00 001124568899999999999999999999953
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=307.39 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=191.8
Q ss_pred eeeeeCcEEEEEEEeCC--CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCC
Q 048419 337 LVGSGGFGRVYRGLMPS--LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.||+|+||.||+|.... ....+++|.+.... ......+.+|+..++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997533 34578999876443 3445678899999999999999999999999999999999999999
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC-c
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP-Q 492 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~ 492 (653)
|.+++...........++...+.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999977543223445678889999999999999999 89999999999999999999999999998754322111 1
Q ss_pred ccccccCCcccCcccccc-------CCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 493 TTHIVGTLGYLAPELTRT-------GKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||....+.+. +...+.. . .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~----~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVRE----Q-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhc----c-CccCC
Confidence 122345678999998743 356789999999999999999 7788865433221 1111111 0 00111
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+. ........+.+++..|| .||++||++.+|++.|.
T Consensus 232 ~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 11223456677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.41 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=207.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||+|+||+||++....+++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677889999999999999998889999999886543 34467889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... +.+++.....++.+++.+|.|||+. .+++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999988653 3488999999999999999999972 58999999999999999999999999998754322
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH-----HHHHHHHHhhhcccchhHh
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE-----LLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~ 563 (653)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......+ ..+.++.....
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 226 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-------- 226 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh--------
Confidence 1 1234688999999999888899999999999999999999999985443211 11111111111
Q ss_pred hhhccCcC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 IDQTLDYY-DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 ~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....... .......+.+++.+||+.||.+||++.|++++...
T Consensus 227 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 227 -QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0101011 11234678899999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.59 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=201.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
.+|+..+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|++.+++++|+|++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 356778899999999999998864 67899999864432 3457889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ..++++.++.++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 82 EHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 9999999986543 347899999999999999999999 899999999999999999999999999988654322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++.+|+|||.+.+..++.++||||||+++|||++ |+.||....... +.+.... + .....+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~--~~~~~~~- 224 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINA----G--FRLYKPR- 224 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHhC----C--CCCCCCC-
Confidence 211222335678999999988889999999999999999998 899987543221 1111110 0 0000111
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.....+.+|+.+||+.+|++||++.+++++|.
T Consensus 225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=307.36 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=206.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999998889999999987543 445678899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++... .+++.+...++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999988643 37888899999999999999999 899999999999999999999999999997654322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
. ......++..|+|||.+.+..++.++|+|||||++|||++|..|+........... + .... ..
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~----~~~~--------~~ 219 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---I----PKNN--------PP 219 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---h----hcCC--------CC
Confidence 1 22234578899999999888899999999999999999999999875443211100 0 0000 01
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.........+.+++.+||+.+|.+||++.+++++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 222345677889999999999999999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.65 Aligned_cols=263 Identities=26% Similarity=0.376 Sum_probs=208.5
Q ss_pred ccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeec
Q 048419 319 RFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCR 397 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 397 (653)
..++.++....+.|+..+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++++ +|+|++++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 3566777778889999999999999999999998889999999986543 3345688899999998 6999999999985
Q ss_pred c------cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 048419 398 K------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY 471 (653)
Q Consensus 398 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 471 (653)
. .+..+++|||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++++|+||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCC
Confidence 3 457899999999999999987643 2347888899999999999999999 899999999999999999
Q ss_pred CcEEEEeecCcccccCCCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH
Q 048419 472 LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546 (653)
Q Consensus 472 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~ 546 (653)
+.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 158 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 9999999999876532211 123346889999999875 3457889999999999999999999997543322111
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. +.......+ ........+.+++.+||+.||.+||++.|++++
T Consensus 237 ~------------~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 L------------IPRNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred h------------HhhCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000000101 111234678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.30 Aligned_cols=266 Identities=25% Similarity=0.341 Sum_probs=205.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688899999999999999999988999999998643 33345788999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|++++.|..++... ..+++.+++.++.||+.||.|||+ ++++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99987776655432 347899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc---------c
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL---------E 557 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---------~ 557 (653)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||......+............. .
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 433233345678899999999887 789999999999999999999999875443222111111000000 0
Q ss_pred cchh-----Hhhhhc-c-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 558 GEIT-----QAIDQT-L-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 558 ~~~~-----~~~d~~-l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.... +..+.. . ..++......+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000000 0 01111225779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=301.01 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=217.7
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
|+..+.||.|.-|+||++.+.+++..+|+|++.+.. +....+...|-++|+.++||.++.|++.++..+..||||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 344678999999999999999999999999997653 33455677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
|+||+|..+++.+. .+.+++..++-.+..|+-||+|||. .|||.|||||+||||.++|++-|+||.|+......
T Consensus 159 CpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred CCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999998877 5779999999999999999999999 99999999999999999999999999987543110
Q ss_pred ----------------------------------CC---------------------CcccccccCCcccCccccccCCC
Q 048419 489 ----------------------------------AN---------------------PQTTHIVGTLGYLAPELTRTGKA 513 (653)
Q Consensus 489 ----------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~ 513 (653)
.. ......+||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 01123468999999999999999
Q ss_pred CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC-CHHHHHHHHHHHHHcCCCCCC
Q 048419 514 TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY-DLAEAELVLNLGLFCSAPNPV 592 (653)
Q Consensus 514 ~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~ 592 (653)
+.+.|-|+|||++|||+.|..||.+....+. +..++-+.+... ....+..+.+||.+.|..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999998765432 222332323111 114457789999999999999
Q ss_pred CCCC----HHHHHHHH---------cCCCCCCCCCCcccc
Q 048419 593 YRPD----MRRVVEFL---------LGDSSLPPLPPDIHL 619 (653)
Q Consensus 593 ~RPs----~~evl~~L---------~~~~~~p~~p~~~~~ 619 (653)
+|-- +.||-++- .....+|..|.....
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 9998 88888754 234556666655443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.52 Aligned_cols=249 Identities=30% Similarity=0.410 Sum_probs=203.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-----hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-----QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
+|+..+.||+|++|.||+|....++..|++|.+.... .+..+.+.+|+.++++++|+|++++++++...+.++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999998789999999986543 34567889999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
+||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998653 247899999999999999999999 89999999999999999999999999998865
Q ss_pred cCCCCCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......... ..+. .....
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~----~~~~~---- 220 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FKIG----RSKEL---- 220 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HHHH----hcccC----
Confidence 4332 223456888999999987766 899999999999999999999999764422111 1110 00000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..........+.+++.+||+.+|.+||++.+++++
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11111234667889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=328.97 Aligned_cols=263 Identities=21% Similarity=0.223 Sum_probs=200.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
..+|.+.+.||+|+||.||++.+...++.||||... ...+.+|++++++|+|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 447999999999999999999999989999999642 23456899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+. ++|.+++.... ..++|.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 242 ~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 94 68888886542 358999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhh-----hHHHHHHHHHhhhcc-c---
Q 048419 489 ANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA-----AELLLVDWVKELHLE-G--- 558 (653)
Q Consensus 489 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~-~--- 558 (653)
... ......||..|+|||++.+..++.++|||||||+||||++|..++...... ....+...+...... .
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 211 122356999999999999989999999999999999999988665322110 011112222111000 0
Q ss_pred -----chhHhhhhc-----cCcC---CH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 -----EITQAIDQT-----LDYY---DL----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 -----~~~~~~d~~-----l~~~---~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+....... .... .. .....+.+|+.+||+.||.+|||+.|++++-.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 000000000 0000 00 11246789999999999999999999998743
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=304.94 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=203.5
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc------hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS------QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
+|+..+.||+|++|.||++....+++.||+|.+.... ....+.+..|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777899999999999999998889999999986432 2235678999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCcc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAK 483 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~ 483 (653)
|+||+++++|.+++... ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++ .+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999998653 347899999999999999999999 8999999999999998776 59999999998
Q ss_pred cccCCCC---CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 484 IYEHGAN---PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 484 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
....... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||....................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 228 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT---- 228 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC----
Confidence 6643211 111234578899999999888899999999999999999999999964432111111000000000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....+......+.+++.+|++.+|.+||++.+++.+
T Consensus 229 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 -------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 011222345678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.80 Aligned_cols=265 Identities=25% Similarity=0.319 Sum_probs=203.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|+.++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999999889999999986432 2234568899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|..++... ..+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99998888776543 248999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHH-HHHhhhc-------cc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVD-WVKELHL-------EG 558 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~-~~~~~~~-------~~ 558 (653)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...... ....... ..
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 1223457889999999865 457889999999999999999999997654332211110 0000000 00
Q ss_pred ch-hHhhhhcc-CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 EI-TQAIDQTL-DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 ~~-~~~~d~~l-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.. .....+.. .... ......+.+++.+||+.+|++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 00000000 0000 1124678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.73 Aligned_cols=241 Identities=23% Similarity=0.380 Sum_probs=192.4
Q ss_pred eeeeeeCcEEEEEEEeCCCCc-------EEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 336 NLVGSGGFGRVYRGLMPSLGL-------EVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+.||+|+||.||+|.....+. .+++|.+........+.+.+|+.++++++|+|++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998765443 4889988666556667889999999999999999999999998899999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--------EEEEeec
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN--------AKLGDFG 480 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG 480 (653)
+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999997653 247899999999999999999999 99999999999999987765 6999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCC-CCCChhhhhhHHHHHHHHHhhhccc
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGR-RSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
++..... .....++..|+|||++.+. .++.++|||||||++|||++|. .|+.......... ... ...
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---~~~---~~~ 222 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYE---DRH 222 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---HHH---ccc
Confidence 8865432 1234578899999999764 5789999999999999999995 5554332221110 000 000
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+......+.+++.+||+.+|.+|||++++++.|+
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=304.36 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=206.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc--cceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 406 (653)
+|+..+.||.|+||.||++....++..+|+|.+... .....+.+..|++.+++++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467789999999999999999888999999998643 34445678899999999999999999997754 44689999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC--NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||+++++|.+++...... ...+++.+++.++.||+.||.|||..+ ..+++|+||||+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999764221 346899999999999999999999321 28999999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
...... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+....... +.+.+.. +.
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~----~~----- 226 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKE----GK----- 226 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHHhc----CC-----
Confidence 654332 1233468899999999998889999999999999999999999998654211 1111111 11
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...........+.+++.+|++.+|.+||++.+|+++
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111222345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.68 Aligned_cols=266 Identities=26% Similarity=0.281 Sum_probs=209.0
Q ss_pred ccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeec
Q 048419 319 RFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCR 397 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 397 (653)
.+.+.++..++++|...+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.+++++ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556777788999999999999999999999998889999999986432 2345677899999999 7999999999986
Q ss_pred cc-----ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 398 KQ-----DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 398 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
.. +..++|+||+++++|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence 54 3589999999999999988653211 3458899999999999999999999 8999999999999999999
Q ss_pred cEEEEeecCcccccCCCCCcccccccCCcccCccccccC-----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH
Q 048419 473 NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL 547 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l 547 (653)
.+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.|+.........
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 999999999886543221 11234678899999987543 3688999999999999999999999764432211
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.++. ..... .+. ........+.+++.+||+.+|++||++.|++++
T Consensus 243 ~~~~-----~~~~~-----~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIP-----RNPPP-----TLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHh-----cCCCC-----CCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 00000 010 011223568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=301.86 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=199.6
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
++||+|+||.||++.+.. ++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999987 89999999876533 3567899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcc-
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT- 493 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 493 (653)
.+++.... ..+++..++.++.+++.+|.|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99986543 347889999999999999999999 8999999999999999999999999999986542221111
Q ss_pred cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCC
Q 048419 494 THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572 (653)
Q Consensus 494 ~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 572 (653)
....++..|+|||.+.++.++.++|||||||++|||++ |..||........ ...+.... .+ ..+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~~~~~~-----------~~-~~~ 217 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RERIESGY-----------RM-PAP 217 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHHHhcCC-----------CC-CCC
Confidence 11233567999999988899999999999999999999 7888865443211 11111100 00 011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 573 LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
......+.+++.+||+.+|.+||++.||++.|.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.90 Aligned_cols=265 Identities=27% Similarity=0.354 Sum_probs=202.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999998889999999986432 2235678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|..+.... ..+++.+++.++.||++||.|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999888876543 238999999999999999999999 8999999999999999999999999999986544
Q ss_pred CCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH-HHHHHHhhhcccc----hh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDWVKELHLEGE----IT 561 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~----~~ 561 (653)
.. .......++..|+|||++.+ ..++.++||||||++++||++|+.|+......+... +..+......... ..
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred Cc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 32 22233457889999998865 457789999999999999999999987544322111 1111000000000 00
Q ss_pred Hhhhhcc-Cc---------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 562 QAIDQTL-DY---------YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 562 ~~~d~~l-~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...+... .. ........+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000 00 001224678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.00 Aligned_cols=243 Identities=26% Similarity=0.310 Sum_probs=190.2
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhc---CCCceeeeeeeecccceeEEEEeccCC
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRL---RHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
||+|+||.||+|....+++.||||++.... ......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999889999999986432 22334455677776665 699999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|..++... ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~ 151 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-K 151 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-C
Confidence 9999888653 348899999999999999999999 899999999999999999999999999987543221 2
Q ss_pred cccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCc
Q 048419 492 QTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 570 (653)
......||..|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+ ..+.. .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~~i----~~~~~------~~~- 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YRNI----AFGKV------RFP- 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HHHH----HcCCC------CCC-
Confidence 22345789999999998754 478999999999999999999999976433211 0000 01100 000
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHH
Q 048419 571 YDLAEAELVLNLGLFCSAPNPVYRP----DMRRVVEFL 604 (653)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~~L 604 (653)
.......+.+++.+||+.||.+|| ++.+++++-
T Consensus 218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 011235678999999999999998 567776643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.35 Aligned_cols=256 Identities=27% Similarity=0.318 Sum_probs=214.9
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch---hhHHHHHHHHHHHhhcC-CCceeeeeeeeccccee
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---QGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 402 (653)
.....|...+.||+|.||.||+++.+.+|+.+|+|.+.+... ...+...+|+.+|+++. |||||.+.+.++....+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 344567778999999999999999999999999999976533 34568899999999998 99999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CcEEEEe
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY----LNAKLGD 478 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 478 (653)
++|||+|.||.|.+.+... .+++.....++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999765 28899999999999999999999 999999999999999433 5799999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
||++..... .......+||+.|+|||.+....++..+||||+||++|.|++|..||.......... . ...+
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--~-----i~~~ 253 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--A-----ILRG 253 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--H-----HHcC
Confidence 999998765 345566799999999999999999999999999999999999999998766433221 1 1111
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+. ..-...-......+.+++..|+..||..|+++.+++++.+
T Consensus 254 ~~-----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 DF-----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CC-----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11 0001111233677899999999999999999999999754
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.23 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=202.7
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
...||+|+||.||++....++..||||.+........+.+.+|+..+++++|+|++++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 45699999999999999888999999998766656667889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++... .+++.+++.++.||+.||.|||+ ++++||||||+||++++++.+||+|||++....... ....
T Consensus 107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 176 (292)
T cd06658 107 TDIVTHT------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRK 176 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCc
Confidence 9988532 37889999999999999999999 899999999999999999999999999987653322 2223
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... .+. ..+.+.+. ....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~---------~~~~~~~~-~~~~ 243 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR---RIR---------DNLPPRVK-DSHK 243 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH---------hcCCCccc-cccc
Confidence 3468899999999988889999999999999999999999997544322111 000 00111110 0112
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 575 EAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
....+..++.+||+.||.+|||+.|++++-.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 2356788999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.81 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=196.6
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
...+|...+.||+|+||.||+|....++..||+|..... ....|+.++++++|+||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999999988999999985332 23468999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
++. ++|.+++... ...+++.+++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 138 HYS-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred ccC-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 995 6888888654 2458999999999999999999999 8999999999999999999999999999975332
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhh--------HHHHHHHHHhhhc-cc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA--------ELLLVDWVKELHL-EG 558 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~--------~~~l~~~~~~~~~-~~ 558 (653)
. .......||..|+|||++.+..++.++|||||||++|||+++..++....... ...+.+.+..... ..
T Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 1 22233568999999999998899999999999999999999766543221110 1111111111100 00
Q ss_pred ch---------hHhhhh-ccC-----cC----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 559 EI---------TQAIDQ-TLD-----YY----DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 559 ~~---------~~~~d~-~l~-----~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. ...++. ... .+ .......+..++.+||+.||.+|||+.||+++-
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp 352 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP 352 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCc
Confidence 00 000000 000 00 001123456799999999999999999999863
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.21 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=208.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||.|+||.||+|....++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999988889999999986542 33567899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++..... ...+++.....++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999976432 2458899999999999999999999 99999999999999999999999999998866543
Q ss_pred CCC---cccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 489 ANP---QTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 489 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
... ......|+..|+|||.+... .++.++|+|||||+++||++|+.||....... .+.+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~----------~ 223 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN----------D 223 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC----------C
Confidence 222 12334688999999998776 78899999999999999999999997543321 11111111 0
Q ss_pred hhccCcC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 565 DQTLDYY--DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 565 d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+.+... .......+.+++.+||+.||++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111100 11234678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.07 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=205.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|+..+.||+|+||.||+|+... ....+++|.+.....+ ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 567888999999999999999643 3467999998654433 4678999999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccc----cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKL----RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
+||||+++|+|.+++....... ...+++.+++.++.|++.||+|||+ .+|+|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654211 1258999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ...... .+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~----~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ----AG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH----cC
Confidence 9987543322222233456778999999988888999999999999999999 778886433211 111111 01
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.... .........+.+++.+||+.+|.+||++.|+++.|.
T Consensus 235 ~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1000 001123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=308.70 Aligned_cols=263 Identities=21% Similarity=0.263 Sum_probs=205.5
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|++|.||+|.+..+|..||+|++.... ....+.+.+|+.++++++|+|++++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677899999999999999998889999999987543 33456889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+ +++|.+++.... ..+++.+++.++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999986543 458999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc---hh---
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE---IT--- 561 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~--- 561 (653)
.........++..|+|||.+.+. .++.++||||+||+++||++|+.++........ ..++........ ..
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhcc
Confidence 32223345688999999998654 468899999999999999999887765443221 111111110000 00
Q ss_pred ------HhhhhccC-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 562 ------QAIDQTLD-----YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 562 ------~~~d~~l~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
....+... .........+.+++.+||+.+|.+||++++++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000000 00012247889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=315.79 Aligned_cols=257 Identities=22% Similarity=0.272 Sum_probs=197.2
Q ss_pred ceeeeee--CcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 335 QNLVGSG--GFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 335 ~~~LG~G--~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
.++||+| +|++||++....+|+.||+|++... .....+.+.+|+++++.++||||++++++|...+..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 5689999 7899999999999999999999654 23344567789999999999999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+|+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 83 YGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999996543 2348899999999999999999999 8999999999999999999999999986543321110
Q ss_pred -C-----cccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 491 -P-----QTTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 491 -~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...... +.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-----~~~~~ 229 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLN-----GTVPC 229 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhc-----CCccc
Confidence 0 1112346778999999875 3588999999999999999999999975432211 111100 00000
Q ss_pred hhh-------------------hcc------------------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 AID-------------------QTL------------------DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ~~d-------------------~~l------------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.++ ... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 000 000 001112345788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=305.29 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=203.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCC-CCcEEEEEEeccC----------chhhHHHHHHHHHHHhh-cCCCceeeeeeeecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPS-LGLEVAIKRIGHN----------SQQGMKEFVAEIMSMGR-LRHRNLVQLHGWCRK 398 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 398 (653)
+|+..+.||+|+||.||+|.+.. .++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999877 6789999987532 22344567788888875 799999999999999
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
.+..+++|||+++++|.+++...... ...+++..+++++.|++.+|.|||+. .+++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988543211 34588999999999999999999952 6899999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...+. .+
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~~~~----~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---ATKIV----EA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HHHHh----hc
Confidence 99998654332 23345688999999999988899999999999999999999999875432211 11110 00
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
... + . ........+.+++.+||+.||++||++.|+.++++
T Consensus 229 ~~~----~-~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----P-L--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----c-C--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 0 0 00112456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=313.30 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=205.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch---hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|++|.||+|....+++.+|+|.+..... ...+.+..|++.+++++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468888999999999999999998899999999975432 35567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999987543 3458899999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCC----------------------------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCCh
Q 048419 487 HGANP----------------------------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEP 538 (653)
Q Consensus 487 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~ 538 (653)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 22110 11123578899999999988899999999999999999999999976
Q ss_pred hhhhhHHHHHHHHHhhhcccchhHhhhhccC-cCCHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Q 048419 539 QKAAAELLLVDWVKELHLEGEITQAIDQTLD-YYDLAEAELVLNLGLFCSAPNPVYRPD----MRRVVEF 603 (653)
Q Consensus 539 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~ 603 (653)
...... +.. ....... .........+.+++.+||+.+|++||+ +.|++++
T Consensus 235 ~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 235 SNRDET--FSN-------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CchHHH--HHH-------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 543211 111 1111110 001114577999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=306.76 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=203.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc----EEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL----EVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
.+|+..+.||+|+||.||+|....++. .+|+|.+.... ......+.+|+..+++++|+|+++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456778899999999999999865554 58999886553 4456788999999999999999999999987 78899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++++|+||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999997653 348999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCCcc-cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANPQT-THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
......... ....++..|+|||.+....++.++||||||+++|||++ |+.||......+ +.+.+.. +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~~~-- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEK----GER-- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhC----CCC--
Confidence 653322111 11223568999999988889999999999999999999 999997643321 1111111 100
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
. ..+......+.+++.+||..+|.+||++.++++.|...
T Consensus 230 -----~-~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -----L-PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -----C-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 01111235678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=304.01 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=192.6
Q ss_pred eeeeeeCcEEEEEEEeCC---CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecc-cceeEEEEeccC
Q 048419 336 NLVGSGGFGRVYRGLMPS---LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QDELLLVYDYVP 410 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 410 (653)
+.||+|+||.||+|.+.+ ....+|+|++... .....+.+.+|+.+++.++|||+++++++|.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 3467999998543 34456788899999999999999999998764 456789999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999997543 236777888999999999999999 8999999999999999999999999999975532211
Q ss_pred ---CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCC-CCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 491 ---PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR-RSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 491 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.......++..|+|||.+.+..++.++|||||||++|||++|+ .|+...... .+...+.. +.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~----~~------- 219 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQ----GR------- 219 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhc----CC-------
Confidence 1112234567899999998888999999999999999999965 455433221 11111111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. ..+...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 220 ~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 220 RL-LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00 0011123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=305.31 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=199.3
Q ss_pred eeeeeeCcEEEEEEEeCCCC------cEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 336 NLVGSGGFGRVYRGLMPSLG------LEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+.||+|+||.||+|...+.. +.+|||.+.... ......+.+|+..+++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999876433 689999886543 34567889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccccc--ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-----cEEEEeecC
Q 048419 409 VPNGSLDKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-----NAKLGDFGL 481 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGl 481 (653)
+++++|.+++...... ....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999754221 12447899999999999999999999 8999999999999998877 899999999
Q ss_pred cccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 482 AKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 482 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||....... ....+.. +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~----~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVTA----GG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHhc----CC
Confidence 976533211 11122345678999999999999999999999999999998 999986543321 1111111 00
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. .........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 231 -------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -------RL-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------cc-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 111123467889999999999999999999999985
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.16 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=200.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-----chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--cee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-----SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 402 (653)
.+|+..+.||+|+||.||+|....++..||||.+... .....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999999988999999988532 123456788999999999999999999988664 467
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
+++|||+++++|.+++... ..+++...++++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999998653 237888899999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 483 KIYEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 483 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
+....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......... .. .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~----~~~~~-- 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI--FK----IATQP-- 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--HH----HhcCC--
Confidence 86532111 1122345888999999998888999999999999999999999999754322111 00 00000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.....+......+.+++.+|+. +|.+||++.||+++-
T Consensus 226 ------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 226 ------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred ------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 0011222344567788889985 999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.40 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=203.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-------CCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
.+|...+.||+|+||.||++.... .+..||+|.+... .....+.+.+|+.+++++ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 357788999999999999997532 1246999988654 334567899999999999 7999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
..++++||+++|+|.+++..... .....++|.+++.++.|++.||.|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999976421 012358899999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... +
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence 9999999999999865432211 1122234567999999998889999999999999999998 888886543221 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
...+.. +.. ..........+.+++.+||+.+|.+||++.|+++.|+.-
T Consensus 246 ~~~~~~----~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 246 FKLLKE----GHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred HHHHHc----CCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 000 011112345788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.65 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=204.3
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|...+.||+|+||.||+|....++..|++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 47778999999999999999988899999999876543 3677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999998653 247889999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCcc---cccccCCcccCccccccCC---CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 489 ANPQT---THIVGTLGYLAPELTRTGK---ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 489 ~~~~~---~~~~gt~~y~aPE~~~~~~---~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
..... ....++..|+|||.+.... .+.++||||||++++||++|+.||.......... ..+.. +.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~~----~~--- 223 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVGA----GH--- 223 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHhc----CC---
Confidence 22211 1346788999999998766 8899999999999999999999997543211110 00000 00
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+.+.. .......+.+++.+||+.+|.+||++.+++.+
T Consensus 224 --~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 --KPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --CCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 001100 01124567899999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=303.70 Aligned_cols=239 Identities=26% Similarity=0.462 Sum_probs=191.7
Q ss_pred eeeeeeCcEEEEEEEeCCCC----------cEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 336 NLVGSGGFGRVYRGLMPSLG----------LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
+.||+|+||.||+|.+...+ ..+++|.+...... ...+.+|+.++++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999997665 35888887554433 6788999999999999999999999988 778999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-------cEEEEe
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-------NAKLGD 478 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 478 (653)
+||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999997643 258899999999999999999999 9999999999999999888 799999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccC--CCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhh
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
||++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+.......... +..
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~--- 220 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ--- 220 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh---
Confidence 999986543 1223566789999998876 78899999999999999999 567775543211110 000
Q ss_pred cccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 556 LEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 556 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
... .+ .......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ~~~--------~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH--------RL---PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC--------CC---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00 0011267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.37 Aligned_cols=296 Identities=28% Similarity=0.374 Sum_probs=237.4
Q ss_pred CHHHHHHhhc-CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeee
Q 048419 321 KYAELASVTK-GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396 (653)
Q Consensus 321 ~~~el~~at~-~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 396 (653)
..-|+...|. .|+.-++||+||||.||-++...+|+.+|.|++.+. .+++....++|-.+|++++.+.||.+--.+
T Consensus 175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 3344444444 478889999999999999999999999999998654 344556678899999999999999999999
Q ss_pred cccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 397 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
+..+.+|+|+..|.||+|.-+|.+.+ ...+++...+-.+.+|+-||++||. ++||.|||||+|||||+.|+++|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEe
Confidence 99999999999999999999998876 3568999999999999999999999 99999999999999999999999
Q ss_pred EeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 477 GDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 477 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
+|+|||..+..+.. ....+||.+|||||++.+..|+...|-||+||+||||+.|+.||.........
T Consensus 329 SDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------- 395 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------- 395 (591)
T ss_pred eccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-----------
Confidence 99999998765443 33458999999999999999999999999999999999999999865543211
Q ss_pred ccchhHhhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH----------HHcCCCCCC---CCC
Q 048419 557 EGEITQAIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVE----------FLLGDSSLP---PLP 614 (653)
Q Consensus 557 ~~~~~~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~----------~L~~~~~~p---~~p 614 (653)
+-+|.+. ..++....+++..|....|+.||.+|- .+.+|.+ +|+..+-.| |.|
T Consensus 396 -----eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 396 -----EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred -----HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 1122222 233344567788888999999999996 4446654 344333333 334
Q ss_pred CccccccccccCCcCCC------CCCcccccc
Q 048419 615 PDIHLKDTRNIMGFSDF------PNDSDFFNS 640 (653)
Q Consensus 615 ~~~~~~~~~~~~~~~~~------~~~~~~~~~ 640 (653)
...+.++.-.+.+||+. ..|.+||.+
T Consensus 471 ~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~ 502 (591)
T KOG0986|consen 471 GAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKN 502 (591)
T ss_pred cccchhhhhhhhhcccccceecccccHHHHHh
Confidence 44577888888888876 455677765
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.88 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=204.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|...+.||+|+||.||+|....+|..+|+|.+... .....+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999999988999999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCcccccC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAKIYEH 487 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~ 487 (653)
+++++|.+++.... ...+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999987643 2347899999999999999999999 8999999999999998885 469999999986643
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. .......|++.|+|||.+.+..++.++||||||++++||++|+.|+....... ++.... ...
T Consensus 155 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~---------~~~ 218 (257)
T cd08225 155 SM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC---------QGY 218 (257)
T ss_pred Cc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh---------ccc
Confidence 22 12223458889999999988889999999999999999999999997543221 111111 111
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+..........+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.42 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=201.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch----------hhHHHHHHHHHHHhhcCCCceeeeeeeecccc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ----------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD 400 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 400 (653)
+|...+.||+|+||.||+|....+++.+|+|.++.... ...+.+.+|+..+++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 35667899999999999999988899999998853211 12346788999999999999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+ ++++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998764 348889999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCC-cccccccCCcccCccccccCC--CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 481 LAKIYEHGANP-QTTHIVGTLGYLAPELTRTGK--ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 481 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
+++........ ......++..|+|||.+.... ++.++|+||||++++||++|+.|+.......... + ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~----~~~~ 227 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF--K----LGNK 227 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH--H----hhcc
Confidence 99865432111 123346788999999987654 7889999999999999999999996543321110 0 0000
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. ....+.. .........+.+++.+||+.+|.+||++.+|+++
T Consensus 228 ~-~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 R-SAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-cCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 0000001 1111234678899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.61 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=207.5
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.++.|+..+.||+|.|+.||++.+..+|+.+|+|.+... +..+.+++.+|+.+-+.|+|||||++...+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346677788999999999999999999999999988532 445778899999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEEeecCc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDFGLA 482 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla 482 (653)
+|+|.|++|..-+-.+ ...++...-...+||+++|.|+|. ++|||||+||.|++|-+ .--+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999997655443 347778888899999999999999 99999999999999943 345899999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
..+. ........+||++|||||+++...++..+|||+.||+||-|+.|+.||.+.+.. .+.+.+.. +...
T Consensus 161 i~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~----g~yd- 230 (355)
T KOG0033|consen 161 IEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKA----GAYD- 230 (355)
T ss_pred EEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhc----cccC-
Confidence 9876 233445678999999999999999999999999999999999999999874432 12211111 1000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.-.+.+ ....+...+|+.+||..||.+|.|+.|.+.+-+
T Consensus 231 ~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 231 YPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 000001 112467889999999999999999999887543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.16 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=206.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 406 (653)
++|...+.||.|++|.||++.+..+++.+|+|.+.... ......+.+|++.+++++|+||++++++|.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999998889999999987543 34567789999999999999999999988554 4689999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++..... ....+++..+..++.||++||.|||+ .+++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999998764322 13457888999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhh--hhHHHHHHHHHhhhcccchhHhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKA--AAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+..... .....+..++.... ....
T Consensus 157 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~- 228 (287)
T cd06621 157 NSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPEL- 228 (287)
T ss_pred ccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chhh-
Confidence 321 1234578899999999988999999999999999999999999976522 11111222222110 0000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.... .......+.+.+++.+||+.+|.+|||+.|++++-.
T Consensus 229 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 229 KDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred ccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0000 000123467899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=307.53 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=201.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||.|++|.||+|+...+++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999998889999999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
++ ++|.+++.... ...+++.+++.++.|++.||+|||+ ++++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 68988886543 3458899999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc-c-------
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG-E------- 559 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~------- 559 (653)
.. ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||........ +........... .
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhH
Confidence 21 122335678999999887654 58899999999999999999999975443221 111111100000 0
Q ss_pred hhH-------hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 560 ITQ-------AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 560 ~~~-------~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+.+ .....+..........+.+++.+||+.||.+||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 00000000001123567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.63 Aligned_cols=264 Identities=25% Similarity=0.318 Sum_probs=202.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-----hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-----GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
+|...+.||+|++|.||+|....+++.||||++...... ....+..|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 467788999999999999999888999999999755322 345677899999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+ +++|.+++.... ..+++..++.++.||++||.|||+ ++++|+||||+||+++.++.+||+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999996543 258999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--ccc---
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--EGE--- 559 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~--- 559 (653)
..... ......++..|+|||.+.+ ..++.++|||||||+++||++|..++......... ......... ...
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFEALGTPTEENWPG 229 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHHHcCCCchhhhhh
Confidence 44321 2222356788999998854 45788999999999999999998777654332211 111110000 000
Q ss_pred ---hhHhhhhcc------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 560 ---ITQAIDQTL------DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 560 ---~~~~~d~~l------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
......... ..........+.+++.+||+.+|.+||++.|++++=.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 000000000 0011123467889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.93 Aligned_cols=247 Identities=26% Similarity=0.317 Sum_probs=204.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||++.+..+++.+|+|++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688899999999999999999988999999998643 2234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998664 348899999999999999999999 999999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||....... ....+. .+..
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~------ 215 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKIL----EGKV------ 215 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh----cCCc------
Confidence 43 233468899999999988888999999999999999999999997544211 111100 1110
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
..+......+.+++.+||+.||.+|| +++|++++-
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 01111246788999999999999999 788887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.43 Aligned_cols=267 Identities=21% Similarity=0.305 Sum_probs=200.5
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++++|...+.||+|+||.||+|....++..||+|++..... .....+.+|+..+++++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46789999999999999999999988899999999865432 23346778999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+. ++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++++||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 67777765432 347788889999999999999999 899999999999999999999999999987543
Q ss_pred CCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc------
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE------ 559 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------ 559 (653)
... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||.......+.....|.........
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 155 IPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 221 112233568899999998754 578899999999999999999999975543221111111000000000
Q ss_pred -hhHhhhh--------ccC--cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 560 -ITQAIDQ--------TLD--YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 560 -~~~~~d~--------~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+...... .+. .........+.+++.+|++.||.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 000 0001124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=310.46 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=200.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc----EEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL----EVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....++.+|+.++++++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 456778899999999999999866665 57889886543 23345788999999999999999999999764 4679
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999987543 347889999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... ..+++... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~----~--- 228 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEKG----E--- 228 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHCC----C---
Confidence 6432221 1222345678999999988889999999999999999997 899987543221 11221111 0
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+. ........+.+++..||..+|++||++.++++.|..
T Consensus 229 ----~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 229 ----RLP-QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred ----CCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 001123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=313.02 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=161.5
Q ss_pred ceeeeeeCcEEEEEEEeC--CCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc--cceeEEEEeccC
Q 048419 335 QNLVGSGGFGRVYRGLMP--SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QDELLLVYDYVP 410 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 410 (653)
.++||+|+||.||+|... .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 356889999986442 23456789999999999999999998854 456899999995
Q ss_pred CCCchhhhhccccc----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEEeecCc
Q 048419 411 NGSLDKLLFDKDHK----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL----DTYLNAKLGDFGLA 482 (653)
Q Consensus 411 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 482 (653)
++|.+++...... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4888777543211 12358889999999999999999999 899999999999999 45678999999999
Q ss_pred ccccCCCC--CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChh
Q 048419 483 KIYEHGAN--PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQ 539 (653)
Q Consensus 483 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~ 539 (653)
+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643321 122345789999999998764 5889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.99 Aligned_cols=248 Identities=29% Similarity=0.434 Sum_probs=198.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++|+|++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 3577889999999999999975 47889999986432 346788999999999999999999998654 479999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 81 SKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999999997653 2357899999999999999999999 899999999999999999999999999987543221
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+.. +...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~~~~------- 216 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKECVEK----GYRM------- 216 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhC----CCCC-------
Confidence 12234568999999988899999999999999999998 899887544321 1111111 1000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
......+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 217 -EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254 (254)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence 01112346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.12 Aligned_cols=255 Identities=26% Similarity=0.320 Sum_probs=197.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHH-HhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMS-MGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||.||++.+..+|+.||+|++.... .+....+..|+.. ++.++|+|++++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999999899999999986542 2334455666664 566789999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|++ |+|.+++...... ...+++..++.++.||+.||+|||+ + +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 6888887653221 3568999999999999999999998 6 89999999999999999999999999998653
Q ss_pred CCCCCcccccccCCcccCcccccc----CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRT----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
... ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.|+.......+ .+..... +
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~-----~---- 223 (283)
T cd06617 156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQVVE-----E---- 223 (283)
T ss_pred ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHHHh-----c----
Confidence 321 1122467889999998864 3468899999999999999999999964322111 0100000 0
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..+.+ ........+.+++.+||+.+|.+||++.+++++-
T Consensus 224 -~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 224 -PSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred -CCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00111 0111346688999999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.58 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=200.3
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc------hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS------QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
+|...+.||+|+||.||+|... ++..+|||.+.... ....+.+.+|++.+++++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 3667889999999999999874 58899999886432 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++..
T Consensus 80 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 80 FMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 999999999999996542 47899999999999999999999 8999999999999999999999999999876
Q ss_pred ccCCC-----CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 485 YEHGA-----NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 485 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
..... ........++..|+|||.+.+..++.++|||||||+++||++|+.||.......... .... ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~---~~~~ 226 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIGA---HRGL 226 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hhhh---ccCC
Confidence 43211 111223468899999999998889999999999999999999999997543321110 0000 0000
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. + ..+......+.+++.+||+.+|.+||++.|++++
T Consensus 227 ~-----~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 M-----P---RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred C-----C---CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 1 1111234668899999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.43 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=203.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||++.....++.|++|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999999989999999986543 234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 999999999999654 348899999999999999999999 899999999999999999999999999987421
Q ss_pred CCCC--------------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 487 HGAN--------------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 487 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
.... .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~~~~~ 230 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQVIS 230 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh
Confidence 1100 01112357889999999988889999999999999999999999997543321 1111000
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+... .+. ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 -----~~~~---~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 -----DDIE---WPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -----cccC---CCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 000 001234568899999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.81 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=211.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.++++++|||++++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999988788999999987655555678899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.+. .+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998643 37888999999999999999999 899999999999999999999999999987654332
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
. ......+++.|+|||.+....++.++||||||+++|||++|+.||........... ....+. +..
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~------~~~- 235 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PEL- 235 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCC------CCC-
Confidence 2 22234688899999999888899999999999999999999999976543221100 000000 000
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--cCCCCCCCCCC
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL--LGDSSLPPLPP 615 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L--~~~~~~p~~p~ 615 (653)
.........+.+++.+||+.+|.+||++.+++.+- ....++-.+||
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~ 283 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP 283 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence 01112345688999999999999999999999863 44444444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=304.87 Aligned_cols=258 Identities=27% Similarity=0.341 Sum_probs=204.4
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc-----
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD----- 400 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 400 (653)
..+++|+..+.||+|++|.||+|....+++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 457889999999999999999999988899999999865543 346789999999999 6999999999996644
Q ss_pred -eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 401 -ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 401 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
.+++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999998865321 13468899999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCcccccc-----CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhh
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRT-----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
|++....... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||........ +....
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~--- 231 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKIP--- 231 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHhh---
Confidence 9987654322 22233468889999998753 3467899999999999999999999975432211 11100
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
... .+.+ .........+.+++.+||..||.+|||+.+++++
T Consensus 232 --~~~-----~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 --RNP-----PPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --ccC-----CCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 0111 1111234678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=310.29 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=201.3
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
...||+|+||.||++....++..||+|.+........+.+.+|+..++.++|||++++++++...+..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999999888999999999765555567788999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
..++.. ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ....
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 987743 237899999999999999999999 899999999999999999999999999987554322 1223
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...++..|+|||.+.+..++.++|||||||+++||++|+.||......... ..+... . .... .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~----~-----~~~~-~~~~~ 242 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRDS----P-----PPKL-KNAHK 242 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcc----C-----CCCc-cccCC
Confidence 356889999999999888999999999999999999999999754432211 111110 0 0000 00011
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
....+.+++.+||+.+|.+||++.+++++-
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 235678999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.36 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=202.9
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
|+..+.||+|+||.||+|....++..+|||.+.... ....+.+.+|+..+++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566889999999999999998889999999986442 3445678899999999999999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+++|.+++... .+++..+..++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 86 GGSALDLLEPG------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999998542 37899999999999999999999 999999999999999999999999999987654321
Q ss_pred CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCc
Q 048419 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 570 (653)
.......++..|+|||.+.+..++.++|+|||||+++||++|..|+....... ....+. ... ...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~----~~~--------~~~ 220 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLIP----KNN--------PPT 220 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHHh----cCC--------CCC
Confidence 11223467889999999988889999999999999999999999987543211 111110 000 011
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
........+.+++.+||+.+|.+||++.+++++-
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 1122346688999999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.44 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=199.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|...+.||+|+||.||+|....+|+.+|+|++.... ......+.+|++++++++|+|++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999999899999999986532 22235677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
++ ++|.+++.... ..+++.+++.++.||++||.|||+ ++++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 57888776432 348999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc------hh
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE------IT 561 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 561 (653)
.. ......++..|+|||.+.+.. ++.++|||||||++|||++|+.|+......... + +.+........ +.
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-H-HHHHHHhCCCChHHhHHhh
Confidence 21 122345788999999887644 688999999999999999999986543321111 1 11110000000 00
Q ss_pred Hhhhhc----c-C-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 562 QAIDQT----L-D-----YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 562 ~~~d~~----l-~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+..+.. . . .........+.+++.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 0 0 0011134678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.31 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=189.4
Q ss_pred ceeeeeeCcEEEEEEEeCC--CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc--cceeEEEEeccC
Q 048419 335 QNLVGSGGFGRVYRGLMPS--LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QDELLLVYDYVP 410 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 410 (653)
.+.||+|+||.||+|.... .+..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999654 45789999986442 23457789999999999999999998844 457899999996
Q ss_pred CCCchhhhhcccc----cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEEeecCc
Q 048419 411 NGSLDKLLFDKDH----KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL----DTYLNAKLGDFGLA 482 (653)
Q Consensus 411 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 482 (653)
+ +|.+++..... .....+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 77777653211 112358889999999999999999999 899999999999999 56778999999999
Q ss_pred ccccCCCCC--cccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhH-------HHHHHHHH
Q 048419 483 KIYEHGANP--QTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAE-------LLLVDWVK 552 (653)
Q Consensus 483 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-------~~l~~~~~ 552 (653)
+........ ......+|+.|+|||.+.+. .++.++|||||||++|||+||+.||........ ..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 876443221 22345689999999998764 578999999999999999999999975432110 00000010
Q ss_pred hhh-----------cccchhHhhhh-------------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 553 ELH-----------LEGEITQAIDQ-------------TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 553 ~~~-----------~~~~~~~~~d~-------------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
... ........... .+..........+.+|+.+|++.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00000000000 0000011122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.42 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=205.2
Q ss_pred cCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhh--cCCCceeeeeeeec
Q 048419 320 FKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR--LRHRNLVQLHGWCR 397 (653)
Q Consensus 320 f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~ 397 (653)
.++---+++.+.....+.||+|.||.||+|.++ |+.||||++...+ .+.+.+|.++.+. |+|+||+.+++.-.
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 333344566677888899999999999999997 7899999995433 3556677777765 59999999998765
Q ss_pred ccc----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEE
Q 048419 398 KQD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE-----CNQRVVHRDVKPSNILL 468 (653)
Q Consensus 398 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll 468 (653)
..+ .++||.+|.++|||.+||... .++.+..++++.-+|.||++||.+ ..+.|.|||||+.|||+
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 543 689999999999999999764 388899999999999999999973 35779999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCC---CcccccccCCcccCccccccCC------CCCccceeehHHHHHHHHhCC------
Q 048419 469 DTYLNAKLGDFGLAKIYEHGAN---PQTTHIVGTLGYLAPELTRTGK------ATTSTDVYSYGILMLEVACGR------ 533 (653)
Q Consensus 469 ~~~~~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~s~Gvvl~elltG~------ 533 (653)
..++.+.|+|+|||........ ......+||.+|||||++...- .-..+||||||+++||++...
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 9999999999999987655432 2234568999999999986531 224789999999999997532
Q ss_pred ----CCCChhhhhhHHHHHHHHHhhhcccchhHh-----hhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048419 534 ----RSIEPQKAAAELLLVDWVKELHLEGEITQA-----IDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 534 ----~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-----~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
.||....+.+ ..-+++.++ +.|.. .+...+.+..+.+|+..||..||..|-|+-.+-+
T Consensus 430 eey~~Pyyd~Vp~D-----------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSD-----------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred hhhcCCcccCCCCC-----------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4544332211 111112221 11222 3455678899999999999999999999999988
Q ss_pred HHcCCCC
Q 048419 603 FLLGDSS 609 (653)
Q Consensus 603 ~L~~~~~ 609 (653)
.|.....
T Consensus 499 tl~~l~~ 505 (513)
T KOG2052|consen 499 TLAKLSN 505 (513)
T ss_pred HHHHHhc
Confidence 8865443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=306.00 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=201.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
+.|...+.||+|+||.||+|....+++.||+|++... ..+..+.+.+|+++++.++|||++++.++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5578889999999999999999888999999998643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||++ |+|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 57777765432 348999999999999999999999 899999999999999999999999999987643
Q ss_pred CCCCCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+.......... ... ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~---~~~----~~~~--- 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIA----QNDS--- 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH---HHh----cCCC---
Confidence 22 2346788999999874 4568889999999999999999999987654322110 000 0000
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+. .........+.+++.+||+.+|.+||++.+|+++..-
T Consensus 232 --~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 232 --PT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred --CC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 00 0112234678999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.69 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=206.3
Q ss_pred cceeeeeeCcEEEEEEEeCCCC----cEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLG----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
..++||+|+||+||||.+-..| .+||||++... ..+...++++|+..|.+|+|||+++|+|+|.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 3679999999999999875444 46899988654 5566789999999999999999999999998776 8899999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
||.|+|.+|++.+ +..+-.+..+.|+.|||+||.|||+ +.++||||..+|||+.+-..+||.|||+++....+
T Consensus 779 mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred cccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999886 3557888899999999999999999 99999999999999999999999999999988665
Q ss_pred CCCccc-ccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 489 ANPQTT-HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 489 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
...-.. ...-.+.|||-|.+....++.++|||||||++||++| |..|++.....+ +.+++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhc
Confidence 433222 1233568999999999999999999999999999999 999998754432 2222211
Q ss_pred cc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. ...+..+...+..++.+||..|+..||+++++...+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11 22344566778899999999999999999999987643
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.93 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=201.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCC--CCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPS--LGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELL 403 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 403 (653)
+|+..+.||+|+||.||+|.... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778999999999999999987 78999999997632 33456778899999999999999999999888 7899
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC----CCcEEEEee
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT----YLNAKLGDF 479 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 479 (653)
+||||+++ +|.+++..........+++..++.++.||+.||.|||+ ++++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67776654332223368889999999999999999999 89999999999999999 999999999
Q ss_pred cCcccccCCCC--CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhh-------HHHHHH
Q 048419 480 GLAKIYEHGAN--PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAA-------ELLLVD 549 (653)
Q Consensus 480 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~-------~~~l~~ 549 (653)
|++........ .......++..|+|||.+.+. .++.++|||||||+++||++|+.||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643322 112234678899999987664 57899999999999999999999997544321 001111
Q ss_pred HHHhhhcc-----------cchhHhhhhcc-CcCC---------H--HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 550 WVKELHLE-----------GEITQAIDQTL-DYYD---------L--AEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 550 ~~~~~~~~-----------~~~~~~~d~~l-~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+...... .......+... ..+. . .....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100000 00000000000 0000 0 223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.26 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=208.7
Q ss_pred CcceeeeeeCcEEEEEEEeCC----CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 333 GEQNLVGSGGFGRVYRGLMPS----LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
...++||.|-||.||+|.... ....||||..+.. ..+..+.|++|..+|++++||||++++|.|.+. ..|||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 345789999999999998642 2346899998764 556688999999999999999999999999766 4799999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
.++-|.|..||..+. ..|+.......+.||+.||+|||+ ..+|||||..+|||+.+..-+||+|||+++.++.
T Consensus 471 L~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred cccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999998764 458888899999999999999999 9999999999999999999999999999999887
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
......+...-.+.|||||.+.-.+++.++|||.|||++||++. |.+||....+.+... ....|+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGe------- 609 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGE------- 609 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCC-------
Confidence 76655555555779999999999999999999999999999877 999998765533211 111111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
++ ..+..++..+..|+.+||+.+|.+||.+.|+...|
T Consensus 610 Rl-P~P~nCPp~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 610 RL-PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred CC-CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 11 23445778899999999999999999999988665
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.51 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=199.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||+|++|.||+|....+++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 568889999999999999999988899999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++ +|.+++.... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 975 9999886543 357889999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhh-hHHHHHHHHHhhhcccchhHhhh-
Q 048419 489 ANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAA-AELLLVDWVKELHLEGEITQAID- 565 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d- 565 (653)
.. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .......................
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11 1122346788999998865 45788999999999999999999999654321 11111100000000000000000
Q ss_pred -------------hccCc--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 566 -------------QTLDY--YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 566 -------------~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..+.. ........+.+++.+||+.+|.+||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 001112567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.93 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=202.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcC---CCceeeeeeeecccceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLR---HRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 406 (653)
.|+..+.||+|+||.||+|.+..++..||+|.+... .....+++.+|+.++++++ |+|++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466788999999999999999888999999998654 3345567889999999997 999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++... .+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999988543 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... ......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||......... .. .... ..
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~~-~~~~-----~~ 219 (277)
T cd06917 153 QNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------ML-IPKS-----KP 219 (277)
T ss_pred CCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------hc-cccC-----CC
Confidence 4332 22334688899999988654 4688999999999999999999999754332111 00 0000 00
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+.+.. ......+.+++.+||+.||.+||++.+++++-
T Consensus 220 ~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 220 PRLED--NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 11100 01345788999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.77 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=201.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC--CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS--LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.+|...+.||+|+||.||++...+ .+..||+|.+... +...+|++++++++|+||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 468889999999999999997643 4578999988543 234589999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
++. ++|.+++.. ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 167 ~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 167 KYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 995 688888843 2458999999999999999999999 8999999999999999999999999999976543
Q ss_pred CCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH-HHHHHHHHhhhc------cc-
Q 048419 488 GAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE-LLLVDWVKELHL------EG- 558 (653)
Q Consensus 488 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~------~~- 558 (653)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...+..... ..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 322 222345799999999999988999999999999999999999999975432211 111111111000 00
Q ss_pred --chhHhhhh---cc-CcCC-------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 559 --EITQAIDQ---TL-DYYD-------LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 559 --~~~~~~d~---~l-~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
.+...+.. .. ..+. ......+.+++.+||+.||.+||++.|++.+-...+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 00000000 00 0000 012346778999999999999999999999865443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.29 Aligned_cols=267 Identities=26% Similarity=0.339 Sum_probs=200.5
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----ce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-----DE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 401 (653)
++++|...+.||+|+||.||+|.+..+|+.||||++... .......+..|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 457899999999999999999999888999999998643 233456788999999999999999999987544 35
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.++|+||+++ +|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccc
Confidence 7999999964 78777743 248899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC--cccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 482 AKIYEHGANP--QTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 482 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
+......... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..............+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9865432211 1123467899999998654 468899999999999999999999997543322111000000000000
Q ss_pred chhHhhhhc-------c---CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 559 EITQAIDQT-------L---DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 559 ~~~~~~d~~-------l---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+....+.. + .... ......+.+++.+||+.+|.+||++.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 111101000 0 0000 11245688999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.02 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=204.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++.+++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999998889999999996532 2456789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... ..+++.++..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998654 248889999999999999999999 8999999999999999999999999999886543
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+..........+ ...... .
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~---------~ 217 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET---------A 217 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc---------c
Confidence 32 22334678899999999888899999999999999999999999986543211111 111100 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDM--RRVVE 602 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~ 602 (653)
....+......+.+++.+||+.||.+||++ +|+++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 011112234678899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.82 Aligned_cols=265 Identities=27% Similarity=0.380 Sum_probs=202.8
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+|+..+.||+|++|.||+|....+|..||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47788999999999999999998899999999876533 23466788999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++ +|.+++..... ...+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 85 88888865432 3458999999999999999999999 899999999999999999999999999997654321
Q ss_pred CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH-HHHHHhhhcccchhHhh---
Q 048419 490 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL-VDWVKELHLEGEITQAI--- 564 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~--- 564 (653)
. ......++..|++||.+.+. .++.++|||||||++|||++|+.||......+.... .+... ...........
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTESTWPGISQLP 232 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChhhHHHHhcCc
Confidence 1 11223568899999988654 568899999999999999999999976543221110 00000 00000000000
Q ss_pred ----------hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 565 ----------DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 565 ----------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+..+..........+.+++.+|++.||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000001111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.60 Aligned_cols=250 Identities=29% Similarity=0.420 Sum_probs=207.4
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
|...+.||+|++|.||++....++..+++|++........+.+.+|++.+++++|+|++++++.+...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 66788999999999999999888999999999776555678899999999999999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|.+++.... ..+++..++.++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 82 GSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999987642 358999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+........... ... ....... .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~----~~~~~~~------~ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IAT----NGPPGLR------N 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHh----cCCCCcC------c
Confidence 2345688899999999888899999999999999999999999976533221110 000 0000000 0
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.......+.+++.+||+.||.+|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11114678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=299.10 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=189.9
Q ss_pred eeeeeCcEEEEEEEeCCC--CcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCC
Q 048419 337 LVGSGGFGRVYRGLMPSL--GLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.||+|+||.||+|..... ...+++|.+.... ....+.+.+|+..++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 3456778776443 3456789999999999999999999999999999999999999999
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC-Cc
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN-PQ 492 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 492 (653)
|.+++.+.... ...+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999764321 2346677788999999999999999 8999999999999999999999999999864321111 11
Q ss_pred ccccccCCcccCcccccc-------CCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 493 TTHIVGTLGYLAPELTRT-------GKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.....++..|+|||++.. ..++.++|||||||++|||++ |..|+......+.. .... .+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~-----~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL--NHVI-----KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHH-----hhcccccC
Confidence 123467889999998753 245789999999999999997 46677644332111 1111 11111222
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
++.+. ......+.+++..|| .+|.+||++.+|++.|.
T Consensus 231 ~~~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22221 112356778889999 67999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=302.13 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=205.0
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
|...+.||+|++|.||++....++..+++|++........+.+.+|+.++++++|+|++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567999999999999998888999999998765555567788999999999999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|.+++... .+++.++..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 101 GALTDIVTHT------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999998652 37889999999999999999999 8999999999999999999999999998876543222
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
......|+..|+|||.+.+..++.++|||||||+++||++|+.||........ ...+... . .+.+. .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~~~----~-----~~~~~-~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIRDN----L-----PPKLK-N 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHhc----C-----CCCCc-c
Confidence 22334688999999999888899999999999999999999999875433211 1111110 0 01110 0
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.......+.+++.+||+.+|.+||++.+++++-..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence 11134578999999999999999999999975433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.94 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=205.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||+|++|.||++.+..+++.+|+|++.... ....+.+.+|++.+++++|+||+++++++...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35677889999999999999999889999999987653 34567789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ..+++..+.+++.|++.||+|||+ ..+++|+||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999987642 457888999999999999999998 268999999999999999999999999998765322
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+......... ..+.+.... ....
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~---------~~~~ 221 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIV---------NEPP 221 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHh---------cCCC
Confidence 11 1256888999999999889999999999999999999999999754321110 111111111 0000
Q ss_pred CcCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLA-EAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...... ....+.+++..||..+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 001111 35668899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=296.69 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=209.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||+|++|.||++....+++.|+||++..... ...+.+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999998899999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... ..+++..++.++.|+++||.|||+. .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999764 3488999999999999999999973 69999999999999999999999999999876443
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+...+.. ...
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------~~~ 220 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD------------GPP 220 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc------------CCC
Confidence 322 1234678899999999988899999999999999999999999976542111111111111 011
Q ss_pred CcCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLA-EAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...... ....+.+++.+||+.+|.+||++.|++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111112 35678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=301.36 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=202.6
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEEEEe
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLLVYD 407 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 407 (653)
|+..+.||+|++|.||+|....+++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999999889999999997653 33456788999999999999999999999888 78999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++ +|.+++.... ..+++.+++.++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9975 8888886542 358999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHH-HHHHhhhcccc---hhH
Q 048419 488 GANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLV-DWVKELHLEGE---ITQ 562 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~---~~~ 562 (653)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ +..... .... ...
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENWPGVSK 231 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhcccccc
Confidence 43222333456788999997764 45789999999999999999999999765533221111 100000 0000 000
Q ss_pred -----------hhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 563 -----------AIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 563 -----------~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.....+ ......+...+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00001125678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.67 Aligned_cols=248 Identities=29% Similarity=0.390 Sum_probs=207.0
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
|...+.||.|+||.||-+++..+.+.||||++.... .+.+.+++.|+..|++++|||.+.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455677999999999999999999999999997654 34567889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
| -|+-.++|.-. +++|.+-.+..|+.+.++||.|||+ .+.||||||+.||||.+.|.+||+|||.|.....
T Consensus 108 C-lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred H-hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 9 56888887654 5678999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 489 ANPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
...++||+.|||||++. .+.|+-|+||||+|++..||.-.++|+..+.....+.- +.+.-.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH------------IAQNes 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------------IAQNES 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH------------HHhcCC
Confidence 23468999999999874 57899999999999999999999999887665432210 111111
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
|.|. ..+-...+..++-.||+.-|.+|||..+++++---
T Consensus 243 PtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 243 PTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred CCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 2221 12335678899999999999999999999976543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.69 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=199.2
Q ss_pred cCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc------
Q 048419 332 FGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------ 400 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 400 (653)
|...+.||+|+||.||+|.+. .+++.||||++... .....+++.+|++.+++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999864 34689999998654 3445677899999999999999999999885532
Q ss_pred eeEEEEeccCCCCchhhhhcccc-cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDH-KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
..++++||+++|+|..++..... .....+++...++++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 24789999999999988754321 112347888999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 480 GLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 480 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|+++....... .......++..|++||.+....++.++|||||||++|||++ |+.|+....... +..+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~--- 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLIKG--- 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHHcC---
Confidence 99986543221 11222345678999999988889999999999999999999 888886543321 11111111
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. + .........+.+++.+||+.+|++||++.|+++.|+.
T Consensus 232 ~~--------~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NR--------L-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred Cc--------C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00 0 0111234678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.16 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=209.3
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
..+++|+..+.||+|++|.||+|.+..++..+++|++..... ..+.+.+|++.+++++|+|++++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 456778888999999999999999988899999999976544 5677889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999997643 258999999999999999999999 999999999999999999999999999987554
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.... ......++..|++||.+.+..++.++||||||+++|||++|+.|+.......... .... .....
T Consensus 168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~~-----~~~~~---- 235 (286)
T cd06614 168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LITT-----KGIPP---- 235 (286)
T ss_pred cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh-----cCCCC----
Confidence 3221 1223457889999999988889999999999999999999999987544322111 0000 00000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+ .........+.+++.+||+.+|.+||++.+++++.
T Consensus 236 -~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 236 -L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred -C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0 00111345688999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.03 Aligned_cols=262 Identities=26% Similarity=0.331 Sum_probs=200.9
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
|+..+.||.|++|.||+|.+..+|..||+|++.... ....+.+.+|++.+++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999998889999999986543 223467889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
+ ++|.+++.... ...+++..+++++.|+++||.|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 68999886643 2358999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc--------h
Q 048419 490 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE--------I 560 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------~ 560 (653)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||........ +.+.......... +
T Consensus 154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 1 11223567899999987654 468899999999999999999999975543222 1111111100000 0
Q ss_pred hHhhhh-------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 561 TQAIDQ-------TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 561 ~~~~d~-------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+.... .+..........+.+++.+||+.+|.+||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0000011123578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.10 Aligned_cols=246 Identities=22% Similarity=0.374 Sum_probs=201.2
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEecc----CchhhHHHHHHHHHHHhhcCCCceeeeeeeecccce--eEEEEe
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH----NSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE--LLLVYD 407 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 407 (653)
...+||+|.|-+||||.+..+|.+||--.++. ......+.|..|+.+|+.|+|+||++++.++.+... +-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 35579999999999999999999998655432 245566899999999999999999999998877654 789999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~ 486 (653)
.|..|+|..|+.+.. ..+.+.+..|++||++||.|||++ .++|+|||||.+||||+. -|.+||+|+|||+...
T Consensus 124 L~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999998764 378889999999999999999995 479999999999999965 5899999999999875
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .....|||.|||||... ..|++..||||||++|+||+|+..||..-....+ +.+....|..+..+..
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVTSGIKPAALSK 267 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHHcCCCHHHhhc
Confidence 432 23368999999999887 6899999999999999999999999986554332 1222223333333222
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. ...++.++|.+|+.. ..+|||+.|++..
T Consensus 268 V-------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 V-------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred c-------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 125688999999999 9999999999973
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.53 Aligned_cols=256 Identities=27% Similarity=0.373 Sum_probs=203.4
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
|...+.||+|+||.||+++...++..+|+|++... ..+..+.+.+|++.+++++|+|+++++++|.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55678899999999999999888999999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
++ |+|.+++... ...+++.++..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 107 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 97 4787777543 2358999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 489 ANPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.....++..|+|||.+. ...++.++|||||||++|||++|+.|+........ +..+.....
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~~~---------- 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES---------- 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHhccC----------
Confidence 12346788999999873 45688999999999999999999999875432211 111111000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCCCCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLPPLP 614 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~~p 614 (653)
+ ..........+.+++.+||+.+|.+||++.++++++......+..+
T Consensus 242 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 242 P--TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred C--CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 0 0011123456889999999999999999999999876655444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.56 Aligned_cols=267 Identities=21% Similarity=0.276 Sum_probs=200.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcC-CCceeeeeeeecccce-----
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDE----- 401 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 401 (653)
++|+..+.||+|+||.||+|.+..+++.||||.+.... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999999889999999986542 223457888999999995 6999999999877665
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEeec
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFG 480 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 480 (653)
.++||||+++ +|.+++..........+++.+++.++.||++||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 89888866433223468999999999999999999999 89999999999999998 8999999999
Q ss_pred CcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc-
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG- 558 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 558 (653)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||......... ...........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCCh
Confidence 9886533211 1122356788999998865 45789999999999999999999999765432221 11111000000
Q ss_pred ch-hHhh--------h----hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 EI-TQAI--------D----QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 ~~-~~~~--------d----~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.. .... . ..+..........+.+++.+||+.||.+||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000 0 00000001234668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.03 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=209.8
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
|.+..+||+|+||.|||+.++.+|+.+|||.+... .+.+++..|+.+|++++.+++|+++|.+.....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55678899999999999999999999999998544 4578899999999999999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|++.+.+..+ +++|++.++..+++.-+.||+|||. ..-+|||||+.||||+.+|.+||+|||.|..+.... .
T Consensus 113 GSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 113 GSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 9999999765 5779999999999999999999999 788999999999999999999999999998654321 2
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
....+.||+.|||||++..-.|+.++||||+|++..||..|++||..-.+..... .+.....+.. ..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------MIPT~PPPTF-~K 251 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------MIPTKPPPTF-KK 251 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------eccCCCCCCC-CC
Confidence 2345689999999999999999999999999999999999999998543321110 0000001111 11
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+..-...+.+++..||-..|++|-|+.+++++-
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 233357799999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.77 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=201.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 405 (653)
++|+..+.||+|+||.||+|....+++.+|+|.++.... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 467888999999999999999998899999999965432 2234567899999999999999999998777 789999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
+||++ ++|.+++.... ..+++.+++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 49988886543 358999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH-HHHHH-------Hhhhc
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDWV-------KELHL 556 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~-------~~~~~ 556 (653)
.... .......++..|+|||.+.+. .++.++||||||++++||++|+.||.......... +...+ +....
T Consensus 157 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 4432 122234578899999988754 46889999999999999999999997554322111 00000 00000
Q ss_pred c------cchhHhhhhcc-CcCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 557 E------GEITQAIDQTL-DYYDLA-EAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 557 ~------~~~~~~~d~~l-~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. ..........+ ..+... ..+.+.+++..||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000000001 011111 25668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.60 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=207.7
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|++|.||++....+++.+++|.+... ......++.+|++.+++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477789999999999999999888999999998654 234456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998764321 3458899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
......++..|++||.+.+..++.++|+||||++++||++|+.||....... +...+. .+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~----~~~~-------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQ----RGKY-------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh----cCCC--------
Confidence 2223457889999999998889999999999999999999999997654321 111111 1111
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..........+.+++.+|++.+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11122345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=303.90 Aligned_cols=269 Identities=25% Similarity=0.310 Sum_probs=202.5
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc----
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD---- 400 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 400 (653)
.+.++|+..+.||+|+||.||+|....+++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678889999999999999999999889999999996543 223456778999999999999999999987655
Q ss_pred ------eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 401 ------ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 401 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
.+++|+||+++ +|..++... ...+++.+++.++.||+.||+|||+ .+|+|+||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence 78999999976 777776543 2358999999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
||+|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||.................
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999998765433222222346778999998764 3578899999999999999999999976543322211111100
Q ss_pred hhcccchhHh--------hhh------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 554 LHLEGEITQA--------IDQ------TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 554 ~~~~~~~~~~--------~d~------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.........+ .+. ............+.+++..||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000 000 0000000124678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=298.72 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=195.5
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
||+|+||+||++....+|+.||+|.+.... ......+..|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999986432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++.... ...+++.+++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++....... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 99997654 2358899999999999999999999 899999999999999999999999999988654322 222
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...++..|+|||.+.+..++.++|||||||++++|++|+.||.......... .+... ...........
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~ 220 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRR---------TLEMAVEYPDK 220 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhc---------cccccccCCcc
Confidence 3457889999999988889999999999999999999999997543311000 00000 00000111112
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRP-----DMRRVVE 602 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (653)
....+.+++.+||+.+|.+|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 346788999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=294.65 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=208.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|+||.||++....++..+++|++.... ....+.+.+|++.+++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999998889999999997653 35567889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++...... ...+++.++..++.++++||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999999765321 3568999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
. .......|++.|+|||......++.++||||+|+++++|++|+.|+....... +. .... ... +
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~---~~~~-~~~--------~ 220 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LA---LKIL-KGQ--------Y 220 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HH---HHHh-cCC--------C
Confidence 2 12233468889999999988889999999999999999999999997554221 11 1100 000 1
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...+......+.+++.+||+.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=299.56 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=189.8
Q ss_pred eeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHh---hcCCCceeeeeeeecccceeEEEEeccC
Q 048419 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMG---RLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
+||+|+||.||++....+++.+|+|.+.... ......+.+|..+++ ..+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999998889999999986532 122233444544333 3479999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+++|.+++... ..+++.++..++.|++.||.|||+ ++++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 99999988654 348999999999999999999999 899999999999999999999999999987543321
Q ss_pred CcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 491 PQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+.... . ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----~------~~~~--- 216 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----L------TVNV--- 216 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----h------cCCc---
Confidence 223468999999998864 45789999999999999999999999754322111111000 0 0000
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
..+......+.+++.+||+.||.+|| +++|++++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 11122346788999999999999999 699999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=303.71 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=199.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-------
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------- 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 400 (653)
++|+..+.||+|+||.||+|....+++.||||.+.... ......+.+|+.++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999999899999999986432 222345678999999999999999999986654
Q ss_pred -eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 401 -ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 401 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
..++||||+.+ +|.+++.... ..+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999964 8888775532 348999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCC---cccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh
Q 048419 480 GLAKIYEHGANP---QTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 480 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..............+....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999865432211 11234577899999988664 36889999999999999999999997655433322222221110
Q ss_pred cccchh-----H-------------hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 556 LEGEIT-----Q-------------AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 556 ~~~~~~-----~-------------~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...... + .+...+. .......+.+++.+||+.||.+||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLK--PYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcc--cccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0 0000000 00123457799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.57 Aligned_cols=268 Identities=28% Similarity=0.328 Sum_probs=202.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 404 (653)
.++|+..+.||+|+||.||+|....+|+.||+|++..... .....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3578889999999999999999998899999999864422 2233567899999999999999999998655 46899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+. ++|.+++.... ..+++.+++.++.||++||+|||+ .+++|+||||+||++++++.+||+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 48888876532 458999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHH-HHHHhhhcccchhH
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLV-DWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~~~ 562 (653)
..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ +.... . ......
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~-~-~~~~~~ 234 (309)
T cd07845 158 YGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT-P-NESIWP 234 (309)
T ss_pred cCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC-C-Chhhch
Confidence 64322 11222345788999998865 45789999999999999999999999765443221111 10000 0 000000
Q ss_pred hhh-------hccCcC--------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AID-------QTLDYY--------DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d-------~~l~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.++ ..+... .....+.+.+++.+|++.||.+|||+.|++++-...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 000 000000 001246678999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=301.55 Aligned_cols=264 Identities=25% Similarity=0.321 Sum_probs=199.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|++|.||+|....+++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999998889999999986542 2334678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~ 486 (653)
|++ ++|.+++.... ...+++...+.++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 57888775443 2235778888999999999999999 89999999999999985 5679999999997654
Q ss_pred CCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--cc-----
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--EG----- 558 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~----- 558 (653)
... .......+++.|+|||++.+. .++.++|||||||++|+|+||+.||......+... ........ ..
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 155 IPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--KIFRILGTPNEETWPGV 231 (294)
T ss_pred CCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChhhcccc
Confidence 321 112234568899999988664 57889999999999999999999997654432211 11100000 00
Q ss_pred -chhHhhh-------hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 -EITQAID-------QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 -~~~~~~d-------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+..... ..+..........+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00000011224568899999999999999999999974
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.36 Aligned_cols=258 Identities=21% Similarity=0.241 Sum_probs=196.0
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcC-CCceeeeeeeeccc--ceeEEEEe
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQ--DELLLVYD 407 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 407 (653)
|+..+.||+|+||.||+|....++..||+|++.... .........|+..+.++. |+|++++++++.+. +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999998889999999986542 222234457888899885 99999999999887 88999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|++ ++|.+++.... ..++|.+++.++.|++.||.|||+ .+++|+||+|+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 58888776532 358999999999999999999999 89999999999999999 9999999999986643
Q ss_pred CCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc--cchhHhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE--GEITQAI 564 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~ 564 (653)
... .....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+. ..+....... ..+....
T Consensus 152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhh
Confidence 221 123457889999997644 5578899999999999999999999976543221 1111111000 0000000
Q ss_pred h---------hcc-----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 565 D---------QTL-----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 565 d---------~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. +.. ..........+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 000 00011235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=301.55 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=197.8
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|...+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|+..+.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999999999999999986543 344567889999999996 99999999999998899999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
++. +|.++...........+++.....++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 665543221111134588999999999999999999972 48999999999999999999999999999765432
Q ss_pred CCCcccccccCCcccCccccccC---CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTG---KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||...... .+.+.... .+. .
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~~-----~ 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQVV-KGD-----P 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhhc-CCC-----C
Confidence 2 11233578899999998766 6889999999999999999999999754311 11111110 000 0
Q ss_pred hcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 566 QTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 566 ~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+.+ ..........+.+++.+||+.+|.+||++.+|+++-
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111 111122456789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.34 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=205.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+|+..+.||+|++|.||++.....++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 46778999999999999999988899999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++... ..+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998654 348999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
... .....++..|+|||...+..++.++|||++|+++++|++|+.|+......... ... . ....
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~~--~---~~~~-------- 216 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FRI--V---QDDH-------- 216 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HHH--h---ccCC--------
Confidence 321 23346788999999998888899999999999999999999998754421110 000 0 0000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...+......+.+++.+||+.+|++||++.+++.+
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 01111224678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.77 Aligned_cols=252 Identities=28% Similarity=0.381 Sum_probs=207.7
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 406 (653)
+|...+.||+|++|.||+|....++..|++|++.... ....+.+.+|+..+++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999999889999999986554 35577899999999999999999999999888 8899999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++.... .+++.+++.++.|++++|.|||+ .+++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999987643 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
..... ......++..|+|||.+.....+.++||||||+++++|++|+.||........ ..........
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~------ 221 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKIGSSGE------ 221 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHhccccCC------
Confidence 43321 12334678899999999888899999999999999999999999976542111 0111110000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....+......+.+++.+|++.+|.+||++.+++++
T Consensus 222 --~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 --PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011122235678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.65 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=203.6
Q ss_pred ceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 335 QNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
.++||+|.||.|++|.+... -..||||.++..... ...+|++|+.+|.+|+|+|+++|+|...+ ..+.+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 56799999999999998643 346999999765443 68899999999999999999999999988 66889999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
.|+|.+.|+... +..|.......++.|||.||.||.. +++|||||..+|+||-....+||+||||.+.+.....
T Consensus 194 lGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 194 LGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999998732 5668888889999999999999999 9999999999999999999999999999997755432
Q ss_pred Cc-c-cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 491 PQ-T-THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 491 ~~-~-~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.- . ....-.+.|+|||.++..+++.++|||+|||++|||+| |.-||-+..... +.+.+|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccc
Confidence 21 1 11223568999999999999999999999999999999 778887654322 22222211
Q ss_pred -cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 568 -LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 568 -l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+...+..+.+++.++++.||..+|.+||++..|.+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1233456788999999999999999999999997544
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=307.67 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=201.4
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc--ce
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ--DE 401 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~ 401 (653)
.+.++|...+.||+|+||.||+|.+..+++.+|||++... .......+..|+.+++++ +|+||++++++|... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3457788899999999999999999888999999988542 333455677899999999 999999999988654 36
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.++||||++ ++|..++... .++|..++.++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 899999997 5898887543 47889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCC----CcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 482 AKIYEHGAN----PQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 482 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
+........ .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 986643321 22334568899999998754 4578899999999999999999999975433221111000000000
Q ss_pred c--------cchhHhhhhcc--C-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 557 E--------GEITQAIDQTL--D-----YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 557 ~--------~~~~~~~d~~l--~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. ......++... . .........+.+++.+||+.+|.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00000111000 0 0001124678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.93 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=201.9
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ----- 399 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 399 (653)
...++|+..+.||+|+||.||+|....++..||||.+... .....+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3557899999999999999999999988999999998643 334456778899999999999999999987543
Q ss_pred -ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 400 -DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 400 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
...++||||+. ++|.+.+.. .+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEcc
Confidence 35799999996 588877743 27888899999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc-c
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL-E 557 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~ 557 (653)
||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... ..+..... .
T Consensus 162 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~ 237 (353)
T cd07850 162 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN--KIIEQLGTPS 237 (353)
T ss_pred CccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHhcCCCC
Confidence 99998654322 1223457889999999999899999999999999999999999997544321110 00000000 0
Q ss_pred cc-----------------------hhHhhhhcc-----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 558 GE-----------------------ITQAIDQTL-----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 558 ~~-----------------------~~~~~d~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. ..+.....+ ..........+.+++.+||+.||.+||++.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00 001111110 000112345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.77 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=198.6
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
||.|++|.||++....+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999998889999999986532 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++.... .+++.++..++.||++||.|||+ ++++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 99997642 38899999999999999999999 999999999999999999999999999998764432 222
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...++..|++||.+....++.++|+||||+++|||++|..|+............. +.. + .....++..
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~----~-------~~~~~~~~~ 218 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-ILK----G-------NGKLEFPNY 218 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH-Hhc----c-------CCCCCCCcc
Confidence 3467889999999988889999999999999999999999997654211111100 000 0 000111122
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRPD-----MRRVVEF 603 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 603 (653)
....+.+++.+||+.+|.+||+ ++|++++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 2567899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.19 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=197.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc------
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------ 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 400 (653)
.++|...+.||+|+||.||+|....+|+.||||++... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999888999999998653 2223456889999999999999999999886543
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 46999999964 6665542 247889999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||................. .....
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 237 (342)
T cd07879 163 LARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGPE 237 (342)
T ss_pred CCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHH
Confidence 98764321 223457889999999866 4688999999999999999999999986543221111000000 00000
Q ss_pred hhHhhhh--------cc---CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HcCCC
Q 048419 560 ITQAIDQ--------TL---DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEF--LLGDS 608 (653)
Q Consensus 560 ~~~~~d~--------~l---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 608 (653)
..+.++. .+ .... ......+.+++.+||+.||.+||++.+++++ ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000 00 0000 0123568899999999999999999999975 44433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.90 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=198.8
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCch---hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
||+|+||.||++....+++.+++|.+..... ...+.+.+|++.+++++|+|++++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999865433 4567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC----
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN---- 490 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~---- 490 (653)
.+++.... .+++..++.++.||++||+|||+ ++++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99997542 48999999999999999999999 8999999999999999999999999999876533211
Q ss_pred ---CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 491 ---PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 491 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.......++..|+|||.......+.++||||||++++||++|+.||........ ...+.. +.
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~----~~-------- 217 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNILN----GK-------- 217 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhc----CC--------
Confidence 122334578899999999888899999999999999999999999975543211 111110 00
Q ss_pred cCcCCHH--HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 568 LDYYDLA--EAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 568 l~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
. ..... ....+.+++.+||+.+|.+||++.++.+.|+
T Consensus 218 ~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 I-EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c-CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 00111 2467889999999999999999966666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.02 Aligned_cols=260 Identities=26% Similarity=0.326 Sum_probs=202.5
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
|...+.||+|++|.||+|....+++.+++|++..... .....+..|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 4567889999999999999988899999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++ +|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 8888876542 358999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc------cchhH
Q 048419 490 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE------GEITQ 562 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------~~~~~ 562 (653)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.... +...... ....+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchh
Confidence 122234577889999998776 789999999999999999999999975543222111 0000000 00000
Q ss_pred hhh-----------hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 563 AID-----------QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 563 ~~d-----------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
... ..+..........+.+++..||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00000111235779999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.65 Aligned_cols=267 Identities=24% Similarity=0.318 Sum_probs=202.8
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----c
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-----D 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 400 (653)
+.++|...+.||+|+||.||+|....++..||||.+... .......+..|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 356788999999999999999999989999999998653 333455678899999999999999999988654 3
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 5799999995 6888888653 348899999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh------
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE------ 553 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~------ 553 (653)
+++...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..............+..
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 998654322 12233467889999998764 4688999999999999999999999975433221111110000
Q ss_pred --hhcccchhHhhhhc-------cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 554 --LHLEGEITQAIDQT-------LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 554 --~~~~~~~~~~~d~~-------l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
........+.+... ...........+.+++.+||+.+|.+||++.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 00001111111100 0000112346788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.92 Aligned_cols=246 Identities=23% Similarity=0.337 Sum_probs=200.7
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
...||+|+||.||++....+++.||||++........+.+.+|+..+++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999999888999999998665555667789999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++... .+++...+.++.|++.+|+|||+ .+++|+||+|+||++++++.++|+|||++....... ....
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~ 174 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK 174 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccc
Confidence 9987542 37889999999999999999999 899999999999999999999999999987654322 1223
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...++..|+|||.+.+..++.++|+||+|+++|||++|..||......... ..+... ..+.+.. ...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~~---------~~~~~~~-~~~ 241 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDN---------LPPKLKN-LHK 241 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhh---------CCcccCC-ccc
Confidence 346789999999998888999999999999999999999998754332211 111110 0111100 011
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....+.+++.+||+.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=292.77 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=200.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-----chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--cee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-----SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 402 (653)
.+|+..+.||+|+||.||+|.+..++..||+|.+... ..+..+.+.+|++++++++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999999888999999987432 234456888999999999999999999988654 468
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++++||+++++|.+++... ..+++....+++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999998653 237888899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 483 KIYEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 483 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
+....... .......++..|+|||.+.+..++.++|+|||||+++||++|+.||......... .+. ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~~-- 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FKI----ATQP-- 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HHH----HcCC--
Confidence 86532111 1122346888999999998888999999999999999999999999754322111 110 0000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.....+....+.+.+++..||+ +|..||+..+++.+
T Consensus 226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0011222334678899999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.97 Aligned_cols=270 Identities=24% Similarity=0.321 Sum_probs=204.4
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecc----cce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK----QDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~ 401 (653)
+.++|+..+.||+|++|.||+|....++..||+|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3478888999999999999999999889999999986542 2345677889999999999999999998753 346
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+ ++++||||||+||++++++.+||+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEeccccc
Confidence 899999995 6898888653 338999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC---cccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH-----
Q 048419 482 AKIYEHGANP---QTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK----- 552 (653)
Q Consensus 482 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----- 552 (653)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 9765432211 1123468889999998765 468899999999999999999999997654322111100000
Q ss_pred ---hhhcccchhHhhhhcc--CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 553 ---ELHLEGEITQAIDQTL--DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 553 ---~~~~~~~~~~~~d~~l--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.......+.+..+..- .... ......+.+++.+||+.+|.+||++.+++++..-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0000001111111000 0111 1235779999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=292.38 Aligned_cols=251 Identities=23% Similarity=0.280 Sum_probs=195.3
Q ss_pred HHHHHhhcCcCcceee--eeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc
Q 048419 323 AELASVTKGFGEQNLV--GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ 399 (653)
Q Consensus 323 ~el~~at~~f~~~~~L--G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 399 (653)
.++....++|.+.+.+ |+|+||.||++....++..+|+|.+........ |+.....+ +|+|++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 4445555677777766 999999999999998899999999864322111 22222222 699999999999999
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEe
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGD 478 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 478 (653)
+..++||||+++++|.+++.... .+++.+++.++.|+++||.|||+ .+++||||||+||+++.++ .++|+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999996542 58999999999999999999999 8999999999999999988 999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
||+++..... ....++..|+|||++.+..++.++||||||++++||++|+.||...... .....++.....
T Consensus 154 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~--- 224 (267)
T PHA03390 154 YGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQQ--- 224 (267)
T ss_pred CccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhhc---
Confidence 9998765322 2236788999999999888999999999999999999999999744321 111112211110
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-MRRVVEF 603 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 603 (653)
... .........+.+++.+||+.+|.+||+ +.|++++
T Consensus 225 -------~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 -------KKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -------ccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000 011123467889999999999999996 6998864
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.80 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=213.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.-|...+.||+|-|..|-++++--+|+.||||++.+.. .-....+.+|++.|+-++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44667788999999999999999999999999998763 3345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cCCCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL-DTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~ 486 (653)
.-.+|+|.+||-.+. ..+.++...+.+.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++-.+.
T Consensus 98 LGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999998774 458899999999999999999999 899999999999977 667889999999998776
Q ss_pred CCCCCcccccccCCcccCccccccCCCC-CccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKAT-TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.+. ..+..+|+..|-|||++.+..|+ ++.|||||||+||-|+||+.||+...+.+.+ ..++|
T Consensus 171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImD 233 (864)
T KOG4717|consen 171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMD 233 (864)
T ss_pred Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhc
Confidence 543 45567999999999999998886 5899999999999999999999865543321 22222
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..- ..+.....++.+|+..||..||.+|-+.+||+..-+-
T Consensus 234 CKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 234 CKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred ccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 211 2234456789999999999999999999999976543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=311.07 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=207.2
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
.+...||.|+||.|||+..+.++...|-|++...+.+..+.|+-|+++|..+.||+||+|++.|.-++.++++.|||+||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 34567999999999999999888888999998888889999999999999999999999999999999999999999999
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
-++..+-..+ ..|++.++.-+++|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+..... ....
T Consensus 115 AVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 115 AVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred hHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999887754 569999999999999999999999 9999999999999999999999999998754321 1223
Q ss_pred ccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 493 TTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
...+.||+.|||||+.. ...|+.++||||||++|.||..+.+|-....+.. .+...... ..+.++.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKiaKS-----ePPTLlq-- 257 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKS-----EPPTLLQ-- 257 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHhhc-----CCCcccC--
Confidence 34578999999999774 4578999999999999999999999976544321 11111111 1111111
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+..-...+.++...||..||..||++.+++++-
T Consensus 258 ----PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 258 ----PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred ----cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 112245688999999999999999999998764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.23 Aligned_cols=273 Identities=20% Similarity=0.291 Sum_probs=192.2
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCC-cEEEEE------------------EeccCchhhHHHHHHHHHHHhhcCCCc
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLG-LEVAIK------------------RIGHNSQQGMKEFVAEIMSMGRLRHRN 388 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 388 (653)
..++|+..+.||+|+||+||++..+... ...++| .+. ........+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 3467999999999999999998764322 112222 111 12223456889999999999999
Q ss_pred eeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 048419 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL 468 (653)
Q Consensus 389 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 468 (653)
|+++++++...+..++|+|++. ++|.+++..............+...++.||+.||.|||+ ++|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9999999999999999999984 577777754332112223456677899999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCC-CChhhhhhHHHH
Q 048419 469 DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRS-IEPQKAAAELLL 547 (653)
Q Consensus 469 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p-~~~~~~~~~~~l 547 (653)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987654333333345799999999999998999999999999999999998754 432221111111
Q ss_pred HHHHHhhh-ccc-------chhHhhhhcc-CcC--C-------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 548 VDWVKELH-LEG-------EITQAIDQTL-DYY--D-------LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 548 ~~~~~~~~-~~~-------~~~~~~d~~l-~~~--~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+.+.... ... ++.+.++... ... . ......+.+++.+||+.||.+|||+.|++++-.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 11111100 000 0111111000 000 0 001245678899999999999999999998654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=292.84 Aligned_cols=261 Identities=26% Similarity=0.334 Sum_probs=198.4
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhc---CCCceeeeeeeecccce-----
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRL---RHRNLVQLHGWCRKQDE----- 401 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 401 (653)
|+..+.||+|+||.||+|....+++.||+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999988899999999964322 2234566787777666 59999999999988776
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.+++|||+++ +|.+++.... ...+++.+++.++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999974 8988886543 2358999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
+........ .....++..|+|||.+.+..++.++|||||||++|||++|+.|+......+. +..+...........
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 229 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEE 229 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHh
Confidence 987643321 1233578899999999988899999999999999999999999876543221 111111110000000
Q ss_pred ---------Hhhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 562 ---------QAIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 562 ---------~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....... ..........+.+++.+||+.||.+||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 01111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.45 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=199.2
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEecc
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
|...+.||+|++|.||+|....+++.|+||++..... .......+|+..+++++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5567899999999999999988899999999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
+|+|.+++.... ...+++.++..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 789998887653 2458999999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCccccc-cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH-HHH---------HHHhhhccc
Q 048419 490 NPQTTHIVGTLGYLAPELTR-TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVD---------WVKELHLEG 558 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~-l~~---------~~~~~~~~~ 558 (653)
......++..|+|||.+. ...++.++|+||||++++||++|+.||......+... ... |........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 122346788999999875 4457899999999999999999999986543322111 000 100000000
Q ss_pred chhHhhh----hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 EITQAID----QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 ~~~~~~d----~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+...+. ..+..........+.+++.+||+.+|.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000001113678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.92 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=205.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|++|.||++....+++.||+|++... .....+.+..|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688889999999999999999888999999998653 2334567889999999998 99999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999997643 48999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCC-------------------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH
Q 048419 486 EHGAN-------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546 (653)
Q Consensus 486 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~ 546 (653)
..... .......++..|+|||......++.++||||||++++|+++|+.|+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-- 230 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-- 230 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--
Confidence 43321 112234578899999999888899999999999999999999999986542111
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDM----RRVVEF 603 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~ 603 (653)
+ ..+.. .....+....+.+.+++.+||+.+|.+||++ .+++++
T Consensus 231 ~-~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 F-QKILK-------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H-HHHHh-------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 11110 0001111225678899999999999999999 777754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=290.51 Aligned_cols=244 Identities=24% Similarity=0.267 Sum_probs=190.8
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch---hhHHHHHHHHHH-HhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---QGMKEFVAEIMS-MGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|....+++.||||.+..... .....+..|... ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 469999999999999988899999999865432 223344555544 4455899999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|.+++... ..+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999998654 348899999999999999999999 8999999999999999999999999999875432
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
.....++..|+|||.+.+..++.++||||||+++|||++|..||........ ..... .+... ... ..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~-----~~~~~--~~~---~~ 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FDNIL-----SRRIN--WPE---EV 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-----hcccC--CCC---cc
Confidence 2234578899999999888889999999999999999999999975443211 10000 00000 000 00
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 572 DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.......+.+++.+||+.+|++||++.++.+.|
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 112346789999999999999999776665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.21 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=205.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-----eeE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-----ELL 403 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 403 (653)
+|...+.||+|++|.||+|+...+++.||||++.... ....+.+.+|+..+++++|+||+++++++...+ .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999998889999999987543 445578899999999999999999999987775 789
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
++|||++ ++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 4888888653 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCC--CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhh------
Q 048419 484 IYEHGAN--PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL------ 554 (653)
Q Consensus 484 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------ 554 (653)
....... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||.............-....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 7654321 122334678899999999887 7899999999999999999999999765432211110000000
Q ss_pred --hcccchhHhhhhcc--Cc-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 555 --HLEGEITQAIDQTL--DY-----YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 555 --~~~~~~~~~~d~~l--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.......+.+...- .. ........+.+++.+||+.+|.+||++.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 00001111111000 00 0111346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.41 Aligned_cols=270 Identities=22% Similarity=0.285 Sum_probs=205.1
Q ss_pred cCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeec
Q 048419 320 FKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397 (653)
Q Consensus 320 f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 397 (653)
....++..++++|...+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 345667788899999999999999999999988889999999986532 233567888999999999999999999875
Q ss_pred cc------ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 048419 398 KQ------DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY 471 (653)
Q Consensus 398 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 471 (653)
.. ...+++++++ +++|.+++... .+++..++.++.|+++||+|||+ ++++||||||+||+++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 156 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCC
Confidence 43 3467888887 78998877542 38899999999999999999999 899999999999999999
Q ss_pred CcEEEEeecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHH
Q 048419 472 LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW 550 (653)
Q Consensus 472 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 550 (653)
+.+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ...
T Consensus 157 ~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~ 230 (345)
T cd07877 157 CELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--KLI 230 (345)
T ss_pred CCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH
Confidence 9999999999876432 2233467889999998866 46788999999999999999999998654332211 111
Q ss_pred HHhh----------hcccchhHh---hhhccC----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 551 VKEL----------HLEGEITQA---IDQTLD----YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 551 ~~~~----------~~~~~~~~~---~d~~l~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+... ......... +..... .........+.+++.+|++.||.+||++.+++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 1100 000000000 000000 000012456889999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.38 Aligned_cols=251 Identities=29% Similarity=0.372 Sum_probs=200.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.|...+.||+|+||.||+|+...++..+|+|.+... .....+.+.+|+++++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366678899999999999999888999999998642 33345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+. |+|.+++.... ..+++.++..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 996 58877775432 347889999999999999999999 8999999999999999999999999999876532
Q ss_pred CCCCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
. ....++..|+|||.+. ...++.++|||||||++|||++|+.|+.......... .+.. ...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~-----~~~---- 231 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ-----NES---- 231 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhh-----cCC----
Confidence 1 2345788999999874 3567889999999999999999999986543221111 1110 000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
+ ..........+.+++.+||+.+|.+||++.+++++.....
T Consensus 232 -~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 -P--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -C--CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0 0011123466889999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.46 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=197.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|++|.||+|.+..+++.||||.+.... .....++..|+..+.++. |+||++++++|.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 45777899999999999999998889999999996543 334456777887777775 9999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++.....
T Consensus 95 ~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 47777765432 3589999999999999999999972 4899999999999999999999999999876543
Q ss_pred CCCCcccccccCCcccCccccccCC----CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGK----ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.......+ .+...... ..
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~-----~~--- 236 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTKILQE-----EP--- 236 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHHHhcC-----CC---
Confidence 221 12235778999999987554 78899999999999999999999975322111 11111100 00
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+.+. ........+.+++.+||+.||.+||++.+++++..
T Consensus 237 --~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 237 --PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred --CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0000 00013456899999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=295.48 Aligned_cols=257 Identities=19% Similarity=0.249 Sum_probs=187.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccCchhhH-----------HHHHHHHHHHhhcCCCceeeeee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHNSQQGM-----------KEFVAEIMSMGRLRHRNLVQLHG 394 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g 394 (653)
.++|...++||+|+||.||+|...++ +..+|+|.......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36788999999999999999998776 56777776433221110 11223444566678999999998
Q ss_pred eecccc----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 048419 395 WCRKQD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT 470 (653)
Q Consensus 395 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 470 (653)
.+.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 765543 34677887643 565555432 224677888999999999999999 89999999999999999
Q ss_pred CCcEEEEeecCcccccCCCC------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH
Q 048419 471 YLNAKLGDFGLAKIYEHGAN------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE 544 (653)
Q Consensus 471 ~~~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~ 544 (653)
++.+||+|||+++.+..... .......||+.|+|||+..+..++.++|||||||+++||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999986632211 112234699999999999999999999999999999999999999986532221
Q ss_pred HH---HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 545 LL---LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 545 ~~---l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. ..++.... ..++ +. .....+.+.+++..|++.+|++||++.++++.++
T Consensus 242 ~~~~~~~~~~~~~-~~~~--------~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRL-HEGK--------IK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHh-hhhh--------hc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 01111111 1111 00 0112467889999999999999999999998763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.33 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=195.9
Q ss_pred eeeeee--CcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSG--GFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G--~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
..||+| +||+||++.+..+|+.||+|.+... ..+..+.+.+|+.+++.++|+||++++++|...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999999888999999998643 233457888999999999999999999999999999999999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
++|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999987653 2348888999999999999999999 89999999999999999999999999865433221111
Q ss_pred c------ccccccCCcccCccccccC--CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc-----
Q 048419 492 Q------TTHIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG----- 558 (653)
Q Consensus 492 ~------~~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 558 (653)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||........ +...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 0 0112345679999998763 478999999999999999999999976543221 111110000000
Q ss_pred -----------------chh----------Hhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 559 -----------------EIT----------QAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 559 -----------------~~~----------~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+. ...+..+ ..........+.+++.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000 0000111 011223457789999999999999999999999755
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.45 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=198.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEec--cCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 406 (653)
+.|++.++||+||.+.||++...+ ...+|+|++. ..+.+....|.+|+..|.+|+ |.+|++|++|-..++.+|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457888999999999999998765 5667777764 346667889999999999995 999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||- ..+|..+|.+... ....| .+..+..|++.|+.++|. .+|||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 440 E~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 986 5699999987652 22334 677899999999999999 8999999999999984 4789999999999776
Q ss_pred CCCC-CcccccccCCcccCccccccC-----------CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhh
Q 048419 487 HGAN-PQTTHIVGTLGYLAPELTRTG-----------KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 487 ~~~~-~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
.+.. ......+||+.||+||.+... +..+++||||+||+||+|+.|+.||...... |
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-------~---- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-------I---- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------H----
Confidence 5433 233456899999999988533 3568999999999999999999999854321 1
Q ss_pred hcccchhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 555 HLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 555 ~~~~~~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.++..+.|+.- ..........+.+++..||+.||.+||++.|++++--
T Consensus 580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 12223333322 1111112233899999999999999999999998653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=293.73 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=199.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccCc----hhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHNS----QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
+|+..+.||+|++|.||++... .++..||||.+.... ....+.+.+|+.++.++ +|+||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 357889999986432 22345688999999999 599999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++++|.+++... ..+++..+..++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999998653 347888999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCCCcccccccCCcccCccccccCC--CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGK--ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
+..............|+..|+|||.+.+.. .+.++||||||++++||++|..||........ ..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~---- 226 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK---- 226 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc----
Confidence 865443222222345788999999987665 78899999999999999999999864321110 0011111000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.....+......+.+++.+||+.+|++|||+.++.+.|+-
T Consensus 227 ------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 ------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0001111223567899999999999999999888887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=299.52 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=203.4
Q ss_pred HHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc-cc
Q 048419 324 ELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QD 400 (653)
Q Consensus 324 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 400 (653)
++..++++|+..+.||+|+||.||++....++..||||++... .....+.+..|++++++++|||++++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4456789999999999999999999999988999999988543 23345678899999999999999999998865 55
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++++||+ +++|.+++... .+++.....++.|++.||.|||+ ++++|+||+|+||++++++.+||+|||
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccc
Confidence 789999998 56898887542 37788888999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH-HHHH--------
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDW-------- 550 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~-l~~~-------- 550 (653)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.+.
T Consensus 154 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 154 LARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred cccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 98754321 123356889999998765 568899999999999999999999997554322111 1111
Q ss_pred HHhhhcccchhHhhhhcc--CcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 551 VKELHLEGEITQAIDQTL--DYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 551 ~~~~~~~~~~~~~~d~~l--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.... ..+...+.+.... ...+. .....+.+++.+||+.+|++||++.+++.+-
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 230 INTI-CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHhc-cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 1000 0011111111100 01111 1236789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=293.55 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=197.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccCc----hhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHNS----QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
+|+..+.||+|+||.||++... .+|..||+|++.... ....+.+.+|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677899999999999999874 368899999986532 22346778899999999 599999999999988899
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999998654 347888899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccC--CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
...............|+..|+|||.+... .++.++||||||+++|+|++|+.|+........ ..+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 227 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc---
Confidence 86544322223345688999999998753 467899999999999999999999864321110 11111111000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEF 603 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (653)
...++......+.+++.+||+.+|.+|| ++.+++.+
T Consensus 228 -------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0011112345678999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=277.92 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=200.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEeccCCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
...||.|..|.|+++..+.+|...|||.+... +.+..+.++..+.++..-+ +|+||+.+|||..+...++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 55699999999999999999999999999765 5666778888888777765 899999999999999999999999 44
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
.++.+|... ..++++..+-++...+..||.||.+. ++|+|||+||+|||+|+.|++||||||++..+-... .
T Consensus 176 C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--A 247 (391)
T KOG0983|consen 176 CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--A 247 (391)
T ss_pred HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc--c
Confidence 777777654 35688888889999999999999984 899999999999999999999999999998664432 3
Q ss_pred ccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 493 TTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.+...|.+.|||||.+. ..+|+..+||||||+.|+||.||+.||...+-+-+ .+... .+-..+.|.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~ltkv----------ln~ePP~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VLTKV----------LNEEPPLLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HHHHH----------HhcCCCCCC
Confidence 34557899999999885 34688899999999999999999999986433211 11111 111112221
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
........+.+++..||..|+.+||...+++++-
T Consensus 317 -~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 317 -GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred -cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 1112457789999999999999999999999754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=301.93 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=199.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc---------
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--------- 399 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------- 399 (653)
..+|...+.||.|+||.||+|....++..||+|++........+.+.+|++++++++|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36788999999999999999999989999999999776666677889999999999999999999776543
Q ss_pred -----ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCc
Q 048419 400 -----DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD-TYLN 473 (653)
Q Consensus 400 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~ 473 (653)
...++|+||++ ++|.+++... .+++...+.++.||+.||.|||+ .+++||||||+||+++ .++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCce
Confidence 35789999997 5888877432 37899999999999999999999 8999999999999997 4567
Q ss_pred EEEEeecCcccccCCCCC--cccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHH
Q 048419 474 AKLGDFGLAKIYEHGANP--QTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW 550 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 550 (653)
+||+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.......... ..
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~~ 231 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--LI 231 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH
Confidence 899999999765332111 1122357889999998654 457889999999999999999999997654322211 11
Q ss_pred HHhhhc--c---c----chhHhhh--hccCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 551 VKELHL--E---G----EITQAID--QTLDYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 551 ~~~~~~--~---~----~~~~~~d--~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...... . . ....... ....... ......+.+++.+||+.||.+||++.|++++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 110000 0 0 0000000 0000000 112356889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.05 Aligned_cols=244 Identities=24% Similarity=0.303 Sum_probs=189.9
Q ss_pred eeeeeCcEEEEEEEeCCCCcEEEEEEeccCch---hhHHHHHHHHH---HHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---QGMKEFVAEIM---SMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
+||+|+||.||++....+++.||+|.+..... .....+..|.. .++...|+|++++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999988899999999865421 22223344443 4445579999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+++|..++... ..+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 99999888643 358999999999999999999999 899999999999999999999999999987553321
Q ss_pred CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 491 PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........... ..... .....+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------~~~~~~- 218 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TMAVEL- 218 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh------ccCCCC-
Confidence 1234689999999998754 588999999999999999999999976432111110 00000 000111
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
+......+.+++.+|+..+|.+|| ++.+++++-
T Consensus 219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 111246788999999999999999 999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.30 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=197.2
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
|...+.||+|+||.||+|+...++..|++|++... .....+.+.+|++.+++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44567899999999999999888999999998643 223446788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+. ++|.+++.... ..+++.+++.++.||+.+|.|||+ ++++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 96 57777775432 358999999999999999999999 8999999999999999999999999999864321
Q ss_pred CCCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 489 ANPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.....|+..|+|||++. ...++.++|||||||++|||++|+.|+.......... .... .....
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~---~~~~----~~~~~--- 239 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQ----NDSPT--- 239 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHh----cCCCC---
Confidence 22346888999999974 4568889999999999999999999987654322111 1100 00000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. ........+.+++.+||+.+|.+||++.+++++-..
T Consensus 240 --~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 240 --L--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred --C--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0 011123458899999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=297.77 Aligned_cols=267 Identities=25% Similarity=0.307 Sum_probs=197.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeecccc------
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------ 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 400 (653)
.++|+..+.||+|+||.||+|....+++.+|||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999988899999999864422 22345678999999999999999999874433
Q ss_pred --eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 401 --ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 401 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
.+++|+||+.+ +|...+... ...+++.++..++.|+++||.|||+ ++++|+||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 46999999965 677766543 2358999999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCC----------cccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH
Q 048419 479 FGLAKIYEHGANP----------QTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL 547 (653)
Q Consensus 479 fGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l 547 (653)
||+++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999865432211 11223567889999987654 578999999999999999999999976544322111
Q ss_pred HHHHHhhhcccc------hhHhhh--------hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 548 VDWVKELHLEGE------ITQAID--------QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 548 ~~~~~~~~~~~~------~~~~~d--------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
............ +....+ +.+..........+.+++.+||+.||.+|||+.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111100000000 000000 00000001122568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=299.80 Aligned_cols=269 Identities=25% Similarity=0.289 Sum_probs=200.6
Q ss_pred hcCcCc-ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhh--------------HHHHHHHHHHHhhcCCCceeeee
Q 048419 329 TKGFGE-QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG--------------MKEFVAEIMSMGRLRHRNLVQLH 393 (653)
Q Consensus 329 t~~f~~-~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~ 393 (653)
.++|.. .+.||+|+||.||+|.+..+++.||||.+....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345543 467999999999999998889999999986542211 12477899999999999999999
Q ss_pred eeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 394 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
+++...+..++||||++ |+|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCC
Confidence 99999999999999996 6898888643 348889999999999999999999 89999999999999999999
Q ss_pred EEEEeecCcccccCCC-------------CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChh
Q 048419 474 AKLGDFGLAKIYEHGA-------------NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQ 539 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~ 539 (653)
+||+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998654111 1111223467889999998764 4688999999999999999999999765
Q ss_pred hhhhHHH-HHHHHHhhhcccchhHhhh------------hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 540 KAAAELL-LVDWVKELHLEGEITQAID------------QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 540 ~~~~~~~-l~~~~~~~~~~~~~~~~~d------------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+... +...... .......+..+ +............+.+++.+||+.+|++||++.|++.+..-
T Consensus 238 ~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 238 NEIDQLGRIFELLGT-PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CHHHHHHHHHHHhCC-CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 5432211 1111000 00000000000 00000001124668899999999999999999999987654
Q ss_pred C
Q 048419 607 D 607 (653)
Q Consensus 607 ~ 607 (653)
.
T Consensus 317 ~ 317 (335)
T PTZ00024 317 K 317 (335)
T ss_pred C
Confidence 3
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.99 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=196.6
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecc------
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK------ 398 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------ 398 (653)
...-.+|++.++||+||||.|||++.+-+|+.||||++... +........+|+..+.+|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45667899999999999999999999999999999999755 44556778899999999999999998653100
Q ss_pred --------------------------------------------------------------------------------
Q 048419 399 -------------------------------------------------------------------------------- 398 (653)
Q Consensus 399 -------------------------------------------------------------------------------- 398 (653)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHH
Q 048419 399 -------------------------Q--------DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445 (653)
Q Consensus 399 -------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L 445 (653)
+ -.+||-||||+...|.+++.++... -.-...|+++++|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHH
Confidence 0 1257889999887777777664321 03567789999999999
Q ss_pred HHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc-----------------CCCCCcccccccCCcccCcccc
Q 048419 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE-----------------HGANPQTTHIVGTLGYLAPELT 508 (653)
Q Consensus 446 ~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~ 508 (653)
.|+|+ ++||||||||.||+|+++..+||+|||+|+... .......+..+||.-|+|||++
T Consensus 711 aYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99999 899999999999999999999999999998721 0011234567899999999998
Q ss_pred ccC---CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHH
Q 048419 509 RTG---KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLF 585 (653)
Q Consensus 509 ~~~---~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~ 585 (653)
.+. +|+.|+|+||+||+|+||+. ||....+. .... .....+.++.. ..+..+++..-..++.+
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--a~iL----~~LR~g~iP~~-----~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--ASIL----TNLRKGSIPEP-----ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHH--HHHH----HhcccCCCCCC-----cccccccchHHHHHHHH
Confidence 754 59999999999999999985 45433221 1111 11223433332 12233455667799999
Q ss_pred cCCCCCCCCCCHHHHHH
Q 048419 586 CSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 586 Cl~~dP~~RPs~~evl~ 602 (653)
+++.||.+|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.66 Aligned_cols=259 Identities=22% Similarity=0.242 Sum_probs=192.3
Q ss_pred eeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
.+|.|++ ||.++...+++.||||++... ..+..+.+.+|++.+++++|+||+++++++.+.+..+++|||+++++|
T Consensus 9 ~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 9 CFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3444444 455555557899999998654 445567899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC----
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN---- 490 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~---- 490 (653)
.+++.... ...+++.....++.|+++||.|||+ ++|+|+||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 87 EDLLKTHF---PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99997643 2347888899999999999999999 8999999999999999999999999998875432111
Q ss_pred --CcccccccCCcccCccccccC--CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh----ccc----
Q 048419 491 --PQTTHIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH----LEG---- 558 (653)
Q Consensus 491 --~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~~~---- 558 (653)
.......++..|+|||.+... .++.++|||||||++|||++|+.||........ +.+...... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence 111223567789999998653 578899999999999999999999976433211 111111000 000
Q ss_pred ---chhH----hhhhcc-----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 ---EITQ----AIDQTL-----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ---~~~~----~~d~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+.. ..+... ..........+.+++.+||+.||++|||+.+++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0000 000000 1112233467889999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.35 Aligned_cols=259 Identities=29% Similarity=0.422 Sum_probs=209.3
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
...+-++.....||.|.||.||.|...++|+..|+|.+... .....+...+|+.++..|+|||+|+++|.-..++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34555677788999999999999999999999999988643 3344567789999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
|.||||.+|+|.+++.... .+++.....+..|++.|+.|||+ .+||||||||.||+|+.+|.+|++|||.|.
T Consensus 1311 IFMEyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999999996542 35555666788999999999999 999999999999999999999999999999
Q ss_pred cccCCC---CCcccccccCCcccCccccccCC---CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh-c
Q 048419 484 IYEHGA---NPQTTHIVGTLGYLAPELTRTGK---ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH-L 556 (653)
Q Consensus 484 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-~ 556 (653)
.+.... ........||+.|||||++.+.+ ...+.||||+|||++||+||++||...+.. |....+ .
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~ 1455 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVA 1455 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHh
Confidence 876542 12334568999999999996543 456899999999999999999999876542 211111 1
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.|..++ .+......-.+++..||..||.+|.++.|++++--+.
T Consensus 1456 ~gh~Pq--------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1456 AGHKPQ--------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred ccCCCC--------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 121111 1222345677899999999999999999998876554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=288.16 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=198.6
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-----chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-----SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
+|...+.||+|+||.||++.....+..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 477789999999999999998776666777766432 222344567899999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
+||+++++|.+++...... ...+++.+++.++.|++.||.|||+ .+++|+||+|+||+++. +.+||+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999988653211 3468999999999999999999999 89999999999999975 56999999998765
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ..... .+
T Consensus 156 ~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~-~~------- 220 (260)
T cd08222 156 MGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV------VLRIV-EG------- 220 (260)
T ss_pred CCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHH-cC-------
Confidence 4322 122234578899999999888889999999999999999999999964332110 00000 01
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.....+......+.+++.+||+.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111222345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.97 Aligned_cols=202 Identities=33% Similarity=0.474 Sum_probs=176.2
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc------eeEEE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------ELLLV 405 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV 405 (653)
...+.||+|+||.||+|+++.+|+.||||.++.. .....+....|+++|++|+|+|||++++.-++.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3457899999999999999999999999999764 3445667889999999999999999998765543 57899
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--cC--CCcEEEEeecC
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL--DT--YLNAKLGDFGL 481 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~--~~~~kl~DfGl 481 (653)
||||++|||...|.+... ...|++.+.+.++.+++.||.|||+ ++|+||||||.||++ .+ .-.-||+|||.
T Consensus 96 mEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999977543 5679999999999999999999999 999999999999999 33 33479999999
Q ss_pred cccccCCCCCcccccccCCcccCccccc-cCCCCCccceeehHHHHHHHHhCCCCCChhhh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTR-TGKATTSTDVYSYGILMLEVACGRRSIEPQKA 541 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~ 541 (653)
|+.++.+. .....+||..|++||.+. .+.|+...|.|||||++||.+||..||.....
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99876543 667789999999999998 48899999999999999999999999987554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=280.60 Aligned_cols=249 Identities=25% Similarity=0.309 Sum_probs=205.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...++||+|.||+|-+++-+.+++.+|+|++++. .++....-+.|-+.|+..+||.+..+.-.+...+++|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5688899999999999999999999999999999765 4455566778999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||..||.|.-+|... ..+++...+-....|..||.|||+ ++||.||||.+|.|||.+|++||+|||+++.--
T Consensus 248 eyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999998663 347887778889999999999999 999999999999999999999999999998432
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.....+...+||+.|+|||++....|..+.|-|.+||++|||+||+.||...+...-..++ . . .+
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---l----~---ed---- 384 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---L----M---ED---- 384 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---H----h---hh----
Confidence 2233456689999999999999999999999999999999999999999876543211110 0 0 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (653)
-.++.....+...|....|..||.+|. .++||.++
T Consensus 385 --~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 385 --LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 012222345677788889999999995 57777764
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=300.78 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=210.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
...|.+.+.||+|.|+.|.++++..++..||||.+.+.. ....+.+.+|+++|+.|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456888999999999999999999999999999998763 334466889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+.+|.+.++|...+. ..+.....++.|+.+|++|||+ +.|+|||||++||||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999988754 5557888999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.. ......+|++.|.|||++.+.++ .+++|+||+|++||.|++|..||++..-.+ +-+
T Consensus 207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~ 265 (596)
T KOG0586|consen 207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRP 265 (596)
T ss_pred cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccc
Confidence 43 34456799999999999998876 569999999999999999999998654211 001
Q ss_pred hcc-CcC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTL-DYY--DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l-~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.+ +.+ +.....++.+++.+++-.+|.+|+++.++.+.-+.
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 111 111 11123557788999999999999999999986654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.20 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=202.4
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce---
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE--- 401 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 401 (653)
.+.++|...+.||+|++|.||+|+...++..||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4567899999999999999999999988999999998643 23344667889999999999999999998766554
Q ss_pred ---eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 402 ---LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 402 ---~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
.++|+||+ +++|.+++.. ..+++.+++.++.|+++||.|||+ .+|+|+||||+||++++++.+||+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcc
Confidence 89999999 6699988864 248999999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH-HHHH-----
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL-VDWV----- 551 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~----- 551 (653)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... .+..
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 9999865432 233467889999998865 3678899999999999999999999975443221110 0000
Q ss_pred --HhhhcccchhHhhhhcc--CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 552 --KELHLEGEITQAIDQTL--DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 552 --~~~~~~~~~~~~~d~~l--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
............+.... .... ......+.+++.+||+.+|.+|||+.||+++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 00000000000111000 0000 112467899999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.68 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=201.2
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc--
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-- 400 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 400 (653)
+....++|...+.||+|+||.||++....++..||||++... .....+.+.+|+.++++++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 445678899999999999999999999888999999998543 2333456889999999999999999999886553
Q ss_pred ----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 401 ----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 401 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEE
Confidence 458999999 7789888753 248899999999999999999999 89999999999999999999999
Q ss_pred EeecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh--
Q 048419 477 GDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE-- 553 (653)
Q Consensus 477 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-- 553 (653)
+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||........ +......
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~ 233 (343)
T cd07880 160 LDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTG 233 (343)
T ss_pred eecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcC
Confidence 999999865332 223457889999998875 4588899999999999999999999975543211 1110000
Q ss_pred --------hhcccchhHhhhhc--cC-----cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 554 --------LHLEGEITQAIDQT--LD-----YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 554 --------~~~~~~~~~~~d~~--l~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.............. .. .........+.+++.+|++.||.+|||+.+++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00000000000000 00 00012235688999999999999999999999644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=278.43 Aligned_cols=284 Identities=25% Similarity=0.343 Sum_probs=210.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC----cEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeecc-ccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG----LEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 402 (653)
..|+....||+|.+|.||||....++ +.+|||+++.... .-.....+|+.+++.|+|+|++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35777889999999999999655433 3789999965422 123456789999999999999999999988 6789
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CcEEEEe
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY----LNAKLGD 478 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 478 (653)
++++||.+. +|...++-+.....+.++-.....|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 89998887665556778989999999999999999999 779999999999999776 9999999
Q ss_pred ecCcccccCCCCC--cccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhH------HHHHH
Q 048419 479 FGLAKIYEHGANP--QTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAE------LLLVD 549 (653)
Q Consensus 479 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~------~~l~~ 549 (653)
||+++.+...-.+ ....++-|+.|+|||.+.+. .||.+.|||+.||++.||+|..+.|.+...... ..-.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988665333 23456779999999998775 589999999999999999999887765432211 01111
Q ss_pred HHHhhh---cccchhH----------hhhhccCcCCH---H--------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 550 WVKELH---LEGEITQ----------AIDQTLDYYDL---A--------EAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 550 ~~~~~~---~~~~~~~----------~~d~~l~~~~~---~--------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+.... .+.+... +-+-+...++. . ......+|..++|..||.+|.|+.+.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 111110 0000000 00001000100 0 1133789999999999999999999999886
Q ss_pred C-CCCCCCCCCcc
Q 048419 606 G-DSSLPPLPPDI 617 (653)
Q Consensus 606 ~-~~~~p~~p~~~ 617 (653)
. +.++|+.|-..
T Consensus 340 F~~d~lpp~pt~~ 352 (438)
T KOG0666|consen 340 FTEDPLPPLPTSD 352 (438)
T ss_pred cccCCCCCCcccc
Confidence 4 45577666544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=288.98 Aligned_cols=262 Identities=26% Similarity=0.350 Sum_probs=201.9
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
|+..+.||+|++|.||+|+...+++.+|+|.+.... ....+.+..|+..+++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999999889999999997653 334567889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
+ ++|.+++.... ..+++.++++++.|++.||.|||+ ++++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 58999997652 348999999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH-HHHHHHhhhcccchhHh----
Q 048419 490 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDWVKELHLEGEITQA---- 563 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~---- 563 (653)
. ......++..|+|||.+.+. .++.++|||||||+++||++|+.||.......... +...... .........
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGT-PTEESWPGVTKLP 230 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCC-CcHHHHHhhcccc
Confidence 1 22223457789999998776 78999999999999999999999997654322111 0000000 000000000
Q ss_pred -hhhccCcC--------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 564 -IDQTLDYY--------DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 564 -~d~~l~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+.....+ .......+.+++..||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00001000 00124679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.18 Aligned_cols=263 Identities=26% Similarity=0.334 Sum_probs=204.1
Q ss_pred cccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhc-CCCceeeeeee
Q 048419 318 RRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRL-RHRNLVQLHGW 395 (653)
Q Consensus 318 ~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~ 395 (653)
..|+-++|+. ...||.|+||+|+|-.++..|+..|||+++.... .+.++++.|.+...+- ++||||+++|.
T Consensus 59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 4466555554 4579999999999999999999999999986643 5667888898866555 79999999999
Q ss_pred ecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEE
Q 048419 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAK 475 (653)
Q Consensus 396 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 475 (653)
+..++.+|+.||.| ..||+.+-.......+..+++...-.|.....+||.||-+. ..|||||+||+||||+..|.+|
T Consensus 132 ~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEe
Confidence 99999999999999 45776655443333356688888888999999999999985 7899999999999999999999
Q ss_pred EEeecCcccccCCCCCcccccccCCcccCccccccC--CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 476 LGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 476 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
|||||++..+..+. ..+.-+|...|||||.+... .|+-+|||||||++|+|+.||+.|+..-+..- +.+..
T Consensus 209 LCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-----eql~~ 281 (361)
T KOG1006|consen 209 LCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-----EQLCQ 281 (361)
T ss_pred eecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-----HHHHH
Confidence 99999998664432 22344788899999988533 48889999999999999999999998654311 11110
Q ss_pred hhcccchhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 554 LHLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. ..+.. +.| ..........+...+..|+-.|...||...++.++
T Consensus 282 V-v~gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 V-VIGDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred H-HcCCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0 01111 112 11223356778999999999999999999998864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=277.37 Aligned_cols=264 Identities=21% Similarity=0.312 Sum_probs=210.6
Q ss_pred CHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeeccc
Q 048419 321 KYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQ 399 (653)
Q Consensus 321 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 399 (653)
++.|+-+.| .+.||+|+++.|-.++...+|.++|||++.+..........+|++++.+.+ |+||++|++||+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 456777777 467999999999999988899999999998887777888999999999995 99999999999999
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEE
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL---NAKL 476 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 476 (653)
..+|||||-|.||+|..+|.++ +.+++.+..++.++|+.||.|||. ++|.||||||+|||-.... -+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999875 458999999999999999999999 9999999999999995443 3899
Q ss_pred EeecCcccccC------CCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH
Q 048419 477 GDFGLAKIYEH------GANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL 545 (653)
Q Consensus 477 ~DfGla~~~~~------~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~ 545 (653)
|||.|..-+.. ...+.....+|+..|||||+.. ...|+.+.|.|||||+||-|++|..||.+.-..+.
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC- 299 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC- 299 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-
Confidence 99988764322 1223445568899999999763 23588999999999999999999999986533211
Q ss_pred HHHHHHHhhhcccchhHhhhhcc------C--cCCHH----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 546 LLVDWVKELHLEGEITQAIDQTL------D--YYDLA----EAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 546 ~l~~~~~~~~~~~~~~~~~d~~l------~--~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
-|..|+..+.....| + +++.. ...+..+++...+..++.+|-++.+++.+-..
T Consensus 300 --------GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 300 --------GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred --------CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 112222222211111 1 22322 24667888899999999999999999985543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=281.57 Aligned_cols=237 Identities=26% Similarity=0.352 Sum_probs=195.0
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
||+|+||.||++....+++.+|+|.+.... ......+..|+.++++++|+|++++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999998889999999986542 23456889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 494 (653)
.+++.... .+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence 99997542 48899999999999999999999 999999999999999999999999999998654332 2233
Q ss_pred ccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 495 ~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
...++..|++||...+...+.++|+||||+++|||++|+.||...+... ....+.. . .+ ..+..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~----~--------~~-~~~~~ 215 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKILK----D--------PL-RFPEF 215 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHhc----C--------CC-CCCCC
Confidence 4567889999999988888999999999999999999999997544311 1111111 0 00 11111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRPDMRR 599 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~e 599 (653)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2466789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=274.48 Aligned_cols=278 Identities=21% Similarity=0.277 Sum_probs=214.2
Q ss_pred hhcCcCcc-eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecc----cce
Q 048419 328 VTKGFGEQ-NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRK----QDE 401 (653)
Q Consensus 328 at~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 401 (653)
+|++|.+. ++||-|-.|.|-.+.++.+++.+|+|++... ....+|+++--.. .|+|||.+++.+.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 44555443 5799999999999999999999999998433 3445778765555 69999999998754 346
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEEe
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD---TYLNAKLGD 478 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D 478 (653)
+.+|||.|+||.|.+.+.+++ ...+++++.-+|..||+.|+.|||+ .+|.||||||+|+|.. .|-.+||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eEeeeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecc
Confidence 789999999999999998876 4679999999999999999999999 9999999999999995 455699999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
||+|+.... .......+.|+.|.|||++...+|+...|+||+||++|-|+||.+||....... + ..
T Consensus 208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i---------sp 273 (400)
T KOG0604|consen 208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I---------SP 273 (400)
T ss_pred cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C---------Ch
Confidence 999996543 234455688999999999999999999999999999999999999998654310 0 11
Q ss_pred chhHhhhhccCcCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--cCCCCCCCCCCccccccccccCCcCC
Q 048419 559 EITQAIDQTLDYYDL----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL--LGDSSLPPLPPDIHLKDTRNIMGFSD 630 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L--~~~~~~p~~p~~~~~~~~~~~~~~~~ 630 (653)
.+..-+....-.++. ..++...+++...|..+|.+|-|+.|++.+- .+...+|..|+.....-......|++
T Consensus 274 gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~a~e~w~d 351 (400)
T KOG0604|consen 274 GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKEAVEAWDD 351 (400)
T ss_pred hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcchhhhhhHH
Confidence 111111111112222 2357788999999999999999999999865 45667787776544333333333433
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=293.64 Aligned_cols=263 Identities=23% Similarity=0.275 Sum_probs=195.1
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCC--CcEEEEEEeccC--chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc----ce
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSL--GLEVAIKRIGHN--SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ----DE 401 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 401 (653)
+|...+.||+|+||.||++..... +..||+|++... .....+.+.+|+++++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477789999999999999999877 889999998643 223356788899999999 599999999875432 45
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.++++||+. ++|.+++... ..+++..++.++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999985 6898888543 348899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCC---CcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh--
Q 048419 482 AKIYEHGAN---PQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH-- 555 (653)
Q Consensus 482 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-- 555 (653)
++....... .......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||........ +...+....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 229 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ--LNQILQVLGTP 229 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH--HHHHHHHhCCC
Confidence 986543221 11223468899999998765 4688999999999999999999999875442211 100000000
Q ss_pred --------cccchhHhhhh-------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 556 --------LEGEITQAIDQ-------TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 556 --------~~~~~~~~~d~-------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
........... .+..........+.+++.+|++.||.+|||+.+++++=
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000 00000011245788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=315.27 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=207.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-------CCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
++....+.||+|.||.|++|.... ....||||.++.. ...+.+.+..|+++|+.+ +|+|++.++|+|.+.+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 344556699999999999998531 1467999999755 335678899999999999 6999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhccc---------cccc--ccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKD---------HKLR--KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
..++|.||+..|+|.++|.... .... ..|+..+.+.++.|||.|++||++ .+++||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999998865 1111 238999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCCccccccc--CCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANPQTTHIVG--TLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELL 546 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 546 (653)
.+..+||+|||+++..............+ ...|||||.+....++.|+||||||++||||.| |..|+.+.....+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~-- 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE-- 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH--
Confidence 99999999999999655544333222222 446999999999999999999999999999999 7778765221111
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.++++. |... ..+..+..++.++++.||+.+|++||++.|+.+.++.
T Consensus 531 l~~~l~~----G~r~--------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 LLEFLKE----GNRM--------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHhc----CCCC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1222222 2111 2233346778899999999999999999999999977
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=312.12 Aligned_cols=146 Identities=27% Similarity=0.394 Sum_probs=132.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|.+.+.||+|+||.||+|.+..+++.||||++... .....+.+..|+.+++.++|+||+++++++...+.+++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788899999999999999999988999999998643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
||+++++|.+++... ..+++..++.++.||+.||.|||. ++|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998653 247888899999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=309.00 Aligned_cols=266 Identities=26% Similarity=0.295 Sum_probs=216.9
Q ss_pred CcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeee
Q 048419 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLH 393 (653)
Q Consensus 317 ~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~ 393 (653)
+..-...+++--.++|.+.++||+|+||.|..++++.+++.||+|++.+. ......-|+.|-.+|..-+.+-|++++
T Consensus 62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH 141 (1317)
T ss_pred HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence 33445667777778999999999999999999999999999999999763 344556788999999998999999999
Q ss_pred eeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 394 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
-.|.+++++|+|||||+||+|..+|.... .++++...-.+..|..||.-||+ .|+|||||||+|||||..|+
T Consensus 142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHhcCccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCc
Confidence 99999999999999999999999997754 48999999999999999999999 99999999999999999999
Q ss_pred EEEEeecCcccccCCCCCcccccccCCcccCcccccc-----CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHH
Q 048419 474 AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLV 548 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~ 548 (653)
+||+|||.+-.+..+..-.....+|||.|++||++.. +.|.+.+|-||+||++|||+.|..||....-.+..
T Consensus 214 ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY--- 290 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY--- 290 (1317)
T ss_pred EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH---
Confidence 9999999998877555545556789999999999853 57899999999999999999999999864422111
Q ss_pred HHHHhhhcccchhHhhhhccCcCC--HHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHc
Q 048419 549 DWVKELHLEGEITQAIDQTLDYYD--LAEAELVLNLGLFCSAPNPVYRPD---MRRVVEFLL 605 (653)
Q Consensus 549 ~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L~ 605 (653)
+++..- ...+ .++ .+.++.+.+||.+.+. +|+.|-. +.++-.+.-
T Consensus 291 ---------~KIm~h-k~~l-~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 291 ---------GKIMNH-KESL-SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred ---------HHHhch-hhhc-CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 011110 0011 111 2345677777777665 7788887 888888764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=277.08 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=211.6
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-C-Cc----eeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-H-RN----LVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~g~~~~~~~ 401 (653)
.+++|.+..++|+|.||.|-++.+...+..||||+++...+ ..+.-+-|++.+++|. + |+ +|++.+|+.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 47899999999999999999999999899999999965433 3455667999999994 3 22 7889999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----------
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT----------- 470 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----------- 470 (653)
.|||+|.+ |-|+.++|..+. -.+++..+++.++.|++++++|||+ .+++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCC
Confidence 99999998 669999998765 4678899999999999999999999 99999999999999931
Q ss_pred ---------CCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhh
Q 048419 471 ---------YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKA 541 (653)
Q Consensus 471 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~ 541 (653)
+..+||+|||.|+..... ....+.|..|.|||++.+-.++..+||||+||+|.|+.||...|+..++
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 345899999999875332 2446789999999999999999999999999999999999999988776
Q ss_pred hhHHHHHHHHHhhhcccchhHh-------------------------hhh--cc---CcCCHHHHHHHHHHHHHcCCCCC
Q 048419 542 AAELLLVDWVKELHLEGEITQA-------------------------IDQ--TL---DYYDLAEAELVLNLGLFCSAPNP 591 (653)
Q Consensus 542 ~~~~~l~~~~~~~~~~~~~~~~-------------------------~d~--~l---~~~~~~~~~~l~~l~~~Cl~~dP 591 (653)
.+.+.+.+.+........+... .+. .| ......+..+|.+|+..||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 5554433333221111111111 000 00 01233456789999999999999
Q ss_pred CCCCCHHHHHHHHcC
Q 048419 592 VYRPDMRRVVEFLLG 606 (653)
Q Consensus 592 ~~RPs~~evl~~L~~ 606 (653)
.+|+|++|++++--.
T Consensus 395 ~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 395 ARRITLREALSHPFF 409 (415)
T ss_pred cccccHHHHhcCHHh
Confidence 999999999987543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=272.50 Aligned_cols=220 Identities=21% Similarity=0.195 Sum_probs=177.6
Q ss_pred eCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCchhhhhc
Q 048419 341 GGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD 420 (653)
Q Consensus 341 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 420 (653)
|.+|.||++.+..+++.+|+|++.... .+..|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999996543 233455555666799999999999999999999999999999999865
Q ss_pred ccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCC
Q 048419 421 KDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL 500 (653)
Q Consensus 421 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 500 (653)
.. .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++|||++...... .....++.
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 42 48899999999999999999999 89999999999999999999999999988655432 12234567
Q ss_pred cccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHH
Q 048419 501 GYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVL 580 (653)
Q Consensus 501 ~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 580 (653)
.|+|||......++.++||||+|+++|||++|+.|+....... ..... + ..+......+.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~--------~-~~~~~~~~~~~ 206 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTT--------L-NIPEWVSEEAR 206 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccccc--------c-CCcccCCHHHH
Confidence 8999999988889999999999999999999998765321100 00000 0 01111245688
Q ss_pred HHHHHcCCCCCCCCCCH
Q 048419 581 NLGLFCSAPNPVYRPDM 597 (653)
Q Consensus 581 ~l~~~Cl~~dP~~RPs~ 597 (653)
+++.+|++.||.+||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=298.31 Aligned_cols=268 Identities=19% Similarity=0.185 Sum_probs=176.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCC----CcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeee------ec
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSL----GLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW------CR 397 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 397 (653)
..++|...+.||+|+||.||+|.+..+ +..||||++..... .+....| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999888 89999999754322 1111111 1222222232222211 24
Q ss_pred ccceeEEEEeccCCCCchhhhhcccccc---------------cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 048419 398 KQDELLLVYDYVPNGSLDKLLFDKDHKL---------------RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVK 462 (653)
Q Consensus 398 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 462 (653)
.....++||||+++++|.+++....... ........+..++.||+.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 5567999999999999999987542100 0111234456799999999999999 899999999
Q ss_pred CCcEEEcC-CCcEEEEeecCcccccCCCCCcccccccCCcccCccccccC----------------------CCCCccce
Q 048419 463 PSNILLDT-YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG----------------------KATTSTDV 519 (653)
Q Consensus 463 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDV 519 (653)
|+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986654433334456789999999965322 23456799
Q ss_pred eehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh-cccchhHhhhhcc-----CcCC--HHHHHHHHHHHHHcCCCCC
Q 048419 520 YSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH-LEGEITQAIDQTL-----DYYD--LAEAELVLNLGLFCSAPNP 591 (653)
Q Consensus 520 ~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~d~~l-----~~~~--~~~~~~l~~l~~~Cl~~dP 591 (653)
|||||+||||+++..+.+..... +...+.... ........+.+.. ..+. ........+|+.+||+.||
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQ----FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHH----HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999999987765432111 100000000 0000000111100 0000 0012345589999999999
Q ss_pred CCCCCHHHHHHHHcC
Q 048419 592 VYRPDMRRVVEFLLG 606 (653)
Q Consensus 592 ~~RPs~~evl~~L~~ 606 (653)
.+|||+.|++++-..
T Consensus 439 ~kR~ta~e~L~Hpff 453 (566)
T PLN03225 439 RQRISAKAALAHPYF 453 (566)
T ss_pred ccCCCHHHHhCCcCc
Confidence 999999999997544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=267.90 Aligned_cols=239 Identities=29% Similarity=0.384 Sum_probs=195.7
Q ss_pred CcEEEEEEEeCCCCcEEEEEEeccCchhh-HHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCchhhhhc
Q 048419 342 GFGRVYRGLMPSLGLEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD 420 (653)
Q Consensus 342 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 420 (653)
+||.||+|...++++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998889999999997665444 68899999999999999999999999999999999999999999999866
Q ss_pred ccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCC
Q 048419 421 KDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL 500 (653)
Q Consensus 421 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 500 (653)
.. .+++.+++.++.++++++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++.
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 43 27889999999999999999999 899999999999999999999999999998765432 233456788
Q ss_pred cccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHH
Q 048419 501 GYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVL 580 (653)
Q Consensus 501 ~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 580 (653)
.|++||.+....++.++|||+||+++++|++|..|+....... ...+....... .. ..........+.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~~~~~----~~------~~~~~~~~~~~~ 218 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIGKPKP----PF------PPPEWKISPEAK 218 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHhccCC----CC------ccccccCCHHHH
Confidence 9999999988889999999999999999999999987532211 11111111000 00 000000346788
Q ss_pred HHHHHcCCCCCCCCCCHHHHHH
Q 048419 581 NLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 581 ~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=274.44 Aligned_cols=258 Identities=27% Similarity=0.376 Sum_probs=199.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--ch-----hhHHHHHHHHHHHhhcCCCceeeeeeeec-ccc
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQ-----QGMKEFVAEIMSMGRLRHRNLVQLHGWCR-KQD 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~ 400 (653)
.++|-..++||+|||+.|||+.+-.....||||+-... -+ ...+...+|..+-+.|.||.||++++|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34577778999999999999999888899999986432 11 12345678999999999999999999985 556
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEE
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLG 477 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~ 477 (653)
.+|-|+|||+|.+|+-||..+ +.+++++.+.|+.||+.||.||.+. ..+|||-||||.|||| +..|.+||.
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 789999999999999999775 4589999999999999999999874 4789999999999999 456889999
Q ss_pred eecCcccccCCCCC------cccccccCCcccCccccccC----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH
Q 048419 478 DFGLAKIYEHGANP------QTTHIVGTLGYLAPELTRTG----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL 547 (653)
Q Consensus 478 DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l 547 (653)
||||++.+..+... .+....||.+|++||++.-+ +.+.|.||||.||++|+.+.|++||.......+..
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL- 694 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL- 694 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH-
Confidence 99999998765443 23446799999999998644 57889999999999999999999998654322211
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
. ...+..+-.-... .......+...++.+||+..-++|....++..
T Consensus 695 q--------eNTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 Q--------ENTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred h--------hhchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0 1111111000000 01122456778999999999999988777653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=279.05 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=194.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
.++||.|-||+||-|+++.+|+.||||++.+. .......+.+|+.+|++++||.||.+...|+..+..+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 46899999999999999999999999999754 344557889999999999999999999999999999999999955
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEEeecCcccccCCC
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~~~~~ 489 (653)
+..+.+-... +..|++..-.-++.||+-||.|||. ++|+|+||||+||||.+ -..+||||||.|+.+....
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 5544444433 4568888888889999999999999 99999999999999944 4569999999999987644
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
. ...++||+.|+|||++.++.|+..-|+||.||++|--++|..||....+..+.. +.+.-.+.....
T Consensus 722 F--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI--QNAaFMyPp~PW--------- 788 (888)
T KOG4236|consen 722 F--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI--QNAAFMYPPNPW--------- 788 (888)
T ss_pred h--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh--hccccccCCCch---------
Confidence 3 345789999999999999999999999999999999999999997644322110 000001111111
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+......+|+...|+..-.+|-+....+.+
T Consensus 789 ---~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ---hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1223456677777777777777777666544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=285.17 Aligned_cols=244 Identities=24% Similarity=0.280 Sum_probs=198.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+..|.....+|.|+|+.|-++.+..+++..+||++.... .+-.+|+.++... +|+|++++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 456777778999999999999999999999999996552 2234566555555 79999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cCCCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL-DTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~ 486 (653)
.+.++-|.+.+..... .. .++..|+.+|+.|+.|||+ +++|||||||+|||+ ++.++++|+|||.++...
T Consensus 397 ~l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999888777765431 22 6777899999999999999 999999999999999 699999999999998765
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. ....+-|..|.|||.+....+++++|+||||++||||++|+.|+....... .+. .....+
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~----~~i~~~-------- 529 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIH----TRIQMP-------- 529 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHH----HhhcCC--------
Confidence 43 233466889999999999999999999999999999999999998654431 111 111111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+....+....+|+.+||+.||.+||+|.++..+-..
T Consensus 530 ---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 ---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1223345778899999999999999999999987665
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.34 Aligned_cols=267 Identities=18% Similarity=0.211 Sum_probs=185.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeC----------------CCCcEEEEEEeccCchhhHHH--------------HHHH
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMP----------------SLGLEVAIKRIGHNSQQGMKE--------------FVAE 377 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 377 (653)
..++|++.++||+|+||.||+|... ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 235679999986543332333 3447
Q ss_pred HHHHhhcCCCce-----eeeeeeecc--------cceeEEEEeccCCCCchhhhhccccc-------------------c
Q 048419 378 IMSMGRLRHRNL-----VQLHGWCRK--------QDELLLVYDYVPNGSLDKLLFDKDHK-------------------L 425 (653)
Q Consensus 378 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~ 425 (653)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877654 677788753 34689999999999999999753210 0
Q ss_pred cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCc
Q 048419 426 RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505 (653)
Q Consensus 426 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 505 (653)
...++|..+..++.|++.+|.|||+ ++|+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235677889999999999999999 8999999999999999999999999999976543322222223457899999
Q ss_pred cccccCCC----------------------CCccceeehHHHHHHHHhCCC-CCChhhhhhH------HHHHHHHHhhhc
Q 048419 506 ELTRTGKA----------------------TTSTDVYSYGILMLEVACGRR-SIEPQKAAAE------LLLVDWVKELHL 556 (653)
Q Consensus 506 E~~~~~~~----------------------~~ksDV~s~Gvvl~elltG~~-p~~~~~~~~~------~~l~~~~~~~~~ 556 (653)
|.+..... ..+.||||+||+++||++|.. |+........ ..+..|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 98754321 235799999999999999875 6643211100 01111110 00
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCC---CCCCCHHHHHHHHcC
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNP---VYRPDMRRVVEFLLG 606 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~L~~ 606 (653)
.... +- . ..........+|+.+||..+| .+|+|+.|+++|-..
T Consensus 458 ~~~~----~~--~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 458 GQKY----DF--S-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred ccCC----Cc--c-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 0000 00 0 011224667888899998765 689999999987543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=240.63 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=198.4
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
|...++||+|.+|+||||+..++++.||+|+++..+. ..-...++|+-+++.|+|+|||++++....++.+-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4445689999999999999999999999999875432 22356789999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
.. +|..+..... ..++.+....+..|+++||.++|+ +++.||||||.|.|++.+|++|++|||+++.+....
T Consensus 84 dq-dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hH-HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 54 7877775543 447888888999999999999999 999999999999999999999999999999775432
Q ss_pred CCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCC-hhhhhhHHHHHHHHHhhhcccch---hHhh
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIE-PQKAAAELLLVDWVKELHLEGEI---TQAI 564 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~~---~~~~ 564 (653)
.. ....+-|..|.+|+++.+.+ |+...|+||.||++.|+....+|.- +.+..++....-|+.....++.. ..+.
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 22 12235688999999998765 7889999999999999998655544 43333333322233222222221 2222
Q ss_pred hhcc-CcCCH---------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 565 DQTL-DYYDL---------AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 565 d~~l-~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
|-.. ..++. .....-.++..+.+.-+|..|.++++.+++-..
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 2111 11111 111233466666777799999999999887543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=268.60 Aligned_cols=240 Identities=24% Similarity=0.312 Sum_probs=195.9
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 406 (653)
+|....+||+|+||.|.++..+++.+.+|||++++. ..++.+--+.|-++|.-. +-|.++++...+..-+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 588899999999999999999999999999999765 233344445666666655 5678999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+.||+|--++.+.+. +.++.+.-.+..||-||-+||+ ++|+.||||.+|||||.+|.+||+|||+++.--
T Consensus 430 EyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999988877543 7778888999999999999999 999999999999999999999999999998421
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
. ....+...+||+.|+|||++....|....|-|||||+||||+.|+.||++.++.+- + +.+-+
T Consensus 502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el--F--------------~aI~e 564 (683)
T KOG0696|consen 502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--F--------------QAIME 564 (683)
T ss_pred c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH--H--------------HHHHH
Confidence 1 22334567999999999999999999999999999999999999999998765421 1 11111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRP 595 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (653)
.--.++-..+.+...++...+...|.+|.
T Consensus 565 hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11123444456778888888889998884
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=284.51 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=212.7
Q ss_pred CHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecc-
Q 048419 321 KYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRK- 398 (653)
Q Consensus 321 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 398 (653)
.++.+..-++-|++..+||.|.+|.||+++...+++.+|+|+...... ..++...|.++++.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444556778889999999999999999999999999999866543 335667888899888 69999999999854
Q ss_pred ----cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 399 ----QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 399 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
.+.+|||||||.+||..+++.... ...+.|..+.-|+..++.||++||. ..++|||||-.||||+.++.+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcE
Confidence 357999999999999999998765 5679999999999999999999999 999999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccccC-----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHH
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVD 549 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 549 (653)
||+|||.+..+...- .......||+.|||||++... .|+..+|+||||++..||.-|.+|+..+.+...+.
T Consensus 163 KLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF--- 238 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF--- 238 (953)
T ss_pred EEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---
Confidence 999999998765432 233446899999999998643 46779999999999999999999998765532211
Q ss_pred HHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 550 WVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+.....+.|. .+..-.+.+.+++..||..|-++||++.+++++-
T Consensus 239 ---------~IpRNPPPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 239 ---------LIPRNPPPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred ---------cCCCCCCcccc-chhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 11111122221 1223357899999999999999999999998753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=257.18 Aligned_cols=267 Identities=25% Similarity=0.382 Sum_probs=202.5
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhh-HHHHHHHHHHHhhcCCCceeeeeeeeccc--------ce
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQG-MKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--------DE 401 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~ 401 (653)
|....++|+|.||.||+|+.+.+|+.||+|++-.. .+++ -...++|+.+|..|+|+|++.+++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 44467899999999999999999999999886443 2222 23457899999999999999999998543 24
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
+++|+++|+. +|.-+|.... ..++..++.++..++..||.|+|. ..|+|||+||.|+|++.++.+||+|||+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 8999999976 8888886652 457888999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCC---CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH------
Q 048419 482 AKIYEHGAN---PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV------ 551 (653)
Q Consensus 482 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~------ 551 (653)
++.+....+ +.-+..+-|..|++||.+.+. .++++.|||+.||++.||+||.+-+++..+.....+..-+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987654322 223445568999999988764 6899999999999999999999998877765554433221
Q ss_pred --HhhhcccchhHhhhhc-c--CcCC--HHH------HHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 552 --KELHLEGEITQAIDQT-L--DYYD--LAE------AELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 552 --~~~~~~~~~~~~~d~~-l--~~~~--~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
|+....-.+.+.+.-. + +.+. .+. ....++|+..++..||.+||++.+++.+-..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 1111111111112100 1 0000 111 2367899999999999999999999987654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.99 Aligned_cols=283 Identities=24% Similarity=0.304 Sum_probs=224.0
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+.....||-||||.|=++........+|+|.+++. .....+....|-.+|.+.+.|.||+++--+.+.+..|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 34466799999999999988765556888888653 444556778899999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
|-||.|...|..++ .++.....-++..+++|++|||+ ++||.|||||+|.+|+.+|-+||.|||+|+.+..+
T Consensus 502 ClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 502 CLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999998754 47788888899999999999999 99999999999999999999999999999987653
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
..+..++||+.|.|||++.+...+.+.|.||||+++|||++|++||...++.....+. . .| +|.
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---L----kG-----id~-- 637 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---L----KG-----IDK-- 637 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---H----hh-----hhh--
Confidence 4567789999999999999999999999999999999999999999987764322211 0 00 110
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHcCCC------CCC--CCCCccccccccccCCcCCCCCCc
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFLLGDS------SLP--PLPPDIHLKDTRNIMGFSDFPNDS 635 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~~------~~p--~~p~~~~~~~~~~~~~~~~~~~~~ 635 (653)
-.++....+...+|+++.+..+|.+|-- +.+|-++-+.+. ... +.|...+.+.......|+.+|.+.
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p~dn 717 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFPPDN 717 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCCccc
Confidence 0122233466788899999999999975 788888765321 111 122223455666677788888766
Q ss_pred ccc
Q 048419 636 DFF 638 (653)
Q Consensus 636 ~~~ 638 (653)
++-
T Consensus 718 d~p 720 (732)
T KOG0614|consen 718 DEP 720 (732)
T ss_pred CCC
Confidence 653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=262.05 Aligned_cols=266 Identities=21% Similarity=0.269 Sum_probs=210.3
Q ss_pred HHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCC-----CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeee
Q 048419 322 YAELASVTKGFGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395 (653)
Q Consensus 322 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 395 (653)
.+|+.....+++...++-+|.||.||+|.+.+. .+.|-+|.++.. +.-....++.|...+..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 556666667788888999999999999977543 345667777543 44456788999999999999999999999
Q ss_pred ecccc-eeEEEEeccCCCCchhhhhccc---ccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 048419 396 CRKQD-ELLLVYDYVPNGSLDKLLFDKD---HKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY 471 (653)
Q Consensus 396 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 471 (653)
+.+.. ..+.+|.++.-|+|..+|.... .+....++-.+...++.|++.|++|||+ +++||.||..+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 87654 6789999999999999998321 1223557778889999999999999999 999999999999999999
Q ss_pred CcEEEEeecCcccccCCCCCcc-cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHH
Q 048419 472 LNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVD 549 (653)
Q Consensus 472 ~~~kl~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 549 (653)
.++||+|=.+++.+-....... .....+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.+...
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--- 509 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--- 509 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH---
Confidence 9999999999986644433222 22234678999999999999999999999999999999 888987665533211
Q ss_pred HHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 550 WVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+ ..+|. + -..+..++.++..++.-||..+|++||+++|++.=|.
T Consensus 510 y----lkdGy-------R-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 510 Y----LKDGY-------R-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred H----Hhccc-------e-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 1 11111 1 1234557788999999999999999999999998763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=238.75 Aligned_cols=199 Identities=28% Similarity=0.351 Sum_probs=168.1
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEeccCCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
...||+|++|.|-+.++..+|+..|+|++... ..+..++.+.|+.+..+. .+|.+|.++|....+...++.||.|. .
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 45699999999999999999999999999765 455667788898876655 79999999999999999999999994 4
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
||+.+-.+... ....+++..+-+|+.-+.+||.|||+. ..++|||+||+|||++.+|++|+||||++..+..+. .
T Consensus 130 Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--A 204 (282)
T KOG0984|consen 130 SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--A 204 (282)
T ss_pred hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh--H
Confidence 88776655332 245688999999999999999999995 789999999999999999999999999998765432 2
Q ss_pred ccccccCCcccCcccccc----CCCCCccceeehHHHHHHHHhCCCCCChh
Q 048419 493 TTHIVGTLGYLAPELTRT----GKATTSTDVYSYGILMLEVACGRRSIEPQ 539 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~----~~~~~ksDV~s~Gvvl~elltG~~p~~~~ 539 (653)
.+.-.|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++..
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 233467789999998753 36889999999999999999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=250.07 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=194.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...++||+|+|++|-.+.+..+.+.+|+|++++. ..+...=...|-....+. +||.+|.+..++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5688899999999999999999999999999998754 333344445566666665 799999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
.||.+||+|--++.++. .|+++..+-....|..||.|||+ ++|+.||||.+|||||+.|.+||.|+|+++.-
T Consensus 330 ieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999988876643 48999999999999999999999 99999999999999999999999999999853
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhh--hhhHHHHHHHHHhhhcccchhHh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQK--AAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
- .....+...+||+.|+|||++.+..|....|-|++||+++||+.|+.||+-.. +.+ ....+++.+...+..+
T Consensus 402 l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylfqvilekqi--- 476 (593)
T KOG0695|consen 402 L-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLFQVILEKQI--- 476 (593)
T ss_pred C-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHHHHHhhhcc---
Confidence 2 23345566899999999999999999999999999999999999999997422 111 1111222221111110
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP 595 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (653)
..+.....+...+...-|+.||.+|.
T Consensus 477 ------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 01111234456777788889999885
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-31 Score=250.18 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=203.9
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----ceeEEE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-----DELLLV 405 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 405 (653)
+..+.||-|+||.||.+.++.+|+.||+|++... +-...+.+.+|+.+|.-.+|.|++..++...-. .++|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4467899999999999999999999999998653 334567889999999999999999988865443 257889
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
+|.|. .+|...+-.. ..|+.+...-++.||++||.|||+ .+|.||||||.|.|++++..+||||||+++..
T Consensus 136 TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 99984 5888877653 347888888899999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh--------hhc
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE--------LHL 556 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~ 556 (653)
+.+.....+..+-|..|+|||++.+. .|+.+.||||.||++.||+..+..|....+.....+..-+.. ...
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 76666666666778999999999875 589999999999999999999888877665554433321111 111
Q ss_pred ccchhHhhhhccCc----------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 EGEITQAIDQTLDY----------YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 ~~~~~~~~d~~l~~----------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+|....++....+. -....-.+.+.+...++..||+.|.+..+.+.++.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 12222222211110 01122244667788899999999999999998774
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=279.51 Aligned_cols=247 Identities=27% Similarity=0.367 Sum_probs=189.2
Q ss_pred cCcceeeeeeCcE-EEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEecc
Q 048419 332 FGEQNLVGSGGFG-RVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 332 f~~~~~LG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
|...+++|.|+-| .||+|... |+.||||++-.. ...-..+|+..|+.- +|||||++++.-.++..+||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 5566789999987 67999996 789999998433 233456899999988 5999999999888899999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEEeecCccc
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-----YLNAKLGDFGLAKI 484 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~ 484 (653)
. .+|.+++...... .....-...+.+..|++.||++||+ .+||||||||.||||+. ..+++|+|||+++.
T Consensus 586 ~-~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 5 5999999874111 1111113457889999999999999 89999999999999965 35799999999998
Q ss_pred ccCCCCCc--ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhC-CCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 485 YEHGANPQ--TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACG-RRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 485 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
+..+.... .....||-+|+|||.+....-+.++||||+||++|..++| ..||......+...+ .. ...+.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl----~~---~~~L~ 733 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL----TG---NYTLV 733 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh----cC---cccee
Confidence 87654432 3346799999999999998889999999999999999986 899986543221110 00 00000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. |. ...++ +..+|+.+|++++|..||++.+|+.+
T Consensus 734 ~-----L~-~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 H-----LE-PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred e-----ec-cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 00 01111 78899999999999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=237.49 Aligned_cols=212 Identities=35% Similarity=0.576 Sum_probs=185.2
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCchh
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDK 416 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 416 (653)
||+|.+|.||++....+++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999765433 45678999999999999999999999999999999999999999999
Q ss_pred hhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEeecCcccccCCCCCcccc
Q 048419 417 LLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEHGANPQTTH 495 (653)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~ 495 (653)
++.... ..+++.+++.++.++++++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 987542 348899999999999999999999 89999999999999999 89999999999986644321 1233
Q ss_pred cccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHH
Q 048419 496 IVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574 (653)
Q Consensus 496 ~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 574 (653)
..+...|++||..... ..+.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 575 EAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..+.+++..|++.+|.+||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467889999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=255.12 Aligned_cols=216 Identities=25% Similarity=0.372 Sum_probs=182.7
Q ss_pred cCHHHHHHhhc---CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeee
Q 048419 320 FKYAELASVTK---GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLH 393 (653)
Q Consensus 320 f~~~el~~at~---~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~ 393 (653)
-.|.-|+.+.- -|...+.||-|+||.|.++...++...+|.|.+++.+ +.......+|-.+|.....+-||+|+
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 44555555543 4778889999999999999988889999999997653 34455678899999999999999999
Q ss_pred eeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 394 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
-.|.+.+.+|+||||++||++-.+|-+.+ .+.+...+-.+..+..|+++.|. .|+|||||||+|||||.+|.
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGH 767 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGH 767 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCc
Confidence 99999999999999999999999997754 47888888889999999999999 99999999999999999999
Q ss_pred EEEEeecCccccc---------CCC-----------------C---------------CcccccccCCcccCccccccCC
Q 048419 474 AKLGDFGLAKIYE---------HGA-----------------N---------------PQTTHIVGTLGYLAPELTRTGK 512 (653)
Q Consensus 474 ~kl~DfGla~~~~---------~~~-----------------~---------------~~~~~~~gt~~y~aPE~~~~~~ 512 (653)
+||.||||++-+. .+. . ......+||+.|+|||++....
T Consensus 768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g 847 (1034)
T KOG0608|consen 768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG 847 (1034)
T ss_pred eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC
Confidence 9999999996431 000 0 0011346999999999999999
Q ss_pred CCCccceeehHHHHHHHHhCCCCCChhhhhh
Q 048419 513 ATTSTDVYSYGILMLEVACGRRSIEPQKAAA 543 (653)
Q Consensus 513 ~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~ 543 (653)
++..+|-||.||+||||+.|+.||-...+.+
T Consensus 848 ~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 848 YTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred ccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 9999999999999999999999998766543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=234.28 Aligned_cols=200 Identities=32% Similarity=0.476 Sum_probs=175.2
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
|...+.||+|++|.||++...++++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45678999999999999999888899999999766544 67789999999999999999999999999899999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+++|.+++..... .+++.+++.++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999876431 17889999999999999999999 8999999999999999999999999999987654321
Q ss_pred CcccccccCCcccCcccc-ccCCCCCccceeehHHHHHHHHhCCCCCCh
Q 048419 491 PQTTHIVGTLGYLAPELT-RTGKATTSTDVYSYGILMLEVACGRRSIEP 538 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~s~Gvvl~elltG~~p~~~ 538 (653)
.......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334677899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=250.54 Aligned_cols=286 Identities=22% Similarity=0.231 Sum_probs=218.7
Q ss_pred hhhhHhhhcCCcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-
Q 048419 307 MLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR- 385 (653)
Q Consensus 307 ~~~~~~~~~~~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~- 385 (653)
+.+.|....|..+..+.|+ ..++|......|+|-|++|.+|.+...|..||||++..+.. -.+.=+.|+++|++|+
T Consensus 411 L~DNWdDaEGYYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~ 487 (752)
T KOG0670|consen 411 LQDNWDDAEGYYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLND 487 (752)
T ss_pred cccCcccccceEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhc
Confidence 4456777667666666665 56889999999999999999999998899999999976532 2344468999999995
Q ss_pred -----CCceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 048419 386 -----HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRD 460 (653)
Q Consensus 386 -----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 460 (653)
--|.++++-.|...+++|||+|-+ ..+|.+.|...+. .-.|........+.|+.-||..|-. .+|+|.|
T Consensus 488 AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~---c~vlHaD 561 (752)
T KOG0670|consen 488 ADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHAD 561 (752)
T ss_pred cCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHh---cCeeecc
Confidence 347999999999999999999988 4599999988764 3457888999999999999999999 8999999
Q ss_pred CCCCcEEEcCC-CcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChh
Q 048419 461 VKPSNILLDTY-LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQ 539 (653)
Q Consensus 461 lkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~ 539 (653)
|||.|||+++. ..+||||||.|..... ...+.+.-+..|.|||++.+..|+...|+||.||+||||.||+..|.+.
T Consensus 562 IKPDNiLVNE~k~iLKLCDfGSA~~~~e---neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 562 IKPDNILVNESKNILKLCDFGSASFASE---NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cCccceEeccCcceeeeccCcccccccc---ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 99999999765 4589999999986543 2344455567899999999999999999999999999999999888766
Q ss_pred hhhhHHHHHHHHHhh-----hcccch---------------------------hHhhhh------cc------CcCCHHH
Q 048419 540 KAAAELLLVDWVKEL-----HLEGEI---------------------------TQAIDQ------TL------DYYDLAE 575 (653)
Q Consensus 540 ~~~~~~~l~~~~~~~-----~~~~~~---------------------------~~~~d~------~l------~~~~~~~ 575 (653)
.+...+.+.--+... ...+.. ...+.| .| ..-....
T Consensus 639 TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~ 718 (752)
T KOG0670|consen 639 TNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKI 718 (752)
T ss_pred CcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHH
Confidence 543332221111100 000000 000001 11 1112234
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 576 AELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
...+.+|+-.|+..||++|.|..|.+++-
T Consensus 719 ~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 719 VQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 56789999999999999999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=240.02 Aligned_cols=133 Identities=25% Similarity=0.333 Sum_probs=114.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-----C---Cceeeeeeeeccc--
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-----H---RNLVQLHGWCRKQ-- 399 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~~-- 399 (653)
.+|...++||.|-|++||++.+....+.||+|+.+ ......+.-+.||++|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999999999999999984 33344566789999999984 3 3699999998654
Q ss_pred --ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 400 --DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 400 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
.++|+|+|+. |.+|..+|.... .+.++.....+|++||+.||.|||.+ .+|||-||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 4899999999 778999987754 45689999999999999999999997 5999999999999994
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=223.97 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=197.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccc--eeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQD--ELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV 405 (653)
.++|++.+.+|+|-++.||.|..-.+++.++||.++... .+.+.+|+.+|..|+ ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 467888999999999999999988889999999996543 467889999999997 999999999987764 57899
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEeecCccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKI 484 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~ 484 (653)
+||+.+.+...+. ..|+...+...+.+++.||.|+|+ .||.|||+||.|+++|.. -.++|+|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999887765543 337778888999999999999999 999999999999999865 5699999999998
Q ss_pred ccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhh-hhhHHH----------HHHHHH
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQK-AAAELL----------LVDWVK 552 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~-~~~~~~----------l~~~~~ 552 (653)
+..+.... -.+.+..|--||.+-. ..++..-|+|||||+|..|+..+.||-... +.+++. +..++.
T Consensus 183 YHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 183 YHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred cCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 86554322 2356778889998865 457889999999999999999999986432 222221 222332
Q ss_pred hhh--cccchhHhhhhcc----CcC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 553 ELH--LEGEITQAIDQTL----DYY-----DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 553 ~~~--~~~~~~~~~d~~l----~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+.. .......++...- ..+ ..-...++++++-+.|..|..+|||++|.+.+-
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 221 1112222221111 000 001136788999999999999999999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=252.15 Aligned_cols=196 Identities=25% Similarity=0.346 Sum_probs=170.3
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch---hh-----HHHHHHHHHHHhhcC---CCceeeeeeeeccc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---QG-----MKEFVAEIMSMGRLR---HRNLVQLHGWCRKQ 399 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~-----~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 399 (653)
.|...+.+|+|+||.|+.|.++.+..+|+||.+.+..- .+ .-..-.|+++|..|+ |+||++++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 47778999999999999999999999999999865421 11 123456999999997 99999999999999
Q ss_pred ceeEEEEecc-CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 400 DELLLVYDYV-PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 400 ~~~~lV~E~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
+.+||+||-. ++-+|.+++..+. .+++.+.--|++||+.|+++||+ ++|||||||-+||.++++|-+||+|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence 9999999975 5678999997654 48999999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCC
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIE 537 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~ 537 (653)
||.+.....+. ....+||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998765543 344689999999999998876 457899999999999999988875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=256.34 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=206.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|.....+|.|.+|.|||+++..+++..|+|.++........-..+|+-+++..+|+||+.++|.+...+.++++||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 56777899999999999999999999999999998887778888899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
.+|+|.+.-+-.. +|++.++..+++..++||+|||+ .+-+|||||-.||++++.+.+|++|||.+..+...
T Consensus 95 gggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 95 GGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred CCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh-
Confidence 9999999876643 59999999999999999999999 89999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCcccc---ccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 490 NPQTTHIVGTLGYLAPELT---RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
........||+.|||||+. ..+.|..++|||+.|+...|+--...|.....+.....+. -...+.. +
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~qp--------p 235 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQP--------P 235 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCCC--------C
Confidence 2233456899999999976 3567899999999999999998888776543332211110 0111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
.++ -...-.+.+-++++.|+-.+|.+||++..+++
T Consensus 236 ~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 01112456889999999999999999987765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=232.22 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=198.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-----
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----- 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 400 (653)
...+|...+.+|.|.- .|..+.+.-.++.||+|++... .....+...+|...+..++|+|+++++.++.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456777788898888 7777777777899999998543 2334567788999999999999999999885443
Q ss_pred -eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 401 -ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 401 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
+.|+|||+| ..+|...+... ++=+.+..|+.|++.|++|||+ .+|+||||||+||++..+..+||.||
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e-------lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME-------LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh-------cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccc
Confidence 579999999 45888877622 4556677899999999999999 99999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH------------
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL------------ 547 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l------------ 547 (653)
|+++..... -..+..+.|..|.|||++-+..+.+.+||||.||++.||++|+.-|.+.+.-+....
T Consensus 163 g~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 163 GLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 999865432 345667889999999999888899999999999999999999987765443221110
Q ss_pred ----HHHHHhh------hcccchhHhhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 548 ----VDWVKEL------HLEGEITQAIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 548 ----~~~~~~~------~~~~~~~~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..-++.. +..-...+.+...+ .+.+......+.+++.+||-.||++|-++++++++--
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 0000000 00011111111111 0111123456889999999999999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=225.19 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=189.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeee-ecccceeEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGW-CRKQDELLLV 405 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV 405 (653)
..+.|.+.+.||+|.||.+-++.++.+.+.+++|-+.... -..++|.+|...--.| .|.||+.-++. +...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3456888999999999999999999999999999985442 2357888888655555 48999987764 5666788899
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cC-CCcEEEEeecCcc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL-DT-YLNAKLGDFGLAK 483 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~-~~~~kl~DfGla~ 483 (653)
+||+|.|+|.+-+...+ +-+..-.+++.|+++||.|||+ +++||||||.+|||+ +. ..++||||||+.+
T Consensus 101 qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999998886643 5666677899999999999999 999999999999999 43 4479999999987
Q ss_pred cccCCCCCcccccccCCcccCccccccC-----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTG-----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
..+.. ......+..|.+||..... ...+.+|||+||++++..+||+.||+.....+ ....+ +..+..+
T Consensus 172 k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~--~~~w~~r 244 (378)
T KOG1345|consen 172 KVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWE--WEQWLKR 244 (378)
T ss_pred ccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHH--HHHHhcc
Confidence 54321 2223446689999976432 36789999999999999999999998433222 22223 3333333
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
......+. .. ...+.++++-.+-+.++|++|-...++.++
T Consensus 245 k~~~~P~~-F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 245 KNPALPKK-FN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCccCchh-hc----ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 33322111 01 123567788888999999999665555543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=269.72 Aligned_cols=198 Identities=19% Similarity=0.277 Sum_probs=141.6
Q ss_pred hcCC-Cceeeeeeee-------cccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC
Q 048419 383 RLRH-RNLVQLHGWC-------RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454 (653)
Q Consensus 383 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 454 (653)
.++| +||++++++| .+.+.+++++||+ +++|.++|... ...+++.+++.++.||++||.|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 4566 6888888887 2334577889988 56999999653 2458999999999999999999999 9
Q ss_pred CeEecCCCCCcEEEcCC-------------------CcEEEEeecCcccccCCCC---------------CcccccccCC
Q 048419 455 RVVHRDVKPSNILLDTY-------------------LNAKLGDFGLAKIYEHGAN---------------PQTTHIVGTL 500 (653)
Q Consensus 455 ~ivH~Dlkp~NIll~~~-------------------~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~ 500 (653)
+|+||||||+||||+.. +.+|++|||+++....... .......||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 99999999999999654 4455666666653211000 0011235788
Q ss_pred cccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHH
Q 048419 501 GYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVL 580 (653)
Q Consensus 501 ~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 580 (653)
.|+|||++.+..++.++|||||||+||||++|..|+...... +...... .+.+. .........
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~~---------~~~~~----~~~~~~~~~ 242 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRHR---------VLPPQ----ILLNWPKEA 242 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHHh---------hcChh----hhhcCHHHH
Confidence 999999999999999999999999999999998886532211 1001000 00010 011223456
Q ss_pred HHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 581 NLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 581 ~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.++.+||+++|.+||+|.|++++..
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchh
Confidence 7888999999999999999998654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=225.88 Aligned_cols=269 Identities=25% Similarity=0.371 Sum_probs=199.7
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeCC---CCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccc
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPS---LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQD 400 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 400 (653)
+....+.|...++||+|.|++||++.+.. .+..||+|.+...+. -....+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44566778889999999999999999876 678999999865532 345789999999995 999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEee
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDF 479 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df 479 (653)
..++|+||++.....+++.. ++..++...+..+..||.++|. +|||||||||+|+|.+. -+.-.|.||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred eeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEec
Confidence 99999999999888888754 5677888899999999999999 99999999999999965 466899999
Q ss_pred cCcccccCC--------------CC-----------------------------CcccccccCCcccCcccccc-CCCCC
Q 048419 480 GLAKIYEHG--------------AN-----------------------------PQTTHIVGTLGYLAPELTRT-GKATT 515 (653)
Q Consensus 480 Gla~~~~~~--------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~ 515 (653)
|+|...+.. .. .......||+||.|||++.. ..-+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 999721100 00 01113469999999998754 45788
Q ss_pred ccceeehHHHHHHHHhCCCCCChhhhhhHHH--HH-----HHHHh-hhcccc--h---------hHhhh-------hcc-
Q 048419 516 STDVYSYGILMLEVACGRRSIEPQKAAAELL--LV-----DWVKE-LHLEGE--I---------TQAID-------QTL- 568 (653)
Q Consensus 516 ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~--l~-----~~~~~-~~~~~~--~---------~~~~d-------~~l- 568 (653)
+.||||.||+++-+++++.||-....+.+.. +. .-+++ ....|. + .+... ..+
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999987544322110 00 01111 111122 1 11100 000
Q ss_pred C-cC--------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 D-YY--------DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~-~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. .. .......++++..+|+..||.+|.|+++.+++--.
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF 384 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF 384 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence 0 00 01112478999999999999999999999987643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=206.92 Aligned_cols=166 Identities=19% Similarity=0.159 Sum_probs=125.1
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|.+++... +..++|.+++.++.||++||.|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 6889998754 2459999999999999999999999 55 999999999999999 99998654322
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYY 571 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 571 (653)
..|++.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+..... .. ++.....
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~-~~------~~~~~~~ 131 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMP-AD------DPRDRSN 131 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhc-cC------Ccccccc
Confidence 2588999999999999999999999999999999999999975432111 1111111110 00 0000001
Q ss_pred CHHHH--HHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 572 DLAEA--ELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 572 ~~~~~--~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..... ..+.+++.+||+.+|.+||++.|+++++..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11122 268999999999999999999999998853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=217.94 Aligned_cols=179 Identities=18% Similarity=0.221 Sum_probs=136.9
Q ss_pred HHHHhhcCcCcceeeeeeCcEEEEEEEeCC-CCcEEEEEEeccC-----chhhHHHHHHHHHHHhhcCCCceeeeeeeec
Q 048419 324 ELASVTKGFGEQNLVGSGGFGRVYRGLMPS-LGLEVAIKRIGHN-----SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397 (653)
Q Consensus 324 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 397 (653)
.+..+.++|...+.||+|+||+||+|.+.. +++.+|||++... .....+.+.+|+++|++++|+|+++.+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345566789999999999999999998865 6778899987532 122356789999999999999998533222
Q ss_pred ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCcEEE
Q 048419 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDV-KPSNILLDTYLNAKL 476 (653)
Q Consensus 398 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl 476 (653)
+..++||||+++++|... ... . ...++.|++++|.|||+ ++|+|||| ||+|||++.++++||
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~~-----~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RPH-----G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Ccc-----c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEE
Confidence 457999999999999632 110 0 14678899999999999 99999999 999999999999999
Q ss_pred EeecCcccccCCCC-------CcccccccCCcccCccccccCC------CCCcccee
Q 048419 477 GDFGLAKIYEHGAN-------PQTTHIVGTLGYLAPELTRTGK------ATTSTDVY 520 (653)
Q Consensus 477 ~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~ 520 (653)
+|||+++.+..... ...+...+++.|+|||++...+ .+..+|-|
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999997654321 1123456888999999886432 23346666
|
|
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-21 Score=190.12 Aligned_cols=195 Identities=20% Similarity=0.245 Sum_probs=134.5
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.++.+.|+|.+. ++.|+||++..++.|++||+.|+++ ++|+|+|+|+|.... ..+||||||+++|....
T Consensus 20 ~~w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~--------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~~~- 88 (218)
T cd07308 20 GNWTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPA--------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEPGS- 88 (218)
T ss_pred CCeEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccC--------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCCC-
Confidence 589999999997 8999999999999999999999998 489999999998753 45899999999986532
Q ss_pred CCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCC-CCcCCcccCccccCCCCccccccCC-C
Q 048419 99 NCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISS-LISSASEPASYYSGNNHRIPILLRS-G 176 (653)
Q Consensus 99 ~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns-~~s~~~~~~~~~~~~~~~~~~~l~~-g 176 (653)
.|+.+|..+.- +-+||||||+.|. +-..++|.+-+|- ..+.....-... .......+...+ +
T Consensus 89 ---~g~~~G~~~~~---------~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~-~~~~~c~~~~~~~~ 152 (218)
T cd07308 89 ---DGPLFGGPDKF---------KGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEK-LELASCSLKFRNSN 152 (218)
T ss_pred ---CCcccccCCCC---------CEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCcc-ccccceeEecccCC
Confidence 34456664432 2399999999985 3344566554432 111100000000 000012223332 6
Q ss_pred CceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecceeee
Q 048419 177 DPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSIS 246 (653)
Q Consensus 177 ~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~ 246 (653)
.+++++|.|+ .+.|.|.+..... .....-..++.. .+|+.+|+||||+||...+.|.|++|.+.
T Consensus 153 ~~~~~~I~y~--~~~l~v~i~~~~~---~~~~~c~~~~~~-~l~~~~y~G~sA~tg~~~d~~dIls~~~~ 216 (218)
T cd07308 153 APTTLRISYL--NNTLKVDITYSEG---NNWKECFTVEDV-ILPSQGYFGFSAQTGDLSDNHDILSVHTY 216 (218)
T ss_pred CCeEEEEEEE--CCEEEEEEeCCCC---CCccEEEEcCCc-ccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence 8999999999 6788888864321 111222222221 46789999999999999999999999874
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=205.26 Aligned_cols=258 Identities=21% Similarity=0.226 Sum_probs=192.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCC-cEEEEEEeccCchhhHHHHHHHHHHHhhcCC----Cceeeeeeee-cccceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLG-LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH----RNLVQLHGWC-RKQDELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 404 (653)
+|...+.||+|+||.||++.....+ ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7889999999999999999987654 5788888765433322267788888888863 6888888888 47778899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-----CcEEEEee
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-----LNAKLGDF 479 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df 479 (653)
||+.+ |.+|.++..... ...++....++|+.|++.+|++||+ .|++||||||.|+++... ..+.|.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99988 889999876554 3568899999999999999999999 999999999999999654 46999999
Q ss_pred cCcc--cccCCCC-----C-c-ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHH
Q 048419 480 GLAK--IYEHGAN-----P-Q-TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW 550 (653)
Q Consensus 480 Gla~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 550 (653)
|+++ .+..... . . .....||..|++++...+...+.+.|+||++.++.|+..|..||...........
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~--- 248 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK--- 248 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---
Confidence 9998 3211111 1 1 2335699999999999999999999999999999999999999975443221110
Q ss_pred HHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 551 VKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 551 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+..... ...... + .......+.++...+-..+..++|....+...|..
T Consensus 249 ~~~~~~----~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 249 FEKDPR----KLLTDR-F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHHHhh----hhcccc-c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 000000 000000 1 11123445555555666899999999999888743
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-20 Score=194.60 Aligned_cols=260 Identities=30% Similarity=0.422 Sum_probs=197.6
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh---hHHHHHHHHHHHhhcCCC-ceeeeeeeecccceeEEEEe
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ---GMKEFVAEIMSMGRLRHR-NLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E 407 (653)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+..+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566789999999999999986 78999998655322 467899999999999988 79999999977777899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~ 486 (653)
++.+++|.+++...... ..+.......+..|++.++.|+|+ .+++|||+||+||+++... .++++|||+++...
T Consensus 79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999666544210 257888899999999999999999 8999999999999999988 79999999998654
Q ss_pred CCCCC-----cccccccCCcccCcccccc---CCCCCccceeehHHHHHHHHhCCCCCChhhhh-hHHHHHHHHHhhhcc
Q 048419 487 HGANP-----QTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAA-AELLLVDWVKELHLE 557 (653)
Q Consensus 487 ~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~ 557 (653)
..... ......|+..|+|||.+.. .......|+|++|++++++++|..|+...... ......+.+......
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 43321 2355689999999999987 57888999999999999999999997654421 001111111111110
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
....... ..........+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00001223568889999999999999999988764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-22 Score=192.61 Aligned_cols=244 Identities=17% Similarity=0.283 Sum_probs=186.0
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.+|.+.-.|..|+|++.+ ..+++|++... .....++|..|.-.|+...||||++++|.|.....+.++..|||.|+
T Consensus 196 tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457888899999999975 45666766432 34445789999999999999999999999999999999999999999
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcc
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT 493 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 493 (653)
|+..|++.. .-..+-.|..+++.+||+|++|||+.. +-|.---|.+..+++|++.+++|+= +-+++. -+.
T Consensus 274 lynvlhe~t---~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs-----fqe 343 (448)
T KOG0195|consen 274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQE 343 (448)
T ss_pred HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee-----eec
Confidence 999999865 345677899999999999999999952 3344445889999999999988742 112110 011
Q ss_pred cccccCCcccCccccccCCCC---CccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc-C
Q 048419 494 THIVGTLGYLAPELTRTGKAT---TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL-D 569 (653)
Q Consensus 494 ~~~~gt~~y~aPE~~~~~~~~---~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~ 569 (653)
......+.|++||.++....+ .++|+|||.+++|||.|...||....+.+... ++.-+.| -
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhccccc
Confidence 122446789999999766543 48999999999999999999998765533211 1111112 2
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+......+.+|+.-|++.||.+||.+..|+-+|+.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2334456778899999999999999999999988874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-22 Score=219.83 Aligned_cols=256 Identities=21% Similarity=0.216 Sum_probs=191.7
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEecc----C-ch-hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH----N-SQ-QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~-~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
....++|.|.+|.|+........+..+.|.... . .. .....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999888887766555566665431 1 11 11222666788888899999999888888877766669
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||++ +|..++... ..++..++..+++|+..|+.|||+ .+|.|||+|++|+++..++.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 999998764 247778888999999999999999 999999999999999999999999999998775
Q ss_pred CCCC---CcccccccCCcccCccccccCCCCC-ccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 487 HGAN---PQTTHIVGTLGYLAPELTRTGKATT-STDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 487 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
.... ......+|+..|+|||.+....|++ ..||||.|+++..|++|+.||......+... .+... .....+..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~~--~~~~~~~~ 548 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNNY--SDQRNIFE 548 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhcc--cccccccc
Confidence 4433 3445568999999999999999876 7899999999999999999997654432211 00000 00000000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
...........+...++.++|+.+|.+|-|+.+|++.=
T Consensus 549 ----~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 549 ----GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred ----ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 00001122346778899999999999999999999743
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=174.76 Aligned_cols=272 Identities=21% Similarity=0.256 Sum_probs=198.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC-CceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH-RNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 407 (653)
...|...+.||.|+||.+|.|..-.+|+.||||.-+...+ ..++..|..+.+.|++ ..|..+..|..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3568889999999999999999999999999998644332 3456788999999975 567778888888888999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD---TYLNAKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~ 484 (653)
.. |.+|+++..-.. ..++.++.+-++-|++.-++|+|. ++++||||||+|+|.. ....+.++|||+++.
T Consensus 92 LL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence 98 789998875443 458899999999999999999999 9999999999999994 445689999999987
Q ss_pred ccCC------CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 485 YEHG------ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 485 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
+... .........||..|.+-....+..-+...|+=|+|.+|..+--|..||++........-.+.+...
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek---- 239 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK---- 239 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----
Confidence 6432 122334567999999887777777788999999999999999999999986654332222222211
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHc-CCCCCCCCCCccc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE---FLL-GDSSLPPLPPDIH 618 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~---~L~-~~~~~p~~p~~~~ 618 (653)
++.-.+......++ .++...+.-|=..--++-|...-+.+ +|- ...-.++.-.+|.
T Consensus 240 K~s~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~ 299 (341)
T KOG1163|consen 240 KMSTPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWT 299 (341)
T ss_pred hcCCCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHH
Confidence 11111111112232 34555566676666677777655444 443 3344455555653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-21 Score=215.18 Aligned_cols=251 Identities=22% Similarity=0.242 Sum_probs=182.9
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHH--HhhcCCCceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMS--MGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++...+.||++.|=+|.+|++++ |. |+||++-+.. .-..+.|.++++- ...++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 45567889999999999999875 55 9999985543 3345555555443 444589999999999888888899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc--
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY-- 485 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~-- 485 (653)
|..+ +|++.|.. ++.|..-+...|+.|++.||..+|. .+|+|||||.+|||+++-.-+.|+||...+..
T Consensus 102 yvkh-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHhh-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 9965 89998865 3568888888899999999999999 99999999999999999999999999876532
Q ss_pred cCCCCCccccc----ccCCcccCccccccC-----------CCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHH
Q 048419 486 EHGANPQTTHI----VGTLGYLAPELTRTG-----------KATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVD 549 (653)
Q Consensus 486 ~~~~~~~~~~~----~gt~~y~aPE~~~~~-----------~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 549 (653)
..+.....+.+ ..-.+|+|||.+... ..+++.||||+||++.||++ |+++|.-.+ +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 22222221111 123489999977431 26789999999999999998 577776322 111
Q ss_pred HHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 550 WVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+-.. ........+.. + +...+.++++.|++.||+.|-++.+.++.-.|.
T Consensus 247 Yr~~--~~~~~e~~Le~-I------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 YRSG--NADDPEQLLEK-I------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred Hhcc--CccCHHHHHHh-C------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1111 01111111111 1 123688999999999999999999999875543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=182.51 Aligned_cols=172 Identities=12% Similarity=0.129 Sum_probs=132.1
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhh---HHH------HHHHHHHHhhcCCCceeeeeeeec
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG---MKE------FVAEIMSMGRLRHRNLVQLHGWCR 397 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~H~niv~l~g~~~ 397 (653)
-..++|+..++||.|+||.||.... ++..+|||.+....... ... +.+|+..+.+++|++|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3568899999999999999999655 36689999996542222 122 678999999999999999988755
Q ss_pred cc--------ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 398 KQ--------DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 398 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
.. +..+|+|||++|.+|.++.. ++. ....+++.+|..||+ .+++|||+||+||+++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 33 35789999999999977631 221 245689999999999 9999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVA 530 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ell 530 (653)
.++ ++|+|||............ .+.....+..++|+|+||+.+.-+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 988 9999999887543211110 1333445667999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=178.12 Aligned_cols=139 Identities=17% Similarity=0.138 Sum_probs=107.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh--h-------HH-----------------HHHHHHHHHhhcCCCc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ--G-------MK-----------------EFVAEIMSMGRLRHRN 388 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~H~n 388 (653)
...||+|+||.||+|... +|+.||||+++..... . .. ....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999997 7999999999654211 1 01 1234999999998877
Q ss_pred eeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEE
Q 048419 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL-HEECNQRVVHRDVKPSNIL 467 (653)
Q Consensus 389 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIl 467 (653)
+.....+.. ...+|||||++++++...+... ..+++.+..+++.|++.+|.|| |+ .+|+||||||+|||
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIl 150 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLL 150 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEE
Confidence 643332221 2238999999988776543221 2478889999999999999999 67 89999999999999
Q ss_pred EcCCCcEEEEeecCcccc
Q 048419 468 LDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 468 l~~~~~~kl~DfGla~~~ 485 (653)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=174.18 Aligned_cols=202 Identities=21% Similarity=0.263 Sum_probs=171.0
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEecc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+|...++||+|.||..+.|+.--+++.||||.-...+ ..-++..|....+.|. .++|..++-+..+..+-.||+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 5788999999999999999988889999999864433 2346778888888885 789999888888888889999998
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEEeecCccc
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-----YLNAKLGDFGLAKI 484 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~ 484 (653)
|.||+++..-.+ ..++.+...-++.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+.
T Consensus 107 -GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred -CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 789999876654 458999999999999999999999 99999999999999953 34489999999997
Q ss_pred ccCCC------CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhh
Q 048419 485 YEHGA------NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542 (653)
Q Consensus 485 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~ 542 (653)
+.... ........||.+||+-....+.+-+...|+=|+|-+++..+-|..||++...+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 74332 23344567999999999888888999999999999999999999999976654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=180.63 Aligned_cols=234 Identities=21% Similarity=0.254 Sum_probs=154.8
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCC----------Cceeeeeeee--
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRH----------RNLVQLHGWC-- 396 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~-- 396 (653)
+.....||.|+++.||.+.+.++++.+|||++... .....+++.+|.-....+.+ -.++.-++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34577899999999999999999999999998543 33456778777766655432 1121111111
Q ss_pred -------ccc---c-----eeEEEEeccCCCCchhhhhc---ccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 048419 397 -------RKQ---D-----ELLLVYDYVPNGSLDKLLFD---KDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVH 458 (653)
Q Consensus 397 -------~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 458 (653)
... + ..+++|+-+ .++|.+++.. .... ...+....++.+..|+.+.+++||+ .+++|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 111 1 236778877 5688777543 2211 2346667788888999999999999 99999
Q ss_pred cCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCcccccc--------CCCCCccceeehHHHHHHHH
Q 048419 459 RDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT--------GKATTSTDVYSYGILMLEVA 530 (653)
Q Consensus 459 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDV~s~Gvvl~ell 530 (653)
+||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999988775432111 1234578999997643 24788999999999999999
Q ss_pred hCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCC
Q 048419 531 CGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYR 594 (653)
Q Consensus 531 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R 594 (653)
||+.||+......... .....+. +.++.+..|+..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~-------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE-------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG-------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc-------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998654321100 0222333 556778999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=194.35 Aligned_cols=213 Identities=27% Similarity=0.398 Sum_probs=161.4
Q ss_pred HhhcCCCceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCe-Eec
Q 048419 381 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV-VHR 459 (653)
Q Consensus 381 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~ 459 (653)
|+.+.|.|+.+++|.|.+....++|.+||..|+|.+.+.... ..++|.-...+.++|+.||.|||. .+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHN---SPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence 467899999999999999999999999999999999998753 348899999999999999999999 444 999
Q ss_pred CCCCCcEEEcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccC-------CCCCccceeehHHHHHHHHh
Q 048419 460 DVKPSNILLDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTG-------KATTSTDVYSYGILMLEVAC 531 (653)
Q Consensus 460 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~s~Gvvl~ellt 531 (653)
.++++|.++|..+.+||+|||+......... .......-..-|.|||.+... ..+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9999999999999999999999887643111 111111234579999998763 14678999999999999999
Q ss_pred CCCCCChhhhhhH-HHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 532 GRRSIEPQKAAAE-LLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 532 G~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.||........ ..+..++... -...+.+.+.... +..+.+..++..||..+|.+||++.+|-..++.
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~~-----~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKKG-----GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred ccCccccccccCChHHHHHHHHhc-----CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 9999986332211 1222233320 1111112221111 333479999999999999999999999988865
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=169.80 Aligned_cols=141 Identities=19% Similarity=0.182 Sum_probs=109.7
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh---------------------h-----HHHHHHHHHHHhhcCCCc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ---------------------G-----MKEFVAEIMSMGRLRHRN 388 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~n 388 (653)
...||+|++|.||+|.+. +|+.||||+++..... . ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 7999999998754211 0 112357899999999998
Q ss_pred eeeeeeeecccceeEEEEeccCCCCchhh-hhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 048419 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKL-LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNIL 467 (653)
Q Consensus 389 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 467 (653)
+.....+... ..+|||||++++++... +.. ..++..+..+++.|++.++.+||+. .+|+||||||+|||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEE
Confidence 7444333322 24899999998865443 322 2367778899999999999999983 69999999999999
Q ss_pred EcCCCcEEEEeecCcccccC
Q 048419 468 LDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 468 l~~~~~~kl~DfGla~~~~~ 487 (653)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=165.68 Aligned_cols=186 Identities=16% Similarity=0.084 Sum_probs=138.2
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch----hhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEe
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ----QGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 407 (653)
.....|++|+||+||.+.. .+..++.+.+..... -....+.+|+++|++|. |+++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999997765 477888887754432 11225789999999995 5889999886 44699999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDV-KPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|+.|.+|...+.. ....++.|++++|.++|+ ++|+|||| ||.|||++.++.++|+|||++....
T Consensus 79 yI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 79 YLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999888654311 113477899999999999 99999999 7999999999999999999998654
Q ss_pred CCCCC----c--------ccccccCCcccCccccccC-CCC-CccceeehHHHHHHHHhCCCCCChh
Q 048419 487 HGANP----Q--------TTHIVGTLGYLAPELTRTG-KAT-TSTDVYSYGILMLEVACGRRSIEPQ 539 (653)
Q Consensus 487 ~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDV~s~Gvvl~elltG~~p~~~~ 539 (653)
..... . ......++.|++|+...-. ..+ ...+-++-|+-+|.++|++.+.-..
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 33210 0 0112356778888754322 233 4567778899999999999886543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=167.13 Aligned_cols=136 Identities=23% Similarity=0.262 Sum_probs=108.1
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-----CCCceeeeeeeecccc---e-eE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-----RHRNLVQLHGWCRKQD---E-LL 403 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 403 (653)
...++||+|+||.||. ++.++.. +||++........+.+.+|+..++++ .||||++++|++.+.. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4467899999999996 6666665 69998765445567899999999999 5799999999998874 3 34
Q ss_pred EEEec--cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEEcC----CCcEEE
Q 048419 404 LVYDY--VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL-LYLHEECNQRVVHRDVKPSNILLDT----YLNAKL 476 (653)
Q Consensus 404 lV~E~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl 476 (653)
+|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+ ++|+||||||+|||++. +.+++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 6689999999552 14444 35677778777 99999 99999999999999963 347999
Q ss_pred EeecCc
Q 048419 477 GDFGLA 482 (653)
Q Consensus 477 ~DfGla 482 (653)
+|++.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995443
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.6e-17 Score=160.38 Aligned_cols=199 Identities=15% Similarity=0.155 Sum_probs=129.6
Q ss_pred CCCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCC
Q 048419 18 HANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRP 97 (653)
Q Consensus 18 ~~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~ 97 (653)
..++.+.|+|.+. ++.|+||++...+.|++||+.|+++ .+|+|+|+|+|.+.....+||||||+++....
T Consensus 19 i~~w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~--------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~- 88 (248)
T cd06901 19 MPLWDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYL--------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKERM- 88 (248)
T ss_pred CCCEEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccC--------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcCCC-
Confidence 4689999999987 6799999998889999999999998 47999999999886656789999999997642
Q ss_pred CCCCCCccccCCCcccCCCCCCCCceEEEEeeccccccc-CCCCCCeeeEecC-CCCcCCcccCccccCCCCcccccc-C
Q 048419 98 ENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTEL-IDINDNHVGIDIS-SLISSASEPASYYSGNNHRIPILL-R 174 (653)
Q Consensus 98 ~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~n-s~~s~~~~~~~~~~~~~~~~~~~l-~ 174 (653)
..|..+|-.+.-+. +||-|||+.|.+- .....+-|.+-+| +...-....-+... ..+...... .
T Consensus 89 ---~~G~~fG~~~~f~G---------l~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~-~~~~C~~~~rn 155 (248)
T cd06901 89 ---QPGPVFGSKDNFHG---------LAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHT-ELAGCSAPFRN 155 (248)
T ss_pred ---ccCcccccCCCCce---------EEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchh-hcCceeeeccC
Confidence 23445565443332 8999999998531 0122334534332 21111100000000 000111222 3
Q ss_pred CCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCc-ccccceEEeEecccCcccceeeecceeee
Q 048419 175 SGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSS-VIDEYMYTGFSASTGLITASHNVHGWSIS 246 (653)
Q Consensus 175 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~-~l~~~~~vGFsastg~~~~~~~i~sWsf~ 246 (653)
.+...+++|.|... .|.|.+...+...- ... ..... .||...|+||||+||...+.|.|++-.+.
T Consensus 156 ~~~~t~~rI~Y~~~--~l~v~vd~~~~~~w-~~C----f~~~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~ 221 (248)
T cd06901 156 KDHDTFVAIRYSKG--RLTVMTDIDGKNEW-KEC----FDVTGVRLPTGYYFGASAATGDLSDNHDIISMKLY 221 (248)
T ss_pred CCCCeEEEEEEECC--eEEEEEecCCCCce-eee----EEeCCeecCCCCEEEEEecCCCCCCcEEEEEEEEe
Confidence 45667899999964 46666654332110 111 11122 36778999999999999999999987664
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=162.86 Aligned_cols=141 Identities=17% Similarity=0.186 Sum_probs=109.7
Q ss_pred cCcceeeeeeCcEEEEEEE-eCCCCcEEEEEEeccCchh------------------------hHHHHHHHHHHHhhcCC
Q 048419 332 FGEQNLVGSGGFGRVYRGL-MPSLGLEVAIKRIGHNSQQ------------------------GMKEFVAEIMSMGRLRH 386 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H 386 (653)
|.+.+.||+|++|.||+|. +..+|+.||||++...... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6678899999999999998 5567999999998643210 01235689999999975
Q ss_pred C--ceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 048419 387 R--NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR-VVHRDVKP 463 (653)
Q Consensus 387 ~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp 463 (653)
. .+.+++++ ...++||||+++++|...+... ..+...+...++.|++.++.+||+ .+ ++||||||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp 177 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE 177 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence 3 34444443 2348999999998887655322 224555667899999999999999 88 99999999
Q ss_pred CcEEEcCCCcEEEEeecCcccc
Q 048419 464 SNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 464 ~NIll~~~~~~kl~DfGla~~~ 485 (653)
+||+++ +++++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998754
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.5e-16 Score=150.95 Aligned_cols=198 Identities=19% Similarity=0.200 Sum_probs=134.3
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.+..+.|+|.+. ++.|+||++..++.|.+|.+.|++. -+|+.+|+|+|.... ..+||||||+++....
T Consensus 22 ~~W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~--------~~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~~-- 89 (225)
T cd06902 22 PFWSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTKERG-- 89 (225)
T ss_pred CceEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCC--------CCEEEEEEEEEecCC-CCCCCEEEEEEECCCC--
Confidence 579999999885 8899999999999999999999984 369999999998653 3478999999997542
Q ss_pred CCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecC-CCCcCCcccCccccCCCCccccccC-CC
Q 048419 99 NCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDIS-SLISSASEPASYYSGNNHRIPILLR-SG 176 (653)
Q Consensus 99 ~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s~~~~~~~~~~~~~~~~~~~l~-~g 176 (653)
..|+.+|..+.-+. +||.|||+.|.+ ..+.+.|.+-+| +........-... ...+....... ..
T Consensus 90 --~~G~~~G~~~~f~G---------l~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~~D~~~-~~~~~C~~~~rn~~ 155 (225)
T cd06902 90 --EEGPVFGSSDKWNG---------VGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQNDGLT-QALGSCLRDFRNKP 155 (225)
T ss_pred --CCCCccCCCCcccE---------EEEEEECCCCCC--CCCCcEEEEEECCCCeeccccCCCcc-cccceEEEeccCCC
Confidence 24566777665443 899999998852 344567755543 2221111100000 00011122332 35
Q ss_pred CceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCc-ccccceEEeEecccCcccceeeecceeee
Q 048419 177 DPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSS-VIDEYMYTGFSASTGLITASHNVHGWSIS 246 (653)
Q Consensus 177 ~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~-~l~~~~~vGFsastg~~~~~~~i~sWsf~ 246 (653)
.+.+++|.|... +|.|.+.....+. ......-+++.. .||+..|+||||+||...+.|.|++|++.
T Consensus 156 ~p~~~rI~Y~~~--~l~V~~d~~~~~~--~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~ 222 (225)
T cd06902 156 YPVRAKITYYQN--VLTVSINNGFTPN--KDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTF 222 (225)
T ss_pred CCeEEEEEEECC--eEEEEEeCCcCCC--CCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEe
Confidence 789999999874 5888876422211 111222233333 36788999999999999999999999985
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=190.06 Aligned_cols=199 Identities=22% Similarity=0.236 Sum_probs=156.3
Q ss_pred HHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC---CCceeeeeeeecccc
Q 048419 324 ELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR---HRNLVQLHGWCRKQD 400 (653)
Q Consensus 324 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~ 400 (653)
+++.-...|.+.+.||+|+||+||+|.... |+.||+|+-+..+. -+|.=-.+++.+|+ -+-|..+...+.-.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344445678899999999999999999976 99999999755432 12222223344444 234455555556667
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-------CCCc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD-------TYLN 473 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~ 473 (653)
..+||+||.+.|+|.+++.. .+.++|.....++.|+++.+++||. .+|||+||||+|.||. .+.-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccc
Confidence 78999999999999999973 4568999999999999999999999 9999999999999993 2345
Q ss_pred EEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCC
Q 048419 474 AKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRR 534 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~ 534 (653)
++|+|||-+..+..-.. ......++|-.+--+|...+..++...|.|.++.+++-|+.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 89999999875532221 23455678889999999999999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-18 Score=184.11 Aligned_cols=187 Identities=26% Similarity=0.324 Sum_probs=154.6
Q ss_pred eeeeeCcEEEEEEEe---CCCCcEEEEEEeccCchh--hHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEeccC
Q 048419 337 LVGSGGFGRVYRGLM---PSLGLEVAIKRIGHNSQQ--GMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
++|+|.||.|+++.- .+.|..+|+|.+.+.... .......|..++..++ |+.+|++...+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987542 344778999988654211 1125567888888887 9999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 490 (653)
+|.|...+.... ..+..........++-+++++|+ .+++|||+|++||+++.+|.+|+.|||+.+..-...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 999998886643 35566666677889999999999 999999999999999999999999999998653322
Q ss_pred CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCCh
Q 048419 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEP 538 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~ 538 (653)
..+||..|||||++. ......|-||||++++||+||..||..
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 128999999999998 567889999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=156.70 Aligned_cols=134 Identities=22% Similarity=0.320 Sum_probs=112.7
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--------hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+.||+|++|.||+|.. .|..+++|+...... .....+.+|+..+..++|+++.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 467899998643221 112457889999999999998877777777778899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|++|++|.+++.... + .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999885421 2 788999999999999999 8999999999999999 78899999998875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=178.51 Aligned_cols=145 Identities=19% Similarity=0.238 Sum_probs=115.2
Q ss_pred HHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEec-cC-c------hhhHHHHHHHHHHHhhcCCCceeeee
Q 048419 322 YAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HN-S------QQGMKEFVAEIMSMGRLRHRNLVQLH 393 (653)
Q Consensus 322 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~-~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~ 393 (653)
+.........|...+.||+|+||.||+|.+.+. .+++|+.. .. . ....+.+.+|++++++++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 333344455566788999999999999988643 34444321 11 1 11235688999999999999998888
Q ss_pred eeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 394 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
.++...+..++||||+++++|.+++. .+..++.+++++|.|||+ .+++||||||+|||+ +++.
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCc
Confidence 88877777899999999999988774 345789999999999999 999999999999999 6789
Q ss_pred EEEEeecCcccc
Q 048419 474 AKLGDFGLAKIY 485 (653)
Q Consensus 474 ~kl~DfGla~~~ 485 (653)
++|+|||+++..
T Consensus 466 ~~liDFGla~~~ 477 (535)
T PRK09605 466 LYLIDFGLGKYS 477 (535)
T ss_pred EEEEeCcccccC
Confidence 999999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=152.67 Aligned_cols=142 Identities=18% Similarity=0.190 Sum_probs=109.7
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh----------------------hHHHHHHHHHHHhh
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ----------------------GMKEFVAEIMSMGR 383 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~ 383 (653)
......|...+.||+|+||.||++... +|+.||||++...... ....+..|+..+.+
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 333334667789999999999999885 6899999987543210 11235678889999
Q ss_pred cCCCc--eeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 048419 384 LRHRN--LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDV 461 (653)
Q Consensus 384 l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 461 (653)
+.|++ +.+.++. ...++||||+++++|..+... .....++.+++.++.++|+ .+++|+||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 98774 4444442 345899999999998765421 2345788999999999999 99999999
Q ss_pred CCCcEEEcCCCcEEEEeecCccccc
Q 048419 462 KPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 462 kp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.2e-18 Score=176.30 Aligned_cols=175 Identities=25% Similarity=0.355 Sum_probs=130.9
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
.++|.|++|...+|.++|..+.. ....++.....++.|++.++.| ++.+|+|+||.||+...+..+||+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 57899999999999999976543 3456788889999999999999 588999999999999999999999999
Q ss_pred CcccccCCC-----CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhh
Q 048419 481 LAKIYEHGA-----NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 481 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
+........ ....+...||..||+||.+.+..|+.|+|||+||++|+||+. =..+++.... ..-
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTD 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhh
Confidence 998765543 234456689999999999999999999999999999999986 2222211100 000
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (653)
...+.++.. .+. .-+.-..++.+++.+.|.+||++.++.
T Consensus 472 ~r~g~ip~~---~~~-----d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIPPE---FLQ-----DYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCChH---Hhh-----cCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 112222210 011 112345788899999999999555443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=152.81 Aligned_cols=130 Identities=25% Similarity=0.301 Sum_probs=106.2
Q ss_pred eeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--------hhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.||+|+||.||+|... +..+++|....... ...+.+.+|++++..++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999863 67899998643211 1235677899999999988766555555566677999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++|++|.+++.... . .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988874421 1 789999999999999 9999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-16 Score=157.91 Aligned_cols=196 Identities=20% Similarity=0.252 Sum_probs=137.3
Q ss_pred CCCceeeeeeeecc---------------------------cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHH
Q 048419 385 RHRNLVQLHGWCRK---------------------------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKI 437 (653)
Q Consensus 385 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 437 (653)
+|||||+++++|.+ ...+|+||...+. +|..++..+. .+...+.-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 59999999887643 2357899987754 8999987654 455566678
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCC--CcEEEEeecCcccccCCC-----CCcccccccCCcccCcccc
Q 048419 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILL--DTY--LNAKLGDFGLAKIYEHGA-----NPQTTHIVGTLGYLAPELT 508 (653)
Q Consensus 438 ~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~--~~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~ 508 (653)
+.|+++|+.|||+ ++|.|||+|++|||| |++ ..+.|+|||.+--..... ....-..-|...-||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 9999999999999 999999999999999 333 347899999875432210 0111123467789999988
Q ss_pred ccCC------CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHH
Q 048419 509 RTGK------ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNL 582 (653)
Q Consensus 509 ~~~~------~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 582 (653)
.... --.|+|.|+.|.+.||+++...||....+. ...... +.+. .|...+..+...+.+|
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~--------qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQES--------QLPALPSRVPPVARQL 489 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhh--------hCCCCcccCChHHHHH
Confidence 6432 135899999999999999999999863321 011000 1111 1112223345678899
Q ss_pred HHHcCCCCCCCCCCHHHHHHHH
Q 048419 583 GLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 583 ~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+...|++||.+||+..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999876554433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.9e-15 Score=134.92 Aligned_cols=135 Identities=19% Similarity=0.168 Sum_probs=114.4
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC--CceeeeeeeecccceeEEEEeccCC
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH--RNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..++.++| .++.+++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45789999999999999854 7899999865433 4678899999999976 5899999998888889999999998
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
+.+..+ +......++.+++++|.+||.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 78 ~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 3455667899999999999985555899999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-15 Score=169.82 Aligned_cols=212 Identities=24% Similarity=0.279 Sum_probs=146.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
..+|...+++..|++|.||..+++.+.+.+|+|.- +... .+.+ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch----hhhc---cccccCCccee------------------
Confidence 35788899999999999999999988999999542 2110 0000 22222233322
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
|+-...+...+ .++.. ++.+++|||+ .+|+|||+||+|.+++.-|.+|+.|||+.+.....
T Consensus 136 ---gDc~tllk~~g-----~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG-----PLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ---chhhhhcccCC-----CCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 44444444322 23322 2789999999 99999999999999999999999999998753211
Q ss_pred CC--------------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhh
Q 048419 489 AN--------------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 489 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
.. -....++||+.|+|||++....|....|-|++|+++||.+-|..||.+..+++- +-..+...
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~visd~ 274 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVISDD 274 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhhhhh
Confidence 00 012345899999999999999999999999999999999999999998765431 11111111
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMR 598 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 598 (653)
. ...+ .+.....++.+++...|+.+|..|--..
T Consensus 275 i---~wpE--------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 275 I---EWPE--------EDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred c---cccc--------cCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 0 0011 1122245677888889999999996433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=137.84 Aligned_cols=137 Identities=22% Similarity=0.229 Sum_probs=98.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh--hHHHH----------------------HHHHHHHhhcCCCc--
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ--GMKEF----------------------VAEIMSMGRLRHRN-- 388 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n-- 388 (653)
.+.||+|+||.||+|.+. +++.||||++...... ....+ ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 6899999998653211 11111 34555566664432
Q ss_pred eeeeeeeecccceeEEEEeccCCCCchhh-hhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 048419 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKL-LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNIL 467 (653)
Q Consensus 389 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 467 (653)
+.+.++. ...++||||++++.+... +.... .. .+...++.+++.++.++|.. ++|+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEE
Confidence 3334332 235899999999654322 21111 11 56788999999999999973 68999999999999
Q ss_pred EcCCCcEEEEeecCccccc
Q 048419 468 LDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 468 l~~~~~~kl~DfGla~~~~ 486 (653)
++ ++.++|+|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.3e-14 Score=142.28 Aligned_cols=135 Identities=21% Similarity=0.228 Sum_probs=105.5
Q ss_pred ceeee-eeCcEEEEEEEeCCCCcEEEEEEeccCc-------------hhhHHHHHHHHHHHhhcCCCce--eeeeeeecc
Q 048419 335 QNLVG-SGGFGRVYRGLMPSLGLEVAIKRIGHNS-------------QQGMKEFVAEIMSMGRLRHRNL--VQLHGWCRK 398 (653)
Q Consensus 335 ~~~LG-~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~ 398 (653)
...|| .||.|+||++... +..++||++.... ......+.+|++++.+|+|+++ ++.++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 8999999999885 6789999885321 1223467889999999998875 667776544
Q ss_pred cc----eeEEEEeccCC-CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 399 QD----ELLLVYDYVPN-GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 399 ~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
.. ..++|+|++++ .+|.+++... .++. ..+.+|+.+|.+||+ .+|+|+||||.|||++.++.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~----~~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA------PLSE----EQWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGK 180 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCH----HHHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCC
Confidence 32 23599999997 6888887542 1333 246789999999999 99999999999999999899
Q ss_pred EEEEeecCccc
Q 048419 474 AKLGDFGLAKI 484 (653)
Q Consensus 474 ~kl~DfGla~~ 484 (653)
++|+|||.++.
T Consensus 181 v~LIDfg~~~~ 191 (239)
T PRK01723 181 FWLIDFDRGEL 191 (239)
T ss_pred EEEEECCCccc
Confidence 99999998875
|
|
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-12 Score=126.62 Aligned_cols=186 Identities=15% Similarity=0.133 Sum_probs=123.2
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.+..+.|+|.+. ++.|+||++ .++.|.+|-+.|+++.+ +|+.+|+|+|.... ..+||||||.++.....
T Consensus 21 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~~-------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~~~- 89 (215)
T cd06903 21 PNWQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLKD-------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDGNA- 89 (215)
T ss_pred CCeEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCCC-------CEEEEEEEEecccC-CcCCCEEEEEEECCCcc-
Confidence 579999999887 889999999 99999999999999853 59999999998653 26899999999965432
Q ss_pred CCCCC-ccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEec-CCCCcCCcccCccccCCCCccccc-cCC
Q 048419 99 NCLAN-QFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDI-SSLISSASEPASYYSGNNHRIPIL-LRS 175 (653)
Q Consensus 99 ~~~~g-~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~-ns~~s~~~~~~~~~~~~~~~~~~~-l~~ 175 (653)
.+| ..+|-.+.-+. +||.|||+.|. . ..|-+-+ ++-.......- .....+...+. ...
T Consensus 90 --~~g~~~fG~~~~f~G---------l~I~~Dt~~n~---~---p~i~~~~NDGt~~yd~~~d--~~~~~g~C~~~~rn~ 150 (215)
T cd06903 90 --DVGTSSIYGPSKFDG---------LQLLIDNNGGS---G---GSLRGFLNDGSKDYKNEDV--DSLAFGSCLFAYQDS 150 (215)
T ss_pred --cCCccccCCCCCCcE---------EEEEEECCCCC---C---ceEEEEECCCCeeccccCC--cccccceeeEeccCC
Confidence 122 33444333222 89999999873 1 2333333 22221111110 00000111122 345
Q ss_pred CCceEEEEEecCCceEEEEEEeeCCCCCCCCCcee-eeecCCcccc-cceEEeEecccCcccceeeecceee
Q 048419 176 GDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLIS-LPIDLSSVID-EYMYTGFSASTGLITASHNVHGWSI 245 (653)
Q Consensus 176 g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~-~~~dL~~~l~-~~~~vGFsastg~~~~~~~i~sWsf 245 (653)
+.+.+++|.|......|+|.+.. . . .+. ..+. || .-.|+||||+||...+.|.|++-..
T Consensus 151 ~~p~~iri~Y~~~~~~l~v~vd~--~----~-Cf~~~~v~----lP~~~y~fGiSAaTg~~~d~hdIl~~~~ 211 (215)
T cd06903 151 GVPSTIRLSYDALNSLFKVQVDN--R----L-CFQTDKVQ----LPQGGYRFGITAANADNPESFEILKLKV 211 (215)
T ss_pred CCCEEEEEEEECCCCEEEEEECC--C----E-EEecCCee----cCCCCCEEEEEEcCCCCCCcEEEEEEEE
Confidence 77899999998866788888742 1 1 111 1222 45 5577999999999889999997554
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.50 E-value=8e-13 Score=130.75 Aligned_cols=197 Identities=20% Similarity=0.261 Sum_probs=122.0
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.+..+.|+|.+. ++.|+||++..++.|.+|.+.|++. .+|+.+|+|+|........||||||+++.....
T Consensus 22 ~~W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~--------~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~~- 91 (229)
T PF03388_consen 22 PNWDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPF--------DNWEIEFTFRISGQEKGLGGDGMAFWYTKDPGS- 91 (229)
T ss_dssp TTEEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEE--------SEEEEEEEEEEESS-SSS-S-EEEEEEESSSSS-
T ss_pred CCEEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCc--------cCEEEEEEEEEeccccCcCCCeEEEEEEcCccc-
Confidence 478999999887 8999999999999999999999998 279999999998875566899999999875432
Q ss_pred CCCCCccccCCCcccCCCCCCCCceEEEEeecccccccC-CCCCCeeeEecCC-CCcCCcccCccccCCCCccccccC-C
Q 048419 99 NCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELI-DINDNHVGIDISS-LISSASEPASYYSGNNHRIPILLR-S 175 (653)
Q Consensus 99 ~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgid~ns-~~s~~~~~~~~~~~~~~~~~~~l~-~ 175 (653)
.|..+|..+.-+. +||=||||.|.+-. .-..+.|.+-+|- -.+.....-+. ....+...+..+ .
T Consensus 92 ---~G~~fG~~~~f~G---------l~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~-~~~~~~C~~~~rn~ 158 (229)
T PF03388_consen 92 ---DGPVFGGPDKFDG---------LGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGK-DQSLGSCSADYRNS 158 (229)
T ss_dssp ---SCSBTTB-SS-EE---------EEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTT-TT-SEEEE---BTE
T ss_pred ---cccccCCCcccce---------EEEEEEcccCCCcccccccceEEEEecCCCccccccccCc-ccccccceeccCcC
Confidence 5566676554333 89999999996321 1234566555542 11111111000 000111223333 3
Q ss_pred CCceEEEEEecCCceEEEEEEeeC--CCCCCCCCceee-eecCCcccccceEEeEecccCcccceeeeccee
Q 048419 176 GDPIQAWVDYSSQEMLINVSICPL--GVPKPYRPLISL-PIDLSSVIDEYMYTGFSASTGLITASHNVHGWS 244 (653)
Q Consensus 176 g~~~~~~I~Y~~~~~~l~v~~~~~--~~~~~~~~~l~~-~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWs 244 (653)
+...+++|.|... .+.|.+... .....-...+.. .| .||+..|+||||+||...+.|.|++-.
T Consensus 159 ~~p~~~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~~~~v----~LP~~~yfGvSA~Tg~~~d~hdi~s~~ 224 (229)
T PF03388_consen 159 DVPTRIRISYSKN--TLTVSIDSNYLKNQDDWELCFTTDGV----DLPEGYYFGVSAATGELSDNHDILSVK 224 (229)
T ss_dssp SSEEEEEEEEETT--EEEEEEETSCCSECCTTEEEEEESTE----EGGSSBEEEEEEEESSSGGEEEEEEEE
T ss_pred CCCEEEEEEEECC--eEEEEEecccccCCcCCcEEEEcCCe----ecCCCCEEEEEecCCCCCCcEEEEEEE
Confidence 5677999999865 466666521 111111112221 22 367888999999999999999998743
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.8e-15 Score=165.94 Aligned_cols=256 Identities=25% Similarity=0.272 Sum_probs=189.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCC-CCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPS-LGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 406 (653)
.|...+.||+|.|+.|-...... ....+|+|.+.... ....+....|..+-..+. |+|++++++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45556779999999998877633 34557777765543 233344455777777776 999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH-EECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAKI 484 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 484 (653)
||..++++.+-+.... ....+....-..+.|+..++.|+| . .++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999998883221 123556667789999999999999 7 8999999999999999999 999999999997
Q ss_pred ccC--CCCCccccccc-CCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 485 YEH--GANPQTTHIVG-TLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 485 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
+.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|.... +..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~~ 250 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GRF 250 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---ccc
Confidence 765 33344455678 9999999998874 4567899999999999999999999865443211 11111110 000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.... -........++..+|+..+|..|.+.+++...
T Consensus 251 ~~~~-------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 TQLP-------WNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccCc-------cccCChhhhhcccccccCCchhcccccccccc
Confidence 0000 01123456677888888999999999887653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.2e-14 Score=138.06 Aligned_cols=206 Identities=24% Similarity=0.354 Sum_probs=142.9
Q ss_pred HHHHhhcCCCceeeeeeeecccc-----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC
Q 048419 378 IMSMGRLRHRNLVQLHGWCRKQD-----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452 (653)
Q Consensus 378 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 452 (653)
..-|-++-|.|||+++.|+.+.. +..++.|||..|+|..+|.+.... .+.+....-.+|+.||..||.|||+ |
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34556677999999999986543 578999999999999999875432 4567777778999999999999998 6
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC----CCcccccccCCcccCccccccCCCCCccceeehHHHHHH
Q 048419 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA----NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLE 528 (653)
Q Consensus 453 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~e 528 (653)
..+|+|+++..+-|++..++-+|++---- ....... ........+-++|.+||+-...+.+..+|||+||+..+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 68999999999999999999888753211 1110000 011122346789999998877788889999999999999
Q ss_pred HHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 529 VACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 529 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
|.-|..--........ .+..+...+- .+ +-..-..++.+|++..|..||+|++++.+.
T Consensus 275 mailEiq~tnseS~~~-----------~ee~ia~~i~-~l------en~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVE-----------VEENIANVII-GL------ENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHheeccCCCcceee-----------hhhhhhhhee-ec------cCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 9887643221110000 0001111000 00 001123566789999999999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.2e-12 Score=138.93 Aligned_cols=141 Identities=18% Similarity=0.202 Sum_probs=100.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhH----------------------------------------HHH
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM----------------------------------------KEF 374 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 374 (653)
.+.||.|++|.||+|++. +|+.||||+.+....+.. -.|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999986 589999999865421110 024
Q ss_pred HHHHHHHhhcC----CCceeeeeeeec-ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHH-HHHHH
Q 048419 375 VAEIMSMGRLR----HRNLVQLHGWCR-KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQ-SLLYL 448 (653)
Q Consensus 375 ~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yL 448 (653)
..|+..+.+++ |.+-+.+-..+. -.+..+|||||++|++|.++...... .. .+.+++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHH
Confidence 45665555552 333333333332 23456999999999999887643211 11 34557777666 46788
Q ss_pred HhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 449 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|. .+++|+|++|.||+++.++.++++|||++..+.
T Consensus 274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 899999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.9e-13 Score=142.72 Aligned_cols=249 Identities=22% Similarity=0.250 Sum_probs=184.1
Q ss_pred cCcCcceeeee--eCcEEEEEEEe--CCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcC-CCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGS--GGFGRVYRGLM--PSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~--G~fg~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 402 (653)
..|...+.+|. |.+|.||.+.. ..++..+|+|+-+.. .......-.+|+....+++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999998 788899999985432 2233334456777777774 99999988889999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEE
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQ----SLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLG 477 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~ 477 (653)
++-+|+| +.+|..+.+... ..++....+..+.+..+ ||.++|. .+++|-|+||.||++..+ ...+++
T Consensus 194 fiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence 9999998 478888887653 34677777888888888 9999999 999999999999999999 889999
Q ss_pred eecCcccccCCCCC----cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 478 DFGLAKIYEHGANP----QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 478 DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
|||+...+...... ......|...|++||..+ +.++.+.|+|++|.+++|..++-.+........ |.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~ 336 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WS 336 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cc
Confidence 99999887654321 112235778899999875 578889999999999999999877655432110 11
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
......+.. ++...-...+...+..+++.+|..|++.+.+..
T Consensus 337 ~~r~~~ip~-------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGYIPL-------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccccCch-------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111 111111233444888899999999999888765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.4e-11 Score=129.53 Aligned_cols=170 Identities=19% Similarity=0.207 Sum_probs=129.9
Q ss_pred EEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccc
Q 048419 348 RGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRK 427 (653)
Q Consensus 348 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~ 427 (653)
.|..+.++.+|.|...+...........+-++.|+.|+||||++++......+.+|||+|-+. -|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------ 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------ 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------
Confidence 456667788999998877666555667788899999999999999999999999999999873 566666543
Q ss_pred cchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccc
Q 048419 428 LLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507 (653)
Q Consensus 428 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 507 (653)
......-.+.||+.||.|||+. .+++|++|.-+.|++++.|..||++|.++........ ......--..|..|+.
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEE 176 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhh
Confidence 2334445788999999999974 6899999999999999999999999998865432211 1111122235677775
Q ss_pred cccCCCCCccceeehHHHHHHHHhC
Q 048419 508 TRTGKATTSTDVYSYGILMLEVACG 532 (653)
Q Consensus 508 ~~~~~~~~ksDV~s~Gvvl~elltG 532 (653)
+.... ...|.|.|||+++|++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 53322 457999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=1e-11 Score=136.65 Aligned_cols=145 Identities=17% Similarity=0.181 Sum_probs=94.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhh----------------------------------HH----
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG----------------------------------MK---- 372 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~---- 372 (653)
.|+. +.||+|++|.||+|+++++|+.||||+.+..-.+. .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 78999999999999998779999999996542110 11
Q ss_pred --HHHHHHHHHhhcC----CCceeeeeeeecc-cceeEEEEeccCCCCchhhh--hcccccccccchhhhHHHHHHHHHH
Q 048419 373 --EFVAEIMSMGRLR----HRNLVQLHGWCRK-QDELLLVYDYVPNGSLDKLL--FDKDHKLRKLLTWDQRYKILIGIAQ 443 (653)
Q Consensus 373 --~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia~ 443 (653)
+|..|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.|.++- ...+. ..+.+.......++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH--
Confidence 1344444444442 3333333333322 33568999999999997742 22110 01123332333333333
Q ss_pred HHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEEeecCcccccC
Q 048419 444 SLLYLHEECNQRVVHRDVKPSNILLDTYL----NAKLGDFGLAKIYEH 487 (653)
Q Consensus 444 ~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~ 487 (653)
.. .+++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 7999999999999999888 999999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.1e-11 Score=113.35 Aligned_cols=131 Identities=18% Similarity=0.146 Sum_probs=96.2
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCcee-eeeeeecccceeEEEEeccCCCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLV-QLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.+.|+.|.++.||++... +..+++|....... ....+..|+..++.+.+.+++ +++.+.. ...++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 467899999999999875 67899999754432 223467899999988765544 4444433 23579999999988
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC--NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
+.... . ....++.+++++|..||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 0 11245678999999999932 12369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.3e-10 Score=105.91 Aligned_cols=137 Identities=17% Similarity=0.126 Sum_probs=97.9
Q ss_pred eeeeeeCcEEEEEEEeCC------CCcEEEEEEeccCc-----h-----------------hhHHHHH----HHHHHHhh
Q 048419 336 NLVGSGGFGRVYRGLMPS------LGLEVAIKRIGHNS-----Q-----------------QGMKEFV----AEIMSMGR 383 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-----~-----------------~~~~~~~----~E~~~l~~ 383 (653)
..||.|--+.||.|...+ .+..+|||+.+... . ...+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 35789999874321 0 0122233 78899999
Q ss_pred cCC--CceeeeeeeecccceeEEEEeccCCCCchh-hhhcccccccccchhhhHHHHHHHHHHHHHHH-HhcCCCCeEec
Q 048419 384 LRH--RNLVQLHGWCRKQDELLLVYDYVPNGSLDK-LLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL-HEECNQRVVHR 459 (653)
Q Consensus 384 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~ 459 (653)
+.. -++.+++++ ..-+|||||+.+..+.. .+.+ ..++..+..++..+++.+|..| |+ .+++|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 853 455566654 45689999997654422 2221 1234455667889999999999 77 899999
Q ss_pred CCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 460 DVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 460 Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||++.||+++ ++.+.|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.4e-11 Score=128.49 Aligned_cols=253 Identities=20% Similarity=0.172 Sum_probs=178.0
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeC-CCCcEEEEEEeccCchhhHH--HHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMP-SLGLEVAIKRIGHNSQQGMK--EFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
...-+.+|..+..||.|.|+.|++...+ .++..|++|.+.+....... .-+.|+.+...+ .|.++++....+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4455567889999999999999998765 67889999988654322222 223566666665 4888888777777777
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEee
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDF 479 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 479 (653)
..++=-|||.++++...+.- ...+....++++..|++.++.++|+ ..++|+|+||+||++..+ +..+++||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccc
Confidence 77899999999988766522 2347778889999999999999999 999999999999999775 88999999
Q ss_pred cCcccccCCCCCcccccccCCcc-cCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGY-LAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
|.+..+... .......+..| .+|+......+..+.|+|+||.-+.|.+++...-...... . ....+
T Consensus 412 ~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~--------~--~i~~~ 478 (524)
T KOG0601|consen 412 GCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS--------L--TIRSG 478 (524)
T ss_pred cccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc--------e--eeecc
Confidence 998742211 11111122234 3555566667888999999999999999987644332211 0 00111
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.... + . .....+..+...+..+++..||.+.++..+.+..
T Consensus 479 ~~p~-----~---~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 479 DTPN-----L---P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cccC-----C---C-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111 0 0 1114566777888999999999999988776544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.5e-10 Score=109.42 Aligned_cols=143 Identities=17% Similarity=0.224 Sum_probs=109.3
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCC--ceeeeeeeecccc---eeEEEEec
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHR--NLVQLHGWCRKQD---ELLLVYDY 408 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lV~E~ 408 (653)
.+.|+.|..+.||++...+ |..+++|....... .....+..|+++++.+++. ++.+++.++.... ..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3578999999999998854 67899999754322 2355788999999999764 4577788776643 56899999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhc-------------------------------------
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE------------------------------------- 451 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------- 451 (653)
+++.++.+.+.. ..++..++..++.+++++|..||+.
T Consensus 82 i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 82 VDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred eCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999988776532 1256667777888888888888752
Q ss_pred ----------------CCCCeEecCCCCCcEEEcC--CCcEEEEeecCccc
Q 048419 452 ----------------CNQRVVHRDVKPSNILLDT--YLNAKLGDFGLAKI 484 (653)
Q Consensus 452 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~ 484 (653)
....++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256899999999999988 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.1e-09 Score=106.52 Aligned_cols=190 Identities=19% Similarity=0.234 Sum_probs=132.5
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.+..+.|++.+. +.-++||.+..++.|.++=.+||... +|..-+.|.|.......-|||||+..+-....
T Consensus 72 ~~W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s~--------~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~q- 141 (351)
T KOG3839|consen 72 PNWNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFSR--------DWEVLVHFKVHGQSKNLFGDGMAIWYTKERAQ- 141 (351)
T ss_pred cCccccccEEEE-eeeeeccccccccccccccCCCcccc--------ceeEEEEEEEecCCCcccccceEEEeeccccc-
Confidence 468889998887 66699999999999999999999853 69999999999888888899999999876532
Q ss_pred CCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCC---CCeeeEecCCCCcCCcccCccccCCCC------cc
Q 048419 99 NCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDIN---DNHVGIDISSLISSASEPASYYSGNNH------RI 169 (653)
Q Consensus 99 ~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~---~~Hvgid~ns~~s~~~~~~~~~~~~~~------~~ 169 (653)
.|..+|-++.-+ .+||=.|||.|.+ .|. .+-|.+.+|- -+++|+-+.++ ..
T Consensus 142 ---~GPvFG~~dkF~---------GL~vfidtY~n~~--g~~~~v~P~isvmv~~------gs~sYD~~~Dg~~tel~gc 201 (351)
T KOG3839|consen 142 ---PGPVFGSKDKFT---------GLAVFIDTYGNHN--GPHEHVFPYISVMVNI------GSLSYDHSKDGTHTELAGC 201 (351)
T ss_pred ---CCCCCCCcccce---------eEEEEEeccCCcC--CCcccceeeEEEEecc------CCcccccCCCCCccccccc
Confidence 456677765433 3899999999852 121 2444554432 12222222211 01
Q ss_pred ccccCCC-CceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcc-cccceEEeEecccCcccceeeecceee
Q 048419 170 PILLRSG-DPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSV-IDEYMYTGFSASTGLITASHNVHGWSI 245 (653)
Q Consensus 170 ~~~l~~g-~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~-l~~~~~vGFsastg~~~~~~~i~sWsf 245 (653)
...+++. -...+-|.|+. ++|++..+..+ |. ....-+++..+ +|.--|+|+||+||...+.|.|.|-.+
T Consensus 202 ~a~~rn~~~dt~~~iry~~--~~l~~~~dl~~---~~--~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl 272 (351)
T KOG3839|consen 202 TANFRNLPHDTLVVIRYEK--KTLSISIDLEG---PN--EWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKL 272 (351)
T ss_pred eeeeccCCCcceeEEEecC--CceEEEEecCC---Cc--eeeeeeeecceecccceEEeeeeccCccchhhHHHHhhh
Confidence 1222222 23467889987 66777765543 22 24555667765 688889999999999999999998765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.3e-09 Score=112.82 Aligned_cols=170 Identities=18% Similarity=0.296 Sum_probs=133.1
Q ss_pred EEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc----ceeEEEEeccCC-CCchhhh
Q 048419 344 GRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ----DELLLVYDYVPN-GSLDKLL 418 (653)
Q Consensus 344 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~~~~lV~E~~~~-gsL~~~l 418 (653)
.+.||+...-+|..|++|++.....+.......-++.++++.|.|+|++.+.+... ..+++||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 58899999999999999999544434444455678899999999999999987632 368999999986 5777766
Q ss_pred hcccccc----------cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 419 FDKDHKL----------RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 419 ~~~~~~~----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+...... ...+++..+|.++.|+..||.++|+ .|..-+-|.+++|+++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 5543221 2347788999999999999999999 89999999999999999999999998887765443
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCC
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRR 534 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~ 534 (653)
.. |.+ .-..+-|.=.||.+++.|.||..
T Consensus 447 ~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 20 111 11246788899999999999954
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.2e-09 Score=94.93 Aligned_cols=143 Identities=19% Similarity=0.210 Sum_probs=104.2
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEec-cC-------chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HN-------SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
...+|-||+-+.|+++.+. |+...||.-. +. .+-..+...+|++.+.+++--.|.--.-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999986 6777777532 11 111245678899999998754544434445555566899
Q ss_pred EeccCC-CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEEeecC
Q 048419 406 YDYVPN-GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL---NAKLGDFGL 481 (653)
Q Consensus 406 ~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl 481 (653)
|||+++ .++.+++..... ..........++..|-+.+.-||. .+|+|+||..+||+|.+++ .+.++|||+
T Consensus 89 ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecc
Confidence 999977 477887766542 222223336788999999999999 9999999999999996554 368999999
Q ss_pred ccc
Q 048419 482 AKI 484 (653)
Q Consensus 482 a~~ 484 (653)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.5e-09 Score=95.71 Aligned_cols=130 Identities=22% Similarity=0.269 Sum_probs=98.2
Q ss_pred eeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chh-----hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQ-----GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.+++|+-+.+|.+.+. |..+++|.-... .++ ..+.-.+|+.++.+++--.|.--.=+..+.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5789999999999774 455777754222 111 134567899999998755554444455667777899999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++|..|.+++... +..++..+-.-+.-||. .+|+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888887543 24567777788888999 9999999999999997765 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.2e-09 Score=121.20 Aligned_cols=250 Identities=21% Similarity=0.205 Sum_probs=165.5
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
.-+.|.+.+-+-+|.++.+..+.-...|...++|...... ....+....+-.++-..+||-++...--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456666777888999999888776666556666543221 1112222222222222234555544444455667899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
+++|..+++|...|+..+. ++..........+.++++|||. ..+.|+|++|.|++...++..++.||+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999987652 4444445556678899999999 6799999999999999999999999984432
Q ss_pred ccCC----------------------------CC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCC
Q 048419 485 YEHG----------------------------AN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRR 534 (653)
Q Consensus 485 ~~~~----------------------------~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~ 534 (653)
.... .. .......||+.|.+||...+......+|.|+.|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2100 00 01223468999999999999999999999999999999999999
Q ss_pred CCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048419 535 SIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMR 598 (653)
Q Consensus 535 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 598 (653)
|+......... .....+.+.- ..-......+..+++...+..+|.+|-.|.
T Consensus 1034 p~na~tpq~~f-------~ni~~~~~~~------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIF-------ENILNRDIPW------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhhh-------hccccCCCCC------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99876543211 0000111100 011122334566677777788888887776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.9e-08 Score=92.36 Aligned_cols=125 Identities=26% Similarity=0.342 Sum_probs=81.6
Q ss_pred EEEEEEeCCCCcEEEEEEeccCc--------------h-------h-----hHHHHHHHHHHHhhcCCC--ceeeeeeee
Q 048419 345 RVYRGLMPSLGLEVAIKRIGHNS--------------Q-------Q-----GMKEFVAEIMSMGRLRHR--NLVQLHGWC 396 (653)
Q Consensus 345 ~Vy~~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--niv~l~g~~ 396 (653)
.||.|...+ |..+|||..+... . . ......+|.+.|.++... ++.+++.+-
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 389998854 7899999874321 0 0 112356799999999765 455665442
Q ss_pred cccceeEEEEeccC--CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 397 RKQDELLLVYDYVP--NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY-LHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 397 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
.-+|||||++ |..+..+. ... ++.+....++.+++..+.. +|. .+++|+||.+.||+++++ .
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-DVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-HCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-C
T ss_pred ----CCEEEEEecCCCccchhhHH-hcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-e
Confidence 3479999998 54444332 221 2345566788888886655 567 899999999999999888 9
Q ss_pred EEEEeecCcccc
Q 048419 474 AKLGDFGLAKIY 485 (653)
Q Consensus 474 ~kl~DfGla~~~ 485 (653)
+.|+|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.5e-08 Score=97.59 Aligned_cols=141 Identities=16% Similarity=0.088 Sum_probs=99.8
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-hHH----------HHHHHHHHHhhcCCCc--eeeeeeeecc----
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-GMK----------EFVAEIMSMGRLRHRN--LVQLHGWCRK---- 398 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~n--iv~l~g~~~~---- 398 (653)
+.+-......|.+.... |+.+.||+....... ..+ .+.+|...+.+|...+ ..+++++...
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44554444557777663 678999987433211 112 3778999988885433 3344555433
Q ss_pred -cceeEEEEeccCCC-CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC------
Q 048419 399 -QDELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT------ 470 (653)
Q Consensus 399 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------ 470 (653)
....+||+|++++. +|.+++.... ....+...+..++.+++..+.-||. .||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCC
Confidence 23468999999886 7888875321 1223455677899999999999999 99999999999999975
Q ss_pred -CCcEEEEeecCccc
Q 048419 471 -YLNAKLGDFGLAKI 484 (653)
Q Consensus 471 -~~~~kl~DfGla~~ 484 (653)
+..+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 56899999998863
|
|
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.79 E-value=6e-07 Score=86.07 Aligned_cols=201 Identities=16% Similarity=0.154 Sum_probs=117.7
Q ss_pred CCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCC-CCCCCCCCccccCCC
Q 048419 32 SGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTN-RPENCLANQFLGLPN 110 (653)
Q Consensus 32 ~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~-~~~~~~~g~~lG~~~ 110 (653)
+|+||||+...+|.|-+.|.+++|--+. -...+|.+..-.. ...+|||+||||+-.. .+..+..||.||+.-
T Consensus 31 ~g~LRLT~~~~nqata~~~~~~FPs~~n------~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa~ 103 (255)
T cd06900 31 NNRLRLTDASGNQATAVTLQRLFPSAGN------YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYAQ 103 (255)
T ss_pred cCeEEeccCccCcceeEEEeeeeccCCC------eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCccccccc
Confidence 6899999999999999999998886421 2678888877654 5668999999998544 334567788899987
Q ss_pred cccCCCCCCCCceEEEEeeccccccc-CCCC-------CCeeeEecCCCCcCCcccCccccCCCCc-cccccC------C
Q 048419 111 ITMSSSTKFSTRMLAVEFDIIQNTEL-IDIN-------DNHVGIDISSLISSASEPASYYSGNNHR-IPILLR------S 175 (653)
Q Consensus 111 ~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~-------~~Hvgid~ns~~s~~~~~~~~~~~~~~~-~~~~l~------~ 175 (653)
+... .......-++|-||-|-|... .+.. .+-|+| .+--+. +....|-.+.... ..++.. -
T Consensus 104 ~~~~-~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~v--RGsg~g-~~gY~yl~gt~~~~~~id~~~~~~~~~ 179 (255)
T cd06900 104 RNDG-VPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTV--RGSGSG-YTGYKYITGTGVLPPGIDNNSTSTPAP 179 (255)
T ss_pred ccCC-CCccccceEEEEEeccccccCCCCCccCCcccccceEEE--ECCCCC-CcCceEecccCCCCcccccCCCCCCCC
Confidence 6532 245666789999999877421 1211 133333 111110 1111221111111 111111 1
Q ss_pred CCceEEEEEec-CCceEEEEEEeeCCCCCCCCCcee--eeecCC--cccccceEEeEecccCcccceeeeccee
Q 048419 176 GDPIQAWVDYS-SQEMLINVSICPLGVPKPYRPLIS--LPIDLS--SVIDEYMYTGFSASTGLITASHNVHGWS 244 (653)
Q Consensus 176 g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~~~~l~--~~~dL~--~~l~~~~~vGFsastg~~~~~~~i~sWs 244 (653)
+-++++.||=. +....|+|.-+-.+... ..+++. ..++.. ..+|+..+++|++|||..+-.|.|....
T Consensus 180 ~hrY~i~Ids~~~~~~~vsV~R~~~~gg~-~~~~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdnf~ 252 (255)
T cd06900 180 GHRYRITIDSTNGDNAWLSVERDIGNGGA-YFVVILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDNFQ 252 (255)
T ss_pred ceEEEEEEecCCCCceEEEEEEEccCCce-eEEeecceeeccccCCCCCCccEEEEEEecCCCcccceeecceE
Confidence 23444455443 22334555544322211 111221 112333 5679999999999999999999987643
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.6e-07 Score=92.11 Aligned_cols=191 Identities=17% Similarity=0.211 Sum_probs=127.7
Q ss_pred eEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCCCC
Q 048419 21 LSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENC 100 (653)
Q Consensus 21 l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~ 100 (653)
..--|||.. +.-.|+|+++-.++.|.||-+..+++ -.|..+-+|+|+.. .-.++||||+.-+....
T Consensus 56 W~~~GdAIa-s~eqvRlaPSmrsrkGavWtka~~~f--------e~weVev~~rVtGr-GRiGAdGlaiWYt~~~G---- 121 (497)
T KOG3838|consen 56 WSHHGDAIA-SSEQVRLAPSMRSRKGAVWTKASVPF--------ENWEVEVQFRVTGR-GRIGADGLAIWYTRGRG---- 121 (497)
T ss_pred eeecCcccc-cccceeeccccccccCceeecccCCc--------ccceEEEEEEeccc-ccccCCceEEEEecCCC----
Confidence 566788854 57789999998889999988887777 24899999999876 34489999999986432
Q ss_pred CCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCCC----CccccccCC-
Q 048419 101 LANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNN----HRIPILLRS- 175 (653)
Q Consensus 101 ~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~----~~~~~~l~~- 175 (653)
--|..+|-.+.=+. +++-||.|.|. +--|++-|.+-.|.= +.+..--.+.. +...-+.+|
T Consensus 122 ~~GpVfGg~d~WnG---------igiffDSfdnD--~qknnP~Is~~lndG----t~~ydh~~DGasQ~LssCqrDFRNk 186 (497)
T KOG3838|consen 122 HVGPVFGGLDSWNG---------IGIFFDSFDND--GQKNNPAISVLLNDG----TIPYDHPGDGASQGLSSCQRDFRNK 186 (497)
T ss_pred cccccccccccccc---------eEEEeeccccc--CCcCCccEEEEecCC----cccccCCCccHHHHHHHhhHHhccC
Confidence 23344444443332 79999999986 445677787766531 11110000100 012223333
Q ss_pred CCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcc-cccceEEeEecccCcccceeeecceee
Q 048419 176 GDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSV-IDEYMYTGFSASTGLITASHNVHGWSI 245 (653)
Q Consensus 176 g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~-l~~~~~vGFsastg~~~~~~~i~sWsf 245 (653)
=-++.|+|+|- .++|+|.+...-.+. +-...=++...+ ||..-|+|.||+||....-|+|++..-
T Consensus 187 PyPvRarItY~--~nvLtv~innGmtp~---d~yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~Flt 252 (497)
T KOG3838|consen 187 PYPVRARITYY--GNVLTVMINNGMTPS---DDYEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSFLT 252 (497)
T ss_pred CCCceEEEEEe--ccEEEEEEcCCCCCC---CCcceeEeccceeccCCCeeeeeecccccccccceeeeEE
Confidence 35788999997 557999887554332 112223344443 589999999999999999999998653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.8e-06 Score=83.26 Aligned_cols=142 Identities=18% Similarity=0.141 Sum_probs=105.7
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---c---hhhHHHHHHHHHHHhhcCCC--ceeeeeeeeccc-----c
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---S---QQGMKEFVAEIMSMGRLRHR--NLVQLHGWCRKQ-----D 400 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~-----~ 400 (653)
+.---|+||-+.|++.... |..+-+|+-... + +-....|.+|+..|.+|... .+.++. ++... -
T Consensus 22 e~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~ 98 (216)
T PRK09902 22 EEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW 98 (216)
T ss_pred cCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence 3334678999999998775 457999987521 1 33567899999999999643 344444 33221 1
Q ss_pred eeEEEEeccCC-CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--EEEE
Q 048419 401 ELLLVYDYVPN-GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN--AKLG 477 (653)
Q Consensus 401 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~ 477 (653)
.-+||+|-+++ -+|.+++.+.. ....+..++..++.++++++.-||+ .++.|+|+-+.||+++.++. ++++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEE
Confidence 36899997754 58888886543 2245667788999999999999999 99999999999999986667 9999
Q ss_pred eecCccc
Q 048419 478 DFGLAKI 484 (653)
Q Consensus 478 DfGla~~ 484 (653)
||.-++.
T Consensus 173 DlEk~r~ 179 (216)
T PRK09902 173 DLEKSRR 179 (216)
T ss_pred Ehhccch
Confidence 9986653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.8e-08 Score=106.14 Aligned_cols=153 Identities=19% Similarity=0.235 Sum_probs=105.2
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC--------cccccccCCcccCcccccc
Q 048419 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--------QTTHIVGTLGYLAPELTRT 510 (653)
Q Consensus 439 ~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 510 (653)
.+++.|+.|+|.. .++||++|.|++|.+++++..||+.|+.+......... ..-.......|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4456999999984 79999999999999999999999999988755432110 0011123567999999998
Q ss_pred CCCCCccceeehHHHHHHHHhCCCCCC-hhhhhhHHHHHHHHHhhhcccchhHhhhh-ccCcCCHHHHHHHHHHHHHcCC
Q 048419 511 GKATTSTDVYSYGILMLEVACGRRSIE-PQKAAAELLLVDWVKELHLEGEITQAIDQ-TLDYYDLAEAELVLNLGLFCSA 588 (653)
Q Consensus 511 ~~~~~ksDV~s~Gvvl~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~l~~l~~~Cl~ 588 (653)
...+.++|+||+||++|.+..|+.+.- ...... ........+. ....+......++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-------------~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-------------SYSFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-------------hhhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 888999999999999999996555432 221110 0000010111 1112223345667777888999
Q ss_pred CCCCCCCCHHHHHHHHcC
Q 048419 589 PNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 589 ~dP~~RPs~~evl~~L~~ 606 (653)
.++.-||++.++....-.
T Consensus 251 ~~~~~rp~~~~l~~~~ff 268 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSIPFF 268 (700)
T ss_pred CCcccCcchhhhhccccc
Confidence 999999988888776544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-06 Score=85.04 Aligned_cols=133 Identities=22% Similarity=0.235 Sum_probs=92.9
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh----------------------hHHHHHHHHHHHhhcCCC--ce
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ----------------------GMKEFVAEIMSMGRLRHR--NL 389 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~--ni 389 (653)
+...||-|--+.||.|..+ .|.++|||.-+....+ ......+|.++|.+|... .+
T Consensus 95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578999999999999997 4889999975432110 122456788899988654 55
Q ss_pred eeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 390 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
.+.+++ +.-.+||||+.|--|...- ++.+..-.++..|+.-+.-+-. .||||+|+.+-||+++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 555443 4568999999886665432 1122233344444444444444 7999999999999999
Q ss_pred CCCcEEEEeecCccc
Q 048419 470 TYLNAKLGDFGLAKI 484 (653)
Q Consensus 470 ~~~~~kl~DfGla~~ 484 (653)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999965543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.2e-06 Score=85.65 Aligned_cols=105 Identities=25% Similarity=0.332 Sum_probs=82.7
Q ss_pred HHHHHHHHHHhhcCCC--ceeeeeeeecccc----eeEEEEeccCCC-CchhhhhcccccccccchhhhHHHHHHHHHHH
Q 048419 372 KEFVAEIMSMGRLRHR--NLVQLHGWCRKQD----ELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS 444 (653)
Q Consensus 372 ~~~~~E~~~l~~l~H~--niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 444 (653)
....+|...+.+|... ...+.+++..... ..+||+|++++. +|.+++..... ++...+..++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHH
Confidence 4577888888888543 3455666655532 358999999884 79888866321 4556678899999999
Q ss_pred HHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEEeecCccc
Q 048419 445 LLYLHEECNQRVVHRDVKPSNILLDTYL---NAKLGDFGLAKI 484 (653)
Q Consensus 445 L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~ 484 (653)
+.-||+ .+|+|+|++++|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 9999999999999998877 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.8e-06 Score=87.79 Aligned_cols=257 Identities=18% Similarity=0.139 Sum_probs=154.0
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhh-cCCCceeeeeeee------ccc-ceeEEE
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR-LRHRNLVQLHGWC------RKQ-DELLLV 405 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~------~~~-~~~~lV 405 (653)
..+.||+|+-+.+|..-.- +. .+-|+..........+...| |.. -.||-+-.=+.|= -++ ...-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3567999999999964221 22 34466655443322222222 222 2465443322221 122 236677
Q ss_pred EeccCCCC-chhhhhcc-cccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 406 YDYVPNGS-LDKLLFDK-DHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 406 ~E~~~~gs-L~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
|..+++.- +..++... ....-....|+-.+++++.+|.+.+.||+ .|.+-+|+.++|+|+.+++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence 87776642 22222111 11112457899999999999999999999 899999999999999999999999865544
Q ss_pred cccCCCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhC-CCCCChhhhhhH--HHHHHHHHhhh
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACG-RRSIEPQKAAAE--LLLVDWVKELH 555 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG-~~p~~~~~~~~~--~~l~~~~~~~~ 555 (653)
.... .......+|...|.+||.-. +...+..+|-|.+|+++++++.| +.||.+-..... ..+.. ..
T Consensus 166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~I 239 (637)
T COG4248 166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----DI 239 (637)
T ss_pred eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----hh
Confidence 3322 22233457889999999654 33567899999999999999886 899875332110 00000 00
Q ss_pred cccchhHhhhhcc------CcCCHH-HHHHHHHHHHHcCCC--CCCCCCCHHHHHHHHc
Q 048419 556 LEGEITQAIDQTL------DYYDLA-EAELVLNLGLFCSAP--NPVYRPDMRRVVEFLL 605 (653)
Q Consensus 556 ~~~~~~~~~d~~l------~~~~~~-~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~ 605 (653)
..+.....-+... ...+.. ....+..|-.+|... ++.-|||++..+..|.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 1111111112111 112222 235566677778765 3568999998876663
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.8e-06 Score=92.27 Aligned_cols=141 Identities=20% Similarity=0.253 Sum_probs=90.3
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhH------------------------------H----------HHH
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM------------------------------K----------EFV 375 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~ 375 (653)
+-|+.++-|.||+|++++ |+.||||+.+..-.+.. + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999976 99999999865422110 0 133
Q ss_pred HHHHHHhhcC----CCceeeeeeeecc-cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHH-HHHHH
Q 048419 376 AEIMSMGRLR----HRNLVQLHGWCRK-QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS-LLYLH 449 (653)
Q Consensus 376 ~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH 449 (653)
.|...+.+++ ...-+++=..|.+ .+...|+|||++|-.+.+...-... .++ +..++..++++ +..+=
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d---~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GID---RKELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCC---HHHHHHHHHHHHHHHHH
Confidence 4444444442 2222222222322 3456899999999999887432211 122 22233333332 12222
Q ss_pred hcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 450 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
. .+++|.|..|.||+++.++++.+.|||+...+..
T Consensus 283 ~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 R---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred h---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2 6899999999999999999999999999986644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-05 Score=76.47 Aligned_cols=138 Identities=13% Similarity=0.154 Sum_probs=92.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHH---------HHHHHHHhhcCC---Cceeeeeee
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEF---------VAEIMSMGRLRH---RNLVQLHGW 395 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~ 395 (653)
..++|...+++-......|.+-... |..+++|..+.......+.| .+++..+.+++. .....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888888877777776664 78899999865543322222 233444444432 223332332
Q ss_pred ec-----ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 048419 396 CR-----KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT 470 (653)
Q Consensus 396 ~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 470 (653)
+. -....+++|||++|..|.++.. ++. .++..+++++.-||+ .|++|+|..|+|++++.
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEEC
Confidence 22 2234679999999988866532 221 355667888999999 89999999999999985
Q ss_pred CCcEEEEeecCccc
Q 048419 471 YLNAKLGDFGLAKI 484 (653)
Q Consensus 471 ~~~~kl~DfGla~~ 484 (653)
++ ++++||+..+.
T Consensus 171 ~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 171 NG-IRIIDTQGKRM 183 (229)
T ss_pred Cc-EEEEECccccc
Confidence 54 99999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.6e-05 Score=78.84 Aligned_cols=141 Identities=15% Similarity=0.161 Sum_probs=85.1
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc--eeeeeeeecccceeEEEEeccCCCC
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--LVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
..||+|..+.||+. . +..+++|...... ......+|.+.++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 2 4457889875433 2345678999999986443 4667888877777889999998863
Q ss_pred -chhhhhccc-----------------ccc-cccchhhhHH-HHHH----------HHHH-HHHHHHhc-CCCCeEecCC
Q 048419 414 -LDKLLFDKD-----------------HKL-RKLLTWDQRY-KILI----------GIAQ-SLLYLHEE-CNQRVVHRDV 461 (653)
Q Consensus 414 -L~~~l~~~~-----------------~~~-~~~l~~~~~~-~i~~----------~ia~-~L~yLH~~-~~~~ivH~Dl 461 (653)
+...+.... +.. ........+. ++.. .+.+ ...+|... ....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 221111100 000 0000000000 0000 0111 12222211 1246789999
Q ss_pred CCCcEEEcCCCcEEEEeecCcc
Q 048419 462 KPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 462 kp~NIll~~~~~~kl~DfGla~ 483 (653)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.7e-05 Score=76.18 Aligned_cols=105 Identities=24% Similarity=0.212 Sum_probs=83.3
Q ss_pred HHHHHHHhhcCC-CceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCC
Q 048419 375 VAEIMSMGRLRH-RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453 (653)
Q Consensus 375 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 453 (653)
..|.-+++.+.+ +++.+++|+|- .++|.||.+.+++...-..... -..-+|++|.+|+.++++.+.+|++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888888876 69999999993 3679999987766432100000 1125899999999999999999998766
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 454 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
..+...|++++|+-+++++++|+.|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 67899999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.2e-06 Score=94.98 Aligned_cols=183 Identities=19% Similarity=0.128 Sum_probs=133.5
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc-eeeeeeeecccceeEEEEeccCCC-C
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN-LVQLHGWCRKQDELLLVYDYVPNG-S 413 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-s 413 (653)
+-+++++++++||.+..... ....+.+... ....-++++|.+++||| .++.++-+..+...+++++++.++ +
T Consensus 248 h~fvK~altknpKkRptaek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 45788999999998765433 3336665333 44557889999999999 777788888888899999999877 2
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcc
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT 493 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 493 (653)
-....... ...+...+...+++.-++++++||+ -.-+|+| ||+..+ ...|.+||+....+.... ..
T Consensus 322 ~~~~~~~s----e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 322 SALEMTVS----EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred ccccCChh----hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 22211111 1123344455666777889999998 4457888 776655 678999999987665543 23
Q ss_pred cccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCCh
Q 048419 494 THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEP 538 (653)
Q Consensus 494 ~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~ 538 (653)
....+++.++|||....+.+..+-|+|+.|+-..+|.-|-.|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 445789999999999999999999999999877788777766543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00011 Score=70.90 Aligned_cols=129 Identities=22% Similarity=0.357 Sum_probs=92.0
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc----------------hhhHHHHHHHHHHHhhcC------CCceee
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS----------------QQGMKEFVAEIMSMGRLR------HRNLVQ 391 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~ 391 (653)
....||+|+.-.||. ++. +....||+..... ....++..+|+....++. +.+|.+
T Consensus 5 ~~~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 456899999999995 443 4568899886554 223466777777666665 788999
Q ss_pred eeeeecccceeEEEEeccCC--C----CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 048419 392 LHGWCRKQDELLLVYDYVPN--G----SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465 (653)
Q Consensus 392 l~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 465 (653)
++|+..+.-..-+|+|.+.+ | +|.+++.... ++. .+...+-+-..||-+ ..|+.+|++|.|
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~----~~~~~L~~f~~~l~~---~~Iv~~dl~~~N 148 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE----ELRQALDEFKRYLLD---HHIVIRDLNPHN 148 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH----HHHHHHHHHHHHHHH---cCCeecCCCccc
Confidence 99999999999999998643 2 5666764332 443 333444455567777 899999999999
Q ss_pred EEEcCC--C--cEEEEe
Q 048419 466 ILLDTY--L--NAKLGD 478 (653)
Q Consensus 466 Ill~~~--~--~~kl~D 478 (653)
|++... + .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 999432 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.4e-05 Score=74.06 Aligned_cols=145 Identities=20% Similarity=0.228 Sum_probs=84.9
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCC--ceeeeeeeeccc---ceeEEEEecc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHR--NLVQLHGWCRKQ---DELLLVYDYV 409 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~ 409 (653)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++... ...+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4679999999999998865 48999997443 4556777888888888533 345666644332 3468999999
Q ss_pred CCCCchh----------------hhh---cccccccccchhh--------hHHH------------HHHHHHH-HHHHHH
Q 048419 410 PNGSLDK----------------LLF---DKDHKLRKLLTWD--------QRYK------------ILIGIAQ-SLLYLH 449 (653)
Q Consensus 410 ~~gsL~~----------------~l~---~~~~~~~~~l~~~--------~~~~------------i~~~ia~-~L~yLH 449 (653)
++..+.. .+. ...........+. .... ....+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 111 1100000000000 0000 0112222 334444
Q ss_pred hc----CCCCeEecCCCCCcEEEc-CCCcEEEEeecCcc
Q 048419 450 EE----CNQRVVHRDVKPSNILLD-TYLNAKLGDFGLAK 483 (653)
Q Consensus 450 ~~----~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~ 483 (653)
+. ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 346799999999999999 66666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00011 Score=73.84 Aligned_cols=140 Identities=18% Similarity=0.092 Sum_probs=84.2
Q ss_pred eeeeCc-EEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEeccCCCCch
Q 048419 338 VGSGGF-GRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGSLD 415 (653)
Q Consensus 338 LG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 415 (653)
|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444444 789998764 4678888875432 345677888888884 444567777776666789999999998776
Q ss_pred hhhh-------------------cccccccccch--hhhHHHHHH--------------------HHHHHHHHHHh----
Q 048419 416 KLLF-------------------DKDHKLRKLLT--WDQRYKILI--------------------GIAQSLLYLHE---- 450 (653)
Q Consensus 416 ~~l~-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~---- 450 (653)
.... ..... ..... ...+..... .+...+..|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVA-DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcc-cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 4421 10000 00000 000000000 01111222211
Q ss_pred cCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 451 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
.....++|+|+.|.|||++++....|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 112568999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=86.29 Aligned_cols=150 Identities=14% Similarity=0.226 Sum_probs=93.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCC--cEEEEEEeccCc-hhhHHHHHHHHHHHhhcC-CCce--eeeeeeeccc---ceeEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSLG--LEVAIKRIGHNS-QQGMKEFVAEIMSMGRLR-HRNL--VQLHGWCRKQ---DELLLV 405 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 405 (653)
.+.++.|.+..+|+......+ ..+++|+..... ......+.+|.++++.|. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998775432 467888764322 123456789999999995 6664 7888888765 467899
Q ss_pred EeccCCCCchhh-----------------------hhccccc------ccccc--------hhhhHHHH---------HH
Q 048419 406 YDYVPNGSLDKL-----------------------LFDKDHK------LRKLL--------TWDQRYKI---------LI 439 (653)
Q Consensus 406 ~E~~~~gsL~~~-----------------------l~~~~~~------~~~~l--------~~~~~~~i---------~~ 439 (653)
|||++|..+.+. |+..... ...+. .|...+.- .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 1111000 00000 11111110 11
Q ss_pred HHHHHHHHHHhcCC--------CCeEecCCCCCcEEEcCC-Cc-EEEEeecCccc
Q 048419 440 GIAQSLLYLHEECN--------QRVVHRDVKPSNILLDTY-LN-AKLGDFGLAKI 484 (653)
Q Consensus 440 ~ia~~L~yLH~~~~--------~~ivH~Dlkp~NIll~~~-~~-~kl~DfGla~~ 484 (653)
.+.+.+.+|..... ..+||+|+++.||+++.+ .. .-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 23344566644322 359999999999999753 33 57999999875
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=5.4e-05 Score=83.04 Aligned_cols=159 Identities=21% Similarity=0.280 Sum_probs=99.1
Q ss_pred CCcccCHHHHHHhhc------------CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhh-------------
Q 048419 316 GARRFKYAELASVTK------------GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG------------- 370 (653)
Q Consensus 316 ~~~~f~~~el~~at~------------~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~------------- 370 (653)
..+.++++|+...-+ .|+ .+.||.-+.|.||+|++++ |+.||||+-+..-+..
T Consensus 136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~ 213 (538)
T KOG1235|consen 136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAK 213 (538)
T ss_pred cCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence 345677777654432 233 3579999999999999986 9999999975432111
Q ss_pred ------------------HH------HHHHHHHHHhhc----CCCc------eeeeeeeecccceeEEEEeccCCCCchh
Q 048419 371 ------------------MK------EFVAEIMSMGRL----RHRN------LVQLHGWCRKQDELLLVYDYVPNGSLDK 416 (653)
Q Consensus 371 ------------------~~------~~~~E~~~l~~l----~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~ 416 (653)
.+ +|.+|.+-..+. +|-+ |.+++-.+ .....|+||||+|..+.+
T Consensus 214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~D 291 (538)
T KOG1235|consen 214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKIND 291 (538)
T ss_pred HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCC
Confidence 01 244455433333 3444 22332222 235689999999998877
Q ss_pred hhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC----CCcEEEEeecCcccccC
Q 048419 417 LLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT----YLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfGla~~~~~ 487 (653)
.-.-.. ..++.. .|+..+.++ |++.....|++|+|-.|.||+++. ++.+.+-|||+......
T Consensus 292 l~~i~~----~gi~~~---~i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 292 LDAIDK----RGISPH---DILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHH----cCCCHH---HHHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 643221 113333 333334333 222222368999999999999983 67899999999986644
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00025 Score=69.62 Aligned_cols=154 Identities=19% Similarity=0.173 Sum_probs=95.3
Q ss_pred ccCHHHHHHhhcCcCcceeee---eeCcEEEEEEEeCCCCcEEEEEEeccCchhhH-------------------HH---
Q 048419 319 RFKYAELASVTKGFGEQNLVG---SGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM-------------------KE--- 373 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG---~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~~--- 373 (653)
..+...+....++..+....| .|--+.||+|... ++..+|||++........ ++
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 345566666666666665554 5667789998773 478999999854321110 00
Q ss_pred --HHHHHHHHhhcCCC--ceeeeeeeecccceeEEEEeccCCCCc-hhhhhcccccccccchhhhHHHHHHHHHHHHHHH
Q 048419 374 --FVAEIMSMGRLRHR--NLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448 (653)
Q Consensus 374 --~~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL 448 (653)
...|...|+++... .+.+-+++. .-.|||||+....+ .-.|.. -.+..++...+..++++.+.-|
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHH
Confidence 12355555555322 222222221 23799999965311 112211 1123335666777777777666
Q ss_pred HhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 449 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
-.. .++||+||..-|||+. ++.+.|+|++-+....
T Consensus 183 ~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 183 YKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 553 6899999999999999 8899999999887544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00028 Score=67.66 Aligned_cols=125 Identities=28% Similarity=0.411 Sum_probs=90.5
Q ss_pred cCcCcceeeeeeCc-EEEEEEEeCCCCcEEEEEEecc---Cch------------------hhHHHHHHHHHHHhhcC--
Q 048419 330 KGFGEQNLVGSGGF-GRVYRGLMPSLGLEVAIKRIGH---NSQ------------------QGMKEFVAEIMSMGRLR-- 385 (653)
Q Consensus 330 ~~f~~~~~LG~G~f-g~Vy~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~-- 385 (653)
..++..+.||.|.- |.|||++.. |..+|+|.+.. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 66777899999999 999999996 67999999321 100 11236888999888885
Q ss_pred -CCce--eeeeeeeccc------------------ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHH
Q 048419 386 -HRNL--VQLHGWCRKQ------------------DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS 444 (653)
Q Consensus 386 -H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 444 (653)
+.++ |+.+||..=. ....||.||.+... .+. .+-+.+|.+-
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~d 176 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRD 176 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHH
Confidence 4456 9999987211 12467888776532 122 2334567777
Q ss_pred HHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 445 L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
|..+|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 177 l~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 888999 99999999999987 5699999854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00022 Score=66.18 Aligned_cols=128 Identities=20% Similarity=0.228 Sum_probs=87.8
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceee-eeeeecccceeEEEEeccCCC
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ-LHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~g 412 (653)
..+.|++|++|.||+|.+. |..+|+|+-+..++ ...+..|+++|..+.-.++.+ ++.|-.+ .+.|||+.|-
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 3568999999999999996 56899998755443 467889999999998766654 3333322 3459999887
Q ss_pred CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCcEEEcCCCcEEEEeecCccc
Q 048419 413 SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVK-PSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DfGla~~ 484 (653)
.|.++-... + .+-...++..---|.. .||-|+.|. |...+|-.+..+.|+||..|+.
T Consensus 98 ~L~~~~~~~--------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG--------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc--------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 886654321 1 1223334454334444 788898887 4444555555999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00036 Score=69.77 Aligned_cols=74 Identities=16% Similarity=0.147 Sum_probs=47.2
Q ss_pred eeeeeeCcE-EEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCC---ceeeeeeeecccc---eeEEEEec
Q 048419 336 NLVGSGGFG-RVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHR---NLVQLHGWCRKQD---ELLLVYDY 408 (653)
Q Consensus 336 ~~LG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~E~ 408 (653)
+.|+.||.. .||+. +..+++|..... .....+..|.+.+..|... .+.++++.+...+ ..+++||+
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 467777776 59975 235777875432 2345788899999888532 3444454443322 34889999
Q ss_pred cCCCCchh
Q 048419 409 VPNGSLDK 416 (653)
Q Consensus 409 ~~~gsL~~ 416 (653)
++|.++.+
T Consensus 76 i~G~~l~~ 83 (235)
T cd05155 76 LEGETATA 83 (235)
T ss_pred ecCCCCCc
Confidence 99987754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00074 Score=67.36 Aligned_cols=76 Identities=14% Similarity=0.197 Sum_probs=48.4
Q ss_pred ceeeeeeCcEEEEEEEeCC-CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEEEeccCCC
Q 048419 335 QNLVGSGGFGRVYRGLMPS-LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~g 412 (653)
.+.|..|-...+|+....+ .+..|++|........ .-...+|+.+++.+...++ .++++.+. + .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 3567778888999987643 3567889977543221 1223468888888854333 44444332 2 4799999987
Q ss_pred Cch
Q 048419 413 SLD 415 (653)
Q Consensus 413 sL~ 415 (653)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00099 Score=69.06 Aligned_cols=77 Identities=9% Similarity=0.027 Sum_probs=56.7
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC---Cceeeeeeeeccc---ceeEEEEe
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH---RNLVQLHGWCRKQ---DELLLVYD 407 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E 407 (653)
..+.||.|..+.||+....+ + .+.+|..+... ....+..|.+.|+.|.. -.+.+++++|... +..+||||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 35689999999999986543 3 47777753311 23578899999998853 3678888887543 56899999
Q ss_pred ccCCCCc
Q 048419 408 YVPNGSL 414 (653)
Q Consensus 408 ~~~~gsL 414 (653)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00049 Score=80.08 Aligned_cols=198 Identities=16% Similarity=0.137 Sum_probs=133.2
Q ss_pred HHHHHHHHHhhcCCCceeeeeeeeccccee----EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHH
Q 048419 373 EFVAEIMSMGRLRHRNLVQLHGWCRKQDEL----LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448 (653)
Q Consensus 373 ~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL 448 (653)
....|+..+.++.|+|++.++.|-.+.... .+..|+|+.-++...+.... .++....+.+..++..||.|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHHHHHHHhhhHHHH
Confidence 344577788889999999999987665432 34567888888888876643 477788888999999999999
Q ss_pred HhcCCCCeEecCCCCC---cEEEcCCCcEEEE--eecCcccccCCCCCcccccccCCcccCccccccCCCCC--ccceee
Q 048419 449 HEECNQRVVHRDVKPS---NILLDTYLNAKLG--DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT--STDVYS 521 (653)
Q Consensus 449 H~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDV~s 521 (653)
|+ ....|.-+..+ +--.+..+...++ ||+.......... ......+..+.+||......+.. ..|+|.
T Consensus 303 h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HH---hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHH
Confidence 99 44444444333 3333555666666 8877765543221 11223455688888877665554 479999
Q ss_pred hHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048419 522 YGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601 (653)
Q Consensus 522 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (653)
+|..+..+..|..+-..... +..+++. .. ...+.+...+|+..++++|++..+++
T Consensus 378 lgll~~~~~~~~~i~~~~~~------------------~~~~l~~----~~---~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV------------------PVSLLDV----LS---TSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHHhhhhhcCcccccccc------------------hhhhhcc----cc---chhhhhhhhhhcchhhhhccchhhhh
Confidence 99999999988765432111 0011110 00 11455677789999999999999999
Q ss_pred HHHc
Q 048419 602 EFLL 605 (653)
Q Consensus 602 ~~L~ 605 (653)
.+.-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 8763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0018 Score=69.33 Aligned_cols=77 Identities=12% Similarity=0.093 Sum_probs=54.2
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-----c--hhhHHHHHHHHHHHhhcC---CCceeeeeeeecccceeEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-----S--QQGMKEFVAEIMSMGRLR---HRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 404 (653)
.+.||.|.+..||++...+.++.++||.-... . +...+.+..|.+.|..+. -.++.+++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 46799999999999998654368999985311 1 223456777888888763 24566777763 355789
Q ss_pred EEeccCCCC
Q 048419 405 VYDYVPNGS 413 (653)
Q Consensus 405 V~E~~~~gs 413 (653)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00071 Score=68.55 Aligned_cols=139 Identities=14% Similarity=0.044 Sum_probs=77.5
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEEEeccCCCCchh
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLVYDYVPNGSLDK 416 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 416 (653)
+..|-...+|+... ++..+++|........-.-...+|..+++.+....+ .+++..+. -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45577778998874 366788987644322211134678888888864433 33444332 268999999877643
Q ss_pred h-----------------hhcccccccccchhhhH-HHHHHH---------HHHHHHHHHhc-----CCCCeEecCCCCC
Q 048419 417 L-----------------LFDKDHKLRKLLTWDQR-YKILIG---------IAQSLLYLHEE-----CNQRVVHRDVKPS 464 (653)
Q Consensus 417 ~-----------------l~~~~~~~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~ivH~Dlkp~ 464 (653)
. |+..... ...++...+ .....+ +...+..+-.. ....++|+|+.|.
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRF-GYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 2 1111100 111111111 111111 11112222111 1246899999999
Q ss_pred cEEEcCCCcEEEEeecCccc
Q 048419 465 NILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 465 NIll~~~~~~kl~DfGla~~ 484 (653)
||++++++ +.|+||+.+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99998877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0021 Score=66.87 Aligned_cols=144 Identities=23% Similarity=0.265 Sum_probs=83.9
Q ss_pred eeeeeeCcEEEEEEEeCC------CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEEEec
Q 048419 336 NLVGSGGFGRVYRGLMPS------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 408 (653)
+.|..|-...+|+....+ .+..+++|+...... ......+|.+++..+....+ .++++++. . .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456666667899987653 257899999755432 22345678888888854333 34555543 2 358999
Q ss_pred cCCCCchhhh-----------------hcccccc------cccchhhhHHH--------------------------HHH
Q 048419 409 VPNGSLDKLL-----------------FDKDHKL------RKLLTWDQRYK--------------------------ILI 439 (653)
Q Consensus 409 ~~~gsL~~~l-----------------~~~~~~~------~~~l~~~~~~~--------------------------i~~ 439 (653)
++|..+.... +...... ....-|..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887765321 1111100 00011111111 112
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCcEEEcCC----CcEEEEeecCccc
Q 048419 440 GIAQSLLYLHE------ECNQRVVHRDVKPSNILLDTY----LNAKLGDFGLAKI 484 (653)
Q Consensus 440 ~ia~~L~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~ 484 (653)
.+...+..|.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134679999999999999875 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.005 Score=64.52 Aligned_cols=144 Identities=14% Similarity=0.134 Sum_probs=77.3
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc--eeeeeee------ecccceeEEEEe
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--LVQLHGW------CRKQDELLLVYD 407 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 407 (653)
+.|+.|....+|+....+ | .+++|+...... +....|+..+..|...+ +.+.+.. ....+..++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ-G-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCC-C-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456677777899987643 3 689998752222 33334555555553222 2333321 122456789999
Q ss_pred ccCCCCchh-----------h---hhcccccc------cccchh-hhHHH------------HH-HHHHHHHHHHHh---
Q 048419 408 YVPNGSLDK-----------L---LFDKDHKL------RKLLTW-DQRYK------------IL-IGIAQSLLYLHE--- 450 (653)
Q Consensus 408 ~~~~gsL~~-----------~---l~~~~~~~------~~~l~~-~~~~~------------i~-~~ia~~L~yLH~--- 450 (653)
|++|..+.. . ++...... ...+.| ..... .. ..+...+..+.+
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 1 11100000 001112 11111 11 111112233321
Q ss_pred -cCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 451 -ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 451 -~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
....++||+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1356899999999999999766668999998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0043 Score=64.23 Aligned_cols=145 Identities=13% Similarity=0.082 Sum_probs=86.3
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc--eeeeeeee------cccceeEEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--LVQLHGWC------RKQDELLLVY 406 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~ 406 (653)
.+.|..|....+|+.... +..+++|+... ........|++++..|.+.. +.+++... ...+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456777777899998764 34688998754 22345667888888875433 44444321 2234568999
Q ss_pred eccCCCCchh----hh----------hcccccc------cccchhhhHH----------HHHHHHHHHHHHHHh----cC
Q 048419 407 DYVPNGSLDK----LL----------FDKDHKL------RKLLTWDQRY----------KILIGIAQSLLYLHE----EC 452 (653)
Q Consensus 407 E~~~~gsL~~----~l----------~~~~~~~------~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~ 452 (653)
+|++|..+.. .+ +...... .....|.... .....+..++.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877643 01 1000000 0111222211 011223344455543 23
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 453 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
..+++|+|+.|.||+++++..+.|.||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 46799999999999999987788999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0087 Score=62.40 Aligned_cols=146 Identities=15% Similarity=0.148 Sum_probs=83.4
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc--eeeeeeee------cccceeEEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--LVQLHGWC------RKQDELLLVY 406 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~ 406 (653)
.+.++.|....+|+.... ++ .+++|+..... ..+....|++++..|.... +.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 445677777899988753 33 58888874421 1234456677777774322 34444322 2235678999
Q ss_pred eccCCCCchhh--------------hhccccccc-------ccchhhhHH------------HHHHHHHHHHHHHHh---
Q 048419 407 DYVPNGSLDKL--------------LFDKDHKLR-------KLLTWDQRY------------KILIGIAQSLLYLHE--- 450 (653)
Q Consensus 407 E~~~~gsL~~~--------------l~~~~~~~~-------~~l~~~~~~------------~i~~~ia~~L~yLH~--- 450 (653)
||++|..+... ++....... ..-.|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988654311 111110000 011122111 011223344555543
Q ss_pred -cCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 451 -ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 451 -~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
....+++|+|+.+.||+++.++...|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3457899999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.03 Score=57.32 Aligned_cols=31 Identities=35% Similarity=0.520 Sum_probs=25.8
Q ss_pred CCeEecCCCCCcEEEcCCCc-EEEEeecCccc
Q 048419 454 QRVVHRDVKPSNILLDTYLN-AKLGDFGLAKI 484 (653)
Q Consensus 454 ~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~ 484 (653)
..++|+|++|.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999987555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.025 Score=59.89 Aligned_cols=144 Identities=17% Similarity=0.238 Sum_probs=82.9
Q ss_pred eeeeeeCcEEEEEEEeCC----CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCcee-eeeeeecccceeEEEEeccC
Q 048419 336 NLVGSGGFGRVYRGLMPS----LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLV-QLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 410 (653)
+.|-.|-.-.+|+....+ .+..|++|.......... ...+|..+++.+...++. ++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 445556777899987532 246799998865433222 236788888888654443 45555432 2 5899998
Q ss_pred CCCchhh-----------------hhcccccc-cccchhhhHHHHHHHH-----------------HHHHHHHHh-----
Q 048419 411 NGSLDKL-----------------LFDKDHKL-RKLLTWDQRYKILIGI-----------------AQSLLYLHE----- 450 (653)
Q Consensus 411 ~gsL~~~-----------------l~~~~~~~-~~~l~~~~~~~i~~~i-----------------a~~L~yLH~----- 450 (653)
+.+|... +|+..... .....|.+..++..++ ...+..|.+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111000 1122233333332221 112222221
Q ss_pred cCCCCeEecCCCCCcEEEcC-CCcEEEEeecCccc
Q 048419 451 ECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKI 484 (653)
Q Consensus 451 ~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~ 484 (653)
.....++|+|+++.|||+++ ++.++++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12347899999999999976 46899999998864
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0044 Score=66.58 Aligned_cols=163 Identities=21% Similarity=0.302 Sum_probs=92.3
Q ss_pred HHHHHHHHHHhhcCCCceeeeeeeeccc-ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHh
Q 048419 372 KEFVAEIMSMGRLRHRNLVQLHGWCRKQ-DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450 (653)
Q Consensus 372 ~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~ 450 (653)
.+.+.....++.+.|+|+.+.+.+-... ....+|+|++ +.||++++..+. +... +++ .
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~------l~~~----------s~~----~ 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN------LKDE----------SLL----A 85 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc------cchh----------hhc----c
Confidence 4556677889999999999988876544 3468899998 669998886543 1110 111 1
Q ss_pred cCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHH
Q 048419 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVA 530 (653)
Q Consensus 451 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ell 530 (653)
+++.|- ||+ +++| -++.. | |-. ..+|+|||++|.++.|+.
T Consensus 86 ---~~~~~~-----~~~-------~~td-~~~t~-----------------~--~~~-----~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 86 ---HGVLHL-----NII-------YITD-HFLTK-----------------Y--PSP-----IGPKSDVWSLGFIILELY 125 (725)
T ss_pred ---ccccee-----hhh-------hccc-ccccc-----------------C--CCC-----CCcchhhhhHHHHHHHHH
Confidence 233332 222 2233 11100 0 100 114999999999999999
Q ss_pred hCCCCCChhhhhhHHHHHHHHHhhhcc-cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048419 531 CGRRSIEPQKAAAELLLVDWVKELHLE-GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRV 600 (653)
Q Consensus 531 tG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 600 (653)
-|..-+......+.. ..+...... .......... ....+..+.++++...|+-..|..||...++
T Consensus 126 L~~~l~~~~~~s~~l---~~i~k~~~~d~~~~~~a~e~--~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 126 LGISLEAELTESEYL---EILLKYYTDDQELLSTAMEH--LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HhhHHHHHHHHHHHH---HHHHHhccCchhHHHHHHHH--HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 987655443332221 112222111 1111111111 2223445778899999999999998854443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.041 Score=56.98 Aligned_cols=129 Identities=17% Similarity=0.196 Sum_probs=79.8
Q ss_pred EEEEEEeCCCCcEEEEEEec-cCchhhHHHHHHHHHHHhhcCC--Cceeeeeeeecccc--eeEEEEeccCCCCchhhhh
Q 048419 345 RVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRH--RNLVQLHGWCRKQD--ELLLVYDYVPNGSLDKLLF 419 (653)
Q Consensus 345 ~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~ 419 (653)
.+|..... ++.+++++-. ...........+|...|+.+.- --+.+.+++|.++. ..+.||+|++|..+.+.+.
T Consensus 40 ~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 44444333 6778888221 1233345566678888887742 33555677887776 6799999998854444332
Q ss_pred cccccccccchhhhHHHHH-HHHHHHHHHHH-------------------------------------------------
Q 048419 420 DKDHKLRKLLTWDQRYKIL-IGIAQSLLYLH------------------------------------------------- 449 (653)
Q Consensus 420 ~~~~~~~~~l~~~~~~~i~-~~ia~~L~yLH------------------------------------------------- 449 (653)
.... . .+.+ ..+++.|.-||
T Consensus 118 ~~~~------~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 118 PESL------G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cccc------h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 2110 0 0111 23333333333
Q ss_pred -hcC-----CCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 450 -EEC-----NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 450 -~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
+.. ...++|+|+.+.|++++...-+=|.||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 321 256999999999999998888999999998763
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.0005 Score=81.64 Aligned_cols=163 Identities=15% Similarity=0.000 Sum_probs=113.2
Q ss_pred HHHHHHHHHhhcCCCceeeeeeeecc--cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHh
Q 048419 373 EFVAEIMSMGRLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450 (653)
Q Consensus 373 ~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~ 450 (653)
....|...+++..|+++.....=... ..+.+.+++|+..|.+.+.|-....+ ...+........-.+......-+|.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHHHHHHhccchhhh
Confidence 34445556666789888765543322 23568999999999999988765432 2223322222222232444444444
Q ss_pred cC--CCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHH
Q 048419 451 EC--NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLE 528 (653)
Q Consensus 451 ~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~e 528 (653)
.. ..-.+|++||+-|.+|..+.++|++++|+.+...+. ........+++.|+.|++...-+++.++|+|..|+-+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 32 244789999999999999999999999999843322 223344567889999999998899999999999999999
Q ss_pred HHhCCCCCC
Q 048419 529 VACGRRSIE 537 (653)
Q Consensus 529 lltG~~p~~ 537 (653)
..-|..++.
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 988877654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.016 Score=59.01 Aligned_cols=148 Identities=14% Similarity=0.111 Sum_probs=95.9
Q ss_pred ccCHHHHHHhhcC---cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--------hh----------h----HHH
Q 048419 319 RFKYAELASVTKG---FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--------QQ----------G----MKE 373 (653)
Q Consensus 319 ~f~~~el~~at~~---f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~----------~----~~~ 373 (653)
-+.|--|++..++ ++..+.||-|--+.+|.+.... |.+.++|.-+... .. + .-.
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla 156 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA 156 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence 3556666666654 4667899999999999998864 7888888642210 00 0 112
Q ss_pred HHHHHHHHhhcCC-Cc-eeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhc
Q 048419 374 FVAEIMSMGRLRH-RN-LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451 (653)
Q Consensus 374 ~~~E~~~l~~l~H-~n-iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 451 (653)
...|...|+.|.. .. +.+.+ +.+.-++|||++.+-.|...-+-. +.+ .+...+..-+.-|-.
T Consensus 157 a~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~--------d~~---~ly~~lm~~Iv~la~- 220 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHVE--------DPP---TLYDDLMGLIVRLAN- 220 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeecC--------ChH---HHHHHHHHHHHHHHH-
Confidence 3457777777743 21 22222 334568999999887775543221 122 233333333444444
Q ss_pred CCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 452 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
+|+||+|..-=||+++++..++++||--....
T Consensus 221 --~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 221 --HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred --cCceecccchheeEEecCCCEEEeechHhhcc
Confidence 89999999999999999999999999655443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.054 Score=57.05 Aligned_cols=144 Identities=14% Similarity=0.208 Sum_probs=80.2
Q ss_pred eeeeeeCcEEEEEEEeCCC---CcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCcee-eeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLV-QLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.|..|-.-.+|+....+. +..|++|+....... .-...+|..+++.+..-++. ++++++ ..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence 4455566678898875432 237889987554322 12235788888888655553 455555 222 58999977
Q ss_pred CCchhh-----------------hhcccccc-cccchhhhHHHHHHHH----------------------HHHHHHHHhc
Q 048419 412 GSLDKL-----------------LFDKDHKL-RKLLTWDQRYKILIGI----------------------AQSLLYLHEE 451 (653)
Q Consensus 412 gsL~~~-----------------l~~~~~~~-~~~l~~~~~~~i~~~i----------------------a~~L~yLH~~ 451 (653)
..|..- +|...... ..+-.|..+.++..++ .+-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 11111000 1111233332222221 1112222211
Q ss_pred -----CCCCeEecCCCCCcEEEcC-CCcEEEEeecCccc
Q 048419 452 -----CNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKI 484 (653)
Q Consensus 452 -----~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~ 484 (653)
.+.-.+|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1234799999999999975 57899999998864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.076 Score=54.57 Aligned_cols=73 Identities=19% Similarity=0.303 Sum_probs=48.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC---CCceeeeeeeecccceeEEEEeccCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR---HRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
.+.|+.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 5678989999999977 457889999875 233456788888888883 44577888888777777999999977
Q ss_pred C
Q 048419 412 G 412 (653)
Q Consensus 412 g 412 (653)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.099 Score=54.51 Aligned_cols=33 Identities=21% Similarity=0.230 Sum_probs=29.3
Q ss_pred CCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 452 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
...+++|+|+.++||++++++.+.++||..+..
T Consensus 194 ~~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 194 WRTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred cceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 346899999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.022 Score=55.83 Aligned_cols=31 Identities=35% Similarity=0.463 Sum_probs=22.3
Q ss_pred CCeEecCCCCCcEEE-cCCCcEEEEeecCccc
Q 048419 454 QRVVHRDVKPSNILL-DTYLNAKLGDFGLAKI 484 (653)
Q Consensus 454 ~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~ 484 (653)
..++|+|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.099 Score=55.04 Aligned_cols=74 Identities=11% Similarity=0.040 Sum_probs=47.0
Q ss_pred eeeeeCcEEEEEEEeCCCCcEEEEEEeccC-------chhhHHHHHHHHHHHhhcC--CCc-eeeeeeeecccceeEEEE
Q 048419 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-------SQQGMKEFVAEIMSMGRLR--HRN-LVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lV~ 406 (653)
.||.|....||++..++.+..|+||.-... -+-..++..-|.+.|+... .|. +.+++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999998654468999974311 1223445556777776653 343 344433 3444457999
Q ss_pred eccCCC
Q 048419 407 DYVPNG 412 (653)
Q Consensus 407 E~~~~g 412 (653)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.1 Score=54.37 Aligned_cols=30 Identities=27% Similarity=0.303 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 453 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 368999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 653 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-33 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 5e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 7e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-11 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 1ioa_A | 240 | Arcelin-5, A Lectin-Like Defense Protein From Phase | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 6e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 1viw_B | 205 | Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Le | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 5e-08 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 5e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 7e-08 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 8e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1dhk_B | 223 | Structure Of Porcine Pancreatic Alpha-Amylase Lengt | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-07 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 2pel_A | 236 | Peanut Lectin Length = 236 | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 1bzw_A | 232 | Peanut Lectin Complexed With C-Lactose Length = 232 | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 1uzy_A | 242 | Erythrina Crystagalli Lectin Length = 242 | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-07 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 7e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-07 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 8e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 1ofs_A | 187 | Pea Lectin-sucrose Complex Length = 187 | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 2ltn_A | 181 | Design, Expression, And Crystallization Of Recombin | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 1rin_A | 180 | X-Ray Crystal Structure Of A Pea Lectin-Trimannosid | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 1lof_C | 181 | X-Ray Structure Of A Biantennary Octasaccharide-Lec | 5e-06 | ||
| 1lgc_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 5e-06 | ||
| 1lgb_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 5e-06 | ||
| 1loa_A | 181 | Three-Dimensional Structures Of Complexes Of Lathyr | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1n3o_A | 252 | Pterocarcpus Angolensis Lectin In Complex With Alph | 6e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-06 | ||
| 1q8o_A | 252 | Pterocartpus Angolensis Lectin Pal In Complex With | 7e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 2lal_A | 181 | Crystal Structure Determination And Refinement At 2 | 9e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1VIW|B Chain B, Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Length = 205 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1DHK|B Chain B, Structure Of Porcine Pancreatic Alpha-Amylase Length = 223 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2PEL|A Chain A, Peanut Lectin Length = 236 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181 | Back alignment and structure |
|
| >pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 653 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-126 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-115 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-114 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-71 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-61 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-57 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-56 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 6e-56 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-56 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-55 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 2e-55 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-55 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 3e-55 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 4e-55 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 5e-55 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-54 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 1e-53 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 1e-53 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 3e-53 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 3e-53 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 3e-53 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 4e-53 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-52 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 3e-52 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-52 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 5e-52 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 5e-52 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 5e-52 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-51 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 3e-50 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 3e-50 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 8e-50 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-49 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 2e-49 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 7e-49 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 7e-49 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-48 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-48 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 7e-48 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-47 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 6e-42 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-41 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-40 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-39 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-39 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-39 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-37 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-36 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-36 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-36 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-36 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-35 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-35 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-35 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-35 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-35 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-35 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-34 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-34 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-34 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-34 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-34 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-34 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-34 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-34 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 9e-34 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-33 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-33 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-33 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-33 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-33 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-33 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-33 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-33 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-33 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-33 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-33 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-32 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-32 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-32 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-32 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-32 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-32 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-32 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-31 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-31 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-31 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-31 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-31 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-31 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-31 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-31 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-31 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-31 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-31 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-31 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-31 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 7e-31 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-31 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-30 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-30 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-30 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-30 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-30 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-30 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-30 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-30 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-30 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-30 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-30 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-30 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-29 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 2e-29 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 1e-11 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-29 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-29 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-29 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 4e-29 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 6e-29 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-29 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-28 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-28 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-28 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-28 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-28 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-28 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 7e-28 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 8e-28 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-28 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 9e-28 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-27 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-27 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-27 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-27 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-27 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-27 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-27 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-27 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-27 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-27 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-27 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-27 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-27 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-26 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-26 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-26 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-26 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-26 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-26 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-26 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-26 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-26 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-26 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 9e-26 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 9e-26 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-25 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-25 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-25 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-25 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-25 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-25 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-25 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-25 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 7e-25 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-25 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-24 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-24 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-24 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-24 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-24 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-24 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 9e-24 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-23 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-23 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-23 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-23 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-23 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-23 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-23 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 6e-23 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 8e-23 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-22 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-22 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-22 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-22 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 3e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 9e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-21 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-21 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-21 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-21 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 8e-21 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-20 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-20 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-20 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-19 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-19 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-19 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 9e-19 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-18 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-18 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-18 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-17 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-17 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-17 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-16 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-16 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-16 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-16 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-16 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-16 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 8e-16 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-16 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-15 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-15 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-15 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-13 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-11 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 6e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-11 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-09 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 8e-09 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 4e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-07 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-07 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 8e-05 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-126
Identities = 117/307 (38%), Positives = 182/307 (59%), Gaps = 7/307 (2%)
Query: 309 EDWEIQCG-ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS 367
ED E+ G +RF EL + F +N++G GGFG+VY+G + G VA+KR+
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEER 66
Query: 368 QQGMK-EFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
QG + +F E+ + HRNL++L G+C E LLVY Y+ NGS+ L ++ +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES-Q 125
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
L W +R +I +G A+ L YLH+ C+ +++HRDVK +NILLD A +GDFGLAK+ +
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE-- 544
+ TT + GT+G++APE TGK++ TDV+ YG+++LE+ G+R+ + + A +
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 545 LLLVDWVKELHLEGEITQAIDQTLDY-YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603
++L+DWVK L E ++ +D L Y E E ++ + L C+ +P+ RP M VV
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 604 LLGDSSL 610
L GD
Sbjct: 306 LEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-115
Identities = 105/308 (34%), Positives = 162/308 (52%), Gaps = 13/308 (4%)
Query: 302 KYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIK 361
D + + + + R +L T F + L+G G FG+VY+G++ G +VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALK 69
Query: 362 RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDK 421
R S QG++EF EI ++ RH +LV L G+C +++E++L+Y Y+ NG+L + L+
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 422 DHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481
D ++W+QR +I IG A+ L YLH ++HRDVK NILLD K+ DFG+
Sbjct: 130 DLP-TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185
Query: 482 AKIYEHGANPQTTHI----VGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537
+K G TH+ GTLGY+ PE G+ T +DVYS+G+++ EV C R +I
Sbjct: 186 SKK---GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 538 PQKAAAELLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPD 596
+ L +W E H G++ Q +D L D + + C A + RP
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 597 MRRVVEFL 604
M V+ L
Sbjct: 303 MGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-114
Identities = 104/304 (34%), Positives = 161/304 (52%), Gaps = 22/304 (7%)
Query: 318 RRFKYAELASVTKGFGEQ------NLVGSGGFGRVYRGLMPSLGLEVAIKRIGH----NS 367
F + EL +VT F E+ N +G GGFG VY+G + VA+K++ +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITT 70
Query: 368 QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRK 427
++ ++F EI M + +H NLV+L G+ D+L LVY Y+PNGSL L D
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TP 128
Query: 428 LLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487
L+W R KI G A + +LHE +HRD+K +NILLD AK+ DFGLA+ E
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 488 GANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
A T+ IVGT Y+APE G+ T +D+YS+G+++LE+ G +++ + L
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQL 242
Query: 547 LVDWVKELHLE-GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605
L+D +E+ E I ID+ ++ D E + ++ C RPD+++V + L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 606 GDSS 609
++
Sbjct: 303 EMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-71
Identities = 65/309 (21%), Positives = 120/309 (38%), Gaps = 33/309 (10%)
Query: 320 FKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIM 379
L + + G FG V++ + VA+K +Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSW-QNEYEVY 70
Query: 380 SMGRLRHRNLVQLHGWCRK----QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY 435
S+ ++H N++Q G ++ +L L+ + GSL L +++W++
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELC 124
Query: 436 KILIGIAQSLLYLHEE-------CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488
I +A+ L YLHE+ + HRD+K N+LL L A + DFGLA +E G
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 489 ANP-QTTHIVGTLGYLAPELTRTG-----KATTSTDVYSYGILMLEVACGRRSIEPQKAA 542
+ T VGT Y+APE+ A D+Y+ G+++ E+A + +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 543 AELLLVDWVKELHLEGEITQAIDQTL-------DYYDLAEAELVLNLGLFCSAPNPVYRP 595
L + + + ++ + + + A ++ C + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 596 DMRRVVEFL 604
V E +
Sbjct: 305 SAGCVGERI 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-61
Identities = 80/311 (25%), Positives = 144/311 (46%), Gaps = 44/311 (14%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHN 366
+D +I + +L E+ +G+G FG V+R G +VA+K +
Sbjct: 30 DDMDI-------PWCDLN-----IKEK--IGAGSFGTVHRAEW--HGSDVAVKILMEQDF 73
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
+ + EF+ E+ M RLRH N+V G + L +V +Y+ GSL +LL + +
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
L +R + +A+ + YLH N +VHR++K N+L+D K+ DFGL+++ +
Sbjct: 134 --LDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-K 189
Query: 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR---RSIEPQKAAA 543
+ GT ++APE+ R + +DVYS+G+++ E+A + ++ P + A
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA 249
Query: 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603
V EI + ++ + A ++ C P RP +++
Sbjct: 250 A------VGFKCKRLEIPRNLNPQV-------AAIIEG----CWTNEPWKRPSFATIMDL 292
Query: 604 L--LGDSSLPP 612
L L S++PP
Sbjct: 293 LRPLIKSAVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-57
Identities = 69/313 (22%), Positives = 124/313 (39%), Gaps = 57/313 (18%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ 368
+ E+ + +Q +G GGFG V++G + VAIK +
Sbjct: 12 RLPTL-------ADNEIE-----YEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 369 QG-------MKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDK 421
+G +EF E+ M L H N+V+L+G +V ++VP G L L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL--- 112
Query: 422 DHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-----LNAKL 476
+ W + ++++ IA + Y+ N +VHRD++ NI L + + AK+
Sbjct: 113 -LDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170
Query: 477 GDFGLAKIYEHGANPQTTHIVGTLGYLAPEL--TRTGKATTSTDVYSYGILMLEVACGR- 533
DFGL++ H + ++G ++APE T D YS+ +++ + G
Sbjct: 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 534 --RSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNP 591
K ++ ++E L I + ++ E C + +P
Sbjct: 227 PFDEYSYGKIK----FINMIREEGLRPTIPEDCPP--RLRNVIEL---------CWSGDP 271
Query: 592 VYRPDMRRVVEFL 604
RP +V+ L
Sbjct: 272 KKRPHFSYIVKEL 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 66/323 (20%), Positives = 110/323 (34%), Gaps = 50/323 (15%)
Query: 320 FKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAE-- 377
+E + L+G G +G VY+G + VA+K S + F+ E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVF---SFANRQNFINEKN 57
Query: 378 IMSMGRLRHRNLVQLHGWCRK-----QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD 432
I + + H N+ + + + E LLV +Y PNGSL K L W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWV 111
Query: 433 QRYKILIGIAQSLLYLHEE------CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
++ + + L YLH E + HRD+ N+L+ + DFGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 487 HGANPQ-------TTHIVGTLGYLAPE-------LTRTGKATTSTDVYSYGILMLEVACG 532
+ VGT+ Y+APE L A D+Y+ G++ E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 533 RRSIEPQKAAAELLLV--DWVKELHLEGEITQA---------IDQTLDYYDLAEAELVLN 581
+ P ++ E + V ++ + LA L
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK-E 290
Query: 582 LGLFCSAPNPVYRPDMRRVVEFL 604
C + R + E +
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERM 313
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 6e-56
Identities = 72/261 (27%), Positives = 118/261 (45%), Gaps = 29/261 (11%)
Query: 6 ADTTSFLYNGF--LHANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFK 57
A+ TSF+++ F L NL L+G A ++ +G+L +TN + +G A Y P+
Sbjct: 1 AEETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW 60
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S + F T+F F+I GLAF + + FLGL + +S ST
Sbjct: 61 DSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGLFDSAVSGST 119
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
+ +AVEFD +NT D H+G D++S+ S + S L +G+
Sbjct: 120 Y---QTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKWS------------LANGE 164
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA- 236
+ + Y+S L+ S+ +++ +DLSSV+ E++ GFSA+TG
Sbjct: 165 AAKVLITYNSAVKLLVASLVYPS--SKTSFILADIVDLSSVLPEWVRVGFSAATGASGGK 222
Query: 237 --SHNVHGWSISIGGKAQDLN 255
+H+V WS +
Sbjct: 223 IETHDVFSWSFASKLAGXXTK 243
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 7e-56
Identities = 72/320 (22%), Positives = 125/320 (39%), Gaps = 44/320 (13%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
E VG G FG V + +VAIK+I S+ K F+ E+ + R+ H N+V+
Sbjct: 12 VEEV--VGRGAFGVVCKAKW--RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVK 65
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L+G C + LV +Y GSL +L + T + +Q + YLH
Sbjct: 66 LYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMSWCLQCSQGVAYLHSM 121
Query: 452 CNQRVVHRDVKPSNILLD-TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ ++HRD+KP N+LL K+ DFG A + T+ G+ ++APE+
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEG 177
Query: 511 GKATTSTDVYSYGILMLEVACGRR-----SIEPQKAAAELLLVDWVKELHLEGEITQAID 565
+ DV+S+GI++ EV R+ + + + + +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-----NGTRP--PLIKNLP 230
Query: 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL------LGDSSLPPLPPDIHL 619
+ L C + +P RP M +V+ + + P P H
Sbjct: 231 K--PIESLMTR---------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
Query: 620 KDTRNIMGFSDFPNDSDFFN 639
+ + ++F+
Sbjct: 280 LPPGEDGRVEPYVDFAEFYR 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-55
Identities = 83/309 (26%), Positives = 128/309 (41%), Gaps = 57/309 (18%)
Query: 311 WEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI----GHN 366
EI +AEL E +G GGFG+VYR +G EVA+K +
Sbjct: 2 LEI-------DFAELT-----LEEI--IGIGGFGKVYRAFW--IGDEVAVKAARHDPDED 45
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
Q ++ E L+H N++ L G C K+ L LV ++ G L+++L K
Sbjct: 46 ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---- 101
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD--------TYLNAKLGD 478
+ D + IA+ + YLH+E ++HRD+K SNIL+ + K+ D
Sbjct: 102 --IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159
Query: 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR---RS 535
FGLA+ + G ++APE+ R + +DV+SYG+L+ E+ G R
Sbjct: 160 FGLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
Query: 536 IEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP 595
I+ A V L I + L E C P+P RP
Sbjct: 217 IDGLAVAY------GVAMNKLALPIPSTCPEPF--AKLMED---------CWNPDPHSRP 259
Query: 596 DMRRVVEFL 604
+++ L
Sbjct: 260 SFTNILDQL 268
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 188 bits (477), Expect = 2e-55
Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 26/258 (10%)
Query: 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVT------NKSEGLIGHALYPNPLRFK 57
A++ F + F +L +G A + ++ L +T N G +G ALY P+R
Sbjct: 1 ANSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW 60
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S+ VA F T F FSI FI + + + LGL + ++ +
Sbjct: 61 QSSSLVA-SFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGS 119
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
+++VEFD NT++ D N H+GID++S+ S A+ + +G
Sbjct: 120 --DNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDWQNGKTA---------- 167
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS 237
A + Y+S ++V P ++S ++L++V +++ GFSA+TG T +
Sbjct: 168 --TAHISYNSASKRLSVV---SSYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQT 222
Query: 238 HNVHGWSISIGGKAQDLN 255
+N+ WS N
Sbjct: 223 NNILAWSFRSSLMGYQAN 240
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-55
Identities = 61/306 (19%), Positives = 111/306 (36%), Gaps = 37/306 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
GE +G G FG+ + G + +K + ++ + F+ E+ M L H N+++
Sbjct: 14 HGEV--LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
G K L + +Y+ G+L ++ D + W QR IA + YLH
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLHS- 126
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN-------------PQTTHIVG 498
++HRD+ N L+ N + DFGLA++ + +VG
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558
++APE+ DV+S+GI++ E+ + ++ L
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242
Query: 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL--LGDSSLPPLPPD 616
+ + + C +P RP ++ +L L LP
Sbjct: 243 YCPPNCPPSF--FPITVR---------CCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 617 IHLKDT 622
L+
Sbjct: 292 PQLEQL 297
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-55
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 23/243 (9%)
Query: 6 ADTTSFLYNGFLHAN--LSLEGAAYISTSGILTVTNKSE-GLIGHALYPNPLRFKTSNKS 62
A+T SF +N F N ++ +G + ++G + +TN ++ +G LY P+R +S
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 60
Query: 63 VAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTR 122
F T+F F + G+ F I + + L +
Sbjct: 61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAG----H 116
Query: 123 MLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAW 182
+ VEFD N+E D +HVGID++S+ S + P + SG +
Sbjct: 117 FVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVV------------KVT 164
Query: 183 VDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI-TASHNVH 241
V Y S ++V++ I+ +DL + + E + GFSAS L H +
Sbjct: 165 VIYDSSTKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIR 221
Query: 242 GWS 244
WS
Sbjct: 222 SWS 224
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-55
Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 31/254 (12%)
Query: 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEG-----LIGHALYPNPLRFKT 58
+D SF N F+ A+L +G A +S++G+L +T G +G ALY P+R
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTN-RPENCLANQFLGLPNITMSSST 117
+ F T+F F + PD+ GLAF + + + + +++LGL N + S S
Sbjct: 61 NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDS- 119
Query: 118 KFSTRMLAVEFDIIQNTEL--IDINDNHVGIDISSLISSASEPASYYSGNNHRIPIL-LR 174
S +++AVEFD D N H+GID++ + S + + +G I L
Sbjct: 120 --SNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLA 177
Query: 175 SGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI 234
+ A + Y S ++ +DL ++ E++ GFSA+TG
Sbjct: 178 PNKTLIASLVYPS---------------NQTTFSVAASVDLKEILPEWVRVGFSAATGYP 222
Query: 235 TA--SHNVHGWSIS 246
T +H+V WS +
Sbjct: 223 TEVETHDVLSWSFT 236
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 5e-55
Identities = 67/263 (25%), Positives = 116/263 (44%), Gaps = 34/263 (12%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRFKTS 59
++ F + F NL L+ A +S+SG L +TN + +G A Y P++ +
Sbjct: 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
F T+F F+I GLAF ++ FLGL + + S+
Sbjct: 61 TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDGSNSNF--- 116
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
+AVEFD + N + D + H+GID++S+ S + + +G N
Sbjct: 117 --HTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFVNGENA------------ 161
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS-- 237
+ + Y S L+ S+ + ++S +DL SV+ E++ GFSA+TG+ +
Sbjct: 162 EVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVE 219
Query: 238 -HNVHGWS----ISIGGKAQDLN 255
++V WS +S ++ LN
Sbjct: 220 TNDVLSWSFASKLSDETTSEGLN 242
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-53
Identities = 57/269 (21%), Positives = 113/269 (42%), Gaps = 26/269 (9%)
Query: 6 ADTTSFLYNGF---LHANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRF 56
+D+ SF + F + ++ +G A T+G L + ++ G ALY +P++
Sbjct: 2 SDSVSFTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQL 60
Query: 57 KTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSS 116
+ F T F F + + GLAF + + A ++LGL N + ++
Sbjct: 61 WDNKTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKD-AGEYLGLFNKSTATQ 118
Query: 117 TKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSG 176
+ +++AVEFD N + + H+GI+++S++S A++ + SG
Sbjct: 119 PSKN-QVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSD---------IFSG 168
Query: 177 DPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA 236
A + Y ++ V + P ++S +D+ + E + G SASTG
Sbjct: 169 KIATARISYDGSAEILTVVLSY---PDGSDYILSHSVDMRQNLPESVRVGISASTGNNQF 225
Query: 237 -SHNVHGWSISIGGKAQDLNPMKVPTLEK 264
+ + W S ++ + P + +
Sbjct: 226 LTVYILSWRFSSNLQSTSVKAAMEPEITR 254
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 60/250 (24%), Positives = 99/250 (39%), Gaps = 25/250 (10%)
Query: 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVT----NKSEGLIGHALYPNPLRFKTS 59
+D SF + F +LS +G A + +G+L + N + G A Y P+
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60
Query: 60 NKSVAIDFRTNFVFSIL-PKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
N F T+F F + P GL F + + P A + GL N T S
Sbjct: 61 NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLR-RAGGYFGLFNDTKCDS-- 117
Query: 119 FSTRMLAVEFDIIQN-TELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
S + +AVEFD I + D H+GID++ + S +E + G +
Sbjct: 118 -SYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGL----------NN 166
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL-ITA 236
+ Y + + S+ ++ +DL ++ E++ GFS ST + A
Sbjct: 167 VANVEIIYEASSKTLTASLTYPSDQTSI--SVTSIVDLKEILPEWVSVGFSGSTYIGRQA 224
Query: 237 SHNVHGWSIS 246
+H V W +
Sbjct: 225 THEVLNWYFT 234
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 183 bits (464), Expect = 3e-53
Identities = 63/251 (25%), Positives = 105/251 (41%), Gaps = 26/251 (10%)
Query: 6 ADTTSFLYNGF--LHANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFK 57
D+ SF + F NL +G A+ S + IL +T +G L+ +R
Sbjct: 9 TDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLW 68
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
+ + + +T F F + + FI + A LGL N + +
Sbjct: 69 EKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNE 128
Query: 118 KFSTRMLAVEFDII--QNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRS 175
+ ++LAVEFD QN+ D N H+GID++S+ SS R
Sbjct: 129 S-ANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVRWE------------RRE 175
Query: 176 GDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLIT 235
G + V Y+ I+V P R +S +DL++++ E++ GFSA++G
Sbjct: 176 GKTLNVLVTYNPSTRTIDVV---ATYPDGQRYQLSHVVDLTTILPEWVRVGFSAASGEQF 232
Query: 236 ASHNVHGWSIS 246
+HN+ WS +
Sbjct: 233 QTHNLESWSFT 243
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-53
Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 32/265 (12%)
Query: 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRFK 57
A+T SF +N F+ N+ L+G A +++SG L + E +G ALY P+
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
F +F F+ GLAF + + +LGL N S
Sbjct: 61 DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQ-THAGYLGLFNENESGD- 118
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
+++AVEFD +N+ D + H+GI+++S+ S + L +
Sbjct: 119 ----QVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTSWD------------LANNK 160
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA- 236
+ + Y + L+ S+ + ++S +DL + + E++ GFSA+TGL
Sbjct: 161 VAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPG 218
Query: 237 -SHNVHGWSISIGGKAQDLNPMKVP 260
SH+V WS + N +
Sbjct: 219 ESHDVLSWSFASNLPHASSNIDPLD 243
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-53
Identities = 58/255 (22%), Positives = 105/255 (41%), Gaps = 29/255 (11%)
Query: 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGL-----IGHALYPNPLRFKTS 59
+ SF + F L +G A ++++G+L +TN G+ +G ALY P + S
Sbjct: 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
F T+F F I P GLAF + + LG+ + +
Sbjct: 62 TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGIFKDGYFNKSN- 119
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
+++AVEFD N + D H+GI+++S+ S + P ++ +G
Sbjct: 120 --QIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWTNGEVA------------ 164
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA--- 236
++ Y + + S+ +I +D+ V+ E++ GFSA+TG+
Sbjct: 165 NVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQ 222
Query: 237 SHNVHGWSISIGGKA 251
+++V WS
Sbjct: 223 TNDVLSWSFESNLPG 237
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-53
Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 23/246 (9%)
Query: 7 DTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVA 64
+TTSFL F NL +G Y T LT+T + +G ALY +P+
Sbjct: 2 ETTSFLITKFSPDQQNLIFQGDGYT-TKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNV 60
Query: 65 IDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRML 124
+F T+F F I G F I + +LG+ N +T+ +
Sbjct: 61 ANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAEYDK---TTQTV 116
Query: 125 AVEFDIIQNTELIDIN-DNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWV 183
AVEFD N N D H+GID++S+ S ++ +G +
Sbjct: 117 AVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEA------------NVVI 164
Query: 184 DYSSQEMLINVSICPLG---VPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNV 240
+++ ++ VS+ + +S + L V+ E++ GFSA+TG A+H V
Sbjct: 165 AFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEV 224
Query: 241 HGWSIS 246
WS
Sbjct: 225 LSWSFH 230
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 69/306 (22%), Positives = 126/306 (41%), Gaps = 49/306 (16%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHN 366
+DWEI ++ G++ +GSG FG VY+G +VA+K +
Sbjct: 17 DDWEI-------PDGQIT-----VGQR--IGSGSFGTVYKGKWHG---DVAVKMLNVTAP 59
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
+ Q ++ F E+ + + RH N++ G+ +L +V + SL L H
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL----HASE 114
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
+ I A+ + YLH + ++HRD+K +NI L K+GDFGLA
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 487 HGANPQT-THIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGR---RSIEPQ 539
+ + G++ ++APE+ R + + +DVY++GI++ E+ G+ +I +
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 540 KAAAELLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMR 598
E+ V L ++++ L C RP
Sbjct: 232 DQIIEM-----VGRGSLSPDLSKVRSNCPKRMKRLMAE---------CLKKKRDERPSFP 277
Query: 599 RVVEFL 604
R++ +
Sbjct: 278 RILAEI 283
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 179 bits (454), Expect = 3e-52
Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 24/249 (9%)
Query: 10 SFLYNGFLH-ANLSLEGAAYISTSGILTVTNKS--EGLIGHALYPNPLRFKTSNKSVAID 66
SF Y F +L +G A I T G L + HALY P+ S
Sbjct: 2 SFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVAS 61
Query: 67 FRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAV 126
F T+F F + G+ F + N G IT SS++ + +AV
Sbjct: 62 FITSFSFIVSNVQRYPPTDGVVFFLAPWG--TEIPPNSQGGYLGITDSSNS--QNQFVAV 117
Query: 127 EFDIIQNT-ELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDY 185
EFD N + + +H+GID++S++S + + SG +A + Y
Sbjct: 118 EFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNWN------------RVSGSLEKATIIY 165
Query: 186 SSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSAST-GLITASHNVHGWS 244
S ++ V + IS IDL +V+ E + GFSA+T H+++ WS
Sbjct: 166 DSDTKILTVVMTH---QNGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWS 222
Query: 245 ISIGGKAQD 253
+ K +
Sbjct: 223 FTSTLKEPE 231
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 68/312 (21%), Positives = 124/312 (39%), Gaps = 54/312 (17%)
Query: 308 LEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GH 365
L++W+I + +L GE +G G FG+VY G EVAI+ I
Sbjct: 25 LQEWDI-------PFEQLE-----IGEL--IGKGRFGQVYHGRWHG---EVAIRLIDIER 67
Query: 366 NSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL 425
+++ +K F E+M+ + RH N+V G C L ++ +L ++
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV----RDA 123
Query: 426 RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI- 484
+ +L ++ +I I + + YLH + ++H+D+K N+ D + DFGL I
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179
Query: 485 ---YEHGANPQTTHIVGTLGYLAPELTRTGKA---------TTSTDVYSYGILMLEVACG 532
+ G L +LAPE+ R + +DV++ G + E+
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 533 RRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPV 592
+ Q A A + + G + + + ++ LFC A
Sbjct: 240 EWPFKTQPAEAIIWQMG-------TGMKPNLSQIGMG-------KEISDILLFCWAFEQE 285
Query: 593 YRPDMRRVVEFL 604
RP ++++ L
Sbjct: 286 ERPTFTKLMDML 297
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 5e-52
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKS---EGLIGHALYPNPLRFKTSNKS 62
++ SF F NL L+G A +S+ G L +TN E +G A Y P++
Sbjct: 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 63 VAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTR 122
F TNF F I K + GLAF ++ L ++LGL N T
Sbjct: 61 NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTTNYDR---DAH 116
Query: 123 MLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAW 182
+AV F D N + ID++S+ A+E ++ +G+ +
Sbjct: 117 TVAVVF---------DTVSNRIEIDVNSIRPIATESCNFG----------HNNGEKAEVR 157
Query: 183 VDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITASHN 239
+ Y S + + VS+ + +S + L +++++ GFSA++G T +HN
Sbjct: 158 ITYDSPKNDLRVSLLY--PSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHN 215
Query: 240 VHGWS 244
V WS
Sbjct: 216 VLSWS 220
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 179 bits (454), Expect = 5e-52
Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 33/264 (12%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKTS 59
AD SF + F ++ L+G A + +S L +T +G A Y +P++
Sbjct: 1 ADIQSFSFKNFNSSSFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDK 59
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
+ + T+F +I G+AF ++ + FLG+ + + +
Sbjct: 60 STGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDVYDN--- 115
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
S + +AVEFD NT+ D H+GID++S+ S + +G N
Sbjct: 116 SAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTASWGLANGQNA------------ 162
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITA 236
+ + Y++ L+ S+ + ++S +D+++ + EY+ GFSA+TGL T
Sbjct: 163 EILITYNAATSLLVASLV--HPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTE 220
Query: 237 SHNVHGWS----ISIGGKAQDLNP 256
+H+V WS + + L+
Sbjct: 221 THDVLSWSFASKLPDDSTTEPLDI 244
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-52
Identities = 68/261 (26%), Positives = 106/261 (40%), Gaps = 38/261 (14%)
Query: 8 TTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGL-----IGHALYPNPLRFKTSN 60
T SF +N F L L+ A IS++ +L +T G+ G ALY P++ S
Sbjct: 3 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST 62
Query: 61 KSVAIDFRTNFVFSILPKYP-DLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
F T F FSI +P GL F I N + G+ N
Sbjct: 63 TGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-GGGYFGIYNPLSPY---- 117
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
+AVEFD +NT D H+GID++S+IS+ + P + L +G
Sbjct: 118 --PFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVPFT------------LDNGGIA 161
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA--- 236
+ Y + +++V + I+ +DL V+ E + GFSA+TG +
Sbjct: 162 NVVIKYDASTKILHVVLVF--PSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQR 219
Query: 237 ----SHNVHGWSISIGGKAQD 253
+H++ WS S +
Sbjct: 220 NATETHDILSWSFSASLPGTN 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 47/306 (15%), Positives = 111/306 (36%), Gaps = 53/306 (17%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHN 366
+ I + +L F + + G +++G G ++ +K +
Sbjct: 3 KHSGI-------DFKQLN-----FLTK--LNENHSGELWKGRW--QGNDIVVKVLKVRDW 46
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDKDHK 424
S + ++F E + H N++ + G C+ L+ ++P GSL +L + +
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 425 LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484
+ + Q K + +A+ + +LH + + ++++D + A++ +
Sbjct: 107 V---VDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162
Query: 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTST---DVYSYGILMLEVACGR---RSIEP 538
+ Q+ + ++APE + T+ D++S+ +L+ E+ +
Sbjct: 163 F------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216
Query: 539 QKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMR 598
+ V L I I + ++L+ C +P RP
Sbjct: 217 MEIGM------KVALEGLRPTIPPGISPHV-------SKLMKI----CMNEDPAKRPKFD 259
Query: 599 RVVEFL 604
+V L
Sbjct: 260 MIVPIL 265
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 174 bits (441), Expect = 3e-50
Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 26/257 (10%)
Query: 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGL---IGHALYPNPLRFKTSN 60
+D SF ++ F+ N+ +G A +ST+G+L VT S+ IG ALY P++ S
Sbjct: 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSI 62
Query: 61 KSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFS 120
F T+F F + D F+ + ++ + + GL + + S S S
Sbjct: 63 TGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKS---S 119
Query: 121 TRMLAVEFDIIQNTEL--IDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDP 178
+++AVEFD D + H+GID++S+ S + + +G
Sbjct: 120 NQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRNGEVA----------- 168
Query: 179 IQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA-- 236
+ Y + + V + +I+ +DL +++ E++ GFS G
Sbjct: 169 -DVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFE 225
Query: 237 SHNVHGWSISIGGKAQD 253
+H+V W + +A +
Sbjct: 226 THDVLSWYFTSNLEANN 242
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-50
Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 31/250 (12%)
Query: 7 DTTSFLYNGFLHA--NLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKT 58
+T SF ++ F NL+L+GAA I+ SG+L +T ++ G LY P+
Sbjct: 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD 61
Query: 59 SNKSVAIDFRTNFVFSILPKYP-DLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S F T F FSI Y L GL F + T +LG+ N + +
Sbjct: 62 STTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPA-QGYGYLGVFNNSKQDN- 119
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
S + LAVEFD N H+GID++S+ S ++P L +G
Sbjct: 120 --SYQTLAVEFDTFSNPW-DPPQVPHIGIDVNSIRSIKTQPFQ------------LDNGQ 164
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---I 234
+ Y + +++V + I+ +D+ V+ +++ G S +TG
Sbjct: 165 VANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDA 222
Query: 235 TASHNVHGWS 244
+H+V+ WS
Sbjct: 223 AETHDVYSWS 232
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-50
Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 32/248 (12%)
Query: 7 DTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGL-----IGHALYPNPLRFKTS 59
++TSF + F NL L+ A ++++G L +T + G +G ALY P+
Sbjct: 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH-- 59
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
+ + F T+F F + GLAF + + FLGL +
Sbjct: 60 DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRAHDA--- 115
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
S + +AVEFD N D N H+GID + + S + P + G+
Sbjct: 116 SYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTPFD------------MVYGEKA 161
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA--- 236
+ Y + + S+ +S +DL ++ EY+ GFSA+TGL
Sbjct: 162 NIVITYQASTKALAASLV--FPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVE 219
Query: 237 SHNVHGWS 244
+H++ WS
Sbjct: 220 THDIVSWS 227
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 31/224 (13%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAE--IMSMGRLRHRNLVQL 392
VG G +G V+RG G VA+K S + K + E + + LRH N++
Sbjct: 13 LECVGKGRYGEVWRGSW--QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 393 HGWCRKQD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+L L+ Y GSL L + L +I++ IA L +L
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTL----DTVSCLRIVLSIASGLAHL 121
Query: 449 HEE-----CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ---TTHIVGTL 500
H E + HRD+K NIL+ + D GLA ++ N VGT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 501 GYLAPEL------TRTGKATTSTDVYSYGILMLEVACGRRSIEP 538
Y+APE+ + D++++G+++ EVA S
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-49
Identities = 56/252 (22%), Positives = 93/252 (36%), Gaps = 30/252 (11%)
Query: 7 DTTSFLYNGFLH------ANLSLEGAAYISTSGILTVT------NKSEGLIGHALYPNPL 54
+T +F Y F ++ G A G L +T N G A Y P+
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATR-IPGALQLTKTDANGNPVRSSAGQASYSEPV 60
Query: 55 RFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMS 114
S A F T+F F + Y GLAF + + FLGL +
Sbjct: 61 FLWDSTGKAAS-FYTSFTFLL-KNYGAPTADGLAFFLAPVDSSVKD-YGGFLGLFRHETA 117
Query: 115 SSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLR 174
+ + +++AVEFD N + D H+GID++S++S A+
Sbjct: 118 ADPSKN-QVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGS------- 169
Query: 175 SGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI 234
A + Y ++ ++ V + ++S +DL+ V+ + + GFSA G
Sbjct: 170 --SIATAHITYDARSKILTVLL---SYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVGY- 223
Query: 235 TASHNVHGWSIS 246
+ W
Sbjct: 224 DEVTYILSWHFF 235
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 7e-49
Identities = 66/260 (25%), Positives = 105/260 (40%), Gaps = 37/260 (14%)
Query: 6 ADTTSFLYNGF-LHANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKT 58
A TSF + F L L+G A IS+ G L +T +G A Y +P++ K
Sbjct: 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD 60
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
SN + + TNF F I K + GLAF ++ N P +FLG+ N
Sbjct: 61 SNNVASFN--TNFTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTNNPEP-- 115
Query: 119 FSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDP 178
+ R +AV F+ +N ID + N + + N +G+
Sbjct: 116 -NARTVAVVFNTFKNR--IDFDKNFIKPYV-----------------NENCDFHKYNGEK 155
Query: 179 IQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---IT 235
+ Y S + V + + +S + L +DE++ GFS ++GL T
Sbjct: 156 TDVQITYDSSNNDLRVFLHF--TVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTT 213
Query: 236 ASHNVHGWSISIGGKAQDLN 255
+H+V WS S + + N
Sbjct: 214 ETHDVLSWSFSSKFRNKLSN 233
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-49
Identities = 65/261 (24%), Positives = 105/261 (40%), Gaps = 37/261 (14%)
Query: 7 DTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKT 58
+T SF ++ F L+L+ A I ++G+L +T ++ G ALY P++
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 59 SNKSVAIDFRTNFVFSILPKYPD-LGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S F T F F+I Y GL F ++ N P+ LG+ +
Sbjct: 61 STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQG-EDGGNLGVFKPPEGDNA 119
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
AVEFD QNT D H+GID++S++SS + L +G
Sbjct: 120 ------FAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLHFQ------------LENGG 159
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVI--DEYMYTGFSASTGLIT 235
+ Y S ++NV + V +S +DL E++ G SA+TG
Sbjct: 160 VANVVIKYDSPTKILNVVLAFHSVGTV--YTLSNIVDLKQEFPNSEWVNVGLSATTGYQK 217
Query: 236 AS---HNVHGWSISIGGKAQD 253
+ H + WS + + +
Sbjct: 218 NAVETHEIISWSFTSSLQETN 238
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 56/218 (25%), Positives = 83/218 (38%), Gaps = 31/218 (14%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFV--AEIMSMGRLRHRNLVQL 392
+G G +G V+ G G +VA+K + EI +RH N++
Sbjct: 42 VKQIGKGRYGEVWMGKW--RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 393 HGWCRK----QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
K +L L+ DY NGSL L K L K+ L +L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTL----DAKSMLKLAYSSVSGLCHL 150
Query: 449 HEE-----CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ---TTHIVGTL 500
H E + HRD+K NIL+ + D GLA + N VGT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 501 GYLAPEL------TRTGKATTSTDVYSYGILMLEVACG 532
Y+ PE+ ++ D+YS+G+++ EVA
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 52/242 (21%), Positives = 92/242 (38%), Gaps = 46/242 (19%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAI 65
A TSF+ + F NL L+G A +S++G L ++ S + A Y P++ + S
Sbjct: 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVA 60
Query: 66 DFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLA 125
F TNF +I GL F+++ + +
Sbjct: 61 SFDTNFTMNIRTHRQANSAVGLDFVLVPVQ---------------------PESKGDTVT 99
Query: 126 VEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDY 185
VEFD + ID+N+N + + + G + + Y
Sbjct: 100 VEFDTFLSRISIDVNNNDI--------------------KSVPWDVHDYDGQNAEVRITY 139
Query: 186 SSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS---HNVHG 242
+S + +VS+ K +S ++L + +++ GFSA++G S H+V
Sbjct: 140 NSSTKVFSVSLSNPSTGKSN--NVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLS 197
Query: 243 WS 244
WS
Sbjct: 198 WS 199
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 75/301 (24%), Positives = 118/301 (39%), Gaps = 47/301 (15%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAE--IMSMGRLRHRNLVQL 392
Q +G G FG V+RG G EVA+K S + + + E I LRH N++
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 393 HGWCRKQD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
K + +L LV DY +GSL L + + T + K+ + A L +L
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTV----TVEGMIKLALSTASGLAHL 155
Query: 449 HEE-----CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT---THIVGTL 500
H E + HRD+K NIL+ + D GLA ++ + H VGT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 501 GYLAPEL------TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554
Y+APE+ + ++ D+Y+ G++ E+A R SI +L D V
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSD 274
Query: 555 HLEGEITQA---------IDQTLDYYDLAE--AELVLNLGLFCSAPNPVYRPDMRRVVEF 603
E+ + I + A+++ C N R R+ +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKKT 330
Query: 604 L 604
L
Sbjct: 331 L 331
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 149 bits (376), Expect = 6e-42
Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 20/193 (10%)
Query: 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVA 64
+TTSFL F NL +G Y T LT+T + +G ALY +P+
Sbjct: 2 ETTSFLITKFSPDQQNLIFQGDGYT-TKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNV 60
Query: 65 IDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRML 124
+F T+F F I G F I + +LG+ N +T+ +
Sbjct: 61 ANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAEYDK---TTQTV 116
Query: 125 AVEFDIIQNTELIDIN-DNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWV 183
AVEFD N N D H+GID++S+ S ++ L++G+ +
Sbjct: 117 AVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWK------------LQNGEEANVVI 164
Query: 184 DYSSQEMLINVSI 196
+++ ++ VS+
Sbjct: 165 AFNAATNVLTVSL 177
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
++G G +G VY G S + +AIK I + + EI L+H+N+VQ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYLHEECNQ 454
+ + + + VP GSL LL K L+ Y +IL G L YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LKYLHD---N 141
Query: 455 RVVHRDVKPSNILLDTYL-NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK- 512
++VHRD+K N+L++TY K+ DFG +K G NP T GTL Y+APE+ G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 513 -ATTSTDVYSYGILMLEVACGRR 534
+ D++S G ++E+A G+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKP 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+ +G G F VYR G+ VA+K++ + + + EI + +L H N+++
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
+ + +EL +V + G L +++ K ++L+ +K + + +L ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSALEHMHS- 154
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+RV+HRD+KP+N+ + KLGD GL + + + +VGT Y++PE
Sbjct: 155 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHEN 211
Query: 512 KATTSTDVYSYGILMLEVACGRR 534
+D++S G L+ E+A +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQS 234
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G G F VY+GL +EVA + ++ + F E + L+H N+V+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 395 ----WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY--KILIGIAQSLLYL 448
+ + ++LV + + +G+L L K K+ K+ + + +IL G L +L
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVL-RSWCRQILKG----LQFL 145
Query: 449 HEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
H ++HRD+K NI + + K+GD GLA + ++GT ++APE+
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEM 201
Query: 508 TRTGKATTSTDVYSYGILMLEVACGR 533
S DVY++G+ MLE+A
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 9/202 (4%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG+ G + IK I S + +E E+ + ++H N+VQ
Sbjct: 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ L +V DY G L K + K L DQ + I +L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI--NAQK-GVLFQEDQILDWFVQICLALKHVHD-- 143
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
++++HRD+K NI L +LGDFG+A++ +GT YL+PE+
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP 201
Query: 513 ATTSTDVYSYGILMLEVACGRR 534
+D+++ G ++ E+ +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKH 223
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 15/196 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
G G FG V+ G + + VA+K +F+ E + + H N+V+L G C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ + +V + V G L + + L +++ A + YL + +
Sbjct: 183 QKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY----LAPELTRTGKA 513
HRD+ N L+ K+ DFG+++ G G APE G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 514 TTSTDVYSYGILMLEV 529
++ +DV+S+GIL+ E
Sbjct: 293 SSESDVWSFGILLWET 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
F E L+GSGGFG+V++ G IKR+ +N+++ +E + ++ +L H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE--VKALA--KLDHVNIVH 68
Query: 392 LHG----------------WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY 435
+G K L + ++ G+L++ + + + + L
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRR-GEKLDKVLAL 125
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH 495
++ I + + Y+H +++++RD+KPSNI L K+GDFGL ++ +
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181
Query: 496 IVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRR 534
GTL Y++PE + D+Y+ G+++ E+
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
Q VG G FG V+R G + A+K++ + E E+++ L +V L+G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVE---ELVACAGLSSPRIVPLYG 117
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
R+ + + + + GSL +L+ K L D+ L + L YLH +
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLHT---R 169
Query: 455 RVVHRDVKPSNILLDTY-LNAKLGDFGLAKIYEHGANPQTTH----IVGTLGYLAPELTR 509
R++H DVK N+LL + A L DFG A + ++ I GT ++APE+
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 510 TGKATTSTDVYSYGILMLEVACGRR 534
D++S +ML + G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
F E ++G G FG+V + AIK+I H ++ + ++E+M + L H+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 392 LHG-------------WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKIL 438
+ +K+ L + +Y NG+L L+ ++ ++ W +IL
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH----------- 487
++ Y+H Q ++HRD+KP NI +D N K+GDFGLAK
Sbjct: 127 EALS----YIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 488 --GANPQTTHIVGTLGYLAPE-LTRTGKATTSTDVYSYGILMLEVACG 532
G++ T +GT Y+A E L TG D+YS GI+ E+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKE-FVAEIMSMGRLRHRNLVQLH 393
+G GGF + + A K + + + +E EI L H+++V H
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G+ D + +V + SL + HK RK LT + L I YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSL----LEL-HKRRKALTEPEARYYLRQIVLGCQYLH---R 133
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
RV+HRD+K N+ L+ L K+GDFGLA E+ + + GT Y+APE+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192
Query: 514 TTSTDVYSYGILMLEVACGR 533
+ DV+S G +M + G+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA----EIMSMGRLRHRNLVQL 392
+G GG VY L ++VAIK + +E + E+ + +L H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ D LV +Y+ +L + + + L+ D I + + H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAHD-- 129
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
R+VHRD+KP NIL+D+ K+ DFG+AK + QT H++GT+ Y +PE +
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 513 ATTSTDVYSYGILMLEVACGRR 534
TD+YS GI++ E+ G
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEP 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKE-FVAEIMSMGRLRHRNLVQLH 393
+G GGF + + A K + + + +E EI L H+++V H
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G+ D + +V + SL + HK RK LT + L I YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL----LEL-HKRRKALTEPEARYYLRQIVLGCQYLH---R 159
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
RV+HRD+K N+ L+ L K+GDFGLA E+ + + GT Y+APE+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218
Query: 514 TTSTDVYSYGILMLEVACGR 533
+ DV+S G +M + G+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRL-RHRN 388
F + +G G +G V++ G A+KR + +AE+ S ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
V+L + L L + SL + L Q + L +L +L
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H Q +VH DVKP+NI L KLGDFGL + G Y+APEL
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELL 228
Query: 509 RTGKATTSTDVYSYGILMLEVACGR 533
+ G T+ DV+S G+ +LEVAC
Sbjct: 229 Q-GSYGTAADVFSLGLTILEVACNM 252
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 48/194 (24%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G G +G VY G+ L VA+K + + EF+ E M ++H NLVQL G C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
++ ++ +++ G+L L + + R+ ++ + I+ ++ YL + +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
+HR++ N L+ K+ DFGL+++ + + APE K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 517 TDVYSYGILMLEVA 530
+DV+++G+L+ E+A
Sbjct: 400 SDVWAFGVLLWEIA 413
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 8/204 (3%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G+G +GR + S G + K + G ++ + V+E+ + L+H N+V+ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 395 W--CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE-- 450
R L +V +Y G L ++ K K R+ L + +++ + +L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ V+HRD+KP+N+ LD N KLGDFGLA+I H + T VGT Y++PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNR 190
Query: 511 GKATTSTDVYSYGILMLEVACGRR 534
+D++S G L+ E+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 339 GSGGFGRVYRGL--MPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
GSG FG V +G M + VA+K + N E +AE M +L + +V++ G
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
C + +LV + G L+K L + + + +++ ++ + YL EE
Sbjct: 86 ICEAE-SWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYL-EE--S 136
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL--GYLAPELTRTGK 512
VHRD+ N+LL T AK+ DFGL+K N G + APE K
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 513 ATTSTDVYSYGILMLEV 529
++ +DV+S+G+LM E
Sbjct: 197 FSSKSDVWSFGVLMWEA 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 56/202 (27%), Positives = 81/202 (40%), Gaps = 13/202 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA----EIMSMGRLRHRNLVQL 392
LVG GG G VY VA+K + + F E + GRL+ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
H + +L + + L +L + L + I+ I +L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHA-- 152
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
HRDVKP NIL+ A L DFG+A Q + VGTL Y+APE
Sbjct: 153 -AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 513 ATTSTDVYSYGILMLEVACGRR 534
AT D+Y+ ++ E G
Sbjct: 212 ATYRADIYALTCVLYECLTGSP 233
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
G G F VYR GLEVAIK I + + GM + V E+ +L+H ++++L+ +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
+ + LV + NG + K + ++ + I +LYLH
Sbjct: 80 FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HG 132
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
++HRD+ SN+LL +N K+ DFGLA + T + GT Y++PE+
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191
Query: 516 STDVYSYGILMLEVACGR 533
+DV+S G + + GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 339 GSGGFGRVYRGLMPSLG----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLH 393
GSG FG VY+GL G + VAIK + S + KE + E M + + ++ +L
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLHEE 451
G C + L+ +P G L + + + + LL W + IA+ + YL +
Sbjct: 84 GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLED- 135
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT---LGYLAPELT 508
+R+VHRD+ N+L+ T + K+ DFGLAK+ A + H G + ++A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESI 191
Query: 509 RTGKATTSTDVYSYGILMLEV 529
T +DV+SYG+ + E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWEL 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 29/224 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE-FVAEIMSMGRLRHRNLV 390
F +G GGFG V+ AIKRI +++ +E + E+ ++ +L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 391 QLHG---------WCRKQDELLLVY---DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKIL 438
+ + + +Y +L + + I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIF 124
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI-- 496
+ IA+++ +LH + ++HRD+KPSNI K+GDFGL + QT
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 497 ---------VGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC 531
VGT Y++PE + D++S G+++ E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 339 GSGGFGRVYRG----LMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
G G FG V L + G VA+K++ H++++ +++F EI + L+H N+V+ G
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 78
Query: 395 WCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLHE 450
C L L+ +Y+P GSL L ++ KLL + I + + YL
Sbjct: 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGMEYLGT 132
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL-----AP 505
+R +HRD+ NIL++ K+GDFGL K+ + V G AP
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWYAP 186
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E K + ++DV+S+G+++ E+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYEL 210
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G G +G VY G+ L VA+K + + EF+ E M ++H NLVQL G C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
++ ++ +++ G+L L ++ R+ ++ + I+ ++ YL + +
Sbjct: 79 TREPPFYIITEFMTYGNLLDYL--RECN-RQEVSAVVLLYMATQISSAMEYLEK---KNF 132
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL-----APELTRTG 511
+HRD+ N L+ K+ DFGL+++ T+ APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYN 187
Query: 512 KATTSTDVYSYGILMLEVA 530
K + +DV+++G+L+ E+A
Sbjct: 188 KFSIKSDVWAFGVLLWEIA 206
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 339 GSGGFGRVYRGLMPSLG--LEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGW 395
G G FG V +G+ ++VAIK + +++ E + E M +L + +V+L G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C + + L+LV + G L K L K ++ ++L ++ + YL E +
Sbjct: 79 C-QAEALMLVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEE---KN 130
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTL--GYLAPELTRTGKA 513
VHRD+ N+LL AK+ DFGL+K + T G + APE K
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 514 TTSTDVYSYGILMLEV 529
++ +DV+SYG+ M E
Sbjct: 191 SSRSDVWSYGVTMWEA 206
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 47/214 (21%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNL--VQ 391
+GSGG +V++ L AIK + Q + + EI + +L+ + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L+ + + +V + N L+ L K +K + +R + +++ +H+
Sbjct: 74 LYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQ- 126
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPEL--- 507
+VH D+KP+N L+ KL DFG+A + + VGT+ Y+ PE
Sbjct: 127 --HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 508 --------TRTGKATTSTDVYSYGILMLEVACGR 533
K + +DV+S G ++ + G+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 19/212 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+G GGF V G A+KRI + QQ +E E H N+++L +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 397 RKQD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
++ E L+ + G+L + ++ LT DQ +L+GI + L +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI--------VGTLGYLA 504
+ HRD+KP+NILL L D G + T+ Y A
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 505 PEL---TRTGKATTSTDVYSYGILMLEVACGR 533
PEL TDV+S G ++ + G
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA----EIMSMGRLRHRNLVQL 392
++G GG V+ +VA+K + F E + L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 393 HGWCRKQDELL----LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+ + +V +YV +L ++ + +T + +++ Q+L +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS 132
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGYLAPE 506
H+ ++HRDVKP+NI++ K+ DFG+A+ N QT ++GT YL+PE
Sbjct: 133 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGRR 534
R +DVYS G ++ EV G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 5e-34
Identities = 72/218 (33%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLH---- 393
G+GGFG V R + G +VAIK+ +E EI M +L H N+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 394 --GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
D LL +Y G L K L ++ L +L I+ +L YLHE
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG--LKEGPIRTLLSDISSALRYLHE- 139
Query: 452 CNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
R++HRD+KP NI+L L K+ D G AK + G VGTL YLAPEL
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPELL 195
Query: 509 RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
K T + D +S+G L E G R P +
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 47/214 (21%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNL--VQ 391
+GSGG +V++ L AIK + Q + + EI + +L+ + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L+ + + +V + N L+ L K +K + +R + +++ +H+
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQ- 145
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPEL--- 507
+VH D+KP+N L+ KL DFG+A + + VGT+ Y+ PE
Sbjct: 146 --HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 508 --------TRTGKATTSTDVYSYGILMLEVACGR 533
K + +DV+S G ++ + G+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 339 GSGGFGRVYRGLMPSLG----LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
G G FG V LG VA+K++ H+ ++F EI + L +V+ G
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91
Query: 395 WCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLHE 450
L LV +Y+P+G L L +L +LL + I + + YL
Sbjct: 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLGS 145
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL-----AP 505
+R VHRD+ NIL+++ + K+ DFGLAK+ + ++V G AP
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---YYVVREPGQSPIFWYAP 199
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E + +DV+S+G+++ E+
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYEL 223
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 339 GSGGFGRVYRG----LMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
G G FG V L + G VA+K++ H++++ +++F EI + L+H N+V+ G
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109
Query: 395 WCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLHE 450
C L L+ +Y+P GSL L ++ KLL + I + + YL
Sbjct: 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGMEYLGT 163
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL-----AP 505
+R +HRD+ NIL++ K+GDFGL K+ + + V G AP
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWYAP 217
Query: 506 ELTRTGKATTSTDVYSYGILMLEV 529
E K + ++DV+S+G+++ E+
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYEL 241
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIK--RIGH-NSQQGMKEFVAEIMSMGRLRHRNLVQL 392
G G FG V RG + + VA+K + + + M +F+ E+ +M L HRNL++L
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR--KLLTWDQRYKILIGIAQSLLYLHE 450
+G + +V + P GSL L L + + +A+ + YL
Sbjct: 87 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYLES 139
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY--LAPELT 508
+R +HRD+ N+LL T K+GDFGL + + + + APE
Sbjct: 140 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 509 RTGKATTSTDVYSYGILMLEV 529
+T + ++D + +G+ + E+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEM 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 46/214 (21%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNL--VQ 391
+GSGG +V++ L AIK + Q + + EI + +L+ + ++
Sbjct: 62 KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L+ + + +V + N L+ L K +K + +R + +++ +H+
Sbjct: 121 LYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQ- 173
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPEL--- 507
+VH D+KP+N L+ KL DFG+A + + VG + Y+ PE
Sbjct: 174 --HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 508 --------TRTGKATTSTDVYSYGILMLEVACGR 533
K + +DV+S G ++ + G+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 339 GSGGFGRVYRGLMPSLG----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG+V G +VA+K + + + + EI + L H N+V+
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89
Query: 394 GWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLH 449
G C + + L+ +++P+GSL + L +K+ ++ L + + I + + YL
Sbjct: 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQICKGMDYLG 143
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL-----A 504
++ VHRD+ N+L+++ K+GDFGL K E + + V A
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDRDSPVFWYA 197
Query: 505 PELTRTGKATTSTDVYSYGILMLEVA-CGRRSIEPQKAAAELL 546
PE K ++DV+S+G+ + E+ P +++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHG 394
GSG G V G + G + VAIK + + + +F++E MG+ H N+++L G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+ ++V +Y+ NGSLD L D + T Q +L G+ + YL +
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLSD---L 170
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL--APELTRTGK 512
VHRD+ N+L+D+ L K+ DFGL+++ E + T G + APE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 513 ATTSTDVYSYGILMLEV 529
++++DV+S+G++M EV
Sbjct: 231 FSSASDVWSFGVVMWEV 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 47/225 (20%), Positives = 91/225 (40%), Gaps = 32/225 (14%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRL-RHRN 388
F E +GSG FG V++ + G AIKR + + E+ + L +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+V+ + D +L+ +Y GSL + +++++ + +L+ + + L Y+
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 449 HEECNQRVVHRDVKPSNILLD-------------------TYLNAKLGDFGLAKIYEHGA 489
H +VH D+KPSNI + + K+GD G +
Sbjct: 132 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RIS 185
Query: 490 NPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
+PQ G +LA E+ + D+++ + ++ A
Sbjct: 186 SPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G+G FG V G + + VAIK ++G+ +Q ++F+ E MG+ H N+++L
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLE 112
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G K +++V +Y+ NGSLD L D + T Q +L GIA + YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLSD--- 165
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL--APELTRTG 511
VHRD+ NIL+++ L K+ DFGL ++ E T G + +PE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 512 KATTSTDVYSYGILMLEV 529
K T+++DV+SYGI++ EV
Sbjct: 226 KFTSASDVWSYGIVLWEV 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 339 GSGGFGRVYRGLMPSLG----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
GSG FG V++G+ G + V IK I + +Q + ++++G L H ++V+L
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLHEE 451
G C L LV Y+P GSL + L + LL W + IA+ + YL E
Sbjct: 82 GLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLEE- 133
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRT 510
+VHR++ N+LL + ++ DFG+A + + + ++A E
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 511 GKATTSTDVYSYGILMLEV 529
GK T +DV+SYG+ + E+
Sbjct: 192 GKYTHQSDVWSYGVTVWEL 210
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 339 GSGGFGRVYRGLMPSLG----LEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLH 393
GSG FG VY+GL G + VAIK + + + KE + E M + + ++ +L
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLHEE 451
G C + L+ +P G L + + + + LL W + IA+ + YL +
Sbjct: 84 GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLED- 135
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT---LGYLAPELT 508
+R+VHRD+ N+L+ T + K+ DFGLAK+ A + H G + ++A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESI 191
Query: 509 RTGKATTSTDVYSYGILMLEV 529
T +DV+SYG+ + E+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWEL 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-33
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFV-AEIMSMGRLRHRNLVQL 392
+G G FG VY +A+K + + G++ + E+ LRH N+++L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+G+ + L+ +Y P G++ + + KL K + +A +L Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA-TYITELANALSYCHS-- 127
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
+RV+HRD+KP N+LL + K+ DFG + H + + T + GTL YL PE+
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 513 ATTSTDVYSYGILMLEVACGR 533
D++S G+L E G+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGK 204
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 339 GSGGFGRVYRGLM----PSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG+V G VA+K + Q + EI + L H ++++
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 394 GWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
G C L LV +YVP GSL L L +LL + I + + YLH
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHA- 152
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYL-----APE 506
Q +HRD+ N+LLD K+GDFGLAK G + V G APE
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAPE 207
Query: 507 LTRTGKATTSTDVYSYGILMLEVA-CGRRSIEPQKAAAELLLV 548
+ K ++DV+S+G+ + E+ S P EL+ +
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 26/214 (12%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHG- 394
++G G V+RG G AIK + S + E + +L H+N+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 395 -WCRKQDELLLVYDYVPNGSLDKLLFD--KDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
+L+ ++ P GSL + ++ L + +L + + +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 452 CNQRVVHRDVKPSNILL----DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
+VHR++KP NI+ D KL DFG A+ E + + GT YL P++
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDM 186
Query: 508 TRTGKATTST--------DVYSYGILMLEVACGR 533
D++S G+ A G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 339 GSGGFGRVYRGL--MPSLGLEVAIKRIGHNSQQGMK-EFVAEIMSMGRLRHRNLVQLHGW 395
G G FG V +G+ M ++VAIK + +++ E + E M +L + +V+L G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C + + L+LV + G L K L K ++ ++L ++ + YL E +
Sbjct: 405 C-QAEALMLVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEE---KN 456
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY--LAPELTRTGKA 513
VHR++ N+LL AK+ DFGL+K + T G APE K
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 514 TTSTDVYSYGILMLEV 529
++ +DV+SYG+ M E
Sbjct: 517 SSRSDVWSYGVTMWEA 532
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+ +G G FG V+ G VAIK + G S + F+ E M +LRH LVQL
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQL 244
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ ++ + +V +Y+ GSL L + K L Q + IA + Y+
Sbjct: 245 YAVVSEE-PIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER-- 298
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
VHRD++ +NIL+ L K+ DFGLA++ E + + APE G+
Sbjct: 299 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 513 ATTSTDVYSYGILMLEVA 530
T +DV+S+GIL+ E+
Sbjct: 358 FTIKSDVWSFGILLTELT 375
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 30/230 (13%), Positives = 59/230 (25%), Gaps = 41/230 (17%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+ G V+ + A+K NS+ ++ + RL + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 394 GWCR--------------------------KQDELLLVYDYVPNGSLDKL--LFDKDHKL 425
R LL+ + L+ L D +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVF 187
Query: 426 RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485
R + + + + L + +VH P N+ + LGD
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSAL--- 241
Query: 486 EHGANPQTTHIVGTLGYLAPELTRTGKA--TTSTDVYSYGILMLEVACGR 533
+ + Y E A T + + + G+ + V C
Sbjct: 242 -WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 17/195 (8%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
GSG FG V+ G + +VAIK R G S++ +F+ E M +L H LVQL+G C
Sbjct: 17 GSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+Q + LV +++ +G L L + + + + + + + YL E V
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEE---ACV 125
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY--LAPELTRTGKAT 514
+HRD+ N L+ K+ DFG+ + + T+ +PE+ + +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 515 TSTDVYSYGILMLEV 529
+ +DV+S+G+LM EV
Sbjct: 184 SKSDVWSFGVLMWEV 198
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 335 QNLVGSGGFGRVYRGLMPSLG---LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLV 390
++G G FG VY G + + A+K + + +F+ E + M H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 391 QLHGWCRKQDE-LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
L G C + + L+V Y+ +G L + T + +A+ + YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTL--GYLAPE 506
++ VHRD+ N +LD K+ DFGLA+ +Y+ L ++A E
Sbjct: 146 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 507 LTRTGKATTSTDVYSYGILMLEVA 530
+T K TT +DV+S+G+L+ E+
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELM 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G G FG V G G +VA+K I +++ + F+AE M +LRH NLVQL G
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 395 WC-RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
++ L +V +Y+ GSL L + R +L D K + + +++ YL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG--- 135
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGY--LAPELTRT 510
VHRD+ N+L+ AK+ DFGL K +T G L APE R
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALRE 188
Query: 511 GKATTSTDVYSYGILMLEV 529
K +T +DV+S+GIL+ E+
Sbjct: 189 KKFSTKSDVWSFGILLWEI 207
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 62/194 (31%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G G FG V+ G VAIK + G S + F+ E M +LRH LVQL+
Sbjct: 276 GQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
++ + +V +Y+ GSL L K K L Q + IA + Y+
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFL--KGET-GKYLRLPQLVDMAAQIASGMAYVER---MNY 384
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTS 516
VHRD++ +NIL+ L K+ DFGLA++ E + + APE G+ T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 517 TDVYSYGILMLEVA 530
+DV+S+GIL+ E+
Sbjct: 445 SDVWSFGILLTELT 458
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 339 GSGGFGRVYRGLM----PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G+G FG VY+G++ + VAIK + +++ +F+ E MG+ H N+++L
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G K ++++ +Y+ NG+LDK L +KD + + Q +L GIA + YL
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY--LAPELTRTG 511
VHRD+ NIL+++ L K+ DFGL+++ E T G + APE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 512 KATTSTDVYSYGILMLEV 529
K T+++DV+S+GI+M EV
Sbjct: 226 KFTSASDVWSFGIVMWEV 243
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 26/214 (12%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
++G G V+RG G AIK + S + E + +L H+N+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 396 --CRKQDELLLVYDYVPNGSLDKLLFDK--DHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
+L+ ++ P GSL + + L + +L + + +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 452 CNQRVVHRDVKPSNILL----DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
+VHR++KP NI+ D KL DFG A+ E + + GT YL P++
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDM 186
Query: 508 TRTGKATTST--------DVYSYGILMLEVACGR 533
D++S G+ A G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 40/213 (18%)
Query: 339 GSGGFGRVYRGLMPSLG-------LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
G G F ++++G+ +G EV +K + + + F M +L H++LV
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
+G C DE +LV ++V GSLD L + + + ++ +A ++ +L E
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAAMHFLEE- 131
Query: 452 CNQRVVHRDVKPSNILLDTYLN--------AKLGDFGLAKIYEHGANPQTTHIVGTLGY- 502
++H +V NILL + KL D G++ ++
Sbjct: 132 --NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDILQ 178
Query: 503 -----LAPELTRTGKA-TTSTDVYSYGILMLEV 529
+ PE K +TD +S+G + E+
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 335 QNLVGSGGFGRVYRGLMPSLG---LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLV 390
++G G FG VY G + + A+K + + +F+ E + M H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 391 QLHGWCRKQDE-LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
L G C + + L+V Y+ +G L + T + +A+ + +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTL--GYLAPE 506
++ VHRD+ N +LD K+ DFGLA+ +Y+ + L ++A E
Sbjct: 210 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 507 LTRTGKATTSTDVYSYGILMLEVA 530
+T K TT +DV+S+G+L+ E+
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELM 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVA-EIMSMGRLRHRNLVQLH 393
+G G FG VY +A+K + ++G++ + EI LRH N+++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
+ + + L+ ++ P G L + + K + + +A +L Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFME-ELADALHYCHE--- 132
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
++V+HRD+KP N+L+ K+ DFG + + T + GTL YL PE+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRT-MCGTLDYLPPEMIEGKTH 189
Query: 514 TTSTDVYSYGILMLEVACGR 533
D++ G+L E G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
GSG FG V G +VA+K I G S+ EF E +M +L H LV+ +G C
Sbjct: 17 GSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
K+ + +V +Y+ NG L L L Q ++ + + + +L +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLES---HQF 125
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY--LAPELTRTGKAT 514
+HRD+ N L+D L K+ DFG+ + + + + APE+ K +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 515 TSTDVYSYGILMLEVA-CGRR 534
+ +DV+++GILM EV G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 66/196 (33%), Positives = 97/196 (49%), Gaps = 21/196 (10%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC-R 397
G G FG V G G +VA+K I +++ + F+AE M +LRH NLVQL G
Sbjct: 202 GKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
++ L +V +Y+ GSL L + R +L D K + + +++ YL V
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 311
Query: 458 HRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGY--LAPELTRTGKAT 514
HRD+ N+L+ AK+ DFGL K +T G L APE R K +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFS 364
Query: 515 TSTDVYSYGILMLEVA 530
T +DV+S+GIL+ E+
Sbjct: 365 TKSDVWSFGILLWEIY 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 26/203 (12%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG V++G+ S L VAIK + + ++F+ E ++M + H ++V+L
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLI 82
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G + + ++ + G L L + + L ++ +L YL
Sbjct: 83 GVITENP-VWIIMELCTLGELRSFLQVRKYSL----DLASLILYAYQLSTALAYLES--- 134
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYL-----APEL 507
+R VHRD+ N+L+ + KLGDFGL++ + + +T+ + G L APE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPES 188
Query: 508 TRTGKATTSTDVYSYGILMLEVA 530
+ T+++DV+ +G+ M E+
Sbjct: 189 INFRRFTSASDVWMFGVCMWEIL 211
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G+G FG V G +VAIK + G S+ EF+ E M L H LVQL+G C
Sbjct: 33 GTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
KQ + ++ +Y+ NG L L + H+ Q ++ + +++ YL ++
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLES---KQF 141
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGY--LAPELTRTGKA 513
+HRD+ N L++ K+ DFGL++ + + + T+ + PE+ K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 514 TTSTDVYSYGILMLEVA-CGRR 534
++ +D++++G+LM E+ G+
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKM 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
G G FG VY G+ + + VA+K + + ++F++E + M L H ++V+L G
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
++ ++ + P G L L + L + I +++ YL
Sbjct: 81 IIEEE-PTWIIMELYPYGELGHYLERNKNSL----KVLTLVLYSLQICKAMAYLES---I 132
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTL---GYLAPELTRT 510
VHRD+ NIL+ + KLGDFGL++ I + T +++PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWMSPESINF 188
Query: 511 GKATTSTDVYSYGILMLEV 529
+ TT++DV+ + + M E+
Sbjct: 189 RRFTTASDVWMFAVCMWEI 207
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 27/220 (12%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGW 395
++ GGF VY G E A+KR+ N ++ + + E+ M +L H N+VQ
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 396 C--------RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
Q E LL+ + ++ L K + R L+ D KI +++ +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI----------- 496
+H ++HRD+K N+LL KL DFG A H + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 497 VGTLGYLAPEL---TRTGKATTSTDVYSYGILMLEVACGR 533
T Y PE+ D+++ G ++ + +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 17/196 (8%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G+G FG V+ G +VA+K + G S F+AE M +L+H+ LV+L+
Sbjct: 22 GAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
Q+ + ++ +Y+ NGSL L K LT ++ + IA+ + ++ E +
Sbjct: 78 -TQEPIYIITEYMENGSLVDFL--KTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY--LAPELTRTGKAT 514
+HRD++ +NIL+ L+ K+ DFGLA++ E N T APE G T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 515 TSTDVYSYGILMLEVA 530
+DV+S+GIL+ E+
Sbjct: 189 IKSDVWSFGILLTEIV 204
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 24/205 (11%)
Query: 337 LVGSGGFGRVYRGLMPSL-GLEVAIKRIGHNSQQGMKE-FVAEIMSMGRLRHRNLVQLH- 393
+ GG G +Y L ++ G V +K + H+ + +AE + + H ++VQ+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 394 -GWCRKQDELLLVY---DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+ + Y +YV SL + + L + L+ I +L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-------GQKLPVAEAIAYLLEILPALSYLH 199
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR 509
+V+ D+KP NI+L T KL D G ++ GT G+ APE+ R
Sbjct: 200 S---IGLVYNDLKPENIML-TEEQLKLIDLGAVS-----RINSFGYLYGTPGFQAPEIVR 250
Query: 510 TGKATTSTDVYSYGILMLEVACGRR 534
T +TD+Y+ G + +
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLP 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 5e-31
Identities = 42/319 (13%), Positives = 81/319 (25%), Gaps = 64/319 (20%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRH------- 386
++G G + +K+ E++ + LR
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 387 ---------RNLVQLHGWCRKQDE-------------LLLVYDYVPNGSLDKLLFDKDHK 424
+LV+ + L + ++L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS-S 203
Query: 425 LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484
K L R ++ + + + L LH +VH ++P +I+LD L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 485 YEHGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQ 539
A A + T + D ++ G+ + + C P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL---PN 317
Query: 540 KAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRR 599
A L +W+ I Q + L+ L R +
Sbjct: 318 TDDAALGGSEWI--FRSCKNIPQPV-----------RALLEGF-L---RYPKEDRLLPLQ 360
Query: 600 VVE---FLLGDSSLPPLPP 615
+E + + L P
Sbjct: 361 AMETPEYEQLRTELSAALP 379
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
G FG+VY+G + VAIK + +EF E M RL+H N+V
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-REEFRHEAMLRARLQHPNVVC 76
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKILIG 440
L G K L +++ Y +G L + L D D ++ L ++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGT 499
IA + YL VVH+D+ N+L+ LN K+ D GL ++Y + +
Sbjct: 137 IAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA-----ADYYKLLG 188
Query: 500 LGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
L APE GK + +D++SYG+++ EV
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
F +G G +G VY+ + G VAIK++ + ++E + EI M + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
+G K +L +V +Y GS+ ++ K LT D+ IL + L YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATILQSTLKGLEYLH-- 142
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
R +HRD+K NILL+T +AKL DFG+A + T ++GT ++APE+ +
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 200
Query: 512 KATTSTDVYSYGILMLEVACGR---RSIEPQKA 541
D++S GI +E+A G+ I P +A
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG+V+ +L + VA+K + S+ ++F E + L+H+++V+
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLL----------FDKDHKLRKLLTWDQRYKILIGIAQ 443
G C + LL+V++Y+ +G L++ L + L Q + +A
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGY 502
++YL VHRD+ N L+ L K+GDFG+++ IY + VG
Sbjct: 170 GMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----YYRVGGRTM 221
Query: 503 L-----APELTRTGKATTSTDVYSYGILMLEVA 530
L PE K TT +DV+S+G+++ E+
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 334 EQNLVGSGGFGRVYRGLMPSLG---LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNL 389
++G G FG VY G ++ AIK + Q ++ F+ E + M L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 390 VQLHGWCRKQDE-LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+ L G + ++ Y+ +G L + + ++ T + +A+ + YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTL--GYLAP 505
E Q+ VHRD+ N +LD K+ DFGLA+ I + H L + A
Sbjct: 141 AE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 506 ELTRTGKATTSTDVYSYGILMLEVA 530
E +T + TT +DV+S+G+L+ E+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG+V+ +L + VA+K + + K+F E + L+H ++V+ +
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKILIGIA 442
G C D L++V++Y+ +G L+K L + + + L Q I IA
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLG 501
++YL Q VHRD+ N L+ L K+GDFG+++ +Y + VG
Sbjct: 144 SGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRVGGHT 195
Query: 502 YL-----APELTRTGKATTSTDVYSYGILMLEVA 530
L PE K TT +DV+S+G+++ E+
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398
G+G FG V+ +VA+K + ++ F+AE M L+H LV+LH K
Sbjct: 197 GAGQFGEVWMATYNKHT-KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVH 458
+ + ++ +++ GSL L + + IA+ + ++ + + +H
Sbjct: 255 -EPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307
Query: 459 RDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY--LAPELTRTGKATTS 516
RD++ +NIL+ L K+ DFGLA++ E N T APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 517 TDVYSYGILMLEVA-CGRR 534
+DV+S+GIL++E+ GR
Sbjct: 366 SDVWSFGILLMEIVTYGRI 384
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+ +G G G VY + + G EVAI+++ Q + + EI+ M ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
DEL +V +Y+ GSL ++ + Q + Q+L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH-- 133
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ +V+HRD+K NILL + KL DFG A+I + T +VGT ++APE+
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTR 190
Query: 511 GKATTSTDVYSYGILMLEVACGR---RSIEPQKA 541
D++S GI+ +E+ G + P +A
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG V++G+ S + VAIK + + ++F+ E ++M + H ++V+L
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLI 457
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
G ++ + ++ + G L L + L ++ +L YL
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSL----DLASLILYAYQLSTALAYLES--- 509
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
+R VHRD+ N+L+ + KLGDFGL++ E + + + ++APE +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 514 TTSTDVYSYGILMLEVA 530
T+++DV+ +G+ M E+
Sbjct: 570 TSASDVWMFGVCMWEIL 586
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 15/214 (7%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G G V G +VA+K + QQ + E++ M +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
++ +EL ++ +++ G+L ++ + L +Q + + Q+L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVLQALAYLH-- 158
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTHIVGTLGYLAPELTRT 510
Q V+HRD+K +ILL KL DFG A+I + ++ +VGT ++APE+
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISR 215
Query: 511 GKATTSTDVYSYGILMLEVACG---RRSIEPQKA 541
T D++S GI+++E+ G S P +A
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+ ++G G FG+V++ + GL++A K I + +E EI M +L H NL+Q
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 392 LHGWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
L+ +++++LV +YV G L D+++ D+ + LT + I + + ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRII-DESYN----LTELDTILFMKQICEGIRHMHQ 205
Query: 451 ECNQRVVHRDVKPSNILLDTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
++H D+KP NIL K+ DFGLA+ Y+ + GT +LAPE+
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVV 260
Query: 509 RTGKATTSTDVYSYGILM 526
+ TD++S G++
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 23/212 (10%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLV 390
F ++++G G G + M +VA+KRI + E+ + H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+ + + + + +L + + KD L + +L L +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL----EPITLLQQTTSGLAHLHS 136
Query: 451 ECNQRVVHRDVKPSNILL-----DTYLNAKLGDFGLAKIYEHG--ANPQTTHIVGTLGYL 503
+VHRD+KP NIL+ + A + DFGL K G + + + + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 504 APEL---TRTGKATTSTDVYSYGILMLEVACG 532
APE+ T + D++S G + V
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG V G + L+VA+K ++ ++SQ+ ++EF++E M H N+++L
Sbjct: 43 GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102
Query: 394 GWCRKQD-----ELLLVYDYVPNGSLDK-LLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
G C + + +++ ++ G L LL+ + K + K ++ IA + Y
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYL--- 503
L + +HRD+ N +L + + DFGL+K IY + G + +
Sbjct: 163 LSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS-----GDYYRQGRIAKMPVK 214
Query: 504 --APELTRTGKATTSTDVYSYGILMLEVA 530
A E T+ +DV+++G+ M E+A
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLE--VAIKRI--GHNSQQGMKEFVAEIMSMGRL-RHRNL 389
Q+++G G FG+V + + GL AIKR+ + ++F E+ + +L H N+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGHHPNI 88
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKIL 438
+ L G C + L L +Y P+G+L L F + L+ Q
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK---IYEHGANPQTTH 495
+A+ + YL + ++ +HRD+ NIL+ AK+ DFGL++ +Y
Sbjct: 149 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--------- 196
Query: 496 IVGTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
T+G L A E TT++DV+SYG+L+ E+
Sbjct: 197 -KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 50/206 (24%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+ +G G FG+VY+ G A K I S++ +++++ EI + H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L G +L ++ ++ P G++D ++ +L + LT Q + + ++L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNFLH-- 134
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
++R++HRD+K N+L+ + +L DFG++ + + +GT ++APE+
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192
Query: 512 KATTST-----DVYSYGILMLEVACG 532
+ D++S GI ++E+A
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
G G FG VY G + + L+VA+K + S+Q +F+ E + + + H+N+V+
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL--RKLLTWDQRYKILIGIAQSLLYLHE 450
G + ++ + + G L L + + L + IA YL E
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 451 ECNQRVVHRDVKPSNILLDTY---LNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYL--- 503
+HRD+ N LL AK+GDFG+A+ IY + G L
Sbjct: 159 ---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPVK 210
Query: 504 --APELTRTGKATTSTDVYSYGILMLEVA 530
PE G T+ TD +S+G+L+ E+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 46/217 (21%), Positives = 81/217 (37%), Gaps = 29/217 (13%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI----------------GHNSQQGMKEFVA-EIMSM 381
G F ++ L A+K+ S + + E+ +
Sbjct: 40 NQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 382 GRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDK---DHKLRKLLTWDQRYKIL 438
+++ + G DE+ ++Y+Y+ N S+ K D + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG 498
+ S Y+H E N + HRDVKPSNIL+D KL DFG ++ + + G
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGS--RG 212
Query: 499 TLGYLAPEL--TRTGKATTSTDVYSYGILMLEVACGR 533
T ++ PE + D++S GI + +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
G G FG VY G+ + VAIK + ++ EF+ E M ++V+
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHHVVR 92
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLL-----FDKDHKLRKLLTWDQRYKILIGIAQSLL 446
L G + L++ + + G L L ++ + + + ++ IA +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYL-- 503
YL+ + VHRD+ N ++ K+GDFG+ IYE + G G L
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLPV 204
Query: 504 ---APELTRTGKATTSTDVYSYGILMLEVA 530
+PE + G TT +DV+S+G+++ E+A
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLV 390
F + + +G+G G V++ GL +A K I + + E+ + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+G E+ + +++ GSLD++L K + K+ I + + L YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ ++HRDVKPSNIL+++ KL DFG++ + VGT Y++PE +
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 204
Query: 511 GKATTSTDVYSYGILMLEVACGR 533
+ +D++S G+ ++E+A GR
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGR 227
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 116 bits (290), Expect = 2e-29
Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 15/127 (11%)
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
+ ++AVE D NT++ D + H+GIDI S+ S + + +++G
Sbjct: 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWN------------MQNGKVG 48
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHN 239
A + Y+S + ++ + P +S +DL +V+ E++ G SASTGL ++
Sbjct: 49 TAHIIYNSVDKRLSAV---VSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNT 105
Query: 240 VHGWSIS 246
+ WS +
Sbjct: 106 ILSWSFT 112
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 1e-11
Identities = 27/107 (25%), Positives = 38/107 (35%), Gaps = 9/107 (8%)
Query: 13 YNGFLHANLSLEGAAYISTSGILTVTNKSEGLI------GHALYPNPLRFKTSNKSVAID 66
+L L+G A T G L +T S G AL+ P+ S+ VA
Sbjct: 132 QFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAVVA-S 190
Query: 67 FRTNFVFSILPKYPDLGGQGLAFIIISTN-RPENCLANQFLGLPNIT 112
F F F I G+AF I + + + + LGL
Sbjct: 191 FEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 13/191 (6%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398
GSG FG V+R + + G K I EI M +L H L+ LH
Sbjct: 60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 399 QDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
+ E++L+ +++ G L D++ +D+K ++ + + + L ++HE +V
Sbjct: 120 KYEMVLILEFLSGGELFDRIA-AEDYK----MSEAEVINYMRQACEGLKHMHE---HSIV 171
Query: 458 HRDVKPSNILLDTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
H D+KP NI+ +T + K+ DFGLA + T + APE+
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGF 229
Query: 516 STDVYSYGILM 526
TD+++ G+L
Sbjct: 230 YTDMWAIGVLG 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
G G FG VY G + + L+VA+K + S+Q +F+ E + + + H+N+V+
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFD--KDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
G + ++ + + G L L + L + IA YL E
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199
Query: 451 ECNQRVVHRDVKPSNILLDTY---LNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYL--- 503
+HRD+ N LL AK+GDFG+A+ IY G + G L
Sbjct: 200 ---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPVK 251
Query: 504 --APELTRTGKATTSTDVYSYGILMLEVA 530
PE G T+ TD +S+G+L+ E+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEI-MSMGRLRHRNLVQLHGW 395
+G G +G V + + G +A+KRI + K+ + ++ + M +VQ +G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
++ + + + + + S DK L ++ + KI + ++L +L E +
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LK 146
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFG--------LAKIYEHGANPQTTHIVGTLGYLAPE- 506
++HRD+KPSNILLD N KL DFG +AK T G Y+APE
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----------TRDAGCRPYMAPER 196
Query: 507 ---LTRTGKATTSTDVYSYGILMLEVACGR 533
+DV+S GI + E+A GR
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLV 390
F + +G G FG V++G+ VAIK I ++ +++ EI + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+ +G K +L ++ +Y+ GS LL L Q IL I + L YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLH- 136
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+++ +HRD+K +N+LL + KL DFG+A + T VGT ++APE+ +
Sbjct: 137 --SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 193
Query: 511 GKATTSTDVYSYGILMLEVACG 532
+ D++S GI +E+A G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-29
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 121 TRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQ 180
+ ++AVEFD N + D N H+GID++S+ S + + +G
Sbjct: 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQNGKIA------------T 48
Query: 181 AWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNV 240
A + Y+S ++V+ +S I+L +V+ E++ G SASTG + V
Sbjct: 49 AHISYNSVSKRLSVTSYY---AGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTV 105
Query: 241 HGWSIS 246
H WS +
Sbjct: 106 HSWSFT 111
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 339 GSGGFGRVYRGLMPSLG---LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G FG V + ++VA+K + + ++EF+ E M H ++ +L
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 394 GWCRKQD------ELLLVYDYVPNGSLDK-LLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
G + +++ ++ +G L LL + + L + ++ IA +
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTLGYL-- 503
YL + +HRD+ N +L + + DFGL+ KIY + G L
Sbjct: 152 YLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-----YYRQGCASKLPV 203
Query: 504 ---APELTRTGKATTSTDVYSYGILMLEVA 530
A E T +DV+++G+ M E+
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
+G G +G V + VA+K + E + EI L H N+V+ +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK---ILIGIAQSLLYLHEEC 452
R+ + L +Y G L FD+ + D + ++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE-LTRT 510
+ HRD+KP N+LLD N K+ DFGLA ++ + + + + GTL Y+APE L R
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 511 GKATTSTDVYSYGILMLEVACGR 533
DV+S GI++ + G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G+G FG V+R + G A K + + + EI +M LRH LV LH
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 398 KQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+E++++Y+++ G L +K+ + + ++ D+ + + + + L ++HE
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE---NNY 276
Query: 457 VHRDVKPSNILLDTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
VH D+KP NI+ T + KL DFGL + + GT + APE+
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVG 334
Query: 515 TSTDVYSYGILM 526
TD++S G+L
Sbjct: 335 YYTDMWSVGVLS 346
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
Q ++GSG V +VAIKRI Q M E + EI +M + H N+V +
Sbjct: 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 394 GWCRKQDELLLVYDYVPNGSLD---KLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+DEL LV + GS+ K + K +L IL + + L YLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH- 138
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGL-AKIYEHGANPQTTH---IVGTLGYLAPE 506
+HRDVK NILL + ++ DFG+ A + G + VGT ++APE
Sbjct: 139 --KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 507 LTRTGKA-TTSTDVYSYGILMLEVACGR 533
+ + D++S+GI +E+A G
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 48/205 (23%), Positives = 75/205 (36%), Gaps = 16/205 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G V G V ++RI S + + E+ H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+EL +V ++ GS L+ + IL G+ ++L Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHH---MGY 149
Query: 457 VHRDVKPSNILLDTYLNAKLGDFG-LAKIYEHGANPQTTHI-----VGTLGYLAPELTRT 510
VHR VK S+IL+ L + HG + H V L +L+PE+ +
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 511 GKA--TTSTDVYSYGILMLEVACGR 533
+D+YS GI E+A G
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGH 234
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
+G G +G V + VA+K + E + EI L H N+V+ +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK---ILIGIAQSLLYLHEEC 452
R+ + L +Y G L FD+ + D + ++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE-LTRT 510
+ HRD+KP N+LLD N K+ DFGLA ++ + + + + GTL Y+APE L R
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 511 GKATTSTDVYSYGILMLEVACGR 533
DV+S GI++ + G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 37/223 (16%), Positives = 71/223 (31%), Gaps = 28/223 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR- 385
+L+G G F +VY L + +K EF M RL+
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERLKP 123
Query: 386 --HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQ 443
++ + Q+ +LV + G+L + + K++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 444 SLLYLHEECNQRVVHRDVKPSNILL-----------DTYLNAKLGDFGLAKIYE-HGANP 491
+ +H+ ++H D+KP N +L D L D G + +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 492 QTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
T T G+ E+ + K D + + + G
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 339 GSGGFGRVYRGLMPSLG-------LEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNL 389
G G FG+V + + VA+K + + +++ + + V+E+ M + +H+N+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSL-----------DKLLFDKDHKLRKLLTWDQRYKIL 438
+ L G C + L ++ +Y G+L + +D + + +T+
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIV 497
+A+ + YL Q+ +HRD+ N+L+ K+ DFGLA I +
Sbjct: 164 YQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKK 215
Query: 498 GTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
T G L APE T +DV+S+G+LM E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEI-MSMGRLRHRNLVQLHGW 395
+G G +G V + G +A+KRI Q K + ++ +SM + V +G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
++ ++ + + + + SLDK + + + D KI + I ++L +LH +
Sbjct: 75 LFREGDVWICMELM-DTSLDKFY-KQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE----LTRTG 511
V+HRDVKPSN+L++ K+ DFG++ + G Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 512 KATTSTDVYSYGILMLEVACGR 533
+ +D++S GI M+E+A R
Sbjct: 189 GYSVKSDIWSLGITMIELAILR 210
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 36/219 (16%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIK--RIGHNSQQGMKEFVAEIMSMGRL-RHRNLV 390
G+G FG+V L + VA+K + + + + ++E+ + L H N+V
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLSYLGNHMNIV 90
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLL-------------FDKDHKLRKLLTWDQRYKI 437
L G C L++ +Y G L L L +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHI 496
+A+ + +L + +HRD+ NILL K+ DFGLA I ++
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-----YV 202
Query: 497 VGTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
V L APE T +DV+SYGI + E+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIK--RIGHNSQQGMKEFVAEIMSMGRL-RHRNLV 390
G+G FG+V LG L+VA+K + ++ + + ++E+ M L +H N+V
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-KEALMSELKIMSHLGQHENIV 113
Query: 391 QLHGWCRKQDELLLVYDYVPNGSL---------DKLLFDKDHKLRKLLTWDQRYKILIGI 441
L G C +L++ +Y G L + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 442 AQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVGTL 500
AQ + +L + +HRDV N+LL AK+GDFGLA I +IV
Sbjct: 174 AQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-----YIVKGN 225
Query: 501 GYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
L APE T +DV+SYGIL+ E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI------GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
GSG F V + S GLE A K I +E E+ + ++ H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 393 HGWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
H + +++L+ + V G L D L K+ L+ ++ + I + YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLA-QKES-----LSEEEATSFIKQILDGVNYLHT- 133
Query: 452 CNQRVVHRDVKPSNILL----DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
+++ H D+KP NI+L + KL DFGLA E G + I GT ++APE+
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 508 TRTGKATTSTDVYSYGILM 526
D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
G G FG+V + L VA+K + + S +++ ++E + ++ H ++++L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 393 HGWCRKQDELLLVYDYVPNGSL-------------------DKLLFDKDHKLRKLLTWDQ 433
+G C + LLL+ +Y GSL + DH + LT
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 434 RYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQ 492
I+Q + YL E ++VHRD+ NIL+ K+ DFGL+ +YE
Sbjct: 152 LISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED---- 204
Query: 493 TTHIVGTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
+++ + G + A E TT +DV+S+G+L+ E+
Sbjct: 205 -SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G +G V + + A K+I + + F EI M L H N+++
Sbjct: 13 LENT--IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L+ ++ LV + G LF++ +++ +I+ + ++ Y H+
Sbjct: 71 LYETFEDNTDIYLVMELCTGGE----LFERVVH-KRVFRESDAARIMKDVLSAVAYCHK- 124
Query: 452 CNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
V HRD+KP N L T KL DFGLA ++ G +T VGT Y++P++
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVL 180
Query: 509 RTGKATTSTDVYSYGILM 526
G D +S G++M
Sbjct: 181 E-GLYGPECDEWSAGVMM 197
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 339 GSGGFGRVYRGLMPSLG-------LEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNL 389
G G FG+V + + VA+K + + +++ + + V+E+ M + +H+N+
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSL-----------DKLLFDKDHKLRKLLTWDQRYKIL 438
+ L G C + L ++ +Y G+L + +D + + +T+
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIV 497
+A+ + YL Q+ +HRD+ N+L+ K+ DFGLA I +
Sbjct: 210 YQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKK 261
Query: 498 GTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
T G L APE T +DV+S+G+LM E+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLV 390
F + +GSG FG V+ S GLE IK I + Q E + EI + L H N++
Sbjct: 26 FKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDK---DHKLRKLLTWDQRYKILIGIAQSLLY 447
++ + +V + G L ++ K L+ +++ + +L Y
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 448 LHEECNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
H Q VVH+D+KP NIL + K+ DFGLA++++ + GT Y+A
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMA 194
Query: 505 PELTRTGKATTSTDVYSYGILM 526
PE+ + T D++S G++M
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVM 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 18/193 (9%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398
G G + R + + +E A+K I + + +E EI+ +H N++ L
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEILLRY-GQHPNIITLKDVYDD 87
Query: 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVH 458
+ +V + + G L DK + +K + + +L I +++ YLH Q VVH
Sbjct: 88 GKYVYVVTELMKGGEL----LDKILR-QKFFSEREASAVLFTITKTVEYLHA---QGVVH 139
Query: 459 RDVKPSNILL----DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKA 513
RD+KPSNIL + ++ DFG AK T T ++APE L R G
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPEVLERQGY- 197
Query: 514 TTSTDVYSYGILM 526
+ D++S G+L+
Sbjct: 198 DAACDIWSLGVLL 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI------GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
GSG F V + S GLE A K I +E E+ + ++ H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 393 HGWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
H + +++L+ + V G L D L K+ L+ ++ + I + YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLA-QKES-----LSEEEATSFIKQILDGVNYLHT- 133
Query: 452 CNQRVVHRDVKPSNILL----DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
+++ H D+KP NI+L + KL DFGLA E G + I GT ++APE+
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 508 TRTGKATTSTDVYSYGILM 526
D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQ 391
G G FG+V + VA+K + + + ++E+ + + H N+V
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 392 LHGWCRKQDE-LLLVYDYVPNGSL-----------DKLLFDKDHKLRKLLTWDQRYKILI 439
L G C K L+++ ++ G+L + + LT +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIVG 498
+A+ + +L ++ +HRD+ NILL K+ DFGLA IY+ ++
Sbjct: 156 QVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRK 207
Query: 499 TLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
L APE T +DV+S+G+L+ E+
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 14/197 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398
GSG F V+ G A+K I + EI + +++H N+V L
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77
Query: 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVH 458
LV V G LFD+ + R + T ++ + ++ YLHE +VH
Sbjct: 78 TTHYYLVMQLVSGGE----LFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVH 129
Query: 459 RDVKPSNILLDTY---LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
RD+KP N+L T + DFGL+K+ ++G + GT GY+APE+ +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSK 186
Query: 516 STDVYSYGILMLEVACG 532
+ D +S G++ + CG
Sbjct: 187 AVDCWSIGVITYILLCG 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 22/199 (11%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI------GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
GSG F V + G E A K I +E E+ + +RH N++ L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 393 HGWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
H + +++L+ + V G L D L +K+ LT D+ + L I + YLH
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLA-EKES-----LTEDEATQFLKQILDGVHYLHS- 126
Query: 452 CNQRVVHRDVKPSNILLDTYLNA----KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
+R+ H D+KP NI+L KL DFG+A E G + I GT ++APE+
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEI 182
Query: 508 TRTGKATTSTDVYSYGILM 526
D++S G++
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 44/192 (22%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G FG V+R + S K + EI + RHRN++ LH
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 398 KQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+EL+++++++ + +++ L + + + ++L +LH +
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 457 VHRDVKPSNILLDTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
H D++P NI+ T ++ K+ +FG A+ + G N + + Y APE+ + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVS 181
Query: 515 TSTDVYSYGILM 526
T+TD++S G L+
Sbjct: 182 TATDMWSLGTLV 193
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGWCR 397
GSG FG VA+K I + E V EI++ LRH N+V+
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK---ILIGIAQSLLYLHEECNQ 454
L ++ +Y G L +++ + + R+ +L G++ Y H +
Sbjct: 87 TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---SM 135
Query: 455 RVVHRDVKPSNILLD--TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTG 511
++ HRD+K N LLD K+ DFG +K + P++T VGT Y+APE L R
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQE 193
Query: 512 KATTSTDVYSYGILMLEVACGR 533
DV+S G+ + + G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGA 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 50/218 (22%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 339 GSGGFGRVYRGL-------MPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNL 389
G G FG+V P+ +VA+K + + +++ + + ++E+ M + +H+N+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSL-----------DKLLFDKDHKLRKLLTWDQRYKIL 438
+ L G C + L ++ +Y G+L + ++ H + L+
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQTTHIV 497
+A+ + YL ++ +HRD+ N+L+ K+ DFGLA I+ +
Sbjct: 198 YQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----YYKK 249
Query: 498 GTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
T G L APE T +DV+S+G+L+ E+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 34/223 (15%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHG 394
++G G G V G VA+KR+ + EI + H N+++ +
Sbjct: 21 KILGYGSSGTVVFQGSFQ-GRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKD--HKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
L + + N +L L+ K+ + KL +L IA + +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 453 NQRVVHRDVKPSNILLDT-------------YLNAKLGDFGLAKIYEHGANPQTTH---I 496
+++HRD+KP NIL+ T L + DFGL K + G + T+
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 497 VGTLGYLAPEL-------TRTGKATTSTDVYSYGILMLEVACG 532
GT G+ APEL + T S D++S G + +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--------GHNSQQGMKEFVA-EIMSMGRL-RHRN 388
G G V R + E A+K I Q ++E E+ + ++ H N
Sbjct: 26 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
++QL LV+D + G L FD + + L+ + KI+ + + + L
Sbjct: 86 IIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTE-KVTLSEKETRKIMRALLEVICAL 140
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H+ +VHRD+KP NILLD +N KL DFG + + G + + GT YLAPE+
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAPEII 195
Query: 509 RTGKATTST------DVYSYGILM 526
D++S G++M
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 33/240 (13%), Positives = 70/240 (29%), Gaps = 52/240 (21%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG---MKEFVAEIMSMGRLR-------- 385
++G G + + +K+ E++ + LR
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 386 -----------------HRNLVQLHGWCRKQDE----LLLVYDYVPNGSLDKLLFDKDHK 424
+ ++++ R L + ++L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS-S 198
Query: 425 LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484
K L R ++ + + + L LH + +VH ++P +I+LD L F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 485 YEHGANPQTTHIVGTLGYLAPELT-----------RTGKATTSTDVYSYGILMLEVACGR 533
+ + G+ PEL R T S D ++ G+++ + C
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 65/260 (25%), Positives = 103/260 (39%), Gaps = 41/260 (15%)
Query: 290 IIAGAIHVLQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRG 349
IA ++ + + D ++D + A R +Y + +GSG G V
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYI--------MSKT--LGSGACGEVKLA 154
Query: 350 LMPSLGLEVAIKRI--------GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401
+VAI+ I EI + +L H ++++ + +D
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 213
Query: 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDV 461
+V + + G L FDK K L + ++ YLHE ++HRD+
Sbjct: 214 YYIVLELMEGGEL----FDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDL 265
Query: 462 KPSNILLDTY---LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKA--TT 515
KP N+LL + K+ DFG +KI + +T + GT YLAPE L G A
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNR 323
Query: 516 STDVYSYG-IL--MLEVACG 532
+ D +S G IL L G
Sbjct: 324 AVDCWSLGVILFICL---SG 340
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 15/193 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G G F V R + + GLE A K I S + ++ E +L+H N+V+LH
Sbjct: 15 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+++ LV+D V G L F+ R+ + + I +S+ Y H +
Sbjct: 75 QEESFHYLVFDLVTGGEL----FEDIVA-REFYSEADASHCIQQILESIAYCHS---NGI 126
Query: 457 VHRDVKPSNILLDTYLNA---KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
VHR++KP N+LL + KL DFGLA GT GYL+PE+ +
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPY 184
Query: 514 TTSTDVYSYGILM 526
+ D+++ G+++
Sbjct: 185 SKPVDIWACGVIL 197
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 41/224 (18%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
G G FGRV++ P L VA+K + ++ +F E M + N+V+
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQREAALMAEFDNPNIVK 114
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLL-------------------FDKDHKLRKLLTWD 432
L G C + L+++Y+ G L++ L L+
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 433 QRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANP 491
++ I +A + YL E ++ VHRD+ N L+ + K+ DFGL+ IY
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD--- 228
Query: 492 QTTHIVGTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
+ + PE + TT +DV++YG+++ E+
Sbjct: 229 --YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNL 389
+G G FG V + E A+K I + + E+ + +L H N+
Sbjct: 26 IVCM--LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
++L +V + G L FD+ K RK + +I+ + + Y+H
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGEL----FDEIIK-RKRFSEHDAARIIKQVFSGITYMH 138
Query: 450 EECNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
+ +VHRD+KP NILL++ + K+ DFGL+ ++ + +GT Y+APE
Sbjct: 139 K---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 507 LTRTGKATTSTDVYSYGILM 526
+ R G DV+S G+++
Sbjct: 194 VLR-GTYDEKCDVWSAGVIL 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFVAEIMSMGRLRHR-NLVQLHGW 395
G G F V + + S G E A K + Q E + EI + + ++ LH
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDK-DHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
E++L+ +Y G + F +L ++++ + +++ I + + YLH+
Sbjct: 98 YENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---N 150
Query: 455 RVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
+VH D+KP NILL + + K+ DFG+++ H + I+GT YLAPE+
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNYD 208
Query: 512 KATTSTDVYSYGILM 526
TT+TD+++ GI+
Sbjct: 209 PITTATDMWNIGIIA 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--------GHNSQQGMKEFVAEIMSMGRLR-HRN 388
+G G V R + + G E A+K + ++ + E + ++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY------KILIGIA 442
++ L + LV+D + G L FD LT I+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL----FDY-------LTEKVALSEKETRSIMRSLL 210
Query: 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY 502
+++ +LH +VHRD+KP NILLD + +L DFG + E G + + GT GY
Sbjct: 211 EAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGY 265
Query: 503 LAPELTRTGKATTST------DVYSYGILM 526
LAPE+ + T D+++ G+++
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
G G FG V G E A+K I + + + E+ + +L H N+++L+ +
Sbjct: 35 GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
+ LV + G L FD+ RK + +I+ + + Y+H+ +
Sbjct: 95 FEDKGYFYLVGEVYTGGEL----FDEIIS-RKRFSEVDAARIIRQVLSGITYMHK---NK 146
Query: 456 VVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
+VHRD+KP N+LL++ N ++ DFGL+ +E + +GT Y+APE+ G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVLH-GT 203
Query: 513 ATTSTDVYSYGILMLEVACGR 533
DV+S G+++ + G
Sbjct: 204 YDEKCDVWSTGVILYILLSGC 224
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRN 388
F + +G G FG VY VAIK++ G S + ++ + E+ + +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+Q G ++ LV +Y + D L +K L + + G Q L YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYL 170
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H + ++HRDVK NILL KLGDFG A I P + VGT ++APE+
Sbjct: 171 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANS-FVGTPYWMAPEVI 222
Query: 509 RTGKATT---STDVYSYGILMLEVACG 532
DV+S GI +E+A
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI------GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
GSG F V + S GL+ A K I ++ E+ + ++H N++ L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 393 HGWCRKQDELLLVYDYVPNGSL-DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
H + +++L+ + V G L D L +K+ LT ++ + L I + YLH
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLA-EKES-----LTEEEATEFLKQILNGVYYLHS- 132
Query: 452 CNQRVVHRDVKPSNILLDTYLNA----KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
++ H D+KP NI+L K+ DFGLA + G + I GT ++APE+
Sbjct: 133 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEI 188
Query: 508 TRTGKATTSTDVYSYGILM 526
D++S G++
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 39/223 (17%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQ 391
GSG FG+V + ++VA+K + + ++E+ M +L H N+V
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 392 LHGWCRKQDELLLVYDYVPNGSL------------------DKLLFDKDHKLRKLLTWDQ 433
L G C + L+++Y G L + ++ + +LT++
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 434 RYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA-KIYEHGANPQ 492
+A+ + +L + VHRD+ N+L+ K+ DFGLA I
Sbjct: 174 LLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN--- 227
Query: 493 TTHIVGTLGYL-----APELTRTGKATTSTDVYSYGILMLEVA 530
++V L APE G T +DV+SYGIL+ E+
Sbjct: 228 --YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 16/235 (6%)
Query: 305 DKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI- 363
+ + ++Q F ++ +++ + +GSG +G V +E AIK I
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 364 -GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKD 422
S + + E+ + L H N+++L+ + + LV + G L FD+
Sbjct: 72 KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEI 127
Query: 423 HKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDF 479
R I+ + + YLH+ +VHRD+KP N+LL++ K+ DF
Sbjct: 128 IH-RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRR 534
GL+ ++E+ + +GT Y+APE+ R K DV+S G+++ + G
Sbjct: 184 GLSAVFENQKKMKE--RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+ +G G VYR A+K + K EI + RL H N+++
Sbjct: 57 VESE--LGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L E+ LV + V G LFD+ + + + + I +++ YLHE
Sbjct: 113 LKEIFETPTEISLVLELVTGGE----LFDRIVE-KGYYSERDAADAVKQILEAVAYLHE- 166
Query: 452 CNQRVVHRDVKPSNILLDTYLNA---KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
+VHRD+KP N+L T K+ DFGL+KI EH +T + GT GY APE+
Sbjct: 167 --NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEIL 222
Query: 509 RTGKATTSTDVYSYGILM 526
R D++S GI+
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIK-----RIGHNSQQGMKEFVA-EIMSMGRLRHR--N 388
L+GSGGFG VY G+ S L VAIK RI + V E++ + ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+++L W + D +L+ + P D LFD + R L + + +++ +
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LFDFITE-RGALQEELARSFFWQVLEAVRHC 165
Query: 449 HEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
H N V+HRD+K NIL+D KL DFG + + T GT Y PE
Sbjct: 166 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEW 219
Query: 508 TRTGK-ATTSTDVYSYGILMLEVACGR 533
R + S V+S GIL+ ++ CG
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGH---NSQQGMKEFVA-EIMSMGRLRHRNLVQL 392
L+G G +G+V L A+K + + V EI + RLRH+N++QL
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 393 H---GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK---ILIGIAQSLL 446
KQ + +V +Y G + + D + ++ ++ G+
Sbjct: 72 VDVLYNEEKQK-MYMVMEYCVCGMQE--MLDSVPE-KRFPVCQAHGYFCQLIDGLE---- 123
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIV-GTLGYLAP 505
YLH +Q +VH+D+KP N+LL T K+ G+A+ A T G+ + P
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 506 ELTRTGK--ATTSTDVYSYGILMLEVACGR 533
E+ + D++S G+ + + G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 16/192 (8%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCR 397
G G F + + A+K I + ++ EI ++ H N+V+LH
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFH 76
Query: 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVV 457
Q LV + + G L F++ K +K + + I+ + ++ ++H+ VV
Sbjct: 77 DQLHTFLVMELLNGGEL----FERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 458 HRDVKPSNILL---DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
HRD+KP N+L + L K+ DFG A++ P T TL Y APEL
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQNGYD 187
Query: 515 TSTDVYSYGILM 526
S D++S G+++
Sbjct: 188 ESCDLWSLGVIL 199
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLH 393
LVG G +G V + G VAIK+ + M + +A EI + +LRH NLV L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL-----RKLLTWDQRYKILIGIAQSLLYL 448
C+K+ LV+++V + ++ L + L +K L ++I+ GI +
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL-----FQIINGIG----FC 140
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLAPE- 506
H ++HRD+KP NIL+ KL DFG A+ A + V T Y APE
Sbjct: 141 HS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEVATRWYRAPEL 195
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
L K + DV++ G L+ E+ G
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEI-MSMGRLRHRNLVQLHGW 395
+GSG G+V++ G +A+K++ + ++ K + ++ + + +VQ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
++ + + + +KL +++ + K+ + I ++L YL E+
Sbjct: 93 FITNTDVFIAMELM-GTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
V+HRDVKPSNILLD KL DFG++ + G Y+APE T
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERIDPPDPTK 203
Query: 516 ST-----DVYSYGILMLEVACGRRSIEPQKAAAELL 546
DV+S GI ++E+A G+ + K E+L
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHRNLVQL 392
++G G F V + E AIK + + V + M RL H V+L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFVKL 95
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR-YKILIGIAQSLL---YL 448
+ + ++L Y NG L K + K+ R Y A+ + YL
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFY-----TAEIVSALEYL 146
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPEL 507
H + ++HRD+KP NILL+ ++ ++ DFG AK+ + + VGT Y++PEL
Sbjct: 147 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 508 TRTGKATTSTDVYSYGILMLEVACGR 533
A S+D+++ G ++ ++ G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
G G FG+V G G +VA+K + + + EI ++ RH ++++L+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK---ILIGIAQSLLYLHEEC 452
+ +V +YV G L FD K ++ + R IL + Y H
Sbjct: 80 ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH--- 128
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
VVHRD+KP N+LLD ++NAK+ DFGL+ + G +T+ G+ Y APE+ G+
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GR 185
Query: 513 --ATTSTDVYSYGILMLEVACGR 533
A D++S G+++ + CG
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGT 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLV 390
E L G G RV + E A+K I E+ + + + HRN++
Sbjct: 16 LQEDVL-GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+L + ++D LV++ + GS+ HK R+ + ++ +A +L +LH
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSI----LSHIHK-RRHFNELEASVVVQDVASALDFLH- 128
Query: 451 ECNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHG------ANPQTTHIVGTLG 501
N+ + HRD+KP NIL + K+ DF L + + P+ G+
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 502 YLAPELTRTGKATTST-----DVYSYGILM 526
Y+APE+ S D++S G+++
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI-------------GHNSQQGMKEFVAEIMSMGRLR 385
GSG +G V + E AIK I N ++ +E EI + L
Sbjct: 45 GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
H N+++L + LV ++ G L F++ R I+ I +
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIIN-RHKFDECDAANIMKQILSGI 159
Query: 446 LYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGY 502
YLH+ +VHRD+KP NILL+ LN K+ DFGL+ + + +GT Y
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYY 214
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEVACGRR 534
+APE+ + K DV+S G++M + CG
Sbjct: 215 IAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLV 390
F LVG+G +G+VY+G G AIK + + +E EI + + HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 84
Query: 391 QLHG------WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS 444
+G D+L LV ++ GS+ L+ + L + I I +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREILRG 141
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
L +LH+ +V+HRD+K N+LL KL DFG++ + + T +GT ++A
Sbjct: 142 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 197
Query: 505 PELTRTGKATTST-----DVYSYGILMLEVACG 532
PE+ + +T D++S GI +E+A G
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 54/243 (22%), Positives = 86/243 (35%), Gaps = 50/243 (20%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI-----GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G +G V + AIK + + + ++ E+ M +L H N+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY----------------- 435
+ + + LV + G L L D
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 436 ------------------KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA--K 475
I+ I +L YLH Q + HRD+KP N L T + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 476 LGDFGLAKIYEHGANPQTTH---IVGTLGYLAPE-LTRTGKA-TTSTDVYSYGILMLEVA 530
L DFGL+K + N + GT ++APE L T ++ D +S G+L+ +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 531 CGR 533
G
Sbjct: 271 MGA 273
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIG--HNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G G F V R + + GLE A K I S + ++ E +L+H N+V+LH
Sbjct: 38 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+++ LV+D V G L F+ R+ + + I +S+ Y H +
Sbjct: 98 QEESFHYLVFDLVTGGEL----FEDIVA-REFYSEADASHCIQQILESIAYCHS---NGI 149
Query: 457 VHRDVKPSNILLDTYLNA---KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRT-- 510
VHR++KP N+LL + KL DFGLA GT GYL+PE L +
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPY 207
Query: 511 GKATTSTDVYSYGILM 526
K D+++ G+++
Sbjct: 208 SKP---VDIWACGVIL 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHR 387
+ + ++G+G FG VY+ + G VAIK++ Q + E+ M +L H
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 388 NLVQL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQ----RYKI 437
N+V+L + K+DE L LV DYVP ++ ++ + ++ L Y++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA-RHYSRAKQTLPVIYVKLYMYQL 165
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQTTHI 496
+SL Y+H + + HRD+KP N+LLD KL DFG AK G P ++I
Sbjct: 166 F----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYI 217
Query: 497 VGTLGYLAPELT-RTGKATTSTDVYSYGILMLEVACGR 533
+ Y APEL T+S DV+S G ++ E+ G+
Sbjct: 218 C-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGW 395
+G G +G V++ G VAIK+ + + + +A EI + +L+H NLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKL-----RKLLTWDQRYKILIGIAQSLLYLHE 450
R++ L LV++Y + ++ L + + + ++ L + + H+
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT-----WQTLQAVN----FCHK 120
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTR 509
+HRDVKP NIL+ + KL DFG A++ G + V T Y +PE L
Sbjct: 121 ---HNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVG 176
Query: 510 TGKATTSTDVYSYGILMLEVACGR 533
+ DV++ G + E+ G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI-----GHNSQQGMKEFVAEIMSMGRLRH 386
E+ +G G F V R + G E A I Q ++ E L+H
Sbjct: 15 LFEE--LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLKH 69
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
N+V+LH ++ L++D V G L F+ R+ + + I +++L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVA-REYYSEADASHCIQQILEAVL 124
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNA---KLGDFGLAKIYEHGANPQTTHIVGTLGYL 503
+ H+ VVHR++KP N+LL + L KL DFGLA E GT GYL
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYL 180
Query: 504 APE-LTRT--GKATTSTDVYSYGILM 526
+PE L + GK D+++ G+++
Sbjct: 181 SPEVLRKDPYGKP---VDLWACGVIL 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH---- 393
+G+G FG V++ + EVAIK++ Q + E+ M ++H N+V L
Sbjct: 48 IGNGSFGVVFQAKLVESD-EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 394 --GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQ----RYKILIGIAQSLLY 447
G + + L LV +YVP ++ + KL++ + Y++L +SL Y
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRAS-RHYAKLKQTMPMLLIKLYMYQLL----RSLAY 156
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
+H + + HRD+KP N+LLD KL DFG AKI G P ++I + Y APE
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYIC-SRYYRAPE 211
Query: 507 LTRTGKA-TTSTDVYSYGILMLEVACGR 533
L TT+ D++S G +M E+ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G G F +V G EVAIK I + +++ E+ M L H N+V+L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+ L L+ +Y G + FD ++ + R I ++ Y H +R+
Sbjct: 84 ETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QKRI 135
Query: 457 VHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK--AT 514
VHRD+K N+LLD +N K+ DFG + + G G Y APEL + GK
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKYDG 192
Query: 515 TSTDVYSYGILMLEVACGR 533
DV+S G+++ + G
Sbjct: 193 PEVDVWSLGVILYTLVSGS 211
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
G G FG V + E A+K I + + E+ + +L H N+++L
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+V + G L FD+ K RK + +I+ + + Y+H+ +
Sbjct: 91 EDSSSFYIVGELYTGGEL----FDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 457 VHRDVKPSNILLDT---YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
VHRD+KP NILL++ + K+ DFGL+ ++ + +GT Y+APE+ R G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR-GTY 199
Query: 514 TTSTDVYSYGILMLEVACGRR 534
DV+S G+++ + G
Sbjct: 200 DEKCDVWSAGVILYILLSGTP 220
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIK-----RIGHNSQQGMKEFVA-EIMSMGRLR----H 386
L+G GGFG V+ G + L+VAIK R+ S E+ + ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
+++L W Q+ +LV + + LFD + + L + ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITE-KGPLGEGPSRCFFGQVVAAIQ 153
Query: 447 YLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
+ H ++ VVHRD+K NIL+D AKL DFG + P T GT Y P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDF-DGTRVYSPP 207
Query: 506 ELTRTGK-ATTSTDVYSYGILMLEVACGR 533
E + V+S GIL+ ++ CG
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGW 395
+G G + VY+G VA+K I ++G A E+ + L+H N+V LH
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDI 68
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL--------Y 447
+ L LV++Y+ D L++ L D I + + L Y
Sbjct: 69 IHTEKSLTLVFEYL------------DKDLKQYLD-DCGNIINMHNVKLFLFQLLRGLAY 115
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
H Q+V+HRD+KP N+L++ KL DFGLA+ + V TL Y P++
Sbjct: 116 CHR---QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVVTLWYRPPDI 171
Query: 508 TRTGKA-TTSTDVYSYGILMLEVACGR 533
+T D++ G + E+A GR
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 31/205 (15%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI-----GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G G F V R + G + A+K + + ++ E L+H ++V+L
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRY------KILIGIAQSLLY 447
L +V++++ L + + K Y + I ++L Y
Sbjct: 93 ETYSSDGMLYMVFEFMDGADL----CFE---IVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNA---KLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
H+ ++HRDVKP +LL + N+ KLG FG+A VGT ++A
Sbjct: 146 CHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFMA 201
Query: 505 PE-LTRT--GKATTSTDVYSYGILM 526
PE + R GK DV+ G+++
Sbjct: 202 PEVVKREPYGKP---VDVWGCGVIL 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
G G FG+V G G +VA+K + + + EI ++ RH ++++L+
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK---ILIGIAQSLLYLHEEC 452
++ +V +YV G L FD K +L + R IL G+ Y H
Sbjct: 85 ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH--- 133
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
VVHRD+KP N+LLD ++NAK+ DFGL+ + G +T+ G+ Y APE+ G+
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GR 190
Query: 513 --ATTSTDVYSYGILMLEVACGR 533
A D++S G+++ + CG
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI-------GHNSQQGMKEFVA-EIMSMGRLRHRNLV 390
GSG G V +VAIK I G + V EI + +L H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
++ + ++ +V + + G L FDK K L + ++ YLHE
Sbjct: 79 KIKNFF-DAEDYYIVLELMEGGEL----FDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 451 ECNQRVVHRDVKPSNILLDTY---LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE- 506
++HRD+KP N+LL + K+ DFG +KI + +T + GT YLAPE
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEV 187
Query: 507 LTRTGKA--TTSTDVYSYG-IL--MLEVACG 532
L G A + D +S G IL L G
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICL---SG 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 41/173 (23%), Positives = 67/173 (38%), Gaps = 16/173 (9%)
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
S M +I M +N V + L + +L +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSL 158
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
+ I I IA+++ +LH ++ ++HRD+KPSNI K+GDFGL +
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 487 HGANPQT-----------THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLE 528
QT T VGT Y++PE + D++S G+++ E
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 25/204 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLV 390
+Q L G G G+V G + A+K + ++ E+ + ++V
Sbjct: 32 LSKQVL-GLGVNGKVLECFHRRTGQKCALKLL--YDSPKARQ---EVDHHWQASGGPHIV 85
Query: 391 QLHGWC----RKQDELLLVYDYVPNGSLDKLLFDK-DHKLRKLLTWDQRYKILIGIAQSL 445
+ + LL++ + + G L F + + + T + +I+ I ++
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 446 LYLHEECNQRVVHRDVKPSNILL-DTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGY 502
+LH + HRDVKP N+L +A KL DFG AK T Y
Sbjct: 142 QFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYY 195
Query: 503 LAPELTRTGKATTSTDVYSYGILM 526
+APE+ K S D++S G++M
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEF----VAEIMSMGRLR---HR 387
+G G +G VY+ P G VA+K + N G V E+ + RL H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 388 NLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIA 442
N+V+L ++ ++ LV+++V D LR L +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHV------------DQDLRTYLDKAPPPGLPAETI 122
Query: 443 QSLL--------YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT 494
+ L+ +LH +VHRD+KP NIL+ + KL DFGLA+IY T
Sbjct: 123 KDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALT 177
Query: 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+V TL Y APE+ T D++S G + E+ +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVA--EIMSMGRLRHRNLVQLHG 394
+G G +G V++ VA+KR+ + +G+ A EI + L+H+N+V+LH
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHD 68
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL-------- 446
+L LV+++ D L+K + I +S L
Sbjct: 69 VLHSDKKLTLVFEFC------------DQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLAP 505
+ H + V+HRD+KP N+L++ KL +FGLA+ + G + + V TL Y P
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPP 170
Query: 506 ELTRTGKA-TTSTDVYSYGILMLEVACGRR 534
++ K +TS D++S G + E+A R
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 22/206 (10%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRI--------GHNSQQGMKEFVAEIMSMGRLRHRNLV 390
GSG FG V+ + EV +K I + + EI + R+ H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDK-DHKLRKLLTWDQRYKILIGIAQSLLYLH 449
++ Q LV + +G LD LF D R L I + ++ YL
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPR--LDEPLASYIFRQLVSAVGYLR 147
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR 509
+ ++HRD+K NI++ KL DFG A E G T GT+ Y APE+
Sbjct: 148 ---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEV-L 201
Query: 510 TGK--ATTSTDVYSYGILMLEVACGR 533
G +++S G+ + +
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVA-EIMSMGRLRHRNLVQLHGW 395
G G FG+V +VA+K I + M V EI + LRH ++++L+
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK---ILIGIAQSLLYLHEEC 452
++++V +Y G L FD + +++ + R I+ I Y H
Sbjct: 78 ITTPTDIVMVIEYA-GGEL----FDYIVEKKRMTEDEGRRFFQQIICAIE----YCH--- 125
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
++VHRD+KP N+LLD LN K+ DFGL+ I G +T+ G+ Y APE+ GK
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN-GK 182
Query: 513 --ATTSTDVYSYGILMLEVACGR 533
A DV+S GI++ + GR
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVA--EIMSMGRLRHRNLVQLHG 394
+G G FG V++ G +VA+K++ N ++G A EI + L+H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 83
Query: 395 --------WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
+ R + + LV+D+ +H L LL+ + K + + ++
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFC------------EHDLAGLLS-NVLVKFTLSEIKRVM 130
Query: 447 --------YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT---TH 495
Y+H +++HRD+K +N+L+ KL DFGLA+ + N Q T+
Sbjct: 131 QMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 496 IVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
V TL Y PEL + D++ G +M E+
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-----EIMSMGRLRHRNLVQL 392
+G G F VY+ + VAIK+I + K+ + EI + L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR----KLLTWDQRYKILIGIAQSLLYL 448
+ + LV+D++ L+ ++ D L K L G+ YL
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM----LMTLQGLE----YL 128
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H+ ++HRD+KP+N+LLD KL DFGLAK + N TH V T Y APEL
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELL 184
Query: 509 RTGKA-TTSTDVYSYGILMLEVACGR 533
+ D+++ G ++ E+
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 38/214 (17%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVA--EIMSMGRLRHRNLVQLHG 394
+G G +G VY+ + VAIKRI + ++G+ A E+ + L+HRN+++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV-PGTAIREVSLLKELQHRNIIELKS 100
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL-------- 446
L L+++Y ++ L+K + D+ + + + +S L
Sbjct: 101 VIHHNHRLHLIFEYA------------ENDLKKYM--DKNPDVSMRVIKSFLYQLINGVN 146
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNA-----KLGDFGLAKIYEHGANPQT-THIVGTL 500
+ H +R +HRD+KP N+LL + K+GDFGLA+ + G + TH + TL
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITL 201
Query: 501 GYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
Y PE+ + +TS D++S + E+
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 23/201 (11%), Positives = 59/201 (29%), Gaps = 41/201 (20%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
G + ++ L +L +VA+ + G ++E ++ + + R+ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
+ L+V +++ GSL ++ + + + +A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHR--- 147
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
V PS + + + L + A
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD-------A 179
Query: 514 TTSTDVYSYGILMLEVACGRR 534
D+ G + + R
Sbjct: 180 NPQDDIRGIGASLYALLVNRW 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 12/201 (5%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGW 395
+G+G + VY+GL + G+ VA+K + +S++G A EI M L+H N+V+L+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELKHENIVRLYDV 71
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRK-LLTWDQRYKILIGIAQSLLYLHEECNQ 454
+++L LV++++ N L K + + L + + Q L + HE
Sbjct: 72 IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---N 127
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLAPELTRTGKA 513
+++HRD+KP N+L++ KLGDFGLA+ + G T + V TL Y AP++ +
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 514 -TTSTDVYSYGILMLEVACGR 533
+TS D++S G ++ E+ G+
Sbjct: 186 YSTSIDIWSCGCILAEMITGK 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 23/197 (11%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWC- 396
G G G+V + + A+K + Q + E+ R + ++V++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 397 ---RKQDELLLVYDYVPNGSLDKLLFDK-DHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ LL+V + + G L F + + + T + +I+ I +++ YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-- 179
Query: 453 NQRVVHRDVKPSNILL-DTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR 509
+ HRDVKP N+L NA KL DFG AK N TT T Y+APE+
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTT-PCYTPYYVAPEVLG 236
Query: 510 TGKATTSTDVYSYGILM 526
K S D++S G++M
Sbjct: 237 PEKYDKSCDMWSLGVIM 253
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 8e-23
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVA--EIMSMGRLRHRNLVQLHG 394
+G G +G VY+ + G A+K+I +G+ EI + L+H N+V+L+
Sbjct: 10 IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGI-PSTTIREISILKELKHSNIVKLYD 67
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL-------- 446
+ L+LV++++ D L+KLL + A+S L
Sbjct: 68 VIHTKKRLVLVFEHL------------DQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIA 114
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLAP 505
Y H+ +RV+HRD+KP N+L++ K+ DFGLA+ + G + TH + TL Y AP
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAP 169
Query: 506 ELTRTGKA-TTSTDVYSYGILMLEVACGR 533
++ K +T+ D++S G + E+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH 386
F + + G G FG V G S G+ VAIK++ + + +E + + + L H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHH 78
Query: 387 RNLVQLH-----GWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQ----RY 435
N+VQL R + + L +V +YVP+ +L + ++ + +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-RNYYRRQVAPPPILIKVFLF 136
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQTT 494
+++ +S+ LH V HRD+KP N+L++ KL DFG AK P
Sbjct: 137 QLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVA 190
Query: 495 HIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
+I + Y APEL + TT+ D++S G + E+ G
Sbjct: 191 YIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 30/246 (12%)
Query: 305 DKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVY--RGLMPSLGLEVAIKR 362
DKM D++++ + R + +L E VG G +G VY + + A+K+
Sbjct: 1 DKMDYDFKVKLSSERERVEDLFEY-----EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ 55
Query: 363 IGHNSQQGM-KEFVAEIMSMGRLRHRNLVQLHGWC--RKQDELLLVYDYVPN---GSLDK 416
I G+ EI + L+H N++ L ++ L++DY + +
Sbjct: 56 IE---GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF 112
Query: 417 LLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA-- 474
K +K L +L I + YLH V+HRD+KP+NIL+
Sbjct: 113 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 169
Query: 475 --KLGDFGLAKIYEHGANPQT--THIVGTLGYLAPEL---TRTGKATTSTDVYSYGILML 527
K+ D G A+++ P +V T Y APEL R T + D+++ G +
Sbjct: 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFA 227
Query: 528 EVACGR 533
E+
Sbjct: 228 ELLTSE 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 54/230 (23%), Positives = 93/230 (40%), Gaps = 49/230 (21%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIK-------------------------RIGHNSQQGMKE 373
G G +G V + A+K G +G E
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 374 FVA-EIMSMGRLRHRNLVQLHG--WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLT 430
V EI + +L H N+V+L +D L +V++ V G + + L+
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP--LS 135
Query: 431 WDQ--RY--KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
DQ Y ++ GI YLH Q+++HRD+KPSN+L+ + K+ DFG++ ++
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 487 HGANPQTTHIVGTLGYLAPELTRTGKAT---TSTDVYSYGILMLEVACGR 533
+ VGT ++APE + + DV++ G+ + G+
Sbjct: 189 GSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVA--EIMSMGRLRHRNLVQLHG 394
VG G +G VY+ S G VA+KRI +G+ A EI + L H N+V L
Sbjct: 29 VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHHPNIVSLID 86
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL-------- 446
+ L LV++++ + L+K+L + + + + L
Sbjct: 87 VIHSERCLTLVFEFM------------EKDLKKVLD-ENKTGLQDSQIKIYLYQLLRGVA 133
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT-THIVGTLGYLAP 505
+ H+ R++HRD+KP N+L+++ KL DFGLA+ + G ++ TH V TL Y AP
Sbjct: 134 HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAP 188
Query: 506 ELTRTGKA-TTSTDVYSYGILMLEVACGR 533
++ K +TS D++S G + E+ G+
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-22
Identities = 30/113 (26%), Positives = 41/113 (36%), Gaps = 11/113 (9%)
Query: 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRFK 57
A + SF + F +L +G A + + +L VT G LY PLR
Sbjct: 1 AQSLSFSFTKFDPNQEDLIFQGHATST-NNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLW 59
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPN 110
+ + F T F I Y GLAF I + + FLGL
Sbjct: 60 EDSAVLT-SFDTIINFEISTPYTSRIADGLAFFIAPPDSVIS-YHGGFLGLFP 110
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 9e-22
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 17/223 (7%)
Query: 319 RFKYAELASVTKG-FGEQNLVGSGGFGRVYRGLMPSLGLEVAIK-----RIGHNSQQGMK 372
++K+ E + + F + ++G GGFG V+ M + G A K R+
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 373 EFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD 432
+ E + ++ R +V L + +L LV + G + +++ D +
Sbjct: 233 --MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--E 288
Query: 433 QRYKILIG-IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491
R I L +LH+ + +++RD+KP N+LLD N ++ D GLA E A
Sbjct: 289 PRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQ 343
Query: 492 QTTH-IVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
T GT G++APEL + S D ++ G+ + E+ R
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHRNLVQL 392
+G G FG+V A+K + E V + M L H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHPFLVNL 80
Query: 393 HGWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD-QRYKILIG-IAQSLLYL 448
W QDE + +V D + G L + L++ + + + K+ I + +L YL
Sbjct: 81 --WYSFQDEEDMFMVVDLLLGGDL----R---YHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-L 507
QR++HRD+KP NILLD + + + DF +A + T + GT Y+APE
Sbjct: 132 QN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 508 TRTGKA--TTSTDVYSYGILMLEVACGRR 534
+ A + + D +S G+ E+ GRR
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 18/221 (8%)
Query: 320 FKYAELASVTKG-FGEQNLVGSGGFGRVYRGLMPSLGLEVAIK-----RIGHNSQQGMKE 373
+K+ E VTK F + ++G GGFG V + + G A K RI + M
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA- 231
Query: 374 FVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQ 433
+ E + ++ R +V L +D L LV + G L + + + +
Sbjct: 232 -LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEA 286
Query: 434 RYKILIG-IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492
R I L LH +R+V+RD+KP NILLD + + ++ D GLA
Sbjct: 287 RAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQT 341
Query: 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
VGT+GY+APE+ + + T S D ++ G L+ E+ G+
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 336 NLVGSGGFGRVYRGL-MPSLGLEVAIKRIG-HNSQQGM-----KEFVAEIMSMGRLRHRN 388
+G G +G+V++ + + G VA+KR+ ++GM +E VA + + H N
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPN 75
Query: 389 LVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQ 443
+V+L ++ +L LV+++V D L L + +
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHV------------DQDLTTYLDKVPEPGVPTETIK 123
Query: 444 SLL--------YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH 495
++ +LH RVVHRD+KP NIL+ + KL DFGLA+IY T
Sbjct: 124 DMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTS 178
Query: 496 IVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+V TL Y APE+ T D++S G + E+ +
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIK-----RIGHNSQQGM----KEFVAEIMSMG 382
F ++G GGFG VY G A+K RI + + + ++ + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG- 249
Query: 383 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-I 441
+V + D+L + D + G L L + + + I
Sbjct: 250 --DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFS--EADMRFYAAEI 301
Query: 442 AQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLG 501
L ++H + VV+RD+KP+NILLD + + ++ D GLA + + VGT G
Sbjct: 302 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHG 355
Query: 502 YLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
Y+APE+ + G A +S D +S G ++ ++ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 58/251 (23%), Positives = 89/251 (35%), Gaps = 36/251 (14%)
Query: 298 LQRIKYADKMLEDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLE 357
L++ K D L ++ R + + ++G G FG V S
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAED----YEVVKVIGRGAFGEVQLVRHKSTRKV 96
Query: 358 VAIKRIGHNSQQGMKE---FVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414
A+K + + F E M +VQL + L +V +Y+P G L
Sbjct: 97 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 156
Query: 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQ--------SLLYLHEECNQRVVHRDVKPSNI 466
L+ Y + A+ +L +H +HRDVKP N+
Sbjct: 157 VNLM--------------SNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNM 199
Query: 467 LLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTRTGKA---TTSTDVYSY 522
LLD + KL DFG + VGT Y++PE L G D +S
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 523 GILMLEVACGR 533
G+ + E+ G
Sbjct: 260 GVFLYEMLVGD 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-21
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE---FVAEIMSMGRLRHRNLVQLH 393
++G G FG V + + A+K + E F E + + + LH
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLYLHEEC 452
+ + L LV DY G L LL + +L ++ + + + ++ +H
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-----EEMARFYLAEMVIAIDSVH--- 192
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL----- 507
VHRD+KP NIL+D + +L DFG Q++ VGT Y++PE+
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 508 TRTGKATTSTDVYSYGILMLEVACGR 533
G+ D +S G+ M E+ G
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHR 387
F +G+G FGRV G A+K + +K+ + ++ + +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLL 446
LV+L + L +V +YV G + L ++ + + + I +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFS--EPHARFYAAQIVLTFE 155
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
YLH +++RD+KP N+L+D ++ DFG AK + +T + GT LAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPE 208
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ + + D ++ G+L+ E+A G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 55/210 (26%), Positives = 82/210 (39%), Gaps = 23/210 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE---FVAEIMSMGRLRHRNLVQLH 393
++G G F V M G A+K + E F E + R + QLH
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 394 GWCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLYLHE 450
QDE L LV +Y G L LL ++ + + + I ++ +H
Sbjct: 128 --FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-----AEMARFYLAEIVMAIDSVHR 180
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
VHRD+KP NILLD + +L DFG ++ VGT YL+PE+ +
Sbjct: 181 ---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 511 GKATTSTDVY-------SYGILMLEVACGR 533
T Y + G+ E+ G+
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLR 385
V K + +GSG G V L VAIK++ +Q K E++ M +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 386 HRNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILI 439
H+N++ L + ++ LV + + + ++ L ++ +L
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA--------NLCQVIQMELDHERMSYLLY 171
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT 499
+ + +LH + ++HRD+KPSNI++ + K+ DFGLA+ G + T V T
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVT 226
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
Y APE+ + D++S G +M E+ +
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLR 385
+ K + VGSG +G V + G +VAIK++ S+ K E++ + ++
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 386 HRNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDKD-HK-LRKLLTWDQR--- 434
H N++ L R + LV D K + + ++
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMP----------FMQTDLQKIMGLKFSEEKIQYL 131
Query: 435 -YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT 493
Y++L G L Y+H + VVHRD+KP N+ ++ K+ DFGLA+ A+ +
Sbjct: 132 VYQMLKG----LKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEM 180
Query: 494 THIVGTLGYLAPE-LTRTGKATTSTDVYSYGILMLEVACGR 533
T V T Y APE + + D++S G +M E+ G+
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWC 396
+G G + V+ + + +V +K + K+ EI + LR N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 397 RKQDE--LLLVYDYVPNGSLDKLL--FDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ LV+++V N +L +R + Y+IL L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYD-IRFYM-----YEILKA----LDYCHS-- 148
Query: 453 NQRVVHRDVKPSNILLDTYLNA-KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
++HRDVKP N+++D +L D+GLA+ Y G + V + + PEL
Sbjct: 149 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDY 205
Query: 512 KA-TTSTDVYSYGILMLEVACGRR 534
+ S D++S G ++ + +
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLR 385
V K + +GSG G V L VAIK++ +Q K E++ M +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 386 HRNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDKD-HK-LRKLLTWDQR--- 434
H+N++ L + ++ +V + L D + + ++ L ++
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVME----------LMDANLCQVIQMELDHERMSYL 132
Query: 435 -YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQT 493
Y++L G + +LH + ++HRD+KPSNI++ + K+ DFGLA+ +
Sbjct: 133 LYQMLCG----IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 183
Query: 494 THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
T V T Y APE+ + D++S G +M E+ G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHRNLVQL 392
+G+G FGRV+ G A+K + +K+ V + + H ++++
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFIIRM 71
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD-QRYKILIG-IAQSLLYLHE 450
G + ++ ++ DY+ G L F LRK + K + +L YLH
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGEL----F---SLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPELTR 509
+ +++RD+KP NILLD + K+ DFG AK P T+ + GT Y+APE+
Sbjct: 125 ---KDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTPDYIAPEVVS 176
Query: 510 TGKATTSTDVYSYGILMLEVACGR 533
T S D +S+GIL+ E+ G
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRH 386
V + + +G G +G V + VAIK+I Q + + EI + R RH
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 387 RNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDKD-HKLRK--LLTWDQR---- 434
N++ ++ + ++ +V D L + D +KL K L+ D
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQD----------LMETDLYKLLKTQHLSNDHICYFL 134
Query: 435 YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY--EHGANPQ 492
Y+IL G L Y+H + V+HRD+KPSN+LL+T + K+ DFGLA++ +H
Sbjct: 135 YQILRG----LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 493 TTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
T V T Y APE+ K T S D++S G ++ E+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 64/203 (31%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMS----MGRLRHRNLVQL 392
L+G G FG+V + G A+K + E VA ++ + RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-VAHTLTENRVLQNSRHPFLTAL 213
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR-YKILIGIAQSLLYLHEE 451
+ D L V +Y G L F + R R Y I A L YLH E
Sbjct: 214 KYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSA--LDYLHSE 267
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPELTRT 510
N VV+RD+K N++LD + K+ DFGL K E + T GT YLAPE+
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 511 GKATTSTDVYSYGILMLEVACGR 533
+ D + G++M E+ CGR
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHR 387
+ + + +G GG G V+ + VAIK+I Q +K + EI + RL H
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 388 NLVQLH--------------GWCRKQDELLLVYDYVPNGSLDKLL----FDKDHKLRKLL 429
N+V++ G + + + +V +Y+ L +L ++H +L
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHA--RLF 125
Query: 430 TWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKIY--E 486
Y++L G L Y+H + V+HRD+KP+N+ ++T L K+GDFGLA+I
Sbjct: 126 M----YQLLRG----LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 487 HGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
+ + + T Y +P L + T + D+++ G + E+ G+
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGH--NSQQGMKEFVAEIMSMGRLR 385
V + + VGSG +G V + G +VAIK++ S+ K E+ + +R
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 386 HRNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDKD-HKL--RKLLTWDQR-- 434
H N++ L + LV D KL + L D+
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMP----------FMGTDLGKLMKHEKLGEDRIQF 132
Query: 435 --YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ 492
Y++L G L Y+H ++HRD+KP N+ ++ K+ DFGLA+ A+ +
Sbjct: 133 LVYQMLKG----LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSE 181
Query: 493 TTHIVGTLGYLAPE-LTRTGKATTSTDVYSYGILMLEVACGR 533
T V T Y APE + + T + D++S G +M E+ G+
Sbjct: 182 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 36/227 (15%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA----------- 376
+ + Q + SG +G V G+ G+ VAIKR+ + G +
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 377 EIMSMGRLRHRNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTW 431
EI + H N++ L +L LV + + L +++ H R +++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI----HDQRIVISP 133
Query: 432 DQR----YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487
Y IL+G L LH VVHRD+ P NILL + + DF LA+
Sbjct: 134 QHIQYFMYHILLG----LHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT- 185
Query: 488 GANPQTTHIVGTLGYLAPE-LTRTGKATTSTDVYSYGILMLEVACGR 533
A+ TH V Y APE + + T D++S G +M E+ +
Sbjct: 186 -ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 31/219 (14%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLR 385
V + + + VGSG +G V GL VA+K++ Q + K E+ + ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 386 HRNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLL----FDKDHKLRKLLTWDQRY 435
H N++ L + +++ LV + L+ ++ DH + L+ Y
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHV-QFLI-----Y 139
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH 495
+IL G L Y+H + ++HRD+KPSN+ ++ K+ DFGLA+ + T
Sbjct: 140 QILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTG 188
Query: 496 IVGTLGYLAPE-LTRTGKATTSTDVYSYGILMLEVACGR 533
V T Y APE + + D++S G +M E+ GR
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 52/251 (20%), Positives = 95/251 (37%), Gaps = 59/251 (23%)
Query: 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH 386
+ +K + +G+G FG V G A+K++ Q + E+ M L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDH 59
Query: 387 RNLVQL------------------------------------HGWCRKQDE--LLLVYDY 408
N+++L L ++ +Y
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 409 VPNGSLDKLLFDKDHKLRKLLTWDQ----RYKILIGIAQSLLYLHEECNQRVVHRDVKPS 464
VP+ +L K+L + + + + Y++ + ++H + + HRD+KP
Sbjct: 120 VPD-TLHKVL-KSFIRSGRSIPMNLISIYIYQLFRAVG----FIH---SLGICHRDIKPQ 170
Query: 465 NILLDTYLNA-KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSY 522
N+L+++ N KL DFG AK + + + Y APEL T S D++S
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 523 GILMLEVACGR 533
G + E+ G+
Sbjct: 229 GCVFGELILGK 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 337 LVGSGGFGRVY---RGLMPSLGLEVAIK-----RIGHNSQQGMKEFVAEIMS----MGRL 384
++G GG+G+V+ + + G A+K I N++ A + + +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-----TAHTKAERNILEEV 78
Query: 385 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQ 443
+H +V L + +L L+ +Y+ G L F + + + + + I+
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFM--EDTACFYLAEISM 132
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGY 502
+L +LH+ + +++RD+KP NI+L+ + KL DFGL K E + TH GT+ Y
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEY 187
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+APE+ + D +S G LM ++ G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ--GMK-------------EFVAEIMSM 381
++G G FG+V+ + K G +++Q MK E +
Sbjct: 31 VLGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 382 GRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG- 440
+ H +V+LH + + +L L+ D++ G L F + K ++ K +
Sbjct: 81 VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFT--EEDVKFYLAE 134
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGT 499
+A +L +LH +++RD+KP NILLD + KL DFGL+K E + + + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 189
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+ Y+APE+ T S D +S+G+LM E+ G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 21/154 (13%)
Query: 339 GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWC- 396
G G G+V + + A+K + + E+ R + ++V++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKML--QDCPKARR---EVELHWRASQCPHIVRIVDVYE 81
Query: 397 ---RKQDELLLVYDYVPNGSLDKLLFDK-DHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ LL+V + + G L F + + + T + +I+ I +++ YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-- 135
Query: 453 NQRVVHRDVKPSNILL-DTYLNA--KLGDFGLAK 483
+ HRDVKP N+L NA KL DFG AK
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 42/219 (19%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ--GMK-----------EFVAEIMS--- 380
++G+G +G+V+ + K GH++ + MK + +
Sbjct: 61 VLGTGAYGKVF----------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 381 -MGRLRHRN-LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWD-QRYKI 437
+ +R LV LH + + +L L+ DY+ G L F L + + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL----F---THLSQRERFTEHEVQI 163
Query: 438 LIG-IAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHI 496
+G I +L +LH+ +++RD+K NILLD+ + L DFGL+K + +
Sbjct: 164 YVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 497 VGTLGYLAPELTRTGKA--TTSTDVYSYGILMLEVACGR 533
GT+ Y+AP++ R G + + D +S G+LM E+ G
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 3e-16
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 385 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQ 443
+ L QLH + D L V +YV G L ++ + + IA
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFK--EPHAVFYAAEIAI 453
Query: 444 SLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGY 502
L +L + +++RD+K N++LD+ + K+ DFG+ K E+ + TT GT Y
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDY 508
Query: 503 LAPELTRTGKATTSTDVYSYGILMLEVACGR 533
+APE+ S D +++G+L+ E+ G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 60/245 (24%), Positives = 92/245 (37%), Gaps = 66/245 (26%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA-----EIMSMG 382
+ + ++L+G+G +G V VAIK+I + EI +
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILN 107
Query: 383 RLRHRNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDKD-HKL---RKLLTWDQ 433
RL H ++V++ K DEL +V + D D KL LT
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA----------DSDFKKLFRTPVYLTELH 157
Query: 434 R----YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA------- 482
Y +L+G + Y+H ++HRD+KP+N L++ + K+ DFGLA
Sbjct: 158 IKTLLYNLLVG----VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 483 -------------------KIYEHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSY 522
+ Q T V T Y APEL + T + DV+S
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270
Query: 523 G-ILM 526
G I
Sbjct: 271 GCIFA 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
L QL + D L V ++V G L K R+ + R + I +L++
Sbjct: 86 LTQLFCCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFD--EARARFYAAEIISALMF 139
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE 506
LH+ + +++RD+K N+LLD + KL DFG+ K E N TT GT Y+APE
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ + + D ++ G+L+ E+ CG
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 28/208 (13%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIK-----RIGHNSQQGMKEFVAEIMS----MGRLRHR 387
L+G G FG+V + G A+K I + VA ++ + RH
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRHP 65
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLL 446
L L + D L V +Y G L F + R ++R + I +L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFT--EERARFYGAEIVSALE 119
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAP 505
YLH + VV+RD+K N++LD + K+ DFGL K E ++ T GT YLAP
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGR 533
E+ + D + G++M E+ CGR
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
LV LH + + L V +YV G L + RKL ++ + I+ +L Y
Sbjct: 72 LVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLP--EEHARFYSAEISLALNY 125
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE 506
LHE + +++RD+K N+LLD+ + KL D+G+ K E TT GT Y+APE
Sbjct: 126 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 180
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ R S D ++ G+LM E+ GR
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 13/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
L + + ++ L V +Y+ G L K R I L +
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFD--LSRATFYAAEIILGLQF 133
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE 506
LH + +V+RD+K NILLD + K+ DFG+ K E+ T+ GT Y+APE
Sbjct: 134 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPE 188
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ K S D +S+G+L+ E+ G+
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
LV LH + + L V +YV G L + RKL ++ + I+ +L Y
Sbjct: 115 LVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLP--EEHARFYSAEISLALNY 168
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE 506
LHE + +++RD+K N+LLD+ + KL D+G+ K E TT GT Y+APE
Sbjct: 169 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 223
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ R S D ++ G+LM E+ GR
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG-HNSQQGMKEFVAEIMSMGRLRH 386
++ F ++L+G G +G V G VAIK+I + + EI + +H
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 387 RNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDKD-HKL--RKLLTWDQR---- 434
N++ + +E+ ++ + L D H++ ++L+ D
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQE----------LMQTDLHRVISTQMLSDDHIQYFI 118
Query: 435 YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE-------- 486
Y+ L + LH V+HRD+KPSN+L+++ + K+ DFGLA+I +
Sbjct: 119 YQTLRA----VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 487 -HGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
G V T Y APE+ T + + DV+S G ++ E+ R
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 13/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
L QLH + D L V +YV G L ++ + + IA L +
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFK--EPHAVFYAAEIAIGLFF 136
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE 506
L + +++RD+K N++LD+ + K+ DFG+ K E+ + TT GT Y+APE
Sbjct: 137 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPE 191
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ S D +++G+L+ E+ G+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 51/147 (34%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIG-IAQSLLY 447
LV LH + D+L V DY+ G L F + R L + R + IA +L Y
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFL--EPRARFYAAEIASALGY 154
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPE 506
LH +V+RD+KP NILLD+ + L DFGL K E+ + TT GT YLAPE
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPE 209
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ + D + G ++ E+ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 64/256 (25%), Positives = 102/256 (39%), Gaps = 54/256 (21%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLR 385
V + ++L+G G +G VY + VAIK++ + + K + EI + RL+
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 386 HRNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDKD-HKL---RKLLTWDQR-- 434
+++L+ K DEL +V + D D KL LT +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA----------DSDLKKLFKTPIFLTEEHIKT 133
Query: 435 --YKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA---------- 482
Y +L+G ++HE ++HRD+KP+N LL+ + K+ DFGLA
Sbjct: 134 ILYNLLLG----ENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 483 -----------KIYEHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVA 530
+ Q T V T Y APEL + T S D++S G + E+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 531 CGRRSIEPQKAAAELL 546
+S L
Sbjct: 247 NMLQSHINDPTNRFPL 262
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 3e-13
Identities = 42/201 (20%), Positives = 63/201 (31%), Gaps = 45/201 (22%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--------GHNSQQGMKEFVAEIMSMGRL----- 384
+G G FG V++ + VAIK I + Q+ +E + EI+ L
Sbjct: 28 IGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 385 ----RHRNLVQLHGWCRKQD----ELLLVYDY----------VPNGSLDKLLF------- 419
R + L+ Q LL +D+ P+ D LF
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 420 ---DKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476
D + KL + IL + SL HRD+ N+LL KL
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKL 203
Query: 477 GDFGLAKIYEHGANPQTTHIV 497
K + I+
Sbjct: 204 HYTLNGKSSTIPSCGLQVSII 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 49/259 (18%), Positives = 90/259 (34%), Gaps = 67/259 (25%)
Query: 339 GSGGFGRVYRGLMPSLG-----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRL-RHRNLVQ 391
G G FG+V + VA+K + + + ++E+ + + H N+V
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 392 LHGWCRKQDE-LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYK-------------- 436
L G C K L+++ ++ G+L L K ++ T R++
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK 150
Query: 437 --------------ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD---------TYL- 472
+SL + EE +++D L+ +L
Sbjct: 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210
Query: 473 --------------------NAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTG 511
K+ DFGLA+ IY+ + L ++APE
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 512 KATTSTDVYSYGILMLEVA 530
T +DV+S+G+L+ E+
Sbjct: 271 VYTIQSDVWSFGVLLWEIF 289
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 50/239 (20%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM--KEFVAEIMSMGRLR 385
V + + +G G +G V++ + G VA+K+I Q + EIM + L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 386 -HRNLVQLHGWCRKQD--ELLLVYDYVPNGSLDKLLFDKD-HKLRK--LLTWDQR----Y 435
H N+V L R + ++ LV+D + D H + + +L + Y
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFD----------YMETDLHAVIRANILEPVHKQYVVY 116
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY---------- 485
+++ + YLH ++HRD+KPSNILL+ + K+ DFGL++ +
Sbjct: 117 QLIKV----IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 486 ----------EHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGR 533
P T V T Y APE+ T D++S G ++ E+ CG+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 4e-11
Identities = 80/504 (15%), Positives = 144/504 (28%), Gaps = 176/504 (34%)
Query: 261 TLEKRSHEVVQRRGFSVGITLAGMAFLILIIAGAIHVLQR---------IKYADKMLEDW 311
TL + E+VQ+ F + FL I QR I+ D++ D
Sbjct: 70 TLLSKQEEMVQK--FVEEVLRINYKFL----MSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 312 EIQCG---ARRFKYAELASVTKGF-GEQNLV--GSGGFGRVYRGLMPSLGLEVAIKRIGH 365
++ +R Y +L +N++ G G G+ + L+V
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK------TWVALDVC------ 171
Query: 366 NSQQGMKEFVAEI--MSMGRLRHRNLVQLHGWCRKQDELL-----LVYDYVPNGS----- 413
S + + +I +++ C + +L L+Y PN +
Sbjct: 172 LSYKVQCKMDFKIFWLNLKN------------CNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 414 --------------LDKLLFDKDHKLRKLL----TWDQRY--------KILI-----GIA 442
L +LL K ++ LL + + KIL+ +
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYE-NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278
Query: 443 QSLLYLHEECNQRVVHRDVKPSNI---------LLDTYLNAKLGD----------FGLAK 483
L H + ++ LL YL+ + D L+
Sbjct: 279 DFLS------AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 484 I-------------YEHGANPQTTHIVG-TLGYLAPELTRTGKATTSTDVY-SYGILMLE 528
I ++H + T I+ +L L P R ++ +
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR--------KMFDRLSVFPPS 384
Query: 529 VACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAE---AELVLNL-GL 584
I LL + W + + L Y L E E +++ +
Sbjct: 385 A-----HIPTI-----LLSLIWFD---VIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431
Query: 585 FCS-APNPVYRPDM-RRVVE-------FLLGDSSLPPLPPD------I--HLKDTRNIMG 627
+ + R +V+ F D L P D I HLK+ +
Sbjct: 432 YLELKVKLENEYALHRSIVDHYNIPKTFDSDD--LIPPYLDQYFYSHIGHHLKNIEHPER 489
Query: 628 FSDFPN---DSDFFNSKLMSSQSN 648
+ F D F K+ +
Sbjct: 490 MTLFRMVFLDFRFLEQKIRHDSTA 513
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 6e-11
Identities = 30/226 (13%), Positives = 65/226 (28%), Gaps = 27/226 (11%)
Query: 20 NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79
+ G A S I + + G F+ ++ F + +
Sbjct: 50 FWAHAGNAIPSADQIRIAPS-LKSQRGSVWTKTKAAFE--------NWEVEVTFRVTGR- 99
Query: 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDI 139
+G GLA L G ++ + + FD N +
Sbjct: 100 GRIGADGLAIWYT----ENQGLDGPVFGSADMWNG---------VGIFFDSFDNDGKKNN 146
Query: 140 NDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPL 199
V + + + + + + P++A + Y + + + ++
Sbjct: 147 PAIVVVGNNGQINYDHQNDGATQALASCQRDFR-NKPYPVRAKITYYQKTLTVMINNGFT 205
Query: 200 GVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSI 245
Y + + VI + G SA+TG + H+V +
Sbjct: 206 PDKNDYEFCAKVE---NMVIPTQGHFGISAATGGLADDHDVLSFLT 248
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 41/219 (18%), Positives = 80/219 (36%), Gaps = 34/219 (15%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEF-------VAEIMSMGRLRH 386
+G G F V+ VA+K + ++ E A+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 387 RNLVQLHGW----CRKQDELLLVYDYVPNGSLDKLLFD--KDHKLRKLLTWDQRYKILIG 440
++++L +++V++ L + L K ++ R + +I
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGI-PLIYVKQISKQ 139
Query: 441 IAQSLLYLHEECNQRVVHRDVKPSNILLD------TYLNAKLGDFGLAKIYEHGANPQTT 494
+ L Y+H C ++H D+KP N+L++ + K+ D G A + T
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYD--EHYTN 194
Query: 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
I T Y +PE+ D++S L+ E+ G
Sbjct: 195 SIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKE--FVAEIMSMGRLRHRNLVQ 391
++G G FG+V + + VA+K + + +Q +E + + + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFD--KDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
+ ++ + + ++ L L++ K +K + R K I Q L LH
Sbjct: 164 MLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALH 217
Query: 450 EECNQRVVHRDVKPSNILLDTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
+ R++H D+KP NILL + K+ DFG + YEH T+I + Y APE+
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEH--QRVYTYIQ-SRFYRAPEV 270
Query: 508 TRTGKATTSTDVYSYGILMLEVACGR 533
+ D++S G ++ E+ G
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 36/172 (20%), Positives = 64/172 (37%), Gaps = 32/172 (18%)
Query: 337 LVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNSQQ-----------GMKEFVAEIMS 380
+G GGFG +Y M S +K ++ E + + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 381 MGRLRHRNLVQLH--GWCRKQDEL--LLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRY 435
+L++ + + G K + ++ D G L K+ + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV----L 155
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAK--LGDFGLAKIY 485
++ + I L Y+HE VH D+K SN+LL+ + L D+GLA Y
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 32/181 (17%), Positives = 58/181 (32%), Gaps = 34/181 (18%)
Query: 338 VGSGGFGRVYRGLMPSLGL--------EVAIKRIGHNSQ----------QGMKEFVAEIM 379
G +Y S + ++K + + V +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 380 SMGRLRHRNLVQLHGWCRKQDEL-LLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKI 437
+ + G+ QD+ LV + G SL L D + +L+ ++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL---DVSPKHVLSERSVLQV 164
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAK--LGDFGLAKIYEHGANPQTTH 495
+ +L +LHE VH +V NI +D ++ L +G A Y P H
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC----PSGKH 217
Query: 496 I 496
+
Sbjct: 218 V 218
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 8e-09
Identities = 15/36 (41%), Positives = 22/36 (61%)
Query: 209 ISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWS 244
+S + L V+ E++ GFSA+TG A+H V WS
Sbjct: 6 LSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWS 41
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 4e-08
Identities = 28/231 (12%), Positives = 65/231 (28%), Gaps = 34/231 (14%)
Query: 20 NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSI-LPK 78
+G+ +++ + ++ G P K D+ + F +
Sbjct: 26 LWDFQGSTILTSQYVRLTPDERS-KEGSIWNHQPCFLK--------DWEMHVHFKVHGTG 76
Query: 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELID 138
+L G G+A + + G + LA+ D N E +
Sbjct: 77 KKNLHGDGIALWYT----RDRLVPGPVFGSKDNFHG---------LAIFLDTYPNDETTE 123
Query: 139 INDNHVGI---DISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVS 195
++ + + S + + V YS + +
Sbjct: 124 RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTAD--FRNRDHDTFLAVRYSRGRLTVMTD 181
Query: 196 ICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSIS 246
+ ++ I + + Y G SA TG ++ +H++ +
Sbjct: 182 LEDKN---EWKNCIDIT---GVRLPTGYYFGASAGTGDLSDNHDIISMKLF 226
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 41/170 (24%), Positives = 64/170 (37%), Gaps = 28/170 (16%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397
+G G FG + G VAIK S+ + Q++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQVYYFGP 75
Query: 398 KQDELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL----YLHEEC 452
+V + + G SL+ L D K ++ IA L+ Y+H +
Sbjct: 76 CGKYNAMVLELL--GPSLEDLFDLCDRTFS--------LKTVLMIAIQLISRMEYVHSKN 125
Query: 453 NQRVVHRDVKPSNILLDTYLNAK-----LGDFGLAKIYEHGANPQT-THI 496
+++RDVKP N L+ N + DF LAK Y +P+T HI
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY---IDPETKKHI 169
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 20/207 (9%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKE--FVAEIMSMGRLRHRNLV 390
+L+G G FG+V + VAIK I + Q E + + +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFD--KDHKLRKLLTWDQRYKILIGIAQSLLYL 448
L ++ L LV++ L L+D ++ R + R K + +LL+L
Sbjct: 120 HLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFL 173
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
++H D+KP NILL + K+ DFG + +I + Y +PE
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLG--QRIYQYIQ-SRFYRSPE 228
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGR 533
+ + D++S G +++E+ G
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 30/171 (17%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G G FG ++ G +VAIK ++ Q E + + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE--YRTYKL-LAGCTGIPNVYYF 74
Query: 396 CRKQDELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL----YLHE 450
++ +LV D + G SL+ LL K K + A+ +L +HE
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFS--------VKTVAMAAKQMLARVQSIHE 124
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAK-----LGDFGLAKIYEHGANPQTTHI 496
+ +V+RD+KP N L+ + + DFG+ K Y Q HI
Sbjct: 125 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ--HI 170
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 31/170 (18%), Positives = 60/170 (35%), Gaps = 31/170 (18%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+GSGGFG +Y + + A + + E + + ++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 394 G----------WC-----RKQDELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKI 437
+ + +V + + G L K+ ++ +K ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKI-SGQNGTFKKSTV----LQL 156
Query: 438 LIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAK--LGDFGLAKIY 485
I + L Y+HE VH D+K +N+LL + L D+GL+ Y
Sbjct: 157 GIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 32/171 (18%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRH-RNLVQLHG 394
+GSG FG +Y G + G EVAIK + Q E ++I M ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKM--MQGGVGIPTIRW 72
Query: 395 WCRKQDELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL----YLH 449
+ D ++V + + G SL+ L K K ++ +A ++ Y+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKF--------SLKTVLLLADQMISRIEYIH 122
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAK---LGDFGLAKIYEHGANPQT-THI 496
++ +HRDVKP N L+ + DFGLAK Y + +T HI
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR---DARTHQHI 167
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 32/171 (18%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIK--RIGHNSQQGMKEFVAEIMSMGRLRHRNLV-QLHG 394
+GSG FG +Y G EVAIK + Q + E ++I + L+ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE--SKIYRI--LQGGTGIPNVRW 70
Query: 395 WCRKQDELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL----YLH 449
+ + D +LV D + G SL+ L KL K ++ +A ++ ++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKL--------SLKTVLMLADQMINRVEFVH 120
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAK---LGDFGLAKIYEHGANPQT-THI 496
+ +HRD+KP N L+ A + DFGLAK Y + T HI
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQHI 165
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 33/153 (21%), Positives = 47/153 (30%), Gaps = 55/153 (35%)
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILL--------------------------- 468
KI+ + Q L YLH +C ++H D+KP NILL
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 469 ----------------------DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
L K+ D G A T + T Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLE 263
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGRRSIEPQ 539
+ T D++S + E+A G EP
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 32/142 (22%), Positives = 58/142 (40%), Gaps = 23/142 (16%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHR-----N 388
+G G FGRV A+K + + + E A+I+ ++++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE--ADILK--KIQNDDINNNN 97
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD--KDHKLRKLLTWDQRYKILIGIAQSLL 446
+V+ HG D + L+++ L L++ + + I I ++L
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGF-HIEDIKLYCIEILKALN 151
Query: 447 YLHEECNQRVVHRDVKPSNILL 468
YL + + H D+KP NILL
Sbjct: 152 YLRKM---SLTHTDLKPENILL 170
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 46/227 (20%), Positives = 83/227 (36%), Gaps = 48/227 (21%)
Query: 337 LVGSGGFGRVYRGL-MPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHR----- 387
+G G FG+V L +VA+K I + + E ++ +++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE--INVLK--KIKEKDKENK 81
Query: 388 -NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD--KDHKLRKLLTWDQRYKILIGIAQS 444
V + W + + ++ L K F+ K++ + R + + +
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVR-HMAYQLCHA 135
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNA-------------------KLGDFGLAKIY 485
L +LHE ++ H D+KP NIL ++ DFG A +
Sbjct: 136 LRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TF 191
Query: 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACG 532
+H TT + T Y PE+ DV+S G ++ E G
Sbjct: 192 DH--EHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 653 | |||
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.98 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.5 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.47 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.38 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.8 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 85.27 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.14 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.9 |
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-62 Score=484.28 Aligned_cols=224 Identities=30% Similarity=0.475 Sum_probs=204.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCCC------ceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~~------~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
++++|+|++|. ..||+|+|||++.++|.|+||+.... ++|||+|++||+|||+++++++||+|+|+|.|.+.
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~ 81 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAP 81 (251)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeCC
Confidence 46899999997 68999999999987999999998755 99999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCccc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
+...+||||||||+|....+. .+|+||||+|.+++ +..+|+|||||||++|.+|+||++|||||||||+.|.++++
T Consensus 82 ~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~---~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~ 157 (251)
T 3ipv_A 82 NIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS---GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK 157 (251)
T ss_dssp STTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC---CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC---CccCcEEEEEEecccccccCCCCCCeEEEEcCCCcccccce
Confidence 777899999999999876655 57899999998654 55789999999999998888999999999999999998876
Q ss_pred CccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---c
Q 048419 159 ASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---T 235 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~ 235 (653)
| .+.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++|||+||||||||||.. .
T Consensus 158 ~------------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~ 223 (251)
T 3ipv_A 158 W------------SLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWVRVGFSAATGASGGKI 223 (251)
T ss_dssp C------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCC
T ss_pred e------------EecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcEEEEEEEecCCCcccc
Confidence 5 467999999999999999999999997664 5678999999999999999999999999998 8
Q ss_pred ceeeecceeeeec
Q 048419 236 ASHNVHGWSISIG 248 (653)
Q Consensus 236 ~~~~i~sWsf~~~ 248 (653)
|.|+|++|+|++.
T Consensus 224 e~h~IlsWsF~s~ 236 (251)
T 3ipv_A 224 ETHDVFSWSFASK 236 (251)
T ss_dssp CCCEEEEEEEEEE
T ss_pred ceeEEEEEEEEEE
Confidence 9999999999875
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-62 Score=480.10 Aligned_cols=227 Identities=27% Similarity=0.398 Sum_probs=203.9
Q ss_pred eccCceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCC------CceEEEEcCCCeecccCCCCceeeeEEEEEEEE
Q 048419 4 VHADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSI 75 (653)
Q Consensus 4 ~~~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i 75 (653)
.++..++|+|++|. ..||+|+|||++.++|.|+||+... .++|||+|++||+|||+++|+++||+|+|+|.|
T Consensus 7 ~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F~I 86 (261)
T 3zyr_A 7 NSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSFFL 86 (261)
T ss_dssp -CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEEEE
T ss_pred CcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEEEE
Confidence 45678999999997 6899999999997799999999765 799999999999999999999999999999999
Q ss_pred ecCCCCCCCCceEEEEecCCCC-CCCCCCccccCCCcccCCCCCCCCceEEEEeecc---cccccCCCCCCeeeEecCCC
Q 048419 76 LPKYPDLGGQGLAFIIISTNRP-ENCLANQFLGLPNITMSSSTKFSTRMLAVEFDII---QNTELIDINDNHVGIDISSL 151 (653)
Q Consensus 76 ~~~~~~~~gdGlaF~l~~~~~~-~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~---~n~~~~d~~~~Hvgid~ns~ 151 (653)
.+. ...+||||||||+|.... |.+.+|+||||+|.+++. +...||+|||||||+ +|.+| ||++|||||||||+
T Consensus 87 ~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g-~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNsi 163 (261)
T 3zyr_A 87 SSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTAL-NESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNSI 163 (261)
T ss_dssp ECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTT-CGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESSS
T ss_pred ecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccC-CCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCCC
Confidence 886 667999999999998754 778899999999986541 234689999999999 99776 99999999999999
Q ss_pred CcCCcccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEeccc
Q 048419 152 ISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSAST 231 (653)
Q Consensus 152 ~s~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsast 231 (653)
.|.++++| .+.+|+.++|||+||+.+++|+|+|.+.+. ..|+|++.|||+++|||+|||||||||
T Consensus 164 ~S~~s~~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~v~VGFSAsT 228 (261)
T 3zyr_A 164 RSSKVVRW------------ERREGKTLNVLVTYNPSTRTIDVVATYPDG---QRYQLSHVVDLTTILPEWVRVGFSAAS 228 (261)
T ss_dssp SCSEEEEC------------CCCTTCCEEEEEEEETTTTEEEEEEECTTC---CEEEEEEECCGGGTSCSEEEEEEEEEE
T ss_pred Cccccccc------------cccCCceEEEEEEEcCCCCEEEEEEEcCCC---CCeEEEEEechHHhCcCcEEEEEEecC
Confidence 99988775 356899999999999999999999997653 378999999999999999999999999
Q ss_pred Ccccceeeecceeeeec
Q 048419 232 GLITASHNVHGWSISIG 248 (653)
Q Consensus 232 g~~~~~~~i~sWsf~~~ 248 (653)
|...|.|+|++|+|++.
T Consensus 229 G~~~e~h~IlsWsF~s~ 245 (261)
T 3zyr_A 229 GEQFQTHNLESWSFTST 245 (261)
T ss_dssp SSSCCEEEEEEEEEEEE
T ss_pred CCccceEEEEEEEEEEE
Confidence 99999999999999875
|
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-62 Score=484.54 Aligned_cols=225 Identities=28% Similarity=0.460 Sum_probs=203.6
Q ss_pred eccCceeEEeCCCCCCCeEEecceEecCCCcEEecCCCCC------ceEEEEcCCCeecccCCCCceeeeEEEEEEEEec
Q 048419 4 VHADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILP 77 (653)
Q Consensus 4 ~~~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~~~------~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~ 77 (653)
.++..++|+|++|..+||+|+|||++. +|.|+||+.... ++|||+|++||+|||+++|+++||+|+|+|.|.+
T Consensus 22 ~sa~~~sF~f~~F~~~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsTsFsF~I~~ 100 (281)
T 3ujo_A 22 ASANLISFTFKKFNETNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVASWATSFTFNLQA 100 (281)
T ss_dssp --CEEEEEEESSCCSTTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSSCCBEEEEEEEEEECCC
T ss_pred CcCCcceEEcCCCCccCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCCCCceeEEEEEEEEEec
Confidence 345678999999998999999999997 999999998754 9999999999999999999999999999999998
Q ss_pred CCCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcc
Q 048419 78 KYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASE 157 (653)
Q Consensus 78 ~~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 157 (653)
.+...+||||||||+|....|. .+||||||+|.+++ +..+|+|||||||++|.+| ||++|||||||||+.|.++.
T Consensus 101 ~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~---~~~n~~vAVEFDT~~N~e~-Dp~~nHVGIDvNSi~S~~t~ 175 (281)
T 3ujo_A 101 PNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY---ASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIKSIKTT 175 (281)
T ss_dssp SSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC---CTTSCCEEEEECCSCCCSS-CCSSSEEEEEESSSCCSCEE
T ss_pred CCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC---CccCcEEEEEEeccccccC-CCCCCeEEEEcCCCCccccc
Confidence 8777899999999999876654 67899999998654 5678999999999999886 99999999999999999988
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc---c
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---I 234 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~---~ 234 (653)
+|. +.+|+.++|||+||+.+++|+|++.+.+. ++.|+|++.|||+++|||+||||||||||. .
T Consensus 176 ~~~------------l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~~~~~ 241 (281)
T 3ujo_A 176 SWD------------FANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSERVDLTSVLPEWVSVGFSATTGLSKGY 241 (281)
T ss_dssp ECC------------CCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEECCSTTTSCSEEEEEEEEEECSSTTS
T ss_pred ccc------------ccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEEechHHhccCcEEEEEEeecCCCCcc
Confidence 753 56999999999999999999999998764 457899999999999999999999999996 5
Q ss_pred cceeeecceeeeec
Q 048419 235 TASHNVHGWSISIG 248 (653)
Q Consensus 235 ~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 242 ~e~H~IlsWSFss~ 255 (281)
T 3ujo_A 242 VETNEVLSWSFASK 255 (281)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred cceeEEEEEEEEEE
Confidence 89999999999875
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=470.68 Aligned_cols=223 Identities=28% Similarity=0.444 Sum_probs=203.3
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
.+++|+|+.|. ..||+|+|||++.++|.|+||++. ..++|||+|++||+||++.+++++||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~ 81 (239)
T 1dbn_A 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAPN 81 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 56899999998 689999999999878999999876 67999999999999999999999999999999999877
Q ss_pred CCCCCCceEEEEecCCC-CCCCCCCccccCCCcccCCCCCCCCceEEEEeecccc---cccCCCCCCeeeEecCCCCcCC
Q 048419 80 PDLGGQGLAFIIISTNR-PENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQN---TELIDINDNHVGIDISSLISSA 155 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~-~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n---~~~~d~~~~Hvgid~ns~~s~~ 155 (653)
...+||||||||+|... .|.+++|+||||+|..+ ++..+|+|||||||++| .+ +||++||||||+||+.|.+
T Consensus 82 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~---~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~~ 157 (239)
T 1dbn_A 82 PDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN---SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESIK 157 (239)
T ss_dssp TTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC---CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCSE
T ss_pred CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC---CCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCccccc
Confidence 77799999999999875 47778899999998653 35678999999999999 77 6999999999999999998
Q ss_pred cccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc-
Q 048419 156 SEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI- 234 (653)
Q Consensus 156 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~- 234 (653)
+++| +|.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++|||+||||||||||..
T Consensus 158 ~~~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~ 223 (239)
T 1dbn_A 158 TVQW------------DWINGGVAFATITYLAPNKTLIASLVYPSN--QTTFSVAASVDLKEILPEWVRVGFSAATGYPT 223 (239)
T ss_dssp EEEC------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSGG
T ss_pred eEcc------------cccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCcceEEEEechHHhCCccEEEEEEeccCCCc
Confidence 8775 377999999999999999999999988754 5578999999999999999999999999998
Q ss_pred -cceeeecceeeee
Q 048419 235 -TASHNVHGWSISI 247 (653)
Q Consensus 235 -~~~~~i~sWsf~~ 247 (653)
.|.|+|++|+|++
T Consensus 224 ~~~~h~IlsWsF~s 237 (239)
T 1dbn_A 224 EVETHDVLSWSFTS 237 (239)
T ss_dssp GCCCCEEEEEEEEE
T ss_pred cceeeEEEEEEeEe
Confidence 9999999999985
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=469.22 Aligned_cols=223 Identities=26% Similarity=0.428 Sum_probs=201.0
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
.+++|+|+.|. ..||+|+|||++.++|.|+||++. ..++|||+|++||+||++.+++++||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (237)
T 1fny_A 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 35799999998 589999999999889999999876 67999999999999999999999999999999999877
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccC
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPA 159 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 159 (653)
...+||||||||+|....+. ..|+||||+|..+ ++..+|+|||||||++|.+ +||++||||||+||+.|.++++|
T Consensus 82 ~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~---~~~~~~~vAVEFDT~~n~~-~Dp~~nHVGIdvNsi~S~~~~~~ 156 (237)
T 1fny_A 82 PATTADGLAFFLAPVDTQPL-DLGGMLGIFKDGY---FNKSNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIESIKTVPW 156 (237)
T ss_dssp TTSCCEEEEEEEEETTCCCC-CCGGGTTTCC------CCTTSCCEEEEEECSCCTT-TCCSSSEEEEEESSSSCSEEEEC
T ss_pred CCCCCCCEEEEeccCCCCCC-CCCCcccccccCC---CCccccEEEEEeecccCcc-cCCCCCceEEecCCccccccccc
Confidence 77799999999999876554 7889999998753 3668999999999999987 69999999999999999988775
Q ss_pred ccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cc
Q 048419 160 SYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TA 236 (653)
Q Consensus 160 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~ 236 (653)
+|.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++||++||||||||||.. .|
T Consensus 157 ------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~ 222 (237)
T 1fny_A 157 ------------NWTNGEVANVFISYEASTKSLTASLVYPSL--ETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQ 222 (237)
T ss_dssp ------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCC
T ss_pred ------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccc
Confidence 367999999999999999999999988654 5578999999999999999999999999998 99
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|++|+|++.
T Consensus 223 ~h~IlsWsF~s~ 234 (237)
T 1fny_A 223 TNDVLSWSFESN 234 (237)
T ss_dssp CCEEEEEEEEEE
T ss_pred eeEEEEEEEEEe
Confidence 999999999864
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-60 Score=465.31 Aligned_cols=223 Identities=27% Similarity=0.385 Sum_probs=202.8
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC---CCceEE-EEcCCCeecccCCCCceeeeEEEEEEEEecC-C
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS---EGLIGH-ALYPNPLRFKTSNKSVAIDFRTNFVFSILPK-Y 79 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~---~~~~Gr-~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~-~ 79 (653)
.+++|+|+.|. ..+|+|+|||++.++|.|+||++. .+++|| |+|++||+||++.+++++||+|+|+|.|.+. +
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~ 81 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (242)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 56899999998 689999999999888999999886 689999 9999999999999999999999999999887 5
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeeccccccc-CCCCCCeeeEecCCCCcCCccc
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTEL-IDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
...+||||||||+|....+. ..|+||||+|.++ ++..+|+|||||||++|.++ |||++||||||+||+.|.++++
T Consensus 82 ~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~---~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~ 157 (242)
T 1fx5_A 82 PKAATDGLTFFLAPPDSPLR-RAGGYFGLFNDTK---CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER 157 (242)
T ss_dssp GGGCCCEEEEEEECTTCCCC-BCGGGTTTBSSSC---CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCcEEEEEecCCCCCC-CCCCcccccccCC---CCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceec
Confidence 66789999999999876554 7889999998653 35688999999999999987 8999999999999999998876
Q ss_pred CccccCCCCccccccCCC--CceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEeccc--Ccc
Q 048419 159 ASYYSGNNHRIPILLRSG--DPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSAST--GLI 234 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g--~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsast--g~~ 234 (653)
| +|.+| +.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++||++|||||||+| |..
T Consensus 158 ~------------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~ 223 (242)
T 1fx5_A 158 W------------NKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ 223 (242)
T ss_dssp C------------CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC
T ss_pred c------------cccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCccEEEEEEecccCCCc
Confidence 5 36789 9999999999999999999988754 5568999999999999999999999999 988
Q ss_pred cceeeecceeeeec
Q 048419 235 TASHNVHGWSISIG 248 (653)
Q Consensus 235 ~~~~~i~sWsf~~~ 248 (653)
|.|+|++|+|++.
T Consensus 224 -~~h~IlsWsF~s~ 236 (242)
T 1fx5_A 224 -ATHEVLNWYFTST 236 (242)
T ss_dssp -EEEEEEEEEEEEE
T ss_pred -ceeEEEEEEeEee
Confidence 9999999999875
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-60 Score=462.68 Aligned_cols=220 Identities=26% Similarity=0.377 Sum_probs=201.4
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCC-CCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNK-SEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLG 83 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~-~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~ 83 (653)
.+++|+|+.|. ..||+|+|||++.++|.|+||++ ..+++|||+|++||+||++.+++++||+|+|+|.|.+.+...+
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~~~~ 81 (232)
T 1v6i_A 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYDP 81 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSBC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCCCCC
Confidence 46799999998 68999999999988899999998 8889999999999999999999999999999999998776778
Q ss_pred CCceEEEEecCCC-CCCCC-CCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCcc
Q 048419 84 GQGLAFIIISTNR-PENCL-ANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASY 161 (653)
Q Consensus 84 gdGlaF~l~~~~~-~~~~~-~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~ 161 (653)
||||||||+|... .|.++ +|+||||+|. +..+|+|||||||++|.+++||++||||||+||+.|.++++|
T Consensus 82 gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~------~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~-- 153 (232)
T 1v6i_A 82 ADGIIFFIAPEDTQIPAGSIGGGTLGVSDT------KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-- 153 (232)
T ss_dssp CCEEEEEEEETTCCCCTTCCCGGGTTTSCT------TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC--
T ss_pred CCCEEEEEecCCCCCCCCcCCCcccccccC------CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc--
Confidence 9999999999873 46667 8999999975 346899999999999999899999999999999999988775
Q ss_pred ccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc--ccceee
Q 048419 162 YSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL--ITASHN 239 (653)
Q Consensus 162 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~--~~~~~~ 239 (653)
+|.+|+.++|||+||+.+++|+|+|.+ + +|..|+|++.|||+++||++|||||| |||. ..|.|+
T Consensus 154 ----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~ 219 (232)
T 1v6i_A 154 ----------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHL 219 (232)
T ss_dssp ----------CCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEE
T ss_pred ----------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEE
Confidence 377999999999999999999999998 4 46678999999999999999999999 9998 689999
Q ss_pred ecceeeeec
Q 048419 240 VHGWSISIG 248 (653)
Q Consensus 240 i~sWsf~~~ 248 (653)
|++|+|++.
T Consensus 220 IlsWsF~s~ 228 (232)
T 1v6i_A 220 IRSWSFTST 228 (232)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEEee
Confidence 999999875
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=467.89 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=203.2
Q ss_pred cCceeEEeCCCC---CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEe
Q 048419 6 ADTTSFLYNGFL---HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSIL 76 (653)
Q Consensus 6 ~~~~~f~~~~f~---~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~ 76 (653)
+..++|+|+.|. ..||+|+|||.+. +|.|+||+.. .+++|||+|++||+||++.+|+++||+|+|+|.|.
T Consensus 2 ~~~~~F~f~~F~~~~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~ 80 (257)
T 1hql_A 2 SDSVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLK 80 (257)
T ss_dssp --CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEE
T ss_pred CcceEEEcCCCCCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEe
Confidence 356899999998 5799999999998 9999999875 57999999999999999999999999999999998
Q ss_pred cCCCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCc
Q 048419 77 PKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSAS 156 (653)
Q Consensus 77 ~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~ 156 (653)
+. ...+||||||||+|....+. +.|+||||++.++. .++..+|+|||||||++|.+|.||++||||||+||+.|.++
T Consensus 81 ~~-~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~~-~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s 157 (257)
T 1hql_A 81 IT-GNGPADGLAFFLAPPDSDVK-DAGEYLGLFNKSTA-TQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVAT 157 (257)
T ss_dssp EC-SSCCCCEEEEEEECTTCCCC-CCGGGTTTSCTTTT-TCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEE
T ss_pred cC-CCCCCCcEEEEEecCCCCCC-CCCccccccccccc-cCCccCceEEEEecccccccccCCCCCceeeeeCCccccce
Confidence 87 66789999999999876544 78899999987542 25677899999999999998889999999999999999998
Q ss_pred ccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccC-ccc
Q 048419 157 EPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTG-LIT 235 (653)
Q Consensus 157 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg-~~~ 235 (653)
++|.. -+|.+|+.++|||+|++.+++|+|+|.+.+. ..|+|++.+||+.+||++|||||||||| ...
T Consensus 158 ~~~~~---------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~ 225 (257)
T 1hql_A 158 KRWED---------SDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPESVRVGISASTGNNQF 225 (257)
T ss_dssp EECCH---------HHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCSEEEEEEEEECCSCCC
T ss_pred eccCc---------ccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCCceEEEEEeccCCCcc
Confidence 87631 1366799999999999999999999988654 4589999999999999999999999999 899
Q ss_pred ceeeecceeeeecCcCCCCCCCCCCCccc
Q 048419 236 ASHNVHGWSISIGGKAQDLNPMKVPTLEK 264 (653)
Q Consensus 236 ~~~~i~sWsf~~~~~~~~l~p~~~p~~~~ 264 (653)
|.|+|++|+|++...++..+.+.+|..|+
T Consensus 226 ~~H~IlsWsF~s~~~~~~~~~~~~p~~~~ 254 (257)
T 1hql_A 226 LTVYILSWRFSSNLQSTSVKAAMEPEITR 254 (257)
T ss_dssp EEEEEEEEEEEEEC---------------
T ss_pred ceeEEEEEEeEecCCCCCcccccCCCCCc
Confidence 99999999999987777777777777664
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-60 Score=463.74 Aligned_cols=223 Identities=29% Similarity=0.455 Sum_probs=200.9
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
.+++|+|+.|. ..||+|+|||++.++|.|+||+.. ..++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~ 81 (239)
T 1gzc_A 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCC
Confidence 45799999998 689999999999888999999876 5799999999999999999999999999999999887
Q ss_pred C-CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcc
Q 048419 79 Y-PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASE 157 (653)
Q Consensus 79 ~-~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 157 (653)
+ ...+||||||||+|....+. ..|+||||+|..+ ++..+|+|||||||++|. |.||++||||||+||+.|.+++
T Consensus 82 ~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~---~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~ 156 (239)
T 1gzc_A 82 YTRPLPADGLVFFMGPTKSKPA-QGYGYLGVFNNSK---QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQ 156 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCCC-CCGGGTTTCSSSS---CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEE
T ss_pred CCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC---CCccccEEEEEEeccccc-CCCCCCCeEEEecCCccccccc
Confidence 5 66789999999999876554 7889999998653 456799999999999998 7779999999999999999887
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc---c
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---I 234 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~---~ 234 (653)
+| +|.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++||++||||||||||. .
T Consensus 157 ~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~ 222 (239)
T 1gzc_A 157 PF------------QLDNGQVANVVIKYDAPSKILHVVLVYPSS--GAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDA 222 (239)
T ss_dssp EC------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTC
T ss_pred cc------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccc
Confidence 64 377999999999999999999999987654 567899999999999999999999999997 4
Q ss_pred cceeeecceeeeec
Q 048419 235 TASHNVHGWSISIG 248 (653)
Q Consensus 235 ~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 223 ~~~h~IlsWsF~s~ 236 (239)
T 1gzc_A 223 AETHDVYSWSFQAS 236 (239)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred cceEEEEEEEeEEe
Confidence 89999999999864
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=460.14 Aligned_cols=224 Identities=28% Similarity=0.444 Sum_probs=203.5
Q ss_pred ccCceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC---CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 5 HADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS---EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 5 ~~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~---~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
++..++|+|+.|. ..||+|+|||.+.++|.|+||++. .+++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 2 s~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~- 80 (242)
T 1qnw_A 2 LSDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD- 80 (242)
T ss_dssp -CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-
T ss_pred CccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC-
Confidence 4678999999998 689999999999889999999987 7899999999999999999999999999999999887
Q ss_pred CCCCCCceEEEEecCCC-CCCCCCCccccCCCcccCCCCCCCCceEEEEeecc----cccccCCCCCCeeeEecCCCCcC
Q 048419 80 PDLGGQGLAFIIISTNR-PENCLANQFLGLPNITMSSSTKFSTRMLAVEFDII----QNTELIDINDNHVGIDISSLISS 154 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~-~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~----~n~~~~d~~~~Hvgid~ns~~s~ 154 (653)
...+||||||||+|... .|.++.|+||||+|..+ ++..+|+|||||||+ +|. +||++||||||+||+.|.
T Consensus 81 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~---~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~ 155 (242)
T 1qnw_A 81 KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD---SKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSI 155 (242)
T ss_dssp SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS---CCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCS
T ss_pred CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC---CCccccEEEEEeecccccccCC--CCCCCCcEEEecCCcccc
Confidence 66789999999999874 57778899999998653 356789999999999 887 799999999999999999
Q ss_pred CcccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc
Q 048419 155 ASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI 234 (653)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~ 234 (653)
++++| +|.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++||++|||||||+||..
T Consensus 156 ~~~~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~ 221 (242)
T 1qnw_A 156 KTVKW------------DWRNGEVADVVITYRAPTKSLTVCLSYPSD--GTSNIITASVDLKAILPEWVSVGFSGGVGNA 221 (242)
T ss_dssp EEEEC------------CCCTTCCEEEEEEEEGGGTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEESCG
T ss_pred ceecc------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CcceeEEEeechHHhcCCceEEEEEeccCCC
Confidence 88765 367999999999999999999999987654 5678999999999999999999999999998
Q ss_pred --cceeeecceeeeec
Q 048419 235 --TASHNVHGWSISIG 248 (653)
Q Consensus 235 --~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 222 ~~~~~h~IlsWsF~s~ 237 (242)
T 1qnw_A 222 AEFETHDVLSWYFTSN 237 (242)
T ss_dssp GGCBCCEEEEEEEEEE
T ss_pred ccceEEEEEEEEeEee
Confidence 99999999999875
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-59 Score=455.53 Aligned_cols=217 Identities=27% Similarity=0.369 Sum_probs=199.2
Q ss_pred eeEEeCCCC-CCCeEEecceEecCCCcEEecCC--CCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCC
Q 048419 9 TSFLYNGFL-HANLSLEGAAYISTSGILTVTNK--SEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQ 85 (653)
Q Consensus 9 ~~f~~~~f~-~~~l~~~g~a~~~~~g~l~Lt~~--~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gd 85 (653)
++|+|+.|. ..||+|+|||++.++|.|+||++ ..+++|||+|++||+||++.+++++||+|+|+|.|.+.+...+||
T Consensus 1 ~sF~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~~gd 80 (234)
T 2eig_A 1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYPPTD 80 (234)
T ss_dssp CEEEESSCCSSSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSCCCC
T ss_pred CeEEcCCCCCCCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCCCCC
Confidence 489999998 78999999999987899999998 778999999999999999999999999999999999877777999
Q ss_pred ceEEEEecCCC-CCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCC---CeeeEecCCCCcCCcccCcc
Q 048419 86 GLAFIIISTNR-PENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDIND---NHVGIDISSLISSASEPASY 161 (653)
Q Consensus 86 GlaF~l~~~~~-~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~Hvgid~ns~~s~~~~~~~~ 161 (653)
||||||+|... .|.+..|+||||+|.+ +..+|+|||||||++|. +||++ ||||||+||+.|.++++|
T Consensus 81 GlAF~l~p~~~~~p~~~~g~~LGl~n~~-----~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~~-- 151 (234)
T 2eig_A 81 GVVFFLAPWGTEIPPNSQGGYLGITDSS-----NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVNW-- 151 (234)
T ss_dssp EEEEEEEETTCCCCTTCCGGGTTTCCTT-----CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEEC--
T ss_pred cEEEEEecCCCCCCcCCCCCccccccCC-----CccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceecc--
Confidence 99999999874 5677889999999864 45689999999999998 79999 999999999999988765
Q ss_pred ccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEeccc--Ccccceee
Q 048419 162 YSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSAST--GLITASHN 239 (653)
Q Consensus 162 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsast--g~~~~~~~ 239 (653)
+|.+|+.++|||+||+.+++|+|+|.+ + .|..|+|++.+||+++||++|||||||+| |.. |.|+
T Consensus 152 ----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~ 217 (234)
T 2eig_A 152 ----------NRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHD 217 (234)
T ss_dssp ----------CCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEE
T ss_pred ----------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeE
Confidence 367999999999999999999999998 4 36678999999999999999999999999 988 9999
Q ss_pred ecceeeeec
Q 048419 240 VHGWSISIG 248 (653)
Q Consensus 240 i~sWsf~~~ 248 (653)
|++|+|++.
T Consensus 218 IlsWsF~s~ 226 (234)
T 2eig_A 218 IYSWSFTST 226 (234)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEEec
Confidence 999999875
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-59 Score=460.29 Aligned_cols=220 Identities=27% Similarity=0.457 Sum_probs=200.3
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
.+++|+|+.|. ..+|+|+|||.+.++|.|+||++. ..++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~ 81 (253)
T 1sbf_A 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP 81 (253)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeCC
Confidence 46799999998 689999999999879999999876 5799999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCccc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
+...+||||||||+|....+. +.|+||||+|.. +..+|+|||||||++|. +||++||||||+||+.|.++++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~-~~g~~LGL~n~~-----~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~ 153 (253)
T 1sbf_A 82 DTKRLADGLAFFLAPIDTKPQ-THAGYLGLFNEN-----ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS 153 (253)
T ss_dssp STTSCCEEEEEEEEETTCCCC-CCGGGTTTCCTT-----SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCcEEEEEecCCCCCC-CCCCccccccCC-----CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceec
Confidence 777799999999999876554 788999999864 45689999999999998 7999999999999999998876
Q ss_pred CccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc--cc
Q 048419 159 ASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI--TA 236 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~--~~ 236 (653)
| +|.+|+.++|||+|++.+++|+|+|.+.+. |..|+|++.+||+.+||++||||||||||.. .|
T Consensus 154 ~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~ 219 (253)
T 1sbf_A 154 W------------DLANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGE 219 (253)
T ss_dssp C------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCC
T ss_pred c------------cccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCccce
Confidence 5 367999999999999999999999988654 5568999999999999999999999999998 99
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|++|+|++.
T Consensus 220 ~H~IlsWsF~s~ 231 (253)
T 1sbf_A 220 SHDVLSWSFASN 231 (253)
T ss_dssp EEEEEEEEEEEE
T ss_pred eeEEEEEEeEee
Confidence 999999999875
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=461.15 Aligned_cols=222 Identities=27% Similarity=0.456 Sum_probs=202.0
Q ss_pred CceeEEeCCCCCCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCC
Q 048419 7 DTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYP 80 (653)
Q Consensus 7 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~ 80 (653)
.+++|+|+.|...+|+|+|||.+. +|.|+||++. .+++|||+|++||+||++.+++++||+|+|+|.|.+.+.
T Consensus 2 ~~~~F~f~~F~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 80 (253)
T 1g7y_A 2 DIQSFSFKNFNSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNK 80 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSG
T ss_pred cceEEEcCCCCcCCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 468999999998899999999998 9999999876 579999999999999999999999999999999988766
Q ss_pred CCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCc
Q 048419 81 DLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPAS 160 (653)
Q Consensus 81 ~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 160 (653)
..+||||||||+|....|. +.|+||||++.++ ++..+|+|||||||++|.+ +||++||||||+||+.|.++++|
T Consensus 81 ~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~---~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t~~~- 154 (253)
T 1g7y_A 81 SSSADGIAFALVPVGSEPK-SNSGFLGVFDSDV---YDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTASW- 154 (253)
T ss_dssp GGCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS---CCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC-
T ss_pred CCCCCcEEEEEecCCCCCC-CCCCcccccccCC---CCccCceEEEEecceeccC-cCCCCCcEeeccCCccccceecc-
Confidence 6789999999999876554 7889999998753 3568899999999999988 69999999999999999988775
Q ss_pred cccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cce
Q 048419 161 YYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TAS 237 (653)
Q Consensus 161 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~ 237 (653)
+|.+|+.++|||+|++.+++|+|+|.+.+. |..|+|++.+||+.+||++||||||||||.. .|.
T Consensus 155 -----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~ 221 (253)
T 1g7y_A 155 -----------GLANGQNAEILITYNAATSLLVASLVHPSR--RTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTET 221 (253)
T ss_dssp -----------CCCTTSEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCC
T ss_pred -----------ccCCCCeEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeCcCCCCcccce
Confidence 367899999999999999999999988654 5578999999999999999999999999998 899
Q ss_pred eeecceeeeec
Q 048419 238 HNVHGWSISIG 248 (653)
Q Consensus 238 ~~i~sWsf~~~ 248 (653)
|+|++|+|++.
T Consensus 222 H~IlsWsF~s~ 232 (253)
T 1g7y_A 222 HDVLSWSFASK 232 (253)
T ss_dssp CEEEEEEEEEE
T ss_pred eEEEEEEEEee
Confidence 99999999875
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=454.90 Aligned_cols=223 Identities=28% Similarity=0.452 Sum_probs=200.7
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCC------CceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
.+++|+|+.|. ..+|+|+|+|.+.++|.|+||++.. +++|||+|++||+||++ +++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g~~~sFst~F~F~I~~~ 80 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLVASFETTFTFSISQG 80 (240)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TCSEEEEEEEEEEECCBS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CCCcCcEEEEEEEEEecC
Confidence 56899999998 6799999999998789999999875 79999999999999999 999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCC-CCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcc
Q 048419 79 YPDLGGQGLAFIIISTNRPENC-LANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASE 157 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~-~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 157 (653)
...+||||||+|+|....|.. +.|+||||++.+++ ++..+|+|||||||++|.+++||++||||||+||+.|.+++
T Consensus 81 -~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~--~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~ 157 (240)
T 2fmd_A 81 -SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNN--AGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAAS 157 (240)
T ss_dssp -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC------CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE
T ss_pred -CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcC--CCCcCcEEEEEeccccccccCCCCCCceeecccccccccee
Confidence 667899999999998766654 78999999987653 56688999999999999988899999999999999998887
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccce
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS 237 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~ 237 (653)
+| ++.+|+.++|||+|++.+++|+|+|.+.+. ..|+|++.+||+.+||++|||||||+||...|.
T Consensus 158 ~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~ 222 (240)
T 2fmd_A 158 KW------------DWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQT 222 (240)
T ss_dssp EC------------CCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBC
T ss_pred EE------------EeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCceEEEEEeccCCcccc
Confidence 64 367899999999999999999999987654 468999999999999999999999999999999
Q ss_pred eeecceeeeec
Q 048419 238 HNVHGWSISIG 248 (653)
Q Consensus 238 ~~i~sWsf~~~ 248 (653)
|+|++|+|++.
T Consensus 223 H~IlsWsF~s~ 233 (240)
T 2fmd_A 223 NNILAWSFRSS 233 (240)
T ss_dssp CEEEEEEEEEE
T ss_pred EEEEEEEeEec
Confidence 99999999875
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=461.07 Aligned_cols=221 Identities=29% Similarity=0.446 Sum_probs=201.4
Q ss_pred CceeEEeCCCCCCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCC
Q 048419 7 DTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYP 80 (653)
Q Consensus 7 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~ 80 (653)
.+++|+|+.|...||+|+|||.+.++|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.+.+.
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 81 (252)
T 1fat_A 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (252)
T ss_dssp CCEEEEESSCCGGGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCCCSS
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeCCCC
Confidence 56899999999889999999999878999999876 579999999999999999999999999999999998766
Q ss_pred CCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCc
Q 048419 81 DLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPAS 160 (653)
Q Consensus 81 ~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 160 (653)
..+||||||||+|....+. +.|+||||+|.. +..+|+|||||||++|.+ +||++||||||+||+.|.++++|
T Consensus 82 ~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~-----~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~~~~- 153 (252)
T 1fat_A 82 AGPADGLAFALVPVGSQPK-DKGGFLGLFDGS-----NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTRW- 153 (252)
T ss_dssp CBCCEEEEEEEEETTCCCC-CSGGGTTTCCSS-----CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC-
T ss_pred CCCCCcEEEEEccCCCCCC-CCCccccccccC-----CccCcEEEEEeecccCCC-CCCCCCeEEEecCCccccceecc-
Confidence 7789999999999876554 788999999864 456899999999999988 69999999999999999988765
Q ss_pred cccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cce
Q 048419 161 YYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TAS 237 (653)
Q Consensus 161 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~ 237 (653)
++.+|+.++|||+|++.+++|+|+|.+.+. |..|+|++.+||+.+||++||||||||||.. .|.
T Consensus 154 -----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~ 220 (252)
T 1fat_A 154 -----------DFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVET 220 (252)
T ss_dssp -----------CCCTTCEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCC
T ss_pred -----------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCCcccce
Confidence 367899999999999999999999988654 5578999999999999999999999999998 899
Q ss_pred eeecceeeeec
Q 048419 238 HNVHGWSISIG 248 (653)
Q Consensus 238 ~~i~sWsf~~~ 248 (653)
|+|++|+|++.
T Consensus 221 H~IlsWsF~s~ 231 (252)
T 1fat_A 221 NDVLSWSFASK 231 (252)
T ss_dssp CEEEEEEEEEE
T ss_pred EEEEEEEEEee
Confidence 99999999875
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=453.93 Aligned_cols=224 Identities=29% Similarity=0.442 Sum_probs=202.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGG 84 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g 84 (653)
.+++|+|++|. ..+|+|+|||. .++|.|+||++..+++|||+|++||+|||+.+++++||+|+|+|.|.+.+...+|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~~g 80 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVA 80 (234)
T ss_dssp EEEEEEESSBCTTCTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCC
T ss_pred cceEEEcCCCCCCCCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCCCC
Confidence 46799999998 58999999999 5689999999999999999999999999999999999999999999987767799
Q ss_pred CceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCC--CCeeeEecCCCCcCCcccCccc
Q 048419 85 QGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDIN--DNHVGIDISSLISSASEPASYY 162 (653)
Q Consensus 85 dGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~~~~~~~~ 162 (653)
|||||+|+|....|. +.|+||||++.++ ++..+|+|||||||++|.+ +||+ +||||||+||+.|.++.+|
T Consensus 81 dGlAF~l~p~~~~p~-~~g~~LGl~n~~~---~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~~--- 152 (234)
T 2bqp_A 81 DGFTFFIAPVDTKPQ-TGGGYLGVFNSAE---YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW--- 152 (234)
T ss_dssp CEEEEEEEETTCCCC-CCGGGTTTCSCSS---CCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC---
T ss_pred CcEEEEEecCCCCCC-CCCCccccccccC---CCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccceEee---
Confidence 999999999876665 7889999998763 4567899999999999988 6999 9999999999999988764
Q ss_pred cCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCC---CCCCCceeeeecCCcccccceEEeEecccCcccceee
Q 048419 163 SGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVP---KPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHN 239 (653)
Q Consensus 163 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~---~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~ 239 (653)
++.+|+.++|||+|++.+++|+|+|.+.+.+ +|..|+|++.+||+.+||++||||||||||...|.|+
T Consensus 153 ---------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~ 223 (234)
T 2bqp_A 153 ---------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHE 223 (234)
T ss_dssp ---------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEE
T ss_pred ---------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEE
Confidence 3678999999999999999999999987765 6778999999999999999999999999999999999
Q ss_pred ecceeeeec
Q 048419 240 VHGWSISIG 248 (653)
Q Consensus 240 i~sWsf~~~ 248 (653)
|++|+|++.
T Consensus 224 IlsWsF~s~ 232 (234)
T 2bqp_A 224 VLSWSFHSE 232 (234)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEEee
Confidence 999999864
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=451.61 Aligned_cols=220 Identities=28% Similarity=0.458 Sum_probs=198.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
.+++|+|+.|. ..||+|+|||.+.++|.|+||+.. .+++|||+|++||+|||+.+ ++||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~--~~sFsT~F~F~I~~~~ 79 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT--LASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC--BCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC--cCCEEEEEEEEEeCCC
Confidence 46899999998 689999999999878999999876 47999999999999999877 9999999999999876
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccC
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPA 159 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 159 (653)
...+||||||||+|....|. +.|+||||++.++ ++..+|+|||||||++|. +||++||||||+||+.|.++++|
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~---~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~~~ 153 (233)
T 1n47_A 80 AAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRA---HDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTPF 153 (233)
T ss_dssp TTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSS---CCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCcEEEEEecCCCCCC-CCCCcccccccCC---CCccCceEEEEeccccCC--CCCCCCcEEEccCCccccccccc
Confidence 67789999999999876665 7889999998753 456799999999999998 79999999999999999988764
Q ss_pred ccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cc
Q 048419 160 SYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TA 236 (653)
Q Consensus 160 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~ 236 (653)
++.+|+.++|||+|++.+++|+|+|.+.+. +..|+|++.+||+.+||++||||||||||.. .|
T Consensus 154 ------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~ 219 (233)
T 1n47_A 154 ------------DMVYGEKANIVITYQASTKALAASLVFPVS--QTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVE 219 (233)
T ss_dssp ------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCC
T ss_pred ------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCccccc
Confidence 367999999999999999999999988654 3468999999999999999999999999998 99
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|++|+|++.
T Consensus 220 ~h~IlsWsF~s~ 231 (233)
T 1n47_A 220 THDIVSWSFAVS 231 (233)
T ss_dssp CCEEEEEEEEEE
T ss_pred eeEEEEEEEEee
Confidence 999999999864
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=453.56 Aligned_cols=219 Identities=31% Similarity=0.440 Sum_probs=198.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC-
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK- 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~- 78 (653)
++++|+|+.|. ..||+|+|||++.++|.|+||+.. ..++|||+|++||+|||+.+++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (242)
T 1wbf_A 2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF 81 (242)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCCC
Confidence 46899999998 689999999999878999999876 6899999999999999999999999999999999886
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCccc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
+...+||||||||+|....+. +.|+||||+|.+ ..+|+|||||||++|. +||++||||||+||+.|.++++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~------~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~ 152 (242)
T 1wbf_A 82 PRPHPADGLVFFIAPPNTQTG-EGGGYFGIYNPL------SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP 152 (242)
T ss_dssp CSSCCCEEEEEEEECSSCCCC-CCGGGTTTCCTT------SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCcEEEEEecCCCCCC-CCCCccccccCC------CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceee
Confidence 567789999999999876554 788999999753 4688999999999998 7999999999999999988876
Q ss_pred CccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEeccc----Ccc
Q 048419 159 ASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSAST----GLI 234 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsast----g~~ 234 (653)
| +|.+|+.++|||+||+.+++|+|+|.+.+. |..|+|+..+||+.+||++||||||||| |..
T Consensus 153 ~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~ 218 (242)
T 1wbf_A 153 F------------TLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQ 218 (242)
T ss_dssp C------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCC
T ss_pred e------------EecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCceEEEEEEeecCcCCcc
Confidence 4 377999999999999999999999988754 4568999999999999999999999999 887
Q ss_pred ---cceeeecceeeeec
Q 048419 235 ---TASHNVHGWSISIG 248 (653)
Q Consensus 235 ---~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 219 ~~~~~~h~IlsWsF~s~ 235 (242)
T 1wbf_A 219 RNATETHDILSWSFSAS 235 (242)
T ss_dssp TTCCCCCEEEEEEEEEE
T ss_pred ccccceEEEEEEEeEec
Confidence 89999999999875
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=451.06 Aligned_cols=218 Identities=29% Similarity=0.433 Sum_probs=198.2
Q ss_pred ceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC-
Q 048419 8 TTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK- 78 (653)
Q Consensus 8 ~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~- 78 (653)
+++|+|+.|. ..+|+|+|+|.+.++|.|+||+.. .+++|||+|++||+|||+.+++++||+|+|+|.|.+.
T Consensus 2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~~ 81 (238)
T 1f9k_A 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (238)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecCC
Confidence 5799999998 689999999999878999999876 5799999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCccc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
+...+||||||||+|....+. +.|+||||+|.. +. +|+|||||||++|. +||++||||||+||+.|.++.+
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~-----~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~~ 152 (238)
T 1f9k_A 82 AYPEPADGLTFFMVPPNSPQG-EDGGNLGVFKPP-----EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH 152 (238)
T ss_dssp SSSCCCEEEEEEEECTTCCCC-CSGGGTTTCCSS-----CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCcEEEEEccCCCCCC-CCCCcccccccC-----CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceEe
Confidence 667789999999999876554 788999999864 34 89999999999998 7999999999999999988876
Q ss_pred CccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCccccc--ceEEeEecccCcc--
Q 048419 159 ASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDE--YMYTGFSASTGLI-- 234 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~--~~~vGFsastg~~-- 234 (653)
| +|.+|+.++|||+|++.+++|+|+|.+.+. |..|+|++.|||+.+||+ +||||||||||..
T Consensus 153 ~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~ 218 (238)
T 1f9k_A 153 F------------QLENGGVANVVIKYDSPTKILNVVLAFHSV--GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKN 218 (238)
T ss_dssp C------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTT
T ss_pred e------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCceeEEEEechHHhCCCCceEEEEEEeCcCCCCc
Confidence 4 377999999999999999999999988754 556899999999999999 9999999999998
Q ss_pred -cceeeecceeeeec
Q 048419 235 -TASHNVHGWSISIG 248 (653)
Q Consensus 235 -~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 219 ~~~~h~IlsWsF~s~ 233 (238)
T 1f9k_A 219 AVETHEIISWSFTSS 233 (238)
T ss_dssp CCCEEEEEEEEEEEE
T ss_pred ccceEEEEEeEeEee
Confidence 99999999999875
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-58 Score=451.80 Aligned_cols=221 Identities=24% Similarity=0.359 Sum_probs=198.9
Q ss_pred CceeEEeCCC----C--CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEE
Q 048419 7 DTTSFLYNGF----L--HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFS 74 (653)
Q Consensus 7 ~~~~f~~~~f----~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~ 74 (653)
++++|+|+.| . ..+|+|+|||.+. +|.|+||+.. .+++|||+|++||+||+ .+++++||+|+|+|.
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F~ 79 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTFL 79 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEEE
T ss_pred cceEEEcCCCccccCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEEE
Confidence 4679999999 6 5799999999998 9999999876 57999999999999999 999999999999999
Q ss_pred EecCCCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcC
Q 048419 75 ILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISS 154 (653)
Q Consensus 75 i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~ 154 (653)
|.+. ...+||||||||+|....+. +.|+||||++.+++ .++..+|+|||||||++|.+|.||++||||||+||+.|.
T Consensus 80 I~~~-~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~~-~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~ 156 (243)
T 1gsl_A 80 LKNY-GAPTADGLAFFLAPVDSSVK-DYGGFLGLFRHETA-ADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSV 156 (243)
T ss_dssp EEES-SSSCBCEEEEEEEETTCCCC-CCGGGTTTSCTTTT-TCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCS
T ss_pred EecC-CCCCCCCEEEEEecCCCCCC-CCCCcccccccccc-cCCccCcEEEEEeccccccccCCCCCCceeeccCCcccc
Confidence 9987 66789999999999876554 78899999987542 256678999999999999988899999999999999999
Q ss_pred CcccCccccCCCCccccccCC---CCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEeccc
Q 048419 155 ASEPASYYSGNNHRIPILLRS---GDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSAST 231 (653)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~l~~---g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsast 231 (653)
++++|. |.+ |+.++|||+|++.+++|+|+|.+.+. ..|+|++.+||+.+||++|||||||||
T Consensus 157 ~~~~~~------------l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~~vGFSAsT 221 (243)
T 1gsl_A 157 ATTRWE------------NDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLAKVLPQKVRIGFSAGV 221 (243)
T ss_dssp EEEECC------------HHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHHHHSCSEEEEEEEEEE
T ss_pred ceeeeE------------EeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechHHhCCCceEEEEEecc
Confidence 887752 456 99999999999999999999988654 468999999999999999999999999
Q ss_pred Ccccceeeecceeeeec
Q 048419 232 GLITASHNVHGWSISIG 248 (653)
Q Consensus 232 g~~~~~~~i~sWsf~~~ 248 (653)
| ..|.|+|++|+|++.
T Consensus 222 G-~~~~h~IlsWsF~s~ 237 (243)
T 1gsl_A 222 G-YDEVTYILSWHFFST 237 (243)
T ss_dssp C-BSEEEEEEEEEEEEE
T ss_pred C-CcceeEEEEEEEEee
Confidence 9 999999999999875
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-58 Score=446.58 Aligned_cols=217 Identities=29% Similarity=0.458 Sum_probs=196.8
Q ss_pred CceeEEeCCCCCCCeEEecceEecCCCcEEecCC---CCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCC
Q 048419 7 DTTSFLYNGFLHANLSLEGAAYISTSGILTVTNK---SEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLG 83 (653)
Q Consensus 7 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~---~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~ 83 (653)
..++|+|+.|...||+|+|||.+.++|.|+||++ ..+++|||+|++||+||++.+++++||+|+|+|.|.+.+...+
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 81 (226)
T 1avb_A 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred cceEEEcCCCCccCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCCCCC
Confidence 4579999999988999999999987999999998 6789999999999999999999999999999999998877779
Q ss_pred CCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCcccc
Q 048419 84 GQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYS 163 (653)
Q Consensus 84 gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~ 163 (653)
||||||||+|....|. +.|+||||+|..+ ++..+|+|||||||+ +||||||+||+.|.++++|.
T Consensus 82 gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~---~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~~--- 145 (226)
T 1avb_A 82 AYGLAFALVPVGSRPK-LKGRYLGLFNTTN---YDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESCN--- 145 (226)
T ss_dssp CEEEEEEEEETTCCCC-CCGGGTTTCSCSS---CCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEECC---
T ss_pred CCcEEEEEecCCCCCC-CCCCcccccccCC---CCCcccEEEEEecCc---------CCccceeecCcccCccccCC---
Confidence 9999999999876665 7889999998753 456789999999998 68999999999999988753
Q ss_pred CCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cceeee
Q 048419 164 GNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TASHNV 240 (653)
Q Consensus 164 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~~~i 240 (653)
+.|.+|+.++|||+||+.+++|+|+|.+.+.+ +.|+|++.+||+++||++|||||||+||.. .|.|+|
T Consensus 146 -------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~I 216 (226)
T 1avb_A 146 -------FGHNNGEKAEVRITYDSPKNDLRVSLLYPSSE--EKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNV 216 (226)
T ss_dssp -------SGGGTTCEEEEEEEEEGGGTEEEEEEEETTTT--EEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEE
T ss_pred -------ccccCCCeEEEEEEEeCCCcEEEEEEeecCCC--ccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEE
Confidence 46779999999999999999999999887543 378999999999999999999999999998 999999
Q ss_pred cceeeeec
Q 048419 241 HGWSISIG 248 (653)
Q Consensus 241 ~sWsf~~~ 248 (653)
++|+|++.
T Consensus 217 lsWsF~s~ 224 (226)
T 1avb_A 217 LSWSFSSN 224 (226)
T ss_dssp EEEEEEEE
T ss_pred EEEEEEee
Confidence 99999863
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=440.81 Aligned_cols=216 Identities=29% Similarity=0.463 Sum_probs=194.8
Q ss_pred CceeEEeCCCCCCC-eEEecceEecCCCcEEecCCCC------CceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 7 DTTSFLYNGFLHAN-LSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 7 ~~~~f~~~~f~~~~-l~~~g~a~~~~~g~l~Lt~~~~------~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
.+++|+|+.|...| |+|+|||.+.++|.|+||++.. .++|||+|++||+|||+. +++||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~--~vaSFsT~F~F~I~~~~ 79 (240)
T 1ioa_A 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN--NVASFNTNFTFIIRAKN 79 (240)
T ss_dssp CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS--CBEEEEEEEEEECCBSC
T ss_pred cceEEEcCCCCCCCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC--ccccEEEEEEEEEeCCC
Confidence 56899999999889 9999999998799999998775 799999999999999986 89999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccC
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPA 159 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 159 (653)
...+||||||||+|....|. +.|+||||+|.++ ++..+|+|||||||+ +||||||+||+.|.++.+|
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~~---~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~ 146 (240)
T 1ioa_A 80 QSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTNN---PEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNENC 146 (240)
T ss_dssp TTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCSS---CCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC
T ss_pred CCCCCCcEEEEEecCCCCCC-CCCCcccccccCC---CCCcCcEEEEEecCc---------CCceeeeeCCccccccccC
Confidence 77799999999999876666 8889999998753 456789999999998 6899999999999998875
Q ss_pred ccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cc
Q 048419 160 SYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TA 236 (653)
Q Consensus 160 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~ 236 (653)
. +.|.+|+.++|||+||+.+++|+|+|.+.+. ++.|+|+..|||+++|||+|||||||+||.. .|
T Consensus 147 ~----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~ 214 (240)
T 1ioa_A 147 D----------FHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTE 214 (240)
T ss_dssp C----------HHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCB
T ss_pred C----------ccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceeEEEechHHhCCCceEEEEEeccCCCCcccc
Confidence 3 4677999999999999999999999988754 3478999999999999999999999999998 99
Q ss_pred eeeecceeeeecC
Q 048419 237 SHNVHGWSISIGG 249 (653)
Q Consensus 237 ~~~i~sWsf~~~~ 249 (653)
.|+|++|+|++..
T Consensus 215 ~H~IlsWsF~s~~ 227 (240)
T 1ioa_A 215 THDVLSWSFSSKF 227 (240)
T ss_dssp CCEEEEEEEEEEE
T ss_pred eeEEEEEEEEeeC
Confidence 9999999998753
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=411.41 Aligned_cols=200 Identities=25% Similarity=0.419 Sum_probs=176.3
Q ss_pred CceeEEeCCCCCCCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCc
Q 048419 7 DTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQG 86 (653)
Q Consensus 7 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdG 86 (653)
..++|+|++|...||+|+|+|.+.++|.|+||++..+++|||+|++||+||++.+++++||+|+|+|.|.+++...+|||
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~gdG 81 (223)
T 1dhk_B 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSAVG 81 (223)
T ss_dssp CCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CCSE
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCCCCc
Confidence 56799999999889999999999879999999998899999999999999999999999999999999998777779999
Q ss_pred eEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCCC
Q 048419 87 LAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNN 166 (653)
Q Consensus 87 laF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~ 166 (653)
|||||+|....|. +++|||||||+ +||||||+||+ |.++.+|.
T Consensus 82 lAF~l~p~~~~p~---------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~~------ 124 (223)
T 1dhk_B 82 LDFVLVPVQPESK---------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPWD------ 124 (223)
T ss_dssp EEEEEEEC---------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEECC------
T ss_pred eEEEEecCCCCCC---------------------ccEEEEEecCC---------CCcccccCCcc-ccccccCC------
Confidence 9999999754321 23699999998 68999999999 98887752
Q ss_pred CccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cceeeecce
Q 048419 167 HRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TASHNVHGW 243 (653)
Q Consensus 167 ~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~~~i~sW 243 (653)
+.|.+|+.++|||+||+.+++|+|++.+.+. ++.|+|++.+||+++||++|||||||+||.. .|.|+|++|
T Consensus 125 ----~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsW 198 (223)
T 1dhk_B 125 ----VHDYDGQNAEVRITYNSSTKVFSVSLSNPST--GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSW 198 (223)
T ss_dssp ----GGGTTTSCEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEE
T ss_pred ----ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEE
Confidence 4677999999999999999999999987654 3478999999999999999999999999998 999999999
Q ss_pred eeeecC
Q 048419 244 SISIGG 249 (653)
Q Consensus 244 sf~~~~ 249 (653)
+|++..
T Consensus 199 sF~s~~ 204 (223)
T 1dhk_B 199 SFSSKF 204 (223)
T ss_dssp EEEEEC
T ss_pred EEEecc
Confidence 998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=446.07 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=210.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|...+.||+|+||.||+|++. .+++.||||+++....+..++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34667889999999999999865 3578999999987777778899999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhccccc----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 405 VYDYVPNGSLDKLLFDKDHK----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
|||||++|+|.++|+..... ....++|.++++|+.|||+||+|||+ ++|+||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 99999999999999765321 12469999999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +.+.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHHHH
Confidence 9999999987644322 23344679999999999999999999999999999999999 899998654432 112221
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLP 611 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 611 (653)
. +. ++ ..+...++.+.+|+.+||+.||++||||.||+++|+.-...|
T Consensus 275 ~----g~-------~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 275 Q----GR-------EL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp H----TC-------CC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred c----CC-------CC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1 11 00 112223467889999999999999999999999998654443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-54 Score=441.61 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=213.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|...+.||+|+||+||+|++. .++..||||+++....+..++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677899999999999999875 3478899999987777778899999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccc--------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 405 VYDYVPNGSLDKLLFDKDH--------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
|||||++|+|.++|..... .....++|.++++|+.|||+||+|||+ ++|+||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 9999999999999976431 113469999999999999999999999 89999999999999999999999
Q ss_pred EeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhh
Q 048419 477 GDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 477 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +...+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~~- 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECITQ- 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHHH-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc-
Confidence 999999866443222 2233568999999999999999999999999999999999 899998654432 1112211
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.. ...+...++.+.+|+.+||+.||++||||.||++.|+.
T Consensus 246 ---~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 246 ---GRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp ---TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 11122345678999999999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=437.48 Aligned_cols=258 Identities=25% Similarity=0.365 Sum_probs=211.5
Q ss_pred cCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 332 FGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++..+.||+|+||+||+|.+. .+++.||||+++.. .....++|.+|+.++++|+|||||+++|+|.+.+.++||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445788999999999999974 35688999999654 334467899999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 406 YDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
||||++|+|.++|..... .....++|.++++|+.|||+||+|||+ ++||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCE
Confidence 999999999999976431 113469999999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||......+ +.+.+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i~ 261 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMIR 261 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence 9999999987644322 23345679999999999999999999999999999999998 899998654432 222222
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
. +.. ...+..++..+.+|+.+||+.||.+||||.||+++|+.-
T Consensus 262 ~----~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 N----RQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp T----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred c----CCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 111 111223456788999999999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=435.60 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=205.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+++...+.||+|+||+||+|++.+ .||||+++.. ..+..+.|.+|++++++++|||||+++|+|.+ +.++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 456678899999999999999853 5999998643 45567889999999999999999999999865 56899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
||++|+|.++|.... ..++|.++++|+.|||+||+|||+ ++||||||||+||||++++++||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999997653 459999999999999999999999 8999999999999999999999999999987654
Q ss_pred CC-CCcccccccCCcccCcccccc---CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 488 GA-NPQTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 488 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.. ........||+.|||||++.+ +.++.++|||||||+||||+||+.||........ +...+......
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~~~~~~~~------ 256 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFMVGRGYAS------ 256 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHTTCCC------
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCCCC------
Confidence 32 223445689999999999864 4589999999999999999999999976543221 11112211111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC-CCCCCC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG-DSSLPP 612 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-~~~~p~ 612 (653)
+.+......++..+.+|+.+||+.||++||||.||+++|+. ..++|.
T Consensus 257 --p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 257 --PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp --CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred --CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 11112222345678999999999999999999999998864 233443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=437.25 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=206.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+++|++|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999999999999999999654 34456789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
||++|+|.++|.... ...+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999997643 3457888999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+. ...+.. +...
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~~----~~~~------ 243 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VLKIIS----GSFP------ 243 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH----TCCC------
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHc----CCCC------
Confidence 11 122446799999999999999999999999999999999999999986543221 111111 1110
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.........+.+|+.+||+.||.+|||+.|++++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111234668899999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=431.55 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=213.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+.|+..+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999999999999999997665555667889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999998643 38999999999999999999999 999999999999999999999999999999765432
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ...+... ..+.+.
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~---------~~~~~~ 291 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDN---------LPPRLK 291 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHS---------SCCCCS
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcC---------CCCCCC
Confidence 233456899999999999999999999999999999999999999986543321 1111111 001110
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 011224678899999999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=423.74 Aligned_cols=251 Identities=24% Similarity=0.226 Sum_probs=205.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+.|...++||+|+||.||+|++..+|+.||||+++.... ..+|+.++++|+|||||++++++.+.+.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 457778899999999999999999999999999965432 246999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCcccccCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAKIYEHG 488 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 488 (653)
++|+|.++|... ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+|+.+...
T Consensus 133 ~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 133 EGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999764 358999999999999999999999 9999999999999999987 6999999999976543
Q ss_pred CCC----cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 489 ANP----QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 489 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
... .....+||+.|||||++.+..++.++|||||||++|||+||+.||........ + ..+... ...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~-~~i~~~--~~~----- 274 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--C-LKIASE--PPP----- 274 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--H-HHHHHS--CCG-----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--H-HHHHcC--CCC-----
Confidence 211 12235799999999999999999999999999999999999999976443211 1 111110 000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+...+......+.+++.+||+.||.+|||+.|++++|..
T Consensus 275 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 275 ---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011122335678899999999999999999999998853
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=413.59 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=201.2
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc----cceeEEEE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK----QDELLLVY 406 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 406 (653)
...+.||+|+||.||+|.+..++..||||++... .....+.|.+|++++++|+|||||+++++|.+ .+.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5567899999999999999999999999999643 44456789999999999999999999999865 35689999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEEcC-CCcEEEEeecCcc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR--VVHRDVKPSNILLDT-YLNAKLGDFGLAK 483 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfGla~ 483 (653)
|||++|+|.++|... ..+++..+..++.||++||+|||+ ++ |+||||||+||||+. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999754 358999999999999999999999 66 999999999999974 7999999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.... ......+||+.|||||++.+ +++.++|||||||+||||+||+.||........ +...+. .+.....
T Consensus 181 ~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~----~~~~~~~ 250 (290)
T 3fpq_A 181 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT----SGVKPAS 250 (290)
T ss_dssp GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT----TTCCCGG
T ss_pred eCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHH----cCCCCCC
Confidence 6432 23345689999999999865 699999999999999999999999975433221 111111 1111111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.++ ...+.+.+|+.+||+.||.+|||+.|++++-
T Consensus 251 ~~~-------~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 251 FDK-------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp GGG-------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCc-------cCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 111 1134688999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=421.15 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=209.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||+||+|++..+|+.||||++.+. .....+.+.+|+++|++|+|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4588999999999999999999999999999999653 2344678999999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||++|+|.++|... ..+++.+...++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999764 348999999999999999999999 999999999999999999999999999999775
Q ss_pred CCC-CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGA-NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... .......+||+.|||||++.+..++.++||||+||++|||+||+.||....... +...+.. +..
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~----~~~----- 251 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKIIK----LEY----- 251 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----TCC-----
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHc----CCC-----
Confidence 432 233455789999999999999999999999999999999999999998654322 1111111 100
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (653)
.++......+.+|+.+||+.||.+|||+.|++
T Consensus 252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 01112245688999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=433.20 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=214.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+.|+..+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++|+|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888999999999999999999999999999997765556677899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999998643 38999999999999999999999 999999999999999999999999999999765432
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ...+... ..+.+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~---------~~~~~~ 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDN---------LPPRLK 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHS---------CCCCCS
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcC---------CCCCCc
Confidence 233456899999999999999999999999999999999999999986544321 1111111 011110
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 011224678899999999999999999999986543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=410.54 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=198.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|++++++++|||||++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999654 2334567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||| +|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+||||++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 68999998764 348999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... .....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||....... +...+.. +..
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i~~----~~~----- 229 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNISN----GVY----- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----TCC-----
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHc----CCC-----
Confidence 322 2344689999999999988776 579999999999999999999998654321 1111111 100
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLP 611 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 611 (653)
..+......+.+|+.+||+.||.+|||+.|++++-.-...+|
T Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p 271 (275)
T 3hyh_A 230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP 271 (275)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence 011112456889999999999999999999998655444444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=424.93 Aligned_cols=261 Identities=24% Similarity=0.363 Sum_probs=211.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCC-----CcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCC-Cceeeeeeeeccc-c
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRH-RNLVQLHGWCRKQ-D 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~-~ 400 (653)
.++|+..+.||+|+||.||+|.+.+. ++.||||++.... ....+.|.+|+.+|++++| ||||+++|+|.+. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 46788899999999999999987543 3689999997653 3456789999999999975 8999999999765 5
Q ss_pred eeEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
.++||||||++|+|.++|+..... ....++|.+++.++.|||+||+|||+ ++||||||||+||||+
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeC
Confidence 689999999999999999764321 13458999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
+++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||........ +
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~--~ 297 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F 297 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 9999999999999976544332 3345678999999999999999999999999999999998 8999976443221 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.. +. ++ ..+......+.+++.+||+.||.+|||+.||+++|+.
T Consensus 298 ~~~i~~----g~-------~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 298 CRRLKE----GT-------RM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp HHHHHH----TC-------CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHc----CC-------CC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111111 11 01 1112234678899999999999999999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=420.03 Aligned_cols=264 Identities=27% Similarity=0.332 Sum_probs=198.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc----eeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----ELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 405 (653)
+++...+.||+|+||+||+|++. |+.||||++..... ....+..|+..+.+++|||||+++++|.+.+ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45677899999999999999984 78999999964432 2223345777778899999999999998764 57999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC-----NQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
||||++|+|.++|+.. .++|+++++++.|+++||+|||+.+ .++|+||||||+||||+.++++||+|||
T Consensus 80 ~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999654 3899999999999999999999831 2499999999999999999999999999
Q ss_pred CcccccCCCCC---cccccccCCcccCccccccC------CCCCccceeehHHHHHHHHhCCCCCChhhhhhH----H--
Q 048419 481 LAKIYEHGANP---QTTHIVGTLGYLAPELTRTG------KATTSTDVYSYGILMLEVACGRRSIEPQKAAAE----L-- 545 (653)
Q Consensus 481 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~----~-- 545 (653)
+++........ ......||+.|||||++.+. .++.++|||||||+||||+||+.|+........ .
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99876543321 22345799999999998754 467899999999999999999877643221100 0
Q ss_pred --HHHHHHHhhhcccchhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 546 --LLVDWVKELHLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 546 --~l~~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.+...... +.+++.+ .....+....+.+|+.+||+.||.+||||.||++.|+.
T Consensus 234 ~~~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 234 SDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SSCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred ccchHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 000001110000 0111112 11223566789999999999999999999999999864
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=366.27 Aligned_cols=175 Identities=28% Similarity=0.448 Sum_probs=159.1
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGG 84 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g 84 (653)
.+++|+|+.|. ..+|+|+|+|+ .++|.|+||+....++|||+|++||+||++.+++++||+|+|+|.|.+.+...+|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~~g 80 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVA 80 (181)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCC
T ss_pred cceEEEcCCCCCCCCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCCCC
Confidence 46899999998 68999999999 6789999999999999999999999999999999999999999999987777799
Q ss_pred CceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCC--CCeeeEecCCCCcCCcccCccc
Q 048419 85 QGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDIN--DNHVGIDISSLISSASEPASYY 162 (653)
Q Consensus 85 dGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~~~~~~~~ 162 (653)
|||||||+|....|. +.|+||||+|.++ ++..+|+|||||||++|.+ |||+ +|||||||||+.|.++++|
T Consensus 81 dGlAF~l~p~~~~p~-~~g~~LGL~n~~~---~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~--- 152 (181)
T 2ltn_A 81 DGFTFFIAPVDTKPQ-TGGGYLGVFNSAE---YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW--- 152 (181)
T ss_dssp CEEEEEEEETTCCCC-CCGGGTTTCSCSS---CCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC---
T ss_pred CceEEEEecCCCCCC-CCCccccccccCC---CCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceecc---
Confidence 999999999876665 7899999998753 4667899999999999988 6999 9999999999999988775
Q ss_pred cCCCCccccccCCCCceEEEEEecCCceEEEEEEeeC
Q 048419 163 SGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPL 199 (653)
Q Consensus 163 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~ 199 (653)
+|.+|+.++|||+||+.+++|+|+|.+.
T Consensus 153 ---------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~ 180 (181)
T 2ltn_A 153 ---------KLQNGEEANVVIAFNAATNVLTVSLTYP 180 (181)
T ss_dssp ---------CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred ---------ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence 3579999999999999999999999763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=412.30 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=199.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|+..+.||+|+||+||+|+.. .+++.||||++.... ......+.+|+++|++++|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999873 457899999996542 2233468889999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|||||++|+|.++|... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999764 358999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
..... ......+||+.|||||++.+..++.++||||+||++|||+||+.||...+..+. ...+.. +.
T Consensus 176 ~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~~----~~----- 242 (304)
T 3ubd_A 176 SIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---MTMILK----AK----- 242 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----CC-----
T ss_pred ccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---HHHHHc----CC-----
Confidence 54322 223446899999999999999999999999999999999999999986544321 111111 00
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFL 604 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 604 (653)
. .++......+.+|+.+||+.||.+||| ++|++++-
T Consensus 243 ---~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 243 ---L-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp ---C-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred ---C-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence 0 011123456889999999999999998 56777643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=406.30 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=193.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc--------
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-------- 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 400 (653)
++|+..+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999999999999999997554 344567999999999999999999999986544
Q ss_pred ----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 401 ----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 401 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
.+|+|||||++|+|.+++..... ....++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEE
Confidence 37999999999999999976542 2334566788999999999999999 99999999999999999999999
Q ss_pred EeecCcccccCCCCC-----------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH
Q 048419 477 GDFGLAKIYEHGANP-----------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL 545 (653)
Q Consensus 477 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~ 545 (653)
+|||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||....+..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~-- 234 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV-- 234 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH--
Confidence 999999876543221 1233579999999999999999999999999999999996 776432211
Q ss_pred HHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 546 LLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 546 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.....+. ........ ......+.+|+.+||+.||.+|||+.|++++-
T Consensus 235 ~~~~~~~----~~~~p~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 235 RTLTDVR----NLKFPPLF--------TQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp HHHHHHH----TTCCCHHH--------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHh----cCCCCCCC--------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 1111111 11111111 12234567899999999999999999999854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=400.95 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=208.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc------cc
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK------QD 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 400 (653)
.++|+..+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+++|++|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46799999999999999999999999999999999654 33445678899999999999999999998754 35
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
.+|||||||+ |+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 7899999995 6899998764 359999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCC---CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 481 LAKIYEHGA---NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 481 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
+++.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.............
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998764321 1233456899999999998765 568999999999999999999999987654433221111110000
Q ss_pred cc--------chhHhhhhcc--CcCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 557 EG--------EITQAIDQTL--DYYDLA-----EAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 557 ~~--------~~~~~~d~~l--~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. .....+.... ...+.. ....+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 00 0000000000 001111 23568899999999999999999999987644
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=387.90 Aligned_cols=293 Identities=38% Similarity=0.720 Sum_probs=248.5
Q ss_pred CCcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-hhHHHHHHHHHHHhhcCCCceeeeee
Q 048419 316 GARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-QGMKEFVAEIMSMGRLRHRNLVQLHG 394 (653)
Q Consensus 316 ~~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g 394 (653)
....|++.++..++++|...+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3568999999999999999999999999999999865 588999999865432 22336889999999999999999999
Q ss_pred eecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 395 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
+|...+..++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 999999999999999999999999875432 4558999999999999999999999333399999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhh--hHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA--AELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~ 552 (653)
||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......+|+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999999877654444445567999999999998889999999999999999999999999754322 2334566777
Q ss_pred hhhcccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCC
Q 048419 553 ELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSL 610 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 610 (653)
.......+....+..+ ..........+.+++.+||+.||.+|||+.||+++|++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 7666666667666666 566778889999999999999999999999999999986443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=386.20 Aligned_cols=286 Identities=36% Similarity=0.616 Sum_probs=240.6
Q ss_pred CcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeee
Q 048419 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396 (653)
Q Consensus 317 ~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 396 (653)
..++++.++..++++|+..+.||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||++++++|
T Consensus 26 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp ----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred ceeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345677778889999999999999999999999975 5889999999777667788899999999999999999999999
Q ss_pred cccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 397 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
.+.+..++||||+++|+|.+++...... ...++|.+++.++.|+++||.|||+ ++|+||||||+||+++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEE
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999765321 3458999999999999999999999 89999999999999999999999
Q ss_pred EeecCcccccCCC-CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh
Q 048419 477 GDFGLAKIYEHGA-NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 477 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.............|.....
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 9999998654322 222334568999999999988899999999999999999999999998655443334455555555
Q ss_pred cccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 556 LEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 556 ~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
..+.+...+++.+ ..........+.+++.+||+.||.+|||+.||+++|+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 5555556666655 455677889999999999999999999999999999753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=385.68 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=201.3
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
...++|+..+.||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+++ +||||+++++++.+.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45688999999999999999999864 457899999986543 345678999999998 699999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEeecC
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGL 481 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 481 (653)
++|||||++|+|.+++. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+
T Consensus 96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 99999999999999883 27889999999999999999999 999999999999999877 7999999999
Q ss_pred cccccCCCC---------------------------CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCC
Q 048419 482 AKIYEHGAN---------------------------PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGR 533 (653)
Q Consensus 482 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~ 533 (653)
|+....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986533211 112345799999999998765 5899999999999999999999
Q ss_pred CCCChhhhhhHHHHHHHHHhhh---------------------cccchhHhhhh---------cc-----C-----cCCH
Q 048419 534 RSIEPQKAAAELLLVDWVKELH---------------------LEGEITQAIDQ---------TL-----D-----YYDL 573 (653)
Q Consensus 534 ~p~~~~~~~~~~~l~~~~~~~~---------------------~~~~~~~~~d~---------~l-----~-----~~~~ 573 (653)
.||.......+. +........ ........... .+ . ....
T Consensus 245 ~Pf~~~~~~~~~-l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 245 YPFYKASDDLTA-LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp SSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCHHHH-HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 999654322111 111100000 00000000000 00 0 0000
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 574 AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+.+.+|+.+||+.||.+|||++|++++-.
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 12356889999999999999999999998654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=407.32 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=214.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|+..+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|++|+|||||++++++.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999999999999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC--CcEEEEeecCccccc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY--LNAKLGDFGLAKIYE 486 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~ 486 (653)
|++|+|.++|.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 236 ~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999986542 358999999999999999999999 999999999999999754 899999999999765
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+... .........
T Consensus 309 ~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i~~~--~~~~~~~~~- 380 (573)
T 3uto_A 309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSC--DWNMDDSAF- 380 (573)
T ss_dssp TT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHTT--CCCCCSGGG-
T ss_pred CC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHhC--CCCCCcccc-
Confidence 43 234456899999999999999999999999999999999999999986554321 1111111 001110000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 381 ------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 381 ------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp ------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred ------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 112356789999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=400.71 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=203.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHH---HHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEF---VAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|+..++||+|+||.||+|++..+|+.||||++.+.. .+..... ..++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56999999999999999999999999999999996431 1222223 34567778889999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
||||||+||+|.++|... ..+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999764 348999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
..... .....+||+.|||||++.. ..|+.++|+||+||+||||++|+.||..........+...+...
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-------- 409 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------- 409 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--------
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--------
Confidence 76543 2344689999999999964 57999999999999999999999999765432211111111110
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 604 (653)
.. .++......+.+|+.+||+.||.+|++ +.||+++-
T Consensus 410 ----~~-~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 410 ----AV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp ----CC-CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ----CC-CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 00 111123466889999999999999998 78888754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.78 Aligned_cols=281 Identities=37% Similarity=0.608 Sum_probs=233.6
Q ss_pred CCcccCHHHHHHhhcCcCcc------eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC----chhhHHHHHHHHHHHhhcC
Q 048419 316 GARRFKYAELASVTKGFGEQ------NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN----SQQGMKEFVAEIMSMGRLR 385 (653)
Q Consensus 316 ~~~~f~~~el~~at~~f~~~------~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~ 385 (653)
....|++.++..++++|... +.||+|+||.||+|.. ++..||||++... ..+..+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45789999999999999888 8999999999999987 4789999998643 2345678999999999999
Q ss_pred CCceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 048419 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465 (653)
Q Consensus 386 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 465 (653)
||||+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~N 163 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSAN 163 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGG
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHH
Confidence 99999999999999999999999999999999976432 3568999999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH
Q 048419 466 ILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE 544 (653)
Q Consensus 466 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~ 544 (653)
|+++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 99999999999999999876543222 2233578999999998864 588999999999999999999999986543221
Q ss_pred HHHHHHHHhh-hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 545 LLLVDWVKEL-HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 545 ~~l~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+..+.... .....+.+.+++.+..........+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 243 --LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp --TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111111 1223455566666666677788899999999999999999999999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=362.44 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=213.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999999889999999999766656677889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|+|.+++... .+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999653 38899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ...... +.+
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~----------~~~ 236 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNGT----------PEL 236 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHHCS----------CCC
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCCC----------CCC
Confidence 32 23345799999999999999999999999999999999999999976544322111 111000 000
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+......+.+++.+||+.||.+|||+.|++++-.-
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 0111234568899999999999999999999986543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=366.42 Aligned_cols=257 Identities=21% Similarity=0.369 Sum_probs=212.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56788999999999999999999999999999997777777889999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999997643 458999999999999999999999 899999999999999999999999999998764332
Q ss_pred CCc-------------ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 490 NPQ-------------TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 490 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
... .....||+.|+|||.+.+..++.++|||||||++|||++|..|+......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~----------~ 232 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD----------F 232 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT----------S
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH----------H
Confidence 211 11457999999999999999999999999999999999999988653321100 0
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
........+... +......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 233 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 233 GLNVRGFLDRYC---PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279 (310)
T ss_dssp SBCHHHHHHHTC---CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhhccccccC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001111111111 11223468899999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.85 Aligned_cols=268 Identities=21% Similarity=0.301 Sum_probs=221.2
Q ss_pred CCcccCHHHHHHhhcC----------cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC
Q 048419 316 GARRFKYAELASVTKG----------FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR 385 (653)
Q Consensus 316 ~~~~f~~~el~~at~~----------f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 385 (653)
....+++++++.+++. |...+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.++++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3467899999998875 677789999999999999998889999999997766666788999999999999
Q ss_pred CCceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 048419 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465 (653)
Q Consensus 386 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 465 (653)
||||+++++++...+..++||||+++++|.+++... .+++.+++.++.|+++||.|||+ ++|+||||||+|
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~N 171 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDS 171 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHH
Confidence 999999999999999999999999999999998643 38999999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH
Q 048419 466 ILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL 545 (653)
Q Consensus 466 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~ 545 (653)
||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~- 249 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA- 249 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-
T ss_pred EEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999999987654322 23445799999999999999999999999999999999999999976543221
Q ss_pred HHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 546 LLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 546 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.... .+.+. ........+.+++.+||+.||.+|||+.|++++...
T Consensus 250 --~~~~~~~~---------~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 250 --MKRLRDSP---------PPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp --HHHHHHSS---------CCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred --HHHHhcCC---------CCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 11111110 01110 011123568899999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=379.22 Aligned_cols=270 Identities=20% Similarity=0.226 Sum_probs=218.2
Q ss_pred cccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeee
Q 048419 318 RRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHG 394 (653)
Q Consensus 318 ~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g 394 (653)
..+.+.+++..+++|+..++||+|+||+||+|++..+++.||||++.... ....+.+.+|..++.+++||||+++++
T Consensus 62 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp HHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred ccchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34567777788899999999999999999999999999999999996432 122334889999999999999999999
Q ss_pred eecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 395 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
+|.+.+.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+
T Consensus 142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCE
T ss_pred EEeeCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCE
Confidence 9999999999999999999999997642 348999999999999999999999 999999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHH
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVD 549 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 549 (653)
||+|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. .
T Consensus 215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~---~ 291 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---G 291 (437)
T ss_dssp EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H
T ss_pred EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH---H
Confidence 99999999876544333334468999999999987 567899999999999999999999999865443211 1
Q ss_pred HHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHc
Q 048419 550 WVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVY--RPDMRRVVEFLL 605 (653)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 605 (653)
.+....... ............+.+|+.+||+.+|.+ ||++.|++++-.
T Consensus 292 ~i~~~~~~~--------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 292 KIMNHKERF--------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HHHTHHHHC--------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred hhhhccccc--------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 111000000 000000112456889999999888888 999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=363.20 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=211.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
.++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46789999999999999999999889999999999654 4455678899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999764 348899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCcccccccCCcccCccccccCCCC-CccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKAT-TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.. .......||+.|+|||.+.+..+. .++||||+||++|||++|+.||....... +.+.+.. +.
T Consensus 166 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~----~~------ 230 (328)
T 3fe3_A 166 VG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR----GK------ 230 (328)
T ss_dssp SS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----CC------
T ss_pred CC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CC------
Confidence 43 234456799999999999888765 79999999999999999999998654322 1111111 10
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 231 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 231 ---YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 0111122456889999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.77 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=204.4
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
...++|+..+.||+|+||.||+|... +..||||++... ..+..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34567888999999999999999874 789999998654 34456789999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR--VVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 112 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999999976542 3458999999999999999999999 78 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..+......
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~----- 257 (309)
T 3p86_A 187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKCKR----- 257 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHHSCCC-----
T ss_pred ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCCC-----
Confidence 8644322 2233457899999999999999999999999999999999999999865443211 111111000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
...+......+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 258 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 258 ------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=357.20 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=209.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.++|+..+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+..+++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46789999999999999999999989999999998543 334567899999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999654 348999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
............||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . ... .........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~----~~~-~~~~~~~~~ 234 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--I----KHI-QDSVPNVTT 234 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--H----HHH-SSCCCCHHH
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--H----HHh-hccCCCcch
Confidence 544333344567999999999999999999999999999999999999999865432211 0 000 111111100
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHcCCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRP-DMRRVVEFLLGDS 608 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~ 608 (653)
. ........+.+++.+||+.||.+|| ++.++.+.|+...
T Consensus 235 ~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 235 D----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp H----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred h----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0 1112246788999999999999999 9999999997643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=361.03 Aligned_cols=267 Identities=22% Similarity=0.325 Sum_probs=208.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEE----eCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--cee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGL----MPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DEL 402 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 402 (653)
.++|+..+.||+|+||.||+|. ...+++.||||++........+.+.+|++++++++||||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3578889999999999999998 4567899999999877777778899999999999999999999998654 458
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 99999999999999997653 348999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc---
Q 048419 483 KIYEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE--- 557 (653)
Q Consensus 483 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--- 557 (653)
+....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+........ .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM----RMIGNDKQGQMI 237 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH----HHHCTTCCTHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH----hhhcCccccchh
Confidence 87644321 122234567789999999999999999999999999999999999875432210 000000000
Q ss_pred -cchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 -GEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 -~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+.+.+.... ...+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00111111111 11223345779999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=359.00 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=209.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5788899999999999999999989999999999653 2344667889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999998653 348899999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+.+.. +.
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~----~~------- 221 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILM----EE------- 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----CC-------
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHHHc----CC-------
Confidence 221 23344679999999999999999999999999999999999999997654321 1111111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
+ .++......+.+++.+||+.||.+|| ++.|++++-
T Consensus 222 -~-~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 222 -I-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp -C-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -C-CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 0 01112345688999999999999999 999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=361.42 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=208.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC---cEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG---LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||.||+|.+..++ ..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999987544 45999999765 445567899999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 129 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999996543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 486 EHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 486 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ ...+....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~~~~~------- 271 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---ISSVEEGY------- 271 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHHHTTC-------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHcCC-------
Confidence 543222 1222346778999999998899999999999999999999 9999976543321 11111110
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
....+......+.+|+.+||+.||.+||++.||++.|+..
T Consensus 272 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 272 -----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111122346788999999999999999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.59 Aligned_cols=265 Identities=24% Similarity=0.354 Sum_probs=204.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc----eeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----ELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 405 (653)
++|+..++||+|+||.||+|.+. ++.||||++..... ....+..|+.++++++||||+++++++.... .+++|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 57888999999999999999986 78999999965433 3445667999999999999999999998754 47999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCcEEEcCCCcEE
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ----------RVVHRDVKPSNILLDTYLNAK 475 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~ivH~Dlkp~NIll~~~~~~k 475 (653)
|||+++|+|.+++... .+++..++.++.|+++||.|||+ . +|+||||||+|||++.++.+|
T Consensus 101 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 9999999999999653 38999999999999999999999 7 999999999999999999999
Q ss_pred EEeecCcccccCCCC-CcccccccCCcccCccccccC-----CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHH
Q 048419 476 LGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTG-----KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVD 549 (653)
Q Consensus 476 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 549 (653)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987654332 223345799999999998763 45678999999999999999999997543221111110
Q ss_pred HHHhhhcccchhHhh-----hhccC--cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 550 WVKELHLEGEITQAI-----DQTLD--YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 550 ~~~~~~~~~~~~~~~-----d~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+.+ .+.+. .........+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000000000011111 01110 1123456779999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=366.05 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=211.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC-------CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP-------SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
++|...+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+.+++++ +||||++++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 67888999999999999999863 24568999999755 344567899999999999 8999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
.+++||||+++|+|.+++...... ....+++.+++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 999999999999999999765321 12358899999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999986644322 22333467889999999999999999999999999999999 999997644322 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+.... ....+......+.+++.+||+.||.+||++.|+++.|+.
T Consensus 315 ~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 315 FKLLKEGH------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHHHHTTC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCC------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111110 011122234678899999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=347.49 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=210.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3678889999999999999998874 77899999965432 346789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred cCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999997642 458999999999999999999999 89999999999999999999999999999876544
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... .+.. +.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~~~----~~-------- 222 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL---KVSQ----GH-------- 222 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---HHHT----TC--------
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH---HHHc----CC--------
Confidence 3333333456778999999998889999999999999999999 999997654432111 1110 00
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
....+......+.+++.+||+.||.+|||+.|++++|+.-
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0001111235688999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=368.08 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=198.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||.||+|++. ..+..||||++... .....+.|.+|+.++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999876 45778999999754 344567899999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++.... ..+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 125 ~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999997643 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCc--ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 486 EHGANPQ--TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 486 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~~~~~------ 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVDEGYR------ 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHHTTEE------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC------
Confidence 5432211 122345778999999999999999999999999999998 999997654322 1111111100
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+++.+||+.||.+||++.||++.|+.
T Consensus 269 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 269 ------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 11112334678999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.97 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=210.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh------hHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ------GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
..++|...+.||+|+||.||+|.+..+|+.||||.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999999999999999999754321 35788999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL----NAKLG 477 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 477 (653)
+++||||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 99999999999999999653 348999999999999999999999 8999999999999998777 79999
Q ss_pred eecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... .
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~~i~~~--~ 234 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANITAV--S 234 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHTT--C
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhc--C
Confidence 999998765432 23345799999999999988999999999999999999999999976543221 1111110 0
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
........ . .....+.+++.+||+.||.+|||+.|++++-.
T Consensus 235 ~~~~~~~~---~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 235 YDFDEEFF---S----QTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CCCCHHHH---T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCCchhc---c----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 00000000 0 12356889999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=355.69 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=199.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..++||+|+||+||+|.+..+++.||||++... .......+..|+..+.++ +|+||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999999988999999998653 233444566666666665 8999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+ +++|.+++.... ..++|.+++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 137 e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp ECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred ecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999 679999886643 458999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+........ ...+.....+..
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----------~~~~~~~~~~~~ 275 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ----------LRQGYLPPEFTA 275 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH----------HTTTCCCHHHHT
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----------HhccCCCccccc
Confidence 322 2334569999999999875 789999999999999999999877654332110 111111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.....+.+++.+||+.||.+|||+.|++++-.
T Consensus 276 -------~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 276 -------GLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp -------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -------CCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 12367889999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=369.69 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=209.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|...+.||+|+||.||+|.+..+++.||||.+... ..+..+.|.+|++++++++||||++++++|...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 5678889999999999999999888999999998754 334456789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|+|.+++.... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 194 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 194 VQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999997542 358899999999999999999999 89999999999999999999999999999864332
Q ss_pred CCCcc-cccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 489 ANPQT-THIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 489 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
..... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..+.+....
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~----------- 332 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVEKGG----------- 332 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHHTTC-----------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-----------
Confidence 11111 11235678999999998899999999999999999998 999997654322 111111110
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+ ..+......+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 333 ~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 333 RL-PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 00 1111234578899999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.08 Aligned_cols=271 Identities=21% Similarity=0.266 Sum_probs=214.9
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc--eeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD--ELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 405 (653)
.++|...++||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999999999999999997543 344677889999999999999999999987665 78999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEEeecC
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL----DTYLNAKLGDFGL 481 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl 481 (653)
|||+++++|.+++..... ...+++.+++.++.||++||.|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999987542 2348999999999999999999999 899999999999999 8888899999999
Q ss_pred cccccCCCCCcccccccCCcccCccccc--------cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH--HHHHHHH
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTR--------TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE--LLLVDWV 551 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~ 551 (653)
++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ..+....
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 98765432 223457999999999886 56789999999999999999999999974332211 1111111
Q ss_pred HhhhcccchhHh---hh------hcc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 552 KELHLEGEITQA---ID------QTL---DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 552 ~~~~~~~~~~~~---~d------~~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
... ....+... .. ..+ ..........+.+++.+||+.||++|||+.|++++...+
T Consensus 241 ~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCC-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111 11000000 00 011 133456778899999999999999999999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.81 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=207.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||++....+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999999899999999996532 234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999764 348899999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. .
T Consensus 158 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~------------~ 218 (318)
T 1fot_A 158 D----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILN------------A 218 (318)
T ss_dssp S----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHH------------C
T ss_pred C----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHh------------C
Confidence 3 22345799999999999999999999999999999999999999976543211 111110 0
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
.+ .++......+.+++.+||+.||.+|| ++.|++++-
T Consensus 219 ~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 219 EL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CC-CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 01 01112235688999999999999999 899999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=349.54 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=208.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 568889999999999999999874 77899999965432 3467899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ..+++..++.++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999996643 458999999999999999999999 899999999999999999999999999998654332
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+.... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~~~~~~~~------------~ 225 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGF------------R 225 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTC------------C
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHhcCc------------c
Confidence 222233456778999999998999999999999999999999 9999976543221 11111100 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+||++.|++++|+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 01111124568899999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=367.35 Aligned_cols=265 Identities=22% Similarity=0.232 Sum_probs=213.9
Q ss_pred CHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeec
Q 048419 321 KYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397 (653)
Q Consensus 321 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 397 (653)
.+.+++...++|...++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566667789999999999999999999999999999999986421 122345789999999999999999999999
Q ss_pred ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEE
Q 048419 398 KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477 (653)
Q Consensus 398 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 477 (653)
+.+.+++||||+++|+|.+++... .+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEe
Confidence 999999999999999999998643 37889999999999999999999 899999999999999999999999
Q ss_pred eecCcccccCCCCCcccccccCCcccCccccccCC----CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK----ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
|||+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......... ..+..
T Consensus 211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~~i~~ 287 (410)
T 3v8s_A 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---SKIMN 287 (410)
T ss_dssp CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHT
T ss_pred ccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH---HHHHh
Confidence 99999876543322334568999999999997655 788999999999999999999999865433211 11110
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHcC
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVY--RPDMRRVVEFLLG 606 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~ 606 (653)
... ....+. .......+.+|+.+||+.+|.+ ||++.||+++-..
T Consensus 288 ~~~-----~~~~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 288 HKN-----SLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp HHH-----HCCCCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ccc-----cccCCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 000 000000 0012456889999999999988 9999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.39 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=210.5
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------hhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
..++|...+.||+|+||.||+|.+..++..||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34568889999999999999999998999999999865422 136789999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL----NAKLG 477 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 477 (653)
.++||||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999999653 348999999999999999999999 9999999999999998887 89999
Q ss_pred eecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+... .
T Consensus 161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~--~ 233 (326)
T 2y0a_A 161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAV--N 233 (326)
T ss_dssp CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHHT--C
T ss_pred ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHhc--C
Confidence 999998765332 223457999999999999889999999999999999999999999765432211 111110 0
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
........ . .....+.+++.+||+.||.+|||+.|++++-.-
T Consensus 234 ~~~~~~~~---~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 234 YEFEDEYF---S----NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp CCCCHHHH---T----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCcCcccc---c----cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 00000000 0 123568899999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.19 Aligned_cols=256 Identities=18% Similarity=0.246 Sum_probs=211.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999999999999999986543 345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCcEEEEeecCcccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT--YLNAKLGDFGLAKIY 485 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~ 485 (653)
|+++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 82 ~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred eCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999996542 358999999999999999999999 89999999999999987 789999999999876
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..... .......
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~--~~~~~~~ 227 (321)
T 1tki_A 155 KPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEY--TFDEEAF 227 (321)
T ss_dssp CTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCC--CCCHHHH
T ss_pred CCC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHcCCC--CCChhhh
Confidence 543 23344679999999999998889999999999999999999999997654322 1111111000 0000000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
. .....+.+++.+||+.||.+|||+.|++++-.
T Consensus 228 ---~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 228 ---K----EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ---T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ---c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 0 12356889999999999999999999999664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.18 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=208.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999999899999999986543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999654 348999999999999999999999 9999999999999999999999999999986543
Q ss_pred CC-CCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 488 GA-NPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 488 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.. ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+........
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~------- 229 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLN------- 229 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCTTST-------
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcccccCC-------
Confidence 22 122334579999999999987765 7799999999999999999999976543211 1111111110000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
........+.+|+.+||+.||.+|||+.|++++.....
T Consensus 230 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 00112356789999999999999999999998776543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.35 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=202.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-------
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------- 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 400 (653)
.++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467888999999999999999999889999999997543 345678999999999999999999999885543
Q ss_pred --------------------------------------------------eeEEEEeccCCCCchhhhhcccccccccch
Q 048419 401 --------------------------------------------------ELLLVYDYVPNGSLDKLLFDKDHKLRKLLT 430 (653)
Q Consensus 401 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~ 430 (653)
..++|||||++++|.+++..... ....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence 37999999999999999987543 34456
Q ss_pred hhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC-----------CcccccccC
Q 048419 431 WDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN-----------PQTTHIVGT 499 (653)
Q Consensus 431 ~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt 499 (653)
+..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 77789999999999999999 8999999999999999999999999999987654321 122335699
Q ss_pred CcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHH
Q 048419 500 LGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELV 579 (653)
Q Consensus 500 ~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 579 (653)
+.|+|||.+.+..++.++|||||||++|||++|..|+..... ...... ...... ........+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-----~~~~~~----~~~~~~--------~~~~~~~~~ 302 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-----IITDVR----NLKFPL--------LFTQKYPQE 302 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-----HHHHHH----TTCCCH--------HHHHHCHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-----HHHHhh----ccCCCc--------ccccCChhH
Confidence 999999999999999999999999999999998776532211 111111 111111 011233567
Q ss_pred HHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 580 LNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 580 ~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+++.+||+.||.+|||+.|++++-
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHccCCCCcCCCHHHHhhch
Confidence 8999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=363.75 Aligned_cols=271 Identities=23% Similarity=0.332 Sum_probs=215.3
Q ss_pred ccCHHHHHHhhcCcCcceeeeeeCcEEEEEEE-----eCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceee
Q 048419 319 RFKYAELASVTKGFGEQNLVGSGGFGRVYRGL-----MPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQ 391 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~ 391 (653)
.+...+.....++|...+.||+|+||.||+|. ...+++.||||++... .....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 34445555567889999999999999999998 5556789999999764 344567899999999999 7999999
Q ss_pred eeeeecccce-eEEEEeccCCCCchhhhhcccccc---------------------------------------------
Q 048419 392 LHGWCRKQDE-LLLVYDYVPNGSLDKLLFDKDHKL--------------------------------------------- 425 (653)
Q Consensus 392 l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~--------------------------------------------- 425 (653)
++++|.+.+. .++||||+++|+|.+++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 899999999999999997653210
Q ss_pred ----------------cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 426 ----------------RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 426 ----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
...+++..++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1228899999999999999999999 899999999999999999999999999998664332
Q ss_pred C-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 490 N-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 490 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
. .......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ +...+....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~------------ 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGT------------ 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTC------------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCC------------
Confidence 2 22334568899999999999999999999999999999998 9999976443221 111111100
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+......+.+++.+||+.||.+|||+.||+++|+.
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 001111224568899999999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.33 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=210.2
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
...++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4457899999999999999999999999999999999654 34456788999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEEeecC
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL---NAKLGDFGL 481 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl 481 (653)
||||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999988654 348999999999999999999999 8999999999999997654 599999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+...... ..
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~~~~~--~~ 250 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKAGAYD--YP 250 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCC--CC
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCCCC--CC
Confidence 98765322 2234579999999999998899999999999999999999999997654321 11111111000 00
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+.. ......+.+|+.+||+.||.+||++.|++++-
T Consensus 251 ---~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 251 ---SPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp ---TTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred ---cccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0000 11235688999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=380.34 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=213.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|.+..++..||||++.... ...+.|.+|+.+|++++||||++++++|.+.+.+++||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 45778899999999999999998889999999996543 34678999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 299 ~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 299 TYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp TTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred CCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999997643 3458899999999999999999999 899999999999999999999999999998765433
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+....++.++|||||||++|||++ |+.||....... +.+.+.... .
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~-----------~- 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDY-----------R- 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTC-----------C-
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-----------C-
Confidence 222233456789999999998899999999999999999999 999997654322 111111110 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
...+......+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111222346788999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=355.83 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=208.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999999899999999986532 234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999764 348999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+.+.. +.
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~----~~------- 254 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVS----GK------- 254 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----CC-------
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHHHHc----CC-------
Confidence 32 234579999999999999999999999999999999999999998654321 1111111 10
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~ 605 (653)
+ .++......+.+++.+||+.||.+||+ +.||+++-.
T Consensus 255 -~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 255 -V-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -C-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -C-CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 0 011122456889999999999999998 899987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=359.76 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=213.0
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 34689999999999999999999999999999999977666666789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCcEEEEeecCcccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT--YLNAKLGDFGLAKIY 485 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~ 485 (653)
|+++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 129 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999999987542 358999999999999999999999 89999999999999974 577999999999876
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...... .+
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~~~~~------~~ 270 (387)
T 1kob_A 202 NPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRCDWE------FD 270 (387)
T ss_dssp CTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHCCCC------CC
T ss_pred CCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCCC------CC
Confidence 5432 23345799999999999988999999999999999999999999986543221 1111111000 00
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..........+.+++.+||+.||.+|||+.|++++-.
T Consensus 271 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 271 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 0001122456889999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.05 Aligned_cols=270 Identities=23% Similarity=0.247 Sum_probs=216.6
Q ss_pred CcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeee
Q 048419 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLH 393 (653)
Q Consensus 317 ~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~ 393 (653)
+..+.+.++....++|+..++||+|+||.||+++...+|+.||||++.+.. ....+.+.+|..++.+++||||++++
T Consensus 48 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 344566777777899999999999999999999999899999999996532 22334588999999999999999999
Q ss_pred eeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 394 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
+++.+.+.+++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.+++
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSC
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCC
Confidence 99999999999999999999999997542 358999999999999999999999 99999999999999999999
Q ss_pred EEEEeecCcccccCCCCCcccccccCCcccCccccc-------cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH
Q 048419 474 AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR-------TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~ 546 (653)
+||+|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~- 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY- 279 (412)
T ss_dssp EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-
T ss_pred EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-
Confidence 999999999876543332333468999999999987 356899999999999999999999999865443211
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHc
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYR---PDMRRVVEFLL 605 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~L~ 605 (653)
..+........ +..........+.+|+.+||+ +|.+| |++.|++++-.
T Consensus 280 --~~i~~~~~~~~--------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 280 --GKIVHYKEHLS--------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp --HHHHTHHHHCC--------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred --HHHHhcccCcC--------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 11110000000 000011224678899999999 99998 69999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.71 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=200.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcE----EEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLE----VAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|+..+.||+|+||.||+|.+..+++. ||+|.+... .....+.+.+|+.++++++||||++++++|.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5688899999999999999998766654 588887543 3345678999999999999999999999998765 789
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++.
T Consensus 94 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999997653 458999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+.....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~------ 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGER------ 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCC------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHHHcCCC------
Confidence 6543322 2233456889999999999999999999999999999999 999997654322 1111111100
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+||++.|++++|+.
T Consensus 238 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 238 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11112234578899999999999999999999998864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=356.59 Aligned_cols=258 Identities=20% Similarity=0.282 Sum_probs=208.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-----hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-----QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457888999999999999999999999999999985421 224678899999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEEeec
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN---AKLGDFG 480 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG 480 (653)
+|||||++++|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999888654321 3358899999999999999999999 89999999999999977655 9999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~i~~~~~---~~ 251 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER---LFEGIIKGKY---KM 251 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH---HHHHHHHTCC---CC
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH---HHHHHHcCCC---CC
Confidence 998765432 2233457999999999999889999999999999999999999999864321 1111111100 00
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.... .. .....+.+|+.+||+.||.+|||+.|++++-
T Consensus 252 ~~~~---~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 252 NPRQ---WS----HISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp CHHH---HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Cccc---cc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 0000 00 1235688999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=361.65 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=204.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 404 (653)
-++|+..++||+|+||.||+|++..+++.||||++... .....+.+..|..+++.+ +||||+++++++.+.+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999653 234456788999999988 69999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999764 348999999999999999999999 8999999999999999999999999999985
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.+..
T Consensus 174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~----------- 238 (353)
T 3txo_A 174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAILN----------- 238 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH-----------
T ss_pred cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH---HHHHHc-----------
Confidence 4322 2233446799999999999988899999999999999999999999986544321 111111
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDM------RRVVEFL 604 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L 604 (653)
... .++......+.+++.+||+.||.+||++ .|++++-
T Consensus 239 -~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 239 -DEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp -CCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred -CCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 000 1111234568899999999999999998 7888654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=359.73 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=208.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|.+..+++.||||++.... .+..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57889999999999999999998899999999986431 222457889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+ +|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 78999888654 348999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....... +...+.
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i~ 221 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKKVN 221 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCCCC
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHH
Confidence 432 2334579999999999987775 689999999999999999999997543211 001111
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLP 611 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 611 (653)
......+......+.+|+.+||+.||.+|||+.|++++-.....+|
T Consensus 222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 1111112223466889999999999999999999998765443333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=346.89 Aligned_cols=269 Identities=24% Similarity=0.301 Sum_probs=207.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688899999999999999999999999999999654 33445788899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++ +|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 666655443 2358999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--ccchhHh-
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--EGEITQA- 563 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~- 563 (653)
.. .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+........ .+......... .......
T Consensus 154 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 PV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGG
T ss_pred cc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhc
Confidence 22 2233457899999999997765 79999999999999999999888644332221 11111111100 0000000
Q ss_pred --hh----------hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 564 --ID----------QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 564 --~d----------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
.+ ..+..........+.+++.+||+.||.+|||+.|++++-....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 00 0000111223467889999999999999999999998765443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.51 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=199.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--------------------------hhHHHHHHHHHHHhh
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--------------------------QGMKEFVAEIMSMGR 383 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 383 (653)
++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 578899999999999999999998999999999865421 123568899999999
Q ss_pred cCCCceeeeeeeecc--cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 048419 384 LRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDV 461 (653)
Q Consensus 384 l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 461 (653)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.+++.++.||++||.|||+ ++|+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 999999999999976 5678999999999999887643 348999999999999999999999 89999999
Q ss_pred CCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCC---CCCccceeehHHHHHHHHhCCCCCCh
Q 048419 462 KPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK---ATTSTDVYSYGILMLEVACGRRSIEP 538 (653)
Q Consensus 462 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~s~Gvvl~elltG~~p~~~ 538 (653)
||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998765432 2233457999999999997665 37789999999999999999999976
Q ss_pred hhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 539 QKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 539 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
..... +...+..... .. + ........+.+++.+||+.||.+||++.|++++
T Consensus 243 ~~~~~---~~~~~~~~~~--~~-----~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERIMC---LHSKIKSQAL--EF-----P----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSHHH---HHHHHHHCCC--CC-----C----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccHHH---HHHHHhcccC--CC-----C----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 44321 1111111000 00 0 001123568899999999999999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=366.41 Aligned_cols=258 Identities=23% Similarity=0.286 Sum_probs=210.1
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
...++|...+.||+|+||.||+|.+..+|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999999999999999996543 3445678999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEEeecC
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD---TYLNAKLGDFGL 481 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl 481 (653)
||||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999998764 348999999999999999999999 8999999999999998 467899999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... +...+..... ...
T Consensus 160 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~--~~~ 233 (444)
T 3soa_A 160 AIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQQIKAGAY--DFP 233 (444)
T ss_dssp CBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTCC--CCC
T ss_pred eEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHhCCC--CCC
Confidence 98765432 22334679999999999999899999999999999999999999997654322 1111111100 000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+.. ......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 234 ---~~~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 234 ---SPEW----DTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp ---TTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred ---cccc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 0000 112456889999999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=346.45 Aligned_cols=260 Identities=18% Similarity=0.194 Sum_probs=210.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|...+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+..++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467899999999999999999998889999999986442 234578899999999 79999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-----EEEEeecCc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN-----AKLGDFGLA 482 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla 482 (653)
|+ +++|.+++.... ..+++.+++.++.||++||+|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 87 ~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99 999999997643 348999999999999999999999 89999999999999987776 999999999
Q ss_pred ccccCCCCC------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 483 KIYEHGANP------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 483 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
+........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 876543221 23445799999999999998999999999999999999999999986433222111111111111
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.....+.. . .....+.+++.+||+.||.+||++.+|++.|+.
T Consensus 239 ~~~~~~~~----~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 239 STPLRELC----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HSCHHHHT----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CccHHHHH----h----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 11111110 0 124678899999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.66 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=211.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
..++|...+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.++++++||||++++++|.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 35678889999999999999999863 4589999999765 34456789999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccc-------------------cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKL-------------------RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVK 462 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 462 (653)
.++||||+++|+|.+++....... ...+++.+++.++.||++||.|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 999999999999999997643110 1468999999999999999999999 899999999
Q ss_pred CCcEEEcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhh
Q 048419 463 PSNILLDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQK 540 (653)
Q Consensus 463 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~ 540 (653)
|+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986543221 22233467889999999998899999999999999999999 999997654
Q ss_pred hhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 541 AAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 541 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
... +...+. .+.. ...+......+.+++.+||+.||.+||++.+++++|+..
T Consensus 282 ~~~---~~~~~~----~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 282 HEE---VIYYVR----DGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp HHH---HHHHHH----TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hHH---HHHHHh----CCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 322 111111 1111 111122346788999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.24 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=204.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..++||+|+||.||+|++..+++.||||++.+. .....+.+..|..++.++ +||||+++++++.+.+.+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 5688999999999999999999999999999999754 223345678899999887 899999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 132 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999998754 348999999999999999999999 89999999999999999999999999999853
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH--HHHHHHHhhhcccchhHh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL--LLVDWVKELHLEGEITQA 563 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 563 (653)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.+....
T Consensus 204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-------- 274 (396)
T 4dc2_A 204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------- 274 (396)
T ss_dssp CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--------
T ss_pred ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--------
Confidence 222 22344568999999999999999999999999999999999999999643211100 0000011100
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDM------RRVVEFL 604 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L 604 (653)
.... ..++......+.+|+.+||+.||.+||++ .||+++-
T Consensus 275 ~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 275 LEKQ-IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp HHCC-CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred hccc-cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 0011 11122234678899999999999999985 6777654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.03 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=205.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 467888999999999999999987 477899999975432 346789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 101 MANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999997642 348999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+.... .
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~~~---------~-- 239 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQGL---------R-- 239 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTC---------C--
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH---HHHhccc---------C--
Confidence 2222233456788999999998899999999999999999998 99999865432211 1111100 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+|||+.|++++|..
T Consensus 240 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 240 -LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 01111123578899999999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=354.86 Aligned_cols=267 Identities=24% Similarity=0.264 Sum_probs=209.3
Q ss_pred HHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-----chhhHHHHHHHHHHHhhcCCCceeeeeeeec
Q 048419 323 AELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-----SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397 (653)
Q Consensus 323 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 397 (653)
.++..+.++|...+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 34567788999999999999999999999999999999998643 3445678999999999999999999999999
Q ss_pred ccceeEEEEeccCCCCchhhhhcccc-----------------------------------cccccchhhhHHHHHHHHH
Q 048419 398 KQDELLLVYDYVPNGSLDKLLFDKDH-----------------------------------KLRKLLTWDQRYKILIGIA 442 (653)
Q Consensus 398 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~ia 442 (653)
+.+..++||||+++|+|.+++..... .....+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 99999999999999999999853111 0122357788899999999
Q ss_pred HHHHHHHhcCCCCeEecCCCCCcEEEcCCC--cEEEEeecCcccccCCCC---CcccccccCCcccCcccccc--CCCCC
Q 048419 443 QSLLYLHEECNQRVVHRDVKPSNILLDTYL--NAKLGDFGLAKIYEHGAN---PQTTHIVGTLGYLAPELTRT--GKATT 515 (653)
Q Consensus 443 ~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~ 515 (653)
+||+|||+ ++|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.
T Consensus 179 ~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 8999999999999998776 899999999986543221 12344579999999999875 67889
Q ss_pred ccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC
Q 048419 516 STDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP 595 (653)
Q Consensus 516 ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (653)
++|||||||++|||++|+.||......... ........ ... .+.. ......+.+++.+||+.||.+||
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~---~~~---~~~~----~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQVLNKKL---CFE---NPNY----NVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCC---CTT---SGGG----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHhccc---ccC---Cccc----ccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999999765443211 11111100 000 0000 01235688999999999999999
Q ss_pred CHHHHHHHH
Q 048419 596 DMRRVVEFL 604 (653)
Q Consensus 596 s~~evl~~L 604 (653)
++.|++++-
T Consensus 324 s~~~~l~hp 332 (345)
T 3hko_A 324 DAMRALQHP 332 (345)
T ss_dssp CHHHHHHSH
T ss_pred CHHHHhcCh
Confidence 999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=363.63 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=208.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|...+.||+|+||.||+|.+ ..++..||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 5678899999999999999994 345778999999654 4455667899999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhccccc--ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEEe
Q 048419 404 LVYDYVPNGSLDKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL---NAKLGD 478 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~D 478 (653)
+||||+++|+|.+++...... ....+++.+++.++.||++||+|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999765321 12458999999999999999999999 8999999999999998555 599999
Q ss_pred ecCcccccCC-CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 479 FGLAKIYEHG-ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 479 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
||+++..... .........||+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +.+.+....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~~~~- 303 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTSGG- 303 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHTTC-
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-
Confidence 9999855322 1222334567899999999999999999999999999999998 999997654322 111111110
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...........+.+|+.+||+.||.+||++.+|+++|+.
T Consensus 304 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 304 -----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 001111234568899999999999999999999999965
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.73 Aligned_cols=258 Identities=19% Similarity=0.193 Sum_probs=208.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|...+.||+|+||.||+|....+++.||||++..... .+.+.+|+.+++++ +|+||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4678999999999999999999988899999999865432 24578999999999 99999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-----EEEEeecCc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN-----AKLGDFGLA 482 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla 482 (653)
|+ +++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99 999999997642 458999999999999999999999 89999999999999998887 999999999
Q ss_pred ccccCCCCC------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 483 KIYEHGANP------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 483 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
+........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 876443221 12356799999999999999999999999999999999999999986543222111111111110
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...... .. .. .+ .+.+++..||+.||.+||++.+|++.|+
T Consensus 238 ~~~~~~-~~---~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 238 ATPIEV-LC---EN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HSCHHH-HT---TT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred cCCHHH-Hh---cc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 000000 00 00 12 7899999999999999999999999885
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=359.63 Aligned_cols=276 Identities=22% Similarity=0.299 Sum_probs=218.0
Q ss_pred CcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-----CCceee
Q 048419 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-----HRNLVQ 391 (653)
Q Consensus 317 ~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 391 (653)
...+++.+.....++|...+.||+|+||.||+|.+..+++.||||++... ....+.+..|+.++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 45677888888889999999999999999999999888999999999643 344567788999999986 999999
Q ss_pred eeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-
Q 048419 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT- 470 (653)
Q Consensus 392 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~- 470 (653)
+++++...+..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDP 173 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccc
Confidence 999999999999999999 899999997654 2458899999999999999999999 99999999999999975
Q ss_pred ------------------------CCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHH
Q 048419 471 ------------------------YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILM 526 (653)
Q Consensus 471 ------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl 526 (653)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999864432 2345789999999999999999999999999999
Q ss_pred HHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh--------hhh----------------------ccCcCCHHHH
Q 048419 527 LEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA--------IDQ----------------------TLDYYDLAEA 576 (653)
Q Consensus 527 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--------~d~----------------------~l~~~~~~~~ 576 (653)
|||++|+.||......+..................+. ++. .+........
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 9999999999865543322211111100000000000 000 0000000112
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 577 ELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+.+.+|+.+||+.||.+|||+.|++++-
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 5688999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=372.84 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=209.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.++++++||||+++++++. .+..++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 34678889999999999999999864 7889999997543 34678999999999999999999999986 567899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999997643 2357889999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
..........++..|+|||.+....++.++|||||||++|||++ |+.||......+. ...+.....
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~~~~---------- 403 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALERGYR---------- 403 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHHTCC----------
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCC----------
Confidence 21111223346788999999998899999999999999999999 9999976543321 111111110
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+ ..+......+.+|+.+||+.||.+|||+.+|++.|+.-
T Consensus 404 -~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 404 -M-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp -C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -C-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 11122346788999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=352.45 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=215.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||+|.+..++..||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 456788899999999999999999988999999999654 3456789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp CCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred cCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999997654 3558999999999999999999999 8999999999999999999999999999987665
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..+.+....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~~~~----------- 229 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDY----------- 229 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTC-----------
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhccC-----------
Confidence 44333444567889999999998899999999999999999999 999987644322 111111110
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 011112234678899999999999999999999998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=355.16 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=213.5
Q ss_pred cCcCcceeeeeeCcEEEEEEE----eCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeec--ccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGL----MPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR--KQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 403 (653)
++|+..+.||+|+||.||+|. ...+++.||||++........+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 568889999999999999998 45678999999998777777788999999999999999999999886 455689
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 103 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999997642 348999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 484 IYEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 484 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
........ ......||..|+|||.+.+..++.++|||||||++|||++|+.|+.......... ..+.........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHH
Confidence 76543221 1233457888999999998889999999999999999999999987544321100 00000000001111
Q ss_pred Hhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 562 QAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 562 ~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.+.... ...+......+.+|+.+||+.||.+|||+.|++++|+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 300 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1222211 12233345778999999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=358.95 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=202.1
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
.+.||+|+||.||+|....+|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999999989999999999877666778899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCCCcEEEEeecCcccccCCCCCc
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL--DTYLNAKLGDFGLAKIYEHGANPQ 492 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~ 492 (653)
.+++.... ..+++.+++.++.||++||.|||+ ++|+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 99886542 358899999999999999999999 899999999999999 677899999999998765432 2
Q ss_pred ccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCC
Q 048419 493 TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572 (653)
Q Consensus 493 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 572 (653)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.......+. .. .....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~~---~~---~~~~~--- 313 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRWD---LE---DEEFQ--- 313 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCCC---SC---SGGGT---
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCC---CC---hhhhc---
Confidence 2334699999999999988999999999999999999999999986543321 1111111110 00 00001
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 573 LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.....+.+++.+||+.||.+||++.|++++-
T Consensus 314 -~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 314 -DISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -cCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 1235788999999999999999999999854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=347.19 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=196.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
.++|...+.||+|+||.||+|.+..+ +..||+|++... .....+.+.+|+..+++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 46788899999999999999998643 457999998654 3445678999999999999999999999984 456899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999997542 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ ...+... .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~----~---- 234 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENG----E---- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTT----C----
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcC----C----
Confidence 65443333334457789999999998899999999999999999997 9999976543221 1111110 0
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001112234678899999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.45 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=207.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||++....+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5688899999999999999999999999999998643 2334678889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999764 348999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCcccccc---CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+...+.
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----------- 233 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----------- 233 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-----------
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----------
Confidence 33 23345689999999999864 358899999999999999999999997543322111111111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-MRRVVEF 603 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 603 (653)
.....++......+.+|+.+||+.||.+||+ +.+|+++
T Consensus 234 --~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 234 --TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 1111122223467889999999999999998 7888763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=359.40 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=212.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCC-------CCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ 399 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 399 (653)
.++|...+.||+|+||.||+|.+.. .+..||||++... .....+.+.+|+++++++ +||||++++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3678889999999999999998642 3467999999754 344567899999999999 999999999999999
Q ss_pred ceeEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL 468 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 468 (653)
+..++||||+++|+|.+++...... ....+++.+++.++.||++||.|||+ ++|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 9999999999999999999765321 12458999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHH
Q 048419 469 DTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELL 546 (653)
Q Consensus 469 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 546 (653)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987644322 22334467889999999999999999999999999999999 999997654321
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+.+.+..... ...+......+.+++.+||+.||.+|||+.||+++|+..
T Consensus 302 ~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 302 LFKLLKEGHR------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHTTCC------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCC------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111100 011112346788999999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=346.24 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=199.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhh--cCCCceeeeeeeecc----cce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR--LRHRNLVQLHGWCRK----QDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~ 401 (653)
..++|...+.||+|+||.||+|.+ +++.||||++... ..+.+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 356889999999999999999998 4889999998543 33455666666666 799999999998654 346
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEEcCCCc
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH--------EECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
.++||||+++|+|.+++... .+++..+++++.||+.||+||| + ++|+||||||+|||++.++.
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSC
T ss_pred eEEehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCC
Confidence 89999999999999999543 4899999999999999999999 6 89999999999999999999
Q ss_pred EEEEeecCcccccCCCCCc---ccccccCCcccCccccccC------CCCCccceeehHHHHHHHHhC----------CC
Q 048419 474 AKLGDFGLAKIYEHGANPQ---TTHIVGTLGYLAPELTRTG------KATTSTDVYSYGILMLEVACG----------RR 534 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDV~s~Gvvl~elltG----------~~ 534 (653)
+||+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||++| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999998665433221 2234799999999999876 455799999999999999999 78
Q ss_pred CCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 535 SIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 535 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
||......... ............. .+.+ ..........+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 232 pf~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 232 PFYDVVPNDPS-FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTTTSCSSCC-HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccCCCCcc-hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 87643221110 0000000000000 0111 11223467889999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=346.18 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=206.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC-------cEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG-------LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 402 (653)
++|...+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56888999999999999999987665 47999999777777778899999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--------E
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN--------A 474 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 474 (653)
++||||+++++|.+++.... ..+++.+++.++.||++||.|||+ ++|+||||||+|||++.++. +
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999997653 348899999999999999999999 89999999999999998887 9
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
||+|||++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+........ .......
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQFYED 233 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHT
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHHHhhc
Confidence 9999999875422 233468899999999987 6789999999999999999996555443322111 1111110
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCC
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSS 609 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 609 (653)
...+. ......+.+++.+||+.||.+|||+.|++++|+.-..
T Consensus 234 ---~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 234 ---RHQLP-----------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ---TCCCC-----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ---cCCCC-----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00000 0113457899999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.52 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=208.1
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
...++|...+.||+|+||.||+|++..+++.||||++.... ....+.+..|..++.++ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999999999999996532 33456788899999887 899999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999753 348999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+... .
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~--~----- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMD--N----- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC--C-----
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHhC--C-----
Confidence 8643222 22345689999999999999899999999999999999999999998654322 11111110 0
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMR-RVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L 604 (653)
. .++......+.+++.+||+.||.+||++. +++++-
T Consensus 235 ---~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 235 ---P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred ---C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 0 11111245688999999999999999998 777543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.45 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=207.2
Q ss_pred cCcCcceeeeeeCcEEEEEEE----eCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--cee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGL----MPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 402 (653)
+.|+..+.||+|+||.||+|. ...+++.||||++... .....+.+.+|+.++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457889999999999999998 4567899999999754 334567889999999999999999999999876 568
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccc
Confidence 99999999999999996543 348999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc--
Q 048419 483 KIYEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG-- 558 (653)
Q Consensus 483 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 558 (653)
........ .......||..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF----LKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHHCSCCGGGHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH----hhccCCcccccCH
Confidence 87654332 12233467888999999998899999999999999999999999865432210 00000000000
Q ss_pred -chhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 559 -EITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 559 -~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+...+.... ...+......+.+|+.+||+.||.+|||+.|+++.|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111111 11222345678999999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=353.76 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=206.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||.||+|++..+++.||||++... .....+.+.+|..+++++ +||||+++++++.+.+.+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4688899999999999999999999999999999754 334566788999999988 899999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999653 348999999999999999999999 89999999999999999999999999999854
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH--HHHHHHHhhhcccchhHh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL--LLVDWVKELHLEGEITQA 563 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 563 (653)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.+.....
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~------- 232 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL------- 232 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH-------
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH-------
Confidence 3221 2334568999999999999989999999999999999999999999643211100 00001111000
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDM------RRVVEFL 604 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L 604 (653)
.... ..+......+.+++.+||+.||.+||++ .|++++-
T Consensus 233 -~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 233 -EKQI-RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp -HCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred -cCCC-CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 0001 1112234678899999999999999995 6777654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=349.03 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=211.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccccee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 402 (653)
.++|...+.||+|+||.||+|.+ ..++..||||++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788899999999999999987 344689999999754 345567899999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhhhccccc-------------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK-------------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKP 463 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 463 (653)
++||||+++++|.+++...... ....+++.+++.++.||++||.|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 9999999999999999765320 12358999999999999999999999 8999999999
Q ss_pred CcEEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhh
Q 048419 464 SNILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKA 541 (653)
Q Consensus 464 ~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~ 541 (653)
+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876443221 1223457788999999998889999999999999999999 9999976543
Q ss_pred hhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 542 AAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 542 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. +...+.... ....+......+.+++.+||+.||.+||++.|++++|+.
T Consensus 259 ~~---~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 ER---LFNLLKTGH------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GG---HHHHHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH---HHHHhhcCC------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22 111111110 011112234678899999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=341.31 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=209.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||+|.+..++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45678999999999999999999999999999999977666667889999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 484 (653)
|+++++|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+||++ +.++.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 87 LCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp CCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999988653 348999999999999999999999 899999999999999 8889999999999987
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
..... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......... ..+.... .......
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~--~~~~~~~ 230 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM---LKIREGT--FTFPEKD 230 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCC--CCCCHHH
T ss_pred ccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHhCC--CCCCchh
Confidence 65432 2334578999999999865 4899999999999999999999999865432211 1111100 0000000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
. . .....+.+++.+||+.||.+||++.|++++-
T Consensus 231 ~---~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 231 W---L----NVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp H---T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred h---h----cCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0 0 1236788999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=347.78 Aligned_cols=269 Identities=25% Similarity=0.302 Sum_probs=205.5
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
..++|+..+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 44778999999999999999999864 8999999996542 23356788999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++ +|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EECCSE-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EcCCCC-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 999975 8888876543 458999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH--
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ-- 562 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-- 562 (653)
.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...................
T Consensus 170 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 170 GIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred CCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 4332 22334578999999999876 5689999999999999999999999976554332211110000000000000
Q ss_pred ----hhhhcc---CcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 ----AIDQTL---DYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ----~~d~~l---~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+... ..... .....+.+|+.+||+.||.+|||+.|++++-..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 000000 00111 123578899999999999999999999986543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=349.13 Aligned_cols=264 Identities=24% Similarity=0.238 Sum_probs=209.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeec----ccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR----KQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~l 404 (653)
.++|...+.||+|+||.||++....+++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467889999999999999999998889999999997777777788999999999999999999999986 3457899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++|+|.+++...... ...+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999764221 3568999999999999999999999 8999999999999999999999999999876
Q ss_pred ccCCCCC--------cccccccCCcccCccccccCC---CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 485 YEHGANP--------QTTHIVGTLGYLAPELTRTGK---ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 485 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......... +.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh-
Confidence 4321111 112345799999999987543 688999999999999999999999653221111 000000
Q ss_pred hhcccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCC
Q 048419 554 LHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSL 610 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 610 (653)
... ..........+.+++.+||+.||.+||++.+++++|+...+.
T Consensus 262 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 262 ------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp ------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 000 001112245788999999999999999999999999875543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=351.38 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=195.4
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCc---EEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGL---EVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD 400 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 400 (653)
....++|...+.||+|+||.||+|.+..++. .||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445689999999999999999999876654 8999998654 4455778999999999999999999999998776
Q ss_pred ee------EEEEeccCCCCchhhhhcccccc-cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 401 EL------LLVYDYVPNGSLDKLLFDKDHKL-RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 401 ~~------~lV~E~~~~gsL~~~l~~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
.. ++||||+++|+|.+++....... ...+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence 54 99999999999999997643211 2258999999999999999999999 89999999999999999999
Q ss_pred EEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHH
Q 048419 474 AKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 551 (653)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ ...+
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~ 252 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---YNYL 252 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---HHHH
Confidence 99999999986644322 22233456789999999999999999999999999999999 8999976543221 1111
Q ss_pred HhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 552 KELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 552 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. .............+.+++.+||+.||.+|||+.++++.|+.
T Consensus 253 ~~------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 253 IG------------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp HT------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred hc------------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 00011112234678899999999999999999999998875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=341.95 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=194.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc----hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS----QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..+.||+|+||.||+|.+. +..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 57888999999999999999985 7899999986542 23356789999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCcEEEcC--------CCcE
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR---VVHRDVKPSNILLDT--------YLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---ivH~Dlkp~NIll~~--------~~~~ 474 (653)
|||+++++|.+++... .+++.+++.++.|+++||.|||+ ++ |+||||||+|||++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 9999999999998543 48899999999999999999999 66 999999999999986 7789
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhh
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 554 (653)
||+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+...
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~ 229 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY---GVAMN 229 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---HHHTS
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---hhhcC
Confidence 999999998654322 223478999999999998899999999999999999999999998654322110 00000
Q ss_pred hcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 555 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.. ....+......+.+++.+||+.||.+|||+.|++++|+.
T Consensus 230 ----~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 ----KL-------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----CC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----CC-------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 00 011112234678899999999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.78 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=212.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeec--ccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR--KQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l 404 (653)
.++|+..+.||+|+||.||++....+++.||+|++... .....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36788899999999999999999989999999999654 3445678999999999999999999999874 4568999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCcEEEcCCCcEEEEee
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR-----VVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
||||+++++|.+++..... ....+++.+++.++.|++.||.|||+ ++ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999976432 13458999999999999999999999 67 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
|+++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... +...+.. +.
T Consensus 161 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~~----~~ 232 (279)
T 2w5a_A 161 GLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIRE----GK 232 (279)
T ss_dssp CHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----TC
T ss_pred chheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHhh----cc
Confidence 9998754322 12233568999999999998889999999999999999999999998654321 1111111 11
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCCC
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLPP 612 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 612 (653)
. ...+......+.+++.+||+.||.+||++.||++++....+.++
T Consensus 233 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 277 (279)
T 2w5a_A 233 F--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277 (279)
T ss_dssp C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred c--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence 0 11111234678899999999999999999999999887665544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.71 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=194.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+.++|...+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||++++++|.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4678999999999999999999999889999999996543 34568899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 484 (653)
|+++++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 129 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 129 LVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred eCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999998754 348999999999999999999999 89999999999999975 88999999999986
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +...+.. ... ...
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i~~----~~~-~~~ 271 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRILN----CEY-YFI 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHHHT----TCC-CCC
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHHHh----CCC-ccC
Confidence 54322 22345789999999999998999999999999999999999999975443211 1111111 000 000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 00111234568899999999999999999999986543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.13 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=207.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 404 (653)
-++|...+.||+|+||.||+|....+++.||||++... .....+.+..|..++..+ +||||+++++++.+.+.+++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 36789999999999999999999988999999999654 233456788999999988 79999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 99 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999754 348999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+.+..
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~----------- 235 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIME----------- 235 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH-----------
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHHHh-----------
Confidence 43221 23345679999999999999999999999999999999999999998654321 1111111
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEFL 604 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 604 (653)
..+ .++......+.+|+.+||+.||.+||+ +.+++++-
T Consensus 236 -~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 236 -HNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp -CCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred -CCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 000 111123467889999999999999995 68888654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.13 Aligned_cols=268 Identities=21% Similarity=0.237 Sum_probs=207.9
Q ss_pred hcCcCcceeeeee--CcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSG--GFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G--~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
.++|+..+.||+| +||.||+|.+..+++.||||++... ..+..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3678899999999 9999999999989999999999654 34456778899999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|||||++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 104 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999997653 2458999999999999999999999 8999999999999999999999999999865
Q ss_pred ccCCC------CCcccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 485 YEHGA------NPQTTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 485 ~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~ 255 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVP 255 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCC
Confidence 42211 111223478999999999987 578999999999999999999999997644322110 00000000
Q ss_pred ---------cc-------------chhHhhh---hc-------cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 557 ---------EG-------------EITQAID---QT-------LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 557 ---------~~-------------~~~~~~d---~~-------l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. .+.+.+. +. ...........+.+|+.+||+.||.+|||+.|++++-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 00 0000000 00 0001112246689999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=348.31 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=198.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce----
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE---- 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 401 (653)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999999888999999999754 33445678999999999999999999999876653
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 49999999999999999754 348999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 482 AKIYEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 482 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ....... ...
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~---~~~ 237 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRE---DPI 237 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHC---CCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcC---CCC
Confidence 987644322 222345689999999999999999999999999999999999999986544221 1111111 000
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...... ......+.+++.+||+.||.+||+..++++.
T Consensus 238 ~~~~~~-------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 238 PPSARH-------EGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CHHHHS-------TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred Cccccc-------CCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 000000 0123568899999999999999987776653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.29 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=204.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999999889999999986543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... ..+++..++.++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999887653 348999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh-
Q 048419 488 GANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID- 565 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d- 565 (653)
.. .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.............. .......
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (311)
T 4agu_A 155 PS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP-RHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH-HHHHHHHT
T ss_pred cc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc-cccccccc
Confidence 22 22234578999999999876 56899999999999999999999999876544332221111000000 0000000
Q ss_pred ------hcc---Cc-CC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 566 ------QTL---DY-YD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 566 ------~~l---~~-~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+ .. .. ......+.+++.+||+.||.+|||+.|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 000 00 00 112456889999999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.54 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=209.4
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
..++|+..+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999999999999999998653 344567888999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEEeecCc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN---AKLGDFGLA 482 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla 482 (653)
|||+++++|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999888654 348999999999999999999999 89999999999999976655 999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+...... .
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~--~-- 226 (284)
T 3kk8_A 156 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQIKAGAYD--Y-- 226 (284)
T ss_dssp EECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCCC--C--
T ss_pred EEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---HHHHHhcccc--C--
Confidence 8664322 22345789999999999999999999999999999999999999976543221 1111111000 0
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..+.. ......+.+++.+||+.||.+|||+.|++++-
T Consensus 227 -~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 227 -PSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp -CTTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred -Cchhh----cccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 00000 11235688999999999999999999999854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=348.07 Aligned_cols=261 Identities=22% Similarity=0.343 Sum_probs=211.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceeeeeeeecccce
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 401 (653)
.++|...+.||+|+||.||+|.+ ..+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788899999999999999984 4567899999997553 34567899999999999 99999999999999999
Q ss_pred eEEEEeccCCCCchhhhhccccc-------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK-------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL 468 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 468 (653)
.++||||+++|+|.+++...... ....+++.+++.++.||++||.|||+ ++|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999765321 12358999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCCCc-ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHH
Q 048419 469 DTYLNAKLGDFGLAKIYEHGANPQ-TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELL 546 (653)
Q Consensus 469 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 546 (653)
+.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 999999999999998765443221 223457889999999998899999999999999999999 9999876443211
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+...+..... ..........+.+++.+||+.||.+|||+.|++++|+.
T Consensus 257 ~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 257 FYKMIKEGFR------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHHHTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhccCCC------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1111111100 00111234678899999999999999999999999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.49 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=203.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcE----EEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLE----VAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|...+.||+|+||.||+|.+..+++. ||+|.+... .....+.+.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4688899999999999999998777665 788877543 2333456788999999999999999999986 456899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++|+|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999997652 458999999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||........ .+.+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~------ 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLLEKGER------ 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHHHTTCB------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHHHcCCC------
Confidence 6543322 2234567889999999998999999999999999999999 9999986543221 111111100
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+||++.|++++|+.
T Consensus 236 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~ 273 (325)
T 3kex_A 236 ------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273 (325)
T ss_dssp ------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred ------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00111123357789999999999999999999999965
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.11 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=204.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-------hHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-------GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
.++|...+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999999989999999998653221 1267899999999999999999999997765
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEEcCCCc-----E
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR--VVHRDVKPSNILLDTYLN-----A 474 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~-----~ 474 (653)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++ |+||||||+|||++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeE
Confidence 69999999999999887653 458999999999999999999999 78 999999999999988776 9
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccc--cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR--TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
||+|||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||......... ......
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~ 243 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMIR 243 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHHH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHHh
Confidence 9999999975432 234457899999999984 455788999999999999999999999764432211 111111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..... ..........+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 244 ~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLR-----------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCC-----------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11100 11112234678999999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=353.28 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=209.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccce
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 401 (653)
.++|...+.||+|+||.||+|.+ ..++..||||++... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788899999999999999996 345678999999754 333457889999999999 89999999999999999
Q ss_pred eEEEEeccCCCCchhhhhccccc------------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK------------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKP 463 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 463 (653)
.++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 99999999999999999765321 01347899999999999999999999 8999999999
Q ss_pred CcEEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhh
Q 048419 464 SNILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKA 541 (653)
Q Consensus 464 ~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~ 541 (653)
+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 9999999999999999999876543322 2233467889999999998899999999999999999998 9999976543
Q ss_pred hhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 542 AAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 542 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
... +...+..... ...+......+.+|+.+||+.||.+|||+.|++++|+..
T Consensus 281 ~~~--~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 281 DAN--FYKLIQNGFK------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp SHH--HHHHHHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH--HHHHHhcCCC------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 211 1111111100 011112346788999999999999999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=366.68 Aligned_cols=255 Identities=28% Similarity=0.403 Sum_probs=203.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3567788999999999999999975 5679999997543 235689999999999999999999999976 678999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 260 ~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 260 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999997543 3458999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.........++..|+|||.+....++.++|||||||++|||++ |+.||......+ +.+.+.... +
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~-----------~ 399 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGY-----------R 399 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTC-----------C
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-----------C
Confidence 3223333457789999999998999999999999999999999 999997654322 111111110 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+ ..+......+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 400 ~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 400 M-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred C-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 11122346788999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.73 Aligned_cols=248 Identities=30% Similarity=0.390 Sum_probs=203.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-eeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD-ELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~ 408 (653)
++|...+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++++++||||++++++|.+.+ .+++||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46778899999999999999986 6799999996543 4578999999999999999999999987665 78999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|+|.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999997653 3347899999999999999999999 89999999999999999999999999999854322
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. ...+.. +. .
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~----~~-------~ 404 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK----GY-------K 404 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHHHT----TC-------C
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc----CC-------C
Confidence 122357889999999999999999999999999999998 9999976543221 111111 10 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 405 -~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 405 -MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01122335678899999999999999999999998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=340.44 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=207.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|...+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 56788999999999999999986 478899999975433 3467899999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++++|.+++.... ..+++..++.++.|+++||.|||+ ++++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp TTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999997642 358899999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+.....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~~~~------------ 223 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFR------------ 223 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTCC------------
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhcCCc------------
Confidence 112233456788999999998899999999999999999999 899997654321 1111111100
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+||++.+++++|+.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00111224568899999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.93 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=205.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.++|...+.||+|+||.||+|.+..++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888999999999999999999999999999985432 22356788999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998654 348899999999999999999999 89999999999999999999999999998654
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~----------- 222 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---KRISRV----------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHHT-----------
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH---HHHHhC-----------
Confidence 322 223457899999999999989999999999999999999999999865432211 111110
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
....+......+.+++.+||+.||.+||++.|++++-.
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 00111122456789999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.28 Aligned_cols=267 Identities=25% Similarity=0.378 Sum_probs=196.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467888999999999999999999889999999996543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhccccc-ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHK-LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|++ |+|.+++...... ....+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999988764311 12358899999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--cc-----
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--EG----- 558 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~----- 558 (653)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........... ....... ..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL--IFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCSCCTTTCGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCCChhHhhhh
Confidence 3222 22345789999999998764 689999999999999999999999986554332211 1111000 00
Q ss_pred ----------------chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 ----------------EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ----------------~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+.+.+.+.. .......+.+++.+||+.||.+|||+.|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGC---SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhhcccccccccchhHHHhhcccc---cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 0000111111 0112357899999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=345.61 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=210.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------hhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
..++|...+.||+|+||.||+|.+..+|+.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35678899999999999999999998999999999865422 136789999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL----NAKLG 477 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 477 (653)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999999753 348999999999999999999999 8999999999999999887 79999
Q ss_pred eecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..+... .
T Consensus 162 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~--~ 234 (321)
T 2a2a_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITSV--S 234 (321)
T ss_dssp CCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHTT--C
T ss_pred cCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHhc--c
Confidence 999998765432 223457899999999999889999999999999999999999999765432211 111110 0
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
........ . .....+.+++.+||+.||.+|||+.|++++-.
T Consensus 235 ~~~~~~~~---~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 235 YDFDEEFF---S----HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp CCCCHHHH---T----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred cccChhhh---c----ccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00000000 0 12356889999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.68 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=202.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688899999999999999998 568999999996543 2234678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++ +|.+++.... ..+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CCSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred ecCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 9975 8988886542 348899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--ccchhH--
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--EGEITQ-- 562 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~-- 562 (653)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... ........ ......
T Consensus 153 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 153 PV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGG
T ss_pred cc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHHCCCChhhchhhh
Confidence 22 222345789999999998754 58999999999999999999999998654432211 11111100 000000
Q ss_pred ---hhhhccC--------cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 ---AIDQTLD--------YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ---~~d~~l~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..++... .........+.+++.+||+.||.+|||+.|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0011110 01112346788999999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.06 Aligned_cols=266 Identities=18% Similarity=0.210 Sum_probs=207.1
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCC-----CcEEEEEEeccCchhhH-----------HHHHHHHHHHhhcCCCceee
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNSQQGM-----------KEFVAEIMSMGRLRHRNLVQ 391 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~ 391 (653)
..++|...+.||+|+||.||+|.+..+ ++.||||++........ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 446899999999999999999998764 57899999865542211 12445666778889999999
Q ss_pred eeeeeccc----ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 048419 392 LHGWCRKQ----DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNIL 467 (653)
Q Consensus 392 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 467 (653)
+++++... ...++||||+ +++|.+++... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEE
Confidence 99998765 4589999999 99999999764 2458999999999999999999999 89999999999999
Q ss_pred Ec--CCCcEEEEeecCcccccCCCCC------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChh
Q 048419 468 LD--TYLNAKLGDFGLAKIYEHGANP------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQ 539 (653)
Q Consensus 468 l~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~ 539 (653)
++ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98 8899999999999876432111 113345999999999999999999999999999999999999999864
Q ss_pred hhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 540 KAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 540 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..... ........ ....+.+.+++.+.. ......+.+++..||+.+|.+||++.+|++.|+.
T Consensus 265 ~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 265 LKDPK--YVRDSKIR-YRENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TTCHH--HHHHHHHH-HHHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCHH--HHHHHHHH-hhhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 33221 11111111 122344455544311 1124678899999999999999999999998853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.87 Aligned_cols=268 Identities=26% Similarity=0.307 Sum_probs=203.9
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-----hhhHHHHHHHHHHHhhc---CCCceeeeeeeecc
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-----QQGMKEFVAEIMSMGRL---RHRNLVQLHGWCRK 398 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~ 398 (653)
..+++|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++++ +||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34678999999999999999999998899999999986432 11224556677766666 49999999999977
Q ss_pred cc-----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc
Q 048419 399 QD-----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 399 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 473 (653)
.. ..++||||+. ++|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 54 5799999997 59999997654 2448999999999999999999999 89999999999999999999
Q ss_pred EEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 474 AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .....
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~i~~~ 234 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG--KIFDL 234 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH--HHHHH
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHH
Confidence 9999999998764332 2345678999999999999999999999999999999999999998655433211 11111
Q ss_pred hh--cccchhHhh---hhcc---CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 554 LH--LEGEITQAI---DQTL---DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 554 ~~--~~~~~~~~~---d~~l---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. ......... .... .... ......+.+++.+||+.||.+|||+.|++++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 10 000000000 0000 0000 112367889999999999999999999998653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.05 Aligned_cols=249 Identities=18% Similarity=0.306 Sum_probs=203.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 405 (653)
++|...+.||+|+||.||+|.+. +..||||++... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 56888999999999999999985 789999999754 345567899999999999999999999999887 778999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR--VVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
|||+++|+|.+++.... ...+++.+++.++.||++||.|||+ ++ ++||||||+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence 99999999999997654 3358999999999999999999999 78 9999999999999999999999999876
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCC---ccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATT---STDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
.... ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||......... .. +.. .+.
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~-~~~---~~~- 228 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG--MK-VAL---EGL- 228 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH--HH-HHH---SCC-
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH--HH-HHh---cCC-
Confidence 4322 2346899999999998765544 799999999999999999999765432211 00 100 000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. ...+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 229 ----~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 229 ----R---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp ----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 01112234568899999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.73 Aligned_cols=260 Identities=23% Similarity=0.235 Sum_probs=202.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
-++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 36789999999999999999999888999999999654 233457889999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999754 348999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
............|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+...+.... ....
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~---~~~~--- 255 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAI---PRPS--- 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCC---CCGG---
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCC---CCcc---
Confidence 544333334457899999999999889999999999999999999999999865432 1111111110 0000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHcCCCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRP-DMRRVVEFLLGDSS 609 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~ 609 (653)
.........+.+++.+||+.||.+|| ++.++++.|+....
T Consensus 256 ----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 256 ----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp ----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 11112235688999999999999999 99999999976533
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.40 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=202.3
Q ss_pred cCcCcc-eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQ-NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 407 (653)
+.|... +.||+|+||.||+|.+..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 556663 7899999999999999888999999999776666677899999999985 79999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN---AKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~ 484 (653)
|+++++|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 92 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred cCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999764 348899999999999999999999 89999999999999988776 99999999986
Q ss_pred ccCCCC------CcccccccCCcccCcccccc-----CCCCCccceeehHHHHHHHHhCCCCCChhhhhh----------
Q 048419 485 YEHGAN------PQTTHIVGTLGYLAPELTRT-----GKATTSTDVYSYGILMLEVACGRRSIEPQKAAA---------- 543 (653)
Q Consensus 485 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~---------- 543 (653)
...... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223468999999999875 458899999999999999999999997643211
Q ss_pred --HHHHHHHHHhhhcccchhHhhhhccCcCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 544 --ELLLVDWVKELHLEGEITQAIDQTLDYYDL----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 544 --~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
...+.+.+.. .....+. .....+.+|+.+||+.||.+|||+.|++++-.-.
T Consensus 244 ~~~~~~~~~i~~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 244 ACQNMLFESIQE-------------GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHHH-------------CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred hHHHHHHHHHhc-------------cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 0001111110 0001111 1235788999999999999999999999976544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=363.62 Aligned_cols=252 Identities=25% Similarity=0.308 Sum_probs=199.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|....+++.||||++... .......+.+|+.++++++||||++++++|.+.+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 5688999999999999999999999999999999643 3344567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. ++|+||||||+||||+.++.+||+|||+++...
T Consensus 228 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 228 EYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred eeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998653 3589999999999999999999962 689999999999999999999999999998643
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.+... ..
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~~--~~-------- 366 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILME--EI-------- 366 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC--CC--------
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHHhC--CC--------
Confidence 222 223446799999999999999999999999999999999999999976543221 1111110 00
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 605 (653)
.++......+.+|+.+||+.||.+|| ++.|++++-.
T Consensus 367 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 367 ---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 01112245688999999999999999 9999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.04 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=203.6
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
..++|...+.||+|+||.||++....++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3467889999999999999999999899999999986543 334678899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEEeecCcc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLGDFGLAK 483 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~ 483 (653)
||+++|+|.+++...... ...+++..++.++.|+++||.|||+ ++|+||||||+||++ +.++.+||+|||+++
T Consensus 100 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999998664321 3568999999999999999999999 899999999999999 556889999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
...... ......||+.|+|||.+. ..++.++|||||||++|||++|+.||......... ...... .
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~~~~--~------ 241 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKATYK--E------ 241 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHC--C------
T ss_pred ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhhccC--C------
Confidence 654322 233457899999999886 56889999999999999999999999865432211 111100 0
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.............+.+++.+||+.||.+|||+.|++++-
T Consensus 242 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 242 --PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp --CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred --cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000000001235678999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.12 Aligned_cols=250 Identities=30% Similarity=0.396 Sum_probs=204.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
+.|...+.||+|+||.||+|....+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999999888999999999654 2334567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||++ |+|.+++... ...+++.+++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 6888887543 2458999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
. .....||+.|+|||++. ...++.++|||||||++|||++|+.||......... ...... .
T Consensus 206 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~~~~-----~---- 269 (348)
T 1u5q_A 206 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQN-----E---- 269 (348)
T ss_dssp S-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHS-----C----
T ss_pred C-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhc-----C----
Confidence 3 22357899999999984 567899999999999999999999999765432211 111110 0
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.+ ........+.+++.+||+.||.+|||+.+++++..-
T Consensus 270 -~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 270 -SPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp -CCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred -CCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 0111 011123568899999999999999999999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.21 Aligned_cols=272 Identities=22% Similarity=0.353 Sum_probs=218.1
Q ss_pred ccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeee
Q 048419 319 RFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQL 392 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 392 (653)
.+...+.....++|...+.||+|+||.||+|.+. ..+..||||.+... .......+.+|+.++++++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 4455566667788999999999999999999875 34688999999654 33455678999999999999999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhccccc-----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHK-----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNIL 467 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 467 (653)
++++.+.+..++||||+++|+|.+++...... ....+++..+++++.||+.||.|||+ ++|+||||||+||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEE
Confidence 99999999999999999999999999764321 01346889999999999999999999 89999999999999
Q ss_pred EcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHH
Q 048419 468 LDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAEL 545 (653)
Q Consensus 468 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~ 545 (653)
++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence 99999999999999986543221 12233456889999999998899999999999999999999 889987654321
Q ss_pred HHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 546 LLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 546 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
+...+.. +. +..........+.+++.+||+.||.+|||+.|++++|+...
T Consensus 249 -~~~~~~~----~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 249 -VLRFVME----GG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -HHHHHHT----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -HHHHHHc----CC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111111 11 11111223466889999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.74 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=203.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCC---CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPS---LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
..++|...+.||+|+||.||+|.+.. .+..||||.+... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34678889999999999999998643 3456999999765 344567899999999999999999999998654 568
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+||||+++++|.+++.... ..+++..++.++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 9999999999999997642 348899999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~~~~------ 232 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEKGDR------ 232 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHHTCC------
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhcCCC------
Confidence 765443333344567889999999998899999999999999999998 9999975443221 111111000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+||++.|++++|+.
T Consensus 233 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 233 ------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 00111224568899999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.44 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=197.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccCc----hhhHHHHHHHHHHHhhcCCCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHNS----QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 402 (653)
++|...+.||+|+||.||+++.. .+++.||||++.... ......+.+|+.++++++||||+++++++...+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 57889999999999999999974 578999999997542 23445678999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999653 348889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+.+...
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~-------- 236 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKILKC-------- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHT--------
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhC--------
Confidence 7543221 122345799999999999988999999999999999999999999986543221 1111110
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHc
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFLL 605 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 605 (653)
.+ ..+......+.+++.+||+.||.+|| ++.|++++-.
T Consensus 237 ----~~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 237 ----KL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp ----CC-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred ----CC-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 00 01112245688999999999999999 8889988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.36 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=207.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 367888999999999999999986 46789999996543 345788999999999999999999999864 458999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++++|.+++.... ...+++.+++.++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++......
T Consensus 89 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 89 MENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999997643 2358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+.....
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~~~----------- 228 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERGYR----------- 228 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCC-----------
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHHhcccC-----------
Confidence 3223333456789999999988889999999999999999999 899997644322 1111111100
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 229 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 229 -MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 01111234678899999999999999999999998864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.71 Aligned_cols=265 Identities=18% Similarity=0.200 Sum_probs=201.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC---CCcEEEEEEeccCchhh-----------HHHHHHHHHHHhhcCCCceeeeeee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS---LGLEVAIKRIGHNSQQG-----------MKEFVAEIMSMGRLRHRNLVQLHGW 395 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~ 395 (653)
++|...+.||+|+||.||+|.+.. .+..+|||++....... .+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 578889999999999999999976 68899999986553221 1246678899999999999999999
Q ss_pred ecc----cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 048419 396 CRK----QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY 471 (653)
Q Consensus 396 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 471 (653)
+.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 987 67899999999 999999997643 58999999999999999999999 899999999999999888
Q ss_pred C--cEEEEeecCcccccCCCC------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhh
Q 048419 472 L--NAKLGDFGLAKIYEHGAN------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA 543 (653)
Q Consensus 472 ~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~ 543 (653)
+ .+||+|||+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999987643211 11234579999999999999899999999999999999999999996532221
Q ss_pred HHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 544 ELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
... . ...... ...+...+..... .......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 268 ~~~-~-~~~~~~-~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAV-Q-TAKTNL-LDELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHH-H-HHHHHH-HHTTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHH-H-HHHHhh-cccccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111 1 111110 1111111111110 0022457899999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=338.18 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=206.0
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeee-cccceeEEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC-RKQDELLLVY 406 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 406 (653)
..++|...+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.++++++|+++++.+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 35789999999999999999999988899999999865432 24688999999999998877766666 5556789999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEEeecCcc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLGDFGLAK 483 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~ 483 (653)
||+ +++|.+++.... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999 899999997432 358999999999999999999999 899999999999999 588999999999998
Q ss_pred cccCCCCC------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 484 IYEHGANP------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 484 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 76543321 124457999999999999999999999999999999999999999864322111111111111101
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..... +. . .....+.+++.+||+.||.+||++.+|++.|+.
T Consensus 237 ~~~~~-~~---~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 237 TPIEV-LC---K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp SCHHH-HT---T----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CchHH-HH---h----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 11000 00 1 123568899999999999999999999998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=359.26 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=197.9
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcC-CCceeeeeeeecccc--e
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQD--E 401 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~ 401 (653)
...++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999999999999999998543 3445677889999999997 999999999986544 6
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
+++|||||+ ++|..++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999997 5898888643 48889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCC--------------------CCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhh
Q 048419 482 AKIYEHG--------------------ANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQK 540 (653)
Q Consensus 482 a~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~ 540 (653)
++..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865321 1112334579999999999876 678999999999999999999999998665
Q ss_pred hhhHHHHHHHHHhhhcccch-----------hHhhh---h-------ccCcC-------------CHHHHHHHHHHHHHc
Q 048419 541 AAAELLLVDWVKELHLEGEI-----------TQAID---Q-------TLDYY-------------DLAEAELVLNLGLFC 586 (653)
Q Consensus 541 ~~~~~~l~~~~~~~~~~~~~-----------~~~~d---~-------~l~~~-------------~~~~~~~l~~l~~~C 586 (653)
........ +. ....... ...+. . ..... .......+.+|+.+|
T Consensus 236 ~~~~~~~i--~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 236 TMNQLERI--IG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp HHHHHHHH--HH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHH--HH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 43322111 11 0000000 00000 0 00000 001235688999999
Q ss_pred CCCCCCCCCCHHHHHHHHc
Q 048419 587 SAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 587 l~~dP~~RPs~~evl~~L~ 605 (653)
|+.||.+|||+.|++++-.
T Consensus 313 L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 313 LQFNPNKRISANDALKHPF 331 (388)
T ss_dssp CCSSGGGSCCHHHHTTSTT
T ss_pred hccCcccCCCHHHHhCCHH
Confidence 9999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=350.92 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=200.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhh-HHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|...+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999999889999999996543221 22456799999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
++ |+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 97 58988887643 458899999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh-
Q 048419 489 ANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ- 566 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~- 566 (653)
. .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.......................
T Consensus 154 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 T-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred c-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2 22234568999999999876 56899999999999999999999999876544322211111111111111111000
Q ss_pred --------ccCcC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 --------TLDYY-----DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 --------~l~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..... .......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 00000 0112356889999999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=342.63 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=197.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46788899999999999999985 688999998543 345789999999999999999999999874 479999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc-EEEEeecCcccccCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN-AKLGDFGLAKIYEHG 488 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~ 488 (653)
++|+|.+++..... ...+++..++.++.|+++||.|||+...++|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp TTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999976542 235788899999999999999999865568999999999999998886 799999999765332
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .. +... .+.. +
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~-~~~~---~~~~-----~-- 223 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM-WAVH---NGTR-----P-- 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH-HHHH---TTCC-----C--
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH-HHHh---cCCC-----C--
Confidence 22346899999999999989999999999999999999999999754322111 10 1100 0000 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.........+.+++.+||+.||.+|||+.|++++|+.
T Consensus 224 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp -CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 0111123568899999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=369.27 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=211.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.++|...++||+|+||.||+|.+..+|+.||||++... .......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 45689999999999999999999989999999999653 223456788999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999997654 3458999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH-HHHHHHHHhhhcccchhHhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE-LLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~ 564 (653)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...+..
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----------- 403 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------- 403 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-----------
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-----------
Confidence 4332 23345899999999999988999999999999999999999999986432111 111111111
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFL 604 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (653)
....++......+.+|+.+||+.||.+|| ++.||+++-
T Consensus 404 --~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 404 --VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred --ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 00111222346788999999999999999 789998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.19 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=196.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
.++|...+.||+|+||.||+|.+.. .||||++... .....+.+.+|+.++++++|+||+++++++ ..+..++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4678889999999999999998753 5999998654 345567899999999999999999999976 445689999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 99 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999996543 458999999999999999999999 899999999999999999999999999998654
Q ss_pred CCC-CCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 487 HGA-NPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 487 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||........ +.+.+......
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~----- 244 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLS----- 244 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSCC-----
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcccccC-----
Confidence 321 22233457899999999986 56688899999999999999999999976543221 11222111111
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.+..........+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 245 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 245 ---PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp ---CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11111122335678999999999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=363.23 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=207.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999999899999999996432 234567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999754 348999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... +...+.. +.
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~----~~------ 232 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKICD----GI------ 232 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHHHT----TC------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHHhc----CC------
Confidence 432 2334579999999999988765 689999999999999999999998654321 1111111 10
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
. ..+......+.+|+.+||+.||.+|||+.|++++-
T Consensus 233 --~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 233 --F-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp --C-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --c-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 0 01111235688999999999999999999999854
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.38 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=211.7
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCc-----EEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecc
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGL-----EVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRK 398 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 398 (653)
....++|...+.||+|+||.||+|.+..++. .||+|.+... .....+.+.+|+.+++++ +||||++++++|..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345788999999999999999999876553 7999999755 334567899999999999 89999999999999
Q ss_pred cceeEEEEeccCCCCchhhhhccccc---------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHK---------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence 99999999999999999999764321 02347899999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........ +
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence 9999999999999866443222 2233457889999999998899999999999999999999 8899875433211 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+..... ...+......+.+++.+||+.||.+|||+.||+++|+.
T Consensus 277 ~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 277 YKLVKDGYQ------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHHHHTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCCC------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 111111100 00111124678899999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.58 Aligned_cols=255 Identities=21% Similarity=0.269 Sum_probs=196.9
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|...+.||+|+||.||++....+++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 4679999999999999999999998999999999965432 235688999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--EEEEeecCccccc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN--AKLGDFGLAKIYE 486 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~~~ 486 (653)
+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999998653 348999999999999999999999 99999999999999987765 9999999997533
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCc-cceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTS-TDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.. .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ...+... ..
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~---------~~ 236 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRI---------LS 236 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHH---------HT
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHH---------hc
Confidence 22 22234579999999999988877665 89999999999999999999864432111 1111110 00
Q ss_pred hccC-cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 566 QTLD-YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 566 ~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.... .........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 0000 000112356889999999999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.68 Aligned_cols=266 Identities=22% Similarity=0.327 Sum_probs=209.3
Q ss_pred cCcCcceeeeeeCcEEEEEEE----eCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc--eeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGL----MPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD--ELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~ 403 (653)
++|...+.||+|+||.||+|. ...+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 567889999999999999998 35578999999998777777788999999999999999999999987654 689
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+||||+++++|.+++.... ..+++.+++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 121 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999997653 348899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc----c
Q 048419 484 IYEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL----E 557 (653)
Q Consensus 484 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----~ 557 (653)
........ ......++..|+|||.+.+..++.++|||||||++|||++|+.|+......- .+....... .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~----~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF----MRMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH----HHHHCTTCCTHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH----HHhhccccchhhhH
Confidence 76543221 1123356778999999998889999999999999999999999886432210 000000000 0
Q ss_pred cchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 GEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+.+.+.... ...+......+.+++.+||+.||.+||++.||++.|+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01111111111 11122335678999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=345.64 Aligned_cols=269 Identities=22% Similarity=0.346 Sum_probs=214.4
Q ss_pred CcccCHHHHHHhhcCcCcc-eeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcC-CCceeee
Q 048419 317 ARRFKYAELASVTKGFGEQ-NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLR-HRNLVQL 392 (653)
Q Consensus 317 ~~~f~~~el~~at~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l 392 (653)
...+.+.......++|... +.||+|+||.||+|....+++.||||++... .......+.+|+.++++++ ||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3445556667778888877 8999999999999999989999999998654 2334678899999999995 6999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-- 470 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-- 470 (653)
++++.+.+..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBT
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCC
Confidence 999999999999999999999999986543 3568999999999999999999999 89999999999999987
Q ss_pred -CCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHH
Q 048419 471 -YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVD 549 (653)
Q Consensus 471 -~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 549 (653)
++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--- 243 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL--- 243 (327)
T ss_dssp TBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---
T ss_pred CCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---
Confidence 7899999999998764322 2234579999999999999999999999999999999999999997654432111
Q ss_pred HHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 550 WVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+.... .... ..........+.+++.+||+.||.+|||+.|++++-.
T Consensus 244 ~i~~~~--~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 244 NISQVN--VDYS-------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HHHHTC--CCCC-------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred HHHhcc--cccC-------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 111100 0000 0111123466889999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.65 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=202.7
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeee-cccceeEEE
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC-RKQDELLLV 405 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV 405 (653)
...++|...+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.++++++|++++..+.++ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 456789999999999999999999988899999998754322 23578899999999988877777766 556678999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEEeecCc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLGDFGLA 482 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla 482 (653)
|||+ +++|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999 999999997542 348999999999999999999999 899999999999999 78999999999999
Q ss_pred ccccCCCC------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 483 KIYEHGAN------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 483 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 87654322 122345789999999999999999999999999999999999999976433221111111111110
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...... .. . .....+.+++.+||+.||.+||++.+|++.|+.
T Consensus 236 ~~~~~~-~~---~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 236 STPIEV-LC---K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HSCHHH-HT---T----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred cchhhh-hh---c----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 000000 00 1 113578899999999999999999999998864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=364.72 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=209.1
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...++||+|+||.||+|++..+|+.||||++.... ....+.+..|+.++++++||||+++++++.+.+.+++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888999999999999999999899999999996532 234567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998765321 3458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH-HHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE-LLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...+..
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~------------ 407 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE------------ 407 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH------------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh------------
Confidence 4322 23345899999999999998999999999999999999999999976432110 111111110
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDM-----RRVVEF 603 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 603 (653)
.. ..++......+.+|+.+||+.||.+||++ .+|+++
T Consensus 408 ~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 408 QA-VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cc-cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 00 11122234678899999999999999965 777754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.14 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=204.8
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 404 (653)
.+++|...+.||+|+||.||+|.+..+++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 456788999999999999999999988999999998754 334567788999999999 99999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--------------
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-------------- 470 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------------- 470 (653)
||||+++++|.+++...... ...+++.+++.++.||++||.|||+ ++|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999765321 2458999999999999999999999 89999999999999984
Q ss_pred -----CCcEEEEeecCcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhH
Q 048419 471 -----YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAE 544 (653)
Q Consensus 471 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~ 544 (653)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++.......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~- 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH- 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH-
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH-
Confidence 4479999999998764322 23589999999999765 56689999999999999999998775432211
Q ss_pred HHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 545 LLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 545 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+ ..+. +...+......+.+++.+||+.||.+|||+.|++++-.
T Consensus 239 -----~~----~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 239 -----EI----RQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp -----HH----HTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred -----HH----HcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 00 0111 11111122467889999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=346.75 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=209.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeC-------CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMP-------SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ 399 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 399 (653)
.++|...+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+.+++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888999999999999999975 35678999999754 344567899999999999 899999999999999
Q ss_pred ceeEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL 468 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 468 (653)
+..++||||+++|+|.+++...... ....+++.+++.++.||++||.|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999765321 12348899999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHH
Q 048419 469 DTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELL 546 (653)
Q Consensus 469 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 546 (653)
+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999987654322 11233456789999999988889999999999999999999 999997654321
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+...+.... ...........+.+++.+||+.||.+||++.|+++.|+.
T Consensus 268 ~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 315 (334)
T 2pvf_A 268 LFKLLKEGH------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315 (334)
T ss_dssp HHHHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcCC------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111111110 001112234578899999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=338.96 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=202.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc----hhhHHHHHHHHHHHhhcCCCceeeeeeee--cccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS----QQGMKEFVAEIMSMGRLRHRNLVQLHGWC--RKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~ 401 (653)
.-++|...+.||+|+||.||++.+..+++.||||++.... ....+.+.+|+.++++++|+||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999999899999999996532 24467899999999999999999999998 44567
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.++||||++++ |.+++.... ...+++.+++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 777776543 3458999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCC-CCcccccccCCcccCccccccCC--CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 482 AKIYEHGA-NPQTTHIVGTLGYLAPELTRTGK--ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 482 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
+....... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....... +.+.+.. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~~----~ 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFENIGK----G 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH----C
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHHHHhc----C
Confidence 98764322 22223456899999999987644 3779999999999999999999998654321 1111111 0
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
. ...+......+.+++.+||+.||.+|||+.|++++..
T Consensus 229 ~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 229 S---------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp C---------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred C---------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 0 0011123456889999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.94 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=206.8
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc---------
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--------- 398 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 398 (653)
..++|...+.||+|+||.||+|.+..+++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567889999999999999999999889999999996554 346789999999999999999998854
Q ss_pred -------cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 048419 399 -------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY 471 (653)
Q Consensus 399 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 471 (653)
...+++||||+++++|.+++.... ...+++..++.++.||+.||.|||+ ++|+|+||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEET
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCC
Confidence 445899999999999999997653 3458999999999999999999999 899999999999999999
Q ss_pred CcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 472 LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 472 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
+.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+..... ....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~- 230 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFTD- 230 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHHH-
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHHH-
Confidence 999999999998765432 22345689999999999998999999999999999999999988753221 1000
Q ss_pred HhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCCCCC
Q 048419 552 KELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLP 611 (653)
Q Consensus 552 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 611 (653)
...+.+. . .....+.+++.+||+.||.+||++.|++++|+.-...+
T Consensus 231 ---~~~~~~~-------~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 231 ---LRDGIIS-------D----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ---HHTTCCC-------T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ---hhccccc-------c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0111111 1 12345789999999999999999999999997654433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=352.50 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=208.0
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--------hhHHHHHHHHHHHhhcCCCceeeeeeeeccc
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ 399 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 399 (653)
..++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45679999999999999999999999999999999965421 1334677899999999999999999999999
Q ss_pred ceeEEEEeccCCC-CchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 400 DELLLVYDYVPNG-SLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 400 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999777 9999987643 48999999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
||+++...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.......
T Consensus 174 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------- 237 (335)
T 3dls_A 174 FGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------- 237 (335)
T ss_dssp CTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred cccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence 99998765432 2334579999999999988776 789999999999999999999997532210
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
.... ..+......+.+|+.+||+.||.+|||+.|++++-.-..
T Consensus 238 -------~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 238 -------EAAI-HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -------TTCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -------hhcc-CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0000 001112356889999999999999999999999865443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.75 Aligned_cols=274 Identities=24% Similarity=0.310 Sum_probs=204.3
Q ss_pred CCcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhh--cCCCceeeee
Q 048419 316 GARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR--LRHRNLVQLH 393 (653)
Q Consensus 316 ~~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~ 393 (653)
.........-....++|...+.||+|+||.||+|.+. ++.||||++.... ...+..|.+++.. ++||||++++
T Consensus 23 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~ 97 (337)
T 3mdy_A 23 SGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFI 97 (337)
T ss_dssp SCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred CCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEE
Confidence 3445555566667789999999999999999999986 7899999985432 2344455555554 4899999999
Q ss_pred eeeccc----ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCC
Q 048419 394 GWCRKQ----DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC-----NQRVVHRDVKPS 464 (653)
Q Consensus 394 g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~ 464 (653)
+++... ...++||||+++|+|.+++... .+++.+++.++.|++.||.|||+.+ .++|+||||||+
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~ 171 (337)
T 3mdy_A 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171 (337)
T ss_dssp EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGG
T ss_pred EEEccCCCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchH
Confidence 998777 6789999999999999999643 3899999999999999999999820 129999999999
Q ss_pred cEEEcCCCcEEEEeecCcccccCCCCCc---ccccccCCcccCccccccCCCCCc------cceeehHHHHHHHHhC---
Q 048419 465 NILLDTYLNAKLGDFGLAKIYEHGANPQ---TTHIVGTLGYLAPELTRTGKATTS------TDVYSYGILMLEVACG--- 532 (653)
Q Consensus 465 NIll~~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDV~s~Gvvl~elltG--- 532 (653)
|||++.++.+||+|||+++......... .....||+.|+|||.+.+...+.+ +|||||||++|||++|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 9999999999999999998664432211 123579999999999987766665 9999999999999999
Q ss_pred -------CCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 533 -------RRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 533 -------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+.||......... ... ......... ..+.+ ..........+.+|+.+||+.||.+|||+.||+++
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~-~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPSDPS-YED-MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTBCCCCCCTTTTTSCSSCC-HHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccccccccHhhhcCCCCc-hhh-hHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 5666543221100 000 000000000 00111 00112567889999999999999999999999999
Q ss_pred HcC
Q 048419 604 LLG 606 (653)
Q Consensus 604 L~~ 606 (653)
|+.
T Consensus 326 L~~ 328 (337)
T 3mdy_A 326 LAK 328 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.22 Aligned_cols=255 Identities=29% Similarity=0.472 Sum_probs=200.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC----CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL----GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|...+.||+|+||.||+|.+..+ +..||||.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 4566789999999999999987643 346999999754 33455678999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++++|.+++.... ..+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999997642 458999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 485 YEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 485 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+.... .
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~~~~---~-- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDGF---R-- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTC---C--
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHCCC---c--
Confidence 6443221 1222346788999999998899999999999999999999 999997544321 111111110 0
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+++.+||+.||.+||++.+++++|+.
T Consensus 269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00111234678899999999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.65 Aligned_cols=267 Identities=25% Similarity=0.333 Sum_probs=207.3
Q ss_pred cCc-CcceeeeeeCcEEEEEEEe----CCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--ce
Q 048419 330 KGF-GEQNLVGSGGFGRVYRGLM----PSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ--DE 401 (653)
Q Consensus 330 ~~f-~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 401 (653)
++| ...+.||+|+||.||++.+ ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8899999999999988764 3468899999997653 44567899999999999999999999999874 57
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
+++||||+++++|.+++... .+++.+++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccc
Confidence 89999999999999999654 28899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 482 AKIYEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 482 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
++........ ......+|..|+|||.+.+..++.++|||||||++|||++|+.||......... ...+.........
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLR 259 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHH
Confidence 9876543221 123345788899999999888999999999999999999999998754332110 0000000000111
Q ss_pred hhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 560 ITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 560 ~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.+.+.... ...+......+.+|+.+||+.||.+|||+.|+++.|+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 122222221 12223345779999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.75 Aligned_cols=271 Identities=23% Similarity=0.331 Sum_probs=215.0
Q ss_pred ccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceee
Q 048419 319 RFKYAELASVTKGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQ 391 (653)
Q Consensus 319 ~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~ 391 (653)
.+...+.....++|...+.||+|+||.||+|.+ ..+++.||||++.... ....+.+.+|+.+++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344555555678899999999999999999984 3467899999997643 34556889999999999 7999999
Q ss_pred eeeeecccc-eeEEEEeccCCCCchhhhhcccccc-----------cccchhhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 048419 392 LHGWCRKQD-ELLLVYDYVPNGSLDKLLFDKDHKL-----------RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHR 459 (653)
Q Consensus 392 l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 459 (653)
+++++...+ ..++||||+++++|.+++....... ...+++..++.++.||++||.|||+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccc
Confidence 999987765 5899999999999999998754211 1238899999999999999999999 899999
Q ss_pred CCCCCcEEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCC
Q 048419 460 DVKPSNILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIE 537 (653)
Q Consensus 460 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~ 537 (653)
||||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999866443222 2234567889999999999899999999999999999998 999997
Q ss_pred hhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 538 PQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 538 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....... +...+... . ....+......+.+++.+||+.||.+|||+.|++++|+.
T Consensus 253 ~~~~~~~--~~~~~~~~----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 253 GVKIDEE--FCRRLKEG----T--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp TCCCSHH--HHHHHHHT----C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhHH--HHHHhccC----c--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 6443221 11111110 0 000111124568899999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.63 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=182.6
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEeccCCCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++++. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999998543 3466788999999997 9999999999999999999999999999
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---cEEEEeecCcccccCCCC
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL---NAKLGDFGLAKIYEHGAN 490 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~ 490 (653)
|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 99999764 348999999999999999999999 8999999999999997665 89999999998654332
Q ss_pred CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH-HHHHHHHhhhcccchhHhhhhccC
Q 048419 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL-LLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 491 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+... ....+. ..
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~--------~~ 234 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGD--------FS 234 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-HHTTTC--------CC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-HHHcCC--------CC
Confidence 2233457899999999999999999999999999999999999999864432100 0000000 001110 00
Q ss_pred cCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 570 YYD---LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 570 ~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
... ......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 000 112467899999999999999999999997654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=338.57 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=202.1
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCc---EEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccccee-EEEE
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGL---EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL-LLVY 406 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV~ 406 (653)
|...++||+|+||.||+|.+..++. .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4556899999999999998654433 7999999754 344567899999999999999999999999877655 9999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 103 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred ecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999997642 458899999999999999999999 899999999999999999999999999998653
Q ss_pred CCC---CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 487 HGA---NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 487 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
... ........+++.|+|||.+.+..++.++|||||||++|||++|+.|+........ +...+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~------- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLAQGRR------- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHHTTCC-------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhhcCCC-------
Confidence 321 1222344678899999999999999999999999999999996666543322111 1111111110
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01111224578899999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.51 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=208.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 5688899999999999999999999999999998654 3345678899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++... ..+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp CCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999988653 348999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......... .. +... ...
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-~~~~--~~~------- 259 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--LR-IKKN--EYS------- 259 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HH-HHHT--CCC-------
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH--HH-HhcC--CCC-------
Confidence 332 2233457899999999999888999999999999999999999999865432211 00 1000 000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+......+.+++.+||+.||.+||++.|++++-
T Consensus 260 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 260 ----IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0111235678999999999999999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.62 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=201.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcE----EEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLE----VAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
++|+..+.||+|+||.||+|.+..+++. ||+|.+... .....+.+.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5788899999999999999998777664 577777543 3455778999999999999999999999998765 789
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 94 v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999997653 358899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~~~------- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGE------- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTC-------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC-------
Confidence 643322 12233456789999999999999999999999999999999 999998654332 111111110
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
....+......+.+++.+||+.||.+||++.|+++.|+...
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111223456889999999999999999999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.08 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=187.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999999999999998889999999986432 223567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++.... ..+++.+++.++.|+++||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp ECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999997642 458999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .. ....
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~---------~~~~ 227 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NK---------VVLA 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HH---------Hhhc
Confidence 3221 223356899999999999888999999999999999999999999754322100 00 0000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. ..+......+.+++.+||+.||.+||++.+++++-.
T Consensus 228 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 228 DY-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp CC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred cc-CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 00 011122456889999999999999999999998543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.40 Aligned_cols=261 Identities=24% Similarity=0.400 Sum_probs=199.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|....+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688899999999999999999888999999999653 3445678899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++..... ....+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||+++...
T Consensus 112 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999975321 13458899999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+...+.. .....
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~----~~~~~---- 257 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQ----CDYPP---- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHT----TCSCC----
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhc----ccCCC----
Confidence 322 12233568999999999999899999999999999999999999997543211 111111111 10000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+ ........+.+++.+||+.||.+||++.+|++.|+.-
T Consensus 258 -~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 258 -L--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp -C--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0012245688999999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=337.45 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=209.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.++|...+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 36788899999999999999999999999999998654 334567889999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++... ..+++.+++.++.|+++||.|||+ ++++||||||+||+++.++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999988653 348999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+.. ..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~----~~------ 231 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL---RIKK----NE------ 231 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHT----TC------
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhh----cc------
Confidence 43222 2334578999999999998889999999999999999999999998654322110 0000 00
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
. ..+......+.+++.+||+.||.+|||+.|++++.
T Consensus 232 --~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 232 --Y-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp --C-CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred --C-CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0 01111235688999999999999999999999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=335.32 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=209.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|+..+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46788899999999999999999988999999998644 33456788999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... ..+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998653 348899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCC-CcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 488 GAN-PQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 488 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+...... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~---~----- 228 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY---L----- 228 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCTT---S-----
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcccc---c-----
Confidence 221 12234578999999999987665 6799999999999999999999976543211 11112111000 0
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
+ ........+.+++.+||+.||.+|||+.|++++..-.
T Consensus 229 ~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (276)
T 2yex_A 229 N----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (276)
T ss_dssp T----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred C----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence 0 0011235678999999999999999999999865443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.44 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=205.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------hhHHHHHHHHHHHhhcCCCceeeeeeeeccccee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 402 (653)
.++|...+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3568889999999999999999998899999999865421 1367899999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEEe
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL----NAKLGD 478 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 478 (653)
++||||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++++||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999653 348999999999999999999999 8999999999999998877 899999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+... ..
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~--~~ 228 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---TNISAV--NY 228 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHTT--CC
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH---HHhHhc--cc
Confidence 99998764322 223456899999999999889999999999999999999999999865432211 111110 00
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.......+ .....+.+++.+||+.||.+||++.|++++-
T Consensus 229 ~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 229 DFDEEYFS-------NTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCCHHHHT-------TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred CCcchhcc-------cCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 00000000 1235688999999999999999999999843
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=337.78 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=205.6
Q ss_pred cCcCcce-eeeeeCcEEEEEEEeC--CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQN-LVGSGGFGRVYRGLMP--SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~-~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|.... .||+|+||.||+|.+. .++..||||++... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 45788999999764 345577899999999999999999999999 55668999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++... ...+++.+++.++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999654 2458999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 486 EHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 486 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+.. +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~----~~--- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----GK--- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT----TC---
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhc----CC---
Confidence 443221 1223356889999999988889999999999999999998 999997654322 1111111 10
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+......+.+++.+||+.||.+||++.+++++|+.
T Consensus 231 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 231 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011122334678899999999999999999999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.12 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=206.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||++....+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 45678899999999999999999998899999999976655555678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 484 (653)
|+++++|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+||++ +.++.+||+|||++..
T Consensus 87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 87 LVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred cCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999998653 348899999999999999999999 899999999999999 7889999999999975
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +.+.+..... ...
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~--~~~--- 227 (304)
T 2jam_A 159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKIKEGYY--EFE--- 227 (304)
T ss_dssp CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHCCC--CCC---
T ss_pred cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCC--CCC---
Confidence 4322 2234568999999999999899999999999999999999999997654321 1111111100 000
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..........+.+++.+||+.||.+||++.|++++-
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 228 ----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp ----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 001112246788999999999999999999999854
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=360.80 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=202.2
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc------
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ------ 399 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 399 (653)
..++|+..+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999654 444567889999999999999999999998654
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
...++||||+++ +|.+.+.. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEE
Confidence 457999999976 46665532 37889999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc---
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--- 556 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 556 (653)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+... ..+.....
T Consensus 209 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~--~i~~~lg~p~~ 284 (464)
T 3ttj_A 209 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCP 284 (464)
T ss_dssp CCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCSCCH
T ss_pred EeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCCH
Confidence 999876432 23345689999999999999999999999999999999999999998765433211 11111000
Q ss_pred ------ccc---------------hhHhhhhcc-C---cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 557 ------EGE---------------ITQAIDQTL-D---YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 557 ------~~~---------------~~~~~d~~l-~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
... ........+ . .........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 000 001111111 0 0011125678999999999999999999999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=338.07 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=203.9
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccC
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
+|....+||+|+||.||+|.+..+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 34556699999999999999988899999999977666667889999999999999999999999999999999999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCcEEEEeecCcccccCCC
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~ 489 (653)
+++|.+++..... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999976532 2346788899999999999999999 89999999999999987 8999999999998764322
Q ss_pred CCcccccccCCcccCccccccCC--CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGK--ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||............ ...... .
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~--------~-- 244 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK--VGMFKV--------H-- 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH--HHHHCC--------C--
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh--hccccc--------c--
Confidence 2223457899999999987643 789999999999999999999999754332211100 000000 0
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+......+.+++.+||+.||.+||++.|++++-.
T Consensus 245 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 245 -PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp -CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred -ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 1111223457889999999999999999999997543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=352.14 Aligned_cols=254 Identities=22% Similarity=0.262 Sum_probs=193.9
Q ss_pred cCcCcc-eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhh-cCCCceeeeeeeecc----cceeE
Q 048419 330 KGFGEQ-NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR-LRHRNLVQLHGWCRK----QDELL 403 (653)
Q Consensus 330 ~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 403 (653)
++|... ++||+|+||.||+|.+..+++.||||++... ..+.+|+.++.+ ++||||+++++++.. .+.++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 6899999999999999999999999998532 356678887754 489999999998865 56789
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEEeec
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDFG 480 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 480 (653)
+|||||++|+|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 136 lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999997653 3458999999999999999999999 89999999999999987 7899999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH-HHHHHHHhhhcccc
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL-LLVDWVKELHLEGE 559 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~ 559 (653)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+..... .
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~--~ 285 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--E 285 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC--C
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc--c
Confidence 99865432 2234457899999999999999999999999999999999999999764322100 00011110000 0
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. .+. .......+.+|+.+||+.||.+|||+.|++++..
T Consensus 286 ~~---~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 286 FP---NPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CC---TTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CC---Ccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00 000 0123466889999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=354.63 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=195.9
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--------hhhHHHHHHHHHHHhhcCCCceeeeeeeecc
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--------QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 398 (653)
...++|...+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999999999999999986431 1122357899999999999999999999854
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEE
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY---LNAK 475 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~k 475 (653)
+..++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.+ ..+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 4579999999999999988654 348999999999999999999999 899999999999999654 4599
Q ss_pred EEeecCcccccCCCCCcccccccCCcccCcccccc---CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 476 LGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 476 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.+.+.
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~ 358 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 358 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHH
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHh
Confidence 9999999876432 22344679999999999853 5678899999999999999999999975432111 111111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.... ....+.. ......+.+++.+||+.||.+||++.|++++-.
T Consensus 359 ~~~~-~~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 359 SGKY-NFIPEVW--------AEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp TTCC-CCCHHHH--------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred cCCC-CCCchhh--------cccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 1000 0000000 012467889999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=337.28 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=207.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|....++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999999889999999985432 223567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++... ..+++..++.++.|+++||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999754 348899999999999999999999 899999999999999999999999999997654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.. .
T Consensus 166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~----~-------- 227 (284)
T 2vgo_A 166 SL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH---RRIVN----V-------- 227 (284)
T ss_dssp SS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHT----T--------
T ss_pred cc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH---HHHhc----c--------
Confidence 32 223457899999999999989999999999999999999999999765432211 10100 0
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. ..+......+.+++.+||+.||.+||++.|++++-
T Consensus 228 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 228 DL-KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp CC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred cc-CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 00 11112235688999999999999999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.53 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=199.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCC--CceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRH--RNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~l 404 (653)
.++|+..+.||+|+||.||++... +++.||||++... ..+..+.+.+|+.++++++| +||+++++++...+..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456889999999999999999985 4889999998654 44456789999999999986 999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||| +.+++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++.
T Consensus 87 v~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEe-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 999 5688999999764 348899999999999999999999 8999999999999997 67899999999987
Q ss_pred ccCCCCC-cccccccCCcccCcccccc-----------CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 485 YEHGANP-QTTHIVGTLGYLAPELTRT-----------GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 485 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------- 228 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-------- 228 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--------
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--------
Confidence 6543222 2234579999999999865 6788999999999999999999999975332111
Q ss_pred hhhcccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 553 ELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+...+++.. ..++......+.+++.+||+.||.+|||+.|++++...
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp ------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 0111111111 11111223568899999999999999999999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.92 Aligned_cols=244 Identities=26% Similarity=0.312 Sum_probs=193.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHH-HhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMS-MGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+..|..+ ++.++||||+++++++.+.+.+++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999999999999999996542 2334556677776 5778999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999753 347888999999999999999999 99999999999999999999999999999864
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.+..
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~------------ 253 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNILN------------ 253 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HHHHHH------------
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHh------------
Confidence 322 2233456899999999999999999999999999999999999999976543221 111111
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMR 598 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 598 (653)
..+ .++......+.+|+.+||+.||.+||++.
T Consensus 254 ~~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 254 KPL-QLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SCC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ccc-CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 111 01112235688999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=339.12 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=209.9
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.+.|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999998889999999996543 4456789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... .+++.+++.++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++.....
T Consensus 101 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 99999999998642 48999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.. .. .+.
T Consensus 172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~----~~-----~~~ 238 (303)
T 3a7i_A 172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIPK----NN-----PPT 238 (303)
T ss_dssp TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----SC-----CCC
T ss_pred ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhhc----CC-----CCC
Confidence 321 223457899999999999989999999999999999999999999765432211 11111 00 011
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+ .......+.+++.+||+.||.+|||+.|++++..
T Consensus 239 ~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 239 L---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp C---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred C---ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1 1122356889999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.72 Aligned_cols=256 Identities=28% Similarity=0.399 Sum_probs=208.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+++|++++|+||++++++|.+ +..+||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 34668889999999999999999975 5779999997543 335689999999999999999999999976 67899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++|+|.++|.... ...+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999997543 3458899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
..........++..|+|||.+....++.++|||||||+||||++ |+.||......+ +.+.+....
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i~~~~----------- 481 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGY----------- 481 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHHHTTC-----------
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-----------
Confidence 21111222356788999999998999999999999999999999 899997654322 111111110
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
++ ..+......+.+|+.+||+.||++|||+.+|+++|+..
T Consensus 482 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 482 RM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 11122346788999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.36 Aligned_cols=254 Identities=27% Similarity=0.375 Sum_probs=203.5
Q ss_pred hcCcCcce-eeeeeCcEEEEEEE--eCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 329 TKGFGEQN-LVGSGGFGRVYRGL--MPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 329 t~~f~~~~-~LG~G~fg~Vy~~~--~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
.++|...+ .||+|+||.||+|. ....++.||||++.... ....+.+.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 99999999999995 45567899999996542 33467899999999999999999999999 566789
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+||||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999764 348899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc--ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 484 IYEHGANPQ--TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 484 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+.. +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~ 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK----GER 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT----TCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----CCC
Confidence 765433211 122346788999999988889999999999999999999 999998654322 1111111 100
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+++.+||+.||.+||++.++++.|+.
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01112234678899999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.08 Aligned_cols=247 Identities=15% Similarity=0.143 Sum_probs=194.0
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHH---HHHhhcCCCceeeee-------e
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEI---MSMGRLRHRNLVQLH-------G 394 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g 394 (653)
..++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+ +.+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788899999999999999999888999999999643 444567899999 556666899999998 4
Q ss_pred eecccc-----------------eeEEEEeccCCCCchhhhhccccc--ccccchhhhHHHHHHHHHHHHHHHHhcCCCC
Q 048419 395 WCRKQD-----------------ELLLVYDYVPNGSLDKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455 (653)
Q Consensus 395 ~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 455 (653)
++...+ ..++||||+ +|+|.+++...... ....+++..++.++.||+.||+|||+ ++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 444432 278999999 68999999764321 12356679999999999999999999 89
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccC-----------CCCCccceeehHH
Q 048419 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-----------KATTSTDVYSYGI 524 (653)
Q Consensus 456 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~s~Gv 524 (653)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985322 3344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 525 LMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 525 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
++|||++|+.||....... .. ..+..... .....+.+|+.+||+.||.+||++.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~---------------~~-~~~~~~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------------GS-EWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------C---------------CS-GGGGSSCC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCccccccc---------------ch-hhhhhhcc----CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999997543211 00 11111111 123568899999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.22 Aligned_cols=271 Identities=25% Similarity=0.308 Sum_probs=204.2
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-----hHHHHHHHHHHHhhcCCCceeeeeeeecccc
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-----GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD 400 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 400 (653)
....++|...+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 44567899999999999999999999988999999998653221 1246789999999999999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++||||+++ +|.+++.... ..+++.+++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999976 8888886542 458899999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--c
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--E 557 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~ 557 (653)
+++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||........ +......... .
T Consensus 158 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 158 LAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTE 234 (346)
T ss_dssp GGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCT
T ss_pred cceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCCh
Confidence 998764332 223345789999999998654 478999999999999999999999976554322 1111111110 0
Q ss_pred cchhH---hhhhc----cCcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 558 GEITQ---AIDQT----LDYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 558 ~~~~~---~~d~~----l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
....+ ..+.. ....+ ......+.+|+.+||+.||.+|||+.|++++..-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 00000 00000 00001 11236789999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.11 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=210.2
Q ss_pred HHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--------hhHHHHHHHHHHHhhc-CCCceeee
Q 048419 322 YAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--------QGMKEFVAEIMSMGRL-RHRNLVQL 392 (653)
Q Consensus 322 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l 392 (653)
+.......++|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 34445666789999999999999999999988899999999865431 2245678999999999 79999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+|+||||+|||++.++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999753 348999999999999999999999 8999999999999999999
Q ss_pred cEEEEeecCcccccCCCCCcccccccCCcccCcccccc------CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHH
Q 048419 473 NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT------GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~ 546 (653)
.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--- 312 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--- 312 (365)
T ss_dssp CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred CEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---
Confidence 99999999998765432 2344679999999999863 357889999999999999999999997644321
Q ss_pred HHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 547 LVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 547 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
....+......... +... .....+.+++.+||+.||.+||++.|++++-
T Consensus 313 ~~~~i~~~~~~~~~-----~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 313 MLRMIMEGQYQFSS-----PEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHHHHTCCCCCH-----HHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHhCCCCCCC-----cccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 11111111000000 0000 1135688999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=335.59 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=199.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|...+.||+|+||.||+|.+..+++.||||++.... .+..+.+.+|+..+++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999998889999999986432 234568899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999754 348899999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... +.+.+...
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~----------- 226 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGG----------- 226 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC-----------
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhcC-----------
Confidence 322 2233468999999999987765 589999999999999999999997643321 11111110
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+......+.+++.+||+.||.+|||+.|++++-.-
T Consensus 227 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 227 --VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred --cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 000111123568899999999999999999999986543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=348.63 Aligned_cols=261 Identities=16% Similarity=0.155 Sum_probs=202.9
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCC--------CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceee---------
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPS--------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ--------- 391 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 391 (653)
.++|...+.||+|+||.||+|.+.. .++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999976 4789999998644 35789999999999999988
Q ss_pred ------eeeeecc-cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 048419 392 ------LHGWCRK-QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPS 464 (653)
Q Consensus 392 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 464 (653)
+++++.. .+..++||||+ +++|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHH
Confidence 5666655 67889999999 999999998653 3568999999999999999999999 89999999999
Q ss_pred cEEEcCCC--cEEEEeecCcccccCCCC------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCC
Q 048419 465 NILLDTYL--NAKLGDFGLAKIYEHGAN------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSI 536 (653)
Q Consensus 465 NIll~~~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~ 536 (653)
|||++.++ .+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 999999999986643211 1123347899999999999989999999999999999999999999
Q ss_pred ChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 537 EPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 537 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
......... +........ .......+.... .......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 269 ~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 269 TNCLPNTED-IMKQKQKFV--DKPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGGTTCHHH-HHHHHHHHH--HSCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCCcCHHH-HHHHHHhcc--CChhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 875422211 111111110 000111111000 00123678899999999999999999999998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=353.47 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=212.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccc--eeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD--ELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 405 (653)
.++|...++||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357888999999999999999999999999999997543 334677889999999999999999999987765 78999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEEeecC
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL----DTYLNAKLGDFGL 481 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl 481 (653)
|||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999976542 2348999999999999999999999 899999999999999 7888899999999
Q ss_pred cccccCCCCCcccccccCCcccCcccccc--------CCCCCccceeehHHHHHHHHhCCCCCChhhhhh--HHHHHHHH
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRT--------GKATTSTDVYSYGILMLEVACGRRSIEPQKAAA--ELLLVDWV 551 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~ 551 (653)
++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ...+....
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 98764322 2234579999999998865 467889999999999999999999997533211 11111111
Q ss_pred HhhhcccchhHh---hh------hcc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 552 KELHLEGEITQA---ID------QTL---DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 552 ~~~~~~~~~~~~---~d------~~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
... ....+... .. ..+ ..........+.+++.+||+.||++||++.|+++.+..
T Consensus 241 ~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 111 00000000 00 001 12345677889999999999999999999999988754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=353.43 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=199.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcC--CCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLR--HRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||.||+|.+.. ++.||||++... ..+..+.+.+|+.++++++ |+||+++++++...+.+++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 458899999999999999999875 899999998654 3455678999999999996 59999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|| +.+++|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++..
T Consensus 135 ~E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred Ee-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99 56889999997643 47888999999999999999999 8999999999999995 588999999999876
Q ss_pred cCCCCC-cccccccCCcccCcccccc-----------CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 486 EHGANP-QTTHIVGTLGYLAPELTRT-----------GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 486 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~------ 277 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KL------ 277 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HH------
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-HH------
Confidence 443221 2234579999999999865 3688999999999999999999999975432111 01
Q ss_pred hhcccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 554 LHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+++.. ...+......+.+|+.+||+.||.+||++.|++++...
T Consensus 278 -------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 278 -------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp -------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 11111111 01111123568899999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.45 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=208.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|...+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5788899999999999999999989999999999765 344567899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
+++++|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999764 348899999999999999999998 5 899999999999999999999999999975532
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHH-----------------
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW----------------- 550 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~----------------- 550 (653)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2 12335789999999999999999999999999999999999999976543321111000
Q ss_pred ------HHhhhcccchhHhhhhcc-----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 551 ------VKELHLEGEITQAIDQTL-----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 551 ------~~~~~~~~~~~~~~d~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
...........+.++... ..........+.+++.+||+.||.+|||+.|++++-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 000000001111111111 001111245789999999999999999999999855
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=351.22 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=205.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC---CCCcEEEEEEeccCc----hhhHHHHHHHHHHHhhc-CCCceeeeeeeecccce
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP---SLGLEVAIKRIGHNS----QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 401 (653)
++|...+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 57888999999999999999984 468999999986432 22345677899999999 69999999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.++||||+++++|.+++... ..+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999754 348899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~---- 279 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRIL---- 279 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHH----
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHh----
Confidence 98664333333344679999999999985 34788999999999999999999999754321111 01111100
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHcC
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEFLLG 606 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 606 (653)
.....++......+.+|+.+||+.||.+|| ++.|++++...
T Consensus 280 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 280 ------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp ------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ------ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 001111222345688999999999999999 99999988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.09 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=204.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEE--EEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEV--AIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||.||+|.+..++..+ |||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999988777755 99998653 344556789999999999 899999999999999999999
Q ss_pred EeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 406 YDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
|||+++++|.+++..... .....+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 999999999999976531 112468999999999999999999999 999999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHh
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 553 (653)
||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +.+.
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~--- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK--- 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH---
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHHH---
Confidence 99999999743321 12223456889999999988889999999999999999998 999997654321 1111
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+. ....+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 254 -~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 254 -LPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp -GGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hhcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11110 001112234678899999999999999999999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.48 Aligned_cols=271 Identities=24% Similarity=0.336 Sum_probs=211.1
Q ss_pred CCcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhh--cCCCceeeee
Q 048419 316 GARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGR--LRHRNLVQLH 393 (653)
Q Consensus 316 ~~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~ 393 (653)
.....+........++|...+.||+|+||.||+|.+. ++.||||++... ..+.+..|.+++.. ++||||++++
T Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 28 SGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp CCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred CCCCCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 3445555556677889999999999999999999984 889999998543 34567788888887 7899999999
Q ss_pred eeecccc----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHH--------hcCCCCeEecCC
Q 048419 394 GWCRKQD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH--------EECNQRVVHRDV 461 (653)
Q Consensus 394 g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dl 461 (653)
+++...+ ..++||||+++|+|.+++... .+++.+++.++.|++.||.||| + ++|+||||
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dl 173 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDL 173 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCC
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCC
Confidence 9998776 789999999999999999653 3899999999999999999999 6 89999999
Q ss_pred CCCcEEEcCCCcEEEEeecCcccccCCCCC---cccccccCCcccCccccccC------CCCCccceeehHHHHHHHHhC
Q 048419 462 KPSNILLDTYLNAKLGDFGLAKIYEHGANP---QTTHIVGTLGYLAPELTRTG------KATTSTDVYSYGILMLEVACG 532 (653)
Q Consensus 462 kp~NIll~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~s~Gvvl~elltG 532 (653)
||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999999999999999999999876543321 12345789999999998765 234689999999999999999
Q ss_pred ----------CCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048419 533 ----------RRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRV 600 (653)
Q Consensus 533 ----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 600 (653)
+.||........ ....+.... .... ..+.+ ..........+.+|+.+||+.||.+|||+.||
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDP-SVEEMRKVV-CEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSC-CHHHHHHHH-TTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCcCCcccccccCccccCcCcc-cHHHHHHHH-HHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 677765322110 000111110 0000 01111 01123566789999999999999999999999
Q ss_pred HHHHcC
Q 048419 601 VEFLLG 606 (653)
Q Consensus 601 l~~L~~ 606 (653)
+++|+.
T Consensus 328 ~~~L~~ 333 (342)
T 1b6c_B 328 KKTLSQ 333 (342)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999964
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.63 Aligned_cols=255 Identities=24% Similarity=0.286 Sum_probs=190.6
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeee--------cc
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWC--------RK 398 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~--------~~ 398 (653)
...+|+..++||+|+||.||+|.+..+++.||||++........+.+.+|+.+++++. ||||+++++++ ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457888999999999999999998889999999997777777788999999999996 99999999998 34
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEEcCCCcEEE
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR--VVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kl 476 (653)
...+++||||+. |+|.+++..... ...+++.+++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence 456899999995 799998865322 3458999999999999999999999 78 999999999999999999999
Q ss_pred EeecCcccccCCCCC-----------cccccccCCcccCcccc---ccCCCCCccceeehHHHHHHHHhCCCCCChhhhh
Q 048419 477 GDFGLAKIYEHGANP-----------QTTHIVGTLGYLAPELT---RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542 (653)
Q Consensus 477 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~ 542 (653)
+|||+++........ ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876543211 11134589999999998 5667889999999999999999999999754321
Q ss_pred hHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 543 AELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 543 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. ........ .........+.+|+.+||+.||.+||++.|++++|+.
T Consensus 260 ~------~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 260 R------IVNGKYSI------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ------------CCC------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred H------hhcCcccC------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 00000000 0001112347789999999999999999999999965
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.01 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=199.0
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
....++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344568999999999999999999999999999999996543 223457789999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-----cCCCcEEEEe
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL-----DTYLNAKLGD 478 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~D 478 (653)
+||||++ |+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|
T Consensus 110 lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999997 59999987643 48999999999999999999999 899999999999999 4555699999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc-
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL- 556 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~- 556 (653)
||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 181 fg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~ 257 (329)
T 3gbz_A 181 FGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLP 257 (329)
T ss_dssp TTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCC
T ss_pred CCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCC
Confidence 99998764332 223345689999999999774 4899999999999999999999999865543321 111111100
Q ss_pred -ccchhHhh-----hhcc---CcCCHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 -EGEITQAI-----DQTL---DYYDLA------EAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 -~~~~~~~~-----d~~l---~~~~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
........ .... ...... ....+.+|+.+||+.||.+|||+.|++++-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 00000000 0000 000011 2367889999999999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=346.24 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=203.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 406 (653)
..++|...+.||+|+||.||+|.+..+++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45678999999999999999999999999999999965433 234688888888 7999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CcEEEEeecCc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY----LNAKLGDFGLA 482 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla 482 (653)
||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||+..+ +.+||+|||++
T Consensus 96 E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp CCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999998764 348999999999999999999999 899999999999998433 35999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+...+.. +...
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----~~~~- 241 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS----GKFS- 241 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH----CCCC-
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc----CCcc-
Confidence 87654322 23345789999999999887889999999999999999999999975432211111111111 1100
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
............+.+|+.+||+.||.+||++.|++++-
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 00011112346788999999999999999999999854
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.92 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=202.3
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc----cceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK----QDELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 404 (653)
.|...+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 367788999999999999999999999999998643 44556789999999999999999999998765 356899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEEc-CCCcEEEEeecC
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR--VVHRDVKPSNILLD-TYLNAKLGDFGL 481 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGl 481 (653)
||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999653 348899999999999999999999 77 99999999999997 889999999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
+...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||......... ...+. .+...
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~----~~~~~ 248 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVT----SGVKP 248 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHT----TTCCC
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHh----ccCCc
Confidence 9754332 233457899999999886 46899999999999999999999999764432211 11111 11111
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+. .....+.+++.+||+.||.+|||+.|++++-.
T Consensus 249 ~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 249 ASFDK-------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp GGGGG-------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cccCC-------CCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 11111 11256889999999999999999999998643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.20 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=199.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeec-ccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR-KQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~l 404 (653)
.+|...+.||+|+||.||+|.+..+ ...+|+|.+... .....+.+.+|+.++++++||||++++++|. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4577889999999999999997543 346899998754 3445678999999999999999999999865 4557899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++|+|.+++.... ..+++.+++.++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999997643 457899999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCC---CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCC-CCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 485 YEHGAN---PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR-RSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 485 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++|+ .|+....... ....+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~~~------ 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG------ 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHHTT------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhcC------
Confidence 543221 1223346788999999999999999999999999999999955 5554332211 11111110
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.....+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 249 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 249 ------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0001111123568899999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=351.25 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=193.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecc-cceeEEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QDELLLV 405 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 405 (653)
.|...+.||+|+||.||+|.+... +..||||.+... .....+.+.+|+.++++++||||++++++|.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 356678999999999999987432 346899998654 34567789999999999999999999998755 4578999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++.... ..+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999997643 347899999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCCC---cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 486 EHGANP---QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 486 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....+.. +.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~----~~-- 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ----GR-- 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHT----TC--
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHc----CC--
Confidence 432211 1233457789999999999999999999999999999999 666776443221 1111111 10
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+......+.+++.+||+.||.+||++.|+++.|+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001111234578899999999999999999999999965
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.84 Aligned_cols=263 Identities=24% Similarity=0.293 Sum_probs=201.6
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-----
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----- 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 400 (653)
..++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 346789999999999999999999989999999998543 3344577899999999999999999999987653
Q ss_pred -eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 401 -ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 401 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
.+++||||+ +++|.+++... .+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEee
Confidence 469999999 88999998652 38899999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh---
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH--- 555 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--- 555 (653)
|+++..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||........... .+....
T Consensus 173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~--i~~~~g~~~ 246 (367)
T 1cm8_A 173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE--IMKVTGTPP 246 (367)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHHHCCCC
T ss_pred ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcCCCC
Confidence 999875432 334578999999999877 6799999999999999999999999986554332111 111000
Q ss_pred -------cccchhHhhhh-------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 556 -------LEGEITQAIDQ-------TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 556 -------~~~~~~~~~d~-------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
........+.. .+..........+.+|+.+||+.||.+|||+.|++++-..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 00000000000 0001111234678899999999999999999999997543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.59 Aligned_cols=269 Identities=24% Similarity=0.251 Sum_probs=189.9
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc-----cce
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-----QDE 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 401 (653)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+|++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999999989999999999653 34456789999999999999999999999843 357
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 57899988653 348999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCC--------------------------CcccccccCCcccCcccc-ccCCCCCccceeehHHHHHHHHh---
Q 048419 482 AKIYEHGAN--------------------------PQTTHIVGTLGYLAPELT-RTGKATTSTDVYSYGILMLEVAC--- 531 (653)
Q Consensus 482 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~s~Gvvl~ellt--- 531 (653)
++....... ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 987643211 123445789999999976 55679999999999999999999
Q ss_pred --------CCCCCChhhhh-----------------hHHHHHHHHHhhhcccc-----------hhHhhhhc-------c
Q 048419 532 --------GRRSIEPQKAA-----------------AELLLVDWVKELHLEGE-----------ITQAIDQT-------L 568 (653)
Q Consensus 532 --------G~~p~~~~~~~-----------------~~~~l~~~~~~~~~~~~-----------~~~~~d~~-------l 568 (653)
|+.+|.+.... ........+........ ....+... +
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 45555332210 00000001110000000 00000000 0
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.+|+.+||+.||.+|||+.|++++-..
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 00011224678899999999999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=351.79 Aligned_cols=273 Identities=20% Similarity=0.280 Sum_probs=208.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc------CCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL------RHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~ 401 (653)
...+|...+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 345788999999999999999999999999999999653 33456777888888887 57799999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc--EEEEee
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN--AKLGDF 479 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Df 479 (653)
.++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++. +||+||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred EEEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999996 69999887654 2458999999999999999999999 89999999999999999887 999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc--
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE-- 557 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 557 (653)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..+......
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~--~i~~~~~~p~~ 320 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA--CMIELLGMPSQ 320 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCH
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHcCCCCH
Confidence 999764332 234578999999999999999999999999999999999999998765433221 111110000
Q ss_pred ------cchhHhhhhc---------------------------c----CcCCH------HHHHHHHHHHHHcCCCCCCCC
Q 048419 558 ------GEITQAIDQT---------------------------L----DYYDL------AEAELVLNLGLFCSAPNPVYR 594 (653)
Q Consensus 558 ------~~~~~~~d~~---------------------------l----~~~~~------~~~~~l~~l~~~Cl~~dP~~R 594 (653)
......++.. + ..... .....+.+|+.+||+.||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 0000000000 0 00000 113668899999999999999
Q ss_pred CCHHHHHHHHcCCCCCCCCC
Q 048419 595 PDMRRVVEFLLGDSSLPPLP 614 (653)
Q Consensus 595 Ps~~evl~~L~~~~~~p~~p 614 (653)
||+.|++++-.-....|..|
T Consensus 401 pta~e~L~Hpw~~~~~~~~~ 420 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRLPKPP 420 (429)
T ss_dssp CCHHHHHTSTTTC-------
T ss_pred CCHHHHhCChhhccCCCCCC
Confidence 99999999876655554433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=340.27 Aligned_cols=265 Identities=22% Similarity=0.335 Sum_probs=200.6
Q ss_pred HHHHhhcCcCcceeeeeeCcEEEEEEEeCC---CCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc
Q 048419 324 ELASVTKGFGEQNLVGSGGFGRVYRGLMPS---LGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398 (653)
Q Consensus 324 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 398 (653)
++....++|...+.||+|+||.||+|.... ++..||||++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 333455778889999999999999998754 4568999998654 34456789999999999999999999999977
Q ss_pred cc-----eeEEEEeccCCCCchhhhhcccc-cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 399 QD-----ELLLVYDYVPNGSLDKLLFDKDH-KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 399 ~~-----~~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
.+ ..++||||+++++|.+++..... .....+++.+++.++.||++||.|||+ ++|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 65 35999999999999999854321 113568999999999999999999999 8999999999999999999
Q ss_pred cEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHH
Q 048419 473 NAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDW 550 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 550 (653)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .+.
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH
Confidence 999999999986643321 22233457889999999999999999999999999999999 8888876543221 111
Q ss_pred HHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 551 VKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 551 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.... ...........+.+++.+||+.||.+||++.+++++|+.
T Consensus 262 ~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 262 LLHGH------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HHTTC------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCC------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11100 001111234678899999999999999999999999964
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.71 Aligned_cols=256 Identities=14% Similarity=0.117 Sum_probs=204.2
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEE-----eCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC---CCceeeeeeee
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGL-----MPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR---HRNLVQLHGWC 396 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~ 396 (653)
+....++|...+.||+|+||.||+|. ...+++.||||++.... ..++..|++++++++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 33445779999999999999999994 55678999999996554 345667777777775 99999999999
Q ss_pred cccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC------
Q 048419 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT------ 470 (653)
Q Consensus 397 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------ 470 (653)
...+..++|||||++|+|.+++..........+++.+++.++.||++||+|||+ ++|+||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999976433224569999999999999999999999 89999999999999988
Q ss_pred -----CCcEEEEeecCcccccCC-CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH
Q 048419 471 -----YLNAKLGDFGLAKIYEHG-ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE 544 (653)
Q Consensus 471 -----~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~ 544 (653)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 899999999999765422 2223345679999999999999999999999999999999999999996543210
Q ss_pred HHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHcC
Q 048419 545 LLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYR-PDMRRVVEFLLG 606 (653)
Q Consensus 545 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~ 606 (653)
.. +...+... ...+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 293 -------------~~----~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 -------------CK----PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -------------EE----ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -------------ee----echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00 11111111 124567789999999999998 678877777754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=370.46 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=198.8
Q ss_pred eeeeeCcEEEEEEEeC--CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCCCC
Q 048419 337 LVGSGGFGRVYRGLMP--SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 337 ~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.||+|+||.||+|.+. .++..||||+++.. .....+.+.+|+++|++++||||++++++|.. +.+++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 34677999999764 34467889999999999999999999999976 56899999999999
Q ss_pred chhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCc-
Q 048419 414 LDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQ- 492 (653)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 492 (653)
|.+++... ...+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 99999654 3458999999999999999999999 899999999999999999999999999998764332211
Q ss_pred -ccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCc
Q 048419 493 -TTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570 (653)
Q Consensus 493 -~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 570 (653)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ +.+.+.. +. . ..
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~----~~-------~-~~ 559 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----GK-------R-ME 559 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHHT----TC-------C-CC
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----CC-------C-CC
Confidence 122345689999999998999999999999999999998 999998654432 1111111 11 0 01
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+......+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 122345678999999999999999999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=337.54 Aligned_cols=258 Identities=21% Similarity=0.253 Sum_probs=202.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecc--cceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRK--QDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 67888999999999999999998899999999996433 467889999999997 9999999999987 56789999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCcccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAKIY 485 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~ 485 (653)
||+++++|.+++.. +++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 113 e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999988732 7788999999999999999999 8999999999999999776 8999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... +...... .......+.+
T Consensus 182 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~-~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKV-LGTEDLYDYI 257 (330)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHH-HCHHHHHHHH
T ss_pred CCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHh-cCCchhhhHH
Confidence 5432 2234578999999999877 66899999999999999999999999543322111 1111110 0001111111
Q ss_pred hhc-----------------------c-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 565 DQT-----------------------L-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 565 d~~-----------------------l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+.. . ..........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 100 0 0001113467899999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.90 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=202.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
..++|...+.||+|+||.||+|.+..++..||||++.... ......+.+|+.++++++||||++++++|.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457888999999999999999999899999999996542 33456789999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEEeecCc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY---LNAKLGDFGLA 482 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla 482 (653)
||||++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.. +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988654 348899999999999999999999 899999999999999764 45999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
+...... ......||+.|+|||++. ..++.++||||+||++|||++|+.||....... +...+........
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~--- 257 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVEKGKYTFD--- 257 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCCCC---
T ss_pred eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCCC---
Confidence 8765432 234457999999999986 569999999999999999999999998654432 1111111100000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+... .....+.+++.+||+.||.+|||+.|++++-
T Consensus 258 --~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 258 --SPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp --SGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --chhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 00001 1235688999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.15 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=192.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHH--HHHHHhhcCCCceeeeeeee-----ccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVA--EIMSMGRLRHRNLVQLHGWC-----RKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~-----~~~~~~ 402 (653)
++|...+.||+|+||.||+|.. +++.||||++..... ..+.. |+..+..++|+||+++++++ .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 5788899999999999999987 478999999964432 33344 44445568999999999744 333467
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCcEEEcCCCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ---------RVVHRDVKPSNILLDTYLN 473 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~---------~ivH~Dlkp~NIll~~~~~ 473 (653)
++||||+++|+|.+++.... .++..+++++.||++||.|||+ + +|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred EEEEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCc
Confidence 99999999999999996543 5888999999999999999999 6 9999999999999999999
Q ss_pred EEEEeecCcccccCCC-------CCcccccccCCcccCcccccc-------CCCCCccceeehHHHHHHHHhCCCCCChh
Q 048419 474 AKLGDFGLAKIYEHGA-------NPQTTHIVGTLGYLAPELTRT-------GKATTSTDVYSYGILMLEVACGRRSIEPQ 539 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~s~Gvvl~elltG~~p~~~~ 539 (653)
+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998764321 112224469999999999976 35677999999999999999998776543
Q ss_pred hhhhHH--HHHHHHHhhhcccchhHhhh-----hcc-C--cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 540 KAAAEL--LLVDWVKELHLEGEITQAID-----QTL-D--YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 540 ~~~~~~--~l~~~~~~~~~~~~~~~~~d-----~~l-~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...... ..............+...+. +.+ . .........+.+|+.+||+.||.+|||+.|+++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 221100 00000000000000000000 011 0 1122356789999999999999999999999998864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=337.88 Aligned_cols=256 Identities=23% Similarity=0.289 Sum_probs=190.9
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
.++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467889999999999999999998889999999996542 222334455566688899999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
||++ |+|.+++...... ...+++..++.++.|++.||.|||+ + +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 5888887653211 3568999999999999999999999 7 9999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCcccc----ccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELT----RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
.... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||........ .+........
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~------ 231 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVVEEPS------ 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHHHSCC------
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHhccCC------
Confidence 4432 22334689999999996 556789999999999999999999999975332211 1111111100
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+ ..........+.+++.+||+.||.+|||+.|++++-
T Consensus 232 ----~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 232 ----P--QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp ----C--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred ----C--CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 0 001112245688999999999999999999999843
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.67 Aligned_cols=269 Identities=23% Similarity=0.313 Sum_probs=206.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecc--------c
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--------Q 399 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 399 (653)
++|...+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999999899999999986542 2234577899999999999999999999876 3
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
+..++||||+++ +|.+.+.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999975 7777776543 348999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCC---CCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh
Q 048419 480 GLAKIYEHGA---NPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 480 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
|+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998764322 122234578999999998876 457999999999999999999999998765443322221111111
Q ss_pred cccchhHhhh----hcc-----CcCCHH-------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 556 LEGEITQAID----QTL-----DYYDLA-------EAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 556 ~~~~~~~~~d----~~l-----~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
........-. ..+ ...... ....+.+|+.+||+.||.+|||+.|++++-..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 1111111000 000 000111 13458899999999999999999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=334.23 Aligned_cols=249 Identities=30% Similarity=0.385 Sum_probs=197.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-ceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-DELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 407 (653)
.++|...+.||+|+||.||+|... |+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 367888999999999999999885 7899999986443 457789999999999999999999987554 47899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++.... ...+++..++.++.|+++||.|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999997643 3347899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+. .+.
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~----~~~------- 231 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE----KGY------- 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHT----TTC-------
T ss_pred c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----cCC-------
Confidence 2 122357889999999998899999999999999999998 9999975433211 11111 000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...........+.+++.+||+.||.+||++.|+++.|+.
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 011112234678899999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.23 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=205.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEe-----CCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccccee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLM-----PSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 402 (653)
.++|...+.||+|+||.||+|.+ ..++..||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788899999999999999994 456789999999654 445567899999999999999999999999999999
Q ss_pred EEEEeccCCCCchhhhhccccc--ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEE
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK--LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLG 477 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 477 (653)
++||||+++++|.+++...... ....+++.+++.++.||+.||.|||+ ++|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999875321 12458899999999999999999999 89999999999999984 4569999
Q ss_pred eecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhh
Q 048419 478 DFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 478 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +.+.+....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~ 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTSGG 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHHhcCC
Confidence 9999986543221 22233467899999999988899999999999999999998 999987654321 111111110
Q ss_pred cccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 556 LEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 556 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...........+.+++.+||+.||.+||++.+++++|+.
T Consensus 263 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 263 ------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 001111234578899999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.41 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=206.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
..++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.+.+.+++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 456799999999999999999999989999999998543 233467889999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEEeecCc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD---TYLNAKLGDFGLA 482 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla 482 (653)
|||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999988654 348999999999999999999999 8999999999999995 4567999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
+...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... +...+..........
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~- 244 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETGKYAFDLP- 244 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCCSCSG-
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCCCCc-
Confidence 8764432 2344579999999999875 58999999999999999999999997654322 111111110000000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. ......+.+++.+||+.||.+|||+.|++++-.
T Consensus 245 ----~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 245 ----QW----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp ----GG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ----cc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 00 112356889999999999999999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.82 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=205.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----ce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-----DE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 401 (653)
..++|...+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 457899999999999999999999988999999999654 334456788999999999999999999988654 67
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.++||||+. ++|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 899999997 5899888643 48999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC---------cccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 482 AKIYEHGANP---------QTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 482 a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
++........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.............-.
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 9876432211 1223468999999998754 67899999999999999999999999876543322111100
Q ss_pred Hhhhc---------ccchhHhhhhcc--CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 552 KELHL---------EGEITQAIDQTL--DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 552 ~~~~~---------~~~~~~~~d~~l--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..... .....+.+.... .... ......+.+++.+||+.||.+|||+.|++++-.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 00000 000011110000 0000 1224678899999999999999999999986643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=344.38 Aligned_cols=264 Identities=27% Similarity=0.356 Sum_probs=203.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888999999999999999999999999999986543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999998876543 348999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh----------c
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH----------L 556 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----------~ 556 (653)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... ..+.... .
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY--HIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCSCCHHHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCChhhhhHhh
Confidence 22 222345789999999998765 78999999999999999999999998665433221 1111000 0
Q ss_pred -ccchhHhhhhcc-CcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 557 -EGEITQAIDQTL-DYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 557 -~~~~~~~~d~~l-~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.........+.+ ..... .....+.+|+.+||+.||.+|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000111 01111 2246789999999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.87 Aligned_cols=247 Identities=27% Similarity=0.383 Sum_probs=198.4
Q ss_pred eeeeeeCcEEEEEEEe--CCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLM--PSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
+.||+|+||.||+|.+ ...++.||||+++.. .....+++.+|++++++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999954 455688999999754 33446889999999999999999999999964 458899999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCC-
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGAN- 490 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~- 490 (653)
|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999653 348999999999999999999999 8999999999999999999999999999987654322
Q ss_pred -CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 491 -PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 491 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +.+.+.. +..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~----~~~-------- 590 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK----GER-------- 590 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT----TCC--------
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CCC--------
Confidence 12233456789999999999999999999999999999998 999998655432 1111111 100
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122334678999999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.68 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=206.0
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-------------hhHHHHHHHHHHHhhcCCCceeeeee
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-------------QGMKEFVAEIMSMGRLRHRNLVQLHG 394 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 394 (653)
..++|...+.||+|+||.||+|.+..++..||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 56789999999999999999999999999999999865421 33567899999999999999999999
Q ss_pred eecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC--
Q 048419 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-- 472 (653)
Q Consensus 395 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 472 (653)
++.+.+..++|||||++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999988654 348999999999999999999999 8999999999999998775
Q ss_pred -cEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 473 -NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 473 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||....... +...+
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i 259 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIKKV 259 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence 69999999998765432 234457999999999987 468999999999999999999999998654432 11111
Q ss_pred HhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 552 KELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 552 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
........... .. .....+.+|+.+||+.||.+|||+.|++++-.
T Consensus 260 ~~~~~~~~~~~-----~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 260 EKGKYYFDFND-----WK----NISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHCCCCCCHHH-----HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HcCCCCCCccc-----cC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 11100000000 00 12356889999999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.16 Aligned_cols=257 Identities=24% Similarity=0.334 Sum_probs=208.0
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---------hhhHHHHHHHHHHHhhcC-CCceeeeeeee
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---------QQGMKEFVAEIMSMGRLR-HRNLVQLHGWC 396 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~ 396 (653)
...++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999999899999999996542 123467889999999996 99999999999
Q ss_pred cccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 397 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
...+..++||||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999999753 348999999999999999999999 89999999999999999999999
Q ss_pred EeecCcccccCCCCCcccccccCCcccCccccc------cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHH
Q 048419 477 GDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR------TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW 550 (653)
Q Consensus 477 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 550 (653)
+|||++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ....
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~ 240 (298)
T 1phk_A 166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRM 240 (298)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHHH
Confidence 9999998765432 233457899999999885 4568899999999999999999999997654321 1111
Q ss_pred HHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 551 VKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 551 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+...... .. .+. .......+.+++.+||+.||.+|||+.|++++-.
T Consensus 241 ~~~~~~~--~~---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 241 IMSGNYQ--FG---SPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp HHHTCCC--CC---TTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HhcCCcc--cC---ccc----ccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 1110000 00 000 0122456889999999999999999999997543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=345.72 Aligned_cols=263 Identities=22% Similarity=0.243 Sum_probs=205.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC--------CCceeeeeeeec---
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR--------HRNLVQLHGWCR--- 397 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 397 (653)
.++|...+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999999989999999999643 345677889999999996 788999999987
Q ss_pred -ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEcCCC---
Q 048419 398 -KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLDTYL--- 472 (653)
Q Consensus 398 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~--- 472 (653)
.....++||||+ +++|.+++.... ...+++.+++.++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhh
Confidence 566899999999 567766665442 2458999999999999999999999 7 999999999999998775
Q ss_pred ----------------------------------------------cEEEEeecCcccccCCCCCcccccccCCcccCcc
Q 048419 473 ----------------------------------------------NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506 (653)
Q Consensus 473 ----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 506 (653)
.+||+|||+++..... .....||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999876432 23347899999999
Q ss_pred ccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhh---HHHHHHHHHhhhcc--------cchh--------------
Q 048419 507 LTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA---ELLLVDWVKELHLE--------GEIT-------------- 561 (653)
Q Consensus 507 ~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~---~~~l~~~~~~~~~~--------~~~~-------------- 561 (653)
++.+..++.++|||||||++|||++|+.||....... .......+...... +...
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999997543211 00011111110000 0000
Q ss_pred --------HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 562 --------QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 562 --------~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+.+... ..........+.+|+.+||+.||.+|||+.|++++-
T Consensus 344 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 344 KLKPWGLFEVLVEK-YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CCCCCCHHHHHHHT-SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred ccCCcchhHhhhhh-cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 000000 123456678899999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.07 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=209.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
..++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 456788999999999999999999989999999998643 23456789999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEEeecC
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLGDFGL 481 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl 481 (653)
||||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999988764 348999999999999999999999 899999999999999 5678999999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
++...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... +...+..........
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 249 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEKGKYTFELP 249 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCCCSG
T ss_pred eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCCCCCCc
Confidence 98765432 3344579999999999875 68999999999999999999999998654432 111111111000000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. ......+.+++.+||+.||.+|||+.|++++-.
T Consensus 250 -----~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 250 -----QW----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp -----GG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred -----cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 00 112456889999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=342.83 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=205.3
Q ss_pred cccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeee
Q 048419 318 RRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWC 396 (653)
Q Consensus 318 ~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 396 (653)
..+.+.++....++|...+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 44566666778889999999999999999999998889999999986543 3346788999999999 799999999998
Q ss_pred cc------cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 048419 397 RK------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT 470 (653)
Q Consensus 397 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 470 (653)
.. .+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+ ++|+|+||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTE 164 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECT
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcC
Confidence 76 467899999999999999997653 3458899999999999999999999 89999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHH
Q 048419 471 YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL 545 (653)
Q Consensus 471 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~ 545 (653)
++.+||+|||++....... .......|++.|+|||.+. ...++.++|||||||++|||++|+.||.........
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp TCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 9999999999998654322 1223356899999999986 567889999999999999999999999765432211
Q ss_pred HHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 546 LLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 546 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
. .+.. .. .+.+ ........+.+++.+||+.||.+||++.+++++-
T Consensus 244 ~---~~~~----~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 244 F---LIPR----NP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp H---HHHH----SC-----CCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred H---Hhhc----Cc-----cccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 1 0000 00 0111 0111235688999999999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.60 Aligned_cols=274 Identities=25% Similarity=0.300 Sum_probs=209.0
Q ss_pred HHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc--
Q 048419 323 AELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-- 399 (653)
Q Consensus 323 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-- 399 (653)
.+.....++|...+.||+|+||.||+|.+..++..||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 33344567899999999999999999999989999999999754 334457889999999999999999999998655
Q ss_pred ---ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEE
Q 048419 400 ---DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKL 476 (653)
Q Consensus 400 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 476 (653)
...++||||+. |+|.+++... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred cccceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEE
Confidence 36899999997 5899988543 38999999999999999999999 89999999999999999999999
Q ss_pred EeecCcccccCCCCC--cccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 477 GDFGLAKIYEHGANP--QTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 477 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..........
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 999999876432211 1234579999999998654 4589999999999999999999999976554332211100000
Q ss_pred hhccc--------chhHhhhhcc--CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 554 LHLEG--------EITQAIDQTL--DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 554 ~~~~~--------~~~~~~d~~l--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..... .......... .... ......+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 00000 0000000000 0011 1123568899999999999999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=352.07 Aligned_cols=200 Identities=30% Similarity=0.414 Sum_probs=169.8
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----c
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-----D 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 400 (653)
..++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++|+||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357899999999999999999999999999999999653 344567889999999999999999999998766 5
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++||||+. ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 7899999996 5999998653 348999999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCC---------------------CcccccccCCcccCcccc-ccCCCCCccceeehHHHHHHHHhCCCCC
Q 048419 481 LAKIYEHGAN---------------------PQTTHIVGTLGYLAPELT-RTGKATTSTDVYSYGILMLEVACGRRSI 536 (653)
Q Consensus 481 la~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~s~Gvvl~elltG~~p~ 536 (653)
+++....... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9987643321 123556899999999986 5667999999999999999999864443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=339.41 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=203.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|+..+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 44678999999999999999999998899999999977766677889999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++.... ..+++.+++.++.||+.||.|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999986542 348999999999999999999999 8999999999999999999999999998764321
Q ss_pred CCCCcccccccCCcccCcccc-----ccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 488 GANPQTTHIVGTLGYLAPELT-----RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
.. .......||+.|+|||.+ ....++.++||||||+++|||++|+.|+........ +...... ...
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~-----~~~- 240 (302)
T 2j7t_A 170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS-----DPP- 240 (302)
T ss_dssp HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS-----CCC-
T ss_pred cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhcc-----CCc-
Confidence 10 111234689999999988 356788999999999999999999999986543221 1111111 000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+ ..+......+.+++.+||+.||.+|||+.+++++-.
T Consensus 241 ----~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 241 ----TL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp ----CC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred ----cc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 00 001112356889999999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.14 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=207.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEe-CCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc------eeeeeeeecccce
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLM-PSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN------LVQLHGWCRKQDE 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 401 (653)
.++|...+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.++++++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999998 557899999999643 344577889999999997664 9999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----------
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT----------- 470 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----------- 470 (653)
.++||||+ +++|.+++.... ...+++.+++.++.||++||+|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999 889999997654 2458899999999999999999999 89999999999999987
Q ss_pred --------CCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhh
Q 048419 471 --------YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542 (653)
Q Consensus 471 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~ 542 (653)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999864432 23457899999999999989999999999999999999999999865543
Q ss_pred hHHHHHHHHHhhhcccc--------------------------hhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCC
Q 048419 543 AELLLVDWVKELHLEGE--------------------------ITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYR 594 (653)
Q Consensus 543 ~~~~l~~~~~~~~~~~~--------------------------~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~R 594 (653)
................. ......+.. ........+.+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 32221111110000000 000000000 11223456789999999999999999
Q ss_pred CCHHHHHHHH
Q 048419 595 PDMRRVVEFL 604 (653)
Q Consensus 595 Ps~~evl~~L 604 (653)
||+.|++++-
T Consensus 321 pt~~ell~hp 330 (339)
T 1z57_A 321 ITLREALKHP 330 (339)
T ss_dssp CCHHHHTTSG
T ss_pred cCHHHHhcCH
Confidence 9999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.11 Aligned_cols=275 Identities=25% Similarity=0.293 Sum_probs=206.3
Q ss_pred cCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-----------hhhHHHHHHHHHHHhhcCCCc
Q 048419 320 FKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-----------QQGMKEFVAEIMSMGRLRHRN 388 (653)
Q Consensus 320 f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~n 388 (653)
....++..+.++|...+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 4467888999999999999999999999999865 8999999985421 122478999999999999999
Q ss_pred eeeeeeeec-----ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 048419 389 LVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKP 463 (653)
Q Consensus 389 iv~l~g~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 463 (653)
|+++++++. ....+++||||++ |+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 162 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHP 162 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCCh
Confidence 999999983 3346899999997 6888888654 3458999999999999999999999 8999999999
Q ss_pred CcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhh
Q 048419 464 SNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542 (653)
Q Consensus 464 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~ 542 (653)
+|||++.++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HHEEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999854332 22334578999999999876 67899999999999999999999999865543
Q ss_pred hHHHHHHHHHhhhcccc-----------hhHhhhhccCc---C-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 543 AELLLVDWVKELHLEGE-----------ITQAIDQTLDY---Y-----DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 543 ~~~~l~~~~~~~~~~~~-----------~~~~~d~~l~~---~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.... . +........ ..+.+...+.. . .......+.+|+.+||+.||.+|||+.|++++
T Consensus 241 ~~~~--~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 NQLN--K-IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHH--H-HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH--H-HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 2211 1 111111111 11111111100 0 11123668899999999999999999999987
Q ss_pred HcCCC
Q 048419 604 LLGDS 608 (653)
Q Consensus 604 L~~~~ 608 (653)
-.-..
T Consensus 318 p~f~~ 322 (362)
T 3pg1_A 318 PYFES 322 (362)
T ss_dssp GGGTT
T ss_pred chhhh
Confidence 65443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.84 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=199.6
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--------hhhHHHHHHHHHHHhhcCCCceeeeeeeecc
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--------QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK 398 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 398 (653)
...++|...+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34567999999999999999999999999999999986432 1223458899999999999999999999876
Q ss_pred cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EE
Q 048419 399 QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN---AK 475 (653)
Q Consensus 399 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~k 475 (653)
.+ .++||||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence 55 89999999999999988653 348899999999999999999999 89999999999999987664 99
Q ss_pred EEeecCcccccCCCCCcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 476 LGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 476 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
|+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +.+.+.
T Consensus 158 l~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 158 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp ECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred EccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 9999999875432 2223457899999999874 46788999999999999999999999975433211 111111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.... ....+.. . .....+.+++.+||+.||.+||++.|++++
T Consensus 234 ~~~~-~~~~~~~----~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKY-NFIPEVW----A----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCC-CCCHHHH----T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCcc-ccCchhh----h----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1000 0000000 0 123678899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.07 Aligned_cols=266 Identities=22% Similarity=0.294 Sum_probs=200.9
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc------
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK------ 398 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------ 398 (653)
+....++|...+.||+|+||.||+|.+..+|+.||||++...... ..+|++++++++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678899999999999999999999989999999998654322 2379999999999999999999843
Q ss_pred --------------------------------cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHH
Q 048419 399 --------------------------------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446 (653)
Q Consensus 399 --------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~ 446 (653)
...+++||||++ |+|.+.+...... ...+++..++.++.||++||.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Confidence 334889999998 5888877653211 356899999999999999999
Q ss_pred HHHhcCCCCeEecCCCCCcEEEc-CCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHH
Q 048419 447 YLHEECNQRVVHRDVKPSNILLD-TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGI 524 (653)
Q Consensus 447 yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gv 524 (653)
|||+ ++|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||
T Consensus 156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9999 8999999999999998 68899999999998764432 22345789999999998765 4899999999999
Q ss_pred HHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh--hhh--------ccCc------CCHHHHHHHHHHHHHcCC
Q 048419 525 LMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA--IDQ--------TLDY------YDLAEAELVLNLGLFCSA 588 (653)
Q Consensus 525 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~--------~l~~------~~~~~~~~l~~l~~~Cl~ 588 (653)
++|||++|+.||......+.. ...+.... ....... .++ .+.. .+......+.+|+.+||+
T Consensus 231 il~ell~g~~pf~~~~~~~~~--~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQL--VRIIQIMG-TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHH--HHHHHHHC-CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHhCCCCCCCCChHHHH--HHHHHHhC-CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999875543321 11111111 0000000 000 0000 111234668999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 048419 589 PNPVYRPDMRRVVEFL 604 (653)
Q Consensus 589 ~dP~~RPs~~evl~~L 604 (653)
.||.+|||+.|++++-
T Consensus 308 ~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHP 323 (383)
T ss_dssp SSGGGSCCHHHHHTSG
T ss_pred CChhhCCCHHHHhcCH
Confidence 9999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.29 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=199.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeec-----------
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR----------- 397 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 397 (653)
.++|...+.||+|+||.||+|.+..+++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467889999999999999999999889999999998777777888999999999999999999998873
Q ss_pred ---ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCc
Q 048419 398 ---KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD-TYLN 473 (653)
Q Consensus 398 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~ 473 (653)
+.+..++||||++ |+|.+++... .+++..++.++.|+++||+|||+ ++|+||||||+|||++ +++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCe
Confidence 4467899999997 6999998542 38899999999999999999999 8999999999999997 5679
Q ss_pred EEEEeecCcccccCCCC--CcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHH
Q 048419 474 AKLGDFGLAKIYEHGAN--PQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW 550 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 550 (653)
+||+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~ 237 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ--LI 237 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--HH
Confidence 99999999987643211 12233467899999998865 678999999999999999999999998655432211 11
Q ss_pred HHhhhc--ccc-------hhHhhhhcc--CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 551 VKELHL--EGE-------ITQAIDQTL--DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 551 ~~~~~~--~~~-------~~~~~d~~l--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
...... ... +...+.... .... ......+.+++.+||+.||.+|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 111000 000 000011111 0001 11246789999999999999999999999854
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=341.18 Aligned_cols=262 Identities=22% Similarity=0.240 Sum_probs=197.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc------
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------ 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 400 (653)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999989999999999653 3445677889999999999999999999987654
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..++||||+++ +|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 78999999974 78777742 37889999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc----
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL---- 556 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 556 (653)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..+.....
T Consensus 173 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~ 248 (371)
T 2xrw_A 173 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPCPE 248 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHC-CCCCCHH
T ss_pred cccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHH
Confidence 99865432 12334578999999999999899999999999999999999999998654432111 11000000
Q ss_pred --------------------ccchhHhhhhcc-C---cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 --------------------EGEITQAIDQTL-D---YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 --------------------~~~~~~~~d~~l-~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...........+ . .........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000000000000 0 001123577999999999999999999999998653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=352.31 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=206.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC-CceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH-RNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|...++||+|+||.||+|.+..+++.||||++..... ...+..|+++++.|+| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999999988899999998865432 2357889999999987 556666666777788999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCcEEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL---DTYLNAKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 484 (653)
|+ +++|.+++.... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++.
T Consensus 84 ~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99 999999997542 358999999999999999999999 899999999999999 6889999999999987
Q ss_pred ccCCCCC------cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 485 YEHGANP------QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 485 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
....... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 6543221 1235679999999999999999999999999999999999999998654322222222221111111
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.+..+. .. ....+.+|+..||+.+|.+||++.+|+++|+
T Consensus 236 ~~~~l~----~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 236 SIEALC----RG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp CHHHHH----TT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cHHHHh----cC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 111111 11 2357899999999999999999999998875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=331.47 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=198.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc---------
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--------- 398 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 398 (653)
..++|+..+.||+|+||.||+|.+..+++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 35678899999999999999999988899999999954 33456788999999999999999999998754
Q ss_pred ----cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 399 ----QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 399 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
.+..++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCE
Confidence 457899999999999999997643 347888999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCC-------------CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhh
Q 048419 475 KLGDFGLAKIYEHGA-------------NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQK 540 (653)
Q Consensus 475 kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~ 540 (653)
||+|||+++...... ........|++.|+|||.+.+. .++.++|||||||++|||++ |+....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 999999998654321 1122345689999999998754 68999999999999999998 554322
Q ss_pred hhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 541 AAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 541 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
... .....+... .... ...........+.+++.+||+.||.+|||+.|++++-.-
T Consensus 233 ~~~--~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 233 ERV--NILKKLRSV--SIEF-------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp HHH--HHHHHHHST--TCCC-------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred hHH--HHHHhcccc--cccc-------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 211 111111110 0000 012222334668899999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.39 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=190.4
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc------
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ------ 399 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 399 (653)
..++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 346889999999999999999999999999999998653 334567888999999999999999999998654
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
...++|+|++ +++|.+++... .+++..++.++.||++||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999999 78999988642 38999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh-----
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE----- 553 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----- 553 (653)
|+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 177 G~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 177 GLARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cccccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99986543 2334578999999999876 6789999999999999999999999986554332211110000
Q ss_pred ---hhcccchhHhhhhcc--CcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 554 ---LHLEGEITQAIDQTL--DYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 554 ---~~~~~~~~~~~d~~l--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..........+.... ..... .....+.+|+.+||+.||.+|||+.|++++-..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 000000111111100 01111 123568899999999999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=367.69 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=208.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 404 (653)
.++|...++||+|+||.||+|.+..+++.||||++... .....+.+..|..++..+ +|++|+++++++.+.+.++|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999643 233456788899999988 79999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 420 V~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999764 348999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 485 YEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 485 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+.+.. .
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~----~------ 557 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIME----H------ 557 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHS----S------
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHHHh----C------
Confidence 43222 23445689999999999999999999999999999999999999998654322 1111111 0
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDM-----RRVVEF 603 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 603 (653)
.+ .++......+.+|+.+||+.||.+||++ .||+++
T Consensus 558 --~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 558 --NV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --CC-CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --CC-CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 01 1122234678899999999999999997 788764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=333.77 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=203.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
..++|...+.||+|+||.||+|.+..+|+.||||.+.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999999889999999996543 34678899999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+++++|.+++... ...+++.+++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 105 ~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999998643 2458999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+... . .+.
T Consensus 178 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~-~--------~~~ 244 (314)
T 3com_A 178 TM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIPTN-P--------PPT 244 (314)
T ss_dssp TB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHS-C--------CCC
T ss_pred hc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhcC-C--------Ccc
Confidence 22 12234578999999999999899999999999999999999999997654322111 00000 0 000
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
. .........+.+++.+||+.||.+|||+.+++++-
T Consensus 245 ~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 245 F-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp C-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred c-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 0 00111235688999999999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=341.36 Aligned_cols=273 Identities=25% Similarity=0.294 Sum_probs=196.4
Q ss_pred HHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccce-
Q 048419 323 AELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE- 401 (653)
Q Consensus 323 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 401 (653)
.+.....++|...+.||+|+||.||+|.+..+++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445566789999999999999999999999889999999985432 233456788888999999999999999865433
Q ss_pred ------eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEEcC-CC
Q 048419 402 ------LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH--EECNQRVVHRDVKPSNILLDT-YL 472 (653)
Q Consensus 402 ------~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~ 472 (653)
.++||||+++ +|...+..... ....+++..++.++.|++.||.||| + ++|+||||||+|||++. ++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCC
Confidence 7899999976 55554433211 1345888999999999999999999 7 89999999999999986 89
Q ss_pred cEEEEeecCcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 473 NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
.+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ...+
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~ 245 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIV 245 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHH
Confidence 99999999998765432 22345789999999998655 4899999999999999999999999875543221 1222
Q ss_pred Hhhhcc-cchhHhhhhc-----------------cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 552 KELHLE-GEITQAIDQT-----------------LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 552 ~~~~~~-~~~~~~~d~~-----------------l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...... ......+++. ...........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 111100 0011111110 01111224578999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=339.03 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=189.2
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
..++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3468999999999999999999998889999999986542 344567889999999999999999999999999999999
Q ss_pred eccCCCCchhhhhccccc---ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 407 DYVPNGSLDKLLFDKDHK---LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
||+++++|.+++...... ....+++..++.++.||+.||.|||+ ++++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998752110 13458999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCC----CcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 484 IYEHGAN----PQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 484 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ...... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~-~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQND-PP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHTSS-CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhccC-CC
Confidence 6543211 11233568999999999875 568999999999999999999999998654332111 000000 00
Q ss_pred chh-HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 559 EIT-QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 559 ~~~-~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
... ...++.+ .......+.+++.+||+.||.+||++.|++++-
T Consensus 246 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 246 SLETGVQDKEM---LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp CTTC-----CC---CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred ccccccccchh---hhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 000 0111111 011235688999999999999999999999854
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=348.16 Aligned_cols=262 Identities=26% Similarity=0.347 Sum_probs=198.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc------ceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ------DELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 403 (653)
.+|...+.||+|+||.||+|++..+++.||||++..... ...+|++++++++|+||++++++|... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 457888999999999999999998899999999864422 234799999999999999999988432 2467
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEeecCc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLA 482 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla 482 (653)
+||||+++ +|.+.+..... ....+++..++.++.||++||.|||+ ++|+||||||+||||+.+ +.+||+|||++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 99999975 66666543211 13568999999999999999999999 899999999999999965 56899999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc--cc
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE--GE 559 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~ 559 (653)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.+.+...... ..
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ 280 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 8764432 22345789999999998764 789999999999999999999999986554322 22222211100 00
Q ss_pred hhHhhhh--------ccCc------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 560 ITQAIDQ--------TLDY------YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 560 ~~~~~d~--------~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+.+ ..+ .+.. +.......+.+|+.+||+.||.+||++.|++++-.
T Consensus 281 ~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 281 IRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 110 011 0000 11122467899999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.39 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=198.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-CC--cEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-LG--LEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|+..+.||+|+||.||+|.+.. ++ ..||||++... ..+..+.+.+|+.++++++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 578889999999999999998632 23 36899998654 3445678999999999999999999999998765 89
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|+||+++++|.+++.... ..+++.+++.++.|+++||.|||+ ++++|+||||+||+++.++.+||+|||++.
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999997642 458899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 484 IYEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 484 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+.. ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~---~~~- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDK---EGE- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT---SCC-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHHc---cCC-
Confidence 76543221 1223457788999999988889999999999999999999 999997654322 1111111 000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
. ..........+.+++.+||+.||.+||++.+++++|+...
T Consensus 243 ------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 ------R-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------C-CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 0011123467889999999999999999999999997643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.66 Aligned_cols=274 Identities=19% Similarity=0.231 Sum_probs=212.3
Q ss_pred cCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CC-----ceeeee
Q 048419 320 FKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HR-----NLVQLH 393 (653)
Q Consensus 320 f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~ 393 (653)
+...+.....++|...+.||+|+||.||+|.+..+++.||||++... ....+.+..|+.+++.++ |+ ++++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 44455556678999999999999999999999988999999999643 334567788888888885 44 499999
Q ss_pred eeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCC
Q 048419 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL--DTY 471 (653)
Q Consensus 394 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~ 471 (653)
+++...+..++||||++ ++|.+++.... ...+++..++.++.|++.||.|||.. ..+|+||||||+|||+ +.+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence 99999999999999996 59999997654 24589999999999999999999941 2789999999999999 457
Q ss_pred CcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 472 LNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 472 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..+
T Consensus 198 ~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~--~i~ 271 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN--KIV 271 (382)
T ss_dssp CCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH
T ss_pred CcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH
Confidence 88999999999876432 234578999999999999999999999999999999999999998655433211 111
Q ss_pred Hhhhcc--------cchhHhhhhc----------------------------------------c--CcCCHHHHHHHHH
Q 048419 552 KELHLE--------GEITQAIDQT----------------------------------------L--DYYDLAEAELVLN 581 (653)
Q Consensus 552 ~~~~~~--------~~~~~~~d~~----------------------------------------l--~~~~~~~~~~l~~ 581 (653)
...... ....+.++.. . ......+...+.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 110000 0000000000 0 0112344568999
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 582 LGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 582 l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
|+.+||+.||.+|||+.|++++-.
T Consensus 352 li~~mL~~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQHSF 375 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred HHHHhcCCChhhCCCHHHHhcCcc
Confidence 999999999999999999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.88 Aligned_cols=255 Identities=12% Similarity=0.036 Sum_probs=185.6
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhc--CCCceeeee-------eee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRL--RHRNLVQLH-------GWC 396 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~ 396 (653)
...|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999999889999999997653 23456677885555555 699988855 333
Q ss_pred ccc-----------------ceeEEEEeccCCCCchhhhhcccccccccchhhhH------HHHHHHHHHHHHHHHhcCC
Q 048419 397 RKQ-----------------DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQR------YKILIGIAQSLLYLHEECN 453 (653)
Q Consensus 397 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~ 453 (653)
... ..+++||||++ |+|.+++.... ..+++..+ +.++.||++||+|||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~--- 212 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQS--- 212 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---
Confidence 221 34899999998 89999997753 23566666 7888999999999999
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHh
Q 048419 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVAC 531 (653)
Q Consensus 454 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~ellt 531 (653)
++|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 8999999999999999999999999999986532 2224467799999999987 679999999999999999999
Q ss_pred CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 532 GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 532 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
|+.||......... .+............. ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 289 g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 LFLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SSCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCCcCccccc--------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999865332100 000000000000001 00011235678899999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.19 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=202.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccccee---
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDEL--- 402 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 402 (653)
..++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 346788899999999999999999999999999999654 334467889999999999999999999999877654
Q ss_pred ---EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 403 ---LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 403 ---~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
++||||+. ++|.+++. ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999997 58887773 238899999999999999999999 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc-
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE- 557 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~- 557 (653)
|+++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+... ..+......
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~ 262 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPG 262 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCC
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCc
Confidence 999865432 234578999999999877 678999999999999999999999998655432211 111100000
Q ss_pred ---------cchhHhhhhcc--CcCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 ---------GEITQAIDQTL--DYYD-----LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 ---------~~~~~~~d~~l--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
........... .... ......+.+|+.+||+.||.+|||+.|++++-..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 00000010000 0001 1124678999999999999999999999987654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=334.45 Aligned_cols=267 Identities=26% Similarity=0.369 Sum_probs=204.5
Q ss_pred HhhcCcCcceeeeeeCcEEEEEEEeC-CCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhc---CCCceeeeeeeec---
Q 048419 327 SVTKGFGEQNLVGSGGFGRVYRGLMP-SLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRL---RHRNLVQLHGWCR--- 397 (653)
Q Consensus 327 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~--- 397 (653)
.+.++|...+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.+++++ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45688999999999999999999985 668999999986432 11223456677766666 8999999999987
Q ss_pred --ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEE
Q 048419 398 --KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAK 475 (653)
Q Consensus 398 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 475 (653)
.....++||||++ |+|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEE
Confidence 5667899999997 69999997654 2458999999999999999999999 8999999999999999999999
Q ss_pred EEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh
Q 048419 476 LGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 476 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
|+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......... ...+....
T Consensus 161 l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~ 236 (326)
T 1blx_A 161 LADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIG 236 (326)
T ss_dssp ECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHC
T ss_pred EecCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHcC
Confidence 9999999865432 1233457899999999999889999999999999999999999999865543221 11111110
Q ss_pred cc--cchhHh-------h----hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 556 LE--GEITQA-------I----DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 556 ~~--~~~~~~-------~----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. ...... . ...+..........+.+|+.+||+.||.+||++.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00 000000 0 0000111122346788999999999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=333.94 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=202.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce-----
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE----- 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 401 (653)
.++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46788899999999999999999989999999999654 33445788999999999999999999999977654
Q ss_pred -eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 402 -LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 402 -~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
.++||||++ ++|.+++.. .+++.+++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 588887732 38899999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc--
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE-- 557 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 557 (653)
+++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+... .........
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~ 245 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPGT 245 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--HHHHHHCBCCH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCH
Confidence 99865322 234578999999999876 678999999999999999999999998655432211 111110000
Q ss_pred --------cchhHhhhh-------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 558 --------GEITQAIDQ-------TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 558 --------~~~~~~~d~-------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
......+.. .+..........+.+++.+||+.||.+|||+.|++++-..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 000000000 0011112335778999999999999999999999987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=335.08 Aligned_cols=265 Identities=18% Similarity=0.261 Sum_probs=205.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-----------CCceeeeeeeecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-----------HRNLVQLHGWCRK 398 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 398 (653)
++|...+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788999999999999999999888999999999643 334567889999999886 8999999999876
Q ss_pred cc----eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEc----
Q 048419 399 QD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLD---- 469 (653)
Q Consensus 399 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~---- 469 (653)
.+ .+++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEET
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCC
Confidence 54 789999999 889999997643 2458899999999999999999999 7 999999999999994
Q ss_pred --CCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhh----
Q 048419 470 --TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAA---- 543 (653)
Q Consensus 470 --~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~---- 543 (653)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999876432 233478999999999999899999999999999999999999998543211
Q ss_pred HHHHHHHHHhhhcc-------cc----------------------hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCC
Q 048419 544 ELLLVDWVKELHLE-------GE----------------------ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYR 594 (653)
Q Consensus 544 ~~~l~~~~~~~~~~-------~~----------------------~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R 594 (653)
...+...+...... +. +.+.+.. ...........+.+|+.+||+.||.+|
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE-KYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH-TTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh-cccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111111110000 00 0000000 012345677889999999999999999
Q ss_pred CCHHHHHHHHcCC
Q 048419 595 PDMRRVVEFLLGD 607 (653)
Q Consensus 595 Ps~~evl~~L~~~ 607 (653)
||+.|++++-.-.
T Consensus 326 pt~~ell~hp~f~ 338 (373)
T 1q8y_A 326 ADAGGLVNHPWLK 338 (373)
T ss_dssp BCHHHHHTCGGGT
T ss_pred CCHHHHhhChhhh
Confidence 9999999966543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=338.51 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=206.2
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-----------------hHHHHHHHHHHHhhcCCCceee
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-----------------GMKEFVAEIMSMGRLRHRNLVQ 391 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~ 391 (653)
.++|...+.||+|+||.||+|.. +++.||||++...... ..+.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 6899999998643211 1278999999999999999999
Q ss_pred eeeeecccceeEEEEeccCCCCchhh------hhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 048419 392 LHGWCRKQDELLLVYDYVPNGSLDKL------LFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSN 465 (653)
Q Consensus 392 l~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 465 (653)
+++++.+.+..++||||+++++|.++ +.... ...+++..++.++.||+.||.|||+ .++|+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHh
Confidence 99999999999999999999999999 54422 3568999999999999999999997 2699999999999
Q ss_pred EEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccC-CCCC-ccceeehHHHHHHHHhCCCCCChhhhhh
Q 048419 466 ILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATT-STDVYSYGILMLEVACGRRSIEPQKAAA 543 (653)
Q Consensus 466 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDV~s~Gvvl~elltG~~p~~~~~~~~ 543 (653)
|+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||.......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999999876432 33445789999999999877 5666 9999999999999999999998654311
Q ss_pred HHHHHHHHHhhhcccchhH----hhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 544 ELLLVDWVKELHLEGEITQ----AIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 544 ~~~l~~~~~~~~~~~~~~~----~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
. +...+.... ..... ...+.. ..........+.+++.+||+.||.+||++.|++++-.
T Consensus 260 ~--~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 260 E--LFNNIRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp H--HHHHHTSCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred H--HHHHHhccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 1 111111110 00000 000000 0000223467899999999999999999999998653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=332.54 Aligned_cols=266 Identities=20% Similarity=0.285 Sum_probs=206.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCC-cEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc------eeeeeeeecccc
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLG-LEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN------LVQLHGWCRKQD 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~ 400 (653)
..++|...+.||+|+||.||+|.+..++ ..||||++... ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999987666 78999999643 344567889999999998766 899999999999
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE------------
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL------------ 468 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll------------ 468 (653)
..++||||+ +++|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccc
Confidence 999999999 667777776543 2458999999999999999999999 899999999999999
Q ss_pred -------cCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhh
Q 048419 469 -------DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKA 541 (653)
Q Consensus 469 -------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~ 541 (653)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 67889999999999864332 2345789999999999999999999999999999999999999987554
Q ss_pred hhHHHHHHHHHhhhcccchh----------------------Hhhhh---cc---CcCCHHHHHHHHHHHHHcCCCCCCC
Q 048419 542 AAELLLVDWVKELHLEGEIT----------------------QAIDQ---TL---DYYDLAEAELVLNLGLFCSAPNPVY 593 (653)
Q Consensus 542 ~~~~~l~~~~~~~~~~~~~~----------------------~~~d~---~l---~~~~~~~~~~l~~l~~~Cl~~dP~~ 593 (653)
.................... ..+.. .+ ......+...+.+|+.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 33222111111000000000 00000 00 1122344568999999999999999
Q ss_pred CCCHHHHHHHHc
Q 048419 594 RPDMRRVVEFLL 605 (653)
Q Consensus 594 RPs~~evl~~L~ 605 (653)
|||+.|++++-.
T Consensus 325 Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 325 RITLAEALLHPF 336 (355)
T ss_dssp SCCHHHHTTSGG
T ss_pred CcCHHHHhcChh
Confidence 999999997653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=326.09 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=206.4
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
....++|...+.||+|+||.||+|....+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 34557899999999999999999999888999999998653 2345678999999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CcEEEEeec
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY---LNAKLGDFG 480 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG 480 (653)
+|+||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++++|+||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999988653 348999999999999999999999 899999999999999654 469999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
++....... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||....... +...+.........
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETGKYAFDL 243 (287)
T ss_dssp GGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCCCS
T ss_pred cceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCCCCCc
Confidence 998664332 2233468899999999875 58999999999999999999999998654322 11111111000000
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+... .....+.+++.+||+.||.+|||+.|++++-
T Consensus 244 -----~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 244 -----PQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp -----GGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -----hhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 0001 1235688999999999999999999999843
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=335.97 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=182.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHH-HHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIM-SMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|+||.||+|.+..+++.||||++.... ......+..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999999889999999997643 334455666665 7778899999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|+++ +|.+++..........+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 88887764322224568999999999999999999999 7 99999999999999999999999999998664
Q ss_pred CCCCCcccccccCCcccCcccc----ccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 487 HGANPQTTHIVGTLGYLAPELT----RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||........ .... ...+..
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~-- 247 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGDP-- 247 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC--
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCCC--
Confidence 322 22334689999999998 456789999999999999999999999975432110 0000 001100
Q ss_pred hhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 563 AIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 563 ~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+.+ ..........+.+++.+||+.||.+||++.|++++
T Consensus 248 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 ---PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111 11111234678899999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=345.68 Aligned_cols=271 Identities=20% Similarity=0.255 Sum_probs=186.9
Q ss_pred CcCc-ceeeeeeCcEEEEEEEeC--CCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeec--ccceeEEE
Q 048419 331 GFGE-QNLVGSGGFGRVYRGLMP--SLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCR--KQDELLLV 405 (653)
Q Consensus 331 ~f~~-~~~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV 405 (653)
.|.. .++||+|+||.||+|.+. .+++.||||++..... .+.+.+|+.++++++||||+++++++. .....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3544 458999999999999965 4578999999965432 346789999999999999999999994 46789999
Q ss_pred EeccCCCCchhhhhccccc----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCcEEEE
Q 048419 406 YDYVPNGSLDKLLFDKDHK----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILL----DTYLNAKLG 477 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 477 (653)
|||++ ++|.+++...... ....+++..++.++.||+.||.|||+ ++|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 5888877643211 12248999999999999999999999 899999999999999 778999999
Q ss_pred eecCcccccCCCC--CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhh-------HHHH
Q 048419 478 DFGLAKIYEHGAN--PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAA-------ELLL 547 (653)
Q Consensus 478 DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~-------~~~l 547 (653)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987654221 223346789999999998774 58999999999999999999999997543210 0111
Q ss_pred HHHHHhhhcc--cchh---------Hhhhhcc----CcCCH---------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 548 VDWVKELHLE--GEIT---------QAIDQTL----DYYDL---------AEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 548 ~~~~~~~~~~--~~~~---------~~~d~~l----~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...+...... .... ....... ..... .....+.+|+.+||+.||.+|||+.|++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111000 0000 0000000 00000 013567899999999999999999999998
Q ss_pred HcCC
Q 048419 604 LLGD 607 (653)
Q Consensus 604 L~~~ 607 (653)
-...
T Consensus 335 p~f~ 338 (405)
T 3rgf_A 335 PYFL 338 (405)
T ss_dssp GGGT
T ss_pred hhhc
Confidence 7643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=362.98 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=203.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
..++|...+.||+|+||.||+|.+... +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 346688889999999999999998543 567999998654 34445789999999999999999999999854 5689
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+||||+++|+|.+++.... ..+++..++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 467 lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 9999999999999997542 348899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
..............+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....+....
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~~~------- 609 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGE------- 609 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHHTC-------
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcCC-------
Confidence 765443333334567889999999998899999999999999999997 999997654322 111111100
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+......+.+++.+||+.||.+||++.||++.|+.
T Consensus 610 -----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 610 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 001112234678899999999999999999999998864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.69 Aligned_cols=262 Identities=25% Similarity=0.327 Sum_probs=194.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc------eeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD------ELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 403 (653)
.+|...++||+|+||.||+|++..++. +|+|++...... ..+|++++++++||||+++++++...+ .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468889999999999999999976554 899888543221 236999999999999999999985543 378
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCcEEEEeecCc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD-TYLNAKLGDFGLA 482 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla 482 (653)
+||||++++.+........ ....+++..++.++.||++||+|||+ ++|+||||||+|||++ .++.+||+|||++
T Consensus 115 lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEECCSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeeccCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 9999998744433322111 13468999999999999999999999 8999999999999998 7999999999999
Q ss_pred ccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc--cc
Q 048419 483 KIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE--GE 559 (653)
Q Consensus 483 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~ 559 (653)
+...... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+.. ...+...... ..
T Consensus 190 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHH
T ss_pred ccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHH
Confidence 8764432 22345789999999998664 5899999999999999999999999876543322 1222111000 00
Q ss_pred hhHh----hhhcc---Cc------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 560 ITQA----IDQTL---DY------YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 560 ~~~~----~d~~l---~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
+... ..... .. +.......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 0000 00000 00 11123467899999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=332.35 Aligned_cols=257 Identities=21% Similarity=0.239 Sum_probs=177.0
Q ss_pred hhcCcCcc-eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc----ccee
Q 048419 328 VTKGFGEQ-NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK----QDEL 402 (653)
Q Consensus 328 at~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 402 (653)
..++|... ++||+|+||.||+|.+..+++.||||++..... ........++.++|+||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45678885 469999999999999998999999999854321 11222334566799999999999876 4568
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEEee
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDF 479 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 479 (653)
++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 99999999999999998654 3468999999999999999999999 89999999999999976 455999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
|+++..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ........+.
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~ 249 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ 249 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc
Confidence 999865432 2234578999999999988889999999999999999999999997544321100 0000000000
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
. ... ..........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 250 ~-~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 250 Y-GFP----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp --CCC----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred c-ccC----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 000 0000123467889999999999999999999998553
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.60 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=196.8
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------hhHHHHHHHHHHHhhc----CCCceeeeee
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------QGMKEFVAEIMSMGRL----RHRNLVQLHG 394 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g 394 (653)
.....++|...+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34556789999999999999999999988899999999965432 1233456799999998 8999999999
Q ss_pred eecccceeEEEEec-cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCC
Q 048419 395 WCRKQDELLLVYDY-VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD-TYL 472 (653)
Q Consensus 395 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~ 472 (653)
++...+..++|+|+ +++++|.+++... ..+++.+++.++.||++||.|||+ ++|+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence 99999999999999 7899999999763 348999999999999999999999 8999999999999999 889
Q ss_pred cEEEEeecCcccccCCCCCcccccccCCcccCccccccCCCC-CccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHH
Q 048419 473 NAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT-TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWV 551 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 551 (653)
.+||+|||+++..... ......|+..|+|||++.+..+. .++|||||||++|||++|+.||...... .
T Consensus 178 ~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~ 246 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------L 246 (312)
T ss_dssp EEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H
T ss_pred eEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------h
Confidence 9999999999876542 22345689999999998876664 4899999999999999999999754221 0
Q ss_pred HhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 552 KELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 552 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
.. .. .........+.+++.+||+.||.+||++.|++++-.-.
T Consensus 247 ~~-------------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 247 EA-------------EL-HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp HT-------------CC-CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred hh-------------cc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 00 00 01112235688999999999999999999999976543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=333.42 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=202.6
Q ss_pred CcccCHHHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcC--CCceeee
Q 048419 317 ARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLR--HRNLVQL 392 (653)
Q Consensus 317 ~~~f~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l 392 (653)
...+.+..+....++|...+.||+|+||.||++.+.. ++.||||++... .....+.+.+|+.++++++ |+||+++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence 4445555566667889999999999999999999864 889999998643 3455678999999999997 5999999
Q ss_pred eeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 048419 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL 472 (653)
Q Consensus 393 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 472 (653)
++++...+..++||| +.+++|.+++... ..+++.+++.++.||++||.|||+ ++|+||||||+|||+++ +
T Consensus 94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~ 163 (313)
T 3cek_A 94 YDYEITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-G 163 (313)
T ss_dssp EEEEECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-T
T ss_pred EEEeecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-C
Confidence 999999999999999 5688999999764 348899999999999999999999 89999999999999964 8
Q ss_pred cEEEEeecCcccccCCCCC-cccccccCCcccCcccccc-----------CCCCCccceeehHHHHHHHHhCCCCCChhh
Q 048419 473 NAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRT-----------GKATTSTDVYSYGILMLEVACGRRSIEPQK 540 (653)
Q Consensus 473 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~ 540 (653)
.+||+|||+++........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 9999999999876443221 2234568999999999875 468889999999999999999999997543
Q ss_pred hhhHHHHHHHHHhhhcccchhHhhhhcc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 541 AAAELLLVDWVKELHLEGEITQAIDQTL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 541 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..... + ...+++.. ...+......+.+++.+||+.||.+||++.|++++...
T Consensus 244 ~~~~~-~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 244 NQISK-L-------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp SHHHH-H-------------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHH-H-------------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 21110 0 11111111 01111124568899999999999999999999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=333.59 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=199.7
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
..++|...+.||+|+||.||+|.+.+ .+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 34678889999999999999999864 4999998653 233345678899999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++.... ..+++.+++.++.||+.||.|||+ ++++||||||+||+++ ++.+||+|||+++..
T Consensus 108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999997642 458999999999999999999999 8999999999999998 679999999998765
Q ss_pred cCCC----CCcccccccCCcccCcccccc---------CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 486 EHGA----NPQTTHIVGTLGYLAPELTRT---------GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 486 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
.... ........|++.|+|||.+.. ..++.++|||||||++|||++|+.||........ ...+.
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~ 256 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---IWQMG 256 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---HHHHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhc
Confidence 3211 122233468999999999864 3478899999999999999999999986543221 11111
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
. +. .+.+. .......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 257 ~----~~-----~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l 300 (319)
T 2y4i_B 257 T----GM-----KPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300 (319)
T ss_dssp T----TC-----CCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred c----CC-----CCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 10 01110 001234588999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.73 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=204.0
Q ss_pred HHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------hhHHHHHHHHHHHhhcC--CCceeeeeee
Q 048419 324 ELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------QGMKEFVAEIMSMGRLR--HRNLVQLHGW 395 (653)
Q Consensus 324 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~ 395 (653)
+.....++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 344556789999999999999999999988999999999865421 12245678999999996 5999999999
Q ss_pred ecccceeEEEEeccCC-CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCc
Q 048419 396 CRKQDELLLVYDYVPN-GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD-TYLN 473 (653)
Q Consensus 396 ~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~ 473 (653)
+...+..++|+|++.+ ++|.+++... ..+++..++.++.||++||.|||+ ++|+||||||+|||++ .++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999976 8999998753 348899999999999999999999 8999999999999999 7899
Q ss_pred EEEEeecCcccccCCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHH
Q 048419 474 AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVK 552 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 552 (653)
+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..
T Consensus 189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~ 257 (320)
T 3a99_A 189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IR 257 (320)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------HH
T ss_pred EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------hc
Confidence 999999999876532 2234568999999999887665 67899999999999999999999754321 00
Q ss_pred hhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 553 ELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 553 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. . . .........+.+++.+||+.||.+|||+.|++++-.-
T Consensus 258 ~-----~--------~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 258 G-----Q--------V-FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp C-----C--------C-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred c-----c--------c-cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 0 0 0 0011123568899999999999999999999986543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.13 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=181.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhh-HHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQG-MKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|+||.||+|.+..+|+.||||++.... ... .+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56888999999999999999999889999999997543 222 3344455567888899999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ-RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|+ ++.+..+.... ...+++..++.++.||++||.|||+ + +++|+||||+||+++.++.+||+|||++....
T Consensus 105 ~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 99 44555444332 2458999999999999999999998 5 99999999999999999999999999997654
Q ss_pred CCCCCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||........ .+...... .
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~-----~-- 246 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVLQE-----E-- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHHHS-----C--
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHHhcc-----C--
Confidence 322 223456899999999984 45688999999999999999999999975332211 11111110 0
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.+.+. ........+.+++.+||+.||.+||++.|++++-
T Consensus 247 ---~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 247 ---PPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp ---CCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ---CCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 00010 0011235688999999999999999999998743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=335.75 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=189.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
+.|...++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3455678999999999976544 35899999998543 345678999999987 899999999999999999999999
Q ss_pred cCCCCchhhhhccccccc--ccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-------------Cc
Q 048419 409 VPNGSLDKLLFDKDHKLR--KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-------------LN 473 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~ 473 (653)
|. |+|.+++........ ...++..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 699999976542111 112455678899999999999999 899999999999999654 48
Q ss_pred EEEEeecCcccccCCCCC---cccccccCCcccCcccccc-------CCCCCccceeehHHHHHHHHh-CCCCCChhhhh
Q 048419 474 AKLGDFGLAKIYEHGANP---QTTHIVGTLGYLAPELTRT-------GKATTSTDVYSYGILMLEVAC-GRRSIEPQKAA 542 (653)
Q Consensus 474 ~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~ 542 (653)
+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999976543221 1234579999999999865 568999999999999999999 99999754332
Q ss_pred hHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 543 AELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 543 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. ............ ...........+.+++.+||+.||.+|||+.||+++-
T Consensus 247 ~~----~i~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 247 ES----NIIRGIFSLDEM-------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp HH----HHHHTCCCCCCC-------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HH----HHhcCCCCcccc-------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 11 111111110000 0112334567899999999999999999999999743
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.46 Aligned_cols=113 Identities=31% Similarity=0.444 Sum_probs=104.8
Q ss_pred CceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCC
Q 048419 121 TRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLG 200 (653)
Q Consensus 121 ~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~ 200 (653)
||+|||||||++|.+++||++||||||+||+.|.++++| ++.+|+.++|||+||+.+++|+|++++.+
T Consensus 1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~------------~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~ 68 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW------------DWQNGKIATAHISYNSVSKRLSVTSYYAG 68 (133)
T ss_dssp CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------------CCCTTSCEEEEEEEETTTTEEEEEEECSS
T ss_pred CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee------------EEcCCCEEEEEEEEeCCCcEEEEEEccCC
Confidence 578999999999999899999999999999999988765 36799999999999999999999998765
Q ss_pred CCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecceeeeec
Q 048419 201 VPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248 (653)
Q Consensus 201 ~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~~~ 248 (653)
. +.|+|++++||+++||++||||||||||...|.|+|++|+|++.
T Consensus 69 ~---~~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~ 113 (133)
T 1qmo_E 69 S---KPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSS 113 (133)
T ss_dssp S---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred C---ccceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEee
Confidence 4 27899999999999999999999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=349.18 Aligned_cols=259 Identities=29% Similarity=0.378 Sum_probs=201.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecc------ccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK------QDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 402 (653)
++|...+.||+|+||.||+|.+..+|..||||++... .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999999888999999998654 44556789999999999999999999999766 6678
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc---EEEEee
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN---AKLGDF 479 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 479 (653)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++. +||+||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 999999999999999977542 3458999999999999999999999 89999999999999987665 999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
|++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .|.........
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC----
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccc
Confidence 9998765432 2234578999999999999999999999999999999999999997543211 11111100000
Q ss_pred hhHhhh----------hcc---CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048419 560 ITQAID----------QTL---DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRV 600 (653)
Q Consensus 560 ~~~~~d----------~~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 600 (653)
...... ..+ ..........+.+++.+||+.||.+|||+.|+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 000 12233456889999999999999999999663
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=331.71 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=186.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.+|...++||+|+||+||.... .+++.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4688889999999998554333 3588999999965432 2356799999999 799999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEEeecCcc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-----YLNAKLGDFGLAK 483 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~ 483 (653)
|+ |+|.+++.... ..+.+..++.++.||+.||.|||+ ++|+||||||+|||++. ...+||+|||+++
T Consensus 100 ~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 100 CA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 96 59999997653 235566778999999999999999 89999999999999943 3468899999998
Q ss_pred cccCCCC--CcccccccCCcccCccccc---cCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 484 IYEHGAN--PQTTHIVGTLGYLAPELTR---TGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 484 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||.......... ....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------Hhcc
Confidence 7653321 2234457999999999997 4567889999999999999999 889986543221100 0000
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
... . ...........+.+|+.+||+.||.+|||+.||+++-
T Consensus 245 ~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 245 CSL-D-----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp CCC-T-----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred CCc-c-----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 000 0 0111123455688999999999999999999999643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.80 Aligned_cols=230 Identities=22% Similarity=0.273 Sum_probs=181.6
Q ss_pred hcCcCcc-eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHH-hhcCCCceeeeeeeecc----ccee
Q 048419 329 TKGFGEQ-NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSM-GRLRHRNLVQLHGWCRK----QDEL 402 (653)
Q Consensus 329 t~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~ 402 (653)
.++|... ++||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3556666 7899999999999999989999999998532 3567888887 55689999999999876 6778
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEEee
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDF 479 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 479 (653)
++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 99999999999999998754 3458999999999999999999999 89999999999999988 788999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
|++.... +..++.++|||||||++|||++|+.||........ ...
T Consensus 165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------------~~~ 209 (299)
T 3m2w_A 165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPG 209 (299)
T ss_dssp TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CC
T ss_pred ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------------hHH
Confidence 9987532 23467899999999999999999999975432110 000
Q ss_pred hhHhhhhccCcCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 560 ITQAIDQTLDYYDL----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 560 ~~~~~d~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
+...+.......+. .....+.+++.+||+.||.+|||+.|++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00000000001111 1246789999999999999999999999854
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.79 Aligned_cols=246 Identities=15% Similarity=0.108 Sum_probs=185.0
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCC-Cceeeeee---------
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRH-RNLVQLHG--------- 394 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~g--------- 394 (653)
.++.|...++||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++| +|...+..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3455777899999999999999999899999999987432 2336789999999999987 32211111
Q ss_pred ------------eecc-----cceeEEEEeccCCCCchhhhhccc--ccccccchhhhHHHHHHHHHHHHHHHHhcCCCC
Q 048419 395 ------------WCRK-----QDELLLVYDYVPNGSLDKLLFDKD--HKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455 (653)
Q Consensus 395 ------------~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 455 (653)
++.. ....+++|+++ +++|.+++.... ......+++..++.++.||++||+|||+ ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 1111 12356777766 689999885221 0113568999999999999999999999 99
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCcccc----------ccCCCCCccceeehHHH
Q 048419 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT----------RTGKATTSTDVYSYGIL 525 (653)
Q Consensus 456 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDV~s~Gvv 525 (653)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999865432 334567 999999999 55568889999999999
Q ss_pred HHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048419 526 MLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 526 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
+|||++|+.||........ ....+.. ... ..+.+.+|+.+||+.||.+||++.|+++
T Consensus 307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~-~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG---------------SEWIFRS-CKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC---------------SGGGGSS-CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhh---------------HHHHHhh-ccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999976543210 0111110 011 2366889999999999999999877754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.65 Aligned_cols=230 Identities=11% Similarity=0.102 Sum_probs=182.9
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
.++|...+.||+|+||.||+|.+..+++.||||++.... .+..+.+.+|+..+++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367889999999999999999999889999999997542 34457899999999999999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++++|.+++... ....++.+++.||+.||+|||+ ++|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999998532 2344678899999999999999 899999999999999999999997433
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
|++| ++.++|||||||++|||++|+.||........... .. ....+....
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~-~~~~~~~~~--- 224 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AE-RDTAGQPIE--- 224 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CC-BCTTSCBCC---
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HH-HHhccCCCC---
Confidence 3333 68899999999999999999999986543210000 00 000000000
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...........+.+++.+||+.||.+| |+.|+++.|+.
T Consensus 225 --~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 225 --PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp --HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred --hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 000011224568999999999999999 99999999964
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=294.49 Aligned_cols=198 Identities=17% Similarity=0.154 Sum_probs=147.5
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCC-CCCCCceEEEEecCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYP-DLGGQGLAFIIISTNRP 97 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~-~~~gdGlaF~l~~~~~~ 97 (653)
.++.++|+|.+. +|.|+||++..++.||+||+.|+++ +||+|+|+|.|.+.+. ..+||||||+|+|....
T Consensus 25 ~~~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~--------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~~ 95 (253)
T 2dur_A 25 PLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFL--------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRLV 95 (253)
T ss_dssp CSEEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCC--------SSEEEEEEEEEECCCCTTCCCCEEEEEEESCCSC
T ss_pred CCEEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCcc--------CcEEEEEEEEEecCCCCCcCCCcEEEEEECCCCC
Confidence 689999999995 9999999999999999999999997 5899999999998765 56899999999997542
Q ss_pred CCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCC----CCcccccc
Q 048419 98 ENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGN----NHRIPILL 173 (653)
Q Consensus 98 ~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~----~~~~~~~l 173 (653)
.|++||+.+. ++.|||||||+.|.++.| |+++||+++.+..+..+....+. .+.....+
T Consensus 96 ----~G~~lG~~~~---------~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~ 158 (253)
T 2dur_A 96 ----PGPVFGSKDN---------FHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADF 158 (253)
T ss_dssp ----EETBTEECSS---------CEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCC
T ss_pred ----CCcccCcCCC---------CCEEEEEEECCCCCCCCC----CCCcEEEEEecCCceeeeccCCCcccccccccHhh
Confidence 4688996432 456999999999975433 44444444444444332211010 01122234
Q ss_pred -CCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecceeeeec
Q 048419 174 -RSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248 (653)
Q Consensus 174 -~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~~~ 248 (653)
..|+.++|||+|++. +|+|++.+.+.. +..++ ..++ ...||++|||||||+||...+.|+|++|+|..-
T Consensus 159 ~n~g~~~~v~I~Y~~~--~L~V~l~~~~~~-~~~~~--~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl 228 (253)
T 2dur_A 159 RNRDHDTFLAVRYSRG--RLTVMTDLEDKN-EWKNC--IDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL 228 (253)
T ss_dssp BTCSSCEEEEEEEETT--EEEEEEECSSSS-CCEEE--EEEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred ccCCCCeEEEEEEECC--EEEEEEeCCCCC-CceEE--EEeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence 348999999999976 899999875432 33333 3344 335899999999999999999999999999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=343.67 Aligned_cols=238 Identities=25% Similarity=0.325 Sum_probs=192.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCC-CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccce-----
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPS-LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE----- 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 401 (653)
.++|...+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.++++++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999865 6899999998654 34456688999999999999999999999987765
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.+|||||+++++|.+++.. .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999987743 48999999999999999999999 899999999999999886 899999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchh
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEIT 561 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 561 (653)
++..... ....||+.|+|||++.+. ++.++|||||||++|||++|..|+...... .+.
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~~ 285 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GLP 285 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SCC
T ss_pred chhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------------ccc
Confidence 9875432 345799999999998765 488999999999999999998887642110 000
Q ss_pred HhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHc
Q 048419 562 QAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-MRRVVEFLL 605 (653)
Q Consensus 562 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~ 605 (653)
. ..........+.+|+.+||+.||.+||+ +.++.+.|.
T Consensus 286 ~------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 E------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp T------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred c------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0000112356889999999999999995 555555443
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.68 Aligned_cols=204 Identities=16% Similarity=0.185 Sum_probs=153.9
Q ss_pred ceeEEeCCCCC-----CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCC
Q 048419 8 TTSFLYNGFLH-----ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDL 82 (653)
Q Consensus 8 ~~~f~~~~f~~-----~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~ 82 (653)
..||..+.+.. .++.++|+|.+ ++|.|+||++..++.||+||+.|+++ +||+|+|+|+|.+.. ..
T Consensus 33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i-~~~~IrLT~~~~~~~G~~w~~~p~~~--------~sF~t~F~F~I~~~~-~~ 102 (260)
T 1gv9_A 33 KYSFKGPHLVQSDGTVPFWAHAGNAIP-SADQIRIAPSLKSQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-RI 102 (260)
T ss_dssp GGCEECSSCSCTTSCBTTEEEEETCEE-CSSCEEEECSSTTCEEEEEESSCBCC--------SSEEEEEEEEEECSS-SC
T ss_pred ceeEcCccccCCCCccCCeEEcccEEe-eCCEEEeCCCCCCCEEEEEECCCccc--------cCEEEEEEEEEecCC-CC
Confidence 45676665531 68999999998 58999999998899999999999964 799999999998764 36
Q ss_pred CCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccC-CC------CCCeeeEecCC-CCcC
Q 048419 83 GGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELI-DI------NDNHVGIDISS-LISS 154 (653)
Q Consensus 83 ~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~Hvgid~ns-~~s~ 154 (653)
+||||||+|+|.... .|+++|+.+. .+.|||||||+.|.++. +| +++|||||+|+ +.|.
T Consensus 103 ~gdGlAF~l~~~~~~----~g~~~G~~~~---------~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~ 169 (260)
T 1gv9_A 103 GADGLAIWYTENQGL----DGPVFGSADM---------WNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQ 169 (260)
T ss_dssp CCCEEEEEEESSCCC----EEEETTECSC---------CEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHH
T ss_pred CCCeEEEEEecCCCC----CCCccCCCCC---------CCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccc
Confidence 899999999986542 5678888432 35699999999996431 23 35677777664 4333
Q ss_pred CcccCccccCCCCcccccc-CCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc
Q 048419 155 ASEPASYYSGNNHRIPILL-RSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL 233 (653)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~ 233 (653)
....+. ..+ .+|..++|||+|++. +|+|.+.+...+......++..+| ...||++|||||||+||.
T Consensus 170 ~~~~c~----------~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~ 236 (260)
T 1gv9_A 170 ALASCQ----------RDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGG 236 (260)
T ss_dssp CSEEEC----------CCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCS
T ss_pred eeeccC----------hhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCC
Confidence 322211 122 358999999999986 799999864222222346788888 677999999999999999
Q ss_pred ccceeeecceeeee
Q 048419 234 ITASHNVHGWSISI 247 (653)
Q Consensus 234 ~~~~~~i~sWsf~~ 247 (653)
..+.|+|++|+|..
T Consensus 237 ~~e~hdIlsw~~~~ 250 (260)
T 1gv9_A 237 LADDHDVLSFLTFQ 250 (260)
T ss_dssp SCCEEEEEEEEEEE
T ss_pred CcceEEEEEEEEEE
Confidence 99999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.34 Aligned_cols=243 Identities=18% Similarity=0.151 Sum_probs=183.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--------hhhHHHHHHHHHHHhhcC---------C-----
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--------QQGMKEFVAEIMSMGRLR---------H----- 386 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H----- 386 (653)
.++|...+.||+|+||.||+|++ +|+.||||++.... ....+.+.+|+.++++++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35688899999999999999998 47999999997542 233477889999998886 4
Q ss_pred ------------Cceeeeeeeecc-------------cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHH
Q 048419 387 ------------RNLVQLHGWCRK-------------QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGI 441 (653)
Q Consensus 387 ------------~niv~l~g~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i 441 (653)
|||+++++++.+ .+..++||||+++|++.+.+.. ..+++.+++.++.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHH
Confidence 555555555544 6789999999999987776643 347899999999999
Q ss_pred HHHHHHHH-hcCCCCeEecCCCCCcEEEcCCC--------------------cEEEEeecCcccccCCCCCcccccccCC
Q 048419 442 AQSLLYLH-EECNQRVVHRDVKPSNILLDTYL--------------------NAKLGDFGLAKIYEHGANPQTTHIVGTL 500 (653)
Q Consensus 442 a~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~ 500 (653)
+.||.||| + ++|+||||||+||||+.++ .+||+|||+++..... ...||+
T Consensus 171 ~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 8 8999999999999999887 8999999999876532 347999
Q ss_pred cccCccccccCCCCCccceeehHHH-HHHHHhCCCCCChhhhhhHHHHHHHHHhh-hcccchhHhhhhccCcCCHHHHHH
Q 048419 501 GYLAPELTRTGKATTSTDVYSYGIL-MLEVACGRRSIEPQKAAAELLLVDWVKEL-HLEGEITQAIDQTLDYYDLAEAEL 578 (653)
Q Consensus 501 ~y~aPE~~~~~~~~~ksDV~s~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~ 578 (653)
.|+|||++.+.. +.++||||+|++ .+++++|..||....... .+.+.+... ..... ............
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~~~~~s~~ 311 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH--YLTDKMLKQMTFKTK-------CNTPAMKQIKRK 311 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH--HHHHHHHHTCCCSSC-------CCSHHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh--HHHHhhhhhhccCcc-------cchhhhhhcCHH
Confidence 999999998665 889999998777 777889999985421100 011111000 00000 000111235678
Q ss_pred HHHHHHHcCCCCCCCCCCHHHHH-HH
Q 048419 579 VLNLGLFCSAPNPVYRPDMRRVV-EF 603 (653)
Q Consensus 579 l~~l~~~Cl~~dP~~RPs~~evl-~~ 603 (653)
+.+|+.+||+.| |+.|++ ++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 999999999966 999998 65
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-33 Score=270.64 Aligned_cols=115 Identities=28% Similarity=0.408 Sum_probs=106.1
Q ss_pred CCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeC
Q 048419 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPL 199 (653)
Q Consensus 120 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~ 199 (653)
+||+|||||||++|.+|+||++|||||||||+.|.++++| ++.+|+.++|||+||+.+++|+|++.+.
T Consensus 1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~ 68 (237)
T 1nls_A 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW------------NMQNGKVGTAHIIYNSVDKRLSAVVSYP 68 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------------CCCTTCEEEEEEEEETTTTEEEEEEECT
T ss_pred CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc------------cccCCCEEEEEEEEeCCCCEEEEEEecC
Confidence 3689999999999999889999999999999999988775 3679999999999999999999999876
Q ss_pred CCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecceeeeecC
Q 048419 200 GVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIGG 249 (653)
Q Consensus 200 ~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~~~~ 249 (653)
+. ..|+|+++|||+++|+|+||||||||||...|.|+|++|+|++..
T Consensus 69 ~~---~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~ 115 (237)
T 1nls_A 69 NA---DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp TS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred CC---CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence 53 568999999999999999999999999999999999999998764
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=212.01 Aligned_cols=103 Identities=29% Similarity=0.431 Sum_probs=93.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCC------CceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
.+++|+|+.|. ..||+|+|||++.+ |.|+||+... .++|||+|++||+|||+ +++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg~vaSFsT~F~F~I~~~ 79 (113)
T 1qmo_A 2 QSLSFSFTKFDPNQEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVLTSFDTIINFEISTP 79 (113)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEEEECS
T ss_pred cceEEEcCCCCCCCCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CCCEEeeEEEEEEEEecC
Confidence 46799999997 68999999999985 9999998765 79999999999999999 999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNIT 112 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~ 112 (653)
+...+||||||||+|....|. +.|+||||+|.+
T Consensus 80 ~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~ 112 (113)
T 1qmo_A 80 YTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA 112 (113)
T ss_dssp SSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred CCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence 777799999999999876676 899999999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-30 Score=285.71 Aligned_cols=184 Identities=20% Similarity=0.135 Sum_probs=130.5
Q ss_pred eeeeCcEEEEEEEeCCCCcEEEEEEeccC----------chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEEE
Q 048419 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHN----------SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 338 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 406 (653)
.+.|+.|.+..++....|+.++||++... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 55666666665555445888999999643 123356799999999999 7999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||++|++|.++|.... +++. .+|+.||++||+|||+ ++||||||||+||||++++++||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~~-----~l~~---~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-----EIDR---EKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTTC-----CCCH---HHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhCC-----CCCH---HHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999997653 2443 3589999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCC
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRR 534 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~ 534 (653)
.... .....+||++|+|||++.+ .+..++|+|++|+++++|.++..
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 4322 2344679999999999865 56778999999999988866543
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=226.03 Aligned_cols=185 Identities=15% Similarity=0.157 Sum_probs=140.3
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.++.++|+|.+ +++.|+||++ ..+.|++|.+.|+++. ++|+|+|+|+|.... ..+||||||++++....+
T Consensus 31 ~~w~~~G~a~v-~~~~IrLTp~-~~s~G~iW~~~p~~~~-------~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~~~~ 100 (256)
T 2a6y_A 31 NNWQTGEQASL-EEGRIVLTSN-QNSKGSLWLKQGFDLK-------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNIP 100 (256)
T ss_dssp TTEEEEETCEE-ETBEEECCCS-TTCEEEEEESSCEEES-------SCEEEEEEEEEESCC-SCCSCEEEEEEEECSSSC
T ss_pred CCeEEccceEE-eCCEEEECCC-CCceEEEeeCCCCccc-------CCEEEEEEEEEecCC-CCCCCeEEEEEeCCCCcc
Confidence 68999999999 5999999998 6779999888888753 579999999998764 338999999999875432
Q ss_pred CCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCC------CCeeeEecCCCCcCCcccCccccCCCCccccc
Q 048419 99 NCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDIN------DNHVGIDISSLISSASEPASYYSGNNHRIPIL 172 (653)
Q Consensus 99 ~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~ 172 (653)
..|+.+|..+.-+ -+||||||+.|. .|. +.|+++|.+++.+.....+. ..
T Consensus 101 --~~g~~~G~~~~f~---------GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~----------~~ 156 (256)
T 2a6y_A 101 --RDKQLYNGPVNYD---------GLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASCL----------MG 156 (256)
T ss_dssp --CCCTBTTBCTTCE---------EEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEEE----------CC
T ss_pred --cCCcccCcCCCCC---------EEEEEEECCCCC---CceEEEEECCCceecccCCCcccceecce----------ee
Confidence 4677888875322 399999999873 343 56777776653333222221 11
Q ss_pred c-CCCCceEEEEEec-CCceEEEEEEeeCCCCCCCCCceeeeecCCcc-cccce-EEeEecccC---cccceeeecceee
Q 048419 173 L-RSGDPIQAWVDYS-SQEMLINVSICPLGVPKPYRPLISLPIDLSSV-IDEYM-YTGFSASTG---LITASHNVHGWSI 245 (653)
Q Consensus 173 l-~~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~-l~~~~-~vGFsastg---~~~~~~~i~sWsf 245 (653)
. .+|...++||.|+ +..+.|+|.+.. ..-+++..+ ||+++ ||||||+|| ...+.|.|++|+|
T Consensus 157 ~rn~~~~~~v~I~Y~~~~~~~L~V~i~~-----------~~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~ 225 (256)
T 2a6y_A 157 YQDSSVPSTIRVTYDLEDDNLLKVQVDN-----------KVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQF 225 (256)
T ss_dssp CTTCSSCEEEEEEEEGGGTSEEEEEETT-----------EEEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEE
T ss_pred cccCCCcEEEEEEEecCCCcEEEEEEcC-----------EEEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEE
Confidence 2 3789999999999 778899999854 112334444 78997 699999999 7889999999999
Q ss_pred eec
Q 048419 246 SIG 248 (653)
Q Consensus 246 ~~~ 248 (653)
...
T Consensus 226 ~~~ 228 (256)
T 2a6y_A 226 FNG 228 (256)
T ss_dssp EES
T ss_pred Eec
Confidence 874
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-26 Score=253.56 Aligned_cols=185 Identities=17% Similarity=0.188 Sum_probs=145.9
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--------hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--------QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
...++||+|+||.||+|... +..+++|+..... ....+.+.+|++++++++||||+++..++...+..+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999654 6889999864321 1123568999999999999999977777777778899
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
||||+++++|.+++.. +..++.|+++||.|||+ ++|+||||||+|||++. ++||+|||+++.
T Consensus 417 VmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 9999999999999854 45799999999999999 99999999999999998 999999999997
Q ss_pred ccCCCCCc------ccccccCCcccCcccccc--CCCCCccceeehHHHHHHHHhCCCCCC
Q 048419 485 YEHGANPQ------TTHIVGTLGYLAPELTRT--GKATTSTDVYSYGILMLEVACGRRSIE 537 (653)
Q Consensus 485 ~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDV~s~Gvvl~elltG~~p~~ 537 (653)
........ .....||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 64422111 134679999999999986 567888999999999999888877664
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=209.44 Aligned_cols=104 Identities=28% Similarity=0.440 Sum_probs=92.4
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCC------CceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
..++|.|+.|. ..||+|+|+|++.++|.|+||+... .++|||+|++||+|||+ +++++||+|+|+|.|.+.
T Consensus 124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~~vaSFsT~F~F~I~~~ 202 (237)
T 1nls_A 124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKSP 202 (237)
T ss_dssp EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCCS
T ss_pred ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CCCEeeeEEEEEEEEecC
Confidence 45799999997 4699999999998789999998763 68999999999999997 889999999999999876
Q ss_pred CCCCCCCceEEEEecCC-CCCCCCCCccccCCCcc
Q 048419 79 YPDLGGQGLAFIIISTN-RPENCLANQFLGLPNIT 112 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~-~~~~~~~g~~lG~~~~~ 112 (653)
...+||||||||+|.. ..|.+++|+||||+|.+
T Consensus 203 -~~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 203 -DSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred -CCCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 3458999999999987 46788999999999864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=207.79 Aligned_cols=150 Identities=14% Similarity=0.079 Sum_probs=121.0
Q ss_pred HHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------------------hhHHHHHHHHHHHhhcCC
Q 048419 325 LASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------------------QGMKEFVAEIMSMGRLRH 386 (653)
Q Consensus 325 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H 386 (653)
+......|...+.||+|+||.||+|.+ .+|+.||||.+..... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 334445566779999999999999999 6799999999964321 13467899999999999
Q ss_pred CceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 048419 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNI 466 (653)
Q Consensus 387 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 466 (653)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|+++||.|||+ ++|+||||||+||
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NI 224 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNV 224 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHE
Confidence 5 77777553 456799999999999988 421 2344699999999999999 9999999999999
Q ss_pred EEcCCCcEEEEeecCcccccCCCCCcccccccCCcccCccccc
Q 048419 467 LLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR 509 (653)
Q Consensus 467 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 509 (653)
|++ ++.+||+|||+++. +..+.|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999874 23578899874
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.2e-18 Score=166.54 Aligned_cols=189 Identities=13% Similarity=0.111 Sum_probs=129.9
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.+..+.|+|.+. ++.|+||++ ..+.|.+|.+.|+++.+ +|+++|+|+|.... ..+||||||++++....
T Consensus 24 ~~W~~~G~a~i~-~~~IrLTp~-~~~~G~iWs~~p~~~~~-------~weie~~Fri~g~~-~~~gdGlA~W~t~~~~~- 92 (222)
T 2a6z_A 24 NNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYS-GQTDGGISFWFVQDSNI- 92 (222)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS-------CEEEEEEEEEESCC-SCCSCEEEEEEEECSSS-
T ss_pred CCcEEcccEEEc-CCEEEECCC-CCCeEEEEeCCCCCCCC-------CEEEEEEEEEeCCC-CCCCCEEEEEEECCCcc-
Confidence 589999999996 899999999 57789999999998743 59999999998753 34799999999986532
Q ss_pred CCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCC-CcCCcccCccccCCCCcccccc-CCC
Q 048419 99 NCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSL-ISSASEPASYYSGNNHRIPILL-RSG 176 (653)
Q Consensus 99 ~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~-~s~~~~~~~~~~~~~~~~~~~l-~~g 176 (653)
...|..+|..+.-+. +||+|||+.|. .++|.+.+|.= .+..... +... ..+...... ..+
T Consensus 93 -~~~g~~~G~~~~f~G---------L~I~~Dt~~n~------~p~i~~~~ndG~~~yd~~~-~~~~-~~~~C~~~~rn~~ 154 (222)
T 2a6z_A 93 -PRDKQLYNGPVNYDG---------LQLLVDNNGPL------GPTLRGQLNDGQKPVDKTK-IYDQ-SFASCLMGYQDSS 154 (222)
T ss_dssp -CCCCTBTTBCTTCEE---------EEEEEESCSTT------SSEEEEEEEESSSCCCGGG-HHHH-CSEEEECCCTTEE
T ss_pred -cCCCcccCCCCCCCE---------EEEEEECCCCC------CceEEEEECCCCeeeccCC-Cccc-cccccceeccCCC
Confidence 134556676554333 89999998872 46777766431 1111000 0000 000111222 346
Q ss_pred CceEEEEEec-CCceEEEEEEeeCCCCCCCCCceeeeecCCcccccc-eEEeEecccC---cccceeeecceeee
Q 048419 177 DPIQAWVDYS-SQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEY-MYTGFSASTG---LITASHNVHGWSIS 246 (653)
Q Consensus 177 ~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~-~~vGFsastg---~~~~~~~i~sWsf~ 246 (653)
.+.+++|.|+ .....|+|.+.. ...+-...|+ ||+. .|+||||+|| ...+.|.|++|++.
T Consensus 155 ~~~~~rI~Y~~~~~~~l~v~id~------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~ 219 (222)
T 2a6z_A 155 VPSTIRVTYDLEDDNLLKVQVDN------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF 219 (222)
T ss_dssp EEEEEEEEEEGGGTSEEEEEETT------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred CcEEEEEEEEcCCCcEEEEEEcC------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence 7899999998 667789998753 1111112233 5655 4799999999 78899999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-19 Score=177.60 Aligned_cols=141 Identities=16% Similarity=0.125 Sum_probs=106.4
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcE--EEEEEeccCchh------------------------hHHHHHHHHHHHhhcC
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLE--VAIKRIGHNSQQ------------------------GMKEFVAEIMSMGRLR 385 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 385 (653)
|...+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998556888 999987543111 1236788999999998
Q ss_pred CCce--eeeeeeecccceeEEEEeccCC-CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHH-hcCCCCeEecCC
Q 048419 386 HRNL--VQLHGWCRKQDELLLVYDYVPN-GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH-EECNQRVVHRDV 461 (653)
Q Consensus 386 H~ni--v~l~g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dl 461 (653)
|+++ ..++.+ +..+|||||+.+ |.+...|.... ...++.....++.|++.+|.||| + .+|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELG----RELKELDVEGIFNDVVENVKRLYQE---AELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHG----GGGGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHh----hccChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence 8764 333332 356899999942 43322222211 11345678899999999999999 8 89999999
Q ss_pred CCCcEEEcCCCcEEEEeecCcccc
Q 048419 462 KPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 462 kp~NIll~~~~~~kl~DfGla~~~ 485 (653)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-16 Score=163.04 Aligned_cols=140 Identities=11% Similarity=0.040 Sum_probs=96.6
Q ss_pred cCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch--------------hhHHHHHHHHHHHhhcCCCceeeeeeeec
Q 048419 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ--------------QGMKEFVAEIMSMGRLRHRNLVQLHGWCR 397 (653)
Q Consensus 332 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 397 (653)
|++.+.||+|++|.||+|... +|+.||||+++.... ........+.++.....|+|+.+++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 888999999999999999986 589999998753210 01112222222222223344333332211
Q ss_pred ------ccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 048419 398 ------KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY 471 (653)
Q Consensus 398 ------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 471 (653)
.....+|||||+++++|..+.. .+....++.||+.+|.|||+ .+||||||||.|||++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCC
Confidence 1122379999999888865532 12345688999999999999 899999999999999877
Q ss_pred C----------cEEEEeecCccccc
Q 048419 472 L----------NAKLGDFGLAKIYE 486 (653)
Q Consensus 472 ~----------~~kl~DfGla~~~~ 486 (653)
+ .+.|+||+-+....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38999999776543
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.50 E-value=7.3e-13 Score=128.19 Aligned_cols=185 Identities=13% Similarity=0.090 Sum_probs=121.5
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
....+.|+|.+. ++.|+||++ .++.|.+|-+.|+.+- .+|+.+|+|+|...... +||||||.++.....
T Consensus 27 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~~-------~~weiev~Fri~G~~~~-~gdGlA~Wyt~~~~~- 95 (226)
T 2a6v_A 27 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIK-------DAMTIEWTFRSFGFRGS-TKGGLAFWLKQGNEG- 95 (226)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCS-------SCEEEEEEEEEESCCSC-CSCEEEEEEECSCCC-
T ss_pred CCcEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCCC-------CCeEEEEEEEEecCCCC-CCCEEEEEEECCCCC-
Confidence 478999999986 778999999 9999999999999962 25999999999876432 799999999965431
Q ss_pred CCCCCcccc-CCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecC-CCCcCCcccCccccCCCCcccccc-CC
Q 048419 99 NCLANQFLG-LPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDIS-SLISSASEPASYYSGNNHRIPILL-RS 175 (653)
Q Consensus 99 ~~~~g~~lG-~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s~~~~~~~~~~~~~~~~~~~l-~~ 175 (653)
..|...| ..+.-+. +||.|||+.|. .+.|.+-+| +-.+..... . ...+...... ..
T Consensus 96 --~~g~vfGg~~d~f~G---------lgI~~Dt~~n~------~p~i~~~~NDGt~~yd~~~-~---~~~g~C~~~~rn~ 154 (226)
T 2a6v_A 96 --DSTELFGGSSKKFNG---------LMILLRLDDKL------GESVTAYLNDGTKDLDIES-S---PYFASCLFQYQDS 154 (226)
T ss_dssp --CCCTBTTTBCSSCEE---------EEEEEEEETTT------EEEEEEEEEESSSCCCTTT-S---CCSEEEECCCSSC
T ss_pred --CCcccccccCCCccE---------EEEEEECCCCC------CceEEEEECCCCcccCCCC-C---cccceEeEeccCC
Confidence 1223332 1111111 89999998872 233444432 222111110 0 0001111222 45
Q ss_pred CCceEEEEEec-CCceEEEEEEeeCCCCCCCCCcee-eeecCCcccccce--EEeEecccCcccceeeecceeee
Q 048419 176 GDPIQAWVDYS-SQEMLINVSICPLGVPKPYRPLIS-LPIDLSSVIDEYM--YTGFSASTGLITASHNVHGWSIS 246 (653)
Q Consensus 176 g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~~~~l~-~~~dL~~~l~~~~--~vGFsastg~~~~~~~i~sWsf~ 246 (653)
+.+.+++|.|. ...+.|+|.+.. . ..+. ..|+ ||..- |+||||+||...+.|.|++-.+-
T Consensus 155 ~~~t~~ri~Y~~~~~~~l~v~id~------~-~Cf~~~~v~----LP~g~~~yfGiSAaTg~~~D~hdils~~~~ 218 (226)
T 2a6v_A 155 MVPSTLRLTYNPLDNHLLKLQMDN------R-VCFQTRKVK----FMGSSPFRIGTSAINDASKESFEILKMKLY 218 (226)
T ss_dssp SSCEEEEEEEEGGGTSEEEEEETT------E-EEEEESCCC----GGGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred CCCEEEEEEEEccCCCEEEEEEcC------C-eeEEECCee----cCCCCccEEEEEEcCCCCcccEEEEEEEEE
Confidence 68899999997 456789998752 1 1221 1122 45544 99999999999999999987664
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.47 E-value=9e-15 Score=105.92 Aligned_cols=44 Identities=34% Similarity=0.463 Sum_probs=41.1
Q ss_pred CCceeeeecCCcccccceEEeEecccCcccceeeecceeeeecC
Q 048419 206 RPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIGG 249 (653)
Q Consensus 206 ~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~~~~ 249 (653)
+|+|+.++||+++|+|+|||||||+||...|.|+|++|+|+...
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~ 46 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL 46 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence 46899999999999999999999999999999999999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-11 Score=123.77 Aligned_cols=147 Identities=13% Similarity=0.013 Sum_probs=114.0
Q ss_pred HHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEE
Q 048419 326 ASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 326 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 404 (653)
...-.+|.....++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++...+..++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344467877888898999999999754 6789999986432222345788999999985 6778889999988888999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC--------------------------------
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC-------------------------------- 452 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------- 452 (653)
||||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 88 v~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 999999998876531 12234578899999999999811
Q ss_pred ------------------------CCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 453 ------------------------NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 453 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998766667999987753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=116.75 Aligned_cols=138 Identities=15% Similarity=0.056 Sum_probs=98.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc--eeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--LVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E 407 (653)
.++....+.+.|..+.||++... +|..+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34443333335556999999764 4678999997543 2245778999999986545 4558888887778999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC----------------------------------- 452 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 452 (653)
|++|.+|. .... ....++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~~-----------~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 96 EVPGQDLL--SSHL-----------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp CCSSEETT--TSCC-----------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred ecCCcccC--cCcC-----------CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99998884 2110 12256677777777777632
Q ss_pred --------------------CCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 453 --------------------NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 453 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.1e-09 Score=113.19 Aligned_cols=142 Identities=13% Similarity=0.188 Sum_probs=107.0
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEec--cCc-hhhHHHHHHHHHHHhhcC--CCceeeeeeeeccc---ceeEEE
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIG--HNS-QQGMKEFVAEIMSMGRLR--HRNLVQLHGWCRKQ---DELLLV 405 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV 405 (653)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3567999999999998875 4678899875 322 122356788999999997 45678899988776 458999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC---------------------------------
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC--------------------------------- 452 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------- 452 (653)
|||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999998885422 122667788899999999999999731
Q ss_pred ----------------------CCCeEecCCCCCcEEEcCCCc--EEEEeecCccc
Q 048419 453 ----------------------NQRVVHRDVKPSNILLDTYLN--AKLGDFGLAKI 484 (653)
Q Consensus 453 ----------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~ 484 (653)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.7e-09 Score=111.12 Aligned_cols=185 Identities=17% Similarity=0.177 Sum_probs=121.6
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCc--eeeeeeeecccc---eeEEEEec
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRN--LVQLHGWCRKQD---ELLLVYDY 408 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~ 408 (653)
.+.++.|....||+.. ..+++|+... ......+.+|...++.+. +.. +.+++..+...+ ..++|||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4569999999999852 4588998642 234567889999999884 322 445555544433 34889999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhc-------------------------------------
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE------------------------------------- 451 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------- 451 (653)
++|.+|..... ..++..++..++.++++.|..||+.
T Consensus 98 i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 98 IKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 99988865332 2256667778888888888888851
Q ss_pred ------------------CCCCeEecCCCCCcEEEcC--CCcEEEEeecCcccccCCCCCcccccc--------------
Q 048419 452 ------------------CNQRVVHRDVKPSNILLDT--YLNAKLGDFGLAKIYEHGANPQTTHIV-------------- 497 (653)
Q Consensus 452 ------------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~-------------- 497 (653)
....++|+|++|.||++++ ...+.|+||+.+..-.... ......
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHHHHH
Confidence 1145899999999999988 5568899999987532210 000000
Q ss_pred -cCCcccC-ccccccCCCCCccceeehHHHHHHHHhCCCCCC
Q 048419 498 -GTLGYLA-PELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537 (653)
Q Consensus 498 -gt~~y~a-PE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~ 537 (653)
...+... |+... +.....+.|+++.+++++.+|..++.
T Consensus 249 l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0001111 22211 11223689999999999999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.5e-06 Score=85.58 Aligned_cols=136 Identities=21% Similarity=0.187 Sum_probs=98.1
Q ss_pred eeeeeCcE-EEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccceeEEEEeccCCCCc
Q 048419 337 LVGSGGFG-RVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGSL 414 (653)
Q Consensus 337 ~LG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 414 (653)
.+..|..+ .||+......+..+++|+-... ....+..|...|+.|. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44555554 7999887766788999986432 3456788999998884 33467788999888899999999999887
Q ss_pred hhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 048419 415 DKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE------------------------------------------- 451 (653)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------- 451 (653)
.+..... ......+..+++..|.-||..
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 6654321 123344566666666666631
Q ss_pred ------------CCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 452 ------------CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 452 ------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999877777999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.6e-06 Score=87.34 Aligned_cols=136 Identities=21% Similarity=0.186 Sum_probs=92.0
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCC---ceeeeeeeec-ccceeEEEEeccC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHR---NLVQLHGWCR-KQDELLLVYDYVP 410 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~ 410 (653)
.+.++.|....||+. +..+++|+.. .......+..|..+|+.|.+. .+.+++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 467888888999987 4568888852 233456788999999999753 3556666664 4456789999999
Q ss_pred CCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhc---------------------------------------
Q 048419 411 NGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE--------------------------------------- 451 (653)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 451 (653)
|..|.+.... .++..++..++.++++.|..||+.
T Consensus 97 G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 97 GQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp SEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9888653211 122333334444444444444431
Q ss_pred ------------------CCCCeEecCCCCCcEEEcC---CCc-EEEEeecCccc
Q 048419 452 ------------------CNQRVVHRDVKPSNILLDT---YLN-AKLGDFGLAKI 484 (653)
Q Consensus 452 ------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGla~~ 484 (653)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=7e-06 Score=85.90 Aligned_cols=82 Identities=6% Similarity=-0.044 Sum_probs=56.1
Q ss_pred ceee-eeeCcEEEEEEEeC---C---CCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCC---Cceeeeeeeeccc--
Q 048419 335 QNLV-GSGGFGRVYRGLMP---S---LGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRH---RNLVQLHGWCRKQ-- 399 (653)
Q Consensus 335 ~~~L-G~G~fg~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~-- 399 (653)
.+.| +.|....+|+.... + ++..+++|...... ......+..|+.+++.|.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999988753 1 15678899864322 0012456788888888843 3567788887665
Q ss_pred -ceeEEEEeccCCCCchh
Q 048419 400 -DELLLVYDYVPNGSLDK 416 (653)
Q Consensus 400 -~~~~lV~E~~~~gsL~~ 416 (653)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999887764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.3e-05 Score=85.22 Aligned_cols=76 Identities=11% Similarity=0.044 Sum_probs=49.5
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch-------hhHHHHHHHHHHHhhcCC--Cc-eeeeeeeecccceeEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ-------QGMKEFVAEIMSMGRLRH--RN-LVQLHGWCRKQDELLL 404 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 404 (653)
.+.||.|..+.||++....++..++||....... ...+.+..|.++++.+.. +. +.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 5679999999999998765578899998643211 123456778888888742 33 44555443 344689
Q ss_pred EEeccCCC
Q 048419 405 VYDYVPNG 412 (653)
Q Consensus 405 V~E~~~~g 412 (653)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00014 Score=75.22 Aligned_cols=144 Identities=16% Similarity=0.185 Sum_probs=80.8
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC--Cceeeeeee------ecccceeEEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH--RNLVQLHGW------CRKQDELLLVY 406 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~------~~~~~~~~lV~ 406 (653)
.+.|+.|..+.||+.... +..+++|+.... . ..+..|..+++.|.. -.+.+++.. ....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778899998874 345999998652 2 233345555555531 123334431 12355679999
Q ss_pred eccCCCCchh--------------hhhcccccc---------cccchhhhH-----------------------------
Q 048419 407 DYVPNGSLDK--------------LLFDKDHKL---------RKLLTWDQR----------------------------- 434 (653)
Q Consensus 407 E~~~~gsL~~--------------~l~~~~~~~---------~~~l~~~~~----------------------------- 434 (653)
||++|..+.. .++...... ...-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 9999876531 111111000 000112111
Q ss_pred --HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 435 --YKILIGIAQSLLYLHE----------ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 435 --~~i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
..+..++..++.+|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666653 1247899999999999998888999999997753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00063 Score=68.67 Aligned_cols=80 Identities=18% Similarity=0.217 Sum_probs=57.2
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCC---ceeeeeeeecccceeEEEEe
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHR---NLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~E 407 (653)
.....+.+|.|..+.||+.... +|+.|.+|+...........|..|...|+.|.-. .+.+++++. .-++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3455778999999999999986 4889999987554443345678899999888422 344555543 2478999
Q ss_pred ccCCCCch
Q 048419 408 YVPNGSLD 415 (653)
Q Consensus 408 ~~~~gsL~ 415 (653)
|++++...
T Consensus 91 ~l~~~~~~ 98 (288)
T 3f7w_A 91 WVDERPPT 98 (288)
T ss_dssp CCCCCCCC
T ss_pred eecccCCC
Confidence 99876543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00039 Score=74.37 Aligned_cols=77 Identities=12% Similarity=0.097 Sum_probs=46.7
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCCccccccc--CCcccCccccccC---CCCCccceeehHHHHH
Q 048419 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG--TLGYLAPELTRTG---KATTSTDVYSYGILML 527 (653)
Q Consensus 453 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~ksDV~s~Gvvl~ 527 (653)
...++|+|++|.|||++.++ ++|+||+.+..-.... ....... ...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 37899999999999998776 9999999887532110 0000010 1346666654311 1112344556777777
Q ss_pred HHHhC
Q 048419 528 EVACG 532 (653)
Q Consensus 528 elltG 532 (653)
+..++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77655
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0019 Score=65.93 Aligned_cols=76 Identities=16% Similarity=0.073 Sum_probs=60.6
Q ss_pred cceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC---CCceeeeeeeecccceeEEEEeccC
Q 048419 334 EQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR---HRNLVQLHGWCRKQDELLLVYDYVP 410 (653)
Q Consensus 334 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~ 410 (653)
..+.|+.|....+|+.... +..+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567899999999998763 678899987532 3566788999888884 3568888888887888999999999
Q ss_pred CCCc
Q 048419 411 NGSL 414 (653)
Q Consensus 411 ~gsL 414 (653)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8876
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0015 Score=66.90 Aligned_cols=161 Identities=12% Similarity=0.049 Sum_probs=88.9
Q ss_pred cCHHHHHHhhcCcCc-----ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc--eeee
Q 048419 320 FKYAELASVTKGFGE-----QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--LVQL 392 (653)
Q Consensus 320 f~~~el~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 392 (653)
++.+++..+-..|.. .+.|+.|....+|+....+ | .+++|...... ..+.+..|+.++..|.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 445555555555543 3456678888999988753 3 68899886521 1224456777777764222 2333
Q ss_pred eeee------cccceeEEEEeccCCCCchhh--------------hhcccccc-------cccchhhhHHH---------
Q 048419 393 HGWC------RKQDELLLVYDYVPNGSLDKL--------------LFDKDHKL-------RKLLTWDQRYK--------- 436 (653)
Q Consensus 393 ~g~~------~~~~~~~lV~E~~~~gsL~~~--------------l~~~~~~~-------~~~l~~~~~~~--------- 436 (653)
+... ...+..+++++|++|..+... ++...... .....|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3221 123457899999998765321 11110000 01112332111
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 437 ---ILIGIAQSLLYLHEE----CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 437 ---i~~~ia~~L~yLH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
+...+...+..+++. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 111244555666543 235799999999999998876668999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0012 Score=70.76 Aligned_cols=75 Identities=17% Similarity=0.171 Sum_probs=51.1
Q ss_pred ceeeeeeCcEEEEEEEeCC-------CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLVY 406 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 406 (653)
.+.|+.|-...+|++...+ .+..+++|+..... ..+.+..|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578888889999998753 25789999884321 12455579888888854444 566666543 2899
Q ss_pred eccCCCCch
Q 048419 407 DYVPNGSLD 415 (653)
Q Consensus 407 E~~~~gsL~ 415 (653)
||++|.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0027 Score=68.50 Aligned_cols=76 Identities=11% Similarity=0.033 Sum_probs=49.3
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEEEeccCCCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.+.|+.|-...+|+....+.+..+++|+........ -....|..+++.|...++ .++++.+. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 467888888999999886445789999874432111 112578888888865554 46777663 2 25999998865
Q ss_pred ch
Q 048419 414 LD 415 (653)
Q Consensus 414 L~ 415 (653)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.002 Score=67.72 Aligned_cols=145 Identities=22% Similarity=0.241 Sum_probs=85.2
Q ss_pred ceeeeeeCcEEEEEEEeCC-------CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc-eeeeeeeecccceeEEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN-LVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 406 (653)
.+.|..|-...+|++...+ .+..+.+|+.... ......+.+|..+++.|.-.+ ..++++.+.+. +||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence 4567777778899988742 3578999986332 223456668999888885322 35667666542 899
Q ss_pred eccCCCCchhh-h----------------hccccccc-ccc-hhhhHHHHHHHHHH-------------------HHHHH
Q 048419 407 DYVPNGSLDKL-L----------------FDKDHKLR-KLL-TWDQRYKILIGIAQ-------------------SLLYL 448 (653)
Q Consensus 407 E~~~~gsL~~~-l----------------~~~~~~~~-~~l-~~~~~~~i~~~ia~-------------------~L~yL 448 (653)
||++|..|..- + +....... .+. -|.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998666421 1 11110001 111 34555555544322 23333
Q ss_pred Hh-----cCCCCeEecCCCCCcEEEcCC----CcEEEEeecCccc
Q 048419 449 HE-----ECNQRVVHRDVKPSNILLDTY----LNAKLGDFGLAKI 484 (653)
Q Consensus 449 H~-----~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~ 484 (653)
.+ .....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123569999999999999876 7899999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0023 Score=64.95 Aligned_cols=72 Identities=10% Similarity=0.089 Sum_probs=44.9
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEEEecc-CCC
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLVYDYV-PNG 412 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~g 412 (653)
.+.|+.|....+|+. ..+++|+....... .-...+|+..++.+....+ .++++++.+. -++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~--~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPAT--GVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTT--CCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCC--CEEEEeecCCCc
Confidence 678999999999998 34888987543211 1122467777777743333 4556554333 47899999 665
Q ss_pred Cch
Q 048419 413 SLD 415 (653)
Q Consensus 413 sL~ 415 (653)
+|.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.01 Score=60.77 Aligned_cols=144 Identities=13% Similarity=0.082 Sum_probs=80.7
Q ss_pred eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc--eeeeeee-----ecccceeEEEEec
Q 048419 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN--LVQLHGW-----CRKQDELLLVYDY 408 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~E~ 408 (653)
..++ |....||+.... +|+.+++|...... .....+..|...++.|.... +.+++.. ....+..+++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4566 778899987654 36679999985321 12345667888877774322 3444443 1123456789999
Q ss_pred cCCCCchh----h----------hhccccc----ccccchhhhH----H---------------HHHHHHHHHHHHHHhc
Q 048419 409 VPNGSLDK----L----------LFDKDHK----LRKLLTWDQR----Y---------------KILIGIAQSLLYLHEE 451 (653)
Q Consensus 409 ~~~gsL~~----~----------l~~~~~~----~~~~l~~~~~----~---------------~i~~~ia~~L~yLH~~ 451 (653)
++|..+.. . ++..... ....+++... . .+...+...+..+.+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98865431 0 1111000 0011111100 0 0111112223333321
Q ss_pred ----CCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 452 ----CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 452 ----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 235689999999999999 4 899999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0063 Score=62.52 Aligned_cols=143 Identities=15% Similarity=0.109 Sum_probs=72.2
Q ss_pred eeeeeeCcEE-EEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC--CceeeeeeeecccceeEEEEeccCCC
Q 048419 336 NLVGSGGFGR-VYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH--RNLVQLHGWCRKQDELLLVYDYVPNG 412 (653)
Q Consensus 336 ~~LG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g 412 (653)
+.|+.|.... +|+.... ++..+++|....... +.+..|+.+++.+.. -.+.+++.++.+.+ +++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 4465554444 6676542 256677776533221 223456666666632 23556676654444 6899999776
Q ss_pred Cchhhhhccccc-----------------c-cccch-hhh--H---------------H-----HHHHHHHHHHHHHH--
Q 048419 413 SLDKLLFDKDHK-----------------L-RKLLT-WDQ--R---------------Y-----KILIGIAQSLLYLH-- 449 (653)
Q Consensus 413 sL~~~l~~~~~~-----------------~-~~~l~-~~~--~---------------~-----~i~~~ia~~L~yLH-- 449 (653)
.+.+++...... . ...++ |.. . + .....+...+..|.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665444321100 0 00000 000 0 0 00011112222221
Q ss_pred -hcCCCCeEecCCCCCcEEEcCC----CcEEEEeecCccc
Q 048419 450 -EECNQRVVHRDVKPSNILLDTY----LNAKLGDFGLAKI 484 (653)
Q Consensus 450 -~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~ 484 (653)
......++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1124689999999999999874 6799999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0054 Score=64.13 Aligned_cols=75 Identities=11% Similarity=0.100 Sum_probs=44.4
Q ss_pred ceeeeeeCcEEEEEEEeCC--------CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPS--------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLV 405 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV 405 (653)
.+.|+.|....+|+....+ .+..+++|+...... .......|..+++.|...++ .++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567778888999988753 126788888754322 11123578888887753343 3565543 2 2689
Q ss_pred EeccCCCCc
Q 048419 406 YDYVPNGSL 414 (653)
Q Consensus 406 ~E~~~~gsL 414 (653)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0029 Score=60.14 Aligned_cols=105 Identities=15% Similarity=0.071 Sum_probs=68.4
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
-+|.+.|... ..+++++++|.++.|.+.+|.-+-.. +.-..+=+.|..|+|..+|++...+ ..+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 4788888766 46799999999999999998776221 1111233457899999999988754 1110
Q ss_pred cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCC
Q 048419 492 QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIE 537 (653)
Q Consensus 492 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~ 537 (653)
.....+.+||... ...+.+.-|||+|+++|..+--..|-.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 1122456888763 355678899999999999987555433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.056 Score=55.67 Aligned_cols=31 Identities=16% Similarity=0.264 Sum_probs=27.9
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 454 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.16 E-value=0.13 Score=54.69 Aligned_cols=144 Identities=13% Similarity=0.117 Sum_probs=84.0
Q ss_pred ceeeeeeCcEEEEEEEeCCC-------CcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc-eeeeeeeecccceeEEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSL-------GLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN-LVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 406 (653)
.+.+..|-...+|+...... +..+++|+....... .-...+|..+++.|...+ ..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 45677777889999887531 577999987443211 112346788887774323 344555332 27899
Q ss_pred eccCCCCchhh-h----------------hcccc------c--ccccchhhhHHHHHHHH-------------------H
Q 048419 407 DYVPNGSLDKL-L----------------FDKDH------K--LRKLLTWDQRYKILIGI-------------------A 442 (653)
Q Consensus 407 E~~~~gsL~~~-l----------------~~~~~------~--~~~~l~~~~~~~i~~~i-------------------a 442 (653)
||++|..|..- + +.... . ...+..|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 1 11000 0 01112344444433322 1
Q ss_pred HHHHHHHh---------------------cCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 443 QSLLYLHE---------------------ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 443 ~~L~yLH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
..+..|.+ .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11346899999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.80 E-value=0.6 Score=49.07 Aligned_cols=30 Identities=30% Similarity=0.358 Sum_probs=25.3
Q ss_pred CeEecCCCCCcEEE------cCCCcEEEEeecCccc
Q 048419 455 RVVHRDVKPSNILL------DTYLNAKLGDFGLAKI 484 (653)
Q Consensus 455 ~ivH~Dlkp~NIll------~~~~~~kl~DfGla~~ 484 (653)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.27 E-value=0.21 Score=34.21 Aligned_cols=24 Identities=13% Similarity=0.300 Sum_probs=11.1
Q ss_pred ehhhHHHHHHHHHHHHhhhhhhhh
Q 048419 280 TLAGMAFLILIIAGAIHVLQRIKY 303 (653)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~ 303 (653)
++++++++++++++.++++||++.
T Consensus 17 VVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 17 MVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred hhHHHHHHHHHHHHHHHHhhhhHh
Confidence 344444444444444555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.14 E-value=0.19 Score=34.34 Aligned_cols=25 Identities=12% Similarity=0.165 Sum_probs=11.8
Q ss_pred eehhhHHHHHHHHHHHHhhhhhhhh
Q 048419 279 ITLAGMAFLILIIAGAIHVLQRIKY 303 (653)
Q Consensus 279 i~~~~~~~~~~~~~~~~~~~~~~~~ 303 (653)
-++++++++++++.+.++++||++.
T Consensus 15 gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 15 GVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred eehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3344444444444444555555544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.90 E-value=0.12 Score=55.53 Aligned_cols=59 Identities=14% Similarity=0.179 Sum_probs=16.5
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEE------EEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeee
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAI------KRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 396 (653)
.+.|| ||.||+|.+.....+||| |..... ..+....|.+|..+++.++|+|+++.+++.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 45566 999999999765578898 766432 334456788899999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 653 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-55 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 9e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-54 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-54 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-53 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-53 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-53 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 6e-53 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 8e-53 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 8e-53 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 3e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-52 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 4e-52 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 5e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-52 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 5e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-51 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 9e-51 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 1e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-50 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 2e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-49 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 6e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-49 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 2e-48 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-45 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 1e-33 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 8e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 1e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-20 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 2e-05 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 8e-63
Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHN 366
+DWEI G + +GSG FG VY+G +VA+K +
Sbjct: 1 DDWEIPDG--QITV------------GQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
+ Q ++ F E+ + + RH N++ G+ +L +V + SL L H +
Sbjct: 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL----HIIE 98
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
+ I AQ + YLH + ++HRD+K +NI L L K+GDFGLA +
Sbjct: 99 TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 487 HGANP-QTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAA 542
+ Q + G++ ++APE+ R + +DVY++GI++ E+ G+
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----- 210
Query: 543 AELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+ D + + G ++ + + A L+ C RP +++
Sbjct: 211 -NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQILA 265
Query: 603 FL 604
+
Sbjct: 266 SI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 5e-60
Identities = 70/297 (23%), Positives = 122/297 (41%), Gaps = 39/297 (13%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ 368
++WE+ K E +G+G FG V+ G +VA+K +
Sbjct: 6 DEWEVP--RETLKLVER------------LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGS 49
Query: 369 QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL 428
F+AE M +L+H+ LV+L+ Q+ + ++ +Y+ NGSL L
Sbjct: 50 MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPS---GIK 105
Query: 429 LTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488
LT ++ + IA+ + ++ E +HRD++ +NIL+ L+ K+ DFGLA++ E
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162
Query: 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-L 547
+ + APE G T +DV+S+GIL+ E+ R P E++
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222
Query: 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
++ + + + Q L C P RP + L
Sbjct: 223 LERGYRMVRPDNCPEELYQ---------------LMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-59
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM-KEFVAEIMSMGRLRHRNLV 390
F + + +G+G G V++ GL +A K I + + + + E+ + +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+G E+ + +++ GSLD++L + K+ I + + L YL E
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLRE 122
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ +++HRDVKPSNIL+++ KL DFG++ VGT Y++PE +
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG 177
Query: 511 GKATTSTDVYSYGILMLEVACGRRSIEP 538
+ +D++S G+ ++E+A GR I P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPP 205
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 41/314 (13%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ 368
+ WEI + + +G G FG V+ G VAIK +
Sbjct: 10 DAWEIP--RESLRL------------EVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGT 53
Query: 369 QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL 428
+ F+ E M +LRH LVQL+ ++ + +V +Y+ GSL L + K +
Sbjct: 54 MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLR- 111
Query: 429 LTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488
Q + IA + Y+ VHRD++ +NIL+ L K+ DFGLA++ E
Sbjct: 112 --LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166
Query: 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-L 547
+ + APE G+ T +DV+S+GIL+ E+ R P E+L
Sbjct: 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 226
Query: 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL--L 605
V+ + E ++ + +L C P RP + FL
Sbjct: 227 VERGYRMPCPPECPES---------------LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
Query: 606 GDSSLPPLPPDIHL 619
S+ P P +L
Sbjct: 272 FTSTEPQYQPGENL 285
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 33/294 (11%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
Q +G G FG V+RG G EVA+K + ++ AEI LRH N++
Sbjct: 8 QESIGKGRFGEVWRGKWR--GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 395 WCRKQD----ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
K + +L LV DY +GSL L R +T + K+ + A L +LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHM 118
Query: 451 EC-----NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP---QTTHIVGTLGY 502
E + HRD+K NIL+ + D GLA ++ + H VGT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 503 LAPEL------TRTGKATTSTDVYSYGILMLEVACGRR----SIEPQKAAAELLLVDWVK 552
+APE+ + ++ D+Y+ G++ E+A + Q +L+ D
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 553 ELHLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
E + Q + + + ++ + C N R R+ + L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-57
Identities = 62/270 (22%), Positives = 113/270 (41%), Gaps = 25/270 (9%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+GSG FG V+ G + +VAIK I ++F+ E M +L H LVQL+G
Sbjct: 11 QEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C +Q + LV++++ +G L L + L + + + + + +
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGM---AYLEEAC 121
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
V+HRD+ N L+ K+ DFG+ + +T + + +PE+ + ++
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 516 STDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAE 575
+DV+S+G+LM EV + ++ +E++ + I Y
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---------------EDISTGFRLYKPRL 226
Query: 576 A-ELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
A V + C P RP R++ L
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-56
Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 25/271 (9%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G+G FG V G +VAIK I EF+ E M L H LVQL+G
Sbjct: 10 KELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C KQ + ++ +Y+ NG L L + H+ Q ++ + +++ YL +++
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRHRF----QTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATT 515
+HRD+ N L++ K+ DFGL++ + + + PE+ K ++
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 516 STDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAE 575
+D++++G+LM E+ + + +E + I Q L Y
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETA---------------EHIAQGLRLYRPHL 225
Query: 576 A-ELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605
A E V + C RP + ++ +L
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 2e-56
Identities = 76/303 (25%), Positives = 135/303 (44%), Gaps = 40/303 (13%)
Query: 320 FKYAELASVTKGFGE---------QNLVGSGGFGRVYRGLMPSLG---LEVAIKRI-GHN 366
F + + + F + + ++G+G FG V G + G + VAIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 367 SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLR 426
+++ ++F++E MG+ H N++ L G K ++++ +++ NGSLD L D +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 427 KLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486
T Q +L GIA + YL + VHRD+ NIL+++ L K+ DFGL++ E
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 487 HGANPQTTH----IVGTLGYLAPELTRTGKATTSTDVYSYGILMLE-VACGRRSIEPQKA 541
+ T + + APE + K T+++DV+SYGI+M E ++ G R
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 542 AAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVV 601
+ ++ L + A + L L C + +RP ++V
Sbjct: 240 QDVINAIEQDYRLPPPMDCPSA---------------LHQLMLDCWQKDRNHRPKFGQIV 284
Query: 602 EFL 604
L
Sbjct: 285 NTL 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (477), Expect = 2e-55
Identities = 63/296 (21%), Positives = 125/296 (42%), Gaps = 35/296 (11%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ 368
+ WE++ ++ +G G +G VY G+ L VA+K + ++
Sbjct: 10 DKWEME--RTDITM------------KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 55
Query: 369 QGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKL 428
+ ++EF+ E M ++H NLVQL G C ++ ++ +++ G+L L + + R+
Sbjct: 56 E-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQE 111
Query: 429 LTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488
++ + I+ ++ YL + + +HRD+ N L+ K+ DFGL+++
Sbjct: 112 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168
Query: 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLV 548
+ + APE K + +DV+++G+L+ E+A S P +++ +
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228
Query: 549 DWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
K+ +E E V L C NP RP + +
Sbjct: 229 -LEKDYRME-------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 3e-55
Identities = 76/297 (25%), Positives = 115/297 (38%), Gaps = 35/297 (11%)
Query: 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLR 385
K F + +G G FG VY VAIK++ G S + ++ + E+ + +LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
H N +Q G ++ LV +Y + D +K L + + G Q L
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSAS-----DLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
YLH ++HRDVK NILL KLGDFG A I VGT ++AP
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAP 180
Query: 506 EL---TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562
E+ G+ DV+S GI +E+A + + A + L + + E
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPA 233
Query: 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLGDSSLPPLPPDI 617
E N C P RP +++ F+L + + I
Sbjct: 234 LQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-55
Identities = 61/273 (22%), Positives = 111/273 (40%), Gaps = 23/273 (8%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G+G +GR + S G + K + G ++ + V+E+ + L+H N+V+ +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 394 GWC--RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE- 450
R L +V +Y G L ++ K K R+ L + +++ + +L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 451 -ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTR 509
+ V+HRD+KP+N+ LD N KLGDFGLA+I H VGT Y++PE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMN 187
Query: 510 TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569
+D++S G L+ E+ + K + + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL----- 242
Query: 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
++ +RP + ++E
Sbjct: 243 -NEIITR---------MLNLKDYHRPSVEEILE 265
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 184 bits (469), Expect = 9e-55
Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 26/250 (10%)
Query: 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGL---IGHALYPNPLRFKTSN 60
+D SF ++ F+ N+ +G A +ST+G+L VT S+ IG ALY P++ S
Sbjct: 1 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSI 60
Query: 61 KSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFS 120
F T+F F + D F+ + ++ + + GL + + S S S
Sbjct: 61 TGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKS---S 117
Query: 121 TRMLAVEFDIIQNTEL--IDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDP 178
+++AVEFD D + H+GID++S+ S + + +G
Sbjct: 118 NQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRNGEVA----------- 166
Query: 179 IQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA-- 236
+ Y + + V + +I+ +DL +++ E++ GFS G
Sbjct: 167 -DVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFE 223
Query: 237 SHNVHGWSIS 246
+H+V W +
Sbjct: 224 THDVLSWYFT 233
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-54
Identities = 63/283 (22%), Positives = 121/283 (42%), Gaps = 28/283 (9%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G G FG+VY+ + A K I S++ +++++ EI + H N+V+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
++ L ++ ++ G++D ++ +L + LT Q + +L YLH+ +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLHD---NK 130
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL-----TRT 510
++HRD+K NIL + KL DFG++ + +GT ++APE+ ++
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 511 GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570
DV+S GI ++E+A LL +I ++ TL
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------------KIAKSEPPTLAQ 237
Query: 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLGDSSLP 611
+ + C N R ++++ F+ DS+ P
Sbjct: 238 PSRWSSNFK-DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 184 bits (467), Expect = 2e-54
Identities = 61/251 (24%), Positives = 103/251 (41%), Gaps = 29/251 (11%)
Query: 7 DTTSFLYNGFLHA--NLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKT 58
+T SF ++ F NL+L+GAA I+ SG+L +T ++ G LY P+
Sbjct: 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD 61
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
S F T F FSI Y + + + +LG+ N +S
Sbjct: 62 STTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFN---NSKQD 118
Query: 119 FSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDP 178
S + LAVEFD N H+GID++S+ S ++P L +G
Sbjct: 119 NSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQPFQ------------LDNGQV 165
Query: 179 IQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---IT 235
+ Y + +++V + I+ +D+ V+ +++ G S +TG
Sbjct: 166 ANVVIKYDAPSKILHVVLVY--PSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAA 223
Query: 236 ASHNVHGWSIS 246
+H+V+ WS
Sbjct: 224 ETHDVYSWSFQ 234
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-54
Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 25/292 (8%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHR 387
K + +G G G VY + + G EVAI+++ Q + + EI+ M ++
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
N+V DEL +V +Y+ GSL ++ + Q + Q+L +
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEF 131
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
LH +V+HRD+K NILL + KL DFG + + +VGT ++APE+
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEV 187
Query: 508 TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567
D++S GI+ +E+ G + L L+ E + + +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNGTPELQNPEKLSAI 245
Query: 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLGDSSLPPLPPDI 617
D C + R + +++ FL L L P I
Sbjct: 246 F--RDFLNR---------CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-54
Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 32/279 (11%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G G FG VY +A+K + + E+ LRH N+++L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+G+ + L+ +Y P G++ + L + + +A +L Y H
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHS-- 124
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
+RV+HRD+KP N+LL + K+ DFG + H + + T + GTL YL PE+
Sbjct: 125 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 513 ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572
D++S G+L E G+ E + +E + + D
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----SRVEFTFPDFVTEGA--RD 233
Query: 573 LAEAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLGDSS 609
L NP RP +R V+E ++ +SS
Sbjct: 234 LISR---------LLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 181 bits (461), Expect = 1e-53
Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 30/250 (12%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTS 59
++ F + F NL L+ A +S+SG L +TN + G +G A Y P++ +
Sbjct: 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
F T+F F+I GLAF ++ FLGL + + S+
Sbjct: 61 TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDGSNSNF--- 116
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
+AVEFD + N + D + H+GID++S+ S + + +G N
Sbjct: 117 --HTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFVNGENA------------ 161
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS-- 237
+ + Y S L+ S+ + ++S +DL SV+ E++ GFSA+TG+ +
Sbjct: 162 EVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVE 219
Query: 238 -HNVHGWSIS 246
++V WS +
Sbjct: 220 TNDVLSWSFA 229
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 181 bits (460), Expect = 1e-53
Identities = 62/247 (25%), Positives = 103/247 (41%), Gaps = 31/247 (12%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKS---EGLIGHALYPNPLRFKTSNKS 62
++ SF F NL L+G A +S+ G L +TN E +G A Y P++
Sbjct: 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 63 VAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTR 122
F TNF F I K + GLAF ++ L ++LGL N T
Sbjct: 61 NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT---------- 109
Query: 123 MLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAW 182
+ D + D N + ID++S+ A+E ++ +G+ +
Sbjct: 110 --NYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFG----------HNNGEKAEVR 157
Query: 183 VDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITASHN 239
+ Y S + + VS+ + +S + L +++++ GFSA++G T +HN
Sbjct: 158 ITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHN 215
Query: 240 VHGWSIS 246
V WS S
Sbjct: 216 VLSWSFS 222
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-53
Identities = 74/270 (27%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G G FG V G G +VA+K I + + F+AE M +LRH NLVQL G
Sbjct: 13 QTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 396 CRKQDE-LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
++ L +V +Y+ GSL L + R +L D K + + +++ YL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
VHRD+ N+L+ AK+ DFGL K + + + APE R K +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 515 TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574
T +DV+S+GIL+ E+ R P+ +++ +G A D
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMDAPDGC------- 225
Query: 575 EAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
V + C + RP ++ E L
Sbjct: 226 -PPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 29/272 (10%)
Query: 339 GSGGFGRVYRGLMPSL--GLEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRNLVQLHGW 395
G G FG V +G+ ++VAIK + +++ +E + E M +L + +V+L G
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
C+ + L+LV + G L K L K R+ + ++L ++ + YL +
Sbjct: 78 CQAE-ALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKN 129
Query: 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKIY--EHGANPQTTHIVGTLGYLAPELTRTGKA 513
VHRD+ N+LL AK+ DFGL+K + + L + APE K
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 514 TTSTDVYSYGILMLEV-ACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572
++ +DV+SYG+ M E + G++ + K + ++ K + E + Y
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL------YA 243
Query: 573 LAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
L C RPD V + +
Sbjct: 244 LMSD---------CWIYKWEDRPDFLTVEQRM 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 73/281 (25%), Positives = 130/281 (46%), Gaps = 30/281 (10%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLG----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRH 386
Q ++G+G FG VY+G++ + + VAIK + +++ +F+ E MG+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
N+++L G K ++++ +Y+ NG+LDK L +KD + + Q +L GIA
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF----SVLQLVGMLRGIAA--- 121
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGYLA 504
+ N VHRD+ NIL+++ L K+ DFGL+++ E T+ + + A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564
PE K T+++DV+S+GI+M EV + + E++ +AI
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---------------KAI 226
Query: 565 DQTLDY-YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+ + + L + C RP +V L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 180 bits (458), Expect = 3e-53
Identities = 55/249 (22%), Positives = 105/249 (42%), Gaps = 26/249 (10%)
Query: 8 TTSFLYNGF---LHANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRFKT 58
+ SF + F + ++ +G A + +G L + ++ G ALY +P++
Sbjct: 1 SVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWD 59
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
+ F T F F + + GLAF + + A ++LGL N + +++
Sbjct: 60 NKTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVK-DAGEYLGLFNKS-TATQP 116
Query: 119 FSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDP 178
+++AVEFD N + + H+GI+++S++S A++ + SG
Sbjct: 117 SKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSD---------IFSGKI 167
Query: 179 IQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA-S 237
A + Y ++ V L P ++S +D+ + E + G SASTG +
Sbjct: 168 ATARISYDGSAEILTVV---LSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLT 224
Query: 238 HNVHGWSIS 246
+ W S
Sbjct: 225 VYILSWRFS 233
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-53
Identities = 60/272 (22%), Positives = 111/272 (40%), Gaps = 30/272 (11%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGW 395
+G G F VY+GL +EVA + ++ + F E + L+H N+V+ +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 396 C----RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
+ + ++LV + + +G+L L K++ I + L +LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLH-T 130
Query: 452 CNQRVVHRDVKPSNILL-DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
++HRD+K NI + + K+GD GLA + ++GT ++APE+
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE- 186
Query: 511 GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570
K S DVY++G+ MLE+A + AA++ V + +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RRVTSGVKPASFDKVAIPEV-- 242
Query: 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
++ E C N R ++ ++
Sbjct: 243 KEIIEG---------CIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 6e-53
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 43/295 (14%)
Query: 336 NLVGSGGFGRVYRGLMPSL-----GLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNL 389
+G G FGRV++ P L VA+K + S +F E M + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL-------------------RKLLT 430
V+L G C + L+++Y+ G L++ L L+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 431 WDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGA 489
++ I +A + YL E ++ VHRD+ N L+ + K+ DFGL++ IY
Sbjct: 139 CAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVD 549
+ + ++ PE + TT +DV++YG+++ E+ A E++
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI--- 252
Query: 550 WVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+G I + + NL C + P RP + L
Sbjct: 253 ---YYVRDGNILACPEN--------CPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 180 bits (457), Expect = 6e-53
Identities = 61/269 (22%), Positives = 114/269 (42%), Gaps = 34/269 (12%)
Query: 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRFK 57
A+T SF +N F+ N+ L+G A +++SG L + E +G ALY P+
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 58 TSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
F +F F+ GLAF + P + G + + +
Sbjct: 61 DKETGSVASFAASFNFTFYAPDTKRLADGLAFFL----APIDTKPQTHAGYLGLFNENES 116
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
+++AVEFD +N+ D + H+GI+++S+ S L +
Sbjct: 117 --GDQVVAVEFDTFRNSW--DPPNPHIGINVNSIRS------------IKTTSWDLANNK 160
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA- 236
+ + Y + L+ S+ + + ++S +DL + + E++ GFSA+TGL
Sbjct: 161 VAKVLITYDASTSLLVASL--VYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPG 218
Query: 237 -SHNVHGWSISIGGKAQ--DLNPMKVPTL 262
SH+V WS + +++P+ + +
Sbjct: 219 ESHDVLSWSFASNLPHASSNIDPLDLTSF 247
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 179 bits (455), Expect = 8e-53
Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 8 TTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGL-----IGHALYPNPLRFKTSN 60
T SF +N F L L+ A IS++ +L +T G+ G ALY P++ S
Sbjct: 2 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST 61
Query: 61 KSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFS 120
F T F FSI +P I+ + + G+ N
Sbjct: 62 TGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPYPF--- 118
Query: 121 TRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQ 180
+AVEFD +NT D H+GID++S+IS+ +P L +G
Sbjct: 119 ---VAVEFDTFRNTW--DPQIPHIGIDVNSVISTK------------TVPFTLDNGGIAN 161
Query: 181 AWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI------ 234
+ Y + +++V + + I+ +DL V+ E + GFSA+TG
Sbjct: 162 VVIKYDASTKILHVVLVFPSLGTI--YTIADIVDLKQVLPESVNVGFSAATGDPSGKQRN 219
Query: 235 -TASHNVHGWSIS 246
T +H++ WS S
Sbjct: 220 ATETHDILSWSFS 232
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 179 bits (455), Expect = 8e-53
Identities = 64/254 (25%), Positives = 100/254 (39%), Gaps = 37/254 (14%)
Query: 7 DTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKT 58
+T SF ++ F L+L+ A I ++G+L +T ++ G ALY P++
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 59 SNKSVAIDFRTNFVFSILPKYPDL-GGQGLAFIIISTNRPENCLANQFLGLPNITMSSST 117
S F T F F+I Y GL F ++ N P G
Sbjct: 61 STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSP-----QGEDGGNLGVFKPPE 115
Query: 118 KFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
+ AVEFD QNT D H+GID++S++SS + L +G
Sbjct: 116 GDNA--FAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLHFQ------------LENGG 159
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVI--DEYMYTGFSASTGLI- 234
+ Y S ++NV + V +S +DL E++ G SA+TG
Sbjct: 160 VANVVIKYDSPTKILNVVLAFHSVGTV--YTLSNIVDLKQEFPNSEWVNVGLSATTGYQK 217
Query: 235 --TASHNVHGWSIS 246
+H + WS +
Sbjct: 218 NAVETHEIISWSFT 231
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 178 bits (451), Expect = 3e-52
Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 31/254 (12%)
Query: 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEG-----LIGHALYPNPLRFKT 58
+D SF N F+ A+L +G A +S++G+L +T G +G ALY P+R
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTN-RPENCLANQFLGLPNITMSSST 117
+ F T+F F + PD+ GLAF + + + + +++LGL N + S S
Sbjct: 61 NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDS- 119
Query: 118 KFSTRMLAVEFDIIQNTEL--IDINDNHVGIDISSLISSASEPASYYSGNNHRIPIL-LR 174
S +++AVEFD D N H+GID++ + S + + +G I L
Sbjct: 120 --SNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLA 177
Query: 175 SGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI 234
+ A + Y ++ +DL ++ E++ GFSA+TG
Sbjct: 178 PNKTLIASLVYP---------------SNQTTFSVAASVDLKEILPEWVRVGFSAATGYP 222
Query: 235 TA--SHNVHGWSIS 246
T +H+V WS +
Sbjct: 223 TEVETHDVLSWSFT 236
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-52
Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 34/285 (11%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGL--EVAIKRI-GHNSQQGMKEFVAEIMSMGRL-RHRNLV 390
Q+++G G FG+V + + GL + AIKR+ + S+ ++F E+ + +L H N++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRYKILI 439
L G C + L L +Y P+G+L L F + L+ Q
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 440 GIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGT 499
+A+ + YL + ++ +HRD+ NIL+ AK+ DFGL++ E + T
Sbjct: 135 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGRLP 189
Query: 500 LGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559
+ ++A E TT++DV+SYG+L+ E+ + AEL E +G
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQGY 243
Query: 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+ + V +L C P RP +++ L
Sbjct: 244 RLEKPLNC--------DDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 177 bits (450), Expect = 4e-52
Identities = 60/250 (24%), Positives = 97/250 (38%), Gaps = 25/250 (10%)
Query: 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGL----IGHALYPNPLRFKTS 59
+D SF + F +LS +G A + +G+L + L G A Y P+
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60
Query: 60 NKSVAIDFRTNFVF-SILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
N F T+F F P GL F + + P A + GL N T S
Sbjct: 61 NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLR-RAGGYFGLFNDTKCDS-- 117
Query: 119 FSTRMLAVEFDIIQN-TELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGD 177
S + +AVEFD I + D H+GID++ + S +E + G +
Sbjct: 118 -SYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYG----------LNN 166
Query: 178 PIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL-ITA 236
+ Y + + S+ ++ +DL ++ E++ GFS ST + A
Sbjct: 167 VANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQA 224
Query: 237 SHNVHGWSIS 246
+H V W +
Sbjct: 225 THEVLNWYFT 234
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 177 bits (449), Expect = 5e-52
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 23/245 (9%)
Query: 6 ADTTSFLYNGFLHAN--LSLEGAAYISTSGILTVTNKSEG-LIGHALYPNPLRFKTSNKS 62
A+T SF +N F N ++ +G + ++G + +TN ++ +G LY P+R +S
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 60
Query: 63 VAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTR 122
F T+F F + G+ F I + A G S TK +
Sbjct: 61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDT--QIPAGSIGGGTL--GVSDTKGAGH 116
Query: 123 MLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAW 182
+ VEFD N+E D +HVGID++S+ S + P + SG +
Sbjct: 117 FVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVV------------KVT 164
Query: 183 VDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI-TASHNVH 241
V Y S ++V++ I+ +DL + + E + GFSAS L H +
Sbjct: 165 VIYDSSTKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIR 221
Query: 242 GWSIS 246
WS +
Sbjct: 222 SWSFT 226
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-52
Identities = 66/278 (23%), Positives = 111/278 (39%), Gaps = 31/278 (11%)
Query: 334 EQNLVGSGGFGRVYRGLMP--SLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNL 389
E +GSG FG V +G + VA+K + N E +AE M +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
V++ G C + +LV + G L+K L H + +++ ++ + YL
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLE 124
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTT--HIVGTLGYLAPEL 507
VHRD+ N+LL T AK+ DFGL+K N H + + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 508 TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDWVKELHLEGEITQAIDQ 566
K ++ +DV+S+G+LM E + +E+ +++ + + + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM-- 239
Query: 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
YDL C + RP V L
Sbjct: 240 ----YDLMNL---------CWTYDVENRPGFAAVELRL 264
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 174 bits (443), Expect = 5e-51
Identities = 55/252 (21%), Positives = 91/252 (36%), Gaps = 30/252 (11%)
Query: 7 DTTSFLYNGF------LHANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPL 54
+T +F Y F ++ G A G L +T G A Y P+
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPV 60
Query: 55 RFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMS 114
S A F T+F F +L Y GLAF + + + T +
Sbjct: 61 FLWDSTGKAA-SFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAA 118
Query: 115 SSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLR 174
+K +++AVEFD N + D H+GID++S++S A+
Sbjct: 119 DPSKN--QVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYG-------- 168
Query: 175 SGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI 234
A + Y ++ ++ V L ++S +DL+ V+ + + GFSA G
Sbjct: 169 -SSIATAHITYDARSKILTVL---LSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVGY- 223
Query: 235 TASHNVHGWSIS 246
+ W
Sbjct: 224 DEVTYILSWHFF 235
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-51
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 24/270 (8%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G G +G V + VA+K + + + EI L H N+V+ +G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
R+ + L +Y G L + + + + ++YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG---I 122
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH-IVGTLGYLAPELTRTGK- 512
+ HRD+KP N+LLD N K+ DFGLA ++ + + + + GTL Y+APEL + +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 513 ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572
DV+S GI++ + G + + + KE + ID
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--WKEKKTYLNPWKKIDSAP--LA 238
Query: 573 LAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
L NP R + + +
Sbjct: 239 LLHK---------ILVENPSARITIPDIKK 259
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 174 bits (441), Expect = 1e-50
Identities = 61/263 (23%), Positives = 114/263 (43%), Gaps = 33/263 (12%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKTS 59
AD SF + F ++ L+G A + +S L +T +G A Y +P++
Sbjct: 1 ADIQSFSFKNFNSSSFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDK 59
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
+ + T+F +I G+AF ++ + FLG+ + + +
Sbjct: 60 STGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPK-SNSGFLGVFDSDVYDN--- 115
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
S + +AVEFD NT+ D H+GID++S+ S L +G
Sbjct: 116 SAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKS------------IRTASWGLANGQNA 162
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITA 236
+ + Y++ L+ S+ + + ++S +D+++ + EY+ GFSA+TGL T
Sbjct: 163 EILITYNAATSLLVASL--VHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTE 220
Query: 237 SHNVHGWSIS----IGGKAQDLN 255
+H+V WS + + L+
Sbjct: 221 THDVLSWSFASKLPDDSTTEPLD 243
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 42/294 (14%)
Query: 337 LVGSGGFGRVYRGLMPSLG-----LEVAIKRIGHNSQQGMKE-FVAEIMSMGRL-RHRNL 389
++GSG FG+V + ++VA+K + + +E ++E+ M +L H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL------------------RKLLTW 431
V L G C + L+++Y G L L K K +LT+
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 432 DQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGAN 490
+ +A+ + +L + VHRD+ N+L+ K+ DFGLA+ I
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 491 PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDW 550
+ + ++APE G T +DV+SYGIL+ E+ + P
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 551 VKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
++ E + + C A + RP + FL
Sbjct: 281 QNGFKMD-------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-50
Identities = 64/276 (23%), Positives = 117/276 (42%), Gaps = 29/276 (10%)
Query: 338 VGSGGFGRVYRGLMPSL---GLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+G G FG V RG + + VA+K + + + M +F+ E+ +M L HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 392 LHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
L+G + +V + P GSL D+ K + + + +A+ + YL
Sbjct: 76 LYGVVL-TPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES- 129
Query: 452 CNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGYLAPELTR 509
+R +HRD+ N+LL T K+GDFGL + + H + APE +
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 510 TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569
T + ++D + +G+ + E+ + +++L + + + Q +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL--HKIDKEGERLPRPEDCPQDI- 244
Query: 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605
N+ + C A P RP + +FLL
Sbjct: 245 ----------YNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-50
Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 335 QNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHNSQQG-MKEFVAEIMSMGRLRHRNLV 390
++G G FG VY G + + A+K + + G + +F+ E + M H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 391 QLHGWC-RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLH 449
L G C R + L+V Y+ +G L + ++ H T + +A+ +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAK---GMK 144
Query: 450 EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG---ANPQTTHIVGTLGYLAPE 506
+++ VHRD+ N +LD K+ DFGLA+ + T + ++A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566
+T K TT +DV+S+G+L+ E+ P ++ + L+ E
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC----- 259
Query: 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+ + + L C P RP +V +
Sbjct: 260 ---------PDPLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 59/290 (20%), Positives = 106/290 (36%), Gaps = 37/290 (12%)
Query: 336 NLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNSQQGMKE-FVAEIMSMGRL-RHRN 388
+G+G FG+V L + VA+K + ++ +E ++E+ + L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL-------------RKLLTWDQRY 435
+V L G C L++ +Y G L L K L +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTT 494
+A+ + +L + +HRD+ NILL K+ DFGLA+ I
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 495 HIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554
+ + ++APE T +DV+SYGI + E+ S P +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+ + ++ C +P+ RP +++V+ +
Sbjct: 266 RML-------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 6e-50
Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 42/300 (14%)
Query: 310 DWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN 366
D+EIQ R + EL +G G FG V++G+ S L VAIK +
Sbjct: 1 DYEIQ----RERI-EL---------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC 46
Query: 367 SQQGMKE-FVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKL 425
+ ++E F+ E ++M + H ++V+L G ++ + ++ + G L L + + L
Sbjct: 47 TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSL 105
Query: 426 RKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485
++ +L YL +R VHRD+ N+L+ + KLGDFGL++
Sbjct: 106 ----DLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
Query: 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEV-ACGRRSIEPQKAAAE 544
E + + + ++APE + T+++DV+ +G+ M E+ G + + K
Sbjct: 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218
Query: 545 LLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+ ++ + L + + Y L C A +P RP + L
Sbjct: 219 IGRIENGERLPMPPNCPPTL------YSLMTK---------CWAYDPSRRPRFTELKAQL 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (443), Expect = 9e-50
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+G+G FG V+R + G A K + + + EI +M LRH LV LH
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+E++++Y+++ G L + + D+ +K ++ D+ + + + + L ++HE
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHE---NNY 145
Query: 457 VHRDVKPSNILLDTYLN--AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
VH D+KP NI+ T + KL DFGL + + + T GT + APE+
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVG 203
Query: 515 TSTDVYSYGILMLEVACGRR 534
TD++S G+L + G
Sbjct: 204 YYTDMWSVGVLSYILLSGLS 223
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 170 bits (432), Expect = 2e-49
Identities = 53/250 (21%), Positives = 97/250 (38%), Gaps = 27/250 (10%)
Query: 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEG------LIGHALYPNPLRFKT 58
D+ SF + F NL +G A I + + +T +G L+ +
Sbjct: 2 DSLSFGFPTFPSDQKNLIFQGDAQI-KNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWE 60
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
+ S +F++ F FS+ + FI + LGL + +T
Sbjct: 61 KSSSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNT- 119
Query: 119 FSTRMLAVEFDIIQNTEL--IDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSG 176
+ +++AVEFD + D N H+GID++S+ S + G +
Sbjct: 120 SANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKWDRRDGQSL--------- 170
Query: 177 DPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITA 236
V ++ ++V R +S +D+ SV+ E++ GFSA++G
Sbjct: 171 ---NVLVTFNPSTRNLDVV---ATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQ 224
Query: 237 SHNVHGWSIS 246
+H + WS +
Sbjct: 225 THTLESWSFT 234
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-49
Identities = 63/311 (20%), Positives = 121/311 (38%), Gaps = 43/311 (13%)
Query: 309 EDWEIQCGARRFKYAELASVTKGFGEQNLVGSGGFGRVYRGLMPSL-----GLEVAIKRI 363
++WE+ + + +G G FG VY G+ + VAIK +
Sbjct: 13 DEWEVA--REKIT----------MSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58
Query: 364 GHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKD 422
S + EF+ E M ++V+L G + L++ + + G L L
Sbjct: 59 NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118
Query: 423 HKLRKL-----LTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477
+ + + ++ IA + YL + VHRD+ N ++ K+G
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIG 175
Query: 478 DFGLAK-IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSI 536
DFG+ + IYE + + + +++PE + G TT +DV+S+G+++ E+A
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235
Query: 537 EPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD 596
+ ++L +EG + D +++ L C NP RP
Sbjct: 236 YQGLSNEQVL------RFVMEGGLLDKPDNC--------PDMLFELMRMCWQYNPKMRPS 281
Query: 597 MRRVVEFLLGD 607
++ + +
Sbjct: 282 FLEIISSIKEE 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 5e-49
Identities = 69/325 (21%), Positives = 128/325 (39%), Gaps = 30/325 (9%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLG----LEVAIKRI-GHNSQQGMKEFVAEIMSMGRLRH 386
F + ++GSG FG VY+GL G + VAIK + S + KE + E M + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
++ +L G C + L+ +P G L D + + + + IA+ +
Sbjct: 71 PHVCRLLGICL-TSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTHIVGTLGYLAP 505
YL ++R+VHRD+ N+L+ T + K+ DFGLAK + + ++A
Sbjct: 126 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL-LVDWVKELHLEGEITQAI 564
E T +DV+SYG+ + E+ A+E+ +++ + L T
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID- 241
Query: 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDSSLPPLPPDIHLKDTRN 624
V + + C + RP R ++ + P I + +
Sbjct: 242 --------------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 625 IMGFSDFPNDSDFFNSKLMSSQSNS 649
+ +D + + M ++
Sbjct: 288 LPSPTDSNFYRALMDEEDMDDVVDA 312
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 8e-49
Identities = 68/304 (22%), Positives = 119/304 (39%), Gaps = 28/304 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+GSG FG V+R + + G K I EI M +L H L+ LH
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+ E++L+ +++ G L + +D+K ++ + + + L ++HE +
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMHE---HSI 148
Query: 457 VHRDVKPSNILLDTYLNA--KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
VH D+KP NI+ +T + K+ DFGLA + T + APE+
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVG 206
Query: 515 TSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDLA 574
TD+++ G+L + G P +L + VK E + + + D
Sbjct: 207 FYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 575 EAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLGD-SSLPPLPPDIHLKDTRNIM--GFS 629
+ P R + +E +L GD S+L P R + ++
Sbjct: 264 KN---------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 314
Query: 630 DFPN 633
D+P
Sbjct: 315 DWPA 318
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 167 bits (424), Expect = 2e-48
Identities = 59/250 (23%), Positives = 103/250 (41%), Gaps = 29/250 (11%)
Query: 7 DTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKSEGL-----IGHALYPNPLRFKTS 59
+ SF + F L +G A ++++G+L +TN G+ +G ALY P + S
Sbjct: 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
F T+F F I P GLAF + + LG+
Sbjct: 62 TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGIFK---DGYFNK 117
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
S +++AVEFD N + D H+GI+++S+ S + P ++ +G
Sbjct: 118 SNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWTNGEVA------------ 164
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS-- 237
++ Y + + S+ +I +D+ V+ E++ GFSA+TG+
Sbjct: 165 NVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQ 222
Query: 238 -HNVHGWSIS 246
++V WS
Sbjct: 223 TNDVLSWSFE 232
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 167 bits (423), Expect = 2e-48
Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 32/250 (12%)
Query: 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSEGL-----IGHALYPNPLRFKTS 59
++TSF + F NL L+ A ++++G L +T + G +G ALY P+
Sbjct: 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH-- 59
Query: 60 NKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKF 119
+ + F T+F F + GLAF + + FLGL +
Sbjct: 60 DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFA---DRAHDA 115
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
S + +AVEFD N D N H+GID + + S + P + G+
Sbjct: 116 SYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKT------------TPFDMVYGEKA 161
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITA 236
+ Y + + S+ + +S +DL ++ EY+ GFSA+TGL +
Sbjct: 162 NIVITYQASTKALAASL--VFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVE 219
Query: 237 SHNVHGWSIS 246
+H++ WS +
Sbjct: 220 THDIVSWSFA 229
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
++G G F V + E AIK + + + E M RL H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ + ++L Y NG L K + A+ + L
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETC---TRFYTAEIVSALEYLH 125
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH-GANPQTTHIVGTLGYLAPELTRTG 511
+ ++HRD+KP NILL+ ++ ++ DFG AK+ + VGT Y++PEL
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 512 KATTSTDVYSYGILMLEVACGRR 534
A S+D+++ G ++ ++ G
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLP 208
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 162 bits (410), Expect = 1e-46
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 37/251 (14%)
Query: 6 ADTTSFLYNGFLH-ANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRFKT 58
A TSF + F L L+G A IS+ G L +T +G A Y +P++ K
Sbjct: 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD 60
Query: 59 SNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTK 118
SN F TNF F I K + GLAF ++ N P +FLG+ N
Sbjct: 61 SNN--VASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTNNPEP-- 115
Query: 119 FSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDP 178
+ R +AV F+ +N ID + N + ++ +G+
Sbjct: 116 -NARTVAVVFNTFKNR--IDFDKNFIKPYVNENCD-----------------FHKYNGEK 155
Query: 179 IQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---IT 235
+ Y S + V + + +S + L +DE++ GFS ++GL T
Sbjct: 156 TDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTT 213
Query: 236 ASHNVHGWSIS 246
+H+V WS S
Sbjct: 214 ETHDVLSWSFS 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 65/290 (22%), Positives = 120/290 (41%), Gaps = 38/290 (13%)
Query: 336 NLVGSGGFGRVYRGLMPSL-------GLEVAIKRI-GHNSQQGMKEFVAEIMSMGRL-RH 386
+G G FG+V L +VA+K + +++ + + ++E+ M + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDKDHKLRKLLTWDQRY 435
+N++ L G C + L ++ +Y G+L + L ++ H + L+
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 436 KILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH 495
+A+ + YL ++ +HRD+ N+L+ K+ DFGLA+ H + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 496 -IVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKEL 554
+ ++APE T +DV+S+G+L+ E+ S P EL +KE
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--KLLKE- 252
Query: 555 HLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
+D EL + C P RP +++VE L
Sbjct: 253 ----------GHRMDKPSNCTNELY-MMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 155 bits (393), Expect = 2e-44
Identities = 52/244 (21%), Positives = 92/244 (37%), Gaps = 46/244 (18%)
Query: 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAI 65
A TSF+ + F NL L+G A +S++G L ++ S + A Y P++ + S
Sbjct: 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVA 60
Query: 66 DFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLA 125
F TNF +I GL F++ + + +
Sbjct: 61 SFDTNFTMNIRTHRQANSAVGLDFVL---------------------VPVQPESKGDTVT 99
Query: 126 VEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDY 185
VEFD + ID+N+N + + + G + + Y
Sbjct: 100 VEFDTFLSRISIDVNNNDI--------------------KSVPWDVHDYDGQNAEVRITY 139
Query: 186 SSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITAS---HNVHG 242
+S + +VS+ +S ++L + +++ GFSA++G S H+V
Sbjct: 140 NSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLS 197
Query: 243 WSIS 246
WS S
Sbjct: 198 WSFS 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 2e-44
Identities = 63/283 (22%), Positives = 116/283 (40%), Gaps = 28/283 (9%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE-FVAEIMSMGRLRHRNLVQLH 393
++++G+G F V VAIK I + +G + EI + +++H N+V L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
L L+ V G L + +K T +++ + ++ YLH+
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG- 127
Query: 454 QRVVHRDVKPSNILL---DTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+VHRD+KP N+L D + DFGL+K+ + G + GT GY+APE+
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQ 183
Query: 511 GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDY 570
+ + D +S G++ + CG P + L + + + E + D +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 571 YDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLGDSSLP 611
D +P R + ++ ++ GD++L
Sbjct: 241 KDFIRH---------LMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (394), Expect = 1e-43
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 38/284 (13%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRI---------GHNSQQGMKEFVAEIMSMGRLR 385
+ ++G G V R + E A+K I Q+ + + E+ + ++
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 386 -HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQS 444
H N++QL LV+D + G L L +K L+ + KI+ + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEV 122
Query: 445 LLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
+ LH+ +VHRD+KP NILLD +N KL DFG + + G + + GT YLA
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLA 177
Query: 505 PELTRTGKA------TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558
PE+ D++S G++M + G P ++L++ + + +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGNYQF 234
Query: 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+ D + DL P R +
Sbjct: 235 GSPEWDDYSDTVKDLVSR---------FLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 45/200 (22%), Positives = 87/200 (43%), Gaps = 12/200 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+G G FG V+R + S K + EI + RHRN++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+EL+++++++ + + + + L + + + ++L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 457 VHRDVKPSNILLDT--YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
H D++P NI+ T K+ +FG A+ + G N + Y APE+ + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVS 181
Query: 515 TSTDVYSYGILMLEVACGRR 534
T+TD++S G L+ + G
Sbjct: 182 TATDMWSLGTLVYVLLSGIN 201
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-43
Identities = 66/289 (22%), Positives = 114/289 (39%), Gaps = 36/289 (12%)
Query: 336 NLVGSGGFGRVYRGLMPSL-----GLEVAIKRIGHNSQQG-MKEFVAEIMSMGR-LRHRN 388
+G G FG+V + VA+K + + + ++E+ + H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 389 LVQLHGWCRKQDE-LLLVYDYVPNGSLDKLLFDKDHKL-----------RKLLTWDQRYK 436
+V L G C K L+++ ++ G+L L K ++ + LT +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 437 ILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK-IYEHGANPQTTH 495
+A+ + +L ++ +HRD+ NILL K+ DFGLA+ IY+ +
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 496 IVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH 555
L ++APE T +DV+S+G+L+ E+ S P + + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDEEFCRRL 250
Query: 556 LEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
EG +A D T + L C P RP +VE L
Sbjct: 251 KEGTRMRAPDYT--------TPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 1e-42
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
++G GG V+ L +VA+K + F E + L H +V
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 392 LHGWCRKQDE----LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
++ + +V +YV +L ++ + +T + +++ Q+L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNF 126
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP--QTTHIVGTLGYLAP 505
H+ ++HRDVKP+NI++ K+ DFG+A+ N QT ++GT YL+P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 506 ELTRTGKATTSTDVYSYGILMLEVACGRR 534
E R +DVYS G ++ EV G
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 6e-42
Identities = 66/324 (20%), Positives = 128/324 (39%), Gaps = 38/324 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGW 395
++G G G+V + + A+K + Q + E+ R + ++V++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 396 CR----KQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE 451
+ LL+V + + G L + D+ + T + +I+ I +++ YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS- 129
Query: 452 CNQRVVHRDVKPSNILLDTYLN---AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
+ HRDVKP N+L + KL DFG AK + T T Y+APE+
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 509 RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568
K S D++S G++M + CG P + L + +K G+ +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE--FLLGDSSLP--PLPPDIHLKDTRN 624
+ + + L+ N P R + + +++ + +P PL LK+ +
Sbjct: 243 EVSEEVK-MLIRN----LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK- 296
Query: 625 IMGFSDFPNDSDFFNSKLMSSQSN 648
+ + + S L + + +
Sbjct: 297 ----ERWEDVKEEMTSALATMRVD 316
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (387), Expect = 7e-42
Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 18/233 (7%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI------GHNSQQGMKEFVAEIMSMGRLR 385
F ++G GGFG VY G A+K + + + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
+V + D+L + D + G L L + I L
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILGL 120
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAP 505
++H + VV+RD+KP+NILLD + + ++ D GLA + + VGT GY+AP
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 174
Query: 506 ELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557
E+ + G A +S D +S G ++ ++ G K + + + +E
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 13/204 (6%)
Query: 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGR-LRHRNLV 390
++G G FG+V+ AIK + + ++ + E + H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
+ + ++ L V +Y+ G L + + I L +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHS 121
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRT 510
+ +V+RD+K NILLD + K+ DFG+ K G + +T GT Y+APE+
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLG 177
Query: 511 GKATTSTDVYSYGILMLEVACGRR 534
K S D +S+G+L+ E+ G+
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 9/210 (4%)
Query: 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGM-KEFVAEIMSMGRLRH 386
V + + +G G +G V + VAIK+I Q + + EI + R RH
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLL 446
N++ ++ R + Y+ + L+ + L+ D L I + L
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLK 123
Query: 447 YLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY--EHGANPQTTHIVGTLGYLA 504
Y+H V+HRD+KPSN+LL+T + K+ DFGLA++ +H T V T Y A
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 505 PELTRTGKATT-STDVYSYGILMLEVACGR 533
PE+ K T S D++S G ++ E+ R
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (379), Expect = 3e-41
Identities = 71/335 (21%), Positives = 118/335 (35%), Gaps = 51/335 (15%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
+G+G FGRV+ G A+K + + ++ E + + + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
G + ++ ++ DY+ G L LL A+ L L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--------RFPNPVAKFYAAEVCLALEYLH 121
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
++ +++RD+KP NILLD + K+ DFG AK T + GT Y+APE+ T
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKP 177
Query: 513 ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYD 572
S D +S+GIL+ E+ G E L E+ D D
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------EKILNAELRFPPFFNEDVKD 230
Query: 573 LAEAELVLNLGLFCSAPNPVYRPDMRR---------------VVEFLLGDSSLPPLPPDI 617
L + R + V E LL + P P I
Sbjct: 231 LLSR---------LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 281
Query: 618 --HLKDTRNIMGFSDFPNDSDFFNSKLMSSQSNSF 650
DT F +P + + + ++ F
Sbjct: 282 QQGQGDTSQ---FDKYPEEDINYGVQGEDPYADLF 313
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 2e-40
Identities = 55/277 (19%), Positives = 99/277 (35%), Gaps = 26/277 (9%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+GSG FG +Y G + G EVAIK + + E ++ + WC
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 397 RKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRV 456
+ + ++ + SL+ L + + + + + + Y+H +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDL----FNFCSRKFSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 457 VHRDVKPSNIL---LDTYLNAKLGDFGLAKIYEHGANPQ------TTHIVGTLGYLAPEL 507
+HRDVKP N L + DFGLAK Y Q ++ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 508 TRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567
+ + D+ S G +++ G + KAA + E E +++ I+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----ERISEKKMSTPIEVL 240
Query: 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
Y A + C + +PD + +
Sbjct: 241 CKGYPSEFATYLNF----CRSLRFDDKPDYSYLRQLF 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 4e-40
Identities = 68/294 (23%), Positives = 108/294 (36%), Gaps = 43/294 (14%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI------GHNSQQGMKEFVAEIMSMGRLR--HRN 388
L+GSGGFG VY G+ S L VAIK + E++ + ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 389 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
+++L W + D +L+ + + R L + + +++ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC 126
Query: 449 HEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
H V+HRD+K NIL+D KL DFG + + + T GT Y PE
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 180
Query: 508 TRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566
R + S V+S GIL+ ++ CG P + E++ + E I
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
Query: 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF-LLGDSSLPPLPPDIHL 619
C A P RP + + D LP +IHL
Sbjct: 238 -------------------CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHL 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-40
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKE-----FVAEIMSMGRLRHRNLV 390
+ +G G F VY+ + VAIK+I + K+ + EI + L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
L + + LV+D++ + +LT ++ Q L YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 451 ECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE-LTR 509
++HRD+KP+N+LLD KL DFGLAK + TH V T Y APE L
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174
Query: 510 TGKATTSTDVYSYGILMLEVACGR 533
D+++ G ++ E+
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (361), Expect = 6e-39
Identities = 44/280 (15%), Positives = 91/280 (32%), Gaps = 30/280 (10%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN-LVQLHGW 395
+G G FG ++ G +VAIK + + E + L + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 396 CRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR 455
++ +LV D + D L + + + + +HE +
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 456 VVHRDVKPSNILLDTYLN-----AKLGDFGLAKIY------EHGANPQTTHIVGTLGYLA 504
+V+RD+KP N L+ + + DFG+ K Y +H + ++ GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564
+ + D+ + G + + G + KAA + + E + +
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604
E + PD +
Sbjct: 242 AGF--------PEEFYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 6e-39
Identities = 58/276 (21%), Positives = 110/276 (39%), Gaps = 32/276 (11%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI------GHNSQQGMKEFVAEIMSMGRLRHRNLV 390
+GSG F V + S GL+ A K I ++ E+ + ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 391 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHE 450
LH + +++L+ + V G L L +K+ LT ++ + L I L ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQI---LNGVYY 128
Query: 451 ECNQRVVHRDVKPSNILLD----TYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPE 506
+ ++ H D+KP NI+L K+ DFGLA + G + +I GT ++APE
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPE 186
Query: 507 LTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566
+ D++S G++ + G P + + V ++ E E +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+ D +P R ++ ++
Sbjct: 244 SALAKDFIRR---------LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 9/201 (4%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G +G VY+ G VA+K+I ++ + EI + L H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
+++L LV++++ + D + L Q L L +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFM----DASALTGIPLPLIKSYLF---QLLQGLAFCHS 120
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
RV+HRD+KP N+L++T KL DFGLA+ + T +V L
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 514 TTSTDVYSYGILMLEVACGRR 534
+T+ D++S G + E+ R
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-38
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 12/202 (5%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI---GHNSQQGMKEFVAEIMSMGRLRHRNLVQL 392
L+G G FG+V + G A+K + ++ + V E + RH L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 393 HGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ D L V +Y G L L + T ++ A+ + L
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY---GAEIVSALEYLH 122
Query: 453 NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGK 512
++ VV+RD+K N++LD + K+ DFGL K GT YLAPE+
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDND 181
Query: 513 ATTSTDVYSYGILMLEVACGRR 534
+ D + G++M E+ CGR
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 332 FGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQ 391
+ + ++G+G FG VY+ + G VAIK++ Q + E+ M +L H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 392 LHGWCRKQDE------LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
L + E L LV DYVP + ++ L + + +SL
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSL 135
Query: 446 LYLHEECNQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLA 504
Y+H + HRD+KP N+LLD KL DFG AK G P ++I
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAP 191
Query: 505 PELTRTGKATTSTDVYSYGILMLEVACGRR 534
+ T+S DV+S G ++ E+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 4e-37
Identities = 57/283 (20%), Positives = 103/283 (36%), Gaps = 24/283 (8%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G +G V++ VA+KR+ + + + EI + L+H+N+V+LH
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
+L LV+++ L + + Q L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKY-----FDSCNGDLDPEIVKSF---LFQLLKGLGFCHS 119
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
+ V+HRD+KP N+L++ KL +FGLA+ + + +V L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 514 TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLDYYDL 573
+TS D++S G + E+A R + P + L + E ++ + DY
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 574 AEAELVLNLGLF--------------CSAPNPVYRPDMRRVVE 602
+L NPV R ++
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 5e-37
Identities = 68/285 (23%), Positives = 113/285 (39%), Gaps = 23/285 (8%)
Query: 336 NLVGSGGFGRVYRGL-MPSLGLEVAIKRI-----GHNSQQGMKEFVAEIMSMGRLRHRNL 389
+G G +G+V++ + + G VA+KR+ VA + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 390 VQLHGWCRKQDELLLVYDYVPNGSLD-KLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYL 448
V+L C + +D L D + + ++ + + L +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 449 HEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELT 508
H RVVHRD+KP NIL+ + KL DFGLA+IY T +V TL Y APE+
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVL 187
Query: 509 RTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLV----------DWVKELHLEG 558
T D++S G + E+ + +L + DW +++ L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 559 EITQAID-QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602
+ + Q ++ + EL +L L C NP R +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (344), Expect = 1e-36
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 11/200 (5%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G +G VY+ G A+K+I + + EI + L+H N+V+L+
Sbjct: 8 EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
+ L+LV++++ L + L L+ + + Y H+
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHD--- 118
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
+RV+HRD+KP N+L++ K+ DFGLA+ + T IV L + K
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 514 TTSTDVYSYGILMLEVACGR 533
+T+ D++S G + E+ G
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+G G FG V++ G +VA+K++ + + + EI + L+H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 394 GWCRKQDE--------LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
CR + + LV+D+ + + T + +++ + L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSEIKRVMQML---L 127
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTH---IVGTLGY 502
L+ +++HRD+K +N+L+ KL DFGLA+ + N Q V TL Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 503 LAPELTRTGKA-TTSTDVYSYGILMLEVACGRR 534
PEL + D++ G +M E+
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 9e-35
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 15/200 (7%)
Query: 338 VGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
+G+G FGRV G A+K + + ++ + E + + LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+ L +V +YV G + L + I + YLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHS---L 160
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
+++RD+KP N+L+D ++ DFG AK + +T + GT LAPE+ +
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYN 216
Query: 515 TSTDVYSYGILMLEVACGRR 534
+ D ++ G+L+ E+A G
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 9/199 (4%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLHG 394
VGSG +G V + G +VAIK++ S+ K E+ + +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQ 454
+ L D+ K K + L D+ ++ + + L Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHA---A 140
Query: 455 RVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKAT 514
++HRD+KP N+ ++ K+ DFGLA+ + T ++V + + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWMRYT 197
Query: 515 TSTDVYSYGILMLEVACGR 533
+ D++S G +M E+ G+
Sbjct: 198 QTVDIWSVGCIMAEMITGK 216
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 126 bits (318), Expect = 1e-33
Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 15/127 (11%)
Query: 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPI 179
+ ++AVE D NT++ D + H+GIDI S+ S + + +G
Sbjct: 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQNGKVG------------ 48
Query: 180 QAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHN 239
A + Y+S + ++ + P +S +DL +V+ E++ G SASTGL ++
Sbjct: 49 TAHIIYNSVDKRLSAV---VSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNT 105
Query: 240 VHGWSIS 246
+ WS +
Sbjct: 106 ILSWSFT 112
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 86.9 bits (215), Expect = 8e-20
Identities = 29/115 (25%), Positives = 41/115 (35%), Gaps = 9/115 (7%)
Query: 3 VVHADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGL------IGHALYPNPLRF 56
+A F +L L+G A T G L +T S +G AL+ P+
Sbjct: 122 ETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHI 181
Query: 57 KTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPENC-LANQFLGLPN 110
S+ VA F F F I G+AF I + + + LGL
Sbjct: 182 WESSAVVA-SFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFP 234
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (315), Expect = 2e-32
Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 21/216 (9%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHG 394
+G G + V+ + + +V +K + K+ EI + LR N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 395 WCRKQDE--LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC 452
+ LV+++V N +L + LT + I ++L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS-- 147
Query: 453 NQRVVHRDVKPSNILLDT-YLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTG 511
++HRDVKP N+++D + +L D+GLA+ Y G + V + + PEL
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDY 204
Query: 512 KA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELL 546
+ S D++S G ++ + + + L
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 59/256 (23%), Positives = 107/256 (41%), Gaps = 21/256 (8%)
Query: 336 NLVGSGGFGRVYRG---LMPSLGLEVAIKRI----GHNSQQGMKEFVAEIMSMGRLRHR- 387
++G+G +G+V+ G A+K + + + E + +R
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 388 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLY 447
LV LH + + +L L+ DY+ G L L ++ T + I + + +L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQ---IYVGEIVLA 141
Query: 448 LHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPEL 507
L +++RD+K NILLD+ + L DFGL+K + + GT+ Y+AP++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 508 TRTGKA--TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565
R G + + D +S G+LM E+ G P E + L+ E +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 566 QTLDYYDLAEAELVLN 581
+ DL + L+ +
Sbjct: 259 MSALAKDLIQRLLMKD 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 327 SVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRL 384
+V K + +GSG G V L VAIK++ +Q K E++ M +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 385 RHRNLVQLHGWCRKQD------ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKIL 438
H+N++ L Q ++ LV + + + + D ++ +L
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLL 125
Query: 439 IGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVG 498
+ + +LH +HRD+KPSNI++ + K+ DFGLA+ G + T V
Sbjct: 126 YQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV 180
Query: 499 TLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR 533
T Y APE+ + D++S G +M E+ +
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 9/200 (4%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIKRI--GHNSQQGMKEFVAEIMSMGRLRHRNLVQLH 393
+ VGSG +G V GL VA+K++ S K E+ + ++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 394 GWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECN 453
L D L + K +K LT D ++ I + L Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADI 142
Query: 454 QRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA 513
HRD+KPSN+ ++ K+ DFGLA+ + T ++ +
Sbjct: 143 I---HRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHY 196
Query: 514 TTSTDVYSYGILMLEVACGR 533
+ D++S G +M E+ GR
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 2e-26
Identities = 41/232 (17%), Positives = 78/232 (33%), Gaps = 16/232 (6%)
Query: 337 LVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWC 396
+G G F V+ VA+K + + + EI + R+ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 397 RKQDELLLVY--DYVPNGSLDKL---------LFDKDHKLRKLLTWDQRYKILIGIAQSL 445
LL + PNG + L + + +I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGDFGLAKIYEHGANPQTTHIV-GTLGYL 503
Y+H C ++H D+KP N+L++ L +A + + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 504 APELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH 555
+PE+ D++S L+ E+ G EP + + D + ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.1 bits (228), Expect = 1e-21
Identities = 30/227 (13%), Positives = 66/227 (29%), Gaps = 29/227 (12%)
Query: 20 NLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79
+ G A S + + + + G F+ ++ F + +
Sbjct: 25 FWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE--------NWEVEVTFRVTGRG 75
Query: 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDI 139
+G GLA L G ++ + + FD N
Sbjct: 76 -RIGADGLAIWYT----ENQGLDGPVFGSADMWNG---------VGIFFDSFDNDG--KK 119
Query: 140 NDNHVGIDISSLISSASEPASYYSGNNHRIPILLR-SGDPIQAWVDYSSQEMLINVSICP 198
N+ + + ++ + + R P++A + Y + + + ++
Sbjct: 120 NNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGF 179
Query: 199 LGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSI 245
Y + VI + G SA+TG + H+V +
Sbjct: 180 TPDKNDYEFCA---KVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 6e-20
Identities = 28/162 (17%), Positives = 53/162 (32%), Gaps = 23/162 (14%)
Query: 336 NLVGSGGFGRVYRGLMPSLGLEVAIK----------RIGHNSQQGMKEFVAEIMSMGRLR 385
L+G G V+ E +K ++ G F + R
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 386 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSL 445
R L +L G + Y + N L +L+ K+ ++ D+ +L I + +
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE---VLDMILEEV 116
Query: 446 LYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487
+ +VH D+ N+L+ + DF +
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGE 154
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.8 bits (103), Expect = 2e-05
Identities = 32/239 (13%), Positives = 56/239 (23%), Gaps = 42/239 (17%)
Query: 10 SFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRT 69
+ +L + + K+ G K
Sbjct: 13 EVTDQQKELSQWTLGDKVKLEEGRFVLTPGKNT--KGSLWLKPEYSIKD-------AMTI 63
Query: 70 NFVFSILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFD 129
+ F GLAF + N ++ + SS KF+ L +
Sbjct: 64 EWTFRSFGFRGS-TKGGLAFWLKQGNEGDS---------TELFGGSSKKFNG--LMILLR 111
Query: 130 IIQNTEL---IDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYS 186
+ +ND +DI S AS Y S P + Y+
Sbjct: 112 LDDKLGESVTAYLNDGTKDLDIESSPYFASCLFQY-----------QDSMVPSTLRLTYN 160
Query: 187 SQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSI 245
+ + L + R + + G SA S + +
Sbjct: 161 PLDNHL------LKLQMDNRVCFQTR-KVKFMGSSPFRIGTSAINDASKESFEILKMKL 212
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.4 bits (94), Expect = 3e-04
Identities = 24/228 (10%), Positives = 51/228 (22%), Gaps = 41/228 (17%)
Query: 17 LHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSIL 76
+ N A + I+ +N++ G K F + F +
Sbjct: 21 VPNNWQTGEQASLEEGRIVLTSNQNS--KGSLWLKQGFDLKD-------SFTMEWTFRSV 71
Query: 77 PKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTEL 136
G++F + + + + L + D
Sbjct: 72 GYS-GQTDGGISFWFVQDSNI---------PRDKQLYNGPVNYDG--LQLLVDNNGPLGP 119
Query: 137 ---IDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLIN 193
+ND +D + + + S P V Y ++ +
Sbjct: 120 TLRGQLNDGQKPVDKTKIYDQSFASCLM---------GYQDSSVPSTIRVTYDLEDDNL- 169
Query: 194 VSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVH 241
L V + G +A G + +
Sbjct: 170 -----LKVQVDNKVCFQ--TRKVRFPSGSYRIGVTAQNGAVNNNAESF 210
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 653 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.96 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.95 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.84 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.79 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=5.7e-56 Score=435.77 Aligned_cols=225 Identities=24% Similarity=0.372 Sum_probs=197.9
Q ss_pred ceeEEeCCCCC---CCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 8 TTSFLYNGFLH---ANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 8 ~~~f~~~~f~~---~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
+++|+|++|.. .+|+|+|||++. +|.|+||+.. ..++|||+|++||+||+..++++|||+|+|+|.|.+.
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~ 79 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT 79 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCC
Confidence 57999999964 679999999985 8999999754 4589999999999999999999999999999999874
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCccc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
...+||||||||+|....+ +..|++||+++..+. .+...+++|||||||++|.+++||++||||||+||+.|.++.+
T Consensus 80 -~~~~gDGlAFvl~p~~~~~-~~~G~~lGl~~~~~~-~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~ 156 (236)
T d1hqla_ 80 -GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTA-TQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR 156 (236)
T ss_dssp -SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTT-TCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEE
T ss_pred -CCCCCceEEEEEeCCCCCC-CCCcccccccccccc-CCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccc
Confidence 4568999999999976544 468899999987654 1345689999999999999999999999999999999988776
Q ss_pred CccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc-cce
Q 048419 159 ASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI-TAS 237 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~-~~~ 237 (653)
+. ..++.+|+.++|||+||+.+++|+|+|++. ++..|+|++.|||+++|+++||||||||||.. .+.
T Consensus 157 ~~---------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~---~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~ 224 (236)
T d1hqla_ 157 WE---------DSDIFSGKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLT 224 (236)
T ss_dssp CC---------HHHHTSCSCEEEEEEEETTTTEEEEEEEET---TTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEE
T ss_pred cc---------cccccCCCEEEEEEEEeCCCcEEEEEEecC---CCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceE
Confidence 53 457899999999999999999999999874 36678999999999999999999999999975 578
Q ss_pred eeecceeeeec
Q 048419 238 HNVHGWSISIG 248 (653)
Q Consensus 238 ~~i~sWsf~~~ 248 (653)
|+|++|+|++.
T Consensus 225 h~I~sWsF~s~ 235 (236)
T d1hqla_ 225 VYILSWRFSSN 235 (236)
T ss_dssp EEEEEEEEEEE
T ss_pred EEEEEeEeEec
Confidence 99999999863
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=6.8e-55 Score=429.50 Aligned_cols=225 Identities=24% Similarity=0.336 Sum_probs=197.0
Q ss_pred cCceeEEeCCCC------CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEE
Q 048419 6 ADTTSFLYNGFL------HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVF 73 (653)
Q Consensus 6 ~~~~~f~~~~f~------~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f 73 (653)
.++++|+|++|. ..||+|+|||++. +|.|+||+.. ..++|||+|++||+||++ +++++||+|+|+|
T Consensus 1 ~~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~~~asFsT~F~f 78 (243)
T d1leda_ 1 ENTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGKAASFYTSFTF 78 (243)
T ss_dssp CCCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TSCBCEEEEEEEE
T ss_pred CCceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CCcEeeEEEEEEE
Confidence 368999999995 3689999999996 8999999654 358999999999999995 7899999999999
Q ss_pred EEecCCCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCc
Q 048419 74 SILPKYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLIS 153 (653)
Q Consensus 74 ~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s 153 (653)
.|.+. ...+||||||||+|.... .+.+|++||+++..+.. +...+++|||||||++|.+++||++||||||+|++.|
T Consensus 79 ~i~~~-~~~~gdGlAF~l~p~~~~-~~~~g~~lGl~~~~~~~-~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s 155 (243)
T d1leda_ 79 LLKNY-GAPTADGLAFFLAPVDSS-VKDYGGFLGLFRHETAA-DPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVS 155 (243)
T ss_dssp EEEES-SSSCBCEEEEEEEETTCC-CCCCGGGTTTCCTTTTT-CGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSC
T ss_pred EcCCC-CCCCCCceEEEEcCCCCC-CCCCccccccccccccC-CCccCcEEEEEEeCccccccCCCCCCceEEEecCccc
Confidence 88765 456899999999997654 45678999999876541 3456899999999999999999999999999999999
Q ss_pred CCcccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc
Q 048419 154 SASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL 233 (653)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~ 233 (653)
..+.++. ..++.+|+.++|||+||+.+++|+|+|+.. ++..|+|++.|||+++|+++||||||||||.
T Consensus 156 ~~~~~~~---------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~ 223 (243)
T d1leda_ 156 VATTRWE---------NDDAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY 223 (243)
T ss_dssp SEEEECC---------HHHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCEEEEEEECCHHHHSCSEEEEEEEEEECB
T ss_pred ccccccc---------cCCcccCceeEEEEEEECCCCEEEEEEeeC---CCCCceEEEecCHHHhcCCcEEEEEEcccCC
Confidence 8887754 347889999999999999999999999864 4667899999999999999999999999995
Q ss_pred ccceeeecceeeeec
Q 048419 234 ITASHNVHGWSISIG 248 (653)
Q Consensus 234 ~~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 224 -~~~h~I~sWsF~s~ 237 (243)
T d1leda_ 224 -DEVTYILSWHFFST 237 (243)
T ss_dssp -SEEEEEEEEEEEEE
T ss_pred -cceeeEEEEEEEee
Confidence 69999999999864
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=4.1e-54 Score=425.25 Aligned_cols=227 Identities=25% Similarity=0.359 Sum_probs=198.9
Q ss_pred cCceeEEeCCCCC--CCeEEecceEecCCCcEEecCCC----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC-
Q 048419 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKS----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK- 78 (653)
Q Consensus 6 ~~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~- 78 (653)
++++||+|++|++ +||+|+|||++.++|.|+||+.. ..++|||+|++||+||++++++++||+|+|+|.|...
T Consensus 1 ~~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~~ 80 (240)
T d1fx5a_ 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSA 80 (240)
T ss_dssp CCEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESS
T ss_pred CCceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCCC
Confidence 4678999999964 68999999999889999999775 3478999999999999999999999999999999654
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeeccccc-ccCCCCCCeeeEecCCCCcCCcc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNT-ELIDINDNHVGIDISSLISSASE 157 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~-~~~d~~~~Hvgid~ns~~s~~~~ 157 (653)
++..+||||||+|+|... +.+.+|++||+++..+. +..+++|||||||++|. +++||++||||||+||+.+..+.
T Consensus 81 ~~~~ggdG~AFvl~p~~~-~~~~~g~~lGl~~~~~~---~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~ 156 (240)
T d1fx5a_ 81 NPKAATDGLTFFLAPPDS-PLRRAGGYFGLFNDTKC---DSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAE 156 (240)
T ss_dssp CGGGCCCEEEEEEECTTC-CCCBCGGGTTTBSSSCC---CGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCcEEEEECCCCC-CCCCCCccccccccCCC---CccCceEEEEeeccccccccCCCCCCceEEccCCccccccc
Confidence 445689999999999764 56788999999986543 45678999999999984 67899999999999999988777
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc-ccc
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL-ITA 236 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~-~~~ 236 (653)
.+. ..+.+|+.++|||+||+.+++|+|+|.+.+ +|..|+++..|||+.+|+++||||||||||. ..|
T Consensus 157 ~~~----------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~ 224 (240)
T d1fx5a_ 157 RWN----------KRYGLNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQA 224 (240)
T ss_dssp ECC----------CCCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCE
T ss_pred ccc----------cccCCCCeEEEEEEEcCCCCEEEEEEecCC--CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCc
Confidence 653 356789999999999999999999998755 5778899999999999999999999999995 568
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|++|+|++.
T Consensus 225 ~H~I~sWsFsst 236 (240)
T d1fx5a_ 225 THEVLNWYFTST 236 (240)
T ss_dssp EEEEEEEEEEEE
T ss_pred eEEEEEEEeEEe
Confidence 999999999864
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=2.4e-53 Score=419.31 Aligned_cols=225 Identities=28% Similarity=0.450 Sum_probs=197.6
Q ss_pred cCceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC---CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCC
Q 048419 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS---EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYP 80 (653)
Q Consensus 6 ~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~---~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~ 80 (653)
.+++||+|++|. ..||+|+|||++.++|.|+||+.. ..++|||+|++||+||++.+++++||+|+|+|.|.++ .
T Consensus 1 s~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~-~ 79 (237)
T d1qnwa_ 1 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD-K 79 (237)
T ss_dssp CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-S
T ss_pred CCcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecC-C
Confidence 368999999996 378999999999889999999864 4689999999999999999999999999999999765 4
Q ss_pred CCCCCceEEEEecCCCC-CCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccC--CCCCCeeeEecCCCCcCCcc
Q 048419 81 DLGGQGLAFIIISTNRP-ENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELI--DINDNHVGIDISSLISSASE 157 (653)
Q Consensus 81 ~~~gdGlaF~l~~~~~~-~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgid~ns~~s~~~~ 157 (653)
..+||||||+|+|.... +.+++++++|+.+..+ +...+++|||||||++|.+++ ||+++|||||+|++.|.++.
T Consensus 80 ~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~---~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~ 156 (237)
T d1qnwa_ 80 SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD---SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV 156 (237)
T ss_dssp SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS---CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCcceeEEEEeCCCCCCCCCCccccccccCCCC---CCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccc
Confidence 55899999999998744 6678888999988643 356789999999999997654 69999999999999988766
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCccc--
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLIT-- 235 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~-- 235 (653)
.+ ++.+|+.++|||+||+.+++|+|+++..+ +|..|+|++.|||+++|+++||||||||||...
T Consensus 157 ~~------------~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~ 222 (237)
T d1qnwa_ 157 KW------------DWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEF 222 (237)
T ss_dssp EC------------CCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGC
T ss_pred cc------------ccCCCcEEEEEEEEcCCCcEEEEEEecCC--CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCc
Confidence 53 46789999999999999999999998654 678899999999999999999999999999754
Q ss_pred ceeeecceeeeec
Q 048419 236 ASHNVHGWSISIG 248 (653)
Q Consensus 236 ~~~~i~sWsf~~~ 248 (653)
|.|+|++|+|++.
T Consensus 223 q~h~I~sWsF~s~ 235 (237)
T d1qnwa_ 223 ETHDVLSWYFTSN 235 (237)
T ss_dssp BCCEEEEEEEEEE
T ss_pred cEeEEEEeEeEEe
Confidence 8999999999863
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=2.3e-53 Score=419.65 Aligned_cols=223 Identities=29% Similarity=0.467 Sum_probs=195.4
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCCC------CceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
+++||+|++|+ .+||+|+|+|++.++|.|+||+... +++|||+|++||+||++.+++++||+|+|+|.|...
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~~ 81 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEecC
Confidence 57899999997 3689999999998899999998653 488999999999999999999999999999999754
Q ss_pred C-CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcc
Q 048419 79 Y-PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASE 157 (653)
Q Consensus 79 ~-~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 157 (653)
. ...+||||||+|+|....+ ..++++||+++.... ...++.|||||||++|. ++||+++|||||+|++.|..+.
T Consensus 82 ~~~~~g~dG~aF~l~p~~~~~-~~~~g~lg~~~~~~~---~~~~~~vaVEFDT~~n~-~~d~~~~HvgI~vn~~~s~~t~ 156 (239)
T d1gzca_ 82 YTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSKQ---DNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQ 156 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSSC---CGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEE
T ss_pred CCCCCCCCeEEEEECCCCCCC-CCCcccccccccCCC---CCccceEEEEEEccccC-CCCCCCCEEEEEECCccccccC
Confidence 3 3568999999999987544 457889999876543 34577899999999994 7899999999999999988776
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc---c
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---I 234 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~---~ 234 (653)
++ ++.+|+.++|||+||+.+++|+|++.+.+ +|..|+|++.|||+++|+++|||||||+||. .
T Consensus 157 ~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~ 222 (239)
T d1gzca_ 157 PF------------QLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDA 222 (239)
T ss_dssp EC------------CCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTC
T ss_pred Cc------------cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCC
Confidence 53 57899999999999999999999998654 6888999999999999999999999999994 5
Q ss_pred cceeeecceeeeec
Q 048419 235 TASHNVHGWSISIG 248 (653)
Q Consensus 235 ~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 223 ~~~H~V~sWsF~s~ 236 (239)
T d1gzca_ 223 AETHDVYSWSFQAS 236 (239)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred ceeeEEEEEEeEee
Confidence 68999999999975
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=4.2e-53 Score=416.81 Aligned_cols=219 Identities=31% Similarity=0.435 Sum_probs=192.0
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC-
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK- 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~- 78 (653)
+++||+|++|. .+||+|+|||++.++|.|+||+.. .+++|||+|++||+||++.+++++||+|+|+|.|...
T Consensus 1 ~t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~ 80 (237)
T d2d3sa1 1 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF 80 (237)
T ss_dssp CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred CeEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCC
Confidence 47899999995 378999999999878999999864 4699999999999999999999999999999999654
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCccc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
+...+||||||+|+|.... .+..|++||+++.. ..+++|||||||++|. +||++||||||+|++.|.++..
T Consensus 81 ~~~~g~dGlaFvl~p~~~~-~~~~gg~lG~~~~~------~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~~~ 151 (237)
T d2d3sa1 81 PRPHPADGLVFFIAPPNTQ-TGEGGGYFGIYNPL------SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP 151 (237)
T ss_dssp CSSCCCEEEEEEEECSSCC-CCBCGGGTTTBCTT------SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCeEEEEeCCCCcc-CCccccccccccCC------CcCceEEEEEEeecCC--CCCCCCcEEEEcCCCccccccc
Confidence 3445789999999997654 45678899998753 3467899999999997 7999999999999999876544
Q ss_pred CccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc-----
Q 048419 159 ASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL----- 233 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~----- 233 (653)
+.+.+|+.++|||+||+.+++|+|++...+ +|..|+++..|||+.+|+++||||||||||.
T Consensus 152 ------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~ 217 (237)
T d2d3sa1 152 ------------FTLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQ 217 (237)
T ss_dssp ------------CCCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCC
T ss_pred ------------eeecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcEEEEEEeECCCCccCc
Confidence 357899999999999999999999998765 4677899999999999999999999999994
Q ss_pred --ccceeeecceeeeec
Q 048419 234 --ITASHNVHGWSISIG 248 (653)
Q Consensus 234 --~~~~~~i~sWsf~~~ 248 (653)
..|.|+|++|+|++.
T Consensus 218 ~~~~e~h~I~sWsFss~ 234 (237)
T d2d3sa1 218 RNATETHDILSWSFSAS 234 (237)
T ss_dssp TTCCCCCEEEEEEEEEE
T ss_pred cccceeeEEEEeEeEee
Confidence 469999999999864
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=2.7e-52 Score=414.99 Aligned_cols=225 Identities=27% Similarity=0.441 Sum_probs=191.7
Q ss_pred cCceeEEeCCCCC--CCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEec
Q 048419 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILP 77 (653)
Q Consensus 6 ~~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~ 77 (653)
|.++||+|++|.+ .||+|+|+|++.++|.|+||+.. ..++|||+|++||+||++.+++++||+|+|+|.|..
T Consensus 1 a~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~ 80 (251)
T d1g9fa_ 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA 80 (251)
T ss_dssp CEEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEEC
T ss_pred CceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEec
Confidence 4689999999973 68999999999889999999864 358999999999999999999999999999999998
Q ss_pred CCCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcc
Q 048419 78 KYPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASE 157 (653)
Q Consensus 78 ~~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 157 (653)
.+...+||||||+|+|....+ +..+|+||+++.. ...++.|||||||++|. +||+++|||||+|++.|..+.
T Consensus 81 ~~~~~~gDGlAFvl~p~~~~~-~~~~g~lG~~~~~-----~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~~~ 152 (251)
T d1g9fa_ 81 PDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN-----ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTT 152 (251)
T ss_dssp SCC--CCEEEEEEEEETTCCC-CCCGGGTTTCCTT-----SCCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSEEE
T ss_pred CCCCCCCCceEEEEecCCCCC-CCccCccCccccc-----CCCcceEEEEEecccCC--CCCCCCcEeEEecCccccccc
Confidence 877889999999999987544 5677899998753 33467899999999997 799999999999999987665
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCccc--
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLIT-- 235 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~-- 235 (653)
. +++.+|+.++|||+||+.+++|+|++.... +|..|+++..|||+.+|+++||||||||||...
T Consensus 153 ~------------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~ 218 (251)
T d1g9fa_ 153 S------------WDLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPG 218 (251)
T ss_dssp E------------CCCCTTCCEEEEEEEETTTTEEEEEEEEGG--GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCC
T ss_pred c------------eEecCCCEEEEEEEEECCccEEEEEEecCC--CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCC
Confidence 4 367899999999999999999999997643 678889999999999999999999999999754
Q ss_pred ceeeecceeeeecCcCC
Q 048419 236 ASHNVHGWSISIGGKAQ 252 (653)
Q Consensus 236 ~~~~i~sWsf~~~~~~~ 252 (653)
|.|+|++|+|++..+++
T Consensus 219 ~~h~I~sWsF~s~~~~~ 235 (251)
T d1g9fa_ 219 ESHDVLSWSFASNLPHA 235 (251)
T ss_dssp CEEEEEEEEEEEEECC-
T ss_pred ceeEEEEeEeECCCCCC
Confidence 88999999999875443
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=8.4e-52 Score=407.08 Aligned_cols=218 Identities=29% Similarity=0.441 Sum_probs=189.8
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
+++||+|++|. .+||+|+|||++.++|.|+||+.. .+++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 1 ~~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~ 80 (234)
T d1f9ka_ 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQP 80 (234)
T ss_dssp CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred CceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECC
Confidence 47899999996 478999999999889999999874 3589999999999999999999999999999999765
Q ss_pred C-CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcc
Q 048419 79 Y-PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASE 157 (653)
Q Consensus 79 ~-~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 157 (653)
+ ...+||||||+|+|... +.+..|+++|+++... .++.|||||||++|. +||++||||||+|++.|.++.
T Consensus 81 ~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~~~------~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~ 151 (234)
T d1f9ka_ 81 YAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKPPE------GDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTL 151 (234)
T ss_dssp CSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCSSC------CSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEE
T ss_pred CCCCCccceEEEEECCCCC-CcccccccccccCCCC------ccceEEEEEeccccC--CCCCCCcEeEecCCccccccc
Confidence 3 34578999999999775 4456788899887543 356799999999997 899999999999999887665
Q ss_pred cCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccc--cceEEeEecccCc--
Q 048419 158 PASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVID--EYMYTGFSASTGL-- 233 (653)
Q Consensus 158 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~--~~~~vGFsastg~-- 233 (653)
+ +++.+|+.++|||+||+.+++|+|++.... ++..|+|++.|||+.+|+ ++||||||||||.
T Consensus 152 ~------------~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~ 217 (234)
T d1f9ka_ 152 H------------FQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQK 217 (234)
T ss_dssp E------------CCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSST
T ss_pred c------------ccccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCC
Confidence 4 367899999999999999999999998765 466789999999999996 6799999999994
Q ss_pred -ccceeeecceeeee
Q 048419 234 -ITASHNVHGWSISI 247 (653)
Q Consensus 234 -~~~~~~i~sWsf~~ 247 (653)
..|.|+|++|+|++
T Consensus 218 ~~~~~h~I~sWsF~s 232 (234)
T d1f9ka_ 218 NAVETHEIISWSFTS 232 (234)
T ss_dssp TCCCEEEEEEEEEEE
T ss_pred CceeeeEEEEEEeEE
Confidence 46899999999986
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.9e-51 Score=403.36 Aligned_cols=222 Identities=28% Similarity=0.444 Sum_probs=195.9
Q ss_pred cCceeEEeCCCCCCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 6 ~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
+++++|+|++|+..||+|+|||++.++|.|+||+.. .+++|||+|++||+||++.++.++||+|+|+|.|.+.+
T Consensus 1 ~~~~sF~f~~F~~~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~~~ 80 (233)
T d1g8wa_ 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPN 80 (233)
T ss_dssp CEEEEEEESSCCGGGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCCCS
T ss_pred CCceEEECCCCCcCcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEecCC
Confidence 468999999999999999999999889999999754 35899999999999999999999999999999998877
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccC
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPA 159 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 159 (653)
...+||||||+|+|....+ +..|++||+++.. ...++.|||||||+.|.+ +||+++|||||+|++.+..+..+
T Consensus 81 ~~~~gDGlAF~l~~~~~~~-g~~g~~lG~~~g~-----~~~~~~vaVEFDT~~N~~-~d~~~~Hvgi~~n~~~s~~~~~~ 153 (233)
T d1g8wa_ 81 NAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS-----NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTRW 153 (233)
T ss_dssp SCBCCEEEEEEEEETTCCC-CCCGGGTTTCCSS-----CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCeEEEEEecCCCCC-CcccccCCccccC-----CCcccEEEEEeecccCCC-CCCCCCeEEEECCCcceeeeccc
Confidence 7778999999999987644 4678899998643 234678999999999977 59999999999999988766543
Q ss_pred ccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc---ccc
Q 048419 160 SYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITA 236 (653)
Q Consensus 160 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~---~~~ 236 (653)
++.+|+.++|||+|++.+++|.|++...+ ++..|+++..+||+.+||++|||||||+||. ..|
T Consensus 154 ------------~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~ 219 (233)
T d1g8wa_ 154 ------------DFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVE 219 (233)
T ss_dssp ------------CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCC
T ss_pred ------------cccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCce
Confidence 56799999999999999999999998755 5777899999999999999999999999994 457
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|++|+|++.
T Consensus 220 ~h~I~sWsFss~ 231 (233)
T d1g8wa_ 220 TNDVLSWSFASK 231 (233)
T ss_dssp CCEEEEEEEEEE
T ss_pred eeEEEEEEEEEE
Confidence 899999999863
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=3.2e-51 Score=408.81 Aligned_cols=223 Identities=27% Similarity=0.453 Sum_probs=196.3
Q ss_pred cCceeEEeCCCCCCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 6 ~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
|+.+||+|++|+..+|+|+|||++. ++.|+||+.. ..++|||+|++||+||++.+++++||+|+|+|.|.+..
T Consensus 1 a~~~sF~f~~F~~~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~~ 79 (253)
T d1g7ya_ 1 ADIQSFSFKNFNSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPN 79 (253)
T ss_dssp CEEEEEEESSCCSSCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred CcccEEecCCCCcccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecCC
Confidence 4578999999999999999999996 7889999764 35899999999999999999999999999999998877
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccC
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPA 159 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 159 (653)
...+||||||+|+|....+. ..+|++|+++..+. ...++.+||||||++|.+ +||+++|||||+|++.|..++++
T Consensus 80 ~~~ggDGlAF~l~~~~~~~~-~~~g~lgl~~~~~~---~~~~~~vaVEFDT~~n~~-~d~~~~Hvgi~~ns~~s~~~~~~ 154 (253)
T d1g7ya_ 80 KSSSADGIAFALVPVGSEPK-SNSGFLGVFDSDVY---DNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTASW 154 (253)
T ss_dssp GGGCCCEEEEEEEETTCCCC-CCGGGTTTCSCSSC---CGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCceEEEEeCCCCCCC-CCcccccccccCCC---CCcCceEEEEEeceecCC-CCCCCCcEEEeeCCcccccccCC
Confidence 67799999999999876544 56789999876443 345678999999999976 59999999999999998876553
Q ss_pred ccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccC---cccc
Q 048419 160 SYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTG---LITA 236 (653)
Q Consensus 160 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg---~~~~ 236 (653)
.+.+|+.++|||+|++.+++|+|++.... +|..|++++.+||+.+||++|||||||+|| ...|
T Consensus 155 ------------~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~ 220 (253)
T d1g7ya_ 155 ------------GLANGQNAEILITYNAATSLLVASLVHPS--RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTE 220 (253)
T ss_dssp ------------CCCTTSEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCC
T ss_pred ------------CccCCCEEEEEEEEeCCcEEEEEEEecCC--CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCccc
Confidence 57899999999999999999999997643 678889999999999999999999999999 4579
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|++|+|++.
T Consensus 221 ~H~IlsWsF~s~ 232 (253)
T d1g7ya_ 221 THDVLSWSFASK 232 (253)
T ss_dssp CCEEEEEEEEEE
T ss_pred ccEEEEEEeEEe
Confidence 999999999864
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=7.1e-51 Score=403.90 Aligned_cols=226 Identities=28% Similarity=0.443 Sum_probs=197.9
Q ss_pred cCceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 6 ~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
++++||+|++|. ..||+|+|||++.++|.|+||++. ..++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~ 80 (239)
T d1dbna_ 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP 80 (239)
T ss_dssp CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence 468999999996 478999999999889999999764 4579999999999999999999999999999999888
Q ss_pred CCCCCCCceEEEEecCCC-CCCCCCCccccCCCcccCCCCCCCCceEEEEeeccccccc--CCCCCCeeeEecCCCCcCC
Q 048419 79 YPDLGGQGLAFIIISTNR-PENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTEL--IDINDNHVGIDISSLISSA 155 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~-~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~--~d~~~~Hvgid~ns~~s~~ 155 (653)
....+||||||+|+|... .+.+.+|++||+.+..+ .+..++.+||||||++|.++ +||+.+|||||+|++.|..
T Consensus 81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~---~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~ 157 (239)
T d1dbna_ 81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN---SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIK 157 (239)
T ss_dssp STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC---CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSE
T ss_pred CCCCCCCCEEEEEeCCCccCCcccCccccccccccC---CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccc
Confidence 777899999999998774 35667889999998654 34568899999999999765 4899999999999999877
Q ss_pred cccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc-
Q 048419 156 SEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI- 234 (653)
Q Consensus 156 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~- 234 (653)
+..+ .+.+|+.+.|||+|++.+++|.|++.... ++..|.++.++||+++|+++||||||||||..
T Consensus 158 ~~~~------------~~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~ 223 (239)
T d1dbna_ 158 TVQW------------DWINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWVRVGFSAATGYPT 223 (239)
T ss_dssp EEEC------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGG
T ss_pred cccc------------eEeCCceeEEEEEEcCCCCEEEEEEEecC--CCccEEEEEecchHHhcCCcEEEEEEEeCCCCC
Confidence 6554 34689999999999999999999998754 56778999999999999999999999999964
Q ss_pred -cceeeecceeeeec
Q 048419 235 -TASHNVHGWSISIG 248 (653)
Q Consensus 235 -~~~~~i~sWsf~~~ 248 (653)
.|.|+|++|+|++.
T Consensus 224 ~~~~H~I~sWsFss~ 238 (239)
T d1dbna_ 224 EVETHDVLSWSFTST 238 (239)
T ss_dssp GCCCCEEEEEEEEEE
T ss_pred CcceeEEEEEEeEEe
Confidence 47899999999863
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=2.3e-50 Score=397.62 Aligned_cols=224 Identities=27% Similarity=0.356 Sum_probs=190.7
Q ss_pred cCceeEEeCCCCC--CCeEEecceEecCCCcEEecCCC-CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCC
Q 048419 6 ADTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKS-EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDL 82 (653)
Q Consensus 6 ~~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~-~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~ 82 (653)
+.++||+|++|.+ .+|+|+|||.+.++|.|+||++. .+++|||+|++||+||++.+++++||+|+|+|.|.+.+...
T Consensus 1 a~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~~~ 80 (232)
T d1v6ia_ 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYD 80 (232)
T ss_dssp CEEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSB
T ss_pred CccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCCCC
Confidence 4689999999986 45999999999889999999865 58999999999999999999999999999999999887788
Q ss_pred CCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccc
Q 048419 83 GGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYY 162 (653)
Q Consensus 83 ~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 162 (653)
+||||||+|+|....... +++.+|+.+..+ .+..++.|||||||++|.+++||+++|||||+|++.+.....
T Consensus 81 ~gDG~AF~l~~~~~~~~~-~~~~g~~~~~~~---~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~---- 152 (232)
T d1v6ia_ 81 PADGIIFFIAPEDTQIPA-GSIGGGTLGVSD---TKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP---- 152 (232)
T ss_dssp CCCEEEEEEEETTCCCCT-TCCCGGGTTTSC---TTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE----
T ss_pred CCCeEEEEEECCCCCCCC-CccCCccccccc---CCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCcccccccc----
Confidence 999999999997754332 222222222211 345678999999999999889999999999999988776543
Q ss_pred cCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc-ccceeeec
Q 048419 163 SGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL-ITASHNVH 241 (653)
Q Consensus 163 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~-~~~~~~i~ 241 (653)
.++.+|+.++|||+|++.+++|+|++... ++..|.++..|||+.+||++|||||||+||. ..|.|+|+
T Consensus 153 --------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~---~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~ 221 (232)
T d1v6ia_ 153 --------WNSVSGAVVKVTVIYDSSTKTLSVAVTND---NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIR 221 (232)
T ss_dssp --------CCCCTTCEEEEEEEEETTTTEEEEEEECT---TSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEE
T ss_pred --------cccCCCCEEEEEEEEeCCceEEEEEEecC---CCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEE
Confidence 35689999999999999999999998854 4567789999999999999999999999996 46999999
Q ss_pred ceeeeec
Q 048419 242 GWSISIG 248 (653)
Q Consensus 242 sWsf~~~ 248 (653)
+|+|++.
T Consensus 222 sWsFss~ 228 (232)
T d1v6ia_ 222 SWSFTST 228 (232)
T ss_dssp EEEEEEE
T ss_pred EeEeEEe
Confidence 9999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-51 Score=419.61 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=204.0
Q ss_pred cCHHHHHHhhcC---------cCcceeeeeeCcEEEEEEEeCCCCc---EEEEEEeccC-chhhHHHHHHHHHHHhhcCC
Q 048419 320 FKYAELASVTKG---------FGEQNLVGSGGFGRVYRGLMPSLGL---EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRH 386 (653)
Q Consensus 320 f~~~el~~at~~---------f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H 386 (653)
++|+++..++++ |+..++||+|+||+||+|.+..+++ .||||++... .....+.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 455566655544 4456899999999999999876553 6899998654 45556789999999999999
Q ss_pred CceeeeeeeecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 048419 387 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNI 466 (653)
Q Consensus 387 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 466 (653)
||||+++|+|.+.+.+++|||||++|+|.+++.... ..++|.++++++.|||+||.|||+ ++|+||||||+||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NI 159 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNI 159 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceE
Confidence 999999999999999999999999999999887643 358999999999999999999999 9999999999999
Q ss_pred EEcCCCcEEEEeecCcccccCCCCC----cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhh
Q 048419 467 LLDTYLNAKLGDFGLAKIYEHGANP----QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKA 541 (653)
Q Consensus 467 ll~~~~~~kl~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~ 541 (653)
||+.++++||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999876543221 1222457899999999999999999999999999999998 8999976544
Q ss_pred hhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 542 AAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 542 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+ +...+.... ++ ..+......+.+|+.+||+.||.+||||.||++.|+.
T Consensus 240 ~~---~~~~i~~~~-----------~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 240 QD---VINAIEQDY-----------RL-PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp HH---HHHHHHTTC-----------CC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HH---HHHHHHcCC-----------CC-CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22 222222111 01 1122345678899999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=410.82 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=208.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
++|+..+.||+|+||+||+|++..+|+.||||++.... .+..+.+.+|++++++++|||||++++++.+.+.++|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999999999999999996543 33456789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
|++|+|.+++... ..+++.+++.++.||++||+|||+ ++|+||||||+|||+++++++||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999653 358999999999999999999999 99999999999999999999999999999976443
Q ss_pred CC-CcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 489 AN-PQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 489 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......... ...+... ....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~----~~~~----- 226 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK----KTYL----- 226 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTT----CTTS-----
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcC----CCCC-----
Confidence 22 22345689999999999988776 57899999999999999999999764432211 1111110 0000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
.........+.+|+.+||+.||.+|||++|++++-.-..
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 000112356788999999999999999999987654433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=411.03 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=198.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|.+.+ +..||||++.... ...++|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 467888999999999999999864 6789999996543 34578999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.... ..++|..++.++.|||+||.|||+ ++|+||||||+|||+++++++||+|||+++......
T Consensus 83 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999987643 458999999999999999999999 999999999999999999999999999998775544
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCC-CChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRS-IEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........||+.|+|||++.+..++.++|||||||++|||+|++.| +....... +.+.+.....
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~~~~------------ 220 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFR------------ 220 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHHTCC------------
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHhcCC------------
Confidence 3344456789999999999999999999999999999999996544 44332211 1112211110
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+....+.+.+|+.+||+.||.+||||+||+++|+.
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 01111234678899999999999999999999999863
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=7.2e-50 Score=396.35 Aligned_cols=223 Identities=26% Similarity=0.417 Sum_probs=195.1
Q ss_pred CceeEEeCCCCC--CCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 7 DTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 7 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
.++||+|++|.. +|++|+|||.+.++|.|+||++. ..++|||+|++||+||++.+++++||+|+|+|.|.+.+
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~~ 81 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecCC
Confidence 468999999964 79999999999889999999863 46899999999999999999999999999999998887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccC
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPA 159 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 159 (653)
...+||||||+|+|....+ +..|++||+++... ....++.+||||||+.|.++ ||+++|||||+|++.|..+.+.
T Consensus 82 ~~~~gDG~AF~l~~~~~~~-~~~gg~lg~~~~~~---~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~~~ 156 (237)
T d1fnya_ 82 PATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY---FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPW 156 (237)
T ss_dssp TTSCCEEEEEEEEETTCCC-CCCGGGTTTCC------CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEEC
T ss_pred CCCCCCeeEEEEcCCCCCc-ccccCcccccCCCC---ccCccceEEEEeccccccCC-CCCCceEEEecCCCcccccccc
Confidence 7889999999999977544 46678899987543 34567889999999999774 9999999999999988776543
Q ss_pred ccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccC---cccc
Q 048419 160 SYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTG---LITA 236 (653)
Q Consensus 160 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg---~~~~ 236 (653)
++.+|+.++|||+|++.+++|.|++.+.+ ++..|+++..+||+.++|++|||||||+|| ...|
T Consensus 157 ------------~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e 222 (237)
T d1fnya_ 157 ------------NWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQ 222 (237)
T ss_dssp ------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCC
T ss_pred ------------cccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCccc
Confidence 46789999999999999999999998765 566789999999999999999999999999 4568
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|+||+|++.
T Consensus 223 ~H~I~sWsF~s~ 234 (237)
T d1fnya_ 223 TNDVLSWSFESN 234 (237)
T ss_dssp CCEEEEEEEEEE
T ss_pred ccEEEEeEeEEe
Confidence 999999999975
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=1.5e-49 Score=392.00 Aligned_cols=220 Identities=28% Similarity=0.469 Sum_probs=191.8
Q ss_pred CceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC-----CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCC
Q 048419 7 DTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS-----EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKY 79 (653)
Q Consensus 7 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~ 79 (653)
+++||+|++|+ .+||+|+|||.+.++|.|+||++. ..++|||||++||+||+.. .++||+|+|+|.|....
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~--~~~sF~t~f~f~i~~~~ 79 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT--TLASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS--CBCEEEEEEEEECCCSS
T ss_pred CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC--eeeeEEEEEEEEEeCCC
Confidence 57899999995 379999999999888999999865 3589999999999999864 57999999999998877
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccC
Q 048419 80 PDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPA 159 (653)
Q Consensus 80 ~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 159 (653)
...+||||||+|+|....+ +..|++||+++.... +..++.|||||||++|. +||++||||||+|++.+..+.+
T Consensus 80 ~~~~gDGlAF~l~~~~~~~-~~~gg~lGl~~~~~~---~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~~- 152 (233)
T d1n47a_ 80 AAAVADGLAFFLAPPDTQP-QARGGFLGLFADRAH---DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP- 152 (233)
T ss_dssp TTSCCEEEEEEEECTTCCC-CCCGGGTTTCSSSSC---CGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEE-
T ss_pred CCCCCCceEEEECCCCCCC-CCCCCccccccccCC---CCcCceEEEEEEeeecC--CCCCCCceeEccCCcccccccc-
Confidence 7789999999999977544 457789999876443 45577899999999997 7999999999999998876654
Q ss_pred ccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc---ccc
Q 048419 160 SYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITA 236 (653)
Q Consensus 160 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~---~~~ 236 (653)
+.+.+|+.++|||+|++.+++|.|++.... ++..|.++..+||+.+||++|||||||+||. ..|
T Consensus 153 -----------~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~ 219 (233)
T d1n47a_ 153 -----------FDMVYGEKANIVITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVE 219 (233)
T ss_dssp -----------CCCCTTSCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCC
T ss_pred -----------ceecCCCEEEEEEEEcCCCeEEEEEEEeCC--CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCccc
Confidence 357899999999999999999999998654 5777899999999999999999999999994 568
Q ss_pred eeeecceeeeec
Q 048419 237 SHNVHGWSISIG 248 (653)
Q Consensus 237 ~~~i~sWsf~~~ 248 (653)
.|+|++|+|++.
T Consensus 220 ~H~I~sWsFss~ 231 (233)
T d1n47a_ 220 THDIVSWSFAVS 231 (233)
T ss_dssp CCEEEEEEEEEE
T ss_pred ccEEEEEEeEEE
Confidence 999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-51 Score=419.74 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=214.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
.++|+..+.||+|+||+||+|.+..+++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+.+++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356888899999999999999999889999999986543 3467899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
|++|+|.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+||||++++++||+|||+++.....
T Consensus 95 ~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 95 MTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999997654 3568999999999999999999999 89999999999999999999999999999977654
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
.........|++.|+|||++.+..++.++|||||||++|||++|+.|+........ +.+.+.....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~~~~~------------ 234 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYR------------ 234 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCC------------
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHHhcCCC------------
Confidence 44444455689999999999999999999999999999999998777654332211 1112211110
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+....+.+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11112234678999999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=409.87 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=212.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.++++++|||||++++++.+.+.+++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999997665556778999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++......
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999987543 48999999999999999999999 999999999999999999999999999999765433
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......... +
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~----------~- 236 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATNGTPE----------L- 236 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHHCSCC----------C-
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH--HHHHhCCCCC----------C-
Confidence 2334567999999999999999999999999999999999999999765433211 1111111000 0
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..+......+.+|+.+||+.||.+|||+.|++++-
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 00112246688999999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=410.35 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=203.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|+||+||+|+++ ..||||+++.. ..+..+.|.+|+.++++++|||||++++++.+ +.+++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 56778899999999999999875 35999998644 45567889999999999999999999999865 46899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
||++|+|.+++.... ..+++.+++.++.||++||+|||+ ++|+||||||+||||+.++++||+|||+++....
T Consensus 84 y~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999997643 358999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCC-CcccccccCCcccCcccccc---CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 488 GAN-PQTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 488 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ +...+........
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~p~---- 230 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVGRGYLSPD---- 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHHTSCCCC----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCCCCCc----
Confidence 322 23345679999999999864 3478999999999999999999999986543322 1112222111111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+.......++.+.+|+.+||+.||.+|||++||+++|+.
T Consensus 231 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 231 ----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp ----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111222334678999999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=409.67 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=207.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|.++ ++..||||++.... ...+.|.+|++++++++|||||+++|+|.+ +.+++|||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46778899999999999999986 47889999996543 345789999999999999999999998865 5679999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.... ...++|.++++|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+++......
T Consensus 90 ~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999886654 3458999999999999999999999 999999999999999999999999999999876544
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
........||+.|+|||++.++.++.++|||||||++|||+||+.|+.......+ +...+.... . .
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~i~~~~---------~---~ 229 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGY---------R---M 229 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC---------C---C
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC---------C---C
Confidence 3444456789999999999999999999999999999999997666544332211 111111110 0 0
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+....+.+.+|+.+||+.||++||||.||++.|+
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 111123456889999999999999999999999886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=411.56 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=198.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc--cceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--QDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 405 (653)
++|+..+.||+|+||.||+|++..+|+.||||++... .....+.+.+|++++++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688999999999999999999999999999999654 34456778999999999999999999999865 4568999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC--NQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
||||++|+|.+++...... ...+++..++.++.||+.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999764321 456999999999999999999999832 1349999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ +...+.. +..
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i~~----~~~--- 231 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIRE----GKF--- 231 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH----TCC---
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHHHc----CCC---
Confidence 765432 22344689999999999999999999999999999999999999998654322 1111111 111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
...+....+.+.+|+.+||+.||.+|||+.|++++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11111234578899999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=406.16 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=209.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|++..+++.||||++... .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688899999999999999999999999999998643 2334567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||++|+|.+++... ..+++.++..++.||++||+|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999754 348999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ...
T Consensus 158 ~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~--~~~------- 222 (263)
T d2j4za1 158 SS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISRV--EFT------- 222 (263)
T ss_dssp CC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTT--CCC-------
T ss_pred CC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---HHHHHcC--CCC-------
Confidence 32 23446799999999999999999999999999999999999999976543221 1111110 000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.+....+.+.+|+.+||+.||.+|||++|++++
T Consensus 223 ----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 ----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111224568899999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=409.71 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=210.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
+.|+..+.||+|+||.||+|.+..+++.||||++........+.+.+|+++|++++|||||++++++.+.+.+++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45888999999999999999999999999999998777677788999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.+.. ..+++.++..++.||++||.|||+ ++|+||||||+|||++.++++||+|||+++......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999986542 458999999999999999999999 999999999999999999999999999997643211
Q ss_pred CCcccccccCCcccCccccc-----cCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 490 NPQTTHIVGTLGYLAPELTR-----TGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
.......||+.|+|||++. ...++.++|||||||++|||+||+.||........ +...... ..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i~~~-----~~---- 232 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKIAKS-----EP---- 232 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHHS-----CC----
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHHHcC-----CC----
Confidence 1223457999999999984 45688999999999999999999999976544321 1111111 00
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+.+ ..+......+.+|+.+||+.||.+|||+.|++++
T Consensus 233 -~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 -PTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -CCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001 0111234678899999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=397.83 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=212.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.++++++||||++++|+|.+.+.+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57888999999999999999986 578999999976543 4578999999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|..++.... ..+++..+++++.||++||.|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999976653 458899999999999999999999 899999999999999999999999999998765544
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+.. +. ++
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~----~~-------~~ 220 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQ----GL-------RL 220 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT----TC-------CC
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHh----CC-------CC
Confidence 444445678999999999999999999999999999999998 899998665432 1111111 10 00
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+....+.+.+|+.+||+.||++|||+.||+++|.
T Consensus 221 -~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 221 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 111123467899999999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=403.95 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=201.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC----cEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
+.|+..++||+|+||.||+|.++.++ ..||||++... .....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 45778999999999999999986544 47999999654 34445679999999999999999999999999999999
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
|||||.+++|.+++.... ..++|.++++++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999998876543 458999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......+ +.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~~~~------- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGF------- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC-------
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHhccC-------
Confidence 654322 122335689999999999999999999999999999999997666554332211 111211111
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
....+...+..+.+|+.+||+.||++||||.||+++|+..
T Consensus 231 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 231 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 0111223446789999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=402.58 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=205.5
Q ss_pred cCcCccee-eeeeCcEEEEEEEeCC--CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNL-VGSGGFGRVYRGLMPS--LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~-LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+. ||+|+||.||+|.++. ++..||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ +.++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555664 9999999999998753 3558999999754 44557889999999999999999999999965 468999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
||||++|+|.+++... +..+++.++++++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 87 mE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999998654 2458999999999999999999999 99999999999999999999999999999977
Q ss_pred cCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 486 EHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 486 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+.. +...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~~----~~~~- 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----GKRM- 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT----TCCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CCCC-
Confidence 543221 2233468899999999999999999999999999999998 899998654322 1122211 1111
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 232 -------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 232 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp -------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 111223467889999999999999999999999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=400.29 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=199.0
Q ss_pred eeeeeeCcEEEEEEEeCC--CCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEeccCC
Q 048419 336 NLVGSGGFGRVYRGLMPS--LGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 411 (653)
Q Consensus 336 ~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 411 (653)
++||+|+||+||+|.+.. .++.||||+++.. +....+.|.+|+++|++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 4578999999643 33446789999999999999999999999965 457899999999
Q ss_pred CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCCCC
Q 048419 412 GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGANP 491 (653)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 491 (653)
|+|.+++... ..++|.++++++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999998764 348999999999999999999999 89999999999999999999999999999876543322
Q ss_pred --cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhcc
Q 048419 492 --QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTL 568 (653)
Q Consensus 492 --~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 568 (653)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+.. +.. +
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~~----~~~-------~ 229 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK----GER-------M 229 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT----TCC-------C
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHHc----CCC-------C
Confidence 2233568999999999999999999999999999999998 899998654322 1122211 110 1
Q ss_pred CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 569 DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..+...+..+.+|+.+||+.||.+|||+++|+++|+
T Consensus 230 -~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 230 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 111223467889999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=394.23 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=199.8
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc----cceeEEEE
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK----QDELLLVY 406 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 406 (653)
+..+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4567899999999999999999999999998653 44556789999999999999999999999865 34689999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEEc-CCCcEEEEeecCcc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQR--VVHRDVKPSNILLD-TYLNAKLGDFGLAK 483 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGla~ 483 (653)
|||++|+|.+++... ..+++.+++.++.||++||+|||+ ++ |+||||||+||||+ +++.+||+|||+++
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999754 348999999999999999999999 66 99999999999996 57899999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
.... .......||+.|+|||++.+ +++.++|||||||++|||++|+.||........ +...+. .+.....
T Consensus 164 ~~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~----~~~~~~~ 233 (270)
T d1t4ha_ 164 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT----SGVKPAS 233 (270)
T ss_dssp GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT----TTCCCGG
T ss_pred eccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHH----cCCCCcc
Confidence 6433 22345689999999999865 699999999999999999999999975433221 111111 1111111
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+++ ...+.+.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~-------~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FDK-------VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGG-------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCc-------cCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111 123468899999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=411.22 Aligned_cols=265 Identities=25% Similarity=0.340 Sum_probs=208.8
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|+..+.||+|+||+||+|++..+|+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+.+.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999999999999999999754 34445788999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
||++|+|.+++.+. ..+++..+..++.|++.||.|||+. ++|+||||||+||||+.++++||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999754 3489999999999999999999971 3899999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHH-HHHHHh-------------
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLL-VDWVKE------------- 553 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~------------- 553 (653)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........... ......
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 22345899999999999999999999999999999999999999976443211100 000000
Q ss_pred ---------hhcccchhHhhhhccCc----C-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 554 ---------LHLEGEITQAIDQTLDY----Y-DLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 554 ---------~~~~~~~~~~~d~~l~~----~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
........+..+..... . .......+.+++.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000111100000 0 00123568899999999999999999999985
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=1.4e-47 Score=380.87 Aligned_cols=224 Identities=25% Similarity=0.404 Sum_probs=194.0
Q ss_pred CceeEEeCCCCC--CCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 7 DTTSFLYNGFLH--ANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 7 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
+++||+|++|.+ +||+|+|||.+. ++.|+||++. .+++|||+|++||+||++.+++++||+|+|+|.|..+
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~ 80 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSP 80 (241)
T ss_dssp CEEEEEESSCCSCCSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECS
T ss_pred ccEEEEeCCCCCCCCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecC
Confidence 679999999954 789999999996 7889999864 4689999999999999999999999999999999765
Q ss_pred CCCCCCCceEEEEecCC-CCCCCCCCccccCCCcccCCCCCCCCceEEEEeeccccccc--CCCCCCeeeEecCCCCcCC
Q 048419 79 YPDLGGQGLAFIIISTN-RPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTEL--IDINDNHVGIDISSLISSA 155 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~-~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~--~d~~~~Hvgid~ns~~s~~ 155 (653)
. ..+|||+|||+.+.. ..+...+|+++|+++.... .+...++.+||||||++|.+. +||+++|||||+|++.|.+
T Consensus 81 ~-~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~-~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~ 158 (241)
T d1ukga_ 81 L-SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTA-QNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVK 158 (241)
T ss_dssp S-SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGT-TCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSE
T ss_pred C-CCCCCceEEEEeCCCCCcccccCcccccccccccc-cCCccCcccceeccCEecCccCCCCCCCccEeeecCCccccc
Confidence 3 458999999999765 4466777888888876543 245678899999999998654 4689999999999999876
Q ss_pred cccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCccc
Q 048419 156 SEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLIT 235 (653)
Q Consensus 156 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~ 235 (653)
... .++.+|+.++|||+|++.+++|+|++... ++..|.+++.|||+.+|+++||||||||||...
T Consensus 159 ~~~------------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~---~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~ 223 (241)
T d1ukga_ 159 TVK------------WDRRDGQSLNVLVTFNPSTRNLDVVATYS---DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQY 223 (241)
T ss_dssp EEE------------CCCCTTCCEEEEEEEETTTTEEEEEEEET---TCCEEEEEEECCGGGTSCSEEEEEEEEEESSSC
T ss_pred ccc------------cccCCCcEEEEEEEEeCCCcEEEEEEccC---CCCceEEEEEEehHHhCCCcEEEEEEEecCCCC
Confidence 543 35689999999999999999999999874 466788999999999999999999999999999
Q ss_pred ceeeecceeeeec
Q 048419 236 ASHNVHGWSISIG 248 (653)
Q Consensus 236 ~~~~i~sWsf~~~ 248 (653)
|.|+|++|+|++.
T Consensus 224 ~~H~IlsWsFss~ 236 (241)
T d1ukga_ 224 QTHTLESWSFTST 236 (241)
T ss_dssp CEEEEEEEEEEEE
T ss_pred ceeEEEEeEEEEE
Confidence 9999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=403.89 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=206.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+.+++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999999989999999998643 2334577999999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.+.
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999998764 348999999999999999999999 999999999999999999999999999999775
Q ss_pred CCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 487 HGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 487 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. .+..
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~----~~~~----- 227 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKII----KLEY----- 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----TTCC-----
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHHHH----cCCC-----
Confidence 4322 23344679999999999999999999999999999999999999998654322 111111 1110
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVE 602 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (653)
.++....+.+.+|+.+||+.||.+|||++|+++
T Consensus 228 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 011122456889999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=399.90 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=202.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
++|+..+.||+|+||.||+|.++. +..||||++.... ...+.|.+|+.++++++|+|||+++|+|.+ +..++|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 468889999999999999999975 4679999996443 345789999999999999999999999965 5689999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|..++.... ...++|.+++.++.||++||+|||+ ++|+||||||+||||+.++++||+|||+++......
T Consensus 94 ~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999987653 3459999999999999999999999 899999999999999999999999999998775544
Q ss_pred CCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhccC
Q 048419 490 NPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQTLD 569 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 569 (653)
........||+.|+|||++....++.++|||||||++|||+||+.|+.......+ +...+..... .
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~~~~------------~ 233 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR------------M 233 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC------------C
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcCC------------C
Confidence 4444456789999999999999999999999999999999998777654433221 1222221110 0
Q ss_pred cCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 570 YYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
..+....+.+.+++.+||+.||++||+|.+|+++|+.-
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 11122346788999999999999999999999999763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=408.50 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=207.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC-----cEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG-----LEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
++|+..++||+|+||+||+|++...+ ..||||.+... .......+.+|+.++.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 56888999999999999999976543 36999998654 334456789999999998 899999999999999999
Q ss_pred EEEEeccCCCCchhhhhccccc------------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK------------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPS 464 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 464 (653)
++|||||++|+|.++|...... ....++|..++.++.||++||+|||+ ++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 9999999999999999765321 12358999999999999999999999 89999999999
Q ss_pred cEEEcCCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhh
Q 048419 465 NILLDTYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAA 542 (653)
Q Consensus 465 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~ 542 (653)
|||++.++++||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544332 2234568999999999999999999999999999999998 89999764432
Q ss_pred hHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 543 AELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 543 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. +...+..... + ..+....+.+.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~--~~~~~~~~~~-----------~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN--FYKLIQNGFK-----------M-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH--HHHHHHTTCC-----------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHHHHhcCCC-----------C-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1122211110 0 111223467899999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-48 Score=406.73 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=213.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
-++|+..+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999999999999999999877666778899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCcEEEEeecCccccc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD--TYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~ 486 (653)
|++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||+++...
T Consensus 105 ~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999986542 358999999999999999999999 9999999999999995 46789999999998765
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+... .........
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~--~~~~~~~~~- 249 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSC--DWNMDDSAF- 249 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHT--CCCSCCGGG-
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHhC--CCCCCcccc-
Confidence 432 33446899999999999999999999999999999999999999986543221 1111111 001110000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
....+.+.+|+.+||+.||.+|||++|++++-
T Consensus 250 ------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 250 ------SGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp ------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred ------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 11235688999999999999999999999973
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-49 Score=404.25 Aligned_cols=247 Identities=30% Similarity=0.393 Sum_probs=204.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
+.|+..+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999999999999999997543 344567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||++|+|..++... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999997766543 458999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCcccccc---CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRT---GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..... +..
T Consensus 167 ~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~--~~i~~-----~~~--- 231 (309)
T d1u5ra_ 167 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQ-----NES--- 231 (309)
T ss_dssp S-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHH-----SCC---
T ss_pred C-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHh-----CCC---
Confidence 3 234579999999999864 45899999999999999999999999765432211 11110 000
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
+.+ ......+.+.+|+.+||+.||.+|||+.|++++
T Consensus 232 --~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 --PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --CCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 011224678899999999999999999999984
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-49 Score=406.09 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=195.2
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
+.+.|+..+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.++|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999999999999999997543 233456789999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEEeecCcc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD---TYLNAKLGDFGLAK 483 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~ 483 (653)
|||++|+|.++|... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++
T Consensus 87 E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred eccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999764 358999999999999999999999 9999999999999994 57899999999998
Q ss_pred cccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHh
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQA 563 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 563 (653)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+.... ....
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~--~~~~-- 229 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILKAE--YEFD-- 229 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHTTC--CCCC--
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHhccC--CCCC--
Confidence 654332 2334679999999999999999999999999999999999999998654322 111111110 0000
Q ss_pred hhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 564 IDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 564 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
........+.+.+|+.+||+.||.+|||+.|++++-
T Consensus 230 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 230 -----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred -----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 001112246788999999999999999999999963
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-47 Score=402.73 Aligned_cols=255 Identities=21% Similarity=0.255 Sum_probs=213.5
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
-++|+..+.||+|+||.||+|.+..+|+.||||++........+.+.+|+++|++|+|||||++++++.+.+.++|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999999989999999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCcEEEEeecCccccc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD--TYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~ 486 (653)
|++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||+++...
T Consensus 108 ~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 108 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998876542 358999999999999999999999 9999999999999997 67899999999999775
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...+.... ....
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~--~~~~----- 248 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRCD--WEFD----- 248 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHCC--CCCC-----
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC--CCCC-----
Confidence 432 33446799999999999999999999999999999999999999986544321 11111110 0000
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..........+.+|+.+||+.||.+|||+.|++++-
T Consensus 249 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 249 --EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp --SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 001112245688999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=393.83 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=210.6
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc------hhhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS------QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
..++|+..+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3568999999999999999999999999999999986432 2236789999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----cEEEE
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL----NAKLG 477 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 477 (653)
++||||||++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 99999999999999999764 358999999999999999999999 9999999999999998776 49999
Q ss_pred eecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+... .
T Consensus 160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~~~--~ 232 (293)
T d1jksa_ 160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVSAV--N 232 (293)
T ss_dssp CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHTT--C
T ss_pred chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HHHHHhc--C
Confidence 999998765432 23345789999999999998999999999999999999999999986543321 1111111 0
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
........+ .....+.+|+.+||+.||.+|||++|++++-
T Consensus 233 ~~~~~~~~~-------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 233 YEFEDEYFS-------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp CCCCHHHHT-------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CCCCchhcC-------CCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 011111111 1235688999999999999999999999853
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-47 Score=393.32 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=207.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.++++++|||||++++++.+.+.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999999999999999999643 2344678999999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999999887643 47888889999999999999999 999999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. +.
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~----~~------- 217 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILN----AE------- 217 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHH----CC-------
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---HHHHHc----CC-------
Confidence 32 2346899999999999999999999999999999999999999986543221 111110 10
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (653)
. ..+......+.+++.+||+.||.+|| |++|++++
T Consensus 218 -~-~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 -L-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -C-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -C-CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0 01112235688999999999999996 99999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=393.54 Aligned_cols=249 Identities=27% Similarity=0.336 Sum_probs=209.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|++..+|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5689999999999999999999999999999999653 2344677899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
|||++|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999998764 348889999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... +...+.. +.+
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~~----~~~------ 222 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILM----EEI------ 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----CCC------
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHhc----CCC------
Confidence 322 23345689999999999999999999999999999999999999998765432 1111111 100
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 603 (653)
.++......+.+|+.+||+.||.+||+ +.|++++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111122456789999999999999995 8889875
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.6e-47 Score=376.53 Aligned_cols=218 Identities=28% Similarity=0.430 Sum_probs=193.8
Q ss_pred cCceeEEeCCCCCCCeEEecceEecCCCcEEecCC---CCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCC
Q 048419 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNK---SEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDL 82 (653)
Q Consensus 6 ~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~---~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~ 82 (653)
++++||+|+.|+..||+|+|||++.++|.|+||+. ..+++|||+|++||+||++.++.++||+|+|+|.|.+.+...
T Consensus 1 ~~~~sf~f~~F~~~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~~~~ 80 (226)
T d1avba_ 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIEN 80 (226)
T ss_dssp CEEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTS
T ss_pred CCceEEECCCCCccceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCCCCC
Confidence 35789999999999999999999988899999964 457899999999999999999999999999999999887788
Q ss_pred CCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccc
Q 048419 83 GGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYY 162 (653)
Q Consensus 83 ~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 162 (653)
+||||||+|+|....+ +..|+++|+++. ++|||||+.|...+|+..||||||+|+..+..+.+..
T Consensus 81 ~gDG~aF~i~~~~~~~-g~~gg~~gl~~~------------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~~-- 145 (226)
T d1avba_ 81 SAYGLAFALVPVGSRP-KLKGRYLGLFNT------------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCN-- 145 (226)
T ss_dssp CCEEEEEEEEETTCCC-CCCGGGTTTCSC------------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEECC--
T ss_pred CCceEEEEEccCCCCC-CCccccCCcccc------------ccccccceeccccccCCCCEEEEeCCCCccccccccc--
Confidence 9999999999987544 467788999753 4799999999777899999999999999887776543
Q ss_pred cCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCc---ccceee
Q 048419 163 SGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGL---ITASHN 239 (653)
Q Consensus 163 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~---~~~~~~ 239 (653)
..+.+|+.++|||+|++.+++|+|++...+ ++..|.++..+||+.+||++|||||||+||. ..|.|+
T Consensus 146 --------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~ 215 (226)
T d1avba_ 146 --------FGHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHN 215 (226)
T ss_dssp --------SGGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEE
T ss_pred --------cccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeE
Confidence 367899999999999999999999998765 5777889999999999999999999999995 467899
Q ss_pred ecceeeeec
Q 048419 240 VHGWSISIG 248 (653)
Q Consensus 240 i~sWsf~~~ 248 (653)
|+||+|++.
T Consensus 216 IlsWsF~s~ 224 (226)
T d1avba_ 216 VLSWSFSSN 224 (226)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEeEEe
Confidence 999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=389.57 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=196.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..+.||+|+||.||+|.+..+ +..||||.++.. .....+.|.+|+.++++++|||||+++++|. .+.+++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 5688899999999999999998643 357999998654 4445678999999999999999999999996 4678999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
|||+++|+|.+++.... ..+++.+++.++.||++||.|||+ ++|+||||||+||++++++.+||+|||+++..
T Consensus 86 ~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999876543 458999999999999999999999 99999999999999999999999999999877
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAI 564 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 564 (653)
............||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+.. +..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~----~~~---- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN----GER---- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT----TCC----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----CCC----
Confidence 6544444555678999999999999999999999999999999998 888887654432 1111211 110
Q ss_pred hhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 565 DQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 565 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+...++.+.+|+.+||+.||.+|||+.||+++|+.
T Consensus 228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 01112234678999999999999999999999998853
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=3.1e-47 Score=374.81 Aligned_cols=216 Identities=29% Similarity=0.455 Sum_probs=185.8
Q ss_pred cCceeEEeCCCCC-CCeEEecceEecCCCcEEecCCCC------CceEEEEcCCCeecccCCCCceeeeEEEEEEEEecC
Q 048419 6 ADTTSFLYNGFLH-ANLSLEGAAYISTSGILTVTNKSE------GLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPK 78 (653)
Q Consensus 6 ~~~~~f~~~~f~~-~~l~~~g~a~~~~~g~l~Lt~~~~------~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~ 78 (653)
|+.++|+|++|+. .+|+|+|||++.++|.|+||+... +++|||+|++||+||+ +++++||+|+|+|.|.+.
T Consensus 1 a~~~sF~f~~F~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~--~~~~~sFst~F~f~i~~~ 78 (228)
T d1ioaa_ 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD--SNNVASFNTNFTFIIRAK 78 (228)
T ss_dssp CCCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC--SSCBEEEEEEEEEECCBS
T ss_pred CccceEEcCCCCCCCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC--CCceeeEEEEEEEEEecC
Confidence 4678999999975 469999999998889999998653 5789999999999997 467999999999999988
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCccc
Q 048419 79 YPDLGGQGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEP 158 (653)
Q Consensus 79 ~~~~~gdGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 158 (653)
+...+||||||+|+|.+..+ +..|++||+++... ++..++.|||||||+.|. +|++.+||++++++..
T Consensus 79 ~~~~~gDGlAF~l~~~~~~~-~~~g~~lgl~~~~~---~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~------ 146 (228)
T d1ioaa_ 79 NQSISAYGLAFALVPVNSPP-QKKQEFLGIFNTNN---PEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENC------ 146 (228)
T ss_dssp CTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCCSS---CCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEEC------
T ss_pred CCCCCCCEEEEEEeCCCCCC-CCCccccccccccC---CCCcceeEEEEecCcccc--ccCCCCccceeccccc------
Confidence 77789999999999987544 45778999987643 355678899999999986 6888888888876422
Q ss_pred CccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccC---ccc
Q 048419 159 ASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTG---LIT 235 (653)
Q Consensus 159 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg---~~~ 235 (653)
...+.+|+.++|||+||+.+++|+|++.... +|..|.++..+||+++||++|||||||||| ...
T Consensus 147 -----------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~ 213 (228)
T d1ioaa_ 147 -----------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTT 213 (228)
T ss_dssp -----------CHHHHCSSCEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTC
T ss_pred -----------ccccccCcEEEEEEEEcCCCCEEEEEEEeCC--CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCc
Confidence 2356799999999999999999999998754 677889999999999999999999999999 456
Q ss_pred ceeeecceeeeec
Q 048419 236 ASHNVHGWSISIG 248 (653)
Q Consensus 236 ~~~~i~sWsf~~~ 248 (653)
|.|+|++|+|++.
T Consensus 214 ~~h~I~sWsFss~ 226 (228)
T d1ioaa_ 214 ETHDVLSWSFSSK 226 (228)
T ss_dssp BCCEEEEEEEEEE
T ss_pred eEEEEEEEEeEEe
Confidence 8999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-48 Score=396.50 Aligned_cols=261 Identities=23% Similarity=0.358 Sum_probs=210.4
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccCc-hhhHHHHHHHHHHHhhcCCCceeeeeeeecccce
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHNS-QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDE 401 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 401 (653)
-.++|+..+.||+|+||+||+|+..+ +++.||||++.... .+..+.|.+|++++++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45679999999999999999999753 46789999997543 3446789999999999999999999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccc-------------------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDH-------------------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVK 462 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 462 (653)
.++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ ++|+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 9999999999999999975321 112348899999999999999999999 999999999
Q ss_pred CCcEEEcCCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCC-CCCChhh
Q 048419 463 PSNILLDTYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR-RSIEPQK 540 (653)
Q Consensus 463 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~-~p~~~~~ 540 (653)
|+||||+.++++||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. .||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999986543322 2233457889999999999999999999999999999999996 5666544
Q ss_pred hhhHHHHHHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 541 AAAELLLVDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 541 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+ +...+.. +... ..+...+.++.+|+.+||+.||.+||||.||+++|+.
T Consensus 248 ~~e---~~~~v~~----~~~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 248 HEE---VIYYVRD----GNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp HHH---HHHHHHT----TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH---HHHHHHc----CCCC--------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 322 1122221 1111 1112234578899999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=395.47 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=202.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc----EEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL----EVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 404 (653)
.+|+..++||+|+||+||+|.+..+|+ .||||++... ..+..++|.+|++++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 358889999999999999999877665 5899988643 445678899999999999999999999999875 4678
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
++||+.+|+|.+++... ...+++..+++++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 88 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeecccccee
Confidence 88999999999988765 3458999999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 485 YEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 485 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||....... +...+....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~~~------- 230 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGE------- 230 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHHTC-------
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC-------
Confidence 6543332 2334568999999999999999999999999999999998 788887654322 111111110
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
++ ..+......+.+|+.+||+.||.+|||+.||+++|+.
T Consensus 231 ----~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 231 ----RL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ----CC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CC-CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 00 1112234678899999999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=385.43 Aligned_cols=248 Identities=30% Similarity=0.390 Sum_probs=196.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecc-cceeEEEEec
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QDELLLVYDY 408 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~ 408 (653)
++|+..+.||+|+||.||+|.++ |..||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35677899999999999999985 688999999643 345789999999999999999999999865 4568999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCC
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHG 488 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 488 (653)
+++|+|.++|.... ...++|..+++|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999997653 3468999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhhc
Q 048419 489 ANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQT 567 (653)
Q Consensus 489 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 567 (653)
.....++..|+|||++.+..++.++|||||||++|||+| |+.|+......+ +.+++.. +..
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~----~~~------- 218 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK----GYK------- 218 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT----TCC-------
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----CCC-------
Confidence 233467899999999999999999999999999999998 677776543321 2222211 110
Q ss_pred cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 568 LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 568 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
...+......+.+|+.+||+.||.+||||.+|+++|+.
T Consensus 219 -~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 219 -MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11122234678899999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-46 Score=391.82 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=208.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 406 (653)
++|+..+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999999999999999998643 2334567899999999999999999999999999999999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYE 486 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 486 (653)
||+.+|+|..++... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999999764 348999999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... +...+... .
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~----~------- 254 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVSG----K------- 254 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC----C-------
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHhcC----C-------
Confidence 32 234679999999999999999999999999999999999999998654322 11111110 0
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCC-----CCHHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYR-----PDMRRVVEFL 604 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~R-----Ps~~evl~~L 604 (653)
. ..+......+.+++.+||+.||.+| ||+.|++++-
T Consensus 255 -~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 255 -V-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -C-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -C-CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 0 0111234568899999999999999 4999999743
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-46 Score=381.18 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=203.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc----e
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----E 401 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 401 (653)
.++|+..+.||+|+||.||+|.+..+|+.||||++... ..+..+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999999989999999999654 3344567999999999999999999999987654 3
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
+|||||||++++|.+++... ..+++.+++.++.||++||+|||+ ++|+||||||+|||++.++..+|+|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence 79999999999999988654 358999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCC--CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 482 AKIYEHGAN--PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 482 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
+........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. +...+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~~~~~---~~~ 232 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRE---DPI 232 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHC---CCC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--HHHHHhc---CCC
Confidence 876543322 233446799999999999998999999999999999999999999986543321 1111111 111
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHc
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-DMRRVVEFLL 605 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~ 605 (653)
...... ...++.+.+++.+||+.||.+|| |++++++.|.
T Consensus 233 ~~~~~~-------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 233 PPSARH-------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp CGGGTS-------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCchhc-------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 111111 11246788999999999999999 8999988774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-46 Score=379.79 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=207.4
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch---------hhHHHHHHHHHHHhhcC-CCceeeeeeeeccc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ---------QGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQ 399 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 399 (653)
++|+..+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 678899999999999999999998999999999865421 12346889999999997 99999999999999
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
+..|||||||++|+|.++|... ..+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999754 358999999999999999999999 99999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCcccccc------CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHh
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRT------GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 553 (653)
|+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...+..
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---~~~i~~ 229 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIMS 229 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---HHHHHh
Confidence 9999765432 2344679999999998853 3468899999999999999999999987654321 111111
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
.. ..... + .....++.+.+|+.+||+.||.+|||+.||+++
T Consensus 230 ~~--~~~~~---~----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GN--YQFGS---P----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TC--CCCCT---T----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC--CCCCC---c----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 00000 0 011234678899999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=386.16 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=201.9
Q ss_pred ceeeeeeCcEEEEEEEeCCCC---cEEEEEEecc-CchhhHHHHHHHHHHHhhcCCCceeeeeeeecc-cceeEEEEecc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLG---LEVAIKRIGH-NSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK-QDELLLVYDYV 409 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 409 (653)
.++||+|+||+||+|.+..++ ..||||+++. ......++|.+|+++|++++||||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 568999999999999986543 3699999975 355567889999999999999999999999875 45789999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
++|+|.+++.... ..+++..+++++.|+++||.|||+ ++|+||||||+||||++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999987653 457888999999999999999999 999999999999999999999999999998765432
Q ss_pred CC---cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 490 NP---QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 490 ~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.|+....... .+..++.. +..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~----g~~------ 252 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ----GRR------ 252 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TCC------
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc----CCC------
Confidence 22 2234578999999999999999999999999999999999888876533211 11122211 110
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+ ..+....+.+.+|+.+||+.||++||+|.||+++|+.
T Consensus 253 -~-~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 253 -L-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp -C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -C-CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 0111224578899999999999999999999999965
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=390.88 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=204.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCc--EEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGL--EVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 405 (653)
++|+..++||+|+||.||+|++..+|. .||||++... ..+..+.|.+|+++|+++ +|||||+++|+|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999999987776 4778887543 444567899999999999 799999999999999999999
Q ss_pred EeccCCCCchhhhhcccc-----------cccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 406 YDYVPNGSLDKLLFDKDH-----------KLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
|||+++|+|.++|+.... .....++|.++++++.|||+||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 999999999999976521 123568999999999999999999999 899999999999999999999
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCC-CCChhhhhhHHHHHHHHHh
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRR-SIEPQKAAAELLLVDWVKE 553 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~ 553 (653)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||....... +.+.+..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGGG
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHHHh
Confidence 999999998654322 2233468999999999999999999999999999999999765 565443221 1111111
Q ss_pred hhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 554 LHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 554 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
+. + ...+....+.+.+|+.+||+.||++||||.||+++|+.
T Consensus 242 ----~~-------~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 242 ----GY-------R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp ----TC-------C-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cC-------C-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 10 0 01112234678999999999999999999999998865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=388.44 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=205.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC---chhhHHHHHHHHHHHh-hcCCCceeeeeeeecccceeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN---SQQGMKEFVAEIMSMG-RLRHRNLVQLHGWCRKQDELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 405 (653)
++|...+.||+|+||+||+|++..+|+.||||++.+. ..+..+.+..|..++. .++|||||++++++.+.+.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788999999999999999999999999999999643 2334566777777665 68999999999999999999999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccc
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIY 485 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 485 (653)
||||++|+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 99999999999997643 48889999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAID 565 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 565 (653)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+.. ....
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~--~~~~------ 221 (320)
T d1xjda_ 154 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRM--DNPF------ 221 (320)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH--CCCC------
T ss_pred cccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHc--CCCC------
Confidence 4332 23344679999999999999999999999999999999999999998654432 1111111 0001
Q ss_pred hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 048419 566 QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMR-RVVE 602 (653)
Q Consensus 566 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 602 (653)
++......+.+|+.+||+.||.+||++. |+++
T Consensus 222 -----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 -----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1112245688999999999999999995 7764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=383.35 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=197.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCC---CcEEEEEEeccC---chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSL---GLEVAIKRIGHN---SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|+..+.||+|+||.||+|++... ...||||++... ..+..+.|.+|+.+|++++||||++++|+|.+. ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 4688899999999999999986432 347899998653 344567899999999999999999999999764 678
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|||||++|+|.+++.... ..+++..+++++.|||+||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 9999999999999887643 459999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCC--cccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHHHHHHHhhhcccch
Q 048419 484 IYEHGANP--QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLLVDWVKELHLEGEI 560 (653)
Q Consensus 484 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 560 (653)
........ ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||......+ ...++... +..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~~~---~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKE---GER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTS---CCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHHhC---CCC
Confidence 76544322 2233467889999999999999999999999999999998 899997654432 11222211 100
Q ss_pred hHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
. ......+..+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 234 ~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 L--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0 0111223568899999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=385.65 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=198.2
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccc-ce
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQ-DE 401 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 401 (653)
++|+..+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|...+.++ +|+||+++++++.+. +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 568889999999999999999643 3468999999654 344567788898888887 689999999998665 46
Q ss_pred eEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT 470 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 470 (653)
+++|||||++|+|.++|...... ....+++.+++.++.||++||+|||+ ++|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 89999999999999999765321 13458999999999999999999999 99999999999999999
Q ss_pred CCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCC-CCCChhhhhhHHHHH
Q 048419 471 YLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR-RSIEPQKAAAELLLV 548 (653)
Q Consensus 471 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~-~p~~~~~~~~~~~l~ 548 (653)
++++||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||. .||........ +.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence 99999999999987654332 2334467999999999999999999999999999999999975 56654332211 11
Q ss_pred HHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 549 DWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 549 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
..+.. +... ..+....+.+.+++.+||+.||.+|||+.||+++|+.
T Consensus 248 ~~~~~----~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 248 RRLKE----GTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHH----TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhc----CCCC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111 1100 1111234568899999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-46 Score=391.12 Aligned_cols=250 Identities=23% Similarity=0.263 Sum_probs=201.6
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc---hhhHHHHH---HHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS---QQGMKEFV---AEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|+..++||+|+||.||+|++..+|+.||||++.... .+....+. .|+.+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999999999999999985431 12223333 4467778888999999999999999999
Q ss_pred EEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcc
Q 048419 404 LVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAK 483 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 483 (653)
+|||||++|+|.++|... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999764 347889999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhH
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQ 562 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 562 (653)
..... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+. .. ....
T Consensus 156 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~-~~~~---- 224 (364)
T d1omwa3 156 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RM-TLTM---- 224 (364)
T ss_dssp ECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HH-SSSC----
T ss_pred ecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-cccC----
Confidence 76543 2344579999999999865 46899999999999999999999999764432211110 00 0000
Q ss_pred hhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048419 563 AIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPD-----MRRVVEF 603 (653)
Q Consensus 563 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 603 (653)
....+....+.+.+|+.+||+.||.+||| +.|++++
T Consensus 225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00111123456889999999999999999 6888864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=386.97 Aligned_cols=253 Identities=18% Similarity=0.243 Sum_probs=209.1
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEec
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDY 408 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 408 (653)
-++|...+.||+|+||+||+|.+..+++.||||+++.... ....+.+|+++|++++|||||++++++.+.+.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4678999999999999999999999999999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCcEEEEeecCccccc
Q 048419 409 VPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT--YLNAKLGDFGLAKIYE 486 (653)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~ 486 (653)
|++|+|.+++.... ..+++.+++.++.||++||+|||+ ++|+||||||+|||++. ...+||+|||+++...
T Consensus 83 ~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999997643 348999999999999999999999 99999999999999975 4589999999998764
Q ss_pred CCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccchhHhhhh
Q 048419 487 HGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEITQAIDQ 566 (653)
Q Consensus 487 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 566 (653)
.. .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+. ...+... .........+
T Consensus 156 ~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~~~i~~~--~~~~~~~~~~ 228 (321)
T d1tkia_ 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMNA--EYTFDEEAFK 228 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHT--CCCCCHHHHT
T ss_pred cC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhC--CCCCChhhcc
Confidence 32 233446789999999999999999999999999999999999999986554321 1111110 0111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 567 TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 567 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. ....+.+|+.+||+.||.+|||+.|++++
T Consensus 229 ~-------~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 E-------ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp T-------SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-------CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 13568899999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=380.39 Aligned_cols=259 Identities=25% Similarity=0.301 Sum_probs=199.3
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchh-----hHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEecc
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQ-----GMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 409 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 409 (653)
.++||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++.+++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999999999999999998654322 1346889999999999999999999999999999999999
Q ss_pred CCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccCCC
Q 048419 410 PNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEHGA 489 (653)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 489 (653)
+++++..++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 98877766543 2458899999999999999999999 999999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--ccchhHhh--
Q 048419 490 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--EGEITQAI-- 564 (653)
Q Consensus 490 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~-- 564 (653)
. ......||+.|+|||++... .++.++|||||||++|||++|+.||......+... ........ ........
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~--~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTTTSSSTTSS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH--HHHHhcCCCChhhccchhcc
Confidence 2 22345799999999998654 57999999999999999999999997655433221 11111000 00000000
Q ss_pred -h----hccCcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 565 -D----QTLDYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 565 -d----~~l~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
. ......+. ...+.+.+|+.+||+.||.+|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp 281 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence 0 00001111 1236789999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=385.45 Aligned_cols=261 Identities=22% Similarity=0.358 Sum_probs=210.8
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCC-----CCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPS-----LGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELL 403 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 403 (653)
++|...+.||+|+||+||+|.+.. .++.||||+++.. ..+....|.+|++++++++||||++++++|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 567778999999999999998752 3578999999754 4445567999999999999999999999999999999
Q ss_pred EEEeccCCCCchhhhhccccc-----ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEe
Q 048419 404 LVYDYVPNGSLDKLLFDKDHK-----LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGD 478 (653)
Q Consensus 404 lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 478 (653)
+|||||++|+|.+++...... ....+++.++.+++.|+|+||.|||+ ++|+||||||+||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999998764321 12346889999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCC-CCCChhhhhhHHHHHHHHHhhhc
Q 048419 479 FGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGR-RSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 479 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+ .|+........ ...+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---~~~i~---- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRFVM---- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHHHH----
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----
Confidence 999987644322 2233446899999999999999999999999999999999985 66654433221 11111
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCCC
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGDS 608 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (653)
.+... ..+......+.+|+.+||+.||.+||||.||+++|+...
T Consensus 250 ~~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 EGGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hCCCC--------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111 111123467999999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=382.43 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=205.9
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCC-------cEEEEEEeccCc-hhhHHHHHHHHHHHhhc-CCCceeeeeeeecccc
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLG-------LEVAIKRIGHNS-QQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQD 400 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 400 (653)
++|...+.||+|+||.||+|+....+ ..||||++.... .....++.+|...+.++ +|||||+++++|.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46777899999999999999875433 479999997653 34567899999999998 8999999999999999
Q ss_pred eeEEEEeccCCCCchhhhhccccc-----------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHK-----------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
..++|||||++|+|.++|...... ....+++.++++++.||++||+|||+ ++|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 999999999999999999765321 13458999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHh-CCCCCChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGAN-PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVAC-GRRSIEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 547 (653)
.++.+||+|||+++....... .......|++.|+|||.+.++.++.++|||||||++|||++ |+.||....... +
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---H
Confidence 999999999999997755432 23344578999999999999999999999999999999998 677876544321 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.+.. +... ..+......+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 247 ~~~i~~----~~~~--------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 247 FKLLKE----GHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HHHHHT----TCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHc----CCCC--------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 122211 1100 1111234678999999999999999999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=386.92 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=205.8
Q ss_pred hcCcCcc-eeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhc-CCCceeeeeeeecc----ccee
Q 048419 329 TKGFGEQ-NLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRK----QDEL 402 (653)
Q Consensus 329 t~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 402 (653)
-++|.+. ++||+|+||+||+|++..+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3578776 4699999999999999989999999998542 4567899887655 89999999998865 4678
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCcEEEEee
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT---YLNAKLGDF 479 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 479 (653)
|+|||||+||+|.++|.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccc
Confidence 99999999999999997653 3469999999999999999999999 99999999999999975 567999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...+......+.
T Consensus 159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~ 233 (335)
T d2ozaa1 159 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ 233 (335)
T ss_dssp TTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS
T ss_pred ceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCC
Confidence 9998765432 23446799999999999999999999999999999999999999976543211 000111000000
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HcCCCCCCCCC
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF--LLGDSSLPPLP 614 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~p~~p 614 (653)
.. . + ........+.+.+|+.+||+.||.+|||+.|++++ +......|..|
T Consensus 234 ~~-~--~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~ 285 (335)
T d2ozaa1 234 YE-F--P--NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285 (335)
T ss_dssp SS-C--C--TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred CC-C--C--CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence 00 0 0 00001234678999999999999999999999985 44444454443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-46 Score=383.14 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=209.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeC-----CCCcEEEEEEeccC-chhhHHHHHHHHHHHhhc-CCCceeeeeeeeccccee
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMP-----SLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRL-RHRNLVQLHGWCRKQDEL 402 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 402 (653)
++|+..++||+|+||.||+|++. .+++.||||+++.. .......|.+|+.+++++ +|||||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57788999999999999999863 45678999999764 344566799999999999 699999999999999999
Q ss_pred EEEEeccCCCCchhhhhccccc-------------ccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHK-------------LRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD 469 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 469 (653)
++|||||++|+|.+++...... ....+++..+.+++.||++||+|||+ ++++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 9999999999999999765321 12358999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCC-cccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCC-CChhhhhhHHHH
Q 048419 470 TYLNAKLGDFGLAKIYEHGANP-QTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRS-IEPQKAAAELLL 547 (653)
Q Consensus 470 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p-~~~~~~~~~~~l 547 (653)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+|++.| +........ +
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~ 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--F 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--H
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 9999999999999976544332 23446789999999999999999999999999999999995555 443322111 1
Q ss_pred HHHHHhhhcccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 548 VDWVKELHLEGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
.+.+..... ...+......+.+|+.+||+.||.+||||.||+++|+.
T Consensus 258 ~~~i~~~~~------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 258 YKMIKEGFR------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCCC------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 122211110 01111234678999999999999999999999999974
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7e-45 Score=351.46 Aligned_cols=199 Identities=25% Similarity=0.428 Sum_probs=166.4
Q ss_pred cCceeEEeCCCCCCCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCC
Q 048419 6 ADTTSFLYNGFLHANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQ 85 (653)
Q Consensus 6 ~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gd 85 (653)
|.+++|+|++|+..||+|+|||++.++|.|+||++..+++|||+|++||+||++.+++++||+|+|+|.|.+.+...+||
T Consensus 1 a~~~sF~~~~F~~~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gd 80 (204)
T d1dhkb_ 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSAV 80 (204)
T ss_dssp CCCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CCS
T ss_pred CccceEECCCCCccCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCCCCc
Confidence 46789999999989999999999988899999999999999999999999999999999999999999999887777899
Q ss_pred ceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCC
Q 048419 86 GLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGN 165 (653)
Q Consensus 86 GlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~ 165 (653)
||||+|+|.... ..++.+||||||+.| |+++|+++...... .
T Consensus 81 Glaf~~~~~~~~---------------------~~~~~~~vefDt~~n---------~~~~d~~~~~~~~~-~------- 122 (204)
T d1dhkb_ 81 GLDFVLVPVQPE---------------------SKGDTVTVEFDTFLS---------RISIDVNNNDIKSV-P------- 122 (204)
T ss_dssp EEEEEEEEC---------------------------CCEEEEEETTTT---------EEEEEETTEEEEEE-E-------
T ss_pred eEEEEecCCCCC---------------------CCCcEeeEeeEcccc---------cccCcccccccccc-c-------
Confidence 999999985421 223569999999886 55555554322111 1
Q ss_pred CCccccccCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcc---cceeeecc
Q 048419 166 NHRIPILLRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLI---TASHNVHG 242 (653)
Q Consensus 166 ~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~~~i~s 242 (653)
..+.+.+|+.++|||+||+.+++|+|++...+ ++..+.|+..+||+.+||++||||||||||.. .|.|+|++
T Consensus 123 ---~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~Ils 197 (204)
T d1dhkb_ 123 ---WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLS 197 (204)
T ss_dssp ---CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEE
T ss_pred ---cccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEE
Confidence 23467899999999999999999999998765 46668899999999999999999999999963 57899999
Q ss_pred eeeee
Q 048419 243 WSISI 247 (653)
Q Consensus 243 Wsf~~ 247 (653)
|+|++
T Consensus 198 WsFss 202 (204)
T d1dhkb_ 198 WSFSS 202 (204)
T ss_dssp EEEEE
T ss_pred EEEEe
Confidence 99985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=379.03 Aligned_cols=263 Identities=26% Similarity=0.319 Sum_probs=196.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeecccc----eeEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----ELLLV 405 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 405 (653)
+.|...+.||+|+||.||+|++. |+.||||++..... ....+..|+..+.+++||||++++++|.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45667889999999999999974 78999999864322 1222345666677889999999999997654 58999
Q ss_pred EeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 406 YDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEEC-----NQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 406 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
||||++|+|.++|.+. .++|.++++++.|+|.||+|||+.. .++|+||||||+||||+.++++||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999753 3899999999999999999999731 3699999999999999999999999999
Q ss_pred CcccccCCCCC---cccccccCCcccCccccccCC------CCCccceeehHHHHHHHHhCCCCCChhhhhhHH------
Q 048419 481 LAKIYEHGANP---QTTHIVGTLGYLAPELTRTGK------ATTSTDVYSYGILMLEVACGRRSIEPQKAAAEL------ 545 (653)
Q Consensus 481 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~------ 545 (653)
+++........ ......||+.|+|||++.... ++.++|||||||+||||+||..|+.........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99977543321 223467999999999987542 577999999999999999998876532211000
Q ss_pred --HHHHHHHhhhcccchhHhhhhcc--CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 546 --LLVDWVKELHLEGEITQAIDQTL--DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 546 --~l~~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
...+........+. .++.+ .....+....+.+|+.+||+.||.+|||+.||++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 00001111110000 11111 0112345577999999999999999999999999885
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=376.92 Aligned_cols=265 Identities=25% Similarity=0.330 Sum_probs=204.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999999999999999996542 2335688999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+.+ ++.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++....
T Consensus 82 ~~~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9965 4545554332 3569999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCCCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc-cc-hhHh-
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE-GE-ITQA- 563 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~-~~~~- 563 (653)
.. .......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+.. .......... .. ....
T Consensus 155 ~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 155 PV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp CS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGG
T ss_pred Cc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HHHHHhcCCCchhhccccc
Confidence 32 2334457999999999876655 578999999999999999999999865443221 1111111100 00 0000
Q ss_pred -hhhc------cCcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 564 -IDQT------LDYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 564 -~d~~------l~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.... ...... .....+.+|+.+||+.||.+|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence 0000 000111 1236788999999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=371.75 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=199.4
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------hhHHHHHHHHHHHhhcC--CCceeeeeeeecccc
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------QGMKEFVAEIMSMGRLR--HRNLVQLHGWCRKQD 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 400 (653)
.++|+..++||+|+||+||+|++..+|+.||||++..... .....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4679999999999999999999999999999999864311 12234678999999997 899999999999999
Q ss_pred eeEEEEeccCC-CCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CcEEEEe
Q 048419 401 ELLLVYDYVPN-GSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTY-LNAKLGD 478 (653)
Q Consensus 401 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D 478 (653)
..++||||+.+ +++.+++... ..+++.+++.++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 5677777553 358999999999999999999999 999999999999999854 7999999
Q ss_pred ecCcccccCCCCCcccccccCCcccCccccccCCC-CCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 479 FGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKA-TTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 479 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
||+++..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ....
T Consensus 155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------~~~~--- 220 (273)
T d1xwsa_ 155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQ--- 220 (273)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------HHCC---
T ss_pred cccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------hhcc---
Confidence 9999875432 2344679999999999987765 56799999999999999999999754321 0000
Q ss_pred cchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 558 GEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 558 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
.. +.+ ..+..+.+|+.+||+.||.+|||++|++++-
T Consensus 221 ~~----~~~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 221 VF----FRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp CC----CSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred cC----CCC-------CCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 00 011 1235688999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4e-44 Score=366.41 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=201.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCc--hhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNS--QQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|...+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57889999999999999999986 58999999996542 3335789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
|+.++.+..+.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp CCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred eehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99877666665433 459999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccch---hHh
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGEI---TQA 563 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~ 563 (653)
.. .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+...-............. ...
T Consensus 153 ~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 153 PV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred Cc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 32 223344689999999998654 5689999999999999999999999865443321111111100000000 000
Q ss_pred h--hhcc--------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 564 I--DQTL--------DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 564 ~--d~~l--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
. +... ..........+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 00111123678899999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=371.17 Aligned_cols=265 Identities=26% Similarity=0.351 Sum_probs=199.7
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCC-CcEEEEEEeccCc--hhhHHHHHHHHHHHhhc---CCCceeeeeeeecc----
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSL-GLEVAIKRIGHNS--QQGMKEFVAEIMSMGRL---RHRNLVQLHGWCRK---- 398 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 398 (653)
.++|+..+.||+|+||+||+|++..+ ++.||||++.... ......+.+|+.+++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999998654 6779999986432 22233456677776665 79999999999853
Q ss_pred -cceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEE
Q 048419 399 -QDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLG 477 (653)
Q Consensus 399 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 477 (653)
...++++|||++++++....... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 34689999999887765544333 3458899999999999999999999 999999999999999999999999
Q ss_pred eecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcc
Q 048419 478 DFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLE 557 (653)
Q Consensus 478 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 557 (653)
|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+... .........
T Consensus 159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~i~~~~~~~ 234 (305)
T d1blxa_ 159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIGLP 234 (305)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCC
T ss_pred chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH--HHHHhhCCC
Confidence 99998865332 23345689999999999999999999999999999999999999998765433221 111111000
Q ss_pred c--chh------Hhhhhc-----cCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 558 G--EIT------QAIDQT-----LDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 558 ~--~~~------~~~d~~-----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
. ... ...... +........+.+.+|+.+||+.||.+|||+.|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 0 000 000000 0011112246688999999999999999999998763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=364.79 Aligned_cols=270 Identities=22% Similarity=0.288 Sum_probs=202.0
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc--------c
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK--------Q 399 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 399 (653)
++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+.+|++++|+|++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788999999999999999999989999999998543 33345678899999999999999999998855 3
Q ss_pred ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 400 DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 400 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
+.+++||||+.++.+..+... ...++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 468999999988766655433 2347888899999999999999999 99999999999999999999999999
Q ss_pred cCcccccCCCC---CcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhh
Q 048419 480 GLAKIYEHGAN---PQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELH 555 (653)
Q Consensus 480 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 555 (653)
|+++....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99986643221 122334699999999998765 68999999999999999999999998655433322221111111
Q ss_pred cccchhHh--------hhhcc-CcCCHH-------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcCC
Q 048419 556 LEGEITQA--------IDQTL-DYYDLA-------EAELVLNLGLFCSAPNPVYRPDMRRVVEFLLGD 607 (653)
Q Consensus 556 ~~~~~~~~--------~d~~l-~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (653)
........ +.... ...... ....+.+|+.+||+.||++|||++|++++-...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 10000000 00000 011111 134677899999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=370.08 Aligned_cols=261 Identities=26% Similarity=0.325 Sum_probs=196.4
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeeeeeeccc------ceeEE
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ------DELLL 404 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 404 (653)
.|...++||+|+||+||+|++..+|+.||||++..... ...+|+++|++++|+||++++++|... .+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 47778999999999999999999999999999965432 224799999999999999999998442 35789
Q ss_pred EEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCcc
Q 048419 405 VYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAK 483 (653)
Q Consensus 405 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~ 483 (653)
|||||+++.+..+...... ...+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++
T Consensus 97 v~Ey~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999987644443322211 3468999999999999999999999 9999999999999999775 89999999998
Q ss_pred cccCCCCCcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--ccch
Q 048419 484 IYEHGANPQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL--EGEI 560 (653)
Q Consensus 484 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~ 560 (653)
....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+... ..++.... ...+
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~--~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV--EIIKVLGTPTREQI 247 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH--HHHHHHCCCCHHHH
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH--HHHHHhCCChHHhh
Confidence 7654332 233579999999998764 568999999999999999999999997655433221 11111000 0000
Q ss_pred hHh----hhhcc---------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 561 TQA----IDQTL---------DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 561 ~~~----~d~~l---------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
... .+... ..........+.+|+.+||+.||.+|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 000 00000 001112345688999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=368.27 Aligned_cols=263 Identities=24% Similarity=0.295 Sum_probs=198.9
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc-----
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----- 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 400 (653)
..++|+..+.||+|+||+||+|.+..+|+.||||++... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 346899999999999999999999999999999999753 3444678899999999999999999999997665
Q ss_pred -eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEee
Q 048419 401 -ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDF 479 (653)
Q Consensus 401 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 479 (653)
.+++||||+ +.+|..++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccc
Confidence 579999999 5577776643 348999999999999999999999 99999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc--
Q 048419 480 GLAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL-- 556 (653)
Q Consensus 480 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 556 (653)
|+++..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||....................
T Consensus 166 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 166 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 999876432 3446799999999998764 568999999999999999999999987654332211111110000
Q ss_pred -----ccchhHhhhhcc--------CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 557 -----EGEITQAIDQTL--------DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 557 -----~~~~~~~~d~~l--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
...........+ ..........+.+|+.+||+.||.+|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 000000000000 001112235678999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=370.38 Aligned_cols=267 Identities=25% Similarity=0.296 Sum_probs=201.3
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-chhhHHHHHHHHHHHhhcCCCceeeeeeeecccc----ee
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQD----EL 402 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 402 (653)
++.+|+..+.||+|+||+||+|++..+|+.||||++... .....+.+++|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356799999999999999999999999999999999754 3445678899999999999999999999986653 23
Q ss_pred EEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCc
Q 048419 403 LLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLA 482 (653)
Q Consensus 403 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 482 (653)
+++++|+.+|+|.+++... .+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 86 ~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 4555667799999999643 38999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCC--CcccccccCCcccCcccccc-CCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc-
Q 048419 483 KIYEHGAN--PQTTHIVGTLGYLAPELTRT-GKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG- 558 (653)
Q Consensus 483 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 558 (653)
+....... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 86543221 22344679999999999854 457889999999999999999999998655433222111111100000
Q ss_pred -------chhHhhhhc--cCcCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048419 559 -------EITQAIDQT--LDYYDLA-----EAELVLNLGLFCSAPNPVYRPDMRRVVEF 603 (653)
Q Consensus 559 -------~~~~~~d~~--l~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (653)
......... ....+.. ...++.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 0111111 12468899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=355.36 Aligned_cols=266 Identities=24% Similarity=0.285 Sum_probs=208.7
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecccceeEEEEe
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 407 (653)
++|+..+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|+.++++++||||++++++|.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999999999999999998644 33456789999999999999999999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecCcccccC
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKIYEH 487 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 487 (653)
++.+++|..++... +.+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999888877653 347889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc---ccch---
Q 048419 488 GANPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL---EGEI--- 560 (653)
Q Consensus 488 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~--- 560 (653)
... ......++..|+|||.+.... ++.++||||+||++|||++|+.||.......+.. ..+..... ....
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH--HHHHHHHCCCCTTTCTTG
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH--HHHHhhcCCCChhhhhhh
Confidence 332 223345778999999887665 6899999999999999999999975443322211 11111110 0000
Q ss_pred hHhhhh----------ccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHcC
Q 048419 561 TQAIDQ----------TLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLLG 606 (653)
Q Consensus 561 ~~~~d~----------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (653)
....+. .+..........+.+|+.+||+.||.+|||++|++++-.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 000000 0011112234678899999999999999999999987543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-42 Score=356.86 Aligned_cols=259 Identities=20% Similarity=0.234 Sum_probs=197.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCceeeee-eeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNLVQLH-GWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lV~E 407 (653)
.++|+..+.||+|+||.||+|++..+|+.||||++..... .+++..|++++++++|+|++..+ ++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3579999999999999999999998999999999865432 24578899999999877765555 44566778899999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCcEEEEeecCccc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLD---TYLNAKLGDFGLAKI 484 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~ 484 (653)
|+ +++|...+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++.
T Consensus 84 ~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred Ec-CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99 55676666543 2458999999999999999999999 9999999999999985 456799999999997
Q ss_pred ccCCCC------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc
Q 048419 485 YEHGAN------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG 558 (653)
Q Consensus 485 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 558 (653)
...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 754321 12344579999999999999999999999999999999999999997654432221111111111011
Q ss_pred chhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 EITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 ~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
..... . . ..+..+.+++..||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~-~---~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 236 PIEVL-C---K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp CHHHH-T---T----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred ChhHh-c---c----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11111 0 1 12356889999999999999999998887765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-42 Score=351.71 Aligned_cols=259 Identities=18% Similarity=0.188 Sum_probs=205.3
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC-CceeeeeeeecccceeEEEEe
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH-RNLVQLHGWCRKQDELLLVYD 407 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 407 (653)
.++|...+.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.|+| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4679999999999999999999998999999999854422 2356788889999975 899999999999999999999
Q ss_pred ccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCcEEEEeecCc
Q 048419 408 YVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDT-----YLNAKLGDFGLA 482 (653)
Q Consensus 408 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla 482 (653)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEccccee
Confidence 99 689999886643 358899999999999999999999 99999999999999964 578999999999
Q ss_pred ccccCCCC------CcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc
Q 048419 483 KIYEHGAN------PQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL 556 (653)
Q Consensus 483 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 556 (653)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 97654321 123345799999999999999999999999999999999999999975543322221111111111
Q ss_pred ccchhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 EGEITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.....++ ... .++++.+++..|++.+|++||+++.+.+.|+
T Consensus 234 ~~~~~~l----~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 234 STPLREL----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HSCHHHH----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CCChHHh----cCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 1111111 111 1356889999999999999999988877664
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=361.69 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=203.3
Q ss_pred cCcCcceeeeeeCcEEEEEEEe---CCCCcEEEEEEeccC----chhhHHHHHHHHHHHhhcCC-Cceeeeeeeecccce
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLM---PSLGLEVAIKRIGHN----SQQGMKEFVAEIMSMGRLRH-RNLVQLHGWCRKQDE 401 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 401 (653)
++|+..+.||+|+||+||+|+. +.+|+.||||++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999986 446899999998643 22335678899999999977 899999999999999
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeecC
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFGL 481 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 481 (653)
.+++|||+.+|+|.+++.... .++......++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999997653 36778889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCcccCccccccC--CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhcccc
Q 048419 482 AKIYEHGANPQTTHIVGTLGYLAPELTRTG--KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEGE 559 (653)
Q Consensus 482 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 559 (653)
++.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... ......
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~---- 249 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRIL---- 249 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHH----
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcc----
Confidence 987654443344456799999999998754 468899999999999999999999976543221110 000000
Q ss_pred hhHhhhhccCcCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048419 560 ITQAIDQTLDYYDLAEAELVLNLGLFCSAPNPVYRP-----DMRRVVEF 603 (653)
Q Consensus 560 ~~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (653)
... ...+......+.+++.+||+.||.+|| |++|++++
T Consensus 250 -----~~~-~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 -----KSE-PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----HCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----cCC-CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 000 011122356788999999999999999 48899874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-41 Score=351.97 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=199.5
Q ss_pred cCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecc--cceeEEEE
Q 048419 330 KGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRK--QDELLLVY 406 (653)
Q Consensus 330 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 406 (653)
++|+..++||+|+||+||+|++..+|+.||||+++... .+.+.+|+++|++++ ||||+++++++.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999999999999999996543 467889999999995 9999999999864 35689999
Q ss_pred eccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-cEEEEeecCcccc
Q 048419 407 DYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYL-NAKLGDFGLAKIY 485 (653)
Q Consensus 407 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~ 485 (653)
|||++++|..+. +.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceec
Confidence 999999997764 238899999999999999999999 9999999999999998655 5999999999876
Q ss_pred cCCCCCcccccccCCcccCccccccCC-CCCccceeehHHHHHHHHhCCCCCChhhhhhHHH--H---------HHHHHh
Q 048419 486 EHGANPQTTHIVGTLGYLAPELTRTGK-ATTSTDVYSYGILMLEVACGRRSIEPQKAAAELL--L---------VDWVKE 553 (653)
Q Consensus 486 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~--l---------~~~~~~ 553 (653)
.... ......+|+.|+|||.+.+.. ++.++||||+||+++||++|+.||.......... + .++...
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5432 234457899999999987654 7899999999999999999999997543321110 0 011111
Q ss_pred hhccc--chhHhhhh--------cc-CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048419 554 LHLEG--EITQAIDQ--------TL-DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFL 604 (653)
Q Consensus 554 ~~~~~--~~~~~~d~--------~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (653)
..... ........ .. ..........+.+|+.+||+.||.+|||++|++++-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 00000 00000000 00 000112246788999999999999999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=357.73 Aligned_cols=262 Identities=21% Similarity=0.252 Sum_probs=195.0
Q ss_pred hcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeecc------cc
Q 048419 329 TKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRK------QD 400 (653)
Q Consensus 329 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 400 (653)
.++|+..++||+|+||+||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999999999999999999654 34455678999999999999999999999854 36
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
.+|+|||||.++.+ +.+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechh
Confidence 78999999976544 4442 237899999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhc----
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHL---- 556 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 556 (653)
+++...... ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||.......... ..+.....
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~--~i~~~~~~~~~~ 240 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCPE 240 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHH
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH--HHHHhccCCCHH
Confidence 988654432 3344578999999999999999999999999999999999999997554322111 11100000
Q ss_pred -----cc---------------chhHhhhhcc----CcCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 557 -----EG---------------EITQAIDQTL----DYYDLAEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 557 -----~~---------------~~~~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.. .......... ..........+.+|+.+||+.||++|||+.|++++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 00 0011111111 0112234577899999999999999999999998753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=355.82 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=200.2
Q ss_pred hhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC--chhhHHHHHHHHHHHhhcCCCceeeeeeeeccc-----c
Q 048419 328 VTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN--SQQGMKEFVAEIMSMGRLRHRNLVQLHGWCRKQ-----D 400 (653)
Q Consensus 328 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 400 (653)
++++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+++|++++|||+|++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 356899999999999999999999999999999999754 334556788999999999999999999988543 3
Q ss_pred eeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcEEEEeec
Q 048419 401 ELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNAKLGDFG 480 (653)
Q Consensus 401 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 480 (653)
..+++++|+.+|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccc
Confidence 456677788899999998543 38999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccCccccccC-CCCCccceeehHHHHHHHHhCCCCCChhhhhhHHHHHHHHHhhhccc-
Q 048419 481 LAKIYEHGANPQTTHIVGTLGYLAPELTRTG-KATTSTDVYSYGILMLEVACGRRSIEPQKAAAELLLVDWVKELHLEG- 558 (653)
Q Consensus 481 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 558 (653)
++..... ......|++.|+|||...+. .++.++||||+||++|||++|+.||...+........ ........
T Consensus 167 ~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i--~~~~~~~~~ 240 (348)
T d2gfsa1 167 LARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI--LRLVGTPGA 240 (348)
T ss_dssp ---CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCH
T ss_pred hhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCCh
Confidence 9975432 23445788999999987665 4688999999999999999999999765443221111 11100000
Q ss_pred --------chhHhhhhcc---CcCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHc
Q 048419 559 --------EITQAIDQTL---DYYDL-----AEAELVLNLGLFCSAPNPVYRPDMRRVVEFLL 605 (653)
Q Consensus 559 --------~~~~~~d~~l---~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (653)
.........+ ..... .....+.+|+.+||+.||.+|||+.|++++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 0000000001 11111 12356889999999999999999999998643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-36 Score=318.94 Aligned_cols=266 Identities=18% Similarity=0.197 Sum_probs=193.5
Q ss_pred CcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-----------CCceeeeeeeeccc
Q 048419 331 GFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-----------HRNLVQLHGWCRKQ 399 (653)
Q Consensus 331 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~ 399 (653)
+|+..++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4889999999999999999999999999999996543 33467788998888875 57899999887654
Q ss_pred --ceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCc----
Q 048419 400 --DELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLN---- 473 (653)
Q Consensus 400 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---- 473 (653)
...+++++++..+........... ...+++..+..++.||++||+|||+. .+|+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence 456677777655544333322211 45678889999999999999999973 78999999999999976653
Q ss_pred --EEEEeecCcccccCCCCCcccccccCCcccCccccccCCCCCccceeehHHHHHHHHhCCCCCChhhhhhH----HHH
Q 048419 474 --AKLGDFGLAKIYEHGANPQTTHIVGTLGYLAPELTRTGKATTSTDVYSYGILMLEVACGRRSIEPQKAAAE----LLL 547 (653)
Q Consensus 474 --~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~s~Gvvl~elltG~~p~~~~~~~~~----~~l 547 (653)
+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||........ ..+
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 999999999865432 2345799999999999999999999999999999999999999975432111 111
Q ss_pred HHHHHhhhccc-ch-------hHhhh--------------------hccCcCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048419 548 VDWVKELHLEG-EI-------TQAID--------------------QTLDYYDLAEAELVLNLGLFCSAPNPVYRPDMRR 599 (653)
Q Consensus 548 ~~~~~~~~~~~-~~-------~~~~d--------------------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 599 (653)
...+....... .. ....+ .............+.+|+.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11111110000 00 00000 0001233456788999999999999999999999
Q ss_pred HHHHHc
Q 048419 600 VVEFLL 605 (653)
Q Consensus 600 vl~~L~ 605 (653)
++++-.
T Consensus 325 ~L~Hp~ 330 (362)
T d1q8ya_ 325 LVNHPW 330 (362)
T ss_dssp HHTCGG
T ss_pred HhcCcc
Confidence 998743
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.96 E-value=1.4e-30 Score=251.99 Aligned_cols=114 Identities=28% Similarity=0.431 Sum_probs=104.6
Q ss_pred CCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCCCCccccccCCCCceEEEEEecCCceEEEEEEeeC
Q 048419 120 STRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGNNHRIPILLRSGDPIQAWVDYSSQEMLINVSICPL 199 (653)
Q Consensus 120 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~ 199 (653)
+|++|||||||++|.+++||++||||||+|++.|.++.+ +++.+|+.++|||+||+.+++|+|++...
T Consensus 1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~------------~~l~~G~~~~v~I~Yd~~~~~L~V~~~~~ 68 (237)
T d1nlsa_ 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAHIIYNSVDKRLSAVVSYP 68 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE------------CCCCTTCEEEEEEEEETTTTEEEEEEECT
T ss_pred CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceec------------ccccCCCEEEEEEEEecCCcEEEEEEecC
Confidence 378999999999999889999999999999999877654 36789999999999999999999999754
Q ss_pred CCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecceeeeec
Q 048419 200 GVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSISIG 248 (653)
Q Consensus 200 ~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~~~ 248 (653)
++..|+++++|||+++|+++||||||||||...|.|+|++|+|++.
T Consensus 69 ---~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~ 114 (237)
T d1nlsa_ 69 ---NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114 (237)
T ss_dssp ---TSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEE
T ss_pred ---CCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEee
Confidence 4677899999999999999999999999999999999999999875
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=1.1e-27 Score=235.29 Aligned_cols=209 Identities=16% Similarity=0.150 Sum_probs=141.2
Q ss_pred eEEeCCCCC-----CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCC
Q 048419 10 SFLYNGFLH-----ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGG 84 (653)
Q Consensus 10 ~f~~~~f~~-----~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g 84 (653)
||..|.+.. .+..++|+|.+. ++.|+||++..+++|+|||++|+++. +|+|+|+|.+... ...+|
T Consensus 10 sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~~--------~F~~~f~f~~~~~-~~~gg 79 (228)
T d1gv9a_ 10 SFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE--------NWEVEVTFRVTGR-GRIGA 79 (228)
T ss_dssp CEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCCS--------SEEEEEEEEEECS-SSCCC
T ss_pred ccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCcccc--------CcEEEEEEeccCC-CCCCC
Confidence 555565532 357899999886 78899999999999999999999983 6999999999764 35689
Q ss_pred CceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccC
Q 048419 85 QGLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSG 164 (653)
Q Consensus 85 dGlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~ 164 (653)
|||||+|++... ..|+.+|..+.. +-+||||||+.|. +|++.+|+.++.|...............
T Consensus 80 dG~aF~i~~~~~----~~g~~~G~~~~~---------~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~~ 144 (228)
T d1gv9a_ 80 DGLAIWYTENQG----LDGPVFGSADMW---------NGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQ 144 (228)
T ss_dssp CEEEEEEESSCC----CEEEETTECSCC---------EEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHH
T ss_pred CEEEEEEecCCC----CCCCccCcCCCC---------ceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCccc
Confidence 999999998643 345556654432 2389999999997 6888889988876533211111000000
Q ss_pred CCCccccc-cCCCCceEEEEEecCCceEEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecce
Q 048419 165 NNHRIPIL-LRSGDPIQAWVDYSSQEMLINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243 (653)
Q Consensus 165 ~~~~~~~~-l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sW 243 (653)
........ ...+..+++||+|+ .+.|+|++..........+.....++ ...+|++||||||||||...+.|.|++|
T Consensus 145 ~~~~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~H~I~s~ 221 (228)
T d1gv9a_ 145 ALASCQRDFRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSF 221 (228)
T ss_dssp CSEEECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEE
T ss_pred cccceeeeecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCeEEEEEE
Confidence 00001111 12345566666665 56788888765544333333333333 5568999999999999999999999999
Q ss_pred eee
Q 048419 244 SIS 246 (653)
Q Consensus 244 sf~ 246 (653)
.+.
T Consensus 222 ~~~ 224 (228)
T d1gv9a_ 222 LTF 224 (228)
T ss_dssp EEE
T ss_pred EEE
Confidence 875
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.90 E-value=1.7e-24 Score=208.94 Aligned_cols=105 Identities=28% Similarity=0.428 Sum_probs=92.2
Q ss_pred cCceeEEeCCCC--CCCeEEecceEecCCCcEEecCCC------CCceEEEEcCCCeecccCCCCceeeeEEEEEEEEec
Q 048419 6 ADTTSFLYNGFL--HANLSLEGAAYISTSGILTVTNKS------EGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILP 77 (653)
Q Consensus 6 ~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~ 77 (653)
++.++|+|++|. .+||+|+|+|++.++|.|+||+.. ..++|||+|++||+|||+ +++++||+|+|+|.|.+
T Consensus 123 sn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~~~~SFsT~F~F~I~~ 201 (237)
T d1nlsa_ 123 TNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKS 201 (237)
T ss_dssp EEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCC
T ss_pred cccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CCcEeeEEEEEEEEEec
Confidence 457999999996 479999999999889999999754 458999999999999996 78999999999999987
Q ss_pred CCCCCCCCceEEEEecCC-CCCCCCCCccccCCCcc
Q 048419 78 KYPDLGGQGLAFIIISTN-RPENCLANQFLGLPNIT 112 (653)
Q Consensus 78 ~~~~~~gdGlaF~l~~~~-~~~~~~~g~~lG~~~~~ 112 (653)
.+ ..+||||||||+|.. ..|.++.|+||||+|.+
T Consensus 202 ~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T d1nlsa_ 202 PD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp SS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred CC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCC
Confidence 65 458999999999965 44778899999999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=5.5e-22 Score=188.59 Aligned_cols=164 Identities=15% Similarity=0.122 Sum_probs=119.9
Q ss_pred CcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCch------------------hhHHHHHHHHHHHhhcCCCceeeeee
Q 048419 333 GEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQ------------------QGMKEFVAEIMSMGRLRHRNLVQLHG 394 (653)
Q Consensus 333 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g 394 (653)
...++||+|+||.||+|.+. +|+.||||+++.... ........|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34689999999999999985 589999998753210 11233456888999999999988876
Q ss_pred eecccceeEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCcE
Q 048419 395 WCRKQDELLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEECNQRVVHRDVKPSNILLDTYLNA 474 (653)
Q Consensus 395 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 474 (653)
+.. .+++|||+++..+.. ++.....+++.|++++|+|||+ ++|+||||||+|||++++ .+
T Consensus 82 ~~~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EET----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EE
T ss_pred ecC----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CE
Confidence 532 379999998754422 4555667899999999999999 999999999999999865 48
Q ss_pred EEEeecCcccccCCCCCcccccccCCcccC------ccccccCCCCCccceeehHHHHH
Q 048419 475 KLGDFGLAKIYEHGANPQTTHIVGTLGYLA------PELTRTGKATTSTDVYSYGILML 527 (653)
Q Consensus 475 kl~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDV~s~Gvvl~ 527 (653)
+|+|||+|+........ .|.. .|.+ ..++..++|+||..--++
T Consensus 142 ~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EECCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred EEEECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 99999999765432111 1111 1111 356788999999765443
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.84 E-value=1.3e-20 Score=182.51 Aligned_cols=196 Identities=12% Similarity=0.100 Sum_probs=126.2
Q ss_pred EEeCCCC-----CCCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCC
Q 048419 11 FLYNGFL-----HANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQ 85 (653)
Q Consensus 11 f~~~~f~-----~~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gd 85 (653)
|++|.+. ..+..+.|+|.+. +|.|+||++ .++.|.+|++.||++++. |+++|+|.|... ...+||
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~~-------f~~~~~F~i~g~-~~~ggd 79 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKDS-------FTMEWTFRSVGY-SGQTDG 79 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCSC-------EEEEEEEEEESC-CSCCSC
T ss_pred ccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccCCC-------eEEEEEEEEeCC-CCCCCC
Confidence 6777662 2579999999987 899999987 578899999999999754 999999999864 345899
Q ss_pred ceEEEEecCCCCCCCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCC
Q 048419 86 GLAFIIISTNRPENCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGN 165 (653)
Q Consensus 86 GlaF~l~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~ 165 (653)
||||++++.... ...|+++|..+.-+. +||||||+.|. ....|+.++.++..-....... . .
T Consensus 80 G~af~~~~~~~~--~~~g~~~G~~~~~~G---------laV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~~--~-~ 141 (221)
T d2a6za1 80 GISFWFVQDSNI--PRDKQLYNGPVNYDG---------LQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIYD--Q-S 141 (221)
T ss_dssp EEEEEEEECSSS--CCCCTBTTBCTTCEE---------EEEEEESCSTT----SSEEEEEEEESSSCCCGGGHHH--H-C
T ss_pred cEEEEEEcCCCc--cccccccccCCCCce---------EEEEEECCCCC----CCceEEEecCCCccccccCCcc--c-c
Confidence 999999975432 234455565443222 89999999873 2222333333332211111100 0 0
Q ss_pred CCccccc-cCCCCceEEEEEecCCce-EEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecce
Q 048419 166 NHRIPIL-LRSGDPIQAWVDYSSQEM-LINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGW 243 (653)
Q Consensus 166 ~~~~~~~-l~~g~~~~~~I~Y~~~~~-~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sW 243 (653)
.+...+. ..++...+++|.|++.++ .|.|.+... +. ..++--.+-++++|+||||+||...+.|.++.+
T Consensus 142 ~~~~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~--------~c-~~~~~v~lp~~~~~fG~SA~TG~~~~~hd~~~i 212 (221)
T d2a6za1 142 FASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK--------VC-FQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEI 212 (221)
T ss_dssp SEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETTE--------EE-EEESCCCCCSSEEEEEEEEECCSGGGCCCEEEE
T ss_pred cceeeecccCCCCCEEEEEEEecCccceEEEEecCc--------Ee-EEECCeecCCCCEEEEEEEccCCccCCCceEEE
Confidence 0111222 235777899999986554 477776321 11 112211122567899999999998888886543
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=5.4e-20 Score=177.35 Aligned_cols=189 Identities=13% Similarity=0.106 Sum_probs=127.7
Q ss_pred CCeEEecceEecCCCcEEecCCCCCceEEEEcCCCeecccCCCCceeeeEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 048419 19 ANLSLEGAAYISTSGILTVTNKSEGLIGHALYPNPLRFKTSNKSVAIDFRTNFVFSILPKYPDLGGQGLAFIIISTNRPE 98 (653)
Q Consensus 19 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~Gr~~y~~pi~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~ 98 (653)
.+..+.|+|.+. +|.|+||++ .++.|++|+..||++++. |+++|+|.|... ...+||||||++++.....
T Consensus 22 ~~W~~~G~~~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~~-------f~i~~~F~i~g~-~~~~~dG~afw~~~~~~~~ 91 (218)
T d2a6va1 22 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIKDA-------MTIEWTFRSFGF-RGSTKGGLAFWLKQGNEGD 91 (218)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCSSC-------EEEEEEEEEESC-CSCCSCEEEEEEECSCCCC
T ss_pred CccEECCCEEEE-CCEEEECCC-CCCeeEEEeCCccccccc-------ceEEEEEEEeCC-CCCCCCcEEEEEEcCCccc
Confidence 689999999986 899999998 467899999999999854 999999999864 3558999999999754322
Q ss_pred CCCCCccccCCCcccCCCCCCCCceEEEEeecccccccCCCCCCeeeEecCCCCcCCcccCccccCC-CCcccc-ccCCC
Q 048419 99 NCLANQFLGLPNITMSSSTKFSTRMLAVEFDIIQNTELIDINDNHVGIDISSLISSASEPASYYSGN-NHRIPI-LLRSG 176 (653)
Q Consensus 99 ~~~~g~~lG~~~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~-~~~~~~-~l~~g 176 (653)
. .++..|..+.-+. +||||||+.|. .+||.+.+|.=. .+.....+. .+...+ ...++
T Consensus 92 ~--~~~~~G~~~~f~G---------laV~fDt~~n~------~~~i~~~~ndGs----~~~~~~~d~~~g~c~~~~~~~~ 150 (218)
T d2a6va1 92 S--TELFGGSSKKFNG---------LMILLRLDDKL------GESVTAYLNDGT----KDLDIESSPYFASCLFQYQDSM 150 (218)
T ss_dssp C--CTBTTTBCSSCEE---------EEEEEEEETTT------EEEEEEEEEESS----SCCCTTTSCCSEEEECCCSSCS
T ss_pred C--CCcccccCCCcce---------EEEEEECCCCC------CCeEEEEeCCCC----ccccccCCcccceEEecccCCC
Confidence 1 2222333222122 89999999874 368888765311 111000010 011111 23467
Q ss_pred CceEEEEEecCCce-EEEEEEeeCCCCCCCCCceeeeecCCcccccceEEeEecccCcccceeeecceeee
Q 048419 177 DPIQAWVDYSSQEM-LINVSICPLGVPKPYRPLISLPIDLSSVIDEYMYTGFSASTGLITASHNVHGWSIS 246 (653)
Q Consensus 177 ~~~~~~I~Y~~~~~-~l~v~~~~~~~~~~~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~~~i~sWsf~ 246 (653)
...+++|.|++.+. .+.|.+. +. ..+-...|+| ..++++|+||||+||...+.|.|++|++.
T Consensus 151 ~~~~~~i~Y~~~~~~~l~v~id--~~----~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~ 213 (218)
T d2a6va1 151 VPSTLRLTYNPLDNHLLKLQMD--NR----VCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLY 213 (218)
T ss_dssp SCEEEEEEEEGGGTSEEEEEET--TE----EEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred CcEEEEEEEECcccceEEEEeC--Cc----EEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEE
Confidence 88999999987653 4677653 11 1111222333 24577999999999999999999999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=3.5e-07 Score=88.98 Aligned_cols=150 Identities=15% Similarity=0.036 Sum_probs=100.7
Q ss_pred HHHHHhhcCcCcceeeeeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcC-CCceeeeeeeecccce
Q 048419 323 AELASVTKGFGEQNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLR-HRNLVQLHGWCRKQDE 401 (653)
Q Consensus 323 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 401 (653)
.|++..-..|+..+..+.+..+.||+... ++..+.||+...........+.+|...+..|. +--+.+++.++...+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35555556666655544444578998764 46678899886554444445678888887774 4346777888888888
Q ss_pred eEEEEeccCCCCchhhhhcccccccccchhhhHHHHHHHHHHHHHHHHhc------------------------------
Q 048419 402 LLLVYDYVPNGSLDKLLFDKDHKLRKLLTWDQRYKILIGIAQSLLYLHEE------------------------------ 451 (653)
Q Consensus 402 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------ 451 (653)
.++||+++++.++.+.... .....+++.++++.+..||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred eEEEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 9999999999877554321 112233444555555555531
Q ss_pred -----------------------C---CCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 452 -----------------------C---NQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 452 -----------------------~---~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
. ...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 12379999999999999877677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.70 E-value=4.9e-05 Score=72.78 Aligned_cols=76 Identities=14% Similarity=0.041 Sum_probs=52.8
Q ss_pred eeeeeCc-EEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCC--CceeeeeeeecccceeEEEEeccCCCC
Q 048419 337 LVGSGGF-GRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRH--RNLVQLHGWCRKQDELLLVYDYVPNGS 413 (653)
Q Consensus 337 ~LG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 413 (653)
.+..|.. +.||+....+ +..+++|....... ..+..|...++.|.. -.+.+++.++.+.+..++|||+++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 4445543 6899988754 66788898754432 245677777777743 335667888888888999999998876
Q ss_pred chh
Q 048419 414 LDK 416 (653)
Q Consensus 414 L~~ 416 (653)
+.+
T Consensus 93 ~~~ 95 (255)
T d1nd4a_ 93 LLS 95 (255)
T ss_dssp TTT
T ss_pred ccc
Confidence 644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=0.00014 Score=74.48 Aligned_cols=78 Identities=12% Similarity=0.042 Sum_probs=48.9
Q ss_pred ceeeeeeCcEEEEEEEeCCCCcEEEEEEeccC-------chhhHHHHHHHHHHHhhcC-C--CceeeeeeeecccceeEE
Q 048419 335 QNLVGSGGFGRVYRGLMPSLGLEVAIKRIGHN-------SQQGMKEFVAEIMSMGRLR-H--RNLVQLHGWCRKQDELLL 404 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l 404 (653)
.+.||.|....||+.....+++.++||.-... -+........|.+.|+.+. + ..+.+++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 45789999999999998777888999975321 1112233456777777663 2 3455666554 344578
Q ss_pred EEeccCCCCc
Q 048419 405 VYDYVPNGSL 414 (653)
Q Consensus 405 V~E~~~~gsL 414 (653)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.45 E-value=0.0061 Score=61.85 Aligned_cols=75 Identities=17% Similarity=0.178 Sum_probs=50.5
Q ss_pred ceeeeeeCcEEEEEEEeCC-------CCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce-eeeeeeecccceeEEEE
Q 048419 335 QNLVGSGGFGRVYRGLMPS-------LGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL-VQLHGWCRKQDELLLVY 406 (653)
Q Consensus 335 ~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 406 (653)
.+.|+.|-.=.+|++.... ....|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4578888888999998653 2356777776532 223345678888888853344 467777653 5799
Q ss_pred eccCCCCch
Q 048419 407 DYVPNGSLD 415 (653)
Q Consensus 407 E~~~~gsL~ 415 (653)
||+++..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.18 E-value=0.0058 Score=60.26 Aligned_cols=137 Identities=13% Similarity=0.055 Sum_probs=76.9
Q ss_pred EEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCce--eeeee-----eecccceeEEEEeccCCCCchh
Q 048419 344 GRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRNL--VQLHG-----WCRKQDELLLVYDYVPNGSLDK 416 (653)
Q Consensus 344 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~ 416 (653)
-.||++... +|..+++|+.+... ...+++..|...+..|....+ +..+. .....+..+.++++++|..+..
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 489999875 48889999986442 234567778888887753322 11111 1233456788999998754321
Q ss_pred ----hhh----------c----ccccccccch-------------------hhhHHHHHHHHHHHHHHHHh----cCCCC
Q 048419 417 ----LLF----------D----KDHKLRKLLT-------------------WDQRYKILIGIAQSLLYLHE----ECNQR 455 (653)
Q Consensus 417 ----~l~----------~----~~~~~~~~l~-------------------~~~~~~i~~~ia~~L~yLH~----~~~~~ 455 (653)
.+. . .....+..++ ...+..+...+.+.+..+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 010 0 0000011111 11111222223333333332 23467
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 456 VVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 456 ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999743 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.79 E-value=0.048 Score=52.86 Aligned_cols=161 Identities=11% Similarity=-0.006 Sum_probs=83.7
Q ss_pred cCHHHHHHhhcCcCcceee-----eeeCcEEEEEEEeCCCCcEEEEEEeccCchhhHHHHHHHHHHHhhcCCCc-----e
Q 048419 320 FKYAELASVTKGFGEQNLV-----GSGGFGRVYRGLMPSLGLEVAIKRIGHNSQQGMKEFVAEIMSMGRLRHRN-----L 389 (653)
Q Consensus 320 f~~~el~~at~~f~~~~~L-----G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-----i 389 (653)
.+.+|++..-+.|...++. ..|---+.|+....+ | .+++|+..... ..++...|+.++..|...+ .
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 5667888888888664443 345556789988753 4 59999985431 1233445666666664322 1
Q ss_pred eeee-e--eecccceeEEEEeccCCCCchhhhhcc--------------------ccccccc----------------ch
Q 048419 390 VQLH-G--WCRKQDELLLVYDYVPNGSLDKLLFDK--------------------DHKLRKL----------------LT 430 (653)
Q Consensus 390 v~l~-g--~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------------~~~~~~~----------------l~ 430 (653)
+... | +.........++.+..+......-... ....... ..
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 1111 1 111233456667666654332211000 0000000 00
Q ss_pred hhhHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEEcCCCcEEEEeecCccc
Q 048419 431 WDQRYKILIGIAQSLLYLH-EECNQRVVHRDVKPSNILLDTYLNAKLGDFGLAKI 484 (653)
Q Consensus 431 ~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 484 (653)
.......+..+...+.-.+ ...+.++||+|+.++||+++.+...-|.||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111122222222222222 13457899999999999999888778999998763
|